activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
,12147106,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCNCC1)N(C(=O)Cc1cccs1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '9.18', 'le': '0.18', 'lle': '-0.11', 'sei': '6.96'}",CHEMBL2180737,,CHEMBL2180737,4.28,False,http://www.openphacts.org/units/Nanomolar,1754042,=,1,True,=,,IC50,nM,,53100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,53.1
,12147112,[],CHEMBL2188253,Inhibition of wild type IDH1 using DL-isocitrate as substrate by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1cscn1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '10.11', 'le': '0.19', 'lle': '-0.65', 'sei': '7.55'}",CHEMBL2180738,,CHEMBL2180738,4.71,False,http://www.openphacts.org/units/Nanomolar,1754043,=,1,True,=,,IC50,nM,,19700.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,19.7
,12147113,[],CHEMBL2188253,Inhibition of wild type IDH1 using DL-isocitrate as substrate by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1ccncc1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '10.26', 'le': '0.19', 'lle': '-0.59', 'sei': '7.57'}",CHEMBL2180739,,CHEMBL2180739,4.71,False,http://www.openphacts.org/units/Nanomolar,1754044,=,1,True,=,,IC50,nM,,19300.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,19.3
,12147114,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)CN)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '12.85', 'le': '0.24', 'lle': '1.49', 'sei': '6.77'}",CHEMBL2180743,,CHEMBL2180743,5.11,False,http://www.openphacts.org/units/Nanomolar,1754048,=,1,True,=,,IC50,nM,,7800.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,7.8
,12147115,[],CHEMBL2188253,Inhibition of wild type IDH1 using DL-isocitrate as substrate by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1C(C(=O)NC1CCCC1)N(C(=O)Cc1cccs1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '11.35', 'le': '0.22', 'lle': '-0.46', 'sei': '10.35'}",CHEMBL2180746,,CHEMBL2180746,5.11,False,http://www.openphacts.org/units/Nanomolar,1754051,=,1,True,=,,IC50,nM,,7700.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,7.7
,12147116,[],CHEMBL2188253,Inhibition of wild type IDH1 using DL-isocitrate as substrate by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1c[nH]c2ccccc12)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '10.45', 'le': '0.19', 'lle': '-1.18', 'sei': '7.98'}",CHEMBL2180740,,CHEMBL2180740,5.20,False,http://www.openphacts.org/units/Nanomolar,1754045,=,1,True,=,,IC50,nM,,6300.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,6.3
,12147117,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)CN1CCNCC1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '11.25', 'le': '0.21', 'lle': '1.69', 'sei': '8.11'}",CHEMBL2180397,,CHEMBL2180397,5.25,False,http://www.openphacts.org/units/Nanomolar,1753626,=,1,True,=,,IC50,nM,,5640.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,5.64
,12147119,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,CN(C(=O)C(c1ccccc1)N(C(=O)Cc1cccs1)c1cccc(F)c1)C1CCCCC1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '11.72', 'le': '0.23', 'lle': '-0.56', 'sei': '13.40'}",CHEMBL2180751,,CHEMBL2180751,5.44,False,http://www.openphacts.org/units/Nanomolar,1754056,=,1,True,=,,IC50,nM,,3600.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,3.6
,12147120,[],CHEMBL2188253,Inhibition of wild type IDH1 using DL-isocitrate as substrate by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1cccs1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '11.92', 'le': '0.23', 'lle': '-0.42', 'sei': '11.21'}",CHEMBL2180730,,CHEMBL2180730,5.54,False,http://www.openphacts.org/units/Nanomolar,1754035,=,1,True,=,,IC50,nM,,2900.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,2.9
,12147121,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CC1)N(C(=O)Cc1cccs1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '13.11', 'le': '0.25', 'lle': '0.75', 'sei': '11.21'}",CHEMBL2180733,,CHEMBL2180733,5.54,False,http://www.openphacts.org/units/Nanomolar,1754038,=,1,True,=,,IC50,nM,,2880.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,2.88
,12147122,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NCc1ccccc1)N(C(=O)Cc1cccs1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '12.16', 'le': '0.23', 'lle': '-0.09', 'sei': '11.63'}",CHEMBL2180735,,CHEMBL2180735,5.75,False,http://www.openphacts.org/units/Nanomolar,1754040,=,1,True,=,,IC50,nM,,1800.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.8
,12147123,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)CN1CCCC1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '12.82', 'le': '0.24', 'lle': '1.04', 'sei': '10.99'}",CHEMBL2180395,,CHEMBL2180395,5.79,False,http://www.openphacts.org/units/Nanomolar,1753624,=,1,True,=,,IC50,nM,,1630.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.63
,12147124,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,CC(C(=O)NC1CCCCC1)(c1ccccc1)N(C(=O)Cc1cccs1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '12.60', 'le': '0.24', 'lle': '0.02', 'sei': '11.85'}",CHEMBL2180750,,CHEMBL2180750,5.85,False,http://www.openphacts.org/units/Nanomolar,1754055,=,1,True,=,,IC50,nM,,1400.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.4
,12147125,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)CNC1CCCCC1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '12.29', 'le': '0.23', 'lle': '0.32', 'sei': '9.60'}",CHEMBL2180392,,CHEMBL2180392,5.90,False,http://www.openphacts.org/units/Nanomolar,1753621,=,1,True,=,,IC50,nM,,1270.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.27
,12147126,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1cncnc1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '12.94', 'le': '0.24', 'lle': '1.27', 'sei': '7.92'}",CHEMBL2180741,,CHEMBL2180741,5.96,False,http://www.openphacts.org/units/Nanomolar,1754046,=,1,True,=,,IC50,nM,,1100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.1
,12147128,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)CCl)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '14.50', 'le': '0.28', 'lle': '1.15', 'sei': '12.24'}",CHEMBL2180742,,CHEMBL2180742,6.05,False,http://www.openphacts.org/units/Nanomolar,1754047,=,1,True,=,,IC50,nM,,900.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.9
,12147129,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC(C)(C)C)N(C(=O)Cc1cccs1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '13.83', 'le': '0.27', 'lle': '0.64', 'sei': '12.28'}",CHEMBL2180732,,CHEMBL2180732,6.07,False,http://www.openphacts.org/units/Nanomolar,1754037,=,1,True,=,,IC50,nM,,860.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.86
,12147131,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCOCC1)N(C(=O)Cc1cccs1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '13.27', 'le': '0.26', 'lle': '1.38', 'sei': '10.56'}",CHEMBL2180736,,CHEMBL2180736,6.19,False,http://www.openphacts.org/units/Nanomolar,1754041,=,1,True,=,,IC50,nM,,640.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.64
,12147132,[],CHEMBL2188258,Inhibition of IDH1 R132H mutant expressed in human U87 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,Cc1ccccc1C(C(=O)NC1CCCC1)N(C(=O)Cc1cccs1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '13.84', 'le': '0.27', 'lle': '0.67', 'sei': '12.62'}",CHEMBL2180746,,CHEMBL2180746,6.24,False,http://www.openphacts.org/units/Nanomolar,1754051,=,1,True,=,,IC50,nM,,580.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.58
,12147133,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1NC(=O)C(c1ccccc1C)N(C(=O)Cc1cccs1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '13.21', 'le': '0.25', 'lle': '-0.22', 'sei': '12.64'}",CHEMBL2180734,,CHEMBL2180734,6.24,False,http://www.openphacts.org/units/Nanomolar,1754039,=,1,True,=,,IC50,nM,,570.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.57
,12147134,[],CHEMBL2188255,Inhibition of IDH1 R132C mutant overexpressed in human HT1080 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1ccnc1C)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '13.66', 'le': '0.25', 'lle': '1.46', 'sei': '9.40'}",CHEMBL2180727,,CHEMBL2180727,6.32,False,http://www.openphacts.org/units/Nanomolar,1754032,=,1,True,=,,IC50,nM,,480.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.48
,12147135,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)CNC1CCCC1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '13.63', 'le': '0.25', 'lle': '1.16', 'sei': '10.33'}",CHEMBL2180745,,CHEMBL2180745,6.35,False,http://www.openphacts.org/units/Nanomolar,1754050,=,1,True,=,,IC50,nM,,450.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.45
,12147136,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1cccn1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '14.22', 'le': '0.26', 'lle': '1.83', 'sei': '9.48'}",CHEMBL2180399,,CHEMBL2180399,6.38,False,http://www.openphacts.org/units/Nanomolar,1753628,=,1,True,=,,IC50,nM,,420.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.42
,12147137,[],CHEMBL2188255,Inhibition of IDH1 R132C mutant overexpressed in human HT1080 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,Cc1ccccc1C(C(=O)NC1CCCC1)N(C(=O)Cc1cccs1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '14.22', 'le': '0.27', 'lle': '0.84', 'sei': '12.97'}",CHEMBL2180746,,CHEMBL2180746,6.41,False,http://www.openphacts.org/units/Nanomolar,1754051,=,1,True,=,,IC50,nM,,390.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.39
,12147138,[],CHEMBL2188258,Inhibition of IDH1 R132H mutant expressed in human U87 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1ccc2ccccc21)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '12.93', 'le': '0.24', 'lle': '0.12', 'sei': '11.84'}",CHEMBL2180729,,CHEMBL2180729,6.43,False,http://www.openphacts.org/units/Nanomolar,1754034,=,1,True,=,,IC50,nM,,370.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.37
,12147139,[],CHEMBL2188258,Inhibition of IDH1 R132H mutant expressed in human U87 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1c[nH]c2ccccc12)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '12.95', 'le': '0.24', 'lle': '0.06', 'sei': '9.88'}",CHEMBL2180740,,CHEMBL2180740,6.44,False,http://www.openphacts.org/units/Nanomolar,1754045,=,1,True,=,,IC50,nM,,360.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.36
,12147140,[],CHEMBL2188258,Inhibition of IDH1 R132H mutant expressed in human U87 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1cscn1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '14.04', 'le': '0.27', 'lle': '1.18', 'sei': '10.49'}",CHEMBL2180738,,CHEMBL2180738,6.54,False,http://www.openphacts.org/units/Nanomolar,1754043,=,1,True,=,,IC50,nM,,290.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.29
,12147141,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCC1)N(C(=O)Cc1cccs1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '14.98', 'le': '0.29', 'lle': '1.36', 'sei': '13.23'}",CHEMBL2180731,,CHEMBL2180731,6.54,False,http://www.openphacts.org/units/Nanomolar,1754036,=,1,True,=,,IC50,nM,,290.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.29
,12147142,[],CHEMBL2188255,Inhibition of IDH1 R132C mutant overexpressed in human HT1080 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1ccncc1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '14.33', 'le': '0.26', 'lle': '1.29', 'sei': '10.57'}",CHEMBL2180739,,CHEMBL2180739,6.58,False,http://www.openphacts.org/units/Nanomolar,1754044,=,1,True,=,,IC50,nM,,260.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.26
,12147143,[],CHEMBL2188258,Inhibition of IDH1 R132H mutant expressed in human U87 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1c(C)nc2ccccc21)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '12.91', 'le': '0.24', 'lle': '0.60', 'sei': '9.85'}",CHEMBL2180728,,CHEMBL2180728,6.62,False,http://www.openphacts.org/units/Nanomolar,1754033,=,1,True,=,,IC50,nM,,240.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.24
,12147144,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)CN1CCOCC1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '14.16', 'le': '0.27', 'lle': '2.63', 'sei': '10.70'}",CHEMBL2180396,,CHEMBL2180396,6.62,False,http://www.openphacts.org/units/Nanomolar,1753625,=,1,True,=,,IC50,nM,,240.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.24
,12147145,[],CHEMBL2188255,Inhibition of IDH1 R132C mutant overexpressed in human HT1080 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1cscn1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '14.30', 'le': '0.28', 'lle': '1.30', 'sei': '10.69'}",CHEMBL2180738,,CHEMBL2180738,6.66,False,http://www.openphacts.org/units/Nanomolar,1754043,=,1,True,=,,IC50,nM,,220.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.22
,12147146,[],CHEMBL2188258,Inhibition of IDH1 R132H mutant expressed in human U87 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1ccncc1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '14.53', 'le': '0.27', 'lle': '1.38', 'sei': '10.72'}",CHEMBL2180739,,CHEMBL2180739,6.68,False,http://www.openphacts.org/units/Nanomolar,1754044,=,1,True,=,,IC50,nM,,210.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.21
,12147147,[],CHEMBL2188258,Inhibition of IDH1 R132H mutant expressed in human U87 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1cccs1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '14.47', 'le': '0.28', 'lle': '0.76', 'sei': '13.60'}",CHEMBL2180730,,CHEMBL2180730,6.72,False,http://www.openphacts.org/units/Nanomolar,1754035,=,1,True,=,,IC50,nM,,190.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.19
,12147148,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)CNC1CC1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '15.36', 'le': '0.29', 'lle': '2.31', 'sei': '10.94'}",CHEMBL2180744,,CHEMBL2180744,6.72,False,http://www.openphacts.org/units/Nanomolar,1754049,=,1,True,=,,IC50,nM,,190.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.19
,12147149,[],CHEMBL2188255,Inhibition of IDH1 R132C mutant overexpressed in human HT1080 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1ccc2ccccc21)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '13.60', 'le': '0.25', 'lle': '0.46', 'sei': '12.46'}",CHEMBL2180729,,CHEMBL2180729,6.77,False,http://www.openphacts.org/units/Nanomolar,1754034,=,1,True,=,,IC50,nM,,170.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.17
,12147150,[],CHEMBL2188256,Inhibition of IDH1 R132C mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1ccnc1C)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '14.69', 'le': '0.27', 'lle': '1.94', 'sei': '10.11'}",CHEMBL2180727,,CHEMBL2180727,6.80,True,http://www.openphacts.org/units/Nanomolar,1754032,=,1,True,=,,IC50,nM,,160.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.16
,12147151,[],CHEMBL2188255,Inhibition of IDH1 R132C mutant overexpressed in human HT1080 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1cccs1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '14.69', 'le': '0.28', 'lle': '0.86', 'sei': '13.81'}",CHEMBL2180730,,CHEMBL2180730,6.82,False,http://www.openphacts.org/units/Nanomolar,1754035,=,1,True,=,,IC50,nM,,150.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.15
,12147152,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1cncn1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '15.25', 'le': '0.28', 'lle': '2.90', 'sei': '8.55'}",CHEMBL2180400,,CHEMBL2180400,6.85,False,http://www.openphacts.org/units/Nanomolar,1753629,=,1,True,=,,IC50,nM,,140.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.14
,12147153,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)CN1CCc2ccccc21)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '13.72', 'le': '0.25', 'lle': '1.13', 'sei': '13.02'}",CHEMBL2180398,,CHEMBL2180398,6.85,False,http://www.openphacts.org/units/Nanomolar,1753627,=,1,True,=,,IC50,nM,,140.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.14
,12147154,[],CHEMBL2188255,Inhibition of IDH1 R132C mutant overexpressed in human HT1080 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1c(C)nc2ccccc21)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '13.57', 'le': '0.25', 'lle': '0.94', 'sei': '10.35'}",CHEMBL2180728,,CHEMBL2180728,6.96,False,http://www.openphacts.org/units/Nanomolar,1754033,=,1,True,=,,IC50,nM,,110.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.11
,12147155,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1cscn1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '15.03', 'le': '0.29', 'lle': '1.64', 'sei': '11.24'}",CHEMBL2180738,,CHEMBL2180738,7.00,False,http://www.openphacts.org/units/Nanomolar,1754043,=,1,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.1
,12147156,[],CHEMBL2188255,Inhibition of IDH1 R132C mutant overexpressed in human HT1080 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1c[nH]c2ccccc12)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '14.16', 'le': '0.26', 'lle': '0.67', 'sei': '10.81'}",CHEMBL2180740,,CHEMBL2180740,7.05,False,http://www.openphacts.org/units/Nanomolar,1754045,=,1,True,=,,IC50,nM,,90.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.09
,12147157,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCC1)N(C(=O)Cc1cccs1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '15.64', 'le': '0.30', 'lle': '1.48', 'sei': '14.26'}",CHEMBL2180746,,CHEMBL2180746,7.05,False,http://www.openphacts.org/units/Nanomolar,1754051,=,1,True,=,,IC50,nM,,90.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.09
,12147158,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1c(C)nc2ccccc21)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '13.84', 'le': '0.26', 'lle': '1.08', 'sei': '10.56'}",CHEMBL2180728,,CHEMBL2180728,7.10,False,http://www.openphacts.org/units/Nanomolar,1754033,=,1,True,=,,IC50,nM,,80.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.08
,12147159,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)CN(C)c1ccccc1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '14.55', 'le': '0.27', 'lle': '1.31', 'sei': '13.48'}",CHEMBL2180394,,CHEMBL2180394,7.10,False,http://www.openphacts.org/units/Nanomolar,1753623,=,1,True,=,,IC50,nM,,80.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.08
,12147160,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,O=C(NC1CCCCC1)C(c1ccccc1)N(C(=O)Cc1cccs1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '15.75', 'le': '0.30', 'lle': '1.45', 'sei': '14.36'}",CHEMBL2180747,,CHEMBL2180747,7.10,False,http://www.openphacts.org/units/Nanomolar,1754052,=,1,True,=,,IC50,nM,,80.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.08
,12147161,[],CHEMBL2188258,Inhibition of IDH1 R132H mutant expressed in human U87 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1ccnc1C)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '15.47', 'le': '0.29', 'lle': '2.29', 'sei': '10.64'}",CHEMBL2180727,,CHEMBL2180727,7.16,True,http://www.openphacts.org/units/Nanomolar,1754032,=,1,True,=,,IC50,nM,,70.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.07
,12147162,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1ccc2ccccc21)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '14.38', 'le': '0.26', 'lle': '0.84', 'sei': '13.17'}",CHEMBL2180729,,CHEMBL2180729,7.16,False,http://www.openphacts.org/units/Nanomolar,1754034,=,1,True,=,,IC50,nM,,70.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.07
,12147163,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1ccnc1C)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '15.47', 'le': '0.29', 'lle': '2.29', 'sei': '10.64'}",CHEMBL2180727,,CHEMBL2180727,7.16,True,http://www.openphacts.org/units/Nanomolar,1754032,=,1,True,=,,IC50,nM,,70.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.07
,12147164,[],CHEMBL2188256,Inhibition of IDH1 R132C mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1cscn1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '15.51', 'le': '0.30', 'lle': '1.86', 'sei': '11.59'}",CHEMBL2180738,,CHEMBL2180738,7.22,False,http://www.openphacts.org/units/Nanomolar,1754043,=,1,True,=,,IC50,nM,,60.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.06
,12147165,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)CNc1ccccc1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '15.25', 'le': '0.28', 'lle': '1.45', 'sei': '11.75'}",CHEMBL2180393,,CHEMBL2180393,7.22,False,http://www.openphacts.org/units/Nanomolar,1753622,=,1,True,=,,IC50,nM,,60.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.06
,12147166,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1c[nH]c2ccccc12)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '14.51', 'le': '0.27', 'lle': '0.84', 'sei': '11.08'}",CHEMBL2180740,,CHEMBL2180740,7.22,False,http://www.openphacts.org/units/Nanomolar,1754045,=,1,True,=,,IC50,nM,,60.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.06
,12147167,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,O=C(NC1CCCCC1)[C@H](c1ccccc1)N(C(=O)Cc1cccs1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '16.03', 'le': '0.31', 'lle': '1.57', 'sei': '14.62'}",CHEMBL2180748,,CHEMBL2180748,7.22,False,http://www.openphacts.org/units/Nanomolar,1754053,=,1,True,=,,IC50,nM,,60.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.06
,12147168,[],CHEMBL2188256,Inhibition of IDH1 R132C mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1ccncc1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '15.89', 'le': '0.29', 'lle': '2.00', 'sei': '11.72'}",CHEMBL2180739,,CHEMBL2180739,7.30,False,http://www.openphacts.org/units/Nanomolar,1754044,=,1,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.05
,12147169,[],CHEMBL2188256,Inhibition of IDH1 R132C mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCC1)N(C(=O)Cc1cccs1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '16.20', 'le': '0.31', 'lle': '1.73', 'sei': '14.78'}",CHEMBL2180746,,CHEMBL2180746,7.30,False,http://www.openphacts.org/units/Nanomolar,1754051,=,1,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.05
,12147170,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1ccncc1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '15.89', 'le': '0.29', 'lle': '2.00', 'sei': '11.72'}",CHEMBL2180739,,CHEMBL2180739,7.30,False,http://www.openphacts.org/units/Nanomolar,1754044,=,1,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.05
,12147171,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1cccs1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '15.71', 'le': '0.30', 'lle': '1.34', 'sei': '14.78'}",CHEMBL2180730,,CHEMBL2180730,7.30,False,http://www.openphacts.org/units/Nanomolar,1754035,=,1,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.05
,12147172,[],CHEMBL2188256,Inhibition of IDH1 R132C mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1ccc2ccccc21)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '14.87', 'le': '0.27', 'lle': '1.09', 'sei': '13.61'}",CHEMBL2180729,,CHEMBL2180729,7.40,False,http://www.openphacts.org/units/Nanomolar,1754034,=,1,True,=,,IC50,nM,,40.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.04
,12147173,[],CHEMBL2188256,Inhibition of IDH1 R132C mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1c(C)nc2ccccc21)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '14.43', 'le': '0.27', 'lle': '1.38', 'sei': '11.00'}",CHEMBL2180728,,CHEMBL2180728,7.40,False,http://www.openphacts.org/units/Nanomolar,1754033,=,1,True,=,,IC50,nM,,40.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.04
,12147174,[],CHEMBL2188256,Inhibition of IDH1 R132C mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1c[nH]c2ccccc12)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '15.12', 'le': '0.28', 'lle': '1.14', 'sei': '11.54'}",CHEMBL2180740,,CHEMBL2180740,7.52,False,http://www.openphacts.org/units/Nanomolar,1754045,=,1,True,=,,IC50,nM,,30.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.03
,12147175,[],CHEMBL2188256,Inhibition of IDH1 R132C mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cc1cccs1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,"{'bei': '16.19', 'le': '0.31', 'lle': '1.56', 'sei': '15.23'}",CHEMBL2180730,,CHEMBL2180730,7.52,False,http://www.openphacts.org/units/Nanomolar,1754035,=,1,True,=,,IC50,nM,,30.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.03
,12147192,[],CHEMBL2188253,Inhibition of wild type IDH1 using DL-isocitrate as substrate by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1ccc2ccccc21)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,,CHEMBL2180729,,CHEMBL2180729,,False,http://www.openphacts.org/units/Nanomolar,1754034,>,1,True,>,,IC50,nM,,100000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,100.0
,12147193,[],CHEMBL2188253,Inhibition of wild type IDH1 using DL-isocitrate as substrate by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1c(C)nc2ccccc21)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,,CHEMBL2180728,,CHEMBL2180728,,False,http://www.openphacts.org/units/Nanomolar,1754033,>,1,True,>,,IC50,nM,,100000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,100.0
,12147194,[],CHEMBL2188253,Inhibition of wild type IDH1 using DL-isocitrate as substrate by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1ccnc1C)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,,CHEMBL2180727,,CHEMBL2180727,,False,http://www.openphacts.org/units/Nanomolar,1754032,>,1,True,>,,IC50,nM,,100000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,100.0
,12147195,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(CCc1cccs1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,,CHEMBL2180753,,CHEMBL2180753,,False,http://www.openphacts.org/units/Nanomolar,1754058,>,1,True,>,,IC50,nM,,100000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,100.0
,12147196,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(CNC1CCCCC1)N(C(=O)Cc1cccs1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,,CHEMBL2180752,,CHEMBL2180752,,False,http://www.openphacts.org/units/Nanomolar,1754057,>,1,True,>,,IC50,nM,,100000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,100.0
,12147197,[],CHEMBL2188262,Inhibition of IDH1 R132H mutant using alpha-ketoglutarate as substrate after 60 mins by resazurin-based fluorimetric analysis,B,BAO_0000190,BAO_0000019,assay format,O=C(NC1CCCCC1)[C@@H](c1ccccc1)N(C(=O)Cc1cccs1)c1cccc(F)c1,,,CHEMBL2176947,ACS Med. Chem. Lett.,2012.0,,CHEMBL2180749,,CHEMBL2180749,,False,http://www.openphacts.org/units/Nanomolar,1754054,>,1,True,>,,IC50,nM,,11000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,11.0
,15068438,[],CHEMBL3389009,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in D2HG production incubated for 48 hrs by HPLC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,OC1C=CC(Cc2ccccc2)=CN1O,,,CHEMBL3351758,J. Med. Chem.,2014.0,"{'bei': '27.65', 'le': '0.51', 'lle': '3.93', 'sei': '12.86'}",CHEMBL2386125,,CHEMBL2386125,5.62,False,http://www.openphacts.org/units/Nanomolar,2274978,=,1,True,=,,IC50,nM,,2400.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,2.4
,15068439,[],CHEMBL3389009,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in D2HG production incubated for 48 hrs by HPLC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,O=c1cccc(Cc2ccccc2)n1O,,,CHEMBL3351758,J. Med. Chem.,2014.0,"{'bei': '25.20', 'le': '0.46', 'lle': '3.39', 'sei': '12.01'}",CHEMBL2386128,,CHEMBL2386128,5.07,False,http://www.openphacts.org/units/Nanomolar,2274986,=,1,True,=,,IC50,nM,,8500.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,8.5
Not Determined,15068440,[],CHEMBL3389009,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in D2HG production incubated for 48 hrs by HPLC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,O=C(NO)c1cccc(=O)n1O,,,CHEMBL3351758,J. Med. Chem.,2014.0,,CHEMBL3343434,,CHEMBL3343434,,False,,2274990,,1,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
,15068441,[],CHEMBL3389009,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in D2HG production incubated for 48 hrs by HPLC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(Cc2ccccc2)n(O)c(=O)c1,,,CHEMBL3351758,J. Med. Chem.,2014.0,,CHEMBL2386126,,CHEMBL2386126,,False,http://www.openphacts.org/units/Nanomolar,2274992,>,1,True,>,,IC50,nM,,30000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,30.0
Not Determined,15068442,[],CHEMBL3389009,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in D2HG production incubated for 48 hrs by HPLC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)c1cc(Cc2ccccc2)n(O)c(=O)c1,,,CHEMBL3351758,J. Med. Chem.,2014.0,,CHEMBL2386129,,CHEMBL2386129,,False,,2274998,,1,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
,15068443,[],CHEMBL3389009,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in D2HG production incubated for 48 hrs by HPLC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,O=c1cc(O)cc(Cc2ccccc2)n1O,,,CHEMBL3351758,J. Med. Chem.,2014.0,,CHEMBL3343439,,CHEMBL3343439,,False,http://www.openphacts.org/units/Nanomolar,2274999,>,1,True,>,,IC50,nM,,30000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,30.0
,15068444,[],CHEMBL3389009,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in D2HG production incubated for 48 hrs by HPLC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(Cc2ccc(O)cc2)n(O)c(=O)c1,,,CHEMBL3351758,J. Med. Chem.,2014.0,"{'bei': '21.68', 'le': '0.40', 'lle': '3.32', 'sei': '8.03'}",CHEMBL2386127,,CHEMBL2386127,5.01,False,http://www.openphacts.org/units/Nanomolar,2275004,=,1,True,=,,IC50,nM,,9700.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,9.7
,15068445,[],CHEMBL3389009,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in D2HG production incubated for 48 hrs by HPLC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,COc1cccc(Cc2cc(C)cc(=O)n2O)c1,,,CHEMBL3351758,J. Med. Chem.,2014.0,"{'bei': '24.29', 'le': '0.45', 'lle': '3.97', 'sei': '11.58'}",CHEMBL3343444,,CHEMBL3343444,5.96,False,http://www.openphacts.org/units/Nanomolar,2275005,=,1,True,=,,IC50,nM,,1100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.1
,15068446,[],CHEMBL3389009,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in D2HG production incubated for 48 hrs by HPLC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(Cc2cccc(O)c2)n(O)c(=O)c1,,,CHEMBL3351758,J. Med. Chem.,2014.0,"{'bei': '23.44', 'le': '0.44', 'lle': '3.73', 'sei': '8.68'}",CHEMBL3343445,,CHEMBL3343445,5.42,False,http://www.openphacts.org/units/Nanomolar,2275006,=,1,True,=,,IC50,nM,,3800.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,3.8
,15068447,[],CHEMBL3389009,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in D2HG production incubated for 48 hrs by HPLC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(-c2ccc(Cc3cc(C)cc(=O)n3O)cc2)cc1,,,CHEMBL3351758,J. Med. Chem.,2014.0,"{'bei': '18.54', 'le': '0.34', 'lle': '2.30', 'sei': '11.58'}",CHEMBL3343462,,CHEMBL3343462,5.96,False,http://www.openphacts.org/units/Nanomolar,2275024,=,1,True,=,,IC50,nM,,1100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.1
,15068448,[],CHEMBL3389009,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in D2HG production incubated for 48 hrs by HPLC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(Cc2ccc(-c3ccc(O)cc3)cc2)n(O)c(=O)c1,,,CHEMBL3351758,J. Med. Chem.,2014.0,"{'bei': '17.88', 'le': '0.33', 'lle': '2.13', 'sei': '8.80'}",CHEMBL3343463,,CHEMBL3343463,5.50,False,http://www.openphacts.org/units/Nanomolar,2275025,=,1,True,=,,IC50,nM,,3200.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,3.2
,15068449,[],CHEMBL3389009,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in D2HG production incubated for 48 hrs by HPLC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,COc1cccc(-c2ccc(Cc3cc(C)cc(=O)n3O)cc2)c1,,,CHEMBL3351758,J. Med. Chem.,2014.0,"{'bei': '16.18', 'le': '0.30', 'lle': '1.54', 'sei': '10.11'}",CHEMBL3343464,,CHEMBL3343464,5.20,False,http://www.openphacts.org/units/Nanomolar,2275026,=,1,True,=,,IC50,nM,,6300.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,6.3
,15093220,[],CHEMBL3385094,Inhibition of IDH1 R132H mutant (unknown origin) using a-ketoglutarate as substrate by fluorescence biochemical assay,B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@]2(C)C2CC2)n1)c1ccc(CN2CCC(N)CC2)c(F)c1,,,CHEMBL3352118,ACS Med. Chem. Lett.,2014.0,"{'bei': '14.32', 'le': '0.27', 'lle': '2.87', 'sei': '6.95'}",CHEMBL3342784,,CHEMBL3342784,6.71,False,http://www.openphacts.org/units/Nanomolar,2252025,=,1,True,=,,IC50,nM,,194.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.194
,15093221,[],CHEMBL3385094,Inhibition of IDH1 R132H mutant (unknown origin) using a-ketoglutarate as substrate by fluorescence biochemical assay,B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@]2(C)C2CC2)n1)c1ccc(CN2CCC(O)(C(F)(F)F)CC2)cc1F,,,CHEMBL3352118,ACS Med. Chem. Lett.,2014.0,,CHEMBL3342783,,CHEMBL3342783,,False,http://www.openphacts.org/units/Nanomolar,2252024,<,1,True,<,,IC50,nM,,15.9,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.0159
,15093222,[],CHEMBL3385094,Inhibition of IDH1 R132H mutant (unknown origin) using a-ketoglutarate as substrate by fluorescence biochemical assay,B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2C2CC2)n1)c1cn(-c2ccc(F)cc2)cn1,,,CHEMBL3352118,ACS Med. Chem. Lett.,2014.0,"{'bei': '18.38', 'le': '0.36', 'lle': '3.78', 'sei': '9.56'}",CHEMBL3342782,,CHEMBL3342782,8.14,False,http://www.openphacts.org/units/Nanomolar,2252023,=,1,True,=,,IC50,nM,,7.27,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.00727
,15093223,[],CHEMBL3385094,Inhibition of IDH1 R132H mutant (unknown origin) using a-ketoglutarate as substrate by fluorescence biochemical assay,B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(N2C(=O)OC[C@@H]2C2CC2)nc(N[C@@H](C)c2cn(-c3ccc(Cl)cc3)cn2)n1,,,CHEMBL3352118,ACS Med. Chem. Lett.,2014.0,"{'bei': '17.68', 'le': '0.34', 'lle': '3.23', 'sei': '9.11'}",CHEMBL3342781,,CHEMBL3342781,7.76,False,http://www.openphacts.org/units/Nanomolar,2252022,=,1,True,=,,IC50,nM,,17.4,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.0174
,15093224,[],CHEMBL3385093,Inhibition of IDH1 R132H mutant (unknown origin) assessed as inhibition of [3C]2-hydroxyglutarate formation after 45 mins by LC-MS biochemical assay,B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@]2(C)C2CC2)n1)c1ccc(CN2CCC(N)CC2)c(F)c1,,,CHEMBL3352118,ACS Med. Chem. Lett.,2014.0,"{'bei': '13.71', 'le': '0.26', 'lle': '2.58', 'sei': '6.65'}",CHEMBL3342784,,CHEMBL3342784,6.42,False,http://www.openphacts.org/units/Nanomolar,2252025,=,1,True,=,,IC50,nM,,376.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.376
,15093225,[],CHEMBL3385093,Inhibition of IDH1 R132H mutant (unknown origin) assessed as inhibition of [3C]2-hydroxyglutarate formation after 45 mins by LC-MS biochemical assay,B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(N2C(=O)OC[C@@H]2C2CC2)nc(N[C@@H](C)c2cn(-c3ccc(Cl)cc3)cn2)n1,,,CHEMBL3352118,ACS Med. Chem. Lett.,2014.0,"{'bei': '18.39', 'le': '0.36', 'lle': '3.54', 'sei': '9.48'}",CHEMBL3342781,,CHEMBL3342781,8.07,False,http://www.openphacts.org/units/Nanomolar,2252022,=,1,True,=,,IC50,nM,,8.45,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.00845
,15093226,[],CHEMBL3385093,Inhibition of IDH1 R132H mutant (unknown origin) assessed as inhibition of [3C]2-hydroxyglutarate formation after 45 mins by LC-MS biochemical assay,B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@]2(C)C2CC2)n1)c1ccc(CN2CCC(O)(C(F)(F)F)CC2)cc1F,,,CHEMBL3352118,ACS Med. Chem. Lett.,2014.0,"{'bei': '14.81', 'le': '0.29', 'lle': '3.16', 'sei': '8.77'}",CHEMBL3342783,,CHEMBL3342783,7.96,False,http://www.openphacts.org/units/Nanomolar,2252024,=,1,True,=,,IC50,nM,,10.9,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.0109
,15093227,[],CHEMBL3385093,Inhibition of IDH1 R132H mutant (unknown origin) assessed as inhibition of [3C]2-hydroxyglutarate formation after 45 mins by LC-MS biochemical assay,B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2C2CC2)n1)c1cn(-c2ccc(F)cc2)cn1,,,CHEMBL3352118,ACS Med. Chem. Lett.,2014.0,"{'bei': '17.38', 'le': '0.34', 'lle': '3.34', 'sei': '9.04'}",CHEMBL3342782,,CHEMBL3342782,7.70,False,http://www.openphacts.org/units/Nanomolar,2252023,=,1,True,=,,IC50,nM,,20.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.02
,16770214,[],CHEMBL3863789,Inhibition of wild type human C-terminal His8-tagged IDH1 expressed in Escherichia coli Rosetta cells assessed as reduction in isocitrate to alpha-KG conversion preincubated for 15 mins followed by substrate addition in presence of NADP+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)NC2CCCCC2)Oc2cc(C#Cc3cccc(F)c3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,,CHEMBL3934066,,CHEMBL3934066,,False,http://www.openphacts.org/units/Nanomolar,2803851,>,1,True,>,,IC50,nM,,20000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,20.0
,16770215,[],CHEMBL3863788,Inhibition of human C-terminal His8-tagged IDH1-R132C mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 10 mins followed by addition of NADPH and alpha-KG as substrate by fluorescence method,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)NC2CCCCC2)Oc2cc(C#Cc3cccc(F)c3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '9.80', 'le': '0.19', 'lle': '1.63', 'sei': '5.65'}",CHEMBL3934066,,CHEMBL3934066,5.60,False,http://www.openphacts.org/units/Nanomolar,2803851,=,1,True,=,,IC50,nM,,2500.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,2.5
,16770218,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)NC2CCCCC2)Oc2cc(C#CBr)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,,CHEMBL3965229,,CHEMBL3965229,,False,http://www.openphacts.org/units/Nanomolar,2803883,>,1,True,>,,IC50,nM,,20000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,20.0
,16770219,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C#Cc1ccc2c(c1)O[C@@H](CN(C)C(=O)NC1CCCCC1)[C@H](C)CN([C@@H](C)CO)S2(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '10.71', 'le': '0.21', 'lle': '2.70', 'sei': '5.16'}",CHEMBL3979015,,CHEMBL3979015,5.11,False,http://www.openphacts.org/units/Nanomolar,2803882,=,1,True,=,,IC50,nM,,7700.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,7.7
,16770220,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)NC2CCCCC2)Oc2cc(C#C[Si](C)(C)C)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '12.47', 'le': None, 'lle': None, 'sei': None}",CHEMBL3917616,,CHEMBL3917616,6.85,False,http://www.openphacts.org/units/Nanomolar,2803881,=,1,True,=,,IC50,nM,,140.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.14
,16770221,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)NC2CCCCC2)Oc2cc(-c3cccnc3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '9.79', 'le': '0.19', 'lle': '1.70', 'sei': '4.63'}",CHEMBL3889613,,CHEMBL3889613,5.19,False,http://www.openphacts.org/units/Nanomolar,2803880,=,1,True,=,,IC50,nM,,6400.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,6.4
,16770222,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)NC2CCCCC2)Oc2cc(C#CC3CCCCC3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '12.59', 'le': '0.25', 'lle': '2.69', 'sei': '7.10'}",CHEMBL3942920,,CHEMBL3942920,7.05,False,http://www.openphacts.org/units/Nanomolar,2803879,=,1,True,=,,IC50,nM,,90.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.09
,16770223,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)NC2CCCCC2)Oc2cc(C#Cc3cncn3C)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '10.39', 'le': '0.20', 'lle': '3.24', 'sei': '4.95'}",CHEMBL3972520,,CHEMBL3972520,5.80,False,http://www.openphacts.org/units/Nanomolar,2803878,=,1,True,=,,IC50,nM,,1600.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.6
,16770224,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)NC2CCCCC2)Oc2cc(/C=C/c3ccccc3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '12.09', 'le': '0.24', 'lle': '2.12', 'sei': '6.78'}",CHEMBL3939537,,CHEMBL3939537,6.72,False,http://www.openphacts.org/units/Nanomolar,2803877,=,1,True,=,,IC50,nM,,190.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.19
,16770225,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)NC2CCCCC2)Oc2cc(C#Cc3ccccc3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '12.87', 'le': '0.25', 'lle': '3.29', 'sei': '7.18'}",CHEMBL3963718,,CHEMBL3963718,7.12,False,http://www.openphacts.org/units/Nanomolar,2803876,=,1,True,=,,IC50,nM,,75.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.075
,16770226,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,COc1ccc(C#Cc2ccc3c(c2)O[C@@H](CN(C)C(=O)NC2CCCCC2)[C@H](C)CN([C@@H](C)CO)S3(=O)=O)cc1,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '12.06', 'le': '0.23', 'lle': '3.20', 'sei': '6.49'}",CHEMBL3960382,,CHEMBL3960382,7.04,False,http://www.openphacts.org/units/Nanomolar,2803875,=,1,True,=,,IC50,nM,,91.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.091
,16770227,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)NC2CCCCC2)Oc2cc(C#Cc3cncnc3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '11.69', 'le': '0.23', 'lle': '3.87', 'sei': '5.20'}",CHEMBL3891327,,CHEMBL3891327,6.50,False,http://www.openphacts.org/units/Nanomolar,2803874,=,1,True,=,,IC50,nM,,320.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.32
,16770228,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)NC2CCCCC2)Oc2cc(C#Cc3cccnc3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '12.36', 'le': '0.24', 'lle': '3.63', 'sei': '6.12'}",CHEMBL3926310,,CHEMBL3926310,6.85,False,http://www.openphacts.org/units/Nanomolar,2803873,=,1,True,=,,IC50,nM,,140.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.14
,16770229,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)NC2CCCCC2)Oc2cc(C#Cc3ccc(F)cn3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '11.50', 'le': '0.22', 'lle': '3.23', 'sei': '5.88'}",CHEMBL3904242,,CHEMBL3904242,6.58,False,http://www.openphacts.org/units/Nanomolar,2803872,=,1,True,=,,IC50,nM,,260.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.26
,16770230,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)NC2CCCCC2)Oc2cc(C#Cc3ccc(F)c(F)c3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '12.81', 'le': '0.25', 'lle': '3.44', 'sei': '7.62'}",CHEMBL3987085,,CHEMBL3987085,7.55,False,http://www.openphacts.org/units/Nanomolar,2803871,=,1,True,=,,IC50,nM,,28.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.028
,16770231,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)NC2CCCCC2)Oc2cc(C#Cc3cccc(Cl)c3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '12.28', 'le': '0.25', 'lle': '2.74', 'sei': '7.28'}",CHEMBL3909367,,CHEMBL3909367,7.22,False,http://www.openphacts.org/units/Nanomolar,2803870,=,1,True,=,,IC50,nM,,60.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.06
,16770232,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)NC2CCCCC2)Oc2cc(C#Cc3ccc(Cl)cc3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '12.33', 'le': '0.25', 'lle': '2.77', 'sei': '7.31'}",CHEMBL3960589,,CHEMBL3960589,7.25,False,http://www.openphacts.org/units/Nanomolar,2803869,=,1,True,=,,IC50,nM,,56.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.056
,16770233,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)NC2CCCCC2)Oc2cc(C#Cc3ccccc3F)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '12.32', 'le': '0.24', 'lle': '3.07', 'sei': '7.10'}",CHEMBL3972787,,CHEMBL3972787,7.04,False,http://www.openphacts.org/units/Nanomolar,2803868,=,1,True,=,,IC50,nM,,91.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.091
,16770234,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)NC2CCCCC2)Oc2cc(C#Cc3ccc(F)cc3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '13.00', 'le': '0.25', 'lle': '3.46', 'sei': '7.49'}",CHEMBL2359350,,CHEMBL2359350,7.43,False,http://www.openphacts.org/units/Nanomolar,2803867,=,1,True,=,,IC50,nM,,37.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.037
,16770235,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)OC(C)(C)C)Oc2cc(C#Cc3cccc(F)c3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '10.60', 'le': '0.21', 'lle': '1.94', 'sei': '6.01'}",CHEMBL3926431,,CHEMBL3926431,5.80,False,http://www.openphacts.org/units/Nanomolar,2803866,=,1,True,=,,IC50,nM,,1600.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.6
,16770236,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)CCC2CCNCC2)Oc2cc(C#Cc3cccc(F)c3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '9.20', 'le': '0.18', 'lle': '1.81', 'sei': '6.25'}",CHEMBL3945329,,CHEMBL3945329,5.13,False,http://www.openphacts.org/units/Nanomolar,2803865,=,1,True,=,,IC50,nM,,7400.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,7.4
,16770237,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)C2CCOCC2)Oc2cc(C#Cc3cccc(F)c3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '9.13', 'le': '0.18', 'lle': '2.22', 'sei': '5.29'}",CHEMBL3917452,,CHEMBL3917452,5.10,False,http://www.openphacts.org/units/Nanomolar,2803864,=,1,True,=,,IC50,nM,,7900.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,7.9
,16770238,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)N(C)C2CCCCC2)Oc2cc(C#Cc3cccc(F)c3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '8.95', 'le': '0.17', 'lle': '0.93', 'sei': '5.80'}",CHEMBL3973763,,CHEMBL3973763,5.24,False,http://www.openphacts.org/units/Nanomolar,2803863,=,1,True,=,,IC50,nM,,5700.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,5.7
,16770239,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=S)NC2CCCCC2)Oc2cc(C#Cc3cccnc3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '11.91', 'le': '0.24', 'lle': '3.41', 'sei': '7.15'}",CHEMBL3944296,,CHEMBL3944296,6.80,False,http://www.openphacts.org/units/Nanomolar,2803862,=,1,True,=,,IC50,nM,,160.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.16
,16770240,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)C2CCCCC2)Oc2cc(C#Cc3cccc(F)c3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '11.42', 'le': '0.22', 'lle': '2.33', 'sei': '7.29'}",CHEMBL3962802,,CHEMBL3962802,6.36,False,http://www.openphacts.org/units/Nanomolar,2803861,=,1,True,=,,IC50,nM,,440.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.44
,16770241,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)CC2CCCCC2)Oc2cc(C#Cc3cccc(F)c3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '11.29', 'le': '0.22', 'lle': '2.02', 'sei': '7.39'}",CHEMBL3935326,,CHEMBL3935326,6.44,False,http://www.openphacts.org/units/Nanomolar,2803860,=,1,True,=,,IC50,nM,,360.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.36
,16770242,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)c2ccno2)Oc2cc(C#Cc3cccc(F)c3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '8.72', 'le': '0.17', 'lle': '1.97', 'sei': '4.17'}",CHEMBL3895369,,CHEMBL3895369,4.72,False,http://www.openphacts.org/units/Nanomolar,2803859,=,1,True,=,,IC50,nM,,19000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,19.0
,16770243,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,Cc1noc(C)c1NC(=O)N(C)C[C@@H]1Oc2cc(C#Cc3cccc(F)c3)ccc2S(=O)(=O)N([C@@H](C)CO)C[C@H]1C,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '8.48', 'le': '0.17', 'lle': '1.20', 'sei': '3.96'}",CHEMBL3963903,,CHEMBL3963903,4.96,False,http://www.openphacts.org/units/Nanomolar,2803858,=,1,True,=,,IC50,nM,,11000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,11.0
,16770244,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)Nc2ccccc2)Oc2cc(C#Cc3cccc(F)c3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '9.74', 'le': '0.19', 'lle': '1.35', 'sei': '5.55'}",CHEMBL3944764,,CHEMBL3944764,5.51,False,http://www.openphacts.org/units/Nanomolar,2803857,=,1,True,=,,IC50,nM,,3100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,3.1
,16770245,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)NCC2CCCCC2)Oc2cc(C#Cc3cccc(F)c3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '11.60', 'le': '0.23', 'lle': '2.58', 'sei': '6.85'}",CHEMBL3974203,,CHEMBL3974203,6.80,False,http://www.openphacts.org/units/Nanomolar,2803856,=,1,True,=,,IC50,nM,,160.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.16
,16770246,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,CCNC(=O)N(C)C[C@@H]1Oc2cc(C#Cc3cccc(F)c3)ccc2S(=O)(=O)N([C@@H](C)CO)C[C@H]1C,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '11.31', 'le': '0.22', 'lle': '3.19', 'sei': '5.90'}",CHEMBL3953491,,CHEMBL3953491,5.85,False,http://www.openphacts.org/units/Nanomolar,2803855,=,1,True,=,,IC50,nM,,1400.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.4
,16770247,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,CCCNC(=O)N(C)C[C@@H]1Oc2cc(C#Cc3cccc(F)c3)ccc2S(=O)(=O)N([C@@H](C)CO)C[C@H]1C,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '11.77', 'le': '0.23', 'lle': '3.21', 'sei': '6.31'}",CHEMBL3982213,,CHEMBL3982213,6.26,False,http://www.openphacts.org/units/Nanomolar,2803854,=,1,True,=,,IC50,nM,,550.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.55
,16770248,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)NC2CC2)Oc2cc(C#Cc3cccc(F)c3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '11.33', 'le': '0.22', 'lle': '3.20', 'sei': '6.05'}",CHEMBL3926888,,CHEMBL3926888,6.00,False,http://www.openphacts.org/units/Nanomolar,2803853,=,1,True,=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,16770249,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)NC2CCCC2)Oc2cc(C#Cc3cccc(F)c3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '12.73', 'le': '0.25', 'lle': '3.52', 'sei': '7.16'}",CHEMBL3891685,,CHEMBL3891685,7.10,False,http://www.openphacts.org/units/Nanomolar,2803852,=,1,True,=,,IC50,nM,,80.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.08
,16770251,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@H]1CN([C@@H](C)CO)S(=O)(=O)c2ccc(C#Cc3cccc(F)c3)cc2O[C@H]1CN(C)C(=O)NC1CCCCC1,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '9.10', 'le': '0.18', 'lle': '1.23', 'sei': '5.24'}",CHEMBL3948654,,CHEMBL3948654,5.20,False,http://www.openphacts.org/units/Nanomolar,2803894,=,1,True,=,,IC50,nM,,6300.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,6.3
,16770252,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H]1CN([C@H](C)CO)S(=O)(=O)c2ccc(C#Cc3cccc(F)c3)cc2O[C@@H]1CN(C)C(=O)NC1CCCCC1,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '9.23', 'le': '0.18', 'lle': '1.31', 'sei': '5.32'}",CHEMBL2359003,,CHEMBL2359003,5.28,False,http://www.openphacts.org/units/Nanomolar,2803893,=,1,True,=,,IC50,nM,,5300.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,5.3
,16770253,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)C(=O)NC2CCCCC2)Oc2cc(C#Cc3cccc(F)c3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '9.46', 'le': '0.18', 'lle': '1.44', 'sei': '5.45'}",CHEMBL3976839,,CHEMBL3976839,5.41,False,http://www.openphacts.org/units/Nanomolar,2803892,=,1,True,=,,IC50,nM,,3900.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,3.9
,16770254,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@H]1CN([C@H](C)CO)S(=O)(=O)c2ccc(C#Cc3cccc(F)c3)cc2O[C@H]1CN(C)C(=O)NC1CCCCC1,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,,CHEMBL2356922,,CHEMBL2356922,,False,http://www.openphacts.org/units/Nanomolar,2803891,>,1,True,>,,IC50,nM,,20000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,20.0
,16770255,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@H]1CN([C@@H](C)CO)S(=O)(=O)c2ccc(C#Cc3cccc(F)c3)cc2O[C@@H]1CN(C)C(=O)NC1CCCCC1,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '10.49', 'le': '0.20', 'lle': '2.03', 'sei': '6.05'}",CHEMBL2357019,,CHEMBL2357019,6.00,False,http://www.openphacts.org/units/Nanomolar,2803890,=,1,True,=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,16770256,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H]1CN([C@H](C)CO)S(=O)(=O)c2ccc(C#Cc3cccc(F)c3)cc2O[C@H]1CN(C)C(=O)NC1CCCCC1,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '10.88', 'le': '0.21', 'lle': '2.25', 'sei': '6.27'}",CHEMBL3979949,,CHEMBL3979949,6.22,False,http://www.openphacts.org/units/Nanomolar,2803889,=,1,True,=,,IC50,nM,,600.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.6
,16770257,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@H]1CN([C@H](C)CO)S(=O)(=O)c2ccc(C#Cc3cccc(F)c3)cc2O[C@@H]1CN(C)C(=O)NC1CCCCC1,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '10.09', 'le': '0.20', 'lle': '1.80', 'sei': '5.82'}",CHEMBL3950996,,CHEMBL3950996,5.77,False,http://www.openphacts.org/units/Nanomolar,2803888,=,1,True,=,,IC50,nM,,1700.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.7
,16770258,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CN(C)C(=O)NC2CCCCC2)Oc2cc(C#Cc3cccc(F)c3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '12.77', 'le': '0.25', 'lle': '3.33', 'sei': '7.36'}",CHEMBL3934066,,CHEMBL3934066,7.30,False,http://www.openphacts.org/units/Nanomolar,2803851,=,1,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,0.057,0.05
,16770259,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CO)N1C[C@@H](C)[C@H](CCC(=O)NC2CCCCC2)Oc2cc(C#Cc3cccnc3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '9.34', 'le': '0.18', 'lle': '1.56', 'sei': '4.63'}",CHEMBL3970770,,CHEMBL3970770,5.04,False,http://www.openphacts.org/units/Nanomolar,2803884,=,1,True,=,,IC50,nM,,9100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,9.1
,16770260,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,COc1ccc(OC[C@H](C)N2C[C@@H](C)[C@H](CN(C)C(=O)NC3CCCCC3)Oc3cc(C#Cc4cccnc4)ccc3S2(=O)=O)cc1,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '10.62', 'le': '0.20', 'lle': '1.70', 'sei': '6.36'}",CHEMBL3950295,,CHEMBL3950295,7.02,False,http://www.openphacts.org/units/Nanomolar,2803885,=,1,True,=,,IC50,nM,,96.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.096
,16770261,[],CHEMBL3863787,Inhibition of human C-terminal His8-tagged IDH1-R132H mutant expressed in Escherichia coli Rosetta assessed as inhibition of ketoreductase activity by measuring NADPH consumption preincubated for 60 mins followed by addition of alpha-KG as substrate measured after 50 mins in presence of NADPH and Mg2+ by resazurin based diaphorase-coupled fluorescence assay,B,BAO_0000190,BAO_0000019,assay format,C[C@@H](CN(C)C)N1C[C@@H](C)[C@H](CN(C)C(=O)NC2CCCCC2)Oc2cc(C#Cc3ccc(F)cc3)ccc2S1(=O)=O,,,CHEMBL3862029,ACS Med Chem Lett,2016.0,"{'bei': '12.52', 'le': '0.24', 'lle': '2.95', 'sei': '9.12'}",CHEMBL3923861,,CHEMBL3923861,7.50,False,http://www.openphacts.org/units/Nanomolar,2803886,=,1,True,=,,IC50,nM,,32.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.032
198658,17602170,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cnc3[nH]ccc3c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '19.12', 'le': '0.35', 'lle': '3.50', 'sei': '7.30'}",CHEMBL3682142,,CHEMBL3682142,7.01,False,http://www.openphacts.org/units/Nanomolar,2558232,=,37,True,=,,IC50,nM,,98.6,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,98.6
198659,17602171,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@H](C)c2cnc3[nH]ccc3c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.05', 'le': '0.26', 'lle': '1.64', 'sei': '5.36'}",CHEMBL3682143,,CHEMBL3682143,5.15,False,http://www.openphacts.org/units/Nanomolar,2558233,=,37,True,=,,IC50,nM,,7100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,7100.0
282906,17665251,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC(C)(C)[C@@H]2c2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '17.49', 'le': '0.32', 'lle': '1.67', 'sei': '10.09'}",CHEMBL3672095,,CHEMBL3672095,6.80,False,http://www.openphacts.org/units/Nanomolar,2547473,=,37,True,=,,IC50,nM,,160.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,160.0
282907,17665252,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2CCOC2=O)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,,CHEMBL3672096,,CHEMBL3672096,,False,http://www.openphacts.org/units/Nanomolar,2547474,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
282908,17665253,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccccc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '19.86', 'le': '0.37', 'lle': '2.85', 'sei': '9.62'}",CHEMBL3672097,,CHEMBL3672097,6.48,False,http://www.openphacts.org/units/Nanomolar,2547475,=,37,True,=,,IC50,nM,,330.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,330.5
282909,17665254,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@H](C)c2ccccc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.35', 'le': '0.30', 'lle': '1.71', 'sei': '7.92'}",CHEMBL3672098,,CHEMBL3672098,5.34,False,http://www.openphacts.org/units/Nanomolar,2547476,=,37,True,=,,IC50,nM,,4612.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4612.0
282910,17665255,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2c2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '17.47', 'le': '0.32', 'lle': '1.95', 'sei': '9.35'}",CHEMBL3672099,,CHEMBL3672099,6.30,False,http://www.openphacts.org/units/Nanomolar,2547477,=,37,True,=,,IC50,nM,,505.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,505.0
282911,17665256,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC[C@@H]2c2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '13.64', 'le': '0.25', 'lle': '0.56', 'sei': '7.30'}",CHEMBL3672100,,CHEMBL3672100,4.92,False,http://www.openphacts.org/units/Nanomolar,2547478,=,37,True,=,,IC50,nM,,12175.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,12175.0
282912,17665257,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,O=C1OC[C@H](c2ccccc2)N1c1ccnc(NC2CCCC2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.26', 'le': '0.32', 'lle': '2.07', 'sei': '8.31'}",CHEMBL3672101,,CHEMBL3672101,5.60,False,http://www.openphacts.org/units/Nanomolar,2547479,=,37,True,=,,IC50,nM,,2527.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2527.0
282913,17665258,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,O=C1OC[C@H](c2ccccc2)N1c1ccnc(NC2CC2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.49', 'le': '0.30', 'lle': '2.14', 'sei': '7.25'}",CHEMBL3672102,,CHEMBL3672102,4.89,False,http://www.openphacts.org/units/Nanomolar,2547480,=,37,True,=,,IC50,nM,,13011.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,13011.0
282914,17665259,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,O=C1OC[C@H](c2ccccc2)N1c1ccnc(NC2CCCCCC2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.73', 'le': '0.27', 'lle': '0.88', 'sei': '7.71'}",CHEMBL3672103,,CHEMBL3672103,5.19,False,http://www.openphacts.org/units/Nanomolar,2547481,=,37,True,=,,IC50,nM,,6444.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6444.0
282915,17665260,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@H]2c2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '17.79', 'le': '0.32', 'lle': '2.06', 'sei': '9.52'}",CHEMBL3672104,,CHEMBL3672104,6.41,False,http://www.openphacts.org/units/Nanomolar,2547482,=,37,True,=,,IC50,nM,,387.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,387.0
282916,17665261,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC[C@H]2c2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '15.47', 'le': '0.28', 'lle': '1.22', 'sei': '8.28'}",CHEMBL3672105,,CHEMBL3672105,5.58,False,http://www.openphacts.org/units/Nanomolar,2547483,=,37,True,=,,IC50,nM,,2661.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2661.0
282917,17665262,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC[C@H](Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.62', 'le': '0.31', 'lle': '1.64', 'sei': '8.40'}",CHEMBL3672106,,CHEMBL3672106,5.66,False,http://www.openphacts.org/units/Nanomolar,2547484,=,37,True,=,,IC50,nM,,2190.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2190.5
282918,17665263,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC[C@@H](Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '13.59', 'le': '0.25', 'lle': '0.60', 'sei': '6.87'}",CHEMBL3672107,,CHEMBL3672107,4.62,False,http://www.openphacts.org/units/Nanomolar,2547485,=,37,True,=,,IC50,nM,,23722.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,23722.0
282919,17665264,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2C(c2ccccc2)c2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '12.41', 'le': '0.22', 'lle': '-0.22', 'sei': '8.30'}",CHEMBL3672108,,CHEMBL3672108,5.59,False,http://www.openphacts.org/units/Nanomolar,2547486,=,37,True,=,,IC50,nM,,2573.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2573.5
282920,17665265,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)O[C@H](c3ccccc3)[C@@H]2C)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '14.07', 'le': '0.26', 'lle': '0.53', 'sei': '7.82'}",CHEMBL3672109,,CHEMBL3672109,5.27,False,http://www.openphacts.org/units/Nanomolar,2547487,=,37,True,=,,IC50,nM,,5383.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5383.0
282921,17665266,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,O=C1OCCN1c1ccnc(NC2CCCC2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3672110,,CHEMBL3672110,,False,http://www.openphacts.org/units/Nanomolar,2547488,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
282922,17665267,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,O=C1OC[C@H](Cc2ccccc2)N1c1ccnc(NC2CCCC2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.12', 'le': '0.28', 'lle': '1.72', 'sei': '7.60'}",CHEMBL3672111,,CHEMBL3672111,5.12,False,http://www.openphacts.org/units/Nanomolar,2547489,=,37,True,=,,IC50,nM,,7625.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,7625.0
282923,17665268,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,O=C1OC[C@@H](Cc2ccccc2)N1c1ccnc(NC2CCCC2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3672112,,CHEMBL3672112,,False,http://www.openphacts.org/units/Nanomolar,2547490,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
282924,17665269,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)O[C@@H](c3ccccc3)[C@H]2C)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,,CHEMBL3672113,,CHEMBL3672113,,False,http://www.openphacts.org/units/Nanomolar,2547491,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
282925,17665270,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC[C@@H]2C(c2ccccc2)c2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,,CHEMBL3672114,,CHEMBL3672114,,False,http://www.openphacts.org/units/Nanomolar,2547492,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
282926,17665271,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccccc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.48', 'le': '0.31', 'lle': '1.75', 'sei': '7.99'}",CHEMBL3672115,,CHEMBL3672115,5.38,False,http://www.openphacts.org/units/Nanomolar,2547493,=,37,True,=,,IC50,nM,,4169.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4169.0
282927,17665272,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@@H]1COC(=O)N1c1ccnc(N[C@H](C)c2ccccc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.42', 'le': '0.27', 'lle': '1.08', 'sei': '6.99'}",CHEMBL3672116,,CHEMBL3672116,4.71,False,http://www.openphacts.org/units/Nanomolar,2547494,=,37,True,=,,IC50,nM,,19671.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,19671.0
282928,17665273,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@@H]1N(c2ccnc(N[C@@H](C)c3ccccc3)n2)C(=O)OC1(C)C,,,CHEMBL3638632,,2015.0,"{'bei': '17.67', 'le': '0.33', 'lle': '1.85', 'sei': '9.30'}",CHEMBL3672117,,CHEMBL3672117,6.26,False,http://www.openphacts.org/units/Nanomolar,2547495,=,37,True,=,,IC50,nM,,546.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,546.5
282929,17665274,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@@H]1N(c2ccnc(N[C@H](C)c3ccccc3)n2)C(=O)OC1(C)C,,,CHEMBL3638632,,2015.0,"{'bei': '15.37', 'le': '0.29', 'lle': '1.04', 'sei': '8.09'}",CHEMBL3672118,,CHEMBL3672118,5.45,False,http://www.openphacts.org/units/Nanomolar,2547496,=,37,True,=,,IC50,nM,,3564.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3564.0
282930,17665275,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)O[C@@H](c3ccccc3)[C@H]2C)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '11.93', 'le': '0.22', 'lle': '-0.27', 'sei': '6.63'}",CHEMBL3672119,,CHEMBL3672119,4.47,False,http://www.openphacts.org/units/Nanomolar,2547497,=,37,True,=,,IC50,nM,,34091.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,34091.0
282931,17665276,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H]1[C@@H](c2ccccc2)OC(=O)N1c1ccnc(N[C@H](C)c2ccccc2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3672120,,CHEMBL3672120,,False,http://www.openphacts.org/units/Nanomolar,2547498,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
282932,17665277,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC(C)(C)[C@@H]2c2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '14.37', 'le': '0.26', 'lle': '0.45', 'sei': '8.29'}",CHEMBL3672121,,CHEMBL3672121,5.58,False,http://www.openphacts.org/units/Nanomolar,2547499,=,37,True,=,,IC50,nM,,2608.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2608.0
282933,17665278,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@H]2CCc3ccccc32)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.79', 'le': '0.29', 'lle': '1.78', 'sei': '7.94'}",CHEMBL3672122,,CHEMBL3672122,5.34,False,http://www.openphacts.org/units/Nanomolar,2547500,=,37,True,=,,IC50,nM,,4526.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4526.0
282934,17665279,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H]2CCc3ccccc32)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.05', 'le': '0.28', 'lle': '1.53', 'sei': '7.56'}",CHEMBL3672123,,CHEMBL3672123,5.09,False,http://www.openphacts.org/units/Nanomolar,2547501,=,37,True,=,,IC50,nM,,8098.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,8098.0
282935,17665280,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)O[C@@H](c3ccccc3)[C@H]2c2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '13.68', 'le': '0.25', 'lle': '-0.12', 'sei': '8.86'}",CHEMBL3672124,,CHEMBL3672124,5.97,False,http://www.openphacts.org/units/Nanomolar,2547502,=,37,True,=,,IC50,nM,,1072.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1072.0
282936,17665281,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)C[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccccc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.93', 'le': '0.31', 'lle': '1.74', 'sei': '8.56'}",CHEMBL3672125,,CHEMBL3672125,5.76,False,http://www.openphacts.org/units/Nanomolar,2547503,=,37,True,=,,IC50,nM,,1721.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1721.0
282937,17665282,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)C[C@H]1COC(=O)N1c1ccnc(N[C@H](C)c2ccccc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.71', 'le': '0.27', 'lle': '0.99', 'sei': '7.44'}",CHEMBL3672126,,CHEMBL3672126,5.01,False,http://www.openphacts.org/units/Nanomolar,2547504,=,37,True,=,,IC50,nM,,9797.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,9797.0
282938,17665283,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccccn1,,,CHEMBL3638632,,2015.0,"{'bei': '16.67', 'le': '0.31', 'lle': '2.43', 'sei': '6.80'}",CHEMBL3672127,,CHEMBL3672127,5.46,False,http://www.openphacts.org/units/Nanomolar,2547505,=,37,True,=,,IC50,nM,,3483.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3483.0
282939,17665284,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccncc1,,,CHEMBL3638632,,2015.0,"{'bei': '15.64', 'le': '0.29', 'lle': '2.09', 'sei': '6.38'}",CHEMBL3672128,,CHEMBL3672128,5.12,False,http://www.openphacts.org/units/Nanomolar,2547506,=,37,True,=,,IC50,nM,,7588.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,7588.0
282940,17665285,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cccc3ccccc23)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.55', 'le': '0.32', 'lle': '1.83', 'sei': '9.81'}",CHEMBL3672129,,CHEMBL3672129,6.61,False,http://www.openphacts.org/units/Nanomolar,2547507,=,37,True,=,,IC50,nM,,247.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,247.5
282941,17665286,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc([C@@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '13.34', 'le': '0.25', 'lle': '1.12', 'sei': '6.21'}",CHEMBL3672130,,CHEMBL3672130,4.75,False,http://www.openphacts.org/units/Nanomolar,2547508,=,37,True,=,,IC50,nM,,17576.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,17576.0
282942,17665287,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)O[C@H](c3ccccc3)[C@@H]2c2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '12.23', 'le': '0.22', 'lle': '-0.75', 'sei': '7.93'}",CHEMBL3672131,,CHEMBL3672131,5.34,False,http://www.openphacts.org/units/Nanomolar,2547509,=,37,True,=,,IC50,nM,,4595.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4595.0
282943,17665288,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)O[C@H](c3ccccc3)[C@@H]2c2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,,CHEMBL3672132,,CHEMBL3672132,,False,http://www.openphacts.org/units/Nanomolar,2547510,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
282944,17665289,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)O[C@@H](c3ccccc3)[C@H]2c2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '11.58', 'le': '0.21', 'lle': '-1.03', 'sei': '7.51'}",CHEMBL3672133,,CHEMBL3672133,5.05,False,http://www.openphacts.org/units/Nanomolar,2547511,=,37,True,=,,IC50,nM,,8806.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,8806.0
282945,17665290,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@H](C)c2cccc3ccccc23)n1,,,CHEMBL3638632,,2015.0,"{'bei': '12.46', 'le': '0.23', 'lle': '-0.09', 'sei': '6.97'}",CHEMBL3672134,,CHEMBL3672134,4.69,False,http://www.openphacts.org/units/Nanomolar,2547512,=,37,True,=,,IC50,nM,,20340.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,20340.0
282946,17665291,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '17.85', 'le': '0.33', 'lle': '2.72', 'sei': '8.31'}",CHEMBL3672135,,CHEMBL3672135,6.36,False,http://www.openphacts.org/units/Nanomolar,2547513,=,37,True,=,,IC50,nM,,436.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,436.0
282947,17665292,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3cncnc3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.41', 'le': '0.28', 'lle': '2.14', 'sei': '6.69'}",CHEMBL3672136,,CHEMBL3672136,6.23,False,http://www.openphacts.org/units/Nanomolar,2547514,=,37,True,=,,IC50,nM,,584.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,584.0
282948,17665293,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@H](C)c2ccc3ccccc3c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.59', 'le': '0.25', 'lle': '0.33', 'sei': '7.59'}",CHEMBL3672137,,CHEMBL3672137,5.11,False,http://www.openphacts.org/units/Nanomolar,2547515,=,37,True,=,,IC50,nM,,7686.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,7686.0
282949,17665294,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC(C)(C)[C@H]2c2ccccc2)n1)c1ccc(F)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.98', 'le': '0.31', 'lle': '1.63', 'sei': '10.25'}",CHEMBL3672138,,CHEMBL3672138,6.90,False,http://www.openphacts.org/units/Nanomolar,2547516,=,37,True,=,,IC50,nM,,125.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,125.0
282950,17665295,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)C[C@@H]1COC(=O)N1c1ccnc(N[C@H](C)c2ccccc2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3672139,,CHEMBL3672139,,False,http://www.openphacts.org/units/Nanomolar,2547517,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
282951,17665296,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)O[C@H](C)[C@@H]2c2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '17.71', 'le': '0.32', 'lle': '1.89', 'sei': '9.85'}",CHEMBL3672140,,CHEMBL3672140,6.63,False,http://www.openphacts.org/units/Nanomolar,2547518,=,37,True,=,,IC50,nM,,234.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,234.0
282952,17665297,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)O[C@H](C)[C@@H]2c2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '13.69', 'le': '0.25', 'lle': '0.39', 'sei': '7.61'}",CHEMBL3672141,,CHEMBL3672141,5.13,False,http://www.openphacts.org/units/Nanomolar,2547519,=,37,True,=,,IC50,nM,,7481.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,7481.0
282953,17665298,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC(C)(C)[C@@H]2Cc2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '13.99', 'le': '0.26', 'lle': '0.63', 'sei': '8.36'}",CHEMBL3672142,,CHEMBL3672142,5.63,False,http://www.openphacts.org/units/Nanomolar,2547520,=,37,True,=,,IC50,nM,,2345.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2345.5
282954,17665299,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)C[C@@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccccc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.31', 'le': '0.30', 'lle': '1.53', 'sei': '8.24'}",CHEMBL3672143,,CHEMBL3672143,5.55,False,http://www.openphacts.org/units/Nanomolar,2547521,=,37,True,=,,IC50,nM,,2803.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2803.0
282955,17665300,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc3ccccc3c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '18.74', 'le': '0.34', 'lle': '2.28', 'sei': '10.48'}",CHEMBL3672144,,CHEMBL3672144,7.06,False,http://www.openphacts.org/units/Nanomolar,2547522,=,37,True,=,,IC50,nM,,88.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,88.0
282956,17665301,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc([C@@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '13.84', 'le': '0.26', 'lle': '0.77', 'sei': '6.99'}",CHEMBL3672145,,CHEMBL3672145,4.71,False,http://www.openphacts.org/units/Nanomolar,2547523,=,37,True,=,,IC50,nM,,19457.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,19457.0
282957,17665302,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC(C)(C)[C@@H]2Cc2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '11.48', 'le': '0.21', 'lle': '-0.38', 'sei': '6.86'}",CHEMBL3672146,,CHEMBL3672146,4.62,False,http://www.openphacts.org/units/Nanomolar,2547524,=,37,True,=,,IC50,nM,,23847.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,23847.0
282958,17665303,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2c2cccnc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '14.98', 'le': '0.27', 'lle': '1.67', 'sei': '6.75'}",CHEMBL3672147,,CHEMBL3672147,5.41,False,http://www.openphacts.org/units/Nanomolar,2547525,=,37,True,=,,IC50,nM,,3852.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3852.0
282959,17665304,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C2N(c3ccnc(N[C@@H](C)c4ccccc4)n3)C(=O)OC2(C)C)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.37', 'le': '0.30', 'lle': '1.72', 'sei': '8.95'}",CHEMBL3672148,,CHEMBL3672148,6.85,False,http://www.openphacts.org/units/Nanomolar,2547526,=,37,True,=,,IC50,nM,,141.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,141.0
282960,17665305,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,O=C1OC[C@@H](c2ccccc2)N1c1ccnc(NCc2ccccc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.75', 'le': '0.29', 'lle': '1.67', 'sei': '8.10'}",CHEMBL3672149,,CHEMBL3672149,5.46,False,http://www.openphacts.org/units/Nanomolar,2547527,=,37,True,=,,IC50,nM,,3494.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3494.0
282961,17665306,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,O=C1OC[C@H](c2ccccc2)N1c1ccnc(NCc2ccccc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.50', 'le': '0.26', 'lle': '1.23', 'sei': '7.46'}",CHEMBL3672150,,CHEMBL3672150,5.02,False,http://www.openphacts.org/units/Nanomolar,2547528,=,37,True,=,,IC50,nM,,9502.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,9502.0
282962,17665307,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(NCc2ccccc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '18.07', 'le': '0.34', 'lle': '2.57', 'sei': '8.38'}",CHEMBL3672151,,CHEMBL3672151,5.64,False,http://www.openphacts.org/units/Nanomolar,2547529,=,37,True,=,,IC50,nM,,2273.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2273.0
282963,17665308,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(N2CCN(C)CC2)cc1,,,CHEMBL3638632,,2015.0,,CHEMBL3672152,,CHEMBL3672152,,False,http://www.openphacts.org/units/Nanomolar,2547530,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
282964,17665309,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.50', 'le': '0.27', 'lle': '0.57', 'sei': '9.27'}",CHEMBL3672153,,CHEMBL3672153,6.24,False,http://www.openphacts.org/units/Nanomolar,2547531,=,37,True,=,,IC50,nM,,575.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,575.0
282965,17665310,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)ccc2c1,,,CHEMBL3638632,,2015.0,"{'bei': '17.92', 'le': '0.33', 'lle': '2.49', 'sei': '9.51'}",CHEMBL3672154,,CHEMBL3672154,7.28,False,http://www.openphacts.org/units/Nanomolar,2547532,=,37,True,=,,IC50,nM,,52.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,52.0
282966,17665311,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1cccc([C@@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '13.73', 'le': '0.26', 'lle': '1.26', 'sei': '6.39'}",CHEMBL3672155,,CHEMBL3672155,4.89,False,http://www.openphacts.org/units/Nanomolar,2547533,=,37,True,=,,IC50,nM,,12729.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,12729.0
282967,17665312,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cccc(Br)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.85', 'le': '0.37', 'lle': '2.44', 'sei': '10.14'}",CHEMBL3672156,,CHEMBL3672156,6.83,False,http://www.openphacts.org/units/Nanomolar,2547534,=,37,True,=,,IC50,nM,,147.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,147.5
282968,17665313,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(Br)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.22', 'le': '0.38', 'lle': '2.59', 'sei': '10.37'}",CHEMBL3672157,,CHEMBL3672157,6.98,False,http://www.openphacts.org/units/Nanomolar,2547535,=,37,True,=,,IC50,nM,,104.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,104.5
282969,17665314,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2CCOC2=O)n1)c1cccc2ccccc12,,,CHEMBL3638632,,2015.0,"{'bei': '15.46', 'le': '0.28', 'lle': '1.41', 'sei': '7.67'}",CHEMBL3672158,,CHEMBL3672158,5.17,False,http://www.openphacts.org/units/Nanomolar,2547536,=,37,True,=,,IC50,nM,,6790.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6790.0
282970,17665315,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2c2ccccc2)n1)c1ccc2ccccc2c1,,,CHEMBL3638632,,2015.0,"{'bei': '16.08', 'le': '0.29', 'lle': '1.10', 'sei': '9.80'}",CHEMBL3672159,,CHEMBL3672159,6.60,False,http://www.openphacts.org/units/Nanomolar,2547537,=,37,True,=,,IC50,nM,,250.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,250.0
282971,17665316,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@H]2c2ccccc2)n1)c1ccc2ccccc2c1,,,CHEMBL3638632,,2015.0,"{'bei': '17.39', 'le': '0.31', 'lle': '1.64', 'sei': '10.60'}",CHEMBL3672160,,CHEMBL3672160,7.14,False,http://www.openphacts.org/units/Nanomolar,2547538,=,37,True,=,,IC50,nM,,73.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,73.0
282972,17665317,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@H](C)c2cccc(Br)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.01', 'le': '0.29', 'lle': '0.88', 'sei': '7.83'}",CHEMBL3672161,,CHEMBL3672161,5.27,False,http://www.openphacts.org/units/Nanomolar,2547539,=,37,True,=,,IC50,nM,,5342.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5342.0
282973,17665318,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@H](C)c2ccc(Br)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '12.83', 'le': '0.28', 'lle': '0.81', 'sei': '7.72'}",CHEMBL3672162,,CHEMBL3672162,5.20,False,http://www.openphacts.org/units/Nanomolar,2547540,=,37,True,=,,IC50,nM,,6302.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6302.0
282974,17665319,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1cccc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '18.48', 'le': '0.35', 'lle': '2.95', 'sei': '8.60'}",CHEMBL3672163,,CHEMBL3672163,6.59,False,http://www.openphacts.org/units/Nanomolar,2547541,=,37,True,=,,IC50,nM,,258.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,258.5
282975,17665320,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '19.60', 'le': '0.36', 'lle': '2.73', 'sei': '9.91'}",CHEMBL3672164,,CHEMBL3672164,6.67,False,http://www.openphacts.org/units/Nanomolar,2547542,=,37,True,=,,IC50,nM,,212.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,212.5
282976,17665321,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2C(C)(C)C)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '13.77', 'le': '0.26', 'lle': '0.67', 'sei': '6.96'}",CHEMBL3672165,,CHEMBL3672165,4.69,False,http://www.openphacts.org/units/Nanomolar,2547543,=,37,True,=,,IC50,nM,,20503.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,20503.0
282977,17665322,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC[C@@H]2C(C)(C)C)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '13.01', 'le': '0.24', 'lle': '0.41', 'sei': '6.57'}",CHEMBL3672166,,CHEMBL3672166,4.43,False,http://www.openphacts.org/units/Nanomolar,2547544,=,37,True,=,,IC50,nM,,37361.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,37361.0
282978,17665323,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1cccc([C@H](C)Nc2nccc(N3C(=O)OC[C@H]3c3ccccc3)n2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '16.65', 'le': '0.31', 'lle': '2.14', 'sei': '8.49'}",CHEMBL3672167,,CHEMBL3672167,6.50,False,http://www.openphacts.org/units/Nanomolar,2547545,=,37,True,=,,IC50,nM,,316.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,316.0
282979,17665324,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2c2ccccn2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '15.47', 'le': '0.28', 'lle': '1.85', 'sei': '6.97'}",CHEMBL3672168,,CHEMBL3672168,5.59,False,http://www.openphacts.org/units/Nanomolar,2547546,=,37,True,=,,IC50,nM,,2569.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2569.0
282980,17665325,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2c2ccncc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.25', 'le': '0.30', 'lle': '2.13', 'sei': '7.32'}",CHEMBL3672169,,CHEMBL3672169,5.87,False,http://www.openphacts.org/units/Nanomolar,2547547,=,37,True,=,,IC50,nM,,1338.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1338.0
282981,17665326,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@H](C)c2cccc(C(F)(F)F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '12.92', 'le': '0.25', 'lle': '0.45', 'sei': '7.57'}",CHEMBL3672170,,CHEMBL3672170,5.10,False,http://www.openphacts.org/units/Nanomolar,2547548,=,37,True,=,,IC50,nM,,8008.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,8008.0
282982,17665327,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@H](C)c2ccc(C(F)(F)F)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '12.55', 'le': '0.24', 'lle': '0.30', 'sei': '7.35'}",CHEMBL3672171,,CHEMBL3672171,4.95,False,http://www.openphacts.org/units/Nanomolar,2547549,=,37,True,=,,IC50,nM,,11260.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,11260.0
282983,17665328,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@H](C)c2ccccc2F)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.19', 'le': '0.25', 'lle': '0.77', 'sei': '6.75'}",CHEMBL3672172,,CHEMBL3672172,4.54,False,http://www.openphacts.org/units/Nanomolar,2547550,=,37,True,=,,IC50,nM,,28611.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,28611.0
282984,17665329,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@]2(C)c2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '18.82', 'le': '0.34', 'lle': '2.53', 'sei': '10.46'}",CHEMBL3672173,,CHEMBL3672173,7.05,False,http://www.openphacts.org/units/Nanomolar,2547551,=,37,True,=,,IC50,nM,,90.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,90.0
282985,17665330,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(N3CCOCC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.99', 'le': '0.28', 'lle': '2.70', 'sei': '7.73'}",CHEMBL3672174,,CHEMBL3672174,6.17,False,http://www.openphacts.org/units/Nanomolar,2547552,=,37,True,=,,IC50,nM,,679.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,679.0
282986,17665331,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@]2(C)c2ccccc2)n1)c1cnn(-c2ccccc2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '15.86', 'le': '0.29', 'lle': '2.28', 'sei': '8.20'}",CHEMBL3672175,,CHEMBL3672175,6.99,False,http://www.openphacts.org/units/Nanomolar,2547553,=,37,True,=,,IC50,nM,,103.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,103.0
282987,17665332,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)cc(OC)c1Br,,,CHEMBL3638632,,2015.0,"{'bei': '14.44', 'le': '0.32', 'lle': '2.31', 'sei': '7.83'}",CHEMBL3672176,,CHEMBL3672176,6.72,False,http://www.openphacts.org/units/Nanomolar,2547554,=,37,True,=,,IC50,nM,,190.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,190.0
282988,17665333,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc2[nH]ccc2c1,,,CHEMBL3638632,,2015.0,"{'bei': '17.67', 'le': '0.33', 'lle': '2.35', 'sei': '7.77'}",CHEMBL3672177,,CHEMBL3672177,6.46,False,http://www.openphacts.org/units/Nanomolar,2547555,=,37,True,=,,IC50,nM,,350.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,350.0
282989,17665334,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)ccc2c1Br,,,CHEMBL3638632,,2015.0,"{'bei': '14.68', 'le': '0.31', 'lle': '1.56', 'sei': '9.30'}",CHEMBL3672178,,CHEMBL3672178,7.12,False,http://www.openphacts.org/units/Nanomolar,2547556,=,37,True,=,,IC50,nM,,75.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,75.0
282990,17665335,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@H](C)c2ccc(F)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.35', 'le': '0.33', 'lle': '2.20', 'sei': '8.87'}",CHEMBL3672179,,CHEMBL3672179,5.97,False,http://www.openphacts.org/units/Nanomolar,2547557,=,37,True,=,,IC50,nM,,1061.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1061.0
282991,17665336,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@H](C)c2ccccc2C(F)(F)F)n1,,,CHEMBL3638632,,2015.0,"{'bei': '12.70', 'le': '0.24', 'lle': '0.36', 'sei': '7.44'}",CHEMBL3672180,,CHEMBL3672180,5.01,False,http://www.openphacts.org/units/Nanomolar,2547558,=,37,True,=,,IC50,nM,,9767.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,9767.0
282992,17665337,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@]2(C)c2ccccc2)n1)c1ccc2ccccc2c1,,,CHEMBL3638632,,2015.0,"{'bei': '16.25', 'le': '0.29', 'lle': '1.23', 'sei': '10.24'}",CHEMBL3672181,,CHEMBL3672181,6.90,False,http://www.openphacts.org/units/Nanomolar,2547559,=,37,True,=,,IC50,nM,,126.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,126.0
282993,17665338,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(F)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '19.19', 'le': '0.36', 'lle': '2.84', 'sei': '9.81'}",CHEMBL3639710,,CHEMBL3639710,6.61,False,http://www.openphacts.org/units/Nanomolar,2547560,=,37,True,=,,IC50,nM,,246.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,246.0
282994,17665339,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@]2(C)c2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '17.87', 'le': '0.33', 'lle': '2.17', 'sei': '9.94'}",CHEMBL3672182,,CHEMBL3672182,6.69,False,http://www.openphacts.org/units/Nanomolar,2547561,=,37,True,=,,IC50,nM,,203.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,203.0
282995,17665340,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1[C@H](C)Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1,,,CHEMBL3638632,,2015.0,"{'bei': '18.42', 'le': '0.34', 'lle': '2.93', 'sei': '8.57'}",CHEMBL3672183,,CHEMBL3672183,6.57,False,http://www.openphacts.org/units/Nanomolar,2547562,=,37,True,=,,IC50,nM,,272.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,272.0
282996,17665341,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2CCOC2=O)n1)c1ccc2ccccc2c1,,,CHEMBL3638632,,2015.0,"{'bei': '16.57', 'le': '0.30', 'lle': '1.78', 'sei': '8.23'}",CHEMBL3672184,,CHEMBL3672184,5.54,False,http://www.openphacts.org/units/Nanomolar,2547563,=,37,True,=,,IC50,nM,,2875.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2875.0
282997,17665342,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1cccc([C@H](C)Nc2nc(C)cc(N3C(=O)OC[C@@H]3C(C)C)n2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '17.34', 'le': '0.32', 'lle': '2.47', 'sei': '8.39'}",CHEMBL3672185,,CHEMBL3672185,6.42,False,http://www.openphacts.org/units/Nanomolar,2547564,=,37,True,=,,IC50,nM,,377.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,377.5
282998,17665343,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(N2C(=O)OC[C@@H]2C(C)C)nc(N[C@@H](C)c2ccccc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '18.16', 'le': '0.34', 'lle': '2.24', 'sei': '9.18'}",CHEMBL3672186,,CHEMBL3672186,6.18,False,http://www.openphacts.org/units/Nanomolar,2547565,=,37,True,=,,IC50,nM,,655.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,655.0
282999,17665344,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H](C)Nc1nccc(N2C(=O)OC[C@@H]2c2ccccc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.38', 'le': '0.30', 'lle': '1.72', 'sei': '7.94'}",CHEMBL3672187,,CHEMBL3672187,5.35,False,http://www.openphacts.org/units/Nanomolar,2547566,=,37,True,=,,IC50,nM,,4487.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4487.0
283000,17665345,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H](C)Nc1nccc(N2C(=O)OC(C)(C)[C@@H]2c2ccccc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.45', 'le': '0.32', 'lle': '1.77', 'sei': '9.18'}",CHEMBL3672188,,CHEMBL3672188,6.18,False,http://www.openphacts.org/units/Nanomolar,2547567,=,37,True,=,,IC50,nM,,655.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,655.0
283001,17665346,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,O=C1OCCN1c1ccnc(NCC23CC4CC(CC(C4)C2)C3)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3672189,,CHEMBL3672189,,False,http://www.openphacts.org/units/Nanomolar,2547568,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
283002,17665347,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(F)(F)F)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.01', 'le': '0.33', 'lle': '2.06', 'sei': '9.96'}",CHEMBL3672190,,CHEMBL3672190,6.71,False,http://www.openphacts.org/units/Nanomolar,2547569,=,37,True,=,,IC50,nM,,195.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,195.0
283003,17665348,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,[C-]#[N+]c1cccc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '17.65', 'le': '0.33', 'lle': '2.02', 'sei': '8.65'}",CHEMBL3672191,,CHEMBL3672191,6.20,False,http://www.openphacts.org/units/Nanomolar,2547570,=,37,True,=,,IC50,nM,,628.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,628.0
283004,17665349,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cccc(Cl)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '18.66', 'le': '0.37', 'lle': '2.46', 'sei': '10.00'}",CHEMBL3672192,,CHEMBL3672192,6.74,False,http://www.openphacts.org/units/Nanomolar,2547571,=,37,True,=,,IC50,nM,,184.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,184.0
283005,17665350,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC(C)(C)[C@H]2c2ccccc2)n1)c1ccc(N2CCCCC2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '14.36', 'le': '0.26', 'lle': '0.65', 'sei': '9.59'}",CHEMBL3672193,,CHEMBL3672193,6.77,False,http://www.openphacts.org/units/Nanomolar,2547572,=,37,True,=,,IC50,nM,,169.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,169.0
283006,17665351,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccccc2C(F)(F)F)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.26', 'le': '0.27', 'lle': '0.97', 'sei': '8.35'}",CHEMBL3672194,,CHEMBL3672194,5.62,False,http://www.openphacts.org/units/Nanomolar,2547573,=,37,True,=,,IC50,nM,,2382.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2382.0
283007,17665352,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2(C)C)n1)c1cnn(-c2ccccc2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '16.90', 'le': '0.31', 'lle': '2.83', 'sei': '7.51'}",CHEMBL3672195,,CHEMBL3672195,6.40,False,http://www.openphacts.org/units/Nanomolar,2547574,=,37,True,=,,IC50,nM,,401.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,401.0
283008,17665353,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(NCC23CC4CC(CC(C4)C2)C3)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.84', 'le': '0.28', 'lle': '1.41', 'sei': '8.16'}",CHEMBL3672196,,CHEMBL3672196,5.50,False,http://www.openphacts.org/units/Nanomolar,2547575,=,37,True,=,,IC50,nM,,3184.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3184.0
283009,17665354,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC(C)(C)[C@@H]2c2ccccc2)n1)C1CCCCC1,,,CHEMBL3638632,,2015.0,"{'bei': '16.94', 'le': '0.31', 'lle': '1.35', 'sei': '9.92'}",CHEMBL3672197,,CHEMBL3672197,6.68,False,http://www.openphacts.org/units/Nanomolar,2547576,=,37,True,=,,IC50,nM,,207.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,207.0
283010,17665355,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)C2CCCCC2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '19.41', 'le': '0.37', 'lle': '2.61', 'sei': '9.58'}",CHEMBL3672198,,CHEMBL3672198,6.45,False,http://www.openphacts.org/units/Nanomolar,2547577,=,37,True,=,,IC50,nM,,352.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,352.0
283011,17665356,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(COc1ccccc1)Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.04', 'le': '0.30', 'lle': '2.38', 'sei': '7.47'}",CHEMBL3672199,,CHEMBL3672199,5.72,False,http://www.openphacts.org/units/Nanomolar,2547578,=,37,True,=,,IC50,nM,,1918.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1918.0
283012,17665357,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC(C)(C)[C@@H]2c2ccccc2)n1)C1CCCCC1,,,CHEMBL3638632,,2015.0,"{'bei': '13.85', 'le': '0.26', 'lle': '0.13', 'sei': '8.11'}",CHEMBL3672200,,CHEMBL3672200,5.46,False,http://www.openphacts.org/units/Nanomolar,2547579,=,37,True,=,,IC50,nM,,3445.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3445.0
283013,17665358,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1nc(N[C@@H](C)c2ccc3ccccc3c2)ncc1Cl,,,CHEMBL3638632,,2015.0,,CHEMBL3672201,,CHEMBL3672201,,False,http://www.openphacts.org/units/Nanomolar,2547580,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
283014,17665359,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,[C-]#[N+]c1ccc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '17.83', 'le': '0.33', 'lle': '2.09', 'sei': '8.74'}",CHEMBL3672202,,CHEMBL3672202,6.27,False,http://www.openphacts.org/units/Nanomolar,2547581,=,37,True,=,,IC50,nM,,542.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,542.0
283015,17665360,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2(C)C)n1)c1cccc2ccccc12,,,CHEMBL3638632,,2015.0,"{'bei': '18.56', 'le': '0.34', 'lle': '2.19', 'sei': '9.99'}",CHEMBL3672203,,CHEMBL3672203,6.73,False,http://www.openphacts.org/units/Nanomolar,2547582,=,37,True,=,,IC50,nM,,188.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,188.0
283016,17665361,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC(C)(C)[C@H]2c2ccccc2)n1)c1ccc(F)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.98', 'le': '0.31', 'lle': '1.63', 'sei': '10.25'}",CHEMBL3672138,,CHEMBL3672138,6.90,False,http://www.openphacts.org/units/Nanomolar,2547516,=,37,True,=,,IC50,nM,,125.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,125.0
283017,17665362,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(S(N)(=O)=O)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '12.60', 'le': '0.25', 'lle': '2.83', 'sei': '4.01'}",CHEMBL3672204,,CHEMBL3672204,5.11,False,http://www.openphacts.org/units/Nanomolar,2547583,=,37,True,=,,IC50,nM,,7768.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,7768.0
283018,17665363,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(O)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.69', 'le': '0.31', 'lle': '2.38', 'sei': '6.53'}",CHEMBL3672205,,CHEMBL3672205,5.72,False,http://www.openphacts.org/units/Nanomolar,2547584,=,37,True,=,,IC50,nM,,1925.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1925.0
283019,17665364,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2(C)C)n1)C1CCCCC1,,,CHEMBL3638632,,2015.0,"{'bei': '19.34', 'le': '0.37', 'lle': '2.57', 'sei': '9.14'}",CHEMBL3672206,,CHEMBL3672206,6.16,False,http://www.openphacts.org/units/Nanomolar,2547585,=,37,True,=,,IC50,nM,,697.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,697.0
283020,17665365,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1nc(N[C@@H](C)c2ccc3ccccc3c2)ncc1F,,,CHEMBL3638632,,2015.0,"{'bei': '17.84', 'le': '0.33', 'lle': '2.12', 'sei': '10.45'}",CHEMBL3672207,,CHEMBL3672207,7.04,False,http://www.openphacts.org/units/Nanomolar,2547586,=,37,True,=,,IC50,nM,,92.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,92.0
283021,17665366,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1nc(N[C@@H](C)c2ccccc2)ncc1Cl,,,CHEMBL3638632,,2015.0,"{'bei': '15.77', 'le': '0.31', 'lle': '1.41', 'sei': '8.45'}",CHEMBL3672208,,CHEMBL3672208,5.69,False,http://www.openphacts.org/units/Nanomolar,2547587,=,37,True,=,,IC50,nM,,2038.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2038.0
283022,17665367,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)cc(OC)c1Br,,,CHEMBL3638632,,2015.0,"{'bei': '14.44', 'le': '0.32', 'lle': '2.31', 'sei': '7.83'}",CHEMBL3672176,,CHEMBL3672176,6.72,False,http://www.openphacts.org/units/Nanomolar,2547554,=,37,True,=,,IC50,nM,,190.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,190.0
283023,17665368,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)cc1OC,,,CHEMBL3638632,,2015.0,"{'bei': '14.91', 'le': '0.28', 'lle': '2.11', 'sei': '6.72'}",CHEMBL3672209,,CHEMBL3672209,5.76,False,http://www.openphacts.org/units/Nanomolar,2547588,=,37,True,=,,IC50,nM,,1727.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1727.0
283024,17665369,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc([C@H](C)Nc3nccc(N4C(=O)OCC4(C)C)n3)ccc2c1,,,CHEMBL3638632,,2015.0,"{'bei': '17.66', 'le': '0.33', 'lle': '2.38', 'sei': '9.05'}",CHEMBL3672210,,CHEMBL3672210,6.93,False,http://www.openphacts.org/units/Nanomolar,2547589,=,37,True,=,,IC50,nM,,117.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,117.0
283025,17665370,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC(C)(C)[C@@H]2c2ccccc2)n1)c1ccc2ccccc2c1,,,CHEMBL3638632,,2015.0,"{'bei': '14.27', 'le': '0.26', 'lle': '-0.02', 'sei': '9.29'}",CHEMBL3672211,,CHEMBL3672211,6.26,False,http://www.openphacts.org/units/Nanomolar,2547590,=,37,True,=,,IC50,nM,,552.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,552.5
283026,17665371,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC(C)(C)[C@@H]2c2ccccc2)n1)c1ccc(Br)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '14.07', 'le': '0.30', 'lle': '0.69', 'sei': '9.77'}",CHEMBL3672212,,CHEMBL3672212,6.58,False,http://www.openphacts.org/units/Nanomolar,2547591,=,37,True,=,,IC50,nM,,264.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,264.5
283027,17665372,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1cccc([C@H](C)Nc2nccc(N3C(=O)OC(C)(C)[C@@H]3c3ccccc3)n2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '15.70', 'le': '0.29', 'lle': '1.44', 'sei': '8.58'}",CHEMBL3672213,,CHEMBL3672213,6.57,False,http://www.openphacts.org/units/Nanomolar,2547592,=,37,True,=,,IC50,nM,,268.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,268.0
283028,17665373,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)ccc1F,,,CHEMBL3638632,,2015.0,"{'bei': '18.56', 'le': '0.35', 'lle': '3.17', 'sei': '9.08'}",CHEMBL3672214,,CHEMBL3672214,6.95,False,http://www.openphacts.org/units/Nanomolar,2547593,=,37,True,=,,IC50,nM,,112.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,112.0
283029,17665374,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2c2ccccc2)n1)c1ccc(Br)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '15.30', 'le': '0.33', 'lle': '1.61', 'sei': '9.98'}",CHEMBL3672215,,CHEMBL3672215,6.72,False,http://www.openphacts.org/units/Nanomolar,2547594,=,37,True,=,,IC50,nM,,189.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,189.5
283030,17665375,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cccc(N2CCOCC2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '14.57', 'le': '0.27', 'lle': '2.52', 'sei': '7.51'}",CHEMBL3672216,,CHEMBL3672216,6.00,False,http://www.openphacts.org/units/Nanomolar,2547595,=,37,True,=,,IC50,nM,,1012.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1012.0
283031,17665376,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc([C@H](C)Nc3nccc(N4C(=O)OC[C@H]4c4ccccc4)n3)ccc2c1,,,CHEMBL3638632,,2015.0,"{'bei': '15.73', 'le': '0.29', 'lle': '1.42', 'sei': '9.05'}",CHEMBL3672217,,CHEMBL3672217,6.93,False,http://www.openphacts.org/units/Nanomolar,2547596,=,37,True,=,,IC50,nM,,118.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,118.0
283032,17665377,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2(C)C)n1)c1ccc2ccccc2c1,,,CHEMBL3638632,,2015.0,"{'bei': '18.77', 'le': '0.34', 'lle': '2.26', 'sei': '10.10'}",CHEMBL3672218,,CHEMBL3672218,6.80,False,http://www.openphacts.org/units/Nanomolar,2547597,=,37,True,=,,IC50,nM,,158.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,158.0
283033,17665378,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2(C)C)n1)c1ccc(N2CCCCC2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '15.80', 'le': '0.29', 'lle': '1.87', 'sei': '8.85'}",CHEMBL3672219,,CHEMBL3672219,6.25,False,http://www.openphacts.org/units/Nanomolar,2547598,=,37,True,=,,IC50,nM,,565.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,565.0
283034,17665379,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1cccc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '17.76', 'le': '0.33', 'lle': '2.69', 'sei': '8.27'}",CHEMBL3672163,,CHEMBL3672163,6.33,False,http://www.openphacts.org/units/Nanomolar,2547541,=,37,True,=,,IC50,nM,,467.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,467.0
283035,17665380,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc2c(c1)OCCO2,,,CHEMBL3638632,,2015.0,"{'bei': '16.22', 'le': '0.30', 'lle': '2.84', 'sei': '7.27'}",CHEMBL3672220,,CHEMBL3672220,6.24,False,http://www.openphacts.org/units/Nanomolar,2547599,=,37,True,=,,IC50,nM,,582.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,582.0
283036,17665381,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cccnc1,,,CHEMBL3638632,,2015.0,"{'bei': '14.80', 'le': '0.28', 'lle': '1.81', 'sei': '6.04'}",CHEMBL3672221,,CHEMBL3672221,4.84,False,http://www.openphacts.org/units/Nanomolar,2547600,=,37,True,=,,IC50,nM,,14319.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,14319.0
283037,17665382,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,O=C1OC[C@H](Cc2ccccc2)N1c1ccnc(NC2CC2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.53', 'le': '0.27', 'lle': '1.89', 'sei': '6.69'}",CHEMBL3672222,,CHEMBL3672222,4.51,False,http://www.openphacts.org/units/Nanomolar,2547601,=,37,True,=,,IC50,nM,,31016.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,31016.0
283038,17665383,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,O=C1OC[C@H](Cc2ccccc2)N1c1ccnc(NC2CCCCC2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.61', 'le': '0.27', 'lle': '1.36', 'sei': '7.64'}",CHEMBL3672223,,CHEMBL3672223,5.15,False,http://www.openphacts.org/units/Nanomolar,2547602,=,37,True,=,,IC50,nM,,7115.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,7115.0
283039,17665384,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,O=C1OC[C@H](Cc2ccccc2)N1c1ccnc(NCc2ccccc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.28', 'le': '0.28', 'lle': '1.85', 'sei': '8.18'}",CHEMBL3672224,,CHEMBL3672224,5.51,False,http://www.openphacts.org/units/Nanomolar,2547603,=,37,True,=,,IC50,nM,,3102.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3102.0
283040,17665385,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC[C@@H]2Cc2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '13.18', 'le': '0.24', 'lle': '0.72', 'sei': '7.33'}",CHEMBL3672225,,CHEMBL3672225,4.94,False,http://www.openphacts.org/units/Nanomolar,2547604,=,37,True,=,,IC50,nM,,11600.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,11600.0
283041,17665386,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1nn(C)cc1C(C)Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.07', 'le': '0.28', 'lle': '2.52', 'sei': '6.09'}",CHEMBL3672226,,CHEMBL3672226,5.19,False,http://www.openphacts.org/units/Nanomolar,2547605,=,37,True,=,,IC50,nM,,6455.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6455.0
283042,17665387,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)C[C@H](C)Nc1nccc(N2C(=O)OC(C)(C)[C@@H]2c2ccccc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.93', 'le': '0.28', 'lle': '0.70', 'sei': '8.17'}",CHEMBL3672227,,CHEMBL3672227,5.50,False,http://www.openphacts.org/units/Nanomolar,2547606,=,37,True,=,,IC50,nM,,3140.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3140.0
283043,17665388,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)C[C@H](C)Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1,,,CHEMBL3638632,,2015.0,"{'bei': '19.50', 'le': '0.37', 'lle': '2.67', 'sei': '8.87'}",CHEMBL3672228,,CHEMBL3672228,5.97,False,http://www.openphacts.org/units/Nanomolar,2547607,=,37,True,=,,IC50,nM,,1061.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1061.0
283044,17665389,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2(C)C)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '18.90', 'le': '0.35', 'lle': '2.52', 'sei': '8.76'}",CHEMBL3672229,,CHEMBL3672229,5.90,False,http://www.openphacts.org/units/Nanomolar,2547608,=,37,True,=,,IC50,nM,,1252.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1252.0
283045,17665390,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@]2(C)c2ccccc2)n1)c1ccc(F)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '17.97', 'le': '0.33', 'lle': '2.39', 'sei': '10.47'}",CHEMBL3672230,,CHEMBL3672230,7.05,False,http://www.openphacts.org/units/Nanomolar,2547609,=,37,True,=,,IC50,nM,,89.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,89.0
283046,17665391,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@]2(C)c2ccccc2)n1)c1ccc(N2CCCCC2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '15.35', 'le': '0.28', 'lle': '1.51', 'sei': '9.95'}",CHEMBL3676992,,CHEMBL3676992,7.02,False,http://www.openphacts.org/units/Nanomolar,2552748,=,37,True,=,,IC50,nM,,95.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,95.0
283047,17665392,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2Cc2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.95', 'le': '0.31', 'lle': '2.13', 'sei': '9.42'}",CHEMBL3676993,,CHEMBL3676993,6.35,False,http://www.openphacts.org/units/Nanomolar,2552749,=,37,True,=,,IC50,nM,,451.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,451.0
283048,17665393,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,O=C1OC[C@@H](Cc2ccccc2)N1c1ccnc(NC2CC2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3676994,,CHEMBL3676994,,False,http://www.openphacts.org/units/Nanomolar,2552750,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
283049,17665394,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,O=C1OC[C@@H](Cc2ccccc2)N1c1ccnc(NC2CCCCCC2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3676995,,CHEMBL3676995,,False,http://www.openphacts.org/units/Nanomolar,2552751,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
283050,17665395,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,O=C1OC[C@@H](Cc2ccccc2)N1c1ccnc(NC2CCCCC2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.66', 'le': '0.27', 'lle': '1.38', 'sei': '7.67'}",CHEMBL3676996,,CHEMBL3676996,5.17,False,http://www.openphacts.org/units/Nanomolar,2552752,=,37,True,=,,IC50,nM,,6807.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6807.0
283051,17665396,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,O=C1OC[C@@H](Cc2ccccc2)N1c1ccnc(NCc2ccccc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.72', 'le': '0.25', 'lle': '1.28', 'sei': '7.34'}",CHEMBL3676997,,CHEMBL3676997,4.95,False,http://www.openphacts.org/units/Nanomolar,2552753,=,37,True,=,,IC50,nM,,11362.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,11362.0
283052,17665397,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC[C@H]2Cc2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '13.86', 'le': '0.25', 'lle': '0.97', 'sei': '7.71'}",CHEMBL3676998,,CHEMBL3676998,5.19,False,http://www.openphacts.org/units/Nanomolar,2552754,=,37,True,=,,IC50,nM,,6445.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6445.0
283053,17665398,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@H]2Cc2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '14.56', 'le': '0.27', 'lle': '1.23', 'sei': '8.09'}",CHEMBL3676999,,CHEMBL3676999,5.45,False,http://www.openphacts.org/units/Nanomolar,2552755,=,37,True,=,,IC50,nM,,3544.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3544.0
283054,17665399,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1cnc(N[C@@H](C)c2ccccc2)nc1N1C(=O)OC[C@@H]1C(C)C,,,CHEMBL3638632,,2015.0,"{'bei': '18.18', 'le': '0.34', 'lle': '2.25', 'sei': '9.19'}",CHEMBL3677000,,CHEMBL3677000,6.19,False,http://www.openphacts.org/units/Nanomolar,2552756,=,37,True,=,,IC50,nM,,647.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,647.0
283055,17665400,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1nc(N[C@@H](C)c2ccccc2)ncc1F,,,CHEMBL3638632,,2015.0,"{'bei': '18.22', 'le': '0.34', 'lle': '2.51', 'sei': '9.32'}",CHEMBL3677001,,CHEMBL3677001,6.28,False,http://www.openphacts.org/units/Nanomolar,2552757,=,37,True,=,,IC50,nM,,530.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,530.0
283056,17665401,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1cccc([C@H](C)Nc2ncc(C)c(N3C(=O)OC[C@@H]3C(C)C)n2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '15.83', 'le': '0.30', 'lle': '1.92', 'sei': '7.66'}",CHEMBL3677002,,CHEMBL3677002,5.87,False,http://www.openphacts.org/units/Nanomolar,2552758,=,37,True,=,,IC50,nM,,1363.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1363.0
283057,17665402,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1cnc(N[C@@H](C)c2ccc3ccccc3c2)nc1N1C(=O)OC[C@@H]1C(C)C,,,CHEMBL3638632,,2015.0,"{'bei': '16.43', 'le': '0.30', 'lle': '1.32', 'sei': '9.52'}",CHEMBL3677003,,CHEMBL3677003,6.42,False,http://www.openphacts.org/units/Nanomolar,2552759,=,37,True,=,,IC50,nM,,385.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,385.0
283058,17665403,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1cccc([C@H](C)Nc2ncc(F)c(N3C(=O)OC[C@@H]3C(C)C)n2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '16.34', 'le': '0.31', 'lle': '2.34', 'sei': '7.99'}",CHEMBL3677004,,CHEMBL3677004,6.12,False,http://www.openphacts.org/units/Nanomolar,2552760,=,37,True,=,,IC50,nM,,759.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,759.0
283059,17665404,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@]2(C)c2ccccc2)n1)c1ccc2ccccc2c1,,,CHEMBL3638632,,2015.0,"{'bei': '17.22', 'le': '0.31', 'lle': '1.64', 'sei': '10.85'}",CHEMBL3677005,,CHEMBL3677005,7.31,False,http://www.openphacts.org/units/Nanomolar,2552761,=,37,True,=,,IC50,nM,,49.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,49.0
283060,17665405,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc([C@H](C)Nc3nccc(N4C(=O)OC[C@]4(C)c4ccccc4)n3)ccc2c1,,,CHEMBL3638632,,2015.0,"{'bei': '16.28', 'le': '0.30', 'lle': '1.72', 'sei': '9.66'}",CHEMBL3677006,,CHEMBL3677006,7.40,False,http://www.openphacts.org/units/Nanomolar,2552762,=,37,True,=,,IC50,nM,,40.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,40.0
283061,17665406,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@]2(C)c2ccccc2)n1)C1CCCCC1,,,CHEMBL3638632,,2015.0,"{'bei': '17.44', 'le': '0.32', 'lle': '1.90', 'sei': '9.85'}",CHEMBL3677007,,CHEMBL3677007,6.63,False,http://www.openphacts.org/units/Nanomolar,2552763,=,37,True,=,,IC50,nM,,232.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,232.0
283062,17665407,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](CO)Nc1nccc(N2C(=O)OC(C)(C)[C@@H]2c2ccccc2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3677008,,CHEMBL3677008,,False,http://www.openphacts.org/units/Nanomolar,2552764,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
283063,17665408,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC(C)(C)[C@@H]2c2ccccc2)n1)C(C)(C)C,,,CHEMBL3638632,,2015.0,"{'bei': '16.44', 'le': '0.31', 'lle': '1.26', 'sei': '9.00'}",CHEMBL3677009,,CHEMBL3677009,6.06,False,http://www.openphacts.org/units/Nanomolar,2552765,=,37,True,=,,IC50,nM,,873.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,873.0
283064,17665409,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@H]2c2ccccc2)n1)c1cccc2ccccc12,,,CHEMBL3638632,,2015.0,"{'bei': '15.94', 'le': '0.29', 'lle': '1.04', 'sei': '9.71'}",CHEMBL3677010,,CHEMBL3677010,6.54,False,http://www.openphacts.org/units/Nanomolar,2552766,=,37,True,=,,IC50,nM,,287.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,287.0
283065,17665410,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)C(C)(C)C)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.02', 'le': '0.32', 'lle': '1.92', 'sei': '7.74'}",CHEMBL3677011,,CHEMBL3677011,5.22,False,http://www.openphacts.org/units/Nanomolar,2552767,=,37,True,=,,IC50,nM,,6078.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6078.0
283066,17665411,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)C2CC2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.86', 'le': '0.34', 'lle': '2.52', 'sei': '7.70'}",CHEMBL3677012,,CHEMBL3677012,5.19,False,http://www.openphacts.org/units/Nanomolar,2552768,=,37,True,=,,IC50,nM,,6502.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6502.0
283067,17665412,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(Oc3ccccc3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '18.30', 'le': '0.34', 'lle': '2.24', 'sei': '10.00'}",CHEMBL3677013,,CHEMBL3677013,7.66,False,http://www.openphacts.org/units/Nanomolar,2552769,=,37,True,=,,IC50,nM,,22.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,22.0
283068,17665413,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc3c(c2)CCO3)n1,,,CHEMBL3638632,,2015.0,"{'bei': '18.53', 'le': '0.35', 'lle': '3.26', 'sei': '8.91'}",CHEMBL3677014,,CHEMBL3677014,6.83,False,http://www.openphacts.org/units/Nanomolar,2552770,=,37,True,=,,IC50,nM,,149.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,149.0
283069,17665414,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(C)(C)C)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '18.75', 'le': '0.35', 'lle': '2.24', 'sei': '10.65'}",CHEMBL3677015,,CHEMBL3677015,7.17,False,http://www.openphacts.org/units/Nanomolar,2552771,=,37,True,=,,IC50,nM,,67.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,67.0
283070,17665415,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC(C)(C)[C@@H]2c2ccccc2)n1)C1CC1,,,CHEMBL3638632,,2015.0,"{'bei': '19.12', 'le': '0.35', 'lle': '2.58', 'sei': '10.00'}",CHEMBL3677016,,CHEMBL3677016,6.74,False,http://www.openphacts.org/units/Nanomolar,2552772,=,37,True,=,,IC50,nM,,183.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,183.0
283071,17665416,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc([C@H](C)Nc2ncc(F)c(N3C(=O)OC[C@@H]3C(C)C)n2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.55', 'le': '0.31', 'lle': '2.42', 'sei': '8.09'}",CHEMBL3677017,,CHEMBL3677017,6.20,False,http://www.openphacts.org/units/Nanomolar,2552773,=,37,True,=,,IC50,nM,,637.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,637.0
283072,17665417,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC(C)(C)[C@H]2c2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.98', 'le': '0.31', 'lle': '1.47', 'sei': '9.79'}",CHEMBL3677018,,CHEMBL3677018,6.59,False,http://www.openphacts.org/units/Nanomolar,2552774,=,37,True,=,,IC50,nM,,254.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,254.0
283073,17665418,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC(C)(C)[C@H]2c2ccccc2)n1)c1ccc2ccccc2c1,,,CHEMBL3638632,,2015.0,"{'bei': '15.94', 'le': '0.29', 'lle': '0.71', 'sei': '10.38'}",CHEMBL3677019,,CHEMBL3677019,6.99,False,http://www.openphacts.org/units/Nanomolar,2552775,=,37,True,=,,IC50,nM,,102.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,102.0
283074,17665419,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@H]3c3ccccc3)n2)ccc1F,,,CHEMBL3638632,,2015.0,"{'bei': '16.43', 'le': '0.31', 'lle': '2.21', 'sei': '8.76'}",CHEMBL3677020,,CHEMBL3677020,6.71,False,http://www.openphacts.org/units/Nanomolar,2552776,=,37,True,=,,IC50,nM,,195.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,195.0
283075,17665420,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(NC(c2ccccc2)C(F)(F)F)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.68', 'le': '0.30', 'lle': '1.80', 'sei': '8.86'}",CHEMBL3677021,,CHEMBL3677021,5.96,False,http://www.openphacts.org/units/Nanomolar,2552777,=,37,True,=,,IC50,nM,,1083.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1083.0
283076,17665421,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cccc(F)c1,,,CHEMBL3638632,,2015.0,"{'bei': '15.13', 'le': '0.28', 'lle': '1.44', 'sei': '7.74'}",CHEMBL3677022,,CHEMBL3677022,5.21,False,http://www.openphacts.org/units/Nanomolar,2552778,=,37,True,=,,IC50,nM,,6161.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6161.0
283077,17665422,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cccc(F)c1,,,CHEMBL3638632,,2015.0,"{'bei': '19.12', 'le': '0.36', 'lle': '2.82', 'sei': '9.78'}",CHEMBL3677022,,CHEMBL3677022,6.59,False,http://www.openphacts.org/units/Nanomolar,2552778,=,37,True,=,,IC50,nM,,259.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,259.5
283078,17665423,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(-c2ccccc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '13.76', 'le': '0.25', 'lle': '0.24', 'sei': '8.22'}",CHEMBL3677023,,CHEMBL3677023,5.54,False,http://www.openphacts.org/units/Nanomolar,2552779,=,37,True,=,,IC50,nM,,2908.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2908.0
283079,17665424,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(-c2ccccc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '17.54', 'le': '0.32', 'lle': '1.76', 'sei': '10.48'}",CHEMBL3677023,,CHEMBL3677023,7.06,False,http://www.openphacts.org/units/Nanomolar,2552779,=,37,True,=,,IC50,nM,,87.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,87.0
283080,17665425,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(Cl)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '14.10', 'le': '0.28', 'lle': '0.81', 'sei': '7.56'}",CHEMBL3677024,,CHEMBL3677024,5.09,False,http://www.openphacts.org/units/Nanomolar,2552780,=,37,True,=,,IC50,nM,,8156.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,8156.0
283081,17665426,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(Cl)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '19.13', 'le': '0.38', 'lle': '2.62', 'sei': '10.25'}",CHEMBL3677024,,CHEMBL3677024,6.90,False,http://www.openphacts.org/units/Nanomolar,2552780,=,37,True,=,,IC50,nM,,125.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,125.0
283082,17665427,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(Cl)c(Cl)c1,,,CHEMBL3638632,,2015.0,"{'bei': '13.57', 'le': '0.28', 'lle': '0.42', 'sei': '7.96'}",CHEMBL3677025,,CHEMBL3677025,5.36,False,http://www.openphacts.org/units/Nanomolar,2552781,=,37,True,=,,IC50,nM,,4333.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4333.0
283083,17665428,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(Cl)c(Cl)c1,,,CHEMBL3638632,,2015.0,"{'bei': '17.74', 'le': '0.37', 'lle': '2.07', 'sei': '10.41'}",CHEMBL3677025,,CHEMBL3677025,7.01,False,http://www.openphacts.org/units/Nanomolar,2552781,=,37,True,=,,IC50,nM,,97.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,97.0
283084,17665429,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cccc(-n2cccc2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '13.34', 'le': '0.25', 'lle': '0.80', 'sei': '7.23'}",CHEMBL3677026,,CHEMBL3677026,5.22,False,http://www.openphacts.org/units/Nanomolar,2552782,=,37,True,=,,IC50,nM,,5973.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5973.0
283085,17665430,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cccc(-n2cccc2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '17.15', 'le': '0.32', 'lle': '2.29', 'sei': '9.29'}",CHEMBL3677026,,CHEMBL3677026,6.71,False,http://www.openphacts.org/units/Nanomolar,2558227,=,37,True,=,,IC50,nM,,194.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,194.0
283086,17665431,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(-n2cccc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '12.75', 'le': '0.24', 'lle': '0.57', 'sei': '6.90'}",CHEMBL3677027,,CHEMBL3677027,4.99,False,http://www.openphacts.org/units/Nanomolar,2552783,=,37,True,=,,IC50,nM,,10232.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,10232.0
283087,17665432,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(-n2cccc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.52', 'le': '0.30', 'lle': '2.05', 'sei': '8.95'}",CHEMBL3677027,,CHEMBL3677027,6.47,False,http://www.openphacts.org/units/Nanomolar,2552783,=,37,True,=,,IC50,nM,,339.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,339.5
283088,17665433,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)cc1OC,,,CHEMBL3638632,,2015.0,"{'bei': '11.47', 'le': '0.22', 'lle': '0.78', 'sei': '5.17'}",CHEMBL3672209,,CHEMBL3672209,4.43,False,http://www.openphacts.org/units/Nanomolar,2552784,=,37,True,=,,IC50,nM,,36818.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,36818.0
283089,17665434,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)cc1OC,,,CHEMBL3638632,,2015.0,"{'bei': '15.93', 'le': '0.30', 'lle': '2.51', 'sei': '7.18'}",CHEMBL3672209,,CHEMBL3672209,6.16,False,http://www.openphacts.org/units/Nanomolar,2552784,=,37,True,=,,IC50,nM,,696.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,696.0
283090,17665435,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(N2CCCCC2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '12.74', 'le': '0.24', 'lle': '0.60', 'sei': '7.39'}",CHEMBL3677028,,CHEMBL3677028,5.22,False,http://www.openphacts.org/units/Nanomolar,2552785,=,37,True,=,,IC50,nM,,6066.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6066.0
283091,17665436,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(N2CCCCC2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '18.06', 'le': '0.34', 'lle': '2.78', 'sei': '10.48'}",CHEMBL3677028,,CHEMBL3677028,7.40,False,http://www.openphacts.org/units/Nanomolar,2552785,=,37,True,=,,IC50,nM,,40.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,40.0
283092,17665437,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cnn(-c2ccccc2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '13.78', 'le': '0.25', 'lle': '1.59', 'sei': '6.35'}",CHEMBL3677029,,CHEMBL3677029,5.41,False,http://www.openphacts.org/units/Nanomolar,2552786,=,37,True,=,,IC50,nM,,3899.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3899.0
283093,17665438,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cnn(-c2ccccc2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '17.97', 'le': '0.33', 'lle': '3.23', 'sei': '8.28'}",CHEMBL3677029,,CHEMBL3677029,7.05,False,http://www.openphacts.org/units/Nanomolar,2552786,=,37,True,=,,IC50,nM,,89.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,89.0
283094,17665439,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@H]2c2ccccc2)n1)c1ccc(-c2ccccc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '15.88', 'le': '0.29', 'lle': '0.92', 'sei': '10.29'}",CHEMBL3677030,,CHEMBL3677030,6.93,False,http://www.openphacts.org/units/Nanomolar,2552787,=,37,True,=,,IC50,nM,,117.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,117.0
283095,17665440,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@H]2c2ccccc2)n1)c1ccc(-c2ccccc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '12.99', 'le': '0.23', 'lle': '-0.34', 'sei': '8.42'}",CHEMBL3677030,,CHEMBL3677030,5.67,False,http://www.openphacts.org/units/Nanomolar,2552787,=,37,True,=,,IC50,nM,,2134.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2134.0
283096,17665441,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc2c(c1)OCCO2,,,CHEMBL3638632,,2015.0,"{'bei': '13.41', 'le': '0.25', 'lle': '1.76', 'sei': '6.01'}",CHEMBL3672220,,CHEMBL3672220,5.16,False,http://www.openphacts.org/units/Nanomolar,2552788,=,37,True,=,,IC50,nM,,6969.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6969.0
283097,17665442,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc2c(c1)OCCO2,,,CHEMBL3638632,,2015.0,"{'bei': '17.31', 'le': '0.32', 'lle': '3.26', 'sei': '7.76'}",CHEMBL3672220,,CHEMBL3672220,6.66,False,http://www.openphacts.org/units/Nanomolar,2552788,=,37,True,=,,IC50,nM,,221.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,221.0
283098,17665443,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@H]2c2ccccc2)n1)c1ccc(Cl)c(Cl)c1,,,CHEMBL3638632,,2015.0,"{'bei': '16.34', 'le': '0.33', 'lle': '1.36', 'sei': '10.41'}",CHEMBL3677031,,CHEMBL3677031,7.01,False,http://www.openphacts.org/units/Nanomolar,2552789,=,37,True,=,,IC50,nM,,97.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,97.0
283099,17665444,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@H]2c2ccccc2)n1)c1ccc(Cl)c(Cl)c1,,,CHEMBL3638632,,2015.0,"{'bei': '12.49', 'le': '0.25', 'lle': '-0.29', 'sei': '7.96'}",CHEMBL3677031,,CHEMBL3677031,5.36,False,http://www.openphacts.org/units/Nanomolar,2552789,=,37,True,=,,IC50,nM,,4333.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4333.0
283100,17665445,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@]2(C)c2ccccc2)n1)c1ccc(N2CCCCC2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '11.45', 'le': '0.21', 'lle': '-0.27', 'sei': '7.42'}",CHEMBL3676992,,CHEMBL3676992,5.24,False,http://www.openphacts.org/units/Nanomolar,2552790,=,37,True,=,,IC50,nM,,5748.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5748.0
283101,17665446,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@]2(C)c2ccccc2)n1)c1ccc(N2CCCCC2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '15.47', 'le': '0.28', 'lle': '1.57', 'sei': '10.03'}",CHEMBL3676992,,CHEMBL3676992,7.08,False,http://www.openphacts.org/units/Nanomolar,2552790,=,37,True,=,,IC50,nM,,83.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,83.0
283102,17665447,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2(C)C)n1)c1ccc(N2CCCCC2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '12.19', 'le': '0.23', 'lle': '0.44', 'sei': '6.83'}",CHEMBL3672219,,CHEMBL3672219,4.82,False,http://www.openphacts.org/units/Nanomolar,2552791,=,37,True,=,,IC50,nM,,15050.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,15050.0
283103,17665448,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2(C)C)n1)c1ccc(N2CCCCC2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '17.10', 'le': '0.32', 'lle': '2.38', 'sei': '9.58'}",CHEMBL3672219,,CHEMBL3672219,6.76,False,http://www.openphacts.org/units/Nanomolar,2552791,=,37,True,=,,IC50,nM,,173.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,173.0
283104,17665449,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cnn(-c2ccc(F)cc2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '13.68', 'le': '0.26', 'lle': '1.65', 'sei': '6.59'}",CHEMBL3677032,,CHEMBL3677032,5.61,False,http://www.openphacts.org/units/Nanomolar,2552792,=,37,True,=,,IC50,nM,,2435.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2435.0
283105,17665450,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cnn(-c2ccc(F)cc2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '17.29', 'le': '0.32', 'lle': '3.14', 'sei': '8.33'}",CHEMBL3677032,,CHEMBL3677032,7.10,False,http://www.openphacts.org/units/Nanomolar,2552792,=,37,True,=,,IC50,nM,,80.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,80.0
283106,17665451,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-n2cc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)cn2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '14.28', 'le': '0.27', 'lle': '2.20', 'sei': '6.39'}",CHEMBL3639758,,CHEMBL3639758,6.03,False,http://www.openphacts.org/units/Nanomolar,2552793,=,37,True,=,,IC50,nM,,927.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,927.0
283107,17665452,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-n2cc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)cn2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '17.99', 'le': '0.33', 'lle': '3.77', 'sei': '8.05'}",CHEMBL3639758,,CHEMBL3639758,7.60,False,http://www.openphacts.org/units/Nanomolar,2552793,=,37,True,=,,IC50,nM,,25.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25.0
283108,17665453,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C2N(c3ccnc(NC(C)c4ccccc4)n3)C(=O)OC2(C)C)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '13.70', 'le': '0.25', 'lle': '0.60', 'sei': '7.48'}",CHEMBL3677033,,CHEMBL3677033,5.73,False,http://www.openphacts.org/units/Nanomolar,2552794,=,37,True,=,,IC50,nM,,1856.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1856.0
283109,17665454,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C2N(c3ccnc(NC(C)c4ccccc4)n3)C(=O)OC2(C)C)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '17.22', 'le': '0.32', 'lle': '2.08', 'sei': '9.41'}",CHEMBL3677033,,CHEMBL3677033,7.21,False,http://www.openphacts.org/units/Nanomolar,2552794,=,37,True,=,,IC50,nM,,62.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,62.0
283110,17665455,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCNC(C)(C)C3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.81', 'le': '0.28', 'lle': '2.89', 'sei': '8.11'}",CHEMBL3677034,,CHEMBL3677034,6.70,False,http://www.openphacts.org/units/Nanomolar,2552795,=,37,True,=,,IC50,nM,,199.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,199.0
283111,17665456,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCNCC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.75', 'le': '0.26', 'lle': '2.80', 'sei': '7.06'}",CHEMBL3677035,,CHEMBL3677035,5.84,False,http://www.openphacts.org/units/Nanomolar,2552796,=,37,True,=,,IC50,nM,,1458.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1458.0
283112,17665457,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2ccc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)cc2)ccn1,,,CHEMBL3638632,,2015.0,"{'bei': '17.15', 'le': '0.32', 'lle': '2.16', 'sei': '8.92'}",CHEMBL3677036,,CHEMBL3677036,7.16,False,http://www.openphacts.org/units/Nanomolar,2552797,=,37,True,=,,IC50,nM,,69.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,69.0
283113,17665458,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3cnn(C)c3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.39', 'le': '0.32', 'lle': '3.04', 'sei': '8.30'}",CHEMBL3677037,,CHEMBL3677037,7.07,False,http://www.openphacts.org/units/Nanomolar,2552798,=,37,True,=,,IC50,nM,,85.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,85.0
283114,17665459,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(NC(=O)C3CCCCC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.62', 'le': '0.29', 'lle': '1.91', 'sei': '7.32'}",CHEMBL3677038,,CHEMBL3677038,7.06,False,http://www.openphacts.org/units/Nanomolar,2552799,=,37,True,=,,IC50,nM,,88.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,88.0
283115,17665460,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CC4CN(C)CC4C3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.43', 'le': '0.25', 'lle': '2.62', 'sei': '8.45'}",CHEMBL3677039,,CHEMBL3677039,6.24,False,http://www.openphacts.org/units/Nanomolar,2552800,=,37,True,=,,IC50,nM,,576.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,576.0
283116,17665461,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OCC23CCCC3)n1)c1ccc(Oc2ccccc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '15.34', 'le': '0.28', 'lle': '1.03', 'sei': '8.98'}",CHEMBL3677041,,CHEMBL3677041,6.88,False,http://www.openphacts.org/units/Nanomolar,2552802,=,37,True,=,,IC50,nM,,132.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,132.0
283117,17665462,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(NCC2CCCCC2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.38', 'le': '0.33', 'lle': '2.09', 'sei': '8.22'}",CHEMBL3677042,,CHEMBL3677042,5.54,False,http://www.openphacts.org/units/Nanomolar,2552803,=,37,True,=,,IC50,nM,,2913.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2913.0
283118,17665463,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@H]2c2ccccc2)n1)c1ccc(Br)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '14.85', 'le': '0.32', 'lle': '1.42', 'sei': '9.69'}",CHEMBL3677043,,CHEMBL3677043,6.53,False,http://www.openphacts.org/units/Nanomolar,2552804,=,37,True,=,,IC50,nM,,298.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,298.0
283119,17665464,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCn4cnnc4C3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.86', 'le': '0.26', 'lle': '3.17', 'sei': '6.33'}",CHEMBL3677044,,CHEMBL3677044,6.41,False,http://www.openphacts.org/units/Nanomolar,2552805,=,37,True,=,,IC50,nM,,390.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,390.0
283120,17665465,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN(C)C(C)(C)C3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.49', 'le': '0.29', 'lle': '3.21', 'sei': '10.17'}",CHEMBL3677045,,CHEMBL3677045,7.51,False,http://www.openphacts.org/units/Nanomolar,2552806,=,37,True,=,,IC50,nM,,31.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,31.0
283121,17665466,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN(C)CC3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.71', 'le': '0.28', 'lle': '3.20', 'sei': '9.10'}",CHEMBL3677046,,CHEMBL3677046,6.72,False,http://www.openphacts.org/units/Nanomolar,2552807,=,37,True,=,,IC50,nM,,191.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,191.5
283122,17665467,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC1CN(Cc2ccc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)cc2)CC(C)N1,,,CHEMBL3638632,,2015.0,"{'bei': '12.95', 'le': '0.24', 'lle': '2.05', 'sei': '7.10'}",CHEMBL3677047,,CHEMBL3677047,5.86,False,http://www.openphacts.org/units/Nanomolar,2552808,=,37,True,=,,IC50,nM,,1373.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1373.0
283123,17665468,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCCN(C)CC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.73', 'le': '0.26', 'lle': '2.44', 'sei': '8.41'}",CHEMBL3677048,,CHEMBL3677048,6.21,False,http://www.openphacts.org/units/Nanomolar,2552809,=,37,True,=,,IC50,nM,,613.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,613.0
283124,17665469,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN(C(C)(C)C)CC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.06', 'le': '0.24', 'lle': '1.73', 'sei': '8.50'}",CHEMBL3677049,,CHEMBL3677049,6.28,False,http://www.openphacts.org/units/Nanomolar,2552810,=,37,True,=,,IC50,nM,,529.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,529.0
283125,17665470,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN(C)C(C)(C)C3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.02', 'le': '0.28', 'lle': '2.85', 'sei': '9.49'}",CHEMBL3677050,,CHEMBL3677050,7.01,False,http://www.openphacts.org/units/Nanomolar,2552811,=,37,True,=,,IC50,nM,,98.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,98.0
283126,17665471,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN(C(C)C)CC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.49', 'le': '0.25', 'lle': '2.14', 'sei': '8.53'}",CHEMBL3677051,,CHEMBL3677051,6.30,False,http://www.openphacts.org/units/Nanomolar,2552812,=,37,True,=,,IC50,nM,,505.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,505.0
283127,17665472,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN(C)C(C)C3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.43', 'le': '0.27', 'lle': '2.76', 'sei': '8.85'}",CHEMBL3677052,,CHEMBL3677052,6.53,False,http://www.openphacts.org/units/Nanomolar,2552813,=,37,True,=,,IC50,nM,,293.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,293.0
283128,17665473,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCC(F)(F)CC3)cc2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3677053,,CHEMBL3677053,,False,http://www.openphacts.org/units/Nanomolar,2552814,<,37,True,<,,IC50,nM,,22.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,22.0
283129,17665474,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)NC3CCC(OCC(F)(F)F)CC3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.36', 'le': '0.26', 'lle': '2.20', 'sei': '7.18'}",CHEMBL3677054,,CHEMBL3677054,7.58,False,http://www.openphacts.org/units/Nanomolar,2552815,=,37,True,=,,IC50,nM,,26.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,26.0
283130,17665475,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)NC3CCC(C)(O)CC3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.90', 'le': '0.26', 'lle': '2.75', 'sei': '5.95'}",CHEMBL3677055,,CHEMBL3677055,6.94,False,http://www.openphacts.org/units/Nanomolar,2552816,=,37,True,=,,IC50,nM,,114.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,114.0
283131,17665476,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN4CCCC4C3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.89', 'le': '0.28', 'lle': '3.14', 'sei': '9.73'}",CHEMBL3677056,,CHEMBL3677056,7.19,False,http://www.openphacts.org/units/Nanomolar,2552817,=,37,True,=,,IC50,nM,,65.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,65.0
283132,17665477,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN(C4CC4)CC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.44', 'le': '0.29', 'lle': '3.26', 'sei': '9.72'}",CHEMBL3677057,,CHEMBL3677057,7.17,False,http://www.openphacts.org/units/Nanomolar,2552818,=,37,True,=,,IC50,nM,,67.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,67.0
283133,17665478,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN(C4CCC4)CC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.51', 'le': '0.27', 'lle': '2.65', 'sei': '9.41'}",CHEMBL3677058,,CHEMBL3677058,6.95,False,http://www.openphacts.org/units/Nanomolar,2552819,=,37,True,=,,IC50,nM,,113.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,113.0
283134,17665479,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN4CCCCC4C3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.92', 'le': '0.28', 'lle': '2.84', 'sei': '9.67'}",CHEMBL3677059,,CHEMBL3677059,7.14,False,http://www.openphacts.org/units/Nanomolar,2552820,=,37,True,=,,IC50,nM,,72.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,72.0
283135,17665480,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3C4CCC3CN(C)C4)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.96', 'le': '0.26', 'lle': '2.58', 'sei': '8.78'}",CHEMBL3677060,,CHEMBL3677060,6.49,False,http://www.openphacts.org/units/Nanomolar,2552821,=,37,True,=,,IC50,nM,,327.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,327.0
283136,17665481,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CC4CCC(C3)N4C)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.21', 'le': '0.27', 'lle': '2.69', 'sei': '8.94'}",CHEMBL3677061,,CHEMBL3677061,6.60,False,http://www.openphacts.org/units/Nanomolar,2552822,=,37,True,=,,IC50,nM,,251.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,251.0
283137,17665482,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN4CCCC4C3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.71', 'le': '0.27', 'lle': '2.92', 'sei': '9.25'}",CHEMBL3677062,,CHEMBL3677062,6.83,False,http://www.openphacts.org/units/Nanomolar,2552823,=,37,True,=,,IC50,nM,,147.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,147.0
283138,17665483,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2nn[nH]n2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3677063,,CHEMBL3677063,,False,http://www.openphacts.org/units/Nanomolar,2552824,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
283139,17665484,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN(C(=O)OCc4ccccc4)CC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.26', 'le': '0.25', 'lle': '2.32', 'sei': '7.40'}",CHEMBL3677064,,CHEMBL3677064,7.41,False,http://www.openphacts.org/units/Nanomolar,2552825,=,37,True,=,,IC50,nM,,39.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,39.0
283140,17665485,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCC(C)(N)CC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.21', 'le': '0.27', 'lle': '2.49', 'sei': '6.66'}",CHEMBL3677065,,CHEMBL3677065,6.43,False,http://www.openphacts.org/units/Nanomolar,2552826,=,37,True,=,,IC50,nM,,372.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,372.0
283141,17665486,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCC(N(C)C)CC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '12.98', 'le': '0.24', 'lle': '1.90', 'sei': '8.20'}",CHEMBL3677066,,CHEMBL3677066,6.06,False,http://www.openphacts.org/units/Nanomolar,2552827,=,37,True,=,,IC50,nM,,877.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,877.0
283142,17665487,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)NC(C)(C)C)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.44', 'le': '0.33', 'lle': '3.26', 'sei': '7.69'}",CHEMBL3677068,,CHEMBL3677068,7.42,False,http://www.openphacts.org/units/Nanomolar,2552829,=,37,True,=,,IC50,nM,,38.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,38.0
283143,17665488,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)NC3CCCCC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.66', 'le': '0.31', 'lle': '2.83', 'sei': '7.80'}",CHEMBL3677069,,CHEMBL3677069,7.52,False,http://www.openphacts.org/units/Nanomolar,2552830,=,37,True,=,,IC50,nM,,30.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,30.0
283144,17665489,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)Nc3ccccc3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.28', 'le': '0.28', 'lle': '1.93', 'sei': '7.06'}",CHEMBL3677070,,CHEMBL3677070,6.81,False,http://www.openphacts.org/units/Nanomolar,2552831,=,37,True,=,,IC50,nM,,155.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,155.0
283145,17665490,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N3CCCCC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.73', 'le': '0.31', 'lle': '3.06', 'sei': '8.35'}",CHEMBL3677071,,CHEMBL3677071,7.32,False,http://www.openphacts.org/units/Nanomolar,2552832,=,37,True,=,,IC50,nM,,48.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,48.0
283146,17665491,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N3CCN(C)CC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.77', 'le': '0.26', 'lle': '3.21', 'sei': '6.86'}",CHEMBL3677072,,CHEMBL3677072,6.23,False,http://www.openphacts.org/units/Nanomolar,2552833,=,37,True,=,,IC50,nM,,587.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,587.0
283147,17665492,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCCCC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.32', 'le': '0.27', 'lle': '1.44', 'sei': '8.59'}",CHEMBL3677073,,CHEMBL3677073,6.06,False,http://www.openphacts.org/units/Nanomolar,2552834,=,37,True,=,,IC50,nM,,863.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,863.0
283148,17665493,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCOCC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.83', 'le': '0.30', 'lle': '3.28', 'sei': '8.44'}",CHEMBL3677074,,CHEMBL3677074,6.74,False,http://www.openphacts.org/units/Nanomolar,2552835,=,37,True,=,,IC50,nM,,184.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,184.0
283149,17665494,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN(C)CC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.29', 'le': '0.27', 'lle': '2.89', 'sei': '8.49'}",CHEMBL3677075,,CHEMBL3677075,6.26,False,http://www.openphacts.org/units/Nanomolar,2552836,=,37,True,=,,IC50,nM,,543.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,543.0
283150,17665495,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@]2(C)c2ccc(F)cc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '14.94', 'le': '0.28', 'lle': '1.20', 'sei': '8.70'}",CHEMBL3677076,,CHEMBL3677076,5.86,False,http://www.openphacts.org/units/Nanomolar,2552837,=,37,True,=,,IC50,nM,,1373.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1373.0
283151,17665496,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC23CCCC3)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '18.21', 'le': '0.34', 'lle': '2.24', 'sei': '9.15'}",CHEMBL3677077,,CHEMBL3677077,6.16,False,http://www.openphacts.org/units/Nanomolar,2552838,=,37,True,=,,IC50,nM,,687.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,687.0
283152,17665497,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@]2(C)c2ccc(F)cc2)n1)c1ccc(Oc2ccccc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '12.86', 'le': '0.24', 'lle': '-0.22', 'sei': '8.14'}",CHEMBL3677078,,CHEMBL3677078,6.23,False,http://www.openphacts.org/units/Nanomolar,2552839,=,37,True,=,,IC50,nM,,585.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,585.0
283153,17665498,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@]2(C)c2ccccc2)n1)c1ccc(Oc2ccccc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.09', 'le': '0.29', 'lle': '1.20', 'sei': '9.80'}",CHEMBL3677079,,CHEMBL3677079,7.51,False,http://www.openphacts.org/units/Nanomolar,2552840,=,37,True,=,,IC50,nM,,31.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,31.0
283154,17665499,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC23CCCC3)n1)c1ccc(Oc2ccccc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.71', 'le': '0.31', 'lle': '1.48', 'sei': '9.39'}",CHEMBL3677080,,CHEMBL3677080,7.19,False,http://www.openphacts.org/units/Nanomolar,2552841,=,37,True,=,,IC50,nM,,64.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,64.0
283155,17665500,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2(C)C)n1)c1ccc(Oc2ccccc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '18.50', 'le': '0.34', 'lle': '2.30', 'sei': '9.77'}",CHEMBL3677081,,CHEMBL3677081,7.48,False,http://www.openphacts.org/units/Nanomolar,2552842,=,37,True,=,,IC50,nM,,33.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,33.0
283156,17665501,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1nn(Cc2ccccc2)cc1[C@H](C)Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.70', 'le': '0.27', 'lle': '2.00', 'sei': '7.26'}",CHEMBL3677083,,CHEMBL3677083,6.18,False,http://www.openphacts.org/units/Nanomolar,2552844,=,37,True,=,,IC50,nM,,656.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,656.0
283157,17665502,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cnn(C)c1,,,CHEMBL3638632,,2015.0,"{'bei': '15.09', 'le': '0.28', 'lle': '2.62', 'sei': '5.85'}",CHEMBL3677084,,CHEMBL3677084,4.98,False,http://www.openphacts.org/units/Nanomolar,2552845,=,37,True,=,,IC50,nM,,10369.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,10369.0
283158,17665503,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cccc(-n3cccn3)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.09', 'le': '0.32', 'lle': '2.89', 'sei': '7.87'}",CHEMBL3677085,,CHEMBL3677085,6.71,False,http://www.openphacts.org/units/Nanomolar,2552846,=,37,True,=,,IC50,nM,,197.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,197.0
283159,17665504,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-n3cccn3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.77', 'le': '0.31', 'lle': '2.76', 'sei': '7.73'}",CHEMBL3677086,,CHEMBL3677086,6.58,False,http://www.openphacts.org/units/Nanomolar,2552847,=,37,True,=,,IC50,nM,,262.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,262.0
283160,17665505,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1c(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)cnn1-c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '15.80', 'le': '0.29', 'lle': '2.29', 'sei': '7.54'}",CHEMBL3677087,,CHEMBL3677087,6.42,False,http://www.openphacts.org/units/Nanomolar,2552848,=,37,True,=,,IC50,nM,,378.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,378.0
283161,17665506,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@H]2c2ccccn2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '15.47', 'le': '0.28', 'lle': '1.85', 'sei': '6.97'}",CHEMBL3677088,,CHEMBL3677088,5.59,False,http://www.openphacts.org/units/Nanomolar,2552849,=,37,True,=,,IC50,nM,,2569.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2569.0
283162,17665507,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccccc2F)n1,,,CHEMBL3638632,,2015.0,"{'bei': '19.54', 'le': '0.37', 'lle': '2.96', 'sei': '9.99'}",CHEMBL3677089,,CHEMBL3677089,6.73,False,http://www.openphacts.org/units/Nanomolar,2552850,=,37,True,=,,IC50,nM,,186.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,186.0
283163,17665508,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(Oc3ccccc3)nc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.64', 'le': '0.33', 'lle': '2.58', 'sei': '8.27'}",CHEMBL3677090,,CHEMBL3677090,7.40,False,http://www.openphacts.org/units/Nanomolar,2552851,=,37,True,=,,IC50,nM,,40.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,40.0
283164,17665509,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1nc(N[C@@H](C)c2ccc(Oc3ccccc3)cc2)ncc1F,,,CHEMBL3638632,,2015.0,"{'bei': '16.58', 'le': '0.31', 'lle': '1.68', 'sei': '9.45'}",CHEMBL3677091,,CHEMBL3677091,7.24,False,http://www.openphacts.org/units/Nanomolar,2552852,=,37,True,=,,IC50,nM,,58.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,58.0
283165,17665510,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(OC2CCOCC2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.33', 'le': '0.31', 'lle': '2.78', 'sei': '8.12'}",CHEMBL3677093,,CHEMBL3677093,6.97,False,http://www.openphacts.org/units/Nanomolar,2552854,=,37,True,=,,IC50,nM,,108.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,108.0
283166,17665511,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(Oc3ccc(F)cc3)cc2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3677094,,CHEMBL3677094,,False,http://www.openphacts.org/units/Nanomolar,2552855,<,37,True,<,,IC50,nM,,22.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,22.0
283167,17665512,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@H]2c2ccccc2)n1)c1ccc(Br)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '15.52', 'le': '0.33', 'lle': '1.71', 'sei': '10.12'}",CHEMBL3677043,,CHEMBL3677043,6.82,False,http://www.openphacts.org/units/Nanomolar,2552804,=,37,True,=,,IC50,nM,,152.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,152.0
283168,17665513,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@H]2c2cccnc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '15.16', 'le': '0.28', 'lle': '1.74', 'sei': '6.83'}",CHEMBL3677095,,CHEMBL3677095,5.48,False,http://www.openphacts.org/units/Nanomolar,2552856,=,37,True,=,,IC50,nM,,3308.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3308.0
283169,17665514,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@H]2c2ccncc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '12.97', 'le': '0.24', 'lle': '0.95', 'sei': '5.84'}",CHEMBL3677096,,CHEMBL3677096,4.69,False,http://www.openphacts.org/units/Nanomolar,2552857,=,37,True,=,,IC50,nM,,20567.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,20567.0
283170,17665515,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1cccc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3c3ccccc3)n2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '16.21', 'le': '0.30', 'lle': '1.97', 'sei': '8.27'}",CHEMBL3677097,,CHEMBL3677097,6.33,False,http://www.openphacts.org/units/Nanomolar,2552858,=,37,True,=,,IC50,nM,,467.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,467.0
283171,17665516,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC(C)(C)[C@@H]2c2ccccc2)n1)c1ccc(-c2ccccc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '13.64', 'le': '0.25', 'lle': '-0.46', 'sei': '9.41'}",CHEMBL3677098,,CHEMBL3677098,6.33,False,http://www.openphacts.org/units/Nanomolar,2552859,=,37,True,=,,IC50,nM,,463.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,463.0
283172,17665517,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@@]1(C)COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(F)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '19.53', 'le': '0.37', 'lle': '2.84', 'sei': '10.39'}",CHEMBL3677099,,CHEMBL3677099,7.00,False,http://www.openphacts.org/units/Nanomolar,2552860,=,37,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,100.0
283173,17665518,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2(C)C)n1)c1ccc(CN2CCN(C)CC2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '13.58', 'le': '0.25', 'lle': '2.64', 'sei': '7.81'}",CHEMBL3677100,,CHEMBL3677100,5.76,False,http://www.openphacts.org/units/Nanomolar,2552861,=,37,True,=,,IC50,nM,,1717.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1717.0
283174,17665519,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC(C)(C)[C@H]2c2ccccc2)n1)c1ccc(CN2CCN(C)CC2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '13.37', 'le': '0.25', 'lle': '1.82', 'sei': '9.07'}",CHEMBL3677101,,CHEMBL3677101,6.70,False,http://www.openphacts.org/units/Nanomolar,2552862,=,37,True,=,,IC50,nM,,202.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,202.0
283175,17665520,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC(C)(C)[C@@H]2c2ccccc2)n1)c1ccc(CN2CCN(C)CC2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '13.95', 'le': '0.26', 'lle': '2.11', 'sei': '9.46'}",CHEMBL3677102,,CHEMBL3677102,6.98,False,http://www.openphacts.org/units/Nanomolar,2552863,=,37,True,=,,IC50,nM,,104.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,104.0
283176,17665521,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@@]1(C)COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN(C)CC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.55', 'le': '0.27', 'lle': '2.81', 'sei': '8.92'}",CHEMBL3677103,,CHEMBL3677103,6.58,False,http://www.openphacts.org/units/Nanomolar,2552864,=,37,True,=,,IC50,nM,,261.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,261.0
283177,17665522,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@@H]1N(c2ccnc(N[C@@H](C)c3ccc(CN4CCN(C)CC4)cc3)n2)C(=O)OC1(C)C,,,CHEMBL3638632,,2015.0,"{'bei': '13.98', 'le': '0.26', 'lle': '2.37', 'sei': '8.84'}",CHEMBL3677104,,CHEMBL3677104,6.53,False,http://www.openphacts.org/units/Nanomolar,2552865,=,37,True,=,,IC50,nM,,298.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,298.0
283178,17665523,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3ccccn3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.42', 'le': '0.32', 'lle': '2.34', 'sei': '8.76'}",CHEMBL3677105,,CHEMBL3677105,7.03,True,http://www.openphacts.org/units/Nanomolar,2552866,=,37,True,=,,IC50,nM,,94.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,94.0
283179,17665524,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3ccccc3)nc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.40', 'le': '0.30', 'lle': '1.93', 'sei': '8.25'}",CHEMBL3677106,,CHEMBL3677106,6.62,False,http://www.openphacts.org/units/Nanomolar,2552867,=,37,True,=,,IC50,nM,,241.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,241.0
283180,17665525,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc3ncccc3c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.24', 'le': '0.32', 'lle': '2.33', 'sei': '8.11'}",CHEMBL3677107,,CHEMBL3677107,6.51,False,http://www.openphacts.org/units/Nanomolar,2552868,=,37,True,=,,IC50,nM,,312.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,312.0
283181,17665526,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc3cccnc3c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.53', 'le': '0.25', 'lle': '0.93', 'sei': '6.36'}",CHEMBL3677108,,CHEMBL3677108,5.11,False,http://www.openphacts.org/units/Nanomolar,2552869,=,37,True,=,,IC50,nM,,7823.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,7823.0
283182,17665527,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)c3ccccc3)cc2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3677109,,CHEMBL3677109,,False,http://www.openphacts.org/units/Nanomolar,2552870,<,37,True,<,,IC50,nM,,22.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,22.0
283183,17665528,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1nccn1-c1ccc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)cc1F,,,CHEMBL3638632,,2015.0,"{'bei': '15.89', 'le': '0.30', 'lle': '2.48', 'sei': '7.92'}",CHEMBL3677110,,CHEMBL3677110,6.75,False,http://www.openphacts.org/units/Nanomolar,2552871,=,37,True,=,,IC50,nM,,180.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,180.0
283184,17665529,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1nccn1-c1ccc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '15.42', 'le': '0.29', 'lle': '2.14', 'sei': '7.36'}",CHEMBL3677111,,CHEMBL3677111,6.27,False,http://www.openphacts.org/units/Nanomolar,2552872,=,37,True,=,,IC50,nM,,538.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,538.0
283185,17665530,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@H](C)C2CCCC2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.88', 'le': '0.34', 'lle': '2.24', 'sei': '8.45'}",CHEMBL3677112,,CHEMBL3677112,5.69,False,http://www.openphacts.org/units/Nanomolar,2552873,=,37,True,=,,IC50,nM,,2023.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2023.0
283186,17665531,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(N(C)C)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.35', 'le': '0.32', 'lle': '2.71', 'sei': '9.08'}",CHEMBL3677113,,CHEMBL3677113,6.41,False,http://www.openphacts.org/units/Nanomolar,2552874,=,37,True,=,,IC50,nM,,390.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,390.0
283187,17665532,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1cccc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '14.98', 'le': '0.28', 'lle': '2.15', 'sei': '5.95'}",CHEMBL3677114,,CHEMBL3677114,5.74,False,http://www.openphacts.org/units/Nanomolar,2552875,=,37,True,=,,IC50,nM,,1807.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1807.0
283188,17665533,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2nc3ccccc3[nH]2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '12.17', 'le': '0.23', 'lle': '0.95', 'sei': '4.64'}",CHEMBL3677115,,CHEMBL3677115,4.46,False,http://www.openphacts.org/units/Nanomolar,2552876,=,37,True,=,,IC50,nM,,34794.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,34794.0
283189,17665534,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(S(=O)(=O)c3ccc(Cl)cc3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.52', 'le': '0.29', 'lle': '2.16', 'sei': '7.17'}",CHEMBL3677116,,CHEMBL3677116,7.28,False,http://www.openphacts.org/units/Nanomolar,2552877,=,37,True,=,,IC50,nM,,53.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,53.0
283190,17665535,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc([N+](=O)[O-])cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.50', 'le': '0.33', 'lle': '2.96', 'sei': '5.88'}",CHEMBL3677117,,CHEMBL3677117,6.50,False,http://www.openphacts.org/units/Nanomolar,2552878,=,37,True,=,,IC50,nM,,316.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,316.0
283191,17665536,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(N)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.56', 'le': '0.31', 'lle': '2.44', 'sei': '6.05'}",CHEMBL3677118,,CHEMBL3677118,5.65,False,http://www.openphacts.org/units/Nanomolar,2552879,=,37,True,=,,IC50,nM,,2222.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2222.0
283192,17665537,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2nnc(-c3ccccc3)s2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.81', 'le': '0.34', 'lle': '3.16', 'sei': '7.85'}",CHEMBL3677120,,CHEMBL3677120,7.31,False,http://www.openphacts.org/units/Nanomolar,2552881,=,37,True,=,,IC50,nM,,49.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,49.0
283193,17665538,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc2cc(Cl)ccc2[nH]1,,,CHEMBL3638632,,2015.0,"{'bei': '13.89', 'le': '0.27', 'lle': '1.41', 'sei': '5.80'}",CHEMBL3677121,,CHEMBL3677121,5.57,False,http://www.openphacts.org/units/Nanomolar,2552882,=,37,True,=,,IC50,nM,,2696.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2696.0
283194,17665539,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cc(CC(C)(C)C)on2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '18.12', 'le': '0.34', 'lle': '2.81', 'sei': '7.52'}",CHEMBL3677122,,CHEMBL3677122,7.02,False,http://www.openphacts.org/units/Nanomolar,2552883,=,37,True,=,,IC50,nM,,95.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,95.0
283195,17665540,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ncc(-c2ccccc2)cn1,,,CHEMBL3638632,,2015.0,"{'bei': '15.99', 'le': '0.29', 'lle': '2.38', 'sei': '6.94'}",CHEMBL3677123,,CHEMBL3677123,6.47,False,http://www.openphacts.org/units/Nanomolar,2552884,=,37,True,=,,IC50,nM,,342.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,342.0
283196,17665541,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)C2CCN(C(=O)OCc3ccccc3)CC2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.12', 'le': '0.28', 'lle': '2.76', 'sei': '7.30'}",CHEMBL3677124,,CHEMBL3677124,7.07,False,http://www.openphacts.org/units/Nanomolar,2552885,=,37,True,=,,IC50,nM,,85.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,85.0
283197,17665542,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2ccc(C(C)Nc3ncc(F)c(N4CCOC4=O)n3)nc2)ccc1F,,,CHEMBL3638632,,2015.0,"{'bei': '16.35', 'le': '0.31', 'lle': '2.48', 'sei': '8.38'}",CHEMBL3677126,,CHEMBL3677126,6.73,False,http://www.openphacts.org/units/Nanomolar,2552887,=,37,True,=,,IC50,nM,,188.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,188.0
283198,17665543,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2CCOC2=O)n1)c1ncc(Oc2ccc(F)cc2)cn1,,,CHEMBL3638632,,2015.0,"{'bei': '13.60', 'le': '0.25', 'lle': '2.06', 'sei': '5.27'}",CHEMBL3677127,,CHEMBL3677127,5.39,False,http://www.openphacts.org/units/Nanomolar,2552888,=,37,True,=,,IC50,nM,,4052.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4052.0
283199,17665544,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2CCOC2=O)n1)c1ncc(Oc2ccc(F)cc2)cn1,,,CHEMBL3638632,,2015.0,"{'bei': '13.96', 'le': '0.26', 'lle': '2.32', 'sei': '5.65'}",CHEMBL3677128,,CHEMBL3677128,5.79,False,http://www.openphacts.org/units/Nanomolar,2552889,=,37,True,=,,IC50,nM,,1639.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1639.0
283200,17665545,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)[C@H]2CC[C@H](Oc3ccc(F)cc3)CC2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.55', 'le': '0.29', 'lle': '1.84', 'sei': '8.99'}",CHEMBL3677130,,CHEMBL3677130,6.88,False,http://www.openphacts.org/units/Nanomolar,2552891,=,37,True,=,,IC50,nM,,131.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,131.0
283201,17665546,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ncc(Cl)cn2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.65', 'le': '0.31', 'lle': '2.61', 'sei': '6.10'}",CHEMBL3639759,,CHEMBL3639759,5.68,False,http://www.openphacts.org/units/Nanomolar,2552893,=,37,True,=,,IC50,nM,,2107.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2107.0
283202,17665547,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ncc(Oc3ccc(F)c(Cl)c3)cn2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.20', 'le': '0.30', 'lle': '2.18', 'sei': '7.02'}",CHEMBL3677132,,CHEMBL3677132,7.19,False,http://www.openphacts.org/units/Nanomolar,2552894,=,37,True,=,,IC50,nM,,65.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,65.0
283203,17665548,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ncc(Oc2cccnc2)cn1,,,CHEMBL3638632,,2015.0,"{'bei': '12.80', 'le': '0.24', 'lle': '1.78', 'sei': '4.68'}",CHEMBL3677133,,CHEMBL3677133,5.39,False,http://www.openphacts.org/units/Nanomolar,2552895,=,37,True,=,,IC50,nM,,4043.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4043.0
283204,17665549,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ncc(I)cn2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.50', 'le': '0.36', 'lle': '3.56', 'sei': '7.07'}",CHEMBL3677135,,CHEMBL3677135,6.59,False,http://www.openphacts.org/units/Nanomolar,2552897,=,37,True,=,,IC50,nM,,259.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,259.0
283205,17665550,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ncc(Oc2ccc(C(F)(F)F)cn2)cn1,,,CHEMBL3638632,,2015.0,"{'bei': '12.38', 'le': '0.24', 'lle': '1.43', 'sei': '5.26'}",CHEMBL3677136,,CHEMBL3677136,6.06,False,http://www.openphacts.org/units/Nanomolar,2552898,=,37,True,=,,IC50,nM,,868.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,868.0
283206,17665551,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ncccn1,,,CHEMBL3638632,,2015.0,"{'bei': '13.52', 'le': '0.25', 'lle': '2.02', 'sei': '4.77'}",CHEMBL3677137,,CHEMBL3677137,4.44,False,http://www.openphacts.org/units/Nanomolar,2552899,=,37,True,=,,IC50,nM,,36281.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,36281.0
283207,17665552,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nccc(Oc2ccc(F)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '12.28', 'le': '0.23', 'lle': '1.03', 'sei': '5.26'}",CHEMBL3677138,,CHEMBL3677138,5.38,False,http://www.openphacts.org/units/Nanomolar,2552900,=,37,True,=,,IC50,nM,,4139.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4139.0
283208,17665553,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1nc(N[C@@H](C)c2ccc(CN3C[C@H](C)O[C@H](C)C3)cc2)ncc1F,,,CHEMBL3638632,,2015.0,"{'bei': '15.46', 'le': '0.29', 'lle': '2.91', 'sei': '9.14'}",CHEMBL3677139,,CHEMBL3677139,7.29,False,http://www.openphacts.org/units/Nanomolar,2552901,=,37,True,=,,IC50,nM,,51.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,51.0
283209,17665554,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C2N(c3ccnc(N[C@@H](C)c4ccc(Oc5ccccc5)cc4)n3)C(=O)OC2(C)C)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '13.98', 'le': '0.26', 'lle': '0.21', 'sei': '8.32'}",CHEMBL3677140,,CHEMBL3677140,7.14,False,http://www.openphacts.org/units/Nanomolar,2552902,=,37,True,=,,IC50,nM,,73.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,73.0
283210,17665555,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C2N(c3ccnc(N[C@@H](C)c4ccc(Oc5ccccc5)cc4)n3)C(=O)OC2(C)C)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '11.52', 'le': '0.21', 'lle': '-1.05', 'sei': '6.86'}",CHEMBL3677140,,CHEMBL3677140,5.88,False,http://www.openphacts.org/units/Nanomolar,2552902,=,37,True,=,,IC50,nM,,1311.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1311.0
283211,17665556,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@]2(C)c2ccccc2)n1)c1cnn(-c2ccccc2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '11.87', 'le': '0.22', 'lle': '0.52', 'sei': '6.14'}",CHEMBL3677141,,CHEMBL3677141,5.23,False,http://www.openphacts.org/units/Nanomolar,2552903,=,37,True,=,,IC50,nM,,5916.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5916.0
283212,17665557,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@]2(C)c2ccccc2)n1)c1cnn(-c2ccccc2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '15.62', 'le': '0.28', 'lle': '2.17', 'sei': '8.08'}",CHEMBL3677141,,CHEMBL3677141,6.88,False,http://www.openphacts.org/units/Nanomolar,2552903,=,37,True,=,,IC50,nM,,131.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,131.0
283213,17665558,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@]2(C)c2ccccc2)n1)c1cnn(-c2ccccc2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '16.57', 'le': '0.30', 'lle': '2.59', 'sei': '8.57'}",CHEMBL3677142,,CHEMBL3677142,7.30,False,http://www.openphacts.org/units/Nanomolar,2552904,=,37,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
283214,17665559,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@]2(C)c2ccccc2)n1)c1cnn(-c2ccccc2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '12.03', 'le': '0.22', 'lle': '0.59', 'sei': '6.22'}",CHEMBL3677142,,CHEMBL3677142,5.30,False,http://www.openphacts.org/units/Nanomolar,2552904,=,37,True,=,,IC50,nM,,5007.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5007.0
283215,17665560,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@]2(C)c2ccc(F)cc2)n1)c1cnn(-c2ccc(F)cc2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '12.91', 'le': '0.24', 'lle': '1.16', 'sei': '7.22'}",CHEMBL3677143,,CHEMBL3677143,6.15,False,http://www.openphacts.org/units/Nanomolar,2552905,=,37,True,=,,IC50,nM,,705.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,705.0
283216,17665561,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@]2(C)c2ccc(F)cc2)n1)c1cnn(-c2ccc(F)cc2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '11.79', 'le': '0.22', 'lle': '0.63', 'sei': '6.60'}",CHEMBL3677143,,CHEMBL3677143,5.62,False,http://www.openphacts.org/units/Nanomolar,2552905,=,37,True,=,,IC50,nM,,2410.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2410.0
283217,17665562,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1cccc(-n2cc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)cn2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '14.00', 'le': '0.26', 'lle': '2.09', 'sei': '6.27'}",CHEMBL3677144,,CHEMBL3677144,5.92,False,http://www.openphacts.org/units/Nanomolar,2552906,=,37,True,=,,IC50,nM,,1214.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1214.0
283218,17665563,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1cccc(-n2cc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)cn2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '17.95', 'le': '0.33', 'lle': '3.76', 'sei': '8.03'}",CHEMBL3677144,,CHEMBL3677144,7.58,False,http://www.openphacts.org/units/Nanomolar,2552906,=,37,True,=,,IC50,nM,,26.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,26.0
283219,17665564,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1nn(-c2ccccc2)c(C)c1C(C)Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1,,,CHEMBL3638632,,2015.0,"{'bei': '11.42', 'le': '0.21', 'lle': '0.37', 'sei': '5.64'}",CHEMBL3677146,,CHEMBL3677146,4.80,False,http://www.openphacts.org/units/Nanomolar,2552908,=,37,True,=,,IC50,nM,,15718.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,15718.0
283220,17665565,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1nn(-c2ccccc2)c(C)c1C(C)Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.50', 'le': '0.31', 'lle': '2.51', 'sei': '8.15'}",CHEMBL3677146,,CHEMBL3677146,6.94,False,http://www.openphacts.org/units/Nanomolar,2552908,=,37,True,=,,IC50,nM,,115.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,115.0
283221,17665566,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(-n2ccnc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '15.63', 'le': '0.29', 'lle': '2.31', 'sei': '7.20'}",CHEMBL3677147,,CHEMBL3677147,6.13,False,http://www.openphacts.org/units/Nanomolar,2552909,=,37,True,=,,IC50,nM,,736.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,736.5
283222,17665567,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(Oc2cccnc2)c(F)c1,,,CHEMBL3638632,,2015.0,"{'bei': '12.95', 'le': '0.24', 'lle': '0.70', 'sei': '6.33'}",CHEMBL3677148,,CHEMBL3677148,5.67,False,http://www.openphacts.org/units/Nanomolar,2552910,=,37,True,=,,IC50,nM,,2164.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2164.0
283223,17665568,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(Oc2cccnc2)c(F)c1,,,CHEMBL3638632,,2015.0,"{'bei': '17.34', 'le': '0.32', 'lle': '2.63', 'sei': '8.48'}",CHEMBL3677148,,CHEMBL3677148,7.58,False,http://www.openphacts.org/units/Nanomolar,2552910,=,37,True,=,,IC50,nM,,26.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,26.0
283224,17665569,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(OC2CCOCC2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '12.23', 'le': '0.23', 'lle': '1.03', 'sei': '6.08'}",CHEMBL3677093,,CHEMBL3677093,5.22,False,http://www.openphacts.org/units/Nanomolar,2552911,=,37,True,=,,IC50,nM,,6083.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6083.0
283225,17665570,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(OC2CCOCC2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.90', 'le': '0.32', 'lle': '3.02', 'sei': '8.40'}",CHEMBL3677093,,CHEMBL3677093,7.21,False,http://www.openphacts.org/units/Nanomolar,2552911,=,37,True,=,,IC50,nM,,62.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,62.0
283226,17665571,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@H]2c2ccccc2)n1)c1ccc(Cl)c(Cl)c1,,,CHEMBL3638632,,2015.0,"{'bei': '16.06', 'le': '0.32', 'lle': '1.24', 'sei': '10.23'}",CHEMBL3677031,,CHEMBL3677031,6.89,False,http://www.openphacts.org/units/Nanomolar,2552789,=,37,True,=,,IC50,nM,,128.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,128.0
283227,17665572,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@H]2c2ccccc2)n1)c1ccc(Cl)c(Cl)c1,,,CHEMBL3638632,,2015.0,"{'bei': '14.42', 'le': '0.29', 'lle': '0.54', 'sei': '9.19'}",CHEMBL3677031,,CHEMBL3677031,6.19,False,http://www.openphacts.org/units/Nanomolar,2552789,=,37,True,=,,IC50,nM,,646.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,646.0
283228,17665573,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(-c2ccncc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.93', 'le': '0.31', 'lle': '2.14', 'sei': '8.51'}",CHEMBL3677150,,CHEMBL3677150,6.83,False,http://www.openphacts.org/units/Nanomolar,2552913,=,37,True,=,,IC50,nM,,148.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,148.0
283229,17665574,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(N(C)c2ccccc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '12.76', 'le': '0.24', 'lle': '0.11', 'sei': '7.80'}",CHEMBL3677151,,CHEMBL3677151,5.51,False,http://www.openphacts.org/units/Nanomolar,2552914,=,37,True,=,,IC50,nM,,3101.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3101.0
283230,17665575,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(N(C)c2ccccc2)cc1,,,CHEMBL3638632,,2015.0,,CHEMBL3677151,,CHEMBL3677151,,False,http://www.openphacts.org/units/Nanomolar,2552914,<,37,True,<,,IC50,nM,,22.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,22.0
283231,17665576,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1cnn(-c2ccc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)cc2F)c1,,,CHEMBL3638632,,2015.0,"{'bei': '17.76', 'le': '0.33', 'lle': '3.28', 'sei': '8.85'}",CHEMBL3677152,,CHEMBL3677152,7.54,False,http://www.openphacts.org/units/Nanomolar,2552915,=,37,True,=,,IC50,nM,,29.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,29.0
283232,17665577,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1nnc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)o1,,,CHEMBL3638632,,2015.0,,CHEMBL3677154,,CHEMBL3677154,,False,http://www.openphacts.org/units/Nanomolar,2552917,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
283233,17665578,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1nnc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)o1,,,CHEMBL3638632,,2015.0,"{'bei': '13.51', 'le': '0.26', 'lle': '2.17', 'sei': '4.23'}",CHEMBL3677154,,CHEMBL3677154,4.49,False,http://www.openphacts.org/units/Nanomolar,2552917,=,37,True,=,,IC50,nM,,32256.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,32256.0
283234,17665579,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nncn1C,,,CHEMBL3638632,,2015.0,,CHEMBL3677155,,CHEMBL3677155,,False,http://www.openphacts.org/units/Nanomolar,2552918,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
283235,17665580,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nncn1C,,,CHEMBL3638632,,2015.0,,CHEMBL3677155,,CHEMBL3677155,,False,http://www.openphacts.org/units/Nanomolar,2552918,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
283236,17665581,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cn2ncsc2n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.45', 'le': '0.28', 'lle': '2.66', 'sei': '5.53'}",CHEMBL3677156,,CHEMBL3677156,5.40,False,http://www.openphacts.org/units/Nanomolar,2552919,=,37,True,=,,IC50,nM,,4010.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4010.0
283237,17665582,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cn2ncsc2n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.69', 'le': '0.33', 'lle': '3.49', 'sei': '6.39'}",CHEMBL3677156,,CHEMBL3677156,6.23,False,http://www.openphacts.org/units/Nanomolar,2552919,=,37,True,=,,IC50,nM,,583.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,583.0
283238,17665583,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CCn1ncnc1C(C)Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3677157,,CHEMBL3677157,,False,http://www.openphacts.org/units/Nanomolar,2552920,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
283239,17665584,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CCn1ncnc1C(C)Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3677157,,CHEMBL3677157,,False,http://www.openphacts.org/units/Nanomolar,2552920,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
283240,17665585,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CCn1cnnc1C(C)Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3677158,,CHEMBL3677158,,False,http://www.openphacts.org/units/Nanomolar,2552921,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
283241,17665586,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CCn1cnnc1C(C)Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3677158,,CHEMBL3677158,,False,http://www.openphacts.org/units/Nanomolar,2552921,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
283242,17665587,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cn2ccsc2n1,,,CHEMBL3638632,,2015.0,"{'bei': '12.01', 'le': '0.23', 'lle': '1.13', 'sei': '5.29'}",CHEMBL3677159,,CHEMBL3677159,4.47,False,http://www.openphacts.org/units/Nanomolar,2552922,=,37,True,=,,IC50,nM,,33589.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,33589.0
283243,17665588,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cn2ccsc2n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.53', 'le': '0.30', 'lle': '2.44', 'sei': '6.83'}",CHEMBL3677159,,CHEMBL3677159,5.79,False,http://www.openphacts.org/units/Nanomolar,2552922,=,37,True,=,,IC50,nM,,1642.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1642.0
283244,17665589,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(NS(C)(=O)=O)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '11.63', 'le': '0.23', 'lle': '1.88', 'sei': '4.30'}",CHEMBL3677160,,CHEMBL3677160,4.88,False,http://www.openphacts.org/units/Nanomolar,2552923,=,37,True,=,,IC50,nM,,13229.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,13229.0
283245,17665590,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(NS(C)(=O)=O)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '14.45', 'le': '0.29', 'lle': '3.06', 'sei': '5.34'}",CHEMBL3677160,,CHEMBL3677160,6.06,False,http://www.openphacts.org/units/Nanomolar,2552923,=,37,True,=,,IC50,nM,,864.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,864.0
283246,17665591,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(-c2ccccn2)no1,,,CHEMBL3638632,,2015.0,,CHEMBL3677161,,CHEMBL3677161,,False,http://www.openphacts.org/units/Nanomolar,2552924,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
283247,17665592,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(-c2ccccn2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '13.95', 'le': '0.26', 'lle': '2.44', 'sei': '4.63'}",CHEMBL3677161,,CHEMBL3677161,5.52,False,http://www.openphacts.org/units/Nanomolar,2552924,=,37,True,=,,IC50,nM,,3035.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3035.0
283248,17665593,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)n2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '14.95', 'le': '0.28', 'lle': '2.12', 'sei': '5.75'}",CHEMBL3677162,,CHEMBL3677162,6.11,False,http://www.openphacts.org/units/Nanomolar,2552925,=,37,True,=,,IC50,nM,,781.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,781.0
283249,17665594,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)n2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '17.63', 'le': '0.33', 'lle': '3.21', 'sei': '6.78'}",CHEMBL3677162,,CHEMBL3677162,7.20,False,http://www.openphacts.org/units/Nanomolar,2552925,=,37,True,=,,IC50,nM,,63.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,63.0
283250,17665595,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(S(C)(=O)=O)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '11.97', 'le': '0.24', 'lle': '1.81', 'sei': '4.77'}",CHEMBL3677163,,CHEMBL3677163,4.84,False,http://www.openphacts.org/units/Nanomolar,2552926,=,37,True,=,,IC50,nM,,14441.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,14441.0
283251,17665596,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(S(C)(=O)=O)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '14.87', 'le': '0.29', 'lle': '2.99', 'sei': '5.93'}",CHEMBL3677163,,CHEMBL3677163,6.02,False,http://www.openphacts.org/units/Nanomolar,2552926,=,37,True,=,,IC50,nM,,964.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,964.0
283252,17665597,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1noc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3677164,,CHEMBL3677164,,False,http://www.openphacts.org/units/Nanomolar,2552927,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
283253,17665598,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1noc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.80', 'le': '0.32', 'lle': '3.26', 'sei': '5.26'}",CHEMBL3677164,,CHEMBL3677164,5.58,False,http://www.openphacts.org/units/Nanomolar,2552927,=,37,True,=,,IC50,nM,,2602.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2602.0
283254,17665599,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CCc1noc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.52', 'le': '0.26', 'lle': '2.10', 'sei': '4.41'}",CHEMBL3677165,,CHEMBL3677165,4.68,False,http://www.openphacts.org/units/Nanomolar,2552928,=,37,True,=,,IC50,nM,,20809.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,20809.0
283255,17665600,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CCc1noc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.76', 'le': '0.34', 'lle': '3.57', 'sei': '5.79'}",CHEMBL3677165,,CHEMBL3677165,6.15,False,http://www.openphacts.org/units/Nanomolar,2552928,=,37,True,=,,IC50,nM,,706.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,706.0
283256,17665601,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CCCc1noc([C@@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3682140,,CHEMBL3682140,,False,http://www.openphacts.org/units/Nanomolar,2558230,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
283257,17665602,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CCCc1noc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.36', 'le': '0.27', 'lle': '2.21', 'sei': '4.87'}",CHEMBL3682138,,CHEMBL3682138,5.18,False,http://www.openphacts.org/units/Nanomolar,2558228,=,37,True,=,,IC50,nM,,6649.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6649.0
283258,17665603,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(C2CC2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '12.84', 'le': '0.24', 'lle': '1.71', 'sei': '4.33'}",CHEMBL3677166,,CHEMBL3677166,4.60,False,http://www.openphacts.org/units/Nanomolar,2552929,=,37,True,=,,IC50,nM,,25036.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25036.0
283259,17665604,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)c1noc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '12.21', 'le': '0.23', 'lle': '1.26', 'sei': '4.14'}",CHEMBL3677167,,CHEMBL3677167,4.40,False,http://www.openphacts.org/units/Nanomolar,2552930,=,37,True,=,,IC50,nM,,39696.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,39696.0
283260,17665605,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)c1noc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.07', 'le': '0.30', 'lle': '2.65', 'sei': '5.45'}",CHEMBL3677167,,CHEMBL3677167,5.79,False,http://www.openphacts.org/units/Nanomolar,2552930,=,37,True,=,,IC50,nM,,1617.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1617.0
283261,17665606,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CCn1ccc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3677168,,CHEMBL3677168,,False,http://www.openphacts.org/units/Nanomolar,2552931,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
283262,17665607,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CCn1ccc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.36', 'le': '0.31', 'lle': '2.78', 'sei': '6.62'}",CHEMBL3677168,,CHEMBL3677168,5.63,False,http://www.openphacts.org/units/Nanomolar,2552931,=,37,True,=,,IC50,nM,,2321.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2321.0
283263,17665608,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(-c2ccccc2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '16.97', 'le': '0.32', 'lle': '3.01', 'sei': '6.30'}",CHEMBL3677171,,CHEMBL3677171,6.69,False,http://www.openphacts.org/units/Nanomolar,2552934,=,37,True,=,,IC50,nM,,203.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,203.0
283264,17665609,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cnc2[nH]ccc2c1,,,CHEMBL3638632,,2015.0,"{'bei': '19.56', 'le': '0.36', 'lle': '3.66', 'sei': '7.46'}",CHEMBL3677172,,CHEMBL3677172,7.17,False,http://www.openphacts.org/units/Nanomolar,2552935,=,37,True,=,,IC50,nM,,68.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,68.0
283265,17665610,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc2ccccc2s1,,,CHEMBL3638632,,2015.0,"{'bei': '17.87', 'le': '0.35', 'lle': '2.61', 'sei': '8.54'}",CHEMBL3677175,,CHEMBL3677175,6.85,False,http://www.openphacts.org/units/Nanomolar,2552938,=,37,True,=,,IC50,nM,,140.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,140.0
283266,17665611,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cc2ccccn2c1,,,CHEMBL3638632,,2015.0,"{'bei': '16.85', 'le': '0.31', 'lle': '2.28', 'sei': '8.58'}",CHEMBL3677176,,CHEMBL3677176,6.16,False,http://www.openphacts.org/units/Nanomolar,2552939,=,37,True,=,,IC50,nM,,694.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,694.0
283267,17665612,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1-c1noc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.48', 'le': '0.29', 'lle': '2.88', 'sei': '5.69'}",CHEMBL3677177,,CHEMBL3677177,6.57,False,http://www.openphacts.org/units/Nanomolar,2552940,=,37,True,=,,IC50,nM,,268.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,268.0
283268,17665613,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1cccc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)n2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '15.84', 'le': '0.30', 'lle': '3.03', 'sei': '5.82'}",CHEMBL3677178,,CHEMBL3677178,6.72,False,http://www.openphacts.org/units/Nanomolar,2552941,=,37,True,=,,IC50,nM,,189.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,189.0
283269,17665614,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(-c2cccc(F)c2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '16.89', 'le': '0.32', 'lle': '3.14', 'sei': '6.55'}",CHEMBL3677179,,CHEMBL3677179,6.96,False,http://www.openphacts.org/units/Nanomolar,2552942,=,37,True,=,,IC50,nM,,108.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,108.5
283270,17665615,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(C2CCCCC2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '16.08', 'le': '0.30', 'lle': '2.38', 'sei': '6.06'}",CHEMBL3677181,,CHEMBL3677181,6.44,False,http://www.openphacts.org/units/Nanomolar,2552944,=,37,True,=,,IC50,nM,,362.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,362.0
283271,17665616,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nnc(-c2ccc(F)cc2)o1,,,CHEMBL3638632,,2015.0,"{'bei': '16.06', 'le': '0.30', 'lle': '2.81', 'sei': '6.23'}",CHEMBL3677184,,CHEMBL3677184,6.62,False,http://www.openphacts.org/units/Nanomolar,2552947,=,37,True,=,,IC50,nM,,237.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,237.0
283272,17665617,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc2ccccc2o1,,,CHEMBL3638632,,2015.0,"{'bei': '17.44', 'le': '0.32', 'lle': '2.64', 'sei': '6.86'}",CHEMBL3677185,,CHEMBL3677185,6.41,False,http://www.openphacts.org/units/Nanomolar,2552948,=,37,True,=,,IC50,nM,,390.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,390.0
283273,17665618,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1sc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)nc1-c1ccc(Cl)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '12.09', 'le': '0.24', 'lle': '-0.18', 'sei': '6.90'}",CHEMBL3677186,,CHEMBL3677186,5.54,False,http://www.openphacts.org/units/Nanomolar,2552949,=,37,True,=,,IC50,nM,,2907.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2907.0
283274,17665619,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1sc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)nc1-c1ccc(Cl)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '14.68', 'le': '0.30', 'lle': '1.00', 'sei': '8.38'}",CHEMBL3677186,,CHEMBL3677186,6.72,False,http://www.openphacts.org/units/Nanomolar,2552949,=,37,True,=,,IC50,nM,,190.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,190.0
283275,17665620,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CCc1noc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.47', 'le': '0.25', 'lle': '2.09', 'sei': '4.39'}",CHEMBL3677165,,CHEMBL3677165,4.67,False,http://www.openphacts.org/units/Nanomolar,2552928,=,37,True,=,,IC50,nM,,21616.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,21616.0
283276,17665621,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CCc1noc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.91', 'le': '0.28', 'lle': '2.58', 'sei': '4.86'}",CHEMBL3677165,,CHEMBL3677165,5.16,False,http://www.openphacts.org/units/Nanomolar,2552928,=,37,True,=,,IC50,nM,,6850.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6850.5
283277,17665622,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1csc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.16', 'le': '0.26', 'lle': '1.17', 'sei': '5.70'}",CHEMBL3677187,,CHEMBL3677187,4.57,False,http://www.openphacts.org/units/Nanomolar,2552950,=,37,True,=,,IC50,nM,,26674.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,26674.0
283278,17665623,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1csc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.69', 'le': '0.33', 'lle': '2.40', 'sei': '7.23'}",CHEMBL3677187,,CHEMBL3677187,5.80,False,http://www.openphacts.org/units/Nanomolar,2552950,=,37,True,=,,IC50,nM,,1592.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1592.0
283279,17665624,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@H](C)c2cccs2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.12', 'le': '0.28', 'lle': '1.00', 'sei': '6.97'}",CHEMBL3677188,,CHEMBL3677188,4.69,False,http://www.openphacts.org/units/Nanomolar,2552951,=,37,True,=,,IC50,nM,,20287.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,20287.0
283280,17665625,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cccs2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '18.33', 'le': '0.36', 'lle': '2.40', 'sei': '9.05'}",CHEMBL3682141,,CHEMBL3682141,6.09,False,http://www.openphacts.org/units/Nanomolar,2558231,=,37,True,=,,IC50,nM,,808.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,808.0
283281,17665626,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccco1,,,CHEMBL3638632,,2015.0,"{'bei': '17.54', 'le': '0.33', 'lle': '2.33', 'sei': '6.89'}",CHEMBL3677189,,CHEMBL3677189,5.55,False,http://www.openphacts.org/units/Nanomolar,2552952,=,37,True,=,,IC50,nM,,2833.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2833.0
283282,17665627,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccco1,,,CHEMBL3638632,,2015.0,,CHEMBL3677189,,CHEMBL3677189,,False,http://www.openphacts.org/units/Nanomolar,2552952,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
283283,17665628,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(-c2ccncc2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '11.51', 'le': '0.21', 'lle': '1.47', 'sei': '3.82'}",CHEMBL3677190,,CHEMBL3677190,4.55,False,http://www.openphacts.org/units/Nanomolar,2552953,=,37,True,=,,IC50,nM,,27999.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,27999.0
283284,17665629,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(-c2ccncc2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '14.34', 'le': '0.27', 'lle': '2.59', 'sei': '4.76'}",CHEMBL3677190,,CHEMBL3677190,5.67,False,http://www.openphacts.org/units/Nanomolar,2552953,=,37,True,=,,IC50,nM,,2136.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2136.0
283285,17665630,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(-c2ccccc2Cl)no1,,,CHEMBL3638632,,2015.0,"{'bei': '11.94', 'le': '0.23', 'lle': '0.79', 'sei': '4.82'}",CHEMBL3677191,,CHEMBL3677191,5.12,False,http://www.openphacts.org/units/Nanomolar,2552954,=,37,True,=,,IC50,nM,,7595.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,7595.0
283286,17665631,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(-c2ccccc2Cl)no1,,,CHEMBL3638632,,2015.0,"{'bei': '15.83', 'le': '0.31', 'lle': '2.46', 'sei': '6.39'}",CHEMBL3677191,,CHEMBL3677191,6.79,False,http://www.openphacts.org/units/Nanomolar,2552954,=,37,True,=,,IC50,nM,,162.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,162.0
283287,17665632,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '14.09', 'le': '0.28', 'lle': '1.71', 'sei': '5.68'}",CHEMBL3677192,,CHEMBL3677192,6.04,False,http://www.openphacts.org/units/Nanomolar,2552955,=,37,True,=,,IC50,nM,,909.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,909.0
283288,17665633,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '17.54', 'le': '0.34', 'lle': '3.19', 'sei': '7.08'}",CHEMBL3677192,,CHEMBL3677192,7.52,False,http://www.openphacts.org/units/Nanomolar,2552955,=,37,True,=,,IC50,nM,,30.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,30.0
283289,17665634,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(-c2cccnc2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '14.95', 'le': '0.28', 'lle': '2.83', 'sei': '4.96'}",CHEMBL3677193,,CHEMBL3677193,5.91,False,http://www.openphacts.org/units/Nanomolar,2552956,=,37,True,=,,IC50,nM,,1229.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1229.0
283290,17665635,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CCn1nccc1C(C)Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3677194,,CHEMBL3677194,,False,http://www.openphacts.org/units/Nanomolar,2552957,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
283291,17665636,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CCn1nccc1C(C)Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.08', 'le': '0.28', 'lle': '2.34', 'sei': '6.10'}",CHEMBL3677194,,CHEMBL3677194,5.19,False,http://www.openphacts.org/units/Nanomolar,2552957,=,37,True,=,,IC50,nM,,6407.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6407.0
283292,17665637,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)n2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '16.83', 'le': '0.31', 'lle': '2.89', 'sei': '6.47'}",CHEMBL3677195,,CHEMBL3677195,6.88,False,http://www.openphacts.org/units/Nanomolar,2552958,=,37,True,=,,IC50,nM,,133.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,133.0
283293,17665638,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cnc(-c2ccccc2)s1,,,CHEMBL3638632,,2015.0,"{'bei': '15.25', 'le': '0.29', 'lle': '1.50', 'sei': '7.78'}",CHEMBL3677196,,CHEMBL3677196,6.25,False,http://www.openphacts.org/units/Nanomolar,2552959,=,37,True,=,,IC50,nM,,568.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,568.0
283294,17665639,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cnc(-c2ccccc2)s1,,,CHEMBL3638632,,2015.0,"{'bei': '18.06', 'le': '0.35', 'lle': '2.65', 'sei': '9.22'}",CHEMBL3677196,,CHEMBL3677196,7.40,False,http://www.openphacts.org/units/Nanomolar,2552959,=,37,True,=,,IC50,nM,,40.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,40.0
283295,17665640,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1-c1noc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '12.67', 'le': '0.24', 'lle': '1.19', 'sei': '4.87'}",CHEMBL3677197,,CHEMBL3677197,5.18,False,http://www.openphacts.org/units/Nanomolar,2552960,=,37,True,=,,IC50,nM,,6675.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6675.0
283296,17665641,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1-c1noc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.69', 'le': '0.31', 'lle': '2.83', 'sei': '6.41'}",CHEMBL3677197,,CHEMBL3677197,6.82,False,http://www.openphacts.org/units/Nanomolar,2552960,=,37,True,=,,IC50,nM,,153.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,153.0
283297,17665642,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(S(=O)(=O)N(C)C)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '15.08', 'le': '0.30', 'lle': '3.66', 'sei': '6.24'}",CHEMBL3677198,,CHEMBL3677198,6.54,False,http://www.openphacts.org/units/Nanomolar,2552961,=,37,True,=,,IC50,nM,,291.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,291.0
283298,17665643,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)n2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.26', 'le': '0.30', 'lle': '3.21', 'sei': '5.98'}",CHEMBL3677200,,CHEMBL3677200,6.90,False,http://www.openphacts.org/units/Nanomolar,2552963,=,37,True,=,,IC50,nM,,125.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,125.0
283299,17665644,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(-c2ccc(F)cc2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '13.03', 'le': '0.24', 'lle': '1.55', 'sei': '5.06'}",CHEMBL3677201,,CHEMBL3677201,5.37,False,http://www.openphacts.org/units/Nanomolar,2552964,=,37,True,=,,IC50,nM,,4229.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4229.0
283300,17665645,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(-c2ccc(F)cc2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '16.65', 'le': '0.31', 'lle': '3.05', 'sei': '6.46'}",CHEMBL3677201,,CHEMBL3677201,6.87,False,http://www.openphacts.org/units/Nanomolar,2552964,=,37,True,=,,IC50,nM,,136.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,136.0
283301,17665646,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1noc(-c2ccc(Cl)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.68', 'le': '0.33', 'lle': '2.82', 'sei': '6.73'}",CHEMBL3677202,,CHEMBL3677202,7.16,False,http://www.openphacts.org/units/Nanomolar,2552965,=,37,True,=,,IC50,nM,,70.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,70.0
283302,17665647,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2ccc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)nc2)ccc1F,,,CHEMBL3638632,,2015.0,"{'bei': '16.99', 'le': '0.32', 'lle': '2.26', 'sei': '9.22'}",CHEMBL3677203,,CHEMBL3677203,7.40,False,http://www.openphacts.org/units/Nanomolar,2552966,=,37,True,=,,IC50,nM,,40.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,40.0
283303,17665648,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2ccc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)nc2)ccc1F,,,CHEMBL3638632,,2015.0,"{'bei': '12.85', 'le': '0.24', 'lle': '0.46', 'sei': '6.98'}",CHEMBL3677203,,CHEMBL3677203,5.60,False,http://www.openphacts.org/units/Nanomolar,2552966,=,37,True,=,,IC50,nM,,2526.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2526.0
283304,17665649,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ncc(Oc2ccc(F)cc2)cn1,,,CHEMBL3638632,,2015.0,"{'bei': '16.19', 'le': '0.30', 'lle': '2.75', 'sei': '6.93'}",CHEMBL3677204,,CHEMBL3677204,7.10,False,http://www.openphacts.org/units/Nanomolar,2552967,=,37,True,=,,IC50,nM,,80.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,80.0
283305,17665650,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ncc(Oc2ccc(F)cc2)cn1,,,CHEMBL3638632,,2015.0,"{'bei': '12.34', 'le': '0.23', 'lle': '1.06', 'sei': '5.29'}",CHEMBL3677204,,CHEMBL3677204,5.41,False,http://www.openphacts.org/units/Nanomolar,2552967,=,37,True,=,,IC50,nM,,3876.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3876.0
283306,17665651,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(Oc2ccc(F)cc2)cn1,,,CHEMBL3638632,,2015.0,"{'bei': '17.07', 'le': '0.32', 'lle': '2.51', 'sei': '8.35'}",CHEMBL3677205,,CHEMBL3677205,7.47,False,http://www.openphacts.org/units/Nanomolar,2552968,=,37,True,=,,IC50,nM,,34.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,34.0
283307,17665652,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OC(C)(C)[C@H]2c2ccccc2)n1)c1ccc(Oc2ccc(F)cc2)cn1,,,CHEMBL3638632,,2015.0,"{'bei': '13.93', 'le': '0.26', 'lle': '0.62', 'sei': '8.06'}",CHEMBL3677206,,CHEMBL3677206,7.21,False,http://www.openphacts.org/units/Nanomolar,2552969,=,37,True,=,,IC50,nM,,62.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,62.0
283308,17665653,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OC(C)(C)[C@H]2c2ccccc2)n1)c1ccc(Oc2ccc(F)cc2)cn1,,,CHEMBL3638632,,2015.0,"{'bei': '12.92', 'le': '0.24', 'lle': '0.09', 'sei': '7.47'}",CHEMBL3677206,,CHEMBL3677206,6.68,False,http://www.openphacts.org/units/Nanomolar,2552969,=,37,True,=,,IC50,nM,,207.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,207.0
283309,17665654,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cnc(Oc3ccc(F)cc3)cn2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.41', 'le': '0.31', 'lle': '2.84', 'sei': '7.03'}",CHEMBL3677207,,CHEMBL3677207,7.19,False,http://www.openphacts.org/units/Nanomolar,2552970,=,37,True,=,,IC50,nM,,64.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,64.0
283310,17665655,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@H](C)c2cnc(Oc3ccc(F)cc3)cn2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '11.27', 'le': '0.21', 'lle': '0.59', 'sei': '4.83'}",CHEMBL3682139,,CHEMBL3682139,4.94,False,http://www.openphacts.org/units/Nanomolar,2558229,=,37,True,=,,IC50,nM,,11400.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,11400.0
283311,17665656,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cnc(Oc2ccc(F)cc2)nc1,,,CHEMBL3638632,,2015.0,"{'bei': '14.59', 'le': '0.27', 'lle': '2.05', 'sei': '6.25'}",CHEMBL3682004,,CHEMBL3682004,6.40,False,http://www.openphacts.org/units/Nanomolar,2558090,=,37,True,=,,IC50,nM,,401.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,401.0
283312,17665657,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cnc(Oc2ccc(F)cc2)nc1,,,CHEMBL3638632,,2015.0,"{'bei': '11.87', 'le': '0.22', 'lle': '0.86', 'sei': '5.09'}",CHEMBL3682004,,CHEMBL3682004,5.21,False,http://www.openphacts.org/units/Nanomolar,2558090,=,37,True,=,,IC50,nM,,6218.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6218.0
283313,17665658,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ncc(Oc2ccc(F)cc2F)cn1,,,CHEMBL3638632,,2015.0,"{'bei': '15.52', 'le': '0.29', 'lle': '2.60', 'sei': '6.92'}",CHEMBL3682005,,CHEMBL3682005,7.09,False,http://www.openphacts.org/units/Nanomolar,2558091,=,37,True,=,,IC50,nM,,82.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,82.0
283314,17665659,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ncc(-c3cccc(C(F)(F)F)c3)cn2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3682006,,CHEMBL3682006,,False,http://www.openphacts.org/units/Nanomolar,2558092,<,37,True,<,,IC50,nM,,22.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,22.0
283315,17665660,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(F)ccc1-c1cnc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)nc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.41', 'le': '0.31', 'lle': '2.62', 'sei': '7.69'}",CHEMBL3682007,,CHEMBL3682007,7.16,False,http://www.openphacts.org/units/Nanomolar,2558093,=,37,True,=,,IC50,nM,,69.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,69.0
283316,17665661,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CO)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.84', 'le': '0.32', 'lle': '2.88', 'sei': '6.86'}",CHEMBL3682008,,CHEMBL3682008,6.00,False,http://www.openphacts.org/units/Nanomolar,2558094,=,37,True,=,,IC50,nM,,991.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,991.0
283317,17665662,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC1(C)OC(=O)N(c2ccnc(NC(c3ccccc3)C(F)(F)F)n2)[C@@H]1c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '12.75', 'le': '0.24', 'lle': '-0.03', 'sei': '8.38'}",CHEMBL3682009,,CHEMBL3682009,5.64,False,http://www.openphacts.org/units/Nanomolar,2558095,=,37,True,=,,IC50,nM,,2275.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2275.0
283318,17665663,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(NC(c2ccccc2)C(F)(F)F)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.03', 'le': '0.29', 'lle': '1.55', 'sei': '8.49'}",CHEMBL3677021,,CHEMBL3677021,5.72,False,http://www.openphacts.org/units/Nanomolar,2558096,=,37,True,=,,IC50,nM,,1924.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1924.0
283319,17665664,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(NC(c2ccccc2)C(F)(F)F)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3677021,,CHEMBL3677021,,False,http://www.openphacts.org/units/Nanomolar,2558096,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
283320,17665665,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cnc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)nc2)ccc1F,,,CHEMBL3638632,,2015.0,,CHEMBL3682010,,CHEMBL3682010,,False,http://www.openphacts.org/units/Nanomolar,2558097,<,37,True,<,,IC50,nM,,22.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,22.0
283321,17665666,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)C2CCN(C(=O)c3ccc(F)cc3)CC2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.56', 'le': '0.26', 'lle': '2.23', 'sei': '7.05'}",CHEMBL3682012,,CHEMBL3682012,6.18,False,http://www.openphacts.org/units/Nanomolar,2558099,=,37,True,=,,IC50,nM,,665.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,665.0
283322,17665667,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)C2CCN(C(=O)C3CCCCC3)CC2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.04', 'le': '0.30', 'lle': '3.03', 'sei': '8.11'}",CHEMBL3682015,,CHEMBL3682015,7.11,False,http://www.openphacts.org/units/Nanomolar,2558102,=,37,True,=,,IC50,nM,,77.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,77.0
283323,17665668,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(NS(=O)(=O)c3ccccc3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.79', 'le': '0.29', 'lle': '2.69', 'sei': '6.28'}",CHEMBL3682016,,CHEMBL3682016,7.12,False,http://www.openphacts.org/units/Nanomolar,2558103,=,37,True,=,,IC50,nM,,75.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,75.0
283324,17665669,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2nnc(-c3ccccc3)o2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.30', 'le': '0.28', 'lle': '2.35', 'sei': '5.68'}",CHEMBL3682017,,CHEMBL3682017,6.03,False,http://www.openphacts.org/units/Nanomolar,2558104,=,37,True,=,,IC50,nM,,925.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,925.0
283325,17665670,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2noc(CNc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)n2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.40', 'le': '0.30', 'lle': '3.04', 'sei': '6.09'}",CHEMBL3682019,,CHEMBL3682019,6.47,False,http://www.openphacts.org/units/Nanomolar,2558106,=,37,True,=,,IC50,nM,,341.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,341.0
283326,17665671,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)C2CCNCC2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3682020,,CHEMBL3682020,,False,http://www.openphacts.org/units/Nanomolar,2558107,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
283327,17665672,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)C2CCN(C3CCC3)CC2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3682021,,CHEMBL3682021,,False,http://www.openphacts.org/units/Nanomolar,2558108,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
283328,17665673,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)C2CCN(C(C)C)CC2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3682022,,CHEMBL3682022,,False,http://www.openphacts.org/units/Nanomolar,2558109,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
283329,17665674,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)C1CCN(C(=O)c2ccncc2)CC1,,,CHEMBL3638632,,2015.0,,CHEMBL3682023,,CHEMBL3682023,,False,http://www.openphacts.org/units/Nanomolar,2558110,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
283330,17665675,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)C1CCN(C(=O)c2cccnc2)CC1,,,CHEMBL3638632,,2015.0,,CHEMBL3682024,,CHEMBL3682024,,False,http://www.openphacts.org/units/Nanomolar,2558111,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
283331,17665676,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cn(Cc2ccccc2)nn1,,,CHEMBL3638632,,2015.0,"{'bei': '14.99', 'le': '0.28', 'lle': '2.84', 'sei': '6.23'}",CHEMBL3682025,,CHEMBL3682025,6.11,False,http://www.openphacts.org/units/Nanomolar,2558112,=,37,True,=,,IC50,nM,,780.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,780.0
283332,17665677,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cn(Cc2ccccc2)nn1,,,CHEMBL3638632,,2015.0,,CHEMBL3682025,,CHEMBL3682025,,False,http://www.openphacts.org/units/Nanomolar,2558112,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
283333,17665678,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cn(-c2ccccc2)nn1,,,CHEMBL3638632,,2015.0,"{'bei': '17.84', 'le': '0.33', 'lle': '3.81', 'sei': '7.16'}",CHEMBL3682026,,CHEMBL3682026,7.02,False,http://www.openphacts.org/units/Nanomolar,2558113,=,37,True,=,,IC50,nM,,96.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,96.0
283334,17665679,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cn(-c2ccccc2)nn1,,,CHEMBL3638632,,2015.0,"{'bei': '13.44', 'le': '0.25', 'lle': '2.08', 'sei': '5.39'}",CHEMBL3682026,,CHEMBL3682026,5.29,False,http://www.openphacts.org/units/Nanomolar,2558113,=,37,True,=,,IC50,nM,,5160.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5160.0
283335,17665680,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OCC2(C)C)n1)c1cnc(OCC(F)(F)F)c(Cl)c1,,,CHEMBL3638632,,2015.0,"{'bei': '14.03', 'le': '0.29', 'lle': '2.00', 'sei': '7.27'}",CHEMBL3682030,,CHEMBL3682030,6.51,False,http://www.openphacts.org/units/Nanomolar,2558117,=,37,True,=,,IC50,nM,,311.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,311.0
283336,17665681,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OCC2(C)C)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '16.57', 'le': '0.33', 'lle': '2.94', 'sei': '6.75'}",CHEMBL3682035,,CHEMBL3682035,7.17,False,http://www.openphacts.org/units/Nanomolar,2558122,=,37,True,=,,IC50,nM,,67.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,67.0
283337,17665682,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1C(C)OC(=O)N1c1ccnc(N[C@@H](C)c2ccccc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.99', 'le': '0.32', 'lle': '1.76', 'sei': '8.59'}",CHEMBL3682036,,CHEMBL3682036,5.78,False,http://www.openphacts.org/units/Nanomolar,2558123,=,37,True,=,,IC50,nM,,1649.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1649.0
283338,17665683,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1C(C)OC(=O)N1c1nc(N[C@@H](C)c2ccccc2)ncc1F,,,CHEMBL3638632,,2015.0,"{'bei': '17.15', 'le': '0.32', 'lle': '1.99', 'sei': '9.13'}",CHEMBL3682037,,CHEMBL3682037,6.15,False,http://www.openphacts.org/units/Nanomolar,2558124,=,37,True,=,,IC50,nM,,712.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,712.0
283339,17665684,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC(C)(C)C2(C)C)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '17.99', 'le': '0.33', 'lle': '1.96', 'sei': '9.09'}",CHEMBL3682038,,CHEMBL3682038,6.12,False,http://www.openphacts.org/units/Nanomolar,2558125,=,37,True,=,,IC50,nM,,751.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,751.0
283340,17665685,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC1OC(=O)N(c2ccnc(N[C@@H](C)c3cnc(OCC(F)(F)F)c(Cl)c3)n2)C1(C)C,,,CHEMBL3638632,,2015.0,"{'bei': '13.62', 'le': '0.28', 'lle': '1.50', 'sei': '7.00'}",CHEMBL3682045,,CHEMBL3682045,6.26,False,http://www.openphacts.org/units/Nanomolar,2558132,=,37,True,=,,IC50,nM,,546.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,546.0
283341,17665686,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2(C)C)n1)c1cnc(OCC(F)(F)F)c(Cl)c1,,,CHEMBL3638632,,2015.0,"{'bei': '14.74', 'le': '0.30', 'lle': '2.20', 'sei': '7.35'}",CHEMBL3682046,,CHEMBL3682046,6.57,False,http://www.openphacts.org/units/Nanomolar,2558133,=,37,True,=,,IC50,nM,,268.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,268.0
283342,17665687,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OCC2(C)C)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '18.04', 'le': '0.36', 'lle': '2.22', 'sei': '9.29'}",CHEMBL3682050,,CHEMBL3682050,6.26,False,http://www.openphacts.org/units/Nanomolar,2558137,=,37,True,=,,IC50,nM,,553.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,553.0
283343,17665688,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OCC2(C)C)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '18.04', 'le': '0.36', 'lle': '2.22', 'sei': '9.29'}",CHEMBL3682050,,CHEMBL3682050,6.26,False,http://www.openphacts.org/units/Nanomolar,2558137,=,37,True,=,,IC50,nM,,553.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,553.0
283344,17665689,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2CCOC2=O)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '17.11', 'le': '0.35', 'lle': '3.25', 'sei': '6.78'}",CHEMBL3682052,,CHEMBL3682052,7.21,False,http://www.openphacts.org/units/Nanomolar,2558139,=,37,True,=,,IC50,nM,,62.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,62.0
283345,17665690,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2CCOC2=O)n1)c1ccc(-c2cnn(C)c2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '15.91', 'le': '0.31', 'lle': '2.69', 'sei': '7.45'}",CHEMBL3682053,,CHEMBL3682053,6.35,False,http://www.openphacts.org/units/Nanomolar,2558140,=,37,True,=,,IC50,nM,,450.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,450.0
283346,17665691,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(C)(C)C)nc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '18.48', 'le': '0.35', 'lle': '2.77', 'sei': '8.83'}",CHEMBL3682056,,CHEMBL3682056,7.09,False,http://www.openphacts.org/units/Nanomolar,2558143,=,37,True,=,,IC50,nM,,82.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,82.0
283347,17665692,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1c(-c2ccc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)cc2)cnn1C,,,CHEMBL3638632,,2015.0,"{'bei': '16.43', 'le': '0.30', 'lle': '2.57', 'sei': '8.11'}",CHEMBL3682059,,CHEMBL3682059,6.91,False,http://www.openphacts.org/units/Nanomolar,2558146,=,37,True,=,,IC50,nM,,123.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,123.0
283348,17665693,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(F)(F)F)cc2F)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.21', 'le': '0.33', 'lle': '2.31', 'sei': '10.54'}",CHEMBL3682060,,CHEMBL3682060,7.10,False,http://www.openphacts.org/units/Nanomolar,2558147,=,37,True,=,,IC50,nM,,80.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,80.0
283349,17665694,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CCOC1(c2ccc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)cc2)CC1,,,CHEMBL3638632,,2015.0,"{'bei': '18.48', 'le': '0.35', 'lle': '2.93', 'sei': '9.90'}",CHEMBL3682064,,CHEMBL3682064,7.58,False,http://www.openphacts.org/units/Nanomolar,2558151,=,37,True,=,,IC50,nM,,26.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,26.0
283350,17665695,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3cnn(C)c3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.39', 'le': '0.32', 'lle': '3.04', 'sei': '8.30'}",CHEMBL3677037,,CHEMBL3677037,7.07,False,http://www.openphacts.org/units/Nanomolar,2552798,=,37,True,=,,IC50,nM,,85.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,85.0
283351,17665696,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)c1ccc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)c(F)c1,,,CHEMBL3638632,,2015.0,"{'bei': '18.26', 'le': '0.34', 'lle': '2.17', 'sei': '10.48'}",CHEMBL3682065,,CHEMBL3682065,7.06,False,http://www.openphacts.org/units/Nanomolar,2558152,=,37,True,=,,IC50,nM,,88.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,88.0
283352,17665697,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3cnn(C)c3)cc2F)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.76', 'le': '0.31', 'lle': '2.94', 'sei': '8.35'}",CHEMBL3682067,,CHEMBL3682067,7.11,False,http://www.openphacts.org/units/Nanomolar,2558154,=,37,True,=,,IC50,nM,,77.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,77.0
283353,17665698,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3cn[nH]c3)cc2F)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.89', 'le': '0.32', 'lle': '2.77', 'sei': '7.22'}",CHEMBL3682068,,CHEMBL3682068,6.93,False,http://www.openphacts.org/units/Nanomolar,2558155,=,37,True,=,,IC50,nM,,117.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,117.0
283354,17665699,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)NC3CCCC3)c(Cl)c2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3682069,,CHEMBL3682069,,False,http://www.openphacts.org/units/Nanomolar,2558156,<,37,True,<,,IC50,nM,,22.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,22.0
283355,17665700,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cccc(OC3CCCC3)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.86', 'le': '0.30', 'lle': '1.56', 'sei': '8.50'}",CHEMBL3682072,,CHEMBL3682072,6.51,False,http://www.openphacts.org/units/Nanomolar,2558159,=,37,True,=,,IC50,nM,,307.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,307.0
283356,17665701,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1ccc([C@H](C)Nc2ncc(F)c(N3C(=O)OC[C@@H]3C(C)C)n2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.71', 'le': '0.32', 'lle': '2.17', 'sei': '8.78'}",CHEMBL3682073,,CHEMBL3682073,6.73,False,http://www.openphacts.org/units/Nanomolar,2558160,=,37,True,=,,IC50,nM,,188.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,188.0
283357,17665702,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cccc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '16.64', 'le': '0.31', 'lle': '1.98', 'sei': '8.35'}",CHEMBL3682076,,CHEMBL3682076,6.40,False,http://www.openphacts.org/units/Nanomolar,2558163,=,37,True,=,,IC50,nM,,400.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,400.0
283358,17665703,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)COc1cccc([C@H](C)Nc2ncc(F)c(N3C(=O)OC[C@@H]3C(C)C)n2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '15.32', 'le': '0.29', 'lle': '1.58', 'sei': '8.33'}",CHEMBL3682077,,CHEMBL3682077,6.38,False,http://www.openphacts.org/units/Nanomolar,2558164,=,37,True,=,,IC50,nM,,416.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,416.0
283359,17665704,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cccc(OC3CCCOC3)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.20', 'le': '0.27', 'lle': '1.87', 'sei': '7.06'}",CHEMBL3682079,,CHEMBL3682079,6.06,False,http://www.openphacts.org/units/Nanomolar,2558166,=,37,True,=,,IC50,nM,,878.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,878.0
283360,17665705,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cccc(Oc3ccccc3)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.71', 'le': '0.29', 'lle': '1.16', 'sei': '8.59'}",CHEMBL3682080,,CHEMBL3682080,6.58,False,http://www.openphacts.org/units/Nanomolar,2558167,=,37,True,=,,IC50,nM,,266.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,266.0
283361,17665706,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1nc(N[C@@H](C)c2cccc(Oc3ccccc3)c2)ncc1F,,,CHEMBL3638632,,2015.0,"{'bei': '16.14', 'le': '0.30', 'lle': '1.49', 'sei': '9.20'}",CHEMBL3682081,,CHEMBL3682081,7.05,False,http://www.openphacts.org/units/Nanomolar,2558168,=,37,True,=,,IC50,nM,,90.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,90.0
283362,17665707,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(OCC(C)C)ccc1[C@H](C)Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.27', 'le': '0.32', 'lle': '2.15', 'sei': '9.30'}",CHEMBL3682082,,CHEMBL3682082,7.12,False,http://www.openphacts.org/units/Nanomolar,2558170,=,37,True,=,,IC50,nM,,75.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,75.0
283363,17665708,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)ccc1OCC(C)C,,,CHEMBL3638632,,2015.0,"{'bei': '17.52', 'le': '0.33', 'lle': '2.26', 'sei': '9.44'}",CHEMBL3682084,,CHEMBL3682084,7.23,False,http://www.openphacts.org/units/Nanomolar,2558172,=,37,True,=,,IC50,nM,,59.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,59.0
283364,17665709,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCn4ccnc4C3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.74', 'le': '0.27', 'lle': '2.96', 'sei': '7.69'}",CHEMBL3682085,,CHEMBL3682085,6.80,False,http://www.openphacts.org/units/Nanomolar,2558173,=,37,True,=,,IC50,nM,,158.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,158.0
283365,17665710,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCC4CNC4C3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.95', 'le': '0.28', 'lle': '3.32', 'sei': '8.15'}",CHEMBL3682086,,CHEMBL3682086,6.74,False,http://www.openphacts.org/units/Nanomolar,2558174,=,37,True,=,,IC50,nM,,184.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,184.0
283366,17665711,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCC(N)CC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.08', 'le': '0.24', 'lle': '2.19', 'sei': '5.94'}",CHEMBL3682087,,CHEMBL3682087,5.74,False,http://www.openphacts.org/units/Nanomolar,2558175,=,37,True,=,,IC50,nM,,1840.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1840.0
283367,17665712,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCC(C)(O)CC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.45', 'le': '0.25', 'lle': '2.12', 'sei': '6.72'}",CHEMBL3682088,,CHEMBL3682088,6.10,False,http://www.openphacts.org/units/Nanomolar,2558176,=,37,True,=,,IC50,nM,,791.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,791.0
283368,17665713,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCCC(F)(F)C3)cc2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3682089,,CHEMBL3682089,,False,http://www.openphacts.org/units/Nanomolar,2558177,<,37,True,<,,IC50,nM,,22.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,22.0
283369,17665714,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCNC4(CC4)C3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.94', 'le': '0.26', 'lle': '2.71', 'sei': '7.60'}",CHEMBL3682090,,CHEMBL3682090,6.28,False,http://www.openphacts.org/units/Nanomolar,2558178,=,37,True,=,,IC50,nM,,521.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,521.0
283370,17665715,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCNCC34CC4)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.81', 'le': '0.29', 'lle': '3.55', 'sei': '8.62'}",CHEMBL3682091,,CHEMBL3682091,7.12,False,http://www.openphacts.org/units/Nanomolar,2558179,=,37,True,=,,IC50,nM,,75.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,75.0
283371,17665716,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CC(F)(F)C(F)(F)C3)cc2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3682092,,CHEMBL3682092,,False,http://www.openphacts.org/units/Nanomolar,2558180,<,37,True,<,,IC50,nM,,22.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,22.0
283372,17665717,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(=O)N1CCN(Cc2ccc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)cc2)CC1,,,CHEMBL3638632,,2015.0,,CHEMBL3682093,,CHEMBL3682093,,False,http://www.openphacts.org/units/Nanomolar,2558181,<,37,True,<,,IC50,nM,,72.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,72.0
283373,17665718,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1cc(F)nc(N[C@@H](C)c2ccccc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '19.19', 'le': '0.36', 'lle': '2.84', 'sei': '9.81'}",CHEMBL3682094,,CHEMBL3682094,6.61,False,http://www.openphacts.org/units/Nanomolar,2558182,=,37,True,=,,IC50,nM,,246.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,246.0
283374,17665719,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cccc(F)c2F)n1,,,CHEMBL3638632,,2015.0,"{'bei': '18.96', 'le': '0.36', 'lle': '2.96', 'sei': '10.20'}",CHEMBL3682103,,CHEMBL3682103,6.87,False,http://www.openphacts.org/units/Nanomolar,2558191,=,37,True,=,,IC50,nM,,135.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,135.0
283375,17665720,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N[C@H]3CC[C@H](O)CC3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.30', 'le': '0.27', 'lle': '3.15', 'sei': '5.95'}",CHEMBL3682105,,CHEMBL3682105,6.95,False,http://www.openphacts.org/units/Nanomolar,2558193,=,37,True,=,,IC50,nM,,113.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,113.5
283376,17665721,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(Oc3cncnc3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.91', 'le': '0.29', 'lle': '2.48', 'sei': '6.54'}",CHEMBL3682111,,CHEMBL3682111,6.69,False,http://www.openphacts.org/units/Nanomolar,2558199,=,37,True,=,,IC50,nM,,204.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,204.0
283377,17665722,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC3(COC3)C2c2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '15.01', 'le': '0.27', 'lle': '1.92', 'sei': '7.89'}",CHEMBL3682113,,CHEMBL3682113,6.04,False,http://www.openphacts.org/units/Nanomolar,2558202,=,37,True,=,,IC50,nM,,911.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,911.0
283378,17665723,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1nc(N[C@@H](C)c2ccc(C(F)(F)F)cc2F)ncc1F,,,CHEMBL3638632,,2015.0,"{'bei': '15.84', 'le': '0.31', 'lle': '1.89', 'sei': '10.12'}",CHEMBL3682114,,CHEMBL3682114,6.82,False,http://www.openphacts.org/units/Nanomolar,2558203,=,37,True,=,,IC50,nM,,153.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,153.0
283379,17665724,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(NCc2ccc(Oc3ccccc3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.28', 'le': '0.30', 'lle': '1.73', 'sei': '8.60'}",CHEMBL3682115,,CHEMBL3682115,6.58,False,http://www.openphacts.org/units/Nanomolar,2558204,=,37,True,=,,IC50,nM,,260.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,260.0
283380,17665725,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2c2ccccc2)n1)C1CC1,,,CHEMBL3638632,,2015.0,"{'bei': '16.22', 'le': '0.30', 'lle': '2.03', 'sei': '8.25'}",CHEMBL3682119,,CHEMBL3682119,5.55,False,http://www.openphacts.org/units/Nanomolar,2558208,=,37,True,=,,IC50,nM,,2797.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2797.0
283381,17665726,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2c2ccc(-c3ccccc3)cc2)n1)C1CC1,,,CHEMBL3638632,,2015.0,"{'bei': '15.27', 'le': '0.28', 'lle': '1.07', 'sei': '9.08'}",CHEMBL3682121,,CHEMBL3682121,6.12,False,http://www.openphacts.org/units/Nanomolar,2558210,=,37,True,=,,IC50,nM,,764.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,764.0
283382,17665727,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)NC3CCCC3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3682123,,CHEMBL3682123,,False,http://www.openphacts.org/units/Nanomolar,2558212,<,37,True,<,,IC50,nM,,22.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,22.0
283383,17665728,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)NC3CCC(F)(F)CC3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3682124,,CHEMBL3682124,,False,http://www.openphacts.org/units/Nanomolar,2558213,<,37,True,<,,IC50,nM,,22.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,22.0
283384,17665729,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)NC3CCOCC3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.55', 'le': '0.28', 'lle': '3.18', 'sei': '6.49'}",CHEMBL3682125,,CHEMBL3682125,6.86,False,http://www.openphacts.org/units/Nanomolar,2558214,=,37,True,=,,IC50,nM,,138.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,138.0
283385,17665730,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N[C@@H]3CCCC[C@@H]3O)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.65', 'le': '0.28', 'lle': '3.31', 'sei': '6.10'}",CHEMBL3682126,,CHEMBL3682126,7.11,False,http://www.openphacts.org/units/Nanomolar,2558215,=,37,True,=,,IC50,nM,,77.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,77.0
283386,17665731,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)NC3CCS(=O)(=O)CC3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '12.68', 'le': '0.25', 'lle': '3.51', 'sei': '5.05'}",CHEMBL3682127,,CHEMBL3682127,6.59,False,http://www.openphacts.org/units/Nanomolar,2558216,=,37,True,=,,IC50,nM,,257.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,257.0
283387,17665732,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N[C@@H]3CCCC[C@H]3O)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.25', 'le': '0.27', 'lle': '3.12', 'sei': '5.93'}",CHEMBL3682128,,CHEMBL3682128,6.92,False,http://www.openphacts.org/units/Nanomolar,2558217,=,37,True,=,,IC50,nM,,121.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,121.0
283388,17665733,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N(C)C3CCOCC3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.99', 'le': '0.27', 'lle': '2.77', 'sei': '7.01'}",CHEMBL3682129,,CHEMBL3682129,6.79,False,http://www.openphacts.org/units/Nanomolar,2558218,=,37,True,=,,IC50,nM,,161.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,161.0
283389,17665734,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N(C)C)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.26', 'le': '0.29', 'lle': '2.87', 'sei': '7.23'}",CHEMBL3682130,,CHEMBL3682130,6.34,False,http://www.openphacts.org/units/Nanomolar,2558219,=,37,True,=,,IC50,nM,,457.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,457.0
283390,17665735,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N3CCOCC3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.74', 'le': '0.26', 'lle': '3.04', 'sei': '6.49'}",CHEMBL3682131,,CHEMBL3682131,6.29,False,http://www.openphacts.org/units/Nanomolar,2558220,=,37,True,=,,IC50,nM,,519.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,519.0
283391,17665736,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N3CCOC[C@H]3C)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.44', 'le': '0.27', 'lle': '3.18', 'sei': '7.03'}",CHEMBL3682132,,CHEMBL3682132,6.81,False,http://www.openphacts.org/units/Nanomolar,2558221,=,37,True,=,,IC50,nM,,155.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,155.0
283392,17665737,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N3CCC(O)CC3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.39', 'le': '0.25', 'lle': '2.94', 'sei': '5.85'}",CHEMBL3682133,,CHEMBL3682133,6.31,False,http://www.openphacts.org/units/Nanomolar,2558222,=,37,True,=,,IC50,nM,,488.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,488.0
283393,17665738,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,COC1CCN(C(=O)c2ccc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)cc2F)CC1,,,CHEMBL3638632,,2015.0,"{'bei': '15.19', 'le': '0.29', 'lle': '3.36', 'sei': '7.61'}",CHEMBL3682134,,CHEMBL3682134,7.38,False,http://www.openphacts.org/units/Nanomolar,2558223,=,37,True,=,,IC50,nM,,42.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,42.0
283394,17665739,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N3CCC(F)CC3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.44', 'le': '0.29', 'lle': '2.97', 'sei': '8.34'}",CHEMBL3682135,,CHEMBL3682135,7.31,False,http://www.openphacts.org/units/Nanomolar,2558224,=,37,True,=,,IC50,nM,,49.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,49.0
283395,17665740,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N3CCC[C@@H](O)C3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.02', 'le': '0.27', 'lle': '3.24', 'sei': '6.13'}",CHEMBL3682136,,CHEMBL3682136,6.61,False,http://www.openphacts.org/units/Nanomolar,2558225,=,37,True,=,,IC50,nM,,244.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,244.0
283396,17665741,[],CHEMBL3705790,"LC-MS Biochemical Assay: Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N3CCCC3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.74', 'le': '0.30', 'lle': '2.94', 'sei': '7.93'}",CHEMBL3682137,,CHEMBL3682137,6.95,False,http://www.openphacts.org/units/Nanomolar,2558226,=,37,True,=,,IC50,nM,,112.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,112.0
283397,17665742,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccccc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '20.00', 'le': '0.37', 'lle': '2.90', 'sei': '9.69'}",CHEMBL3672097,,CHEMBL3672097,6.53,False,http://www.openphacts.org/units/Nanomolar,2547475,=,37,True,=,,IC50,nM,,296.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,296.0
283398,17665743,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC[C@H](Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '14.75', 'le': '0.27', 'lle': '1.00', 'sei': '7.45'}",CHEMBL3672106,,CHEMBL3672106,5.02,False,http://www.openphacts.org/units/Nanomolar,2547484,=,37,True,=,,IC50,nM,,9550.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,9550.0
283399,17665744,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC(C)(C)[C@@H]2Cc2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '14.21', 'le': '0.26', 'lle': '0.72', 'sei': '8.49'}",CHEMBL3672142,,CHEMBL3672142,5.72,False,http://www.openphacts.org/units/Nanomolar,2547520,=,37,True,=,,IC50,nM,,1910.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1910.0
283400,17665745,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(NCc2ccccc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.39', 'le': '0.30', 'lle': '2.05', 'sei': '7.60'}",CHEMBL3672151,,CHEMBL3672151,5.12,False,http://www.openphacts.org/units/Nanomolar,2547529,=,37,True,=,,IC50,nM,,7580.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,7580.0
283401,17665746,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)ccc2c1,,,CHEMBL3638632,,2015.0,"{'bei': '17.29', 'le': '0.32', 'lle': '2.24', 'sei': '9.18'}",CHEMBL3672154,,CHEMBL3672154,7.03,False,http://www.openphacts.org/units/Nanomolar,2547532,=,37,True,=,,IC50,nM,,94.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,94.0
283402,17665747,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2c2ccncc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '14.86', 'le': '0.27', 'lle': '1.63', 'sei': '6.69'}",CHEMBL3672169,,CHEMBL3672169,5.37,False,http://www.openphacts.org/units/Nanomolar,2547547,=,37,True,=,,IC50,nM,,4270.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4270.0
283403,17665748,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@H](C)c2ccc(F)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.78', 'le': '0.26', 'lle': '0.98', 'sei': '7.05'}",CHEMBL3672179,,CHEMBL3672179,4.75,False,http://www.openphacts.org/units/Nanomolar,2547557,=,37,True,=,,IC50,nM,,17900.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,17900.0
283404,17665749,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@]2(C)c2ccccc2)n1)c1ccc2ccccc2c1,,,CHEMBL3638632,,2015.0,"{'bei': '15.57', 'le': '0.28', 'lle': '0.94', 'sei': '9.82'}",CHEMBL3672181,,CHEMBL3672181,6.61,False,http://www.openphacts.org/units/Nanomolar,2547559,=,37,True,=,,IC50,nM,,245.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,245.0
283405,17665750,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@]2(C)c2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '17.39', 'le': '0.32', 'lle': '1.99', 'sei': '9.67'}",CHEMBL3672182,,CHEMBL3672182,6.51,False,http://www.openphacts.org/units/Nanomolar,2547561,=,37,True,=,,IC50,nM,,308.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,308.0
283406,17665751,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1[C@H](C)Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1,,,CHEMBL3638632,,2015.0,"{'bei': '18.41', 'le': '0.34', 'lle': '2.92', 'sei': '8.57'}",CHEMBL3672183,,CHEMBL3672183,6.56,False,http://www.openphacts.org/units/Nanomolar,2547562,=,37,True,=,,IC50,nM,,275.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,275.0
283407,17665752,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,COc1cccc([C@H](C)Nc2nc(C)cc(N3C(=O)OC[C@@H]3C(C)C)n2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '16.80', 'le': '0.31', 'lle': '2.27', 'sei': '8.13'}",CHEMBL3672185,,CHEMBL3672185,6.22,False,http://www.openphacts.org/units/Nanomolar,2547564,=,37,True,=,,IC50,nM,,598.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,598.0
283408,17665753,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H](C)Nc1nccc(N2C(=O)OC(C)(C)[C@@H]2c2ccccc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.61', 'le': '0.33', 'lle': '1.83', 'sei': '9.27'}",CHEMBL3672188,,CHEMBL3672188,6.24,False,http://www.openphacts.org/units/Nanomolar,2547567,=,37,True,=,,IC50,nM,,571.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,571.0
283409,17665754,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(F)(F)F)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.19', 'le': '0.33', 'lle': '2.13', 'sei': '10.07'}",CHEMBL3672190,,CHEMBL3672190,6.78,False,http://www.openphacts.org/units/Nanomolar,2547569,=,37,True,=,,IC50,nM,,166.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,166.0
283410,17665755,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)C2CCCCC2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '19.41', 'le': '0.37', 'lle': '2.61', 'sei': '9.58'}",CHEMBL3672198,,CHEMBL3672198,6.45,False,http://www.openphacts.org/units/Nanomolar,2547577,=,37,True,=,,IC50,nM,,352.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,352.0
283411,17665756,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,[C-]#[N+]c1ccc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '17.15', 'le': '0.32', 'lle': '1.85', 'sei': '8.41'}",CHEMBL3672202,,CHEMBL3672202,6.03,False,http://www.openphacts.org/units/Nanomolar,2547581,=,37,True,=,,IC50,nM,,939.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,939.0
283412,17665757,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2(C)C)n1)c1cccc2ccccc12,,,CHEMBL3638632,,2015.0,"{'bei': '18.06', 'le': '0.33', 'lle': '2.01', 'sei': '9.72'}",CHEMBL3672203,,CHEMBL3672203,6.55,False,http://www.openphacts.org/units/Nanomolar,2547582,=,37,True,=,,IC50,nM,,284.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,284.0
283413,17665758,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2(C)C)n1)C1CCCCC1,,,CHEMBL3638632,,2015.0,"{'bei': '18.66', 'le': '0.35', 'lle': '2.35', 'sei': '8.82'}",CHEMBL3672206,,CHEMBL3672206,5.94,False,http://www.openphacts.org/units/Nanomolar,2547585,=,37,True,=,,IC50,nM,,1140.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1140.0
283414,17665759,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1nc(N[C@@H](C)c2ccc3ccccc3c2)ncc1F,,,CHEMBL3638632,,2015.0,"{'bei': '17.49', 'le': '0.32', 'lle': '1.98', 'sei': '10.24'}",CHEMBL3672207,,CHEMBL3672207,6.90,False,http://www.openphacts.org/units/Nanomolar,2547586,=,37,True,=,,IC50,nM,,126.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,126.0
283415,17665760,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc2cc([C@H](C)Nc3nccc(N4C(=O)OCC4(C)C)n3)ccc2c1,,,CHEMBL3638632,,2015.0,"{'bei': '17.39', 'le': '0.32', 'lle': '2.28', 'sei': '8.91'}",CHEMBL3672210,,CHEMBL3672210,6.83,False,http://www.openphacts.org/units/Nanomolar,2547589,=,37,True,=,,IC50,nM,,149.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,149.0
283416,17665761,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,COc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)ccc1F,,,CHEMBL3638632,,2015.0,"{'bei': '18.14', 'le': '0.34', 'lle': '3.01', 'sei': '8.87'}",CHEMBL3672214,,CHEMBL3672214,6.79,False,http://www.openphacts.org/units/Nanomolar,2547593,=,37,True,=,,IC50,nM,,162.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,162.0
283417,17665762,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2c2ccccc2)n1)c1ccc(Br)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '13.89', 'le': '0.30', 'lle': '0.99', 'sei': '9.06'}",CHEMBL3672215,,CHEMBL3672215,6.10,False,http://www.openphacts.org/units/Nanomolar,2547594,=,37,True,=,,IC50,nM,,791.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,791.0
283418,17665763,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2(C)C)n1)c1ccc2ccccc2c1,,,CHEMBL3638632,,2015.0,"{'bei': '18.40', 'le': '0.34', 'lle': '2.13', 'sei': '9.90'}",CHEMBL3672218,,CHEMBL3672218,6.67,False,http://www.openphacts.org/units/Nanomolar,2547597,=,37,True,=,,IC50,nM,,215.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,215.0
283419,17665764,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2(C)C)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '17.93', 'le': '0.33', 'lle': '2.22', 'sei': '8.32'}",CHEMBL3672229,,CHEMBL3672229,5.60,False,http://www.openphacts.org/units/Nanomolar,2547608,=,37,True,=,,IC50,nM,,2500.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2500.0
283420,17665765,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@]2(C)c2ccccc2)n1)c1ccc(F)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '17.41', 'le': '0.32', 'lle': '2.17', 'sei': '10.14'}",CHEMBL3672230,,CHEMBL3672230,6.83,False,http://www.openphacts.org/units/Nanomolar,2547609,=,37,True,=,,IC50,nM,,147.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,147.5
283421,17665766,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1nc(N[C@@H](C)c2ccccc2)ncc1F,,,CHEMBL3638632,,2015.0,"{'bei': '18.20', 'le': '0.34', 'lle': '2.50', 'sei': '9.31'}",CHEMBL3677001,,CHEMBL3677001,6.27,False,http://www.openphacts.org/units/Nanomolar,2552757,=,37,True,=,,IC50,nM,,538.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,538.0
283422,17665767,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cnc(N[C@@H](C)c2ccc3ccccc3c2)nc1N1C(=O)OC[C@@H]1C(C)C,,,CHEMBL3638632,,2015.0,"{'bei': '15.94', 'le': '0.29', 'lle': '1.13', 'sei': '9.24'}",CHEMBL3677003,,CHEMBL3677003,6.22,False,http://www.openphacts.org/units/Nanomolar,2552759,=,37,True,=,,IC50,nM,,598.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,598.0
283423,17665768,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,COc1cccc([C@H](C)Nc2ncc(F)c(N3C(=O)OC[C@@H]3C(C)C)n2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '16.65', 'le': '0.32', 'lle': '2.46', 'sei': '8.14'}",CHEMBL3677004,,CHEMBL3677004,6.24,False,http://www.openphacts.org/units/Nanomolar,2552760,=,37,True,=,,IC50,nM,,582.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,582.0
283424,17665769,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@]2(C)c2ccccc2)n1)c1ccc2ccccc2c1,,,CHEMBL3638632,,2015.0,"{'bei': '16.59', 'le': '0.30', 'lle': '1.37', 'sei': '10.45'}",CHEMBL3677005,,CHEMBL3677005,7.04,False,http://www.openphacts.org/units/Nanomolar,2552761,=,37,True,=,,IC50,nM,,91.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,91.0
283425,17665770,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@]2(C)c2ccccc2)n1)C1CCCCC1,,,CHEMBL3638632,,2015.0,"{'bei': '17.36', 'le': '0.32', 'lle': '1.88', 'sei': '9.81'}",CHEMBL3677007,,CHEMBL3677007,6.61,False,http://www.openphacts.org/units/Nanomolar,2552763,=,37,True,=,,IC50,nM,,248.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,248.0
283426,17665771,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC(C)(C)[C@@H]2c2ccccc2)n1)C(C)(C)C,,,CHEMBL3638632,,2015.0,"{'bei': '15.88', 'le': '0.30', 'lle': '1.05', 'sei': '8.69'}",CHEMBL3677009,,CHEMBL3677009,5.85,False,http://www.openphacts.org/units/Nanomolar,2552765,=,37,True,=,,IC50,nM,,1410.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1410.0
283427,17665772,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(Oc3ccccc3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.93', 'le': '0.33', 'lle': '2.08', 'sei': '9.80'}",CHEMBL3677013,,CHEMBL3677013,7.50,False,http://www.openphacts.org/units/Nanomolar,2552769,=,37,True,=,,IC50,nM,,31.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,31.5
283428,17665773,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(C)(C)C)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '19.53', 'le': '0.36', 'lle': '2.54', 'sei': '11.09'}",CHEMBL3677015,,CHEMBL3677015,7.47,False,http://www.openphacts.org/units/Nanomolar,2552771,=,37,True,=,,IC50,nM,,33.9,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,33.9
283429,17665774,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC(C)(C)[C@@H]2c2ccccc2)n1)C1CC1,,,CHEMBL3638632,,2015.0,"{'bei': '19.42', 'le': '0.36', 'lle': '2.68', 'sei': '10.16'}",CHEMBL3677016,,CHEMBL3677016,6.84,False,http://www.openphacts.org/units/Nanomolar,2552772,=,37,True,=,,IC50,nM,,143.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,143.0
283430,17665775,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc([C@H](C)Nc2ncc(F)c(N3C(=O)OC[C@@H]3C(C)C)n2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '15.51', 'le': '0.29', 'lle': '2.03', 'sei': '7.58'}",CHEMBL3677017,,CHEMBL3677017,5.81,False,http://www.openphacts.org/units/Nanomolar,2552773,=,37,True,=,,IC50,nM,,1560.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1560.0
283431,17665776,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(-c2ccccc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.27', 'le': '0.30', 'lle': '1.25', 'sei': '9.72'}",CHEMBL3677023,,CHEMBL3677023,6.55,False,http://www.openphacts.org/units/Nanomolar,2552779,=,37,True,=,,IC50,nM,,283.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,283.0
283432,17665777,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(Cl)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '19.01', 'le': '0.37', 'lle': '2.58', 'sei': '10.19'}",CHEMBL3677024,,CHEMBL3677024,6.86,False,http://www.openphacts.org/units/Nanomolar,2552780,=,37,True,=,,IC50,nM,,138.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,138.0
283433,17665778,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(Cl)c(Cl)c1,,,CHEMBL3638632,,2015.0,"{'bei': '18.12', 'le': '0.38', 'lle': '2.22', 'sei': '10.64'}",CHEMBL3677025,,CHEMBL3677025,7.16,False,http://www.openphacts.org/units/Nanomolar,2552781,=,37,True,=,,IC50,nM,,68.7,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,68.7
283434,17665779,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cnn(-c2ccccc2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '17.25', 'le': '0.32', 'lle': '2.95', 'sei': '7.95'}",CHEMBL3677029,,CHEMBL3677029,6.77,False,http://www.openphacts.org/units/Nanomolar,2552786,=,37,True,=,,IC50,nM,,170.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,170.0
283435,17665780,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc2c(c1)OCCO2,,,CHEMBL3638632,,2015.0,"{'bei': '16.99', 'le': '0.32', 'lle': '3.13', 'sei': '7.61'}",CHEMBL3672220,,CHEMBL3672220,6.53,False,http://www.openphacts.org/units/Nanomolar,2552788,=,37,True,=,,IC50,nM,,294.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,294.0
283436,17665781,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2(C)C)n1)c1ccc(N2CCCCC2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '17.06', 'le': '0.32', 'lle': '2.37', 'sei': '9.56'}",CHEMBL3672219,,CHEMBL3672219,6.75,False,http://www.openphacts.org/units/Nanomolar,2552791,=,37,True,=,,IC50,nM,,179.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,179.0
283437,17665782,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cnn(-c2ccc(F)cc2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '17.49', 'le': '0.33', 'lle': '3.22', 'sei': '8.43'}",CHEMBL3677032,,CHEMBL3677032,7.18,False,http://www.openphacts.org/units/Nanomolar,2552792,=,37,True,=,,IC50,nM,,66.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,66.5
283438,17665783,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-n2cc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)cn2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '17.20', 'le': '0.32', 'lle': '3.44', 'sei': '7.70'}",CHEMBL3639758,,CHEMBL3639758,7.27,False,http://www.openphacts.org/units/Nanomolar,2552793,=,37,True,=,,IC50,nM,,54.1,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,54.1
283439,17665784,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C2N(c3ccnc(NC(C)c4ccccc4)n3)C(=O)OC2(C)C)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.77', 'le': '0.31', 'lle': '1.89', 'sei': '9.17'}",CHEMBL3677033,,CHEMBL3677033,7.02,False,http://www.openphacts.org/units/Nanomolar,2552794,=,37,True,=,,IC50,nM,,95.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,95.5
283440,17665785,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCNC(C)(C)C3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.71', 'le': '0.28', 'lle': '2.85', 'sei': '8.06'}",CHEMBL3677034,,CHEMBL3677034,6.66,False,http://www.openphacts.org/units/Nanomolar,2552795,=,37,True,=,,IC50,nM,,219.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,219.0
283441,17665786,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCNCC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.35', 'le': '0.27', 'lle': '3.05', 'sei': '7.37'}",CHEMBL3677035,,CHEMBL3677035,6.09,False,http://www.openphacts.org/units/Nanomolar,2552796,=,37,True,=,,IC50,nM,,810.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,810.0
283442,17665787,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2ccc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)cc2)ccn1,,,CHEMBL3638632,,2015.0,"{'bei': '18.62', 'le': '0.34', 'lle': '2.77', 'sei': '9.69'}",CHEMBL3677036,,CHEMBL3677036,7.77,False,http://www.openphacts.org/units/Nanomolar,2552797,=,37,True,=,,IC50,nM,,16.9,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,16.9
283443,17665788,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3cnn(C)c3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.82', 'le': '0.31', 'lle': '2.81', 'sei': '8.03'}",CHEMBL3677037,,CHEMBL3677037,6.84,False,http://www.openphacts.org/units/Nanomolar,2552798,=,37,True,=,,IC50,nM,,145.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,145.5
283444,17665789,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(NC(=O)C3CCCCC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.62', 'le': '0.29', 'lle': '1.91', 'sei': '7.31'}",CHEMBL3677038,,CHEMBL3677038,7.05,False,http://www.openphacts.org/units/Nanomolar,2552799,=,37,True,=,,IC50,nM,,88.1,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,88.1
283445,17665790,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CC4CN(C)CC4C3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.91', 'le': '0.26', 'lle': '2.84', 'sei': '8.76'}",CHEMBL3677039,,CHEMBL3677039,6.46,False,http://www.openphacts.org/units/Nanomolar,2552800,=,37,True,=,,IC50,nM,,343.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,343.0
283446,17665791,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2CCOC2=O)n1)c1noc(-c2ccc(Cl)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.44', 'le': '0.32', 'lle': '3.05', 'sei': '5.98'}",CHEMBL3677040,,CHEMBL3677040,6.36,False,http://www.openphacts.org/units/Nanomolar,2552801,=,37,True,=,,IC50,nM,,439.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,439.0
283447,17665792,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OCC23CCCC3)n1)c1ccc(Oc2ccccc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.99', 'le': '0.32', 'lle': '1.77', 'sei': '9.95'}",CHEMBL3677041,,CHEMBL3677041,7.62,False,http://www.openphacts.org/units/Nanomolar,2552802,=,37,True,=,,IC50,nM,,24.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,24.0
283448,17665793,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@H]2c2ccccc2)n1)c1ccc(Br)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '13.89', 'le': '0.30', 'lle': '0.99', 'sei': '9.06'}",CHEMBL3677043,,CHEMBL3677043,6.10,False,http://www.openphacts.org/units/Nanomolar,2552804,=,37,True,=,,IC50,nM,,791.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,791.0
283449,17665794,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCn4cnnc4C3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.79', 'le': '0.26', 'lle': '3.14', 'sei': '6.30'}",CHEMBL3677044,,CHEMBL3677044,6.38,False,http://www.openphacts.org/units/Nanomolar,2552805,=,37,True,=,,IC50,nM,,419.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,419.0
283450,17665795,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN(C)C(C)(C)C3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.86', 'le': '0.30', 'lle': '3.39', 'sei': '10.41'}",CHEMBL3677045,,CHEMBL3677045,7.69,False,http://www.openphacts.org/units/Nanomolar,2552806,=,37,True,=,,IC50,nM,,20.6,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,20.6
283451,17665796,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN(C)CC3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.22', 'le': '0.29', 'lle': '3.43', 'sei': '9.41'}",CHEMBL3677046,,CHEMBL3677046,6.95,False,http://www.openphacts.org/units/Nanomolar,2552807,=,37,True,=,,IC50,nM,,112.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,112.5
283452,17665797,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC1CN(Cc2ccc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)cc2)CC(C)N1,,,CHEMBL3638632,,2015.0,"{'bei': '13.71', 'le': '0.26', 'lle': '2.39', 'sei': '7.51'}",CHEMBL3677047,,CHEMBL3677047,6.20,False,http://www.openphacts.org/units/Nanomolar,2552808,=,37,True,=,,IC50,nM,,625.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,625.0
283453,17665798,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN(C(C)(C)C)CC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.75', 'le': '0.26', 'lle': '2.06', 'sei': '8.95'}",CHEMBL3677049,,CHEMBL3677049,6.61,False,http://www.openphacts.org/units/Nanomolar,2552810,=,37,True,=,,IC50,nM,,247.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,247.0
283454,17665799,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN(C)C(C)(C)C3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.69', 'le': '0.29', 'lle': '3.16', 'sei': '9.92'}",CHEMBL3677050,,CHEMBL3677050,7.32,False,http://www.openphacts.org/units/Nanomolar,2552811,=,37,True,=,,IC50,nM,,47.6,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,47.6
283455,17665800,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN(C(C)C)CC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.99', 'le': '0.26', 'lle': '2.37', 'sei': '8.84'}",CHEMBL3677051,,CHEMBL3677051,6.53,False,http://www.openphacts.org/units/Nanomolar,2552812,=,37,True,=,,IC50,nM,,296.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,296.0
283456,17665801,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN(C)C(C)C3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.14', 'le': '0.28', 'lle': '3.08', 'sei': '9.28'}",CHEMBL3677052,,CHEMBL3677052,6.85,False,http://www.openphacts.org/units/Nanomolar,2552813,=,37,True,=,,IC50,nM,,140.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,140.0
283457,17665802,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCC(F)(F)CC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.93', 'le': '0.32', 'lle': '2.92', 'sei': '11.02'}",CHEMBL3677053,,CHEMBL3677053,7.78,False,http://www.openphacts.org/units/Nanomolar,2552814,=,37,True,=,,IC50,nM,,16.6,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,16.6
283458,17665803,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)NC3CCC(OCC(F)(F)F)CC3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.68', 'le': '0.27', 'lle': '2.37', 'sei': '7.34'}",CHEMBL3677054,,CHEMBL3677054,7.76,False,http://www.openphacts.org/units/Nanomolar,2552815,=,37,True,=,,IC50,nM,,17.3,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,17.3
283459,17665804,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)NC3CCC(C)(O)CC3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.17', 'le': '0.27', 'lle': '2.89', 'sei': '6.07'}",CHEMBL3677055,,CHEMBL3677055,7.08,False,http://www.openphacts.org/units/Nanomolar,2552816,=,37,True,=,,IC50,nM,,83.2,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,83.2
283460,17665805,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN4CCCC4C3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.48', 'le': '0.29', 'lle': '3.42', 'sei': '10.12'}",CHEMBL3677056,,CHEMBL3677056,7.47,False,http://www.openphacts.org/units/Nanomolar,2552817,=,37,True,=,,IC50,nM,,33.9,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,33.9
283461,17665806,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN(C4CC4)CC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.79', 'le': '0.29', 'lle': '3.42', 'sei': '9.93'}",CHEMBL3677057,,CHEMBL3677057,7.33,False,http://www.openphacts.org/units/Nanomolar,2552818,=,37,True,=,,IC50,nM,,46.3,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,46.3
283462,17665807,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN(C4CCC4)CC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.00', 'le': '0.28', 'lle': '2.88', 'sei': '9.72'}",CHEMBL3677058,,CHEMBL3677058,7.18,False,http://www.openphacts.org/units/Nanomolar,2552819,=,37,True,=,,IC50,nM,,66.2,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,66.2
283463,17665808,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN4CCCCC4C3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.42', 'le': '0.29', 'lle': '3.08', 'sei': '10.00'}",CHEMBL3677059,,CHEMBL3677059,7.38,False,http://www.openphacts.org/units/Nanomolar,2552820,=,37,True,=,,IC50,nM,,41.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,41.5
283464,17665809,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3C4CCC3CN(C)C4)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.24', 'le': '0.27', 'lle': '2.71', 'sei': '8.96'}",CHEMBL3677060,,CHEMBL3677060,6.62,False,http://www.openphacts.org/units/Nanomolar,2552821,=,37,True,=,,IC50,nM,,242.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,242.0
283465,17665810,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CC4CCC(C3)N4C)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.18', 'le': '0.25', 'lle': '2.21', 'sei': '8.29'}",CHEMBL3677061,,CHEMBL3677061,6.12,False,http://www.openphacts.org/units/Nanomolar,2552822,=,37,True,=,,IC50,nM,,755.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,755.0
283466,17665811,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN4CCCC4C3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.42', 'le': '0.29', 'lle': '3.25', 'sei': '9.70'}",CHEMBL3677062,,CHEMBL3677062,7.17,False,http://www.openphacts.org/units/Nanomolar,2552823,=,37,True,=,,IC50,nM,,68.4,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,68.4
283467,17665812,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2nn[nH]n2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3677063,,CHEMBL3677063,,False,http://www.openphacts.org/units/Nanomolar,2552824,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
283468,17665813,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN(C(=O)OCc4ccccc4)CC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.05', 'le': '0.26', 'lle': '2.76', 'sei': '7.84'}",CHEMBL3677064,,CHEMBL3677064,7.85,False,http://www.openphacts.org/units/Nanomolar,2552825,=,37,True,=,,IC50,nM,,14.1,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,14.1
283469,17665814,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCC(C)(N)CC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.30', 'le': '0.27', 'lle': '2.53', 'sei': '6.70'}",CHEMBL3677065,,CHEMBL3677065,6.47,False,http://www.openphacts.org/units/Nanomolar,2552826,=,37,True,=,,IC50,nM,,338.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,338.0
283470,17665815,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCC(N(C)C)CC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.27', 'le': '0.27', 'lle': '2.50', 'sei': '9.02'}",CHEMBL3677066,,CHEMBL3677066,6.66,False,http://www.openphacts.org/units/Nanomolar,2552827,=,37,True,=,,IC50,nM,,219.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,219.0
283471,17665816,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CNC(C)(C)C)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '12.17', 'le': '0.23', 'lle': '0.49', 'sei': '6.31'}",CHEMBL3677067,,CHEMBL3677067,5.01,False,http://www.openphacts.org/units/Nanomolar,2552828,=,37,True,=,,IC50,nM,,9800.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,9800.0
283472,17665817,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)NC(C)(C)C)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.77', 'le': '0.31', 'lle': '2.98', 'sei': '7.40'}",CHEMBL3677068,,CHEMBL3677068,7.14,False,http://www.openphacts.org/units/Nanomolar,2552829,=,37,True,=,,IC50,nM,,73.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,73.0
283473,17665818,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)NC3CCCCC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.16', 'le': '0.30', 'lle': '2.61', 'sei': '7.56'}",CHEMBL3677069,,CHEMBL3677069,7.30,False,http://www.openphacts.org/units/Nanomolar,2552830,=,37,True,=,,IC50,nM,,50.6,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.6
283474,17665819,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)Nc3ccccc3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.97', 'le': '0.28', 'lle': '1.79', 'sei': '6.92'}",CHEMBL3677070,,CHEMBL3677070,6.67,False,http://www.openphacts.org/units/Nanomolar,2552831,=,37,True,=,,IC50,nM,,213.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,213.0
283475,17665820,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N3CCCCC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.12', 'le': '0.28', 'lle': '2.36', 'sei': '7.55'}",CHEMBL3677071,,CHEMBL3677071,6.62,False,http://www.openphacts.org/units/Nanomolar,2552832,=,37,True,=,,IC50,nM,,242.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,242.0
283476,17665821,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N3CCN(C)CC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '12.93', 'le': '0.24', 'lle': '2.83', 'sei': '6.44'}",CHEMBL3677072,,CHEMBL3677072,5.85,False,http://www.openphacts.org/units/Nanomolar,2552833,=,37,True,=,,IC50,nM,,1405.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1405.0
283477,17665822,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCCCC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.43', 'le': '0.27', 'lle': '1.49', 'sei': '8.66'}",CHEMBL3677073,,CHEMBL3677073,6.11,False,http://www.openphacts.org/units/Nanomolar,2552834,=,37,True,=,,IC50,nM,,774.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,774.0
283478,17665823,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCOCC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.42', 'le': '0.31', 'lle': '3.53', 'sei': '8.75'}",CHEMBL3677074,,CHEMBL3677074,6.99,False,http://www.openphacts.org/units/Nanomolar,2552835,=,37,True,=,,IC50,nM,,103.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,103.0
283479,17665824,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN(C)CC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.96', 'le': '0.28', 'lle': '3.18', 'sei': '8.88'}",CHEMBL3677075,,CHEMBL3677075,6.56,False,http://www.openphacts.org/units/Nanomolar,2552836,=,37,True,=,,IC50,nM,,276.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,276.0
283480,17665825,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@]2(C)c2ccc(F)cc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '14.65', 'le': '0.27', 'lle': '1.09', 'sei': '8.53'}",CHEMBL3677076,,CHEMBL3677076,5.75,False,http://www.openphacts.org/units/Nanomolar,2552837,=,37,True,=,,IC50,nM,,1790.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1790.0
283481,17665826,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC23CCCC3)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '17.95', 'le': '0.33', 'lle': '2.15', 'sei': '9.02'}",CHEMBL3677077,,CHEMBL3677077,6.08,False,http://www.openphacts.org/units/Nanomolar,2552838,=,37,True,=,,IC50,nM,,842.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,842.0
283482,17665827,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@]2(C)c2ccc(F)cc2)n1)c1ccc(Oc2ccccc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '12.82', 'le': '0.24', 'lle': '-0.24', 'sei': '8.11'}",CHEMBL3677078,,CHEMBL3677078,6.21,False,http://www.openphacts.org/units/Nanomolar,2552839,=,37,True,=,,IC50,nM,,616.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,616.0
283483,17665828,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@]2(C)c2ccccc2)n1)c1ccc(Oc2ccccc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '15.71', 'le': '0.29', 'lle': '1.02', 'sei': '9.57'}",CHEMBL3677079,,CHEMBL3677079,7.33,False,http://www.openphacts.org/units/Nanomolar,2552840,=,37,True,=,,IC50,nM,,46.8,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,46.8
283484,17665829,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC23CCCC3)n1)c1ccc(Oc2ccccc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.39', 'le': '0.30', 'lle': '1.35', 'sei': '9.21'}",CHEMBL3677080,,CHEMBL3677080,7.06,False,http://www.openphacts.org/units/Nanomolar,2552841,=,37,True,=,,IC50,nM,,87.8,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,87.8
283485,17665830,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2(C)C)n1)c1ccc(Oc2ccccc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '17.84', 'le': '0.33', 'lle': '2.04', 'sei': '9.42'}",CHEMBL3677081,,CHEMBL3677081,7.22,False,http://www.openphacts.org/units/Nanomolar,2552842,=,37,True,=,,IC50,nM,,60.8,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,60.8
283486,17665831,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1c([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)cnn1Cc1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '14.87', 'le': '0.28', 'lle': '2.07', 'sei': '7.34'}",CHEMBL3677082,,CHEMBL3677082,6.25,False,http://www.openphacts.org/units/Nanomolar,2552843,=,37,True,=,,IC50,nM,,559.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,559.0
283487,17665832,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1nn(Cc2ccccc2)cc1[C@H](C)Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.15', 'le': '0.26', 'lle': '1.77', 'sei': '6.99'}",CHEMBL3677083,,CHEMBL3677083,5.95,False,http://www.openphacts.org/units/Nanomolar,2552844,=,37,True,=,,IC50,nM,,1120.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1120.0
283488,17665833,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-n3cccn3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.84', 'le': '0.31', 'lle': '2.79', 'sei': '7.76'}",CHEMBL3677086,,CHEMBL3677086,6.61,False,http://www.openphacts.org/units/Nanomolar,2552847,=,37,True,=,,IC50,nM,,245.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,245.5
283489,17665834,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(Oc3ccccc3)nc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.15', 'le': '0.32', 'lle': '2.37', 'sei': '8.04'}",CHEMBL3677090,,CHEMBL3677090,7.19,False,http://www.openphacts.org/units/Nanomolar,2552851,=,37,True,=,,IC50,nM,,63.9,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,63.9
283490,17665835,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1nc(N[C@@H](C)c2ccc(Oc3ccccc3)cc2)ncc1F,,,CHEMBL3638632,,2015.0,"{'bei': '16.05', 'le': '0.30', 'lle': '1.44', 'sei': '9.15'}",CHEMBL3677091,,CHEMBL3677091,7.00,False,http://www.openphacts.org/units/Nanomolar,2552852,=,37,True,=,,IC50,nM,,99.1,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,99.1
283491,17665836,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2CCOC2=O)n1)c1ccc(Oc2ccccc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.39', 'le': '0.30', 'lle': '1.77', 'sei': '8.05'}",CHEMBL3677092,,CHEMBL3677092,6.17,False,http://www.openphacts.org/units/Nanomolar,2552853,=,37,True,=,,IC50,nM,,679.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,679.0
283492,17665837,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(Oc3ccc(F)cc3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.49', 'le': '0.33', 'lle': '2.07', 'sei': '9.97'}",CHEMBL3677094,,CHEMBL3677094,7.63,False,http://www.openphacts.org/units/Nanomolar,2552855,=,37,True,=,,IC50,nM,,23.2,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,23.2
283493,17665838,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@@]1(C)COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(F)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '19.44', 'le': '0.37', 'lle': '2.81', 'sei': '10.34'}",CHEMBL3677099,,CHEMBL3677099,6.97,False,http://www.openphacts.org/units/Nanomolar,2552860,=,37,True,=,,IC50,nM,,108.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,108.0
283494,17665839,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2(C)C)n1)c1ccc(CN2CCN(C)CC2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '13.29', 'le': '0.25', 'lle': '2.51', 'sei': '7.64'}",CHEMBL3677100,,CHEMBL3677100,5.64,False,http://www.openphacts.org/units/Nanomolar,2552861,=,37,True,=,,IC50,nM,,2280.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2280.0
283495,17665840,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC(C)(C)[C@H]2c2ccccc2)n1)c1ccc(CN2CCN(C)CC2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '13.67', 'le': '0.25', 'lle': '1.97', 'sei': '9.27'}",CHEMBL3677101,,CHEMBL3677101,6.84,False,http://www.openphacts.org/units/Nanomolar,2552862,=,37,True,=,,IC50,nM,,143.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,143.0
283496,17665841,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC(C)(C)[C@@H]2c2ccccc2)n1)c1ccc(CN2CCN(C)CC2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '14.54', 'le': '0.27', 'lle': '2.41', 'sei': '9.86'}",CHEMBL3677102,,CHEMBL3677102,7.28,False,http://www.openphacts.org/units/Nanomolar,2552863,=,37,True,=,,IC50,nM,,52.4,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,52.4
283497,17665842,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@@]1(C)COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN(C)CC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.50', 'le': '0.27', 'lle': '2.79', 'sei': '8.89'}",CHEMBL3677103,,CHEMBL3677103,6.56,False,http://www.openphacts.org/units/Nanomolar,2552864,=,37,True,=,,IC50,nM,,273.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,273.0
283498,17665843,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@@H]1N(c2ccnc(N[C@@H](C)c3ccc(CN4CCN(C)CC4)cc3)n2)C(=O)OC1(C)C,,,CHEMBL3638632,,2015.0,"{'bei': '14.48', 'le': '0.27', 'lle': '2.60', 'sei': '9.15'}",CHEMBL3677104,,CHEMBL3677104,6.76,False,http://www.openphacts.org/units/Nanomolar,2552865,=,37,True,=,,IC50,nM,,175.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,175.0
283499,17665844,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3ccccn3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.46', 'le': '0.32', 'lle': '2.36', 'sei': '8.78'}",CHEMBL3677105,,CHEMBL3677105,7.05,False,http://www.openphacts.org/units/Nanomolar,2552866,=,37,True,=,,IC50,nM,,89.9,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,89.9
283500,17665845,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3ccccc3)nc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.20', 'le': '0.30', 'lle': '1.85', 'sei': '8.15'}",CHEMBL3677106,,CHEMBL3677106,6.54,False,http://www.openphacts.org/units/Nanomolar,2552867,=,37,True,=,,IC50,nM,,290.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,290.0
283501,17665846,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1nccn1-c1ccc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '15.25', 'le': '0.28', 'lle': '2.07', 'sei': '7.28'}",CHEMBL3677111,,CHEMBL3677111,6.20,False,http://www.openphacts.org/units/Nanomolar,2552872,=,37,True,=,,IC50,nM,,635.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,635.0
283502,17665847,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@H](C)C2CCCC2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '18.40', 'le': '0.35', 'lle': '2.41', 'sei': '8.70'}",CHEMBL3677112,,CHEMBL3677112,5.86,False,http://www.openphacts.org/units/Nanomolar,2552873,=,37,True,=,,IC50,nM,,1380.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1380.0
283503,17665848,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(N(C)C)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.39', 'le': '0.33', 'lle': '2.73', 'sei': '9.10'}",CHEMBL3677113,,CHEMBL3677113,6.43,False,http://www.openphacts.org/units/Nanomolar,2552874,=,37,True,=,,IC50,nM,,375.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,375.0
283504,17665849,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1cccc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '14.59', 'le': '0.27', 'lle': '2.01', 'sei': '5.80'}",CHEMBL3677114,,CHEMBL3677114,5.59,False,http://www.openphacts.org/units/Nanomolar,2552875,=,37,True,=,,IC50,nM,,2540.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2540.0
283505,17665850,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2nc3ccccc3[nH]2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3677115,,CHEMBL3677115,,False,http://www.openphacts.org/units/Nanomolar,2552876,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
283506,17665851,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(S(=O)(=O)c3ccc(Cl)cc3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.11', 'le': '0.26', 'lle': '1.45', 'sei': '6.47'}",CHEMBL3677116,,CHEMBL3677116,6.57,False,http://www.openphacts.org/units/Nanomolar,2552877,=,37,True,=,,IC50,nM,,269.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,269.0
283507,17665852,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc([N+](=O)[O-])cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '18.10', 'le': '0.34', 'lle': '3.18', 'sei': '6.08'}",CHEMBL3677117,,CHEMBL3677117,6.72,False,http://www.openphacts.org/units/Nanomolar,2552878,=,37,True,=,,IC50,nM,,190.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,190.0
283508,17665853,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(N)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '18.04', 'le': '0.34', 'lle': '2.95', 'sei': '6.60'}",CHEMBL3677118,,CHEMBL3677118,6.16,False,http://www.openphacts.org/units/Nanomolar,2552879,=,37,True,=,,IC50,nM,,694.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,694.5
283509,17665854,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CSc1nnc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)o1,,,CHEMBL3638632,,2015.0,"{'bei': '14.64', 'le': '0.29', 'lle': '2.59', 'sei': '5.02'}",CHEMBL3677119,,CHEMBL3677119,5.33,False,http://www.openphacts.org/units/Nanomolar,2552880,=,37,True,=,,IC50,nM,,4640.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4640.0
283510,17665855,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2nnc(-c3ccccc3)s2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.52', 'le': '0.34', 'lle': '3.04', 'sei': '7.72'}",CHEMBL3677120,,CHEMBL3677120,7.19,False,http://www.openphacts.org/units/Nanomolar,2552881,=,37,True,=,,IC50,nM,,64.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,64.5
283511,17665856,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cc(CC(C)(C)C)on2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.97', 'le': '0.30', 'lle': '1.98', 'sei': '6.63'}",CHEMBL3677122,,CHEMBL3677122,6.19,False,http://www.openphacts.org/units/Nanomolar,2552883,=,37,True,=,,IC50,nM,,648.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,648.0
283512,17665857,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ncc(-c2ccccc2)cn1,,,CHEMBL3638632,,2015.0,"{'bei': '16.31', 'le': '0.30', 'lle': '2.51', 'sei': '7.09'}",CHEMBL3677123,,CHEMBL3677123,6.60,False,http://www.openphacts.org/units/Nanomolar,2552884,=,37,True,=,,IC50,nM,,252.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,252.0
283513,17665858,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(Br)cn2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.94', 'le': '0.33', 'lle': '2.28', 'sei': '7.57'}",CHEMBL3677125,,CHEMBL3677125,6.07,False,http://www.openphacts.org/units/Nanomolar,2552886,=,37,True,=,,IC50,nM,,848.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,848.0
283514,17665859,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2ccc(C(C)Nc3ncc(F)c(N4CCOC4=O)n3)nc2)ccc1F,,,CHEMBL3638632,,2015.0,"{'bei': '14.54', 'le': '0.27', 'lle': '1.73', 'sei': '7.46'}",CHEMBL3677126,,CHEMBL3677126,5.98,False,http://www.openphacts.org/units/Nanomolar,2552887,=,37,True,=,,IC50,nM,,1040.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1040.0
283515,17665860,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2CCOC2=O)n1)c1ncc(Oc2ccc(F)cc2)cn1,,,CHEMBL3638632,,2015.0,"{'bei': '12.57', 'le': '0.23', 'lle': '1.65', 'sei': '4.87'}",CHEMBL3677127,,CHEMBL3677127,4.98,False,http://www.openphacts.org/units/Nanomolar,2552888,=,37,True,=,,IC50,nM,,10400.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,10400.0
283516,17665861,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2CCOC2=O)n1)c1ncc(Oc2ccc(F)cc2)cn1,,,CHEMBL3638632,,2015.0,"{'bei': '13.84', 'le': '0.26', 'lle': '2.27', 'sei': '5.60'}",CHEMBL3677128,,CHEMBL3677128,5.74,False,http://www.openphacts.org/units/Nanomolar,2552889,=,37,True,=,,IC50,nM,,1840.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1840.0
283517,17665862,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ncc(OCc2ccc(F)cc2F)cn1,,,CHEMBL3638632,,2015.0,"{'bei': '14.99', 'le': '0.28', 'lle': '2.77', 'sei': '6.89'}",CHEMBL3677129,,CHEMBL3677129,7.05,False,http://www.openphacts.org/units/Nanomolar,2552890,=,37,True,=,,IC50,nM,,88.7,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,88.7
283518,17665863,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ncc(Oc2cncc(Br)c2)cn1,,,CHEMBL3638632,,2015.0,"{'bei': '12.96', 'le': '0.28', 'lle': '2.12', 'sei': '5.63'}",CHEMBL3677131,,CHEMBL3677131,6.49,False,http://www.openphacts.org/units/Nanomolar,2552892,=,37,True,=,,IC50,nM,,326.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,326.0
283519,17665864,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ncc(Oc3ccc(F)c(Cl)c3)cn2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.61', 'le': '0.31', 'lle': '2.37', 'sei': '7.21'}",CHEMBL3677132,,CHEMBL3677132,7.38,False,http://www.openphacts.org/units/Nanomolar,2552894,=,37,True,=,,IC50,nM,,41.3,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,41.3
283520,17665865,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ncc(Oc2cccnc2)cn1,,,CHEMBL3638632,,2015.0,"{'bei': '11.63', 'le': '0.22', 'lle': '1.29', 'sei': '4.25'}",CHEMBL3677133,,CHEMBL3677133,4.90,False,http://www.openphacts.org/units/Nanomolar,2552895,=,37,True,=,,IC50,nM,,12500.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,12500.0
283521,17665866,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ncc(OCc2cccc(F)c2)cn1,,,CHEMBL3638632,,2015.0,"{'bei': '14.69', 'le': '0.28', 'lle': '2.51', 'sei': '6.49'}",CHEMBL3677134,,CHEMBL3677134,6.65,False,http://www.openphacts.org/units/Nanomolar,2552896,=,37,True,=,,IC50,nM,,225.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,225.0
283522,17665867,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ncc(I)cn2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.54', 'le': '0.34', 'lle': '3.12', 'sei': '6.61'}",CHEMBL3677135,,CHEMBL3677135,6.15,False,http://www.openphacts.org/units/Nanomolar,2552897,=,37,True,=,,IC50,nM,,703.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,703.0
283523,17665868,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ncc(Oc2ccc(C(F)(F)F)cn2)cn1,,,CHEMBL3638632,,2015.0,"{'bei': '11.81', 'le': '0.23', 'lle': '1.15', 'sei': '5.02'}",CHEMBL3677136,,CHEMBL3677136,5.78,False,http://www.openphacts.org/units/Nanomolar,2552898,=,37,True,=,,IC50,nM,,1660.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1660.0
283524,17665869,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ncccn1,,,CHEMBL3638632,,2015.0,,CHEMBL3677137,,CHEMBL3677137,,False,http://www.openphacts.org/units/Nanomolar,2552899,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
283525,17665870,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1nc(N[C@@H](C)c2ccc(CN3C[C@H](C)O[C@H](C)C3)cc2)ncc1F,,,CHEMBL3638632,,2015.0,"{'bei': '16.16', 'le': '0.31', 'lle': '3.24', 'sei': '9.55'}",CHEMBL3677139,,CHEMBL3677139,7.62,False,http://www.openphacts.org/units/Nanomolar,2552901,=,37,True,=,,IC50,nM,,24.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,24.0
283526,17665871,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C2N(c3ccnc(N[C@@H](C)c4ccc(Oc5ccccc5)cc4)n3)C(=O)OC2(C)C)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '13.90', 'le': '0.26', 'lle': '0.17', 'sei': '8.27'}",CHEMBL3677140,,CHEMBL3677140,7.10,False,http://www.openphacts.org/units/Nanomolar,2552902,=,37,True,=,,IC50,nM,,79.9,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,79.9
283527,17665872,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C2N(c3ccnc(N[C@@H](C)c4ccc(Oc5ccccc5)cc4)n3)C(=O)OC2(C)C)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '11.36', 'le': '0.21', 'lle': '-1.13', 'sei': '6.76'}",CHEMBL3677140,,CHEMBL3677140,5.80,False,http://www.openphacts.org/units/Nanomolar,2552902,=,37,True,=,,IC50,nM,,1590.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1590.0
283528,17665873,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,COc1cccc(-n2cc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)cn2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '16.99', 'le': '0.32', 'lle': '3.35', 'sei': '7.60'}",CHEMBL3677144,,CHEMBL3677144,7.18,False,http://www.openphacts.org/units/Nanomolar,2552906,=,37,True,=,,IC50,nM,,66.6,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,66.6
283529,17665874,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1c(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)cnn1-c1ccc(C#N)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '11.05', 'le': '0.20', 'lle': '0.77', 'sei': '4.38'}",CHEMBL3677145,,CHEMBL3677145,4.77,False,http://www.openphacts.org/units/Nanomolar,2552907,=,37,True,=,,IC50,nM,,17100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,17100.0
283530,17665875,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1c(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)cnn1-c1ccc(C#N)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '14.64', 'le': '0.27', 'lle': '2.32', 'sei': '5.80'}",CHEMBL3677145,,CHEMBL3677145,6.32,False,http://www.openphacts.org/units/Nanomolar,2552907,=,37,True,=,,IC50,nM,,483.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,483.0
283531,17665876,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1nn(-c2ccccc2)c(C)c1C(C)Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1,,,CHEMBL3638632,,2015.0,"{'bei': '11.18', 'le': '0.21', 'lle': '0.27', 'sei': '5.52'}",CHEMBL3677146,,CHEMBL3677146,4.70,False,http://www.openphacts.org/units/Nanomolar,2552908,=,37,True,=,,IC50,nM,,19950.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,19950.0
283532,17665877,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1nn(-c2ccccc2)c(C)c1C(C)Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.45', 'le': '0.29', 'lle': '2.07', 'sei': '7.63'}",CHEMBL3677146,,CHEMBL3677146,6.50,False,http://www.openphacts.org/units/Nanomolar,2552908,=,37,True,=,,IC50,nM,,318.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,318.5
283533,17665878,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(-n2ccnc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '12.02', 'le': '0.22', 'lle': '0.90', 'sei': '5.54'}",CHEMBL3677147,,CHEMBL3677147,4.72,False,http://www.openphacts.org/units/Nanomolar,2552909,=,37,True,=,,IC50,nM,,19200.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,19200.0
283534,17665879,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(-n2ccnc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '15.68', 'le': '0.29', 'lle': '2.33', 'sei': '7.23'}",CHEMBL3677147,,CHEMBL3677147,6.16,False,http://www.openphacts.org/units/Nanomolar,2552909,=,37,True,=,,IC50,nM,,700.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,700.5
283535,17665880,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(Oc2cccnc2)c(F)c1,,,CHEMBL3638632,,2015.0,"{'bei': '12.00', 'le': '0.22', 'lle': '0.29', 'sei': '5.87'}",CHEMBL3677148,,CHEMBL3677148,5.25,False,http://www.openphacts.org/units/Nanomolar,2552910,=,37,True,=,,IC50,nM,,5620.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5620.0
283536,17665881,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(Oc2cccnc2)c(F)c1,,,CHEMBL3638632,,2015.0,"{'bei': '16.60', 'le': '0.31', 'lle': '2.30', 'sei': '8.12'}",CHEMBL3677148,,CHEMBL3677148,7.26,False,http://www.openphacts.org/units/Nanomolar,2552910,=,37,True,=,,IC50,nM,,54.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,54.5
283537,17665882,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(OC2CCOCC2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '12.00', 'le': '0.23', 'lle': '0.93', 'sei': '5.96'}",CHEMBL3677093,,CHEMBL3677093,5.12,False,http://www.openphacts.org/units/Nanomolar,2552911,=,37,True,=,,IC50,nM,,7650.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,7650.0
283538,17665883,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(OC2CCOCC2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.79', 'le': '0.32', 'lle': '2.97', 'sei': '8.34'}",CHEMBL3677093,,CHEMBL3677093,7.16,False,http://www.openphacts.org/units/Nanomolar,2552911,=,37,True,=,,IC50,nM,,69.3,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,69.3
283539,17665884,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@H]2c2ccccc2)n1)c1ccc(Cl)c(Cl)c1,,,CHEMBL3638632,,2015.0,"{'bei': '15.08', 'le': '0.30', 'lle': '0.82', 'sei': '9.61'}",CHEMBL3677031,,CHEMBL3677031,6.47,False,http://www.openphacts.org/units/Nanomolar,2552789,=,37,True,=,,IC50,nM,,335.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,335.0
283540,17665885,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(-c2cccnc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '12.85', 'le': '0.24', 'lle': '0.50', 'sei': '6.46'}",CHEMBL3677149,,CHEMBL3677149,5.18,False,http://www.openphacts.org/units/Nanomolar,2552912,=,37,True,=,,IC50,nM,,6530.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6530.0
283541,17665886,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(-c2cccnc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.42', 'le': '0.30', 'lle': '1.94', 'sei': '8.26'}",CHEMBL3677149,,CHEMBL3677149,6.63,False,http://www.openphacts.org/units/Nanomolar,2552912,=,37,True,=,,IC50,nM,,236.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,236.0
283542,17665887,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(-c2ccncc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '12.74', 'le': '0.23', 'lle': '0.45', 'sei': '6.41'}",CHEMBL3677150,,CHEMBL3677150,5.14,False,http://www.openphacts.org/units/Nanomolar,2552913,=,37,True,=,,IC50,nM,,7220.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,7220.0
283543,17665888,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(-c2ccncc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.95', 'le': '0.31', 'lle': '2.15', 'sei': '8.52'}",CHEMBL3677150,,CHEMBL3677150,6.84,False,http://www.openphacts.org/units/Nanomolar,2552913,=,37,True,=,,IC50,nM,,145.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,145.0
283544,17665889,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(N(C)c2ccccc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '12.41', 'le': '0.23', 'lle': '-0.04', 'sei': '7.59'}",CHEMBL3677151,,CHEMBL3677151,5.36,False,http://www.openphacts.org/units/Nanomolar,2552914,=,37,True,=,,IC50,nM,,4400.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4400.0
283545,17665890,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(N(C)c2ccccc2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '17.52', 'le': '0.32', 'lle': '2.16', 'sei': '10.71'}",CHEMBL3677151,,CHEMBL3677151,7.56,False,http://www.openphacts.org/units/Nanomolar,2552914,=,37,True,=,,IC50,nM,,27.6,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,27.6
283546,17665891,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cnn(-c2ccc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)cc2F)c1,,,CHEMBL3638632,,2015.0,"{'bei': '13.36', 'le': '0.25', 'lle': '1.41', 'sei': '6.66'}",CHEMBL3677152,,CHEMBL3677152,5.67,False,http://www.openphacts.org/units/Nanomolar,2552915,=,37,True,=,,IC50,nM,,2130.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2130.0
283547,17665892,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cnn(-c2ccc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)cc2F)c1,,,CHEMBL3638632,,2015.0,"{'bei': '17.80', 'le': '0.33', 'lle': '3.30', 'sei': '8.87'}",CHEMBL3677152,,CHEMBL3677152,7.56,False,http://www.openphacts.org/units/Nanomolar,2552915,=,37,True,=,,IC50,nM,,27.8,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,27.8
283548,17665893,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(C)n(-c2ccc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '12.82', 'le': '0.24', 'lle': '0.96', 'sei': '6.33'}",CHEMBL3677153,,CHEMBL3677153,5.39,False,http://www.openphacts.org/units/Nanomolar,2552916,=,37,True,=,,IC50,nM,,4080.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4080.0
283549,17665894,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(C)n(-c2ccc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.64', 'le': '0.29', 'lle': '2.15', 'sei': '7.72'}",CHEMBL3677153,,CHEMBL3677153,6.58,False,http://www.openphacts.org/units/Nanomolar,2552916,=,37,True,=,,IC50,nM,,265.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,265.0
283550,17665895,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cn2ncsc2n1,,,CHEMBL3638632,,2015.0,"{'bei': '12.36', 'le': '0.24', 'lle': '1.88', 'sei': '4.73'}",CHEMBL3677156,,CHEMBL3677156,4.62,False,http://www.openphacts.org/units/Nanomolar,2552919,=,37,True,=,,IC50,nM,,24200.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,24200.0
283551,17665896,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cn2ncsc2n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.43', 'le': '0.32', 'lle': '3.40', 'sei': '6.29'}",CHEMBL3677156,,CHEMBL3677156,6.14,False,http://www.openphacts.org/units/Nanomolar,2552919,=,37,True,=,,IC50,nM,,731.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,731.0
283552,17665897,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cn2ccsc2n1,,,CHEMBL3638632,,2015.0,,CHEMBL3677159,,CHEMBL3677159,,False,http://www.openphacts.org/units/Nanomolar,2552922,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
283553,17665898,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cn2ccsc2n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.35', 'le': '0.28', 'lle': '2.00', 'sei': '6.31'}",CHEMBL3677159,,CHEMBL3677159,5.34,False,http://www.openphacts.org/units/Nanomolar,2552922,=,37,True,=,,IC50,nM,,4530.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4530.0
283554,17665899,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(NS(C)(=O)=O)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '13.86', 'le': '0.27', 'lle': '2.82', 'sei': '5.12'}",CHEMBL3677160,,CHEMBL3677160,5.82,False,http://www.openphacts.org/units/Nanomolar,2552923,=,37,True,=,,IC50,nM,,1530.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1530.0
283555,17665900,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(-c2ccccn2)no1,,,CHEMBL3638632,,2015.0,,CHEMBL3677161,,CHEMBL3677161,,False,http://www.openphacts.org/units/Nanomolar,2552924,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
283556,17665901,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(-c2ccccn2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '12.87', 'le': '0.24', 'lle': '2.01', 'sei': '4.27'}",CHEMBL3677161,,CHEMBL3677161,5.09,False,http://www.openphacts.org/units/Nanomolar,2552924,=,37,True,=,,IC50,nM,,8135.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,8135.0
283557,17665902,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)n2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '15.02', 'le': '0.28', 'lle': '2.14', 'sei': '5.77'}",CHEMBL3677162,,CHEMBL3677162,6.13,False,http://www.openphacts.org/units/Nanomolar,2552925,=,37,True,=,,IC50,nM,,736.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,736.0
283558,17665903,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)n2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '17.64', 'le': '0.33', 'lle': '3.22', 'sei': '6.78'}",CHEMBL3677162,,CHEMBL3677162,7.21,False,http://www.openphacts.org/units/Nanomolar,2552925,=,37,True,=,,IC50,nM,,62.1,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,62.1
283559,17665904,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(S(C)(=O)=O)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '11.45', 'le': '0.23', 'lle': '1.60', 'sei': '4.56'}",CHEMBL3677163,,CHEMBL3677163,4.63,False,http://www.openphacts.org/units/Nanomolar,2552926,=,37,True,=,,IC50,nM,,23300.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,23300.0
283560,17665905,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(S(C)(=O)=O)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '14.77', 'le': '0.29', 'lle': '2.94', 'sei': '5.89'}",CHEMBL3677163,,CHEMBL3677163,5.97,False,http://www.openphacts.org/units/Nanomolar,2552926,=,37,True,=,,IC50,nM,,1060.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1060.0
283561,17665906,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1noc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3677164,,CHEMBL3677164,,False,http://www.openphacts.org/units/Nanomolar,2552927,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
283562,17665907,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1noc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.08', 'le': '0.27', 'lle': '2.36', 'sei': '4.40'}",CHEMBL3677164,,CHEMBL3677164,4.68,False,http://www.openphacts.org/units/Nanomolar,2552927,=,37,True,=,,IC50,nM,,20950.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,20950.0
283563,17665908,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CCCc1noc([C@@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3682140,,CHEMBL3682140,,False,http://www.openphacts.org/units/Nanomolar,2558230,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
283564,17665909,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CCc1noc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.51', 'le': '0.33', 'lle': '3.48', 'sei': '5.71'}",CHEMBL3677165,,CHEMBL3677165,6.06,False,http://www.openphacts.org/units/Nanomolar,2552928,=,37,True,=,,IC50,nM,,862.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,862.0
283565,17665910,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CCc1noc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3677165,,CHEMBL3677165,,False,http://www.openphacts.org/units/Nanomolar,2552928,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
283566,17665911,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CCCc1noc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.32', 'le': '0.29', 'lle': '2.55', 'sei': '5.20'}",CHEMBL3682138,,CHEMBL3682138,5.52,False,http://www.openphacts.org/units/Nanomolar,2558228,=,37,True,=,,IC50,nM,,3010.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3010.0
283567,17665912,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(C2CC2)no1,,,CHEMBL3638632,,2015.0,,CHEMBL3677166,,CHEMBL3677166,,False,http://www.openphacts.org/units/Nanomolar,2552929,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
283568,17665913,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(C2CC2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '15.00', 'le': '0.28', 'lle': '2.49', 'sei': '5.06'}",CHEMBL3677166,,CHEMBL3677166,5.38,False,http://www.openphacts.org/units/Nanomolar,2552929,=,37,True,=,,IC50,nM,,4190.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4190.0
283569,17665914,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)c1noc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3677167,,CHEMBL3677167,,False,http://www.openphacts.org/units/Nanomolar,2552930,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
283570,17665915,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)c1noc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.72', 'le': '0.30', 'lle': '2.53', 'sei': '5.33'}",CHEMBL3677167,,CHEMBL3677167,5.67,False,http://www.openphacts.org/units/Nanomolar,2552930,=,37,True,=,,IC50,nM,,2155.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2155.0
283571,17665916,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CCn1ccc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3677168,,CHEMBL3677168,,False,http://www.openphacts.org/units/Nanomolar,2552931,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
283572,17665917,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CCn1ccc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.74', 'le': '0.30', 'lle': '2.57', 'sei': '6.36'}",CHEMBL3677168,,CHEMBL3677168,5.42,False,http://www.openphacts.org/units/Nanomolar,2552931,=,37,True,=,,IC50,nM,,3800.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3800.0
283573,17665918,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccccc1O,,,CHEMBL3638632,,2015.0,,CHEMBL3677169,,CHEMBL3677169,,False,http://www.openphacts.org/units/Nanomolar,2552932,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
283574,17665919,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccccc1O,,,CHEMBL3638632,,2015.0,"{'bei': '15.71', 'le': '0.29', 'lle': '2.04', 'sei': '6.14'}",CHEMBL3677169,,CHEMBL3677169,5.38,False,http://www.openphacts.org/units/Nanomolar,2552932,=,37,True,=,,IC50,nM,,4190.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4190.0
283575,17665920,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1c(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)nnn1-c1ccccc1,,,CHEMBL3638632,,2015.0,,CHEMBL3677170,,CHEMBL3677170,,False,http://www.openphacts.org/units/Nanomolar,2552933,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
283576,17665921,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1c(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)nnn1-c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '14.91', 'le': '0.28', 'lle': '2.56', 'sei': '6.20'}",CHEMBL3677170,,CHEMBL3677170,6.08,False,http://www.openphacts.org/units/Nanomolar,2552933,=,37,True,=,,IC50,nM,,839.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,839.0
283577,17665922,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(-c2ccccc2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '11.91', 'le': '0.22', 'lle': '1.02', 'sei': '4.42'}",CHEMBL3677171,,CHEMBL3677171,4.70,False,http://www.openphacts.org/units/Nanomolar,2552934,=,37,True,=,,IC50,nM,,20000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,20000.0
283578,17665923,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(-c2ccccc2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '16.37', 'le': '0.30', 'lle': '2.78', 'sei': '6.08'}",CHEMBL3677171,,CHEMBL3677171,6.46,False,http://www.openphacts.org/units/Nanomolar,2552934,=,37,True,=,,IC50,nM,,349.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,349.0
283579,17665924,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cnc2[nH]ccc2c1,,,CHEMBL3638632,,2015.0,"{'bei': '14.43', 'le': '0.27', 'lle': '1.78', 'sei': '5.51'}",CHEMBL3677172,,CHEMBL3677172,5.29,False,http://www.openphacts.org/units/Nanomolar,2552935,=,37,True,=,,IC50,nM,,5160.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5160.0
283580,17665925,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cnc2[nH]ccc2c1,,,CHEMBL3638632,,2015.0,"{'bei': '19.02', 'le': '0.35', 'lle': '3.46', 'sei': '7.26'}",CHEMBL3677172,,CHEMBL3677172,6.97,False,http://www.openphacts.org/units/Nanomolar,2552935,=,37,True,=,,IC50,nM,,107.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,107.0
283581,17665926,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc2c(c1)ncn2C,,,CHEMBL3638632,,2015.0,"{'bei': '12.22', 'le': '0.23', 'lle': '1.13', 'sei': '5.46'}",CHEMBL3677173,,CHEMBL3677173,4.65,False,http://www.openphacts.org/units/Nanomolar,2552936,=,37,True,=,,IC50,nM,,22500.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,22500.0
283582,17665927,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc2c(c1)ncn2C,,,CHEMBL3638632,,2015.0,"{'bei': '13.99', 'le': '0.26', 'lle': '1.80', 'sei': '6.25'}",CHEMBL3677173,,CHEMBL3677173,5.32,False,http://www.openphacts.org/units/Nanomolar,2552936,=,37,True,=,,IC50,nM,,4740.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4740.0
283583,17665928,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc2[nH]c(=O)[nH]c2c1,,,CHEMBL3638632,,2015.0,"{'bei': '12.25', 'le': '0.23', 'lle': '1.89', 'sei': '4.04'}",CHEMBL3677174,,CHEMBL3677174,4.69,False,http://www.openphacts.org/units/Nanomolar,2552937,=,37,True,=,,IC50,nM,,20600.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,20600.0
283584,17665929,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc2[nH]c(=O)[nH]c2c1,,,CHEMBL3638632,,2015.0,"{'bei': '14.01', 'le': '0.26', 'lle': '2.56', 'sei': '4.62'}",CHEMBL3677174,,CHEMBL3677174,5.36,False,http://www.openphacts.org/units/Nanomolar,2552937,=,37,True,=,,IC50,nM,,4370.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4370.0
283585,17665930,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc2ccccc2s1,,,CHEMBL3638632,,2015.0,"{'bei': '14.96', 'le': '0.29', 'lle': '1.50', 'sei': '7.15'}",CHEMBL3677175,,CHEMBL3677175,5.74,False,http://www.openphacts.org/units/Nanomolar,2552938,=,37,True,=,,IC50,nM,,1830.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1830.0
283586,17665931,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc2ccccc2s1,,,CHEMBL3638632,,2015.0,"{'bei': '17.40', 'le': '0.34', 'lle': '2.43', 'sei': '8.31'}",CHEMBL3677175,,CHEMBL3677175,6.67,False,http://www.openphacts.org/units/Nanomolar,2552938,=,37,True,=,,IC50,nM,,213.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,213.0
283587,17665932,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cc2ccccn2c1,,,CHEMBL3638632,,2015.0,"{'bei': '14.82', 'le': '0.27', 'lle': '1.54', 'sei': '7.55'}",CHEMBL3677176,,CHEMBL3677176,5.42,False,http://www.openphacts.org/units/Nanomolar,2552939,=,37,True,=,,IC50,nM,,3840.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3840.0
283588,17665933,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cc2ccccn2c1,,,CHEMBL3638632,,2015.0,"{'bei': '17.18', 'le': '0.32', 'lle': '2.40', 'sei': '8.75'}",CHEMBL3677176,,CHEMBL3677176,6.28,False,http://www.openphacts.org/units/Nanomolar,2552939,=,37,True,=,,IC50,nM,,526.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,526.0
283589,17665934,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1-c1noc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '11.58', 'le': '0.22', 'lle': '1.23', 'sei': '4.26'}",CHEMBL3677177,,CHEMBL3677177,4.92,False,http://www.openphacts.org/units/Nanomolar,2552940,=,37,True,=,,IC50,nM,,12100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,12100.0
283590,17665935,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1-c1noc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.24', 'le': '0.28', 'lle': '2.78', 'sei': '5.60'}",CHEMBL3677177,,CHEMBL3677177,6.47,False,http://www.openphacts.org/units/Nanomolar,2552940,=,37,True,=,,IC50,nM,,340.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,340.0
283591,17665936,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,COc1cccc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)n2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '11.85', 'le': '0.22', 'lle': '1.34', 'sei': '4.35'}",CHEMBL3677178,,CHEMBL3677178,5.03,False,http://www.openphacts.org/units/Nanomolar,2552941,=,37,True,=,,IC50,nM,,9360.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,9360.0
283592,17665937,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,COc1cccc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)n2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '15.67', 'le': '0.29', 'lle': '2.96', 'sei': '5.76'}",CHEMBL3677178,,CHEMBL3677178,6.65,False,http://www.openphacts.org/units/Nanomolar,2552941,=,37,True,=,,IC50,nM,,224.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,224.0
283593,17665938,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(-c2cccc(F)c2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '12.48', 'le': '0.23', 'lle': '1.33', 'sei': '4.84'}",CHEMBL3677179,,CHEMBL3677179,5.15,False,http://www.openphacts.org/units/Nanomolar,2552942,=,37,True,=,,IC50,nM,,7140.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,7140.0
283594,17665939,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(-c2cccc(F)c2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '16.30', 'le': '0.31', 'lle': '2.90', 'sei': '6.33'}",CHEMBL3677179,,CHEMBL3677179,6.72,False,http://www.openphacts.org/units/Nanomolar,2552942,=,37,True,=,,IC50,nM,,189.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,189.0
283595,17665940,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(C2CCCC2)no1,,,CHEMBL3638632,,2015.0,,CHEMBL3677180,,CHEMBL3677180,,False,http://www.openphacts.org/units/Nanomolar,2552943,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
283596,17665941,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(C2CCCC2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '16.01', 'le': '0.30', 'lle': '2.52', 'sei': '5.82'}",CHEMBL3677180,,CHEMBL3677180,6.19,False,http://www.openphacts.org/units/Nanomolar,2552943,=,37,True,=,,IC50,nM,,648.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,648.0
283597,17665942,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(C2CCCCC2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '11.79', 'le': '0.22', 'lle': '0.66', 'sei': '4.44'}",CHEMBL3677181,,CHEMBL3677181,4.72,False,http://www.openphacts.org/units/Nanomolar,2552944,=,37,True,=,,IC50,nM,,19000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,19000.0
283598,17665943,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(C2CCCCC2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '16.00', 'le': '0.30', 'lle': '2.35', 'sei': '6.03'}",CHEMBL3677181,,CHEMBL3677181,6.41,False,http://www.openphacts.org/units/Nanomolar,2552944,=,37,True,=,,IC50,nM,,390.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,390.0
283599,17665944,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(C(C)(C)C)no1,,,CHEMBL3638632,,2015.0,,CHEMBL3677182,,CHEMBL3677182,,False,http://www.openphacts.org/units/Nanomolar,2552945,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
283600,17665945,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(C(C)(C)C)no1,,,CHEMBL3638632,,2015.0,"{'bei': '16.07', 'le': '0.30', 'lle': '2.71', 'sei': '5.66'}",CHEMBL3677182,,CHEMBL3677182,6.02,False,http://www.openphacts.org/units/Nanomolar,2552945,=,37,True,=,,IC50,nM,,964.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,964.0
283601,17665946,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)Cc1noc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '12.49', 'le': '0.24', 'lle': '1.47', 'sei': '4.40'}",CHEMBL3677183,,CHEMBL3677183,4.68,False,http://www.openphacts.org/units/Nanomolar,2552946,=,37,True,=,,IC50,nM,,21100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,21100.0
283602,17665947,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)Cc1noc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.33', 'le': '0.29', 'lle': '2.53', 'sei': '5.40'}",CHEMBL3677183,,CHEMBL3677183,5.74,False,http://www.openphacts.org/units/Nanomolar,2552946,=,37,True,=,,IC50,nM,,1820.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1820.0
283603,17665948,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nnc(-c2ccc(F)cc2)o1,,,CHEMBL3638632,,2015.0,"{'bei': '12.59', 'le': '0.24', 'lle': '1.37', 'sei': '4.89'}",CHEMBL3677184,,CHEMBL3677184,5.19,False,http://www.openphacts.org/units/Nanomolar,2552947,=,37,True,=,,IC50,nM,,6390.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6390.0
283604,17665949,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nnc(-c2ccc(F)cc2)o1,,,CHEMBL3638632,,2015.0,"{'bei': '15.66', 'le': '0.29', 'lle': '2.64', 'sei': '6.08'}",CHEMBL3677184,,CHEMBL3677184,6.46,False,http://www.openphacts.org/units/Nanomolar,2552947,=,37,True,=,,IC50,nM,,349.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,349.0
283605,17665950,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc2ccccc2o1,,,CHEMBL3638632,,2015.0,"{'bei': '15.98', 'le': '0.30', 'lle': '2.10', 'sei': '6.29'}",CHEMBL3677185,,CHEMBL3677185,5.87,False,http://www.openphacts.org/units/Nanomolar,2552948,=,37,True,=,,IC50,nM,,1350.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1350.0
283606,17665951,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc2ccccc2o1,,,CHEMBL3638632,,2015.0,"{'bei': '17.72', 'le': '0.33', 'lle': '2.74', 'sei': '6.97'}",CHEMBL3677185,,CHEMBL3677185,6.51,False,http://www.openphacts.org/units/Nanomolar,2552948,=,37,True,=,,IC50,nM,,309.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,309.5
283607,17665952,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CCc1noc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.90', 'le': '0.28', 'lle': '2.58', 'sei': '4.86'}",CHEMBL3677165,,CHEMBL3677165,5.16,False,http://www.openphacts.org/units/Nanomolar,2552928,=,37,True,=,,IC50,nM,,6895.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6895.0
283608,17665953,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(-c2ccncc2)no1,,,CHEMBL3638632,,2015.0,,CHEMBL3677190,,CHEMBL3677190,,False,http://www.openphacts.org/units/Nanomolar,2552953,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
283609,17665954,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(-c2ccncc2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '13.70', 'le': '0.26', 'lle': '2.34', 'sei': '4.55'}",CHEMBL3677190,,CHEMBL3677190,5.42,False,http://www.openphacts.org/units/Nanomolar,2552953,=,37,True,=,,IC50,nM,,3810.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3810.0
283610,17665955,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(-c2ccccc2Cl)no1,,,CHEMBL3638632,,2015.0,"{'bei': '11.26', 'le': '0.22', 'lle': '0.50', 'sei': '4.54'}",CHEMBL3677191,,CHEMBL3677191,4.83,False,http://www.openphacts.org/units/Nanomolar,2552954,=,37,True,=,,IC50,nM,,14800.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,14800.0
283611,17665956,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(-c2ccccc2Cl)no1,,,CHEMBL3638632,,2015.0,"{'bei': '14.48', 'le': '0.28', 'lle': '1.88', 'sei': '5.84'}",CHEMBL3677191,,CHEMBL3677191,6.21,False,http://www.openphacts.org/units/Nanomolar,2552954,=,37,True,=,,IC50,nM,,619.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,619.0
283612,17665957,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '13.08', 'le': '0.26', 'lle': '1.28', 'sei': '5.28'}",CHEMBL3677192,,CHEMBL3677192,5.61,False,http://www.openphacts.org/units/Nanomolar,2552955,=,37,True,=,,IC50,nM,,2450.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2450.0
283613,17665958,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '17.29', 'le': '0.34', 'lle': '3.08', 'sei': '6.98'}",CHEMBL3677192,,CHEMBL3677192,7.42,False,http://www.openphacts.org/units/Nanomolar,2552955,=,37,True,=,,IC50,nM,,38.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,38.5
283614,17665959,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(-c2cccnc2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '14.36', 'le': '0.27', 'lle': '2.60', 'sei': '4.77'}",CHEMBL3677193,,CHEMBL3677193,5.68,False,http://www.openphacts.org/units/Nanomolar,2552956,=,37,True,=,,IC50,nM,,2090.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2090.0
283615,17665960,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CCn1nccc1C(C)Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3677194,,CHEMBL3677194,,False,http://www.openphacts.org/units/Nanomolar,2552957,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
283616,17665961,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CCn1nccc1C(C)Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.55', 'le': '0.27', 'lle': '2.16', 'sei': '5.88'}",CHEMBL3677194,,CHEMBL3677194,5.01,False,http://www.openphacts.org/units/Nanomolar,2552957,=,37,True,=,,IC50,nM,,9780.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,9780.0
283617,17665962,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)n2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '17.24', 'le': '0.32', 'lle': '3.05', 'sei': '6.63'}",CHEMBL3677195,,CHEMBL3677195,7.04,False,http://www.openphacts.org/units/Nanomolar,2552958,=,37,True,=,,IC50,nM,,90.8,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,90.8
283618,17665963,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cnc(-c2ccccc2)s1,,,CHEMBL3638632,,2015.0,"{'bei': '14.87', 'le': '0.29', 'lle': '1.34', 'sei': '7.59'}",CHEMBL3677196,,CHEMBL3677196,6.09,False,http://www.openphacts.org/units/Nanomolar,2552959,=,37,True,=,,IC50,nM,,811.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,811.0
283619,17665964,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cnc(-c2ccccc2)s1,,,CHEMBL3638632,,2015.0,"{'bei': '17.94', 'le': '0.35', 'lle': '2.60', 'sei': '9.16'}",CHEMBL3677196,,CHEMBL3677196,7.35,False,http://www.openphacts.org/units/Nanomolar,2552959,=,37,True,=,,IC50,nM,,44.8,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,44.8
283620,17665965,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1-c1noc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '12.91', 'le': '0.24', 'lle': '1.28', 'sei': '4.96'}",CHEMBL3677197,,CHEMBL3677197,5.28,False,http://www.openphacts.org/units/Nanomolar,2552960,=,37,True,=,,IC50,nM,,5310.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5310.0
283621,17665966,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1-c1noc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.49', 'le': '0.25', 'lle': '1.52', 'sei': '5.19'}",CHEMBL3677197,,CHEMBL3677197,5.51,False,http://www.openphacts.org/units/Nanomolar,2552960,=,37,True,=,,IC50,nM,,3075.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3075.0
283622,17665967,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(S(=O)(=O)N(C)C)cc1,,,CHEMBL3638632,,2015.0,,CHEMBL3677198,,CHEMBL3677198,,False,http://www.openphacts.org/units/Nanomolar,2552961,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
283623,17665968,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(S(=O)(=O)N(C)C)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '14.84', 'le': '0.29', 'lle': '3.55', 'sei': '6.14'}",CHEMBL3677198,,CHEMBL3677198,6.43,False,http://www.openphacts.org/units/Nanomolar,2552961,=,37,True,=,,IC50,nM,,368.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,368.5
283624,17665969,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cscn1,,,CHEMBL3638632,,2015.0,"{'bei': '16.59', 'le': '0.33', 'lle': '2.44', 'sei': '6.89'}",CHEMBL3677199,,CHEMBL3677199,5.53,False,http://www.openphacts.org/units/Nanomolar,2552962,=,37,True,=,,IC50,nM,,2935.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2935.0
283625,17665970,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cscn1,,,CHEMBL3638632,,2015.0,,CHEMBL3677199,,CHEMBL3677199,,False,http://www.openphacts.org/units/Nanomolar,2552962,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
283626,17665971,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)n2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '12.28', 'le': '0.23', 'lle': '1.52', 'sei': '4.51'}",CHEMBL3677200,,CHEMBL3677200,5.21,False,http://www.openphacts.org/units/Nanomolar,2552963,=,37,True,=,,IC50,nM,,6155.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6155.0
283627,17665972,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)n2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.36', 'le': '0.31', 'lle': '3.26', 'sei': '6.01'}",CHEMBL3677200,,CHEMBL3677200,6.95,False,http://www.openphacts.org/units/Nanomolar,2552963,=,37,True,=,,IC50,nM,,113.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,113.5
283628,17665973,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(-c2ccc(F)cc2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '12.64', 'le': '0.24', 'lle': '1.39', 'sei': '4.91'}",CHEMBL3677201,,CHEMBL3677201,5.21,False,http://www.openphacts.org/units/Nanomolar,2552964,=,37,True,=,,IC50,nM,,6115.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6115.0
283629,17665974,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc(-c2ccc(F)cc2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '16.12', 'le': '0.30', 'lle': '2.83', 'sei': '6.26'}",CHEMBL3677201,,CHEMBL3677201,6.65,False,http://www.openphacts.org/units/Nanomolar,2552964,=,37,True,=,,IC50,nM,,225.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,225.0
283630,17665975,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1noc(-c2ccc(Cl)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.21', 'le': '0.34', 'lle': '3.05', 'sei': '6.95'}",CHEMBL3677202,,CHEMBL3677202,7.38,False,http://www.openphacts.org/units/Nanomolar,2552965,=,37,True,=,,IC50,nM,,41.4,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,41.4
283631,17665976,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2ccc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)nc2)ccc1F,,,CHEMBL3638632,,2015.0,"{'bei': '17.39', 'le': '0.32', 'lle': '2.44', 'sei': '9.44'}",CHEMBL3677203,,CHEMBL3677203,7.58,False,http://www.openphacts.org/units/Nanomolar,2552966,=,37,True,=,,IC50,nM,,26.6,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,26.6
283632,17665977,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2ccc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)nc2)ccc1F,,,CHEMBL3638632,,2015.0,"{'bei': '12.88', 'le': '0.24', 'lle': '0.47', 'sei': '6.99'}",CHEMBL3677203,,CHEMBL3677203,5.61,False,http://www.openphacts.org/units/Nanomolar,2552966,=,37,True,=,,IC50,nM,,2460.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2460.0
283633,17665978,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ncc(Oc2ccc(F)cc2)cn1,,,CHEMBL3638632,,2015.0,"{'bei': '16.90', 'le': '0.32', 'lle': '3.06', 'sei': '7.24'}",CHEMBL3677204,,CHEMBL3677204,7.41,False,http://www.openphacts.org/units/Nanomolar,2552967,=,37,True,=,,IC50,nM,,39.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,39.0
283634,17665979,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(Oc2ccc(F)cc2)cn1,,,CHEMBL3638632,,2015.0,"{'bei': '16.98', 'le': '0.32', 'lle': '2.47', 'sei': '8.30'}",CHEMBL3677205,,CHEMBL3677205,7.43,False,http://www.openphacts.org/units/Nanomolar,2552968,=,37,True,=,,IC50,nM,,37.3,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,37.3
283635,17665980,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ccc(Oc2ccc(F)cc2)cn1,,,CHEMBL3638632,,2015.0,"{'bei': '12.04', 'le': '0.22', 'lle': '0.31', 'sei': '5.88'}",CHEMBL3677205,,CHEMBL3677205,5.26,False,http://www.openphacts.org/units/Nanomolar,2552968,=,37,True,=,,IC50,nM,,5430.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5430.0
283636,17665981,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OC(C)(C)[C@H]2c2ccccc2)n1)c1ccc(Oc2ccc(F)cc2)cn1,,,CHEMBL3638632,,2015.0,"{'bei': '14.08', 'le': '0.26', 'lle': '0.70', 'sei': '8.14'}",CHEMBL3677206,,CHEMBL3677206,7.29,False,http://www.openphacts.org/units/Nanomolar,2552969,=,37,True,=,,IC50,nM,,51.8,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,51.8
283637,17665982,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OC(C)(C)[C@H]2c2ccccc2)n1)c1ccc(Oc2ccc(F)cc2)cn1,,,CHEMBL3638632,,2015.0,"{'bei': '12.39', 'le': '0.23', 'lle': '-0.18', 'sei': '7.17'}",CHEMBL3677206,,CHEMBL3677206,6.41,False,http://www.openphacts.org/units/Nanomolar,2552969,=,37,True,=,,IC50,nM,,386.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,386.0
283638,17665983,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cnc(Oc3ccc(F)cc3)cn2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.68', 'le': '0.29', 'lle': '2.52', 'sei': '6.71'}",CHEMBL3677207,,CHEMBL3677207,6.87,False,http://www.openphacts.org/units/Nanomolar,2552970,=,37,True,=,,IC50,nM,,134.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,134.0
283639,17665984,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@H](C)c2cnc(Oc3ccc(F)cc3)cn2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '11.04', 'le': '0.21', 'lle': '0.49', 'sei': '4.73'}",CHEMBL3682139,,CHEMBL3682139,4.84,False,http://www.openphacts.org/units/Nanomolar,2558229,=,37,True,=,,IC50,nM,,14500.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,14500.0
283640,17665985,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cnc(Oc2ccc(F)cc2)nc1,,,CHEMBL3638632,,2015.0,"{'bei': '14.19', 'le': '0.27', 'lle': '1.87', 'sei': '6.08'}",CHEMBL3682004,,CHEMBL3682004,6.22,False,http://www.openphacts.org/units/Nanomolar,2558090,=,37,True,=,,IC50,nM,,601.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,601.0
283641,17665986,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cnc(Oc2ccc(F)cc2)nc1,,,CHEMBL3638632,,2015.0,,CHEMBL3682004,,CHEMBL3682004,,False,http://www.openphacts.org/units/Nanomolar,2558090,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
283642,17665987,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1ncc(Oc2ccc(F)cc2F)cn1,,,CHEMBL3638632,,2015.0,"{'bei': '16.18', 'le': '0.31', 'lle': '2.90', 'sei': '7.22'}",CHEMBL3682005,,CHEMBL3682005,7.39,False,http://www.openphacts.org/units/Nanomolar,2558091,=,37,True,=,,IC50,nM,,41.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,41.0
283643,17665988,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ncc(-c3cccc(C(F)(F)F)c3)cn2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.69', 'le': '0.32', 'lle': '2.78', 'sei': '8.47'}",CHEMBL3682006,,CHEMBL3682006,7.89,False,http://www.openphacts.org/units/Nanomolar,2558092,=,37,True,=,,IC50,nM,,13.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,13.0
283644,17665989,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(F)ccc1-c1cnc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)nc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.57', 'le': '0.31', 'lle': '2.69', 'sei': '7.76'}",CHEMBL3682007,,CHEMBL3682007,7.23,False,http://www.openphacts.org/units/Nanomolar,2558093,=,37,True,=,,IC50,nM,,58.8,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,58.8
283645,17665990,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CO)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.65', 'le': '0.31', 'lle': '2.82', 'sei': '6.78'}",CHEMBL3682008,,CHEMBL3682008,5.94,False,http://www.openphacts.org/units/Nanomolar,2558094,=,37,True,=,,IC50,nM,,1160.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1160.0
283646,17665991,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(NC(c2ccccc2)C(F)(F)F)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.57', 'le': '0.28', 'lle': '1.37', 'sei': '8.23'}",CHEMBL3677021,,CHEMBL3677021,5.54,False,http://www.openphacts.org/units/Nanomolar,2558096,=,37,True,=,,IC50,nM,,2870.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2870.0
283647,17665992,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cnc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)nc2)ccc1F,,,CHEMBL3638632,,2015.0,"{'bei': '17.01', 'le': '0.32', 'lle': '2.89', 'sei': '7.97'}",CHEMBL3682010,,CHEMBL3682010,7.43,False,http://www.openphacts.org/units/Nanomolar,2558097,=,37,True,=,,IC50,nM,,37.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,37.5
283648,17665993,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)C2CCN(S(=O)(=O)c3ccc(F)cc3)CC2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.80', 'le': '0.27', 'lle': '3.29', 'sei': '6.48'}",CHEMBL3682011,,CHEMBL3682011,6.79,False,http://www.openphacts.org/units/Nanomolar,2558098,=,37,True,=,,IC50,nM,,164.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,164.0
283649,17665994,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)C2CCN(C(=O)c3ccc(F)cc3)CC2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.36', 'le': '0.25', 'lle': '2.14', 'sei': '6.94'}",CHEMBL3682012,,CHEMBL3682012,6.09,False,http://www.openphacts.org/units/Nanomolar,2558099,=,37,True,=,,IC50,nM,,821.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,821.0
283650,17665995,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)C2CCN(C(=O)C3CCOCC3)CC2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '11.24', 'le': '0.21', 'lle': '2.09', 'sei': '5.17'}",CHEMBL3682013,,CHEMBL3682013,5.01,False,http://www.openphacts.org/units/Nanomolar,2558100,=,37,True,=,,IC50,nM,,9820.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,9820.0
283651,17665996,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)C2CCN(C(=O)N3CCOCC3)CC2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '11.49', 'le': '0.22', 'lle': '2.71', 'sei': '5.12'}",CHEMBL3682014,,CHEMBL3682014,5.13,False,http://www.openphacts.org/units/Nanomolar,2558101,=,37,True,=,,IC50,nM,,7415.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,7415.0
283652,17665997,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)C2CCN(C(=O)C3CCCCC3)CC2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.14', 'le': '0.29', 'lle': '2.64', 'sei': '7.66'}",CHEMBL3682015,,CHEMBL3682015,6.72,False,http://www.openphacts.org/units/Nanomolar,2558102,=,37,True,=,,IC50,nM,,191.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,191.5
283653,17665998,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(NS(=O)(=O)c3ccccc3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.05', 'le': '0.27', 'lle': '2.33', 'sei': '5.96'}",CHEMBL3682016,,CHEMBL3682016,6.76,False,http://www.openphacts.org/units/Nanomolar,2558103,=,37,True,=,,IC50,nM,,172.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,172.0
283654,17665999,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2nnc(-c3ccccc3)o2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.49', 'le': '0.29', 'lle': '2.43', 'sei': '5.75'}",CHEMBL3682017,,CHEMBL3682017,6.11,False,http://www.openphacts.org/units/Nanomolar,2558104,=,37,True,=,,IC50,nM,,780.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,780.0
283655,17666000,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2nnc(S(C)(=O)=O)o2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '12.18', 'le': '0.24', 'lle': '3.41', 'sei': '3.44'}",CHEMBL3682018,,CHEMBL3682018,4.83,False,http://www.openphacts.org/units/Nanomolar,2558105,=,37,True,=,,IC50,nM,,14800.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,14800.0
283656,17666001,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2noc(CNc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)n2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.35', 'le': '0.30', 'lle': '3.02', 'sei': '6.07'}",CHEMBL3682019,,CHEMBL3682019,6.45,False,http://www.openphacts.org/units/Nanomolar,2558106,=,37,True,=,,IC50,nM,,355.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,355.0
283657,17666002,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cn(Cc2ccccc2)nn1,,,CHEMBL3638632,,2015.0,"{'bei': '13.74', 'le': '0.25', 'lle': '2.33', 'sei': '5.71'}",CHEMBL3682025,,CHEMBL3682025,5.60,False,http://www.openphacts.org/units/Nanomolar,2558112,=,37,True,=,,IC50,nM,,2520.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2520.0
283658,17666003,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cn(Cc2ccccc2)nn1,,,CHEMBL3638632,,2015.0,,CHEMBL3682025,,CHEMBL3682025,,False,http://www.openphacts.org/units/Nanomolar,2558112,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
283659,17666004,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cn(-c2ccccc2)nn1,,,CHEMBL3638632,,2015.0,"{'bei': '17.02', 'le': '0.32', 'lle': '3.48', 'sei': '6.83'}",CHEMBL3682026,,CHEMBL3682026,6.70,False,http://www.openphacts.org/units/Nanomolar,2558113,=,37,True,=,,IC50,nM,,202.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,202.0
283660,17666005,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1cn(-c2ccccc2)nn1,,,CHEMBL3638632,,2015.0,"{'bei': '11.87', 'le': '0.22', 'lle': '1.46', 'sei': '4.76'}",CHEMBL3682026,,CHEMBL3682026,4.67,False,http://www.openphacts.org/units/Nanomolar,2558113,=,37,True,=,,IC50,nM,,21300.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,21300.0
283661,17666006,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2CC(C)(C)OC2=O)n1)c1ccc(C(F)(F)F)cc1F,,,CHEMBL3638632,,2015.0,"{'bei': '13.63', 'le': '0.27', 'lle': '0.99', 'sei': '8.42'}",CHEMBL3682027,,CHEMBL3682027,5.67,False,http://www.openphacts.org/units/Nanomolar,2558114,=,37,True,=,,IC50,nM,,2120.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2120.0
283662,17666007,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC1CN(c2nc(N[C@@H](C)c3ccc(C(F)(F)F)cc3F)ncc2F)C(=O)O1,,,CHEMBL3638632,,2015.0,"{'bei': '15.06', 'le': '0.30', 'lle': '1.77', 'sei': '9.00'}",CHEMBL3682028,,CHEMBL3682028,6.06,False,http://www.openphacts.org/units/Nanomolar,2558115,=,37,True,=,,IC50,nM,,873.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,873.0
283663,17666008,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2CC3(CC3)OC2=O)n1)c1ccc(C(F)(F)F)cc1F,,,CHEMBL3638632,,2015.0,"{'bei': '14.48', 'le': '0.28', 'lle': '1.56', 'sei': '8.91'}",CHEMBL3682029,,CHEMBL3682029,6.00,False,http://www.openphacts.org/units/Nanomolar,2558116,=,37,True,=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1000.0
283664,17666009,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OCC2(C)C)n1)c1cnc(OCC(F)(F)F)c(Cl)c1,,,CHEMBL3638632,,2015.0,"{'bei': '13.71', 'le': '0.28', 'lle': '1.85', 'sei': '7.11'}",CHEMBL3682030,,CHEMBL3682030,6.36,False,http://www.openphacts.org/units/Nanomolar,2558117,=,37,True,=,,IC50,nM,,437.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,437.0
283665,17666010,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC(C)(C)C2(C)C)n1)c1cnc(C(C)(F)F)c(Cl)c1,,,CHEMBL3638632,,2015.0,"{'bei': '11.75', 'le': '0.24', 'lle': '-0.08', 'sei': '6.71'}",CHEMBL3682031,,CHEMBL3682031,5.38,False,http://www.openphacts.org/units/Nanomolar,2558118,=,37,True,=,,IC50,nM,,4150.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4150.0
283666,17666011,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OCC2(C)C)n1)c1cnc(C(C)(F)F)c(Cl)c1,,,CHEMBL3638632,,2015.0,"{'bei': '12.99', 'le': '0.26', 'lle': '0.90', 'sei': '6.96'}",CHEMBL3682032,,CHEMBL3682032,5.58,False,http://www.openphacts.org/units/Nanomolar,2558119,=,37,True,=,,IC50,nM,,2610.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2610.0
283667,17666012,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC(C)(C)C2(C)C)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '13.20', 'le': '0.26', 'lle': '1.08', 'sei': '5.73'}",CHEMBL3682033,,CHEMBL3682033,6.09,False,http://www.openphacts.org/units/Nanomolar,2558120,=,37,True,=,,IC50,nM,,821.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,821.0
283668,17666013,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC1OC(=O)N(c2nc(N[C@@H](C)c3nc(-c4ccc(Cl)cc4)no3)ncc2F)C1(C)C,,,CHEMBL3638632,,2015.0,"{'bei': '14.78', 'le': '0.29', 'lle': '1.98', 'sei': '6.21'}",CHEMBL3682034,,CHEMBL3682034,6.60,False,http://www.openphacts.org/units/Nanomolar,2558121,=,37,True,=,,IC50,nM,,249.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,249.0
283669,17666014,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OCC2(C)C)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '15.84', 'le': '0.31', 'lle': '2.63', 'sei': '6.45'}",CHEMBL3682035,,CHEMBL3682035,6.86,False,http://www.openphacts.org/units/Nanomolar,2558122,=,37,True,=,,IC50,nM,,139.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,139.0
283670,17666015,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1C(C)OC(=O)N1c1ccnc(N[C@@H](C)c2ccccc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '18.29', 'le': '0.34', 'lle': '2.21', 'sei': '9.24'}",CHEMBL3682036,,CHEMBL3682036,6.22,False,http://www.openphacts.org/units/Nanomolar,2558123,=,37,True,=,,IC50,nM,,595.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,595.0
283671,17666016,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1C(C)OC(=O)N1c1nc(N[C@@H](C)c2ccccc2)ncc1F,,,CHEMBL3638632,,2015.0,"{'bei': '17.11', 'le': '0.32', 'lle': '1.97', 'sei': '9.11'}",CHEMBL3682037,,CHEMBL3682037,6.13,False,http://www.openphacts.org/units/Nanomolar,2558124,=,37,True,=,,IC50,nM,,734.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,734.0
283672,17666017,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC(C)(C)C2(C)C)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '18.04', 'le': '0.34', 'lle': '1.98', 'sei': '9.12'}",CHEMBL3682038,,CHEMBL3682038,6.14,False,http://www.openphacts.org/units/Nanomolar,2558125,=,37,True,=,,IC50,nM,,723.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,723.0
283673,17666018,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC(C)(C)C2(C)C)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.59', 'le': '0.31', 'lle': '1.65', 'sei': '8.83'}",CHEMBL3682039,,CHEMBL3682039,5.95,False,http://www.openphacts.org/units/Nanomolar,2558126,=,37,True,=,,IC50,nM,,1130.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1130.0
283674,17666019,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC1OC(=O)N(c2ccnc(N[C@@H](C)c3ccccc3)n2)C1(C)C,,,CHEMBL3638632,,2015.0,"{'bei': '16.17', 'le': '0.30', 'lle': '1.51', 'sei': '7.84'}",CHEMBL3682040,,CHEMBL3682040,5.28,False,http://www.openphacts.org/units/Nanomolar,2558127,=,37,True,=,,IC50,nM,,5270.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5270.0
283675,17666020,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC1OC(=O)N(c2nc(N[C@@H](C)c3ccccc3)ncc2F)C1(C)C,,,CHEMBL3638632,,2015.0,"{'bei': '16.32', 'le': '0.31', 'lle': '1.71', 'sei': '8.35'}",CHEMBL3682041,,CHEMBL3682041,5.62,False,http://www.openphacts.org/units/Nanomolar,2558128,=,37,True,=,,IC50,nM,,2390.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2390.0
283676,17666021,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OCC2(C)C)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '17.67', 'le': '0.33', 'lle': '2.32', 'sei': '8.67'}",CHEMBL3682042,,CHEMBL3682042,5.84,False,http://www.openphacts.org/units/Nanomolar,2558129,=,37,True,=,,IC50,nM,,1450.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1450.0
283677,17666022,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1C(C)OC(=O)N1c1ccnc(N[C@@H](C)c2cnc(OCC(F)(F)F)c(Cl)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.31', 'le': '0.27', 'lle': '1.30', 'sei': '7.05'}",CHEMBL3682043,,CHEMBL3682043,6.31,False,http://www.openphacts.org/units/Nanomolar,2558130,=,37,True,=,,IC50,nM,,494.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,494.0
283678,17666023,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC(C)(C)C2(C)C)n1)c1cnc(OCC(F)(F)F)c(Cl)c1,,,CHEMBL3638632,,2015.0,"{'bei': '13.75', 'le': '0.28', 'lle': '1.37', 'sei': '7.28'}",CHEMBL3682044,,CHEMBL3682044,6.52,False,http://www.openphacts.org/units/Nanomolar,2558131,=,37,True,=,,IC50,nM,,305.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,305.0
283679,17666024,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC1OC(=O)N(c2ccnc(N[C@@H](C)c3cnc(OCC(F)(F)F)c(Cl)c3)n2)C1(C)C,,,CHEMBL3638632,,2015.0,"{'bei': '13.09', 'le': '0.27', 'lle': '1.26', 'sei': '6.73'}",CHEMBL3682045,,CHEMBL3682045,6.02,False,http://www.openphacts.org/units/Nanomolar,2558132,=,37,True,=,,IC50,nM,,960.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,960.0
283680,17666025,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2(C)C)n1)c1cnc(OCC(F)(F)F)c(Cl)c1,,,CHEMBL3638632,,2015.0,"{'bei': '14.84', 'le': '0.30', 'lle': '2.24', 'sei': '7.39'}",CHEMBL3682046,,CHEMBL3682046,6.61,False,http://www.openphacts.org/units/Nanomolar,2558133,=,37,True,=,,IC50,nM,,243.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,243.0
283681,17666026,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2CCOC2=O)n1)c1cc(F)c(Br)cc1F,,,CHEMBL3638632,,2015.0,"{'bei': '15.73', 'le': '0.36', 'lle': '2.77', 'sei': '9.74'}",CHEMBL3682047,,CHEMBL3682047,6.56,False,http://www.openphacts.org/units/Nanomolar,2558134,=,37,True,=,,IC50,nM,,275.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,275.0
283682,17666027,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)c1cc(F)c([C@H](C)Nc2ncc(F)c(N3CCOC3=O)n2)cc1F,,,CHEMBL3638632,,2015.0,"{'bei': '16.66', 'le': '0.32', 'lle': '2.19', 'sei': '9.41'}",CHEMBL3682048,,CHEMBL3682048,6.34,False,http://www.openphacts.org/units/Nanomolar,2558135,=,37,True,=,,IC50,nM,,460.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,460.0
283683,17666028,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2(C)C)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '17.14', 'le': '0.33', 'lle': '3.02', 'sei': '6.69'}",CHEMBL3682049,,CHEMBL3682049,7.11,False,http://www.openphacts.org/units/Nanomolar,2558136,=,37,True,=,,IC50,nM,,77.3,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,77.3
283684,17666029,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OCC2(C)C)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '18.21', 'le': '0.36', 'lle': '2.28', 'sei': '9.38'}",CHEMBL3682050,,CHEMBL3682050,6.32,False,http://www.openphacts.org/units/Nanomolar,2558137,=,37,True,=,,IC50,nM,,484.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,484.0
283685,17666030,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OCC2(C)C)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '18.21', 'le': '0.36', 'lle': '2.28', 'sei': '9.38'}",CHEMBL3682050,,CHEMBL3682050,6.32,False,http://www.openphacts.org/units/Nanomolar,2558137,=,37,True,=,,IC50,nM,,484.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,484.0
283686,17666031,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OCC2(C)C)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '16.76', 'le': '0.34', 'lle': '2.79', 'sei': '7.09'}",CHEMBL3682051,,CHEMBL3682051,7.53,False,http://www.openphacts.org/units/Nanomolar,2558138,=,37,True,=,,IC50,nM,,29.4,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,29.4
283687,17666032,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2CCOC2=O)n1)c1ccc(-c2cnn(C)c2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.10', 'le': '0.31', 'lle': '2.76', 'sei': '7.54'}",CHEMBL3682053,,CHEMBL3682053,6.42,False,http://www.openphacts.org/units/Nanomolar,2558140,=,37,True,=,,IC50,nM,,380.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,380.0
283688,17666033,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(F)cc(N2C(=O)OCC2(C)C)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3638632,,2015.0,"{'bei': '17.27', 'le': '0.34', 'lle': '3.24', 'sei': '7.03'}",CHEMBL3682054,,CHEMBL3682054,7.47,False,http://www.openphacts.org/units/Nanomolar,2558141,=,37,True,=,,IC50,nM,,33.6,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,33.6
283689,17666034,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C3(C)CC3)cc2F)n1,,,CHEMBL3638632,,2015.0,"{'bei': '18.93', 'le': '0.36', 'lle': '2.72', 'sei': '11.20'}",CHEMBL3682055,,CHEMBL3682055,7.54,False,http://www.openphacts.org/units/Nanomolar,2558142,=,37,True,=,,IC50,nM,,28.7,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,28.7
283690,17666035,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(C)(C)C)nc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '18.85', 'le': '0.35', 'lle': '2.91', 'sei': '9.01'}",CHEMBL3682056,,CHEMBL3682056,7.23,False,http://www.openphacts.org/units/Nanomolar,2558143,=,37,True,=,,IC50,nM,,59.2,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,59.2
283691,17666036,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1nc(N[C@@H](C)c2ccc(C(C)(C)C)nc2)ncc1F,,,CHEMBL3638632,,2015.0,"{'bei': '14.45', 'le': '0.27', 'lle': '1.34', 'sei': '7.23'}",CHEMBL3682057,,CHEMBL3682057,5.80,False,http://www.openphacts.org/units/Nanomolar,2558144,=,37,True,=,,IC50,nM,,1580.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1580.0
283692,17666037,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C3(C)CC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '18.67', 'le': '0.35', 'lle': '2.43', 'sei': '10.55'}",CHEMBL3682058,,CHEMBL3682058,7.11,False,http://www.openphacts.org/units/Nanomolar,2558145,=,37,True,=,,IC50,nM,,78.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,78.5
283693,17666038,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1c(-c2ccc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)cc2)cnn1C,,,CHEMBL3638632,,2015.0,"{'bei': '15.31', 'le': '0.28', 'lle': '2.10', 'sei': '7.56'}",CHEMBL3682059,,CHEMBL3682059,6.44,False,http://www.openphacts.org/units/Nanomolar,2558146,=,37,True,=,,IC50,nM,,363.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,363.0
283694,17666039,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(F)(F)F)cc2F)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.32', 'le': '0.32', 'lle': '1.94', 'sei': '9.99'}",CHEMBL3682060,,CHEMBL3682060,6.73,False,http://www.openphacts.org/units/Nanomolar,2558147,=,37,True,=,,IC50,nM,,187.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,187.0
283695,17666040,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C3CC3)cc2F)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.27', 'le': '0.32', 'lle': '1.99', 'sei': '9.86'}",CHEMBL3682061,,CHEMBL3682061,6.64,False,http://www.openphacts.org/units/Nanomolar,2558148,=,37,True,=,,IC50,nM,,230.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,230.0
283696,17666041,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C3CC3)nc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.68', 'le': '0.31', 'lle': '2.23', 'sei': '7.64'}",CHEMBL3682062,,CHEMBL3682062,6.13,False,http://www.openphacts.org/units/Nanomolar,2558149,=,37,True,=,,IC50,nM,,745.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,745.0
283697,17666042,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C3(C)CC3)nc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.78', 'le': '0.33', 'lle': '2.70', 'sei': '8.45'}",CHEMBL3682063,,CHEMBL3682063,6.78,False,http://www.openphacts.org/units/Nanomolar,2558150,=,37,True,=,,IC50,nM,,165.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,165.0
283698,17666043,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CCOC1(c2ccc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)cc2)CC1,,,CHEMBL3638632,,2015.0,"{'bei': '18.70', 'le': '0.35', 'lle': '3.02', 'sei': '10.02'}",CHEMBL3682064,,CHEMBL3682064,7.68,False,http://www.openphacts.org/units/Nanomolar,2558151,=,37,True,=,,IC50,nM,,21.1,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,21.1
283699,17666044,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3cnn(C)c3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.82', 'le': '0.31', 'lle': '2.81', 'sei': '8.03'}",CHEMBL3677037,,CHEMBL3677037,6.84,False,http://www.openphacts.org/units/Nanomolar,2552798,=,37,True,=,,IC50,nM,,145.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,145.5
283700,17666045,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)c1ccc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)c(F)c1,,,CHEMBL3638632,,2015.0,"{'bei': '19.07', 'le': '0.36', 'lle': '2.48', 'sei': '10.94'}",CHEMBL3682065,,CHEMBL3682065,7.37,False,http://www.openphacts.org/units/Nanomolar,2558152,=,37,True,=,,IC50,nM,,42.7,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,42.7
283701,17666046,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C3(C#N)CC3)cc2F)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.27', 'le': '0.32', 'lle': '2.74', 'sei': '7.76'}",CHEMBL3682066,,CHEMBL3682066,7.07,False,http://www.openphacts.org/units/Nanomolar,2558153,=,37,True,=,,IC50,nM,,85.1,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,85.1
283702,17666047,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3cnn(C)c3)cc2F)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.99', 'le': '0.32', 'lle': '3.04', 'sei': '8.47'}",CHEMBL3682067,,CHEMBL3682067,7.21,False,http://www.openphacts.org/units/Nanomolar,2558154,=,37,True,=,,IC50,nM,,61.3,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,61.3
283703,17666048,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3cn[nH]c3)cc2F)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.56', 'le': '0.33', 'lle': '3.05', 'sei': '7.50'}",CHEMBL3682068,,CHEMBL3682068,7.21,False,http://www.openphacts.org/units/Nanomolar,2558155,=,37,True,=,,IC50,nM,,62.2,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,62.2
283704,17666049,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)NC3CCCC3)c(Cl)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.12', 'le': '0.33', 'lle': '3.12', 'sei': '8.38'}",CHEMBL3682069,,CHEMBL3682069,8.08,False,http://www.openphacts.org/units/Nanomolar,2558156,=,37,True,=,,IC50,nM,,8.35,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,8.35
283705,17666050,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)NC3CCCCC3)c(Cl)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.65', 'le': '0.32', 'lle': '2.74', 'sei': '8.39'}",CHEMBL3682070,,CHEMBL3682070,8.09,False,http://www.openphacts.org/units/Nanomolar,2558157,=,37,True,=,,IC50,nM,,8.12,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,8.12
283706,17666051,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N[C@H]3CC[C@H](O)CC3)c(Cl)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.22', 'le': '0.28', 'lle': '2.82', 'sei': '6.12'}",CHEMBL3682071,,CHEMBL3682071,7.14,False,http://www.openphacts.org/units/Nanomolar,2558158,=,37,True,=,,IC50,nM,,72.7,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,72.7
283707,17666052,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cccc(OC3CCCC3)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.18', 'le': '0.30', 'lle': '1.69', 'sei': '8.68'}",CHEMBL3682072,,CHEMBL3682072,6.64,False,http://www.openphacts.org/units/Nanomolar,2558159,=,37,True,=,,IC50,nM,,227.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,227.0
283708,17666053,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1ccc([C@H](C)Nc2ncc(F)c(N3C(=O)OC[C@@H]3C(C)C)n2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '16.10', 'le': '0.31', 'lle': '1.92', 'sei': '8.46'}",CHEMBL3682073,,CHEMBL3682073,6.48,False,http://www.openphacts.org/units/Nanomolar,2558160,=,37,True,=,,IC50,nM,,331.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,331.0
283709,17666054,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cccc(OC3CCCCC3)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.87', 'le': '0.30', 'lle': '1.40', 'sei': '8.80'}",CHEMBL3682074,,CHEMBL3682074,6.74,False,http://www.openphacts.org/units/Nanomolar,2558161,=,37,True,=,,IC50,nM,,183.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,183.0
283710,17666055,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cccc(OC3CCCCCC3)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.92', 'le': '0.30', 'lle': '1.25', 'sei': '9.12'}",CHEMBL3682075,,CHEMBL3682075,6.98,False,http://www.openphacts.org/units/Nanomolar,2558162,=,37,True,=,,IC50,nM,,104.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,104.0
283711,17666056,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1cccc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '17.14', 'le': '0.32', 'lle': '2.17', 'sei': '8.61'}",CHEMBL3682076,,CHEMBL3682076,6.59,False,http://www.openphacts.org/units/Nanomolar,2558163,=,37,True,=,,IC50,nM,,257.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,257.0
283712,17666057,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)COc1cccc([C@H](C)Nc2ncc(F)c(N3C(=O)OC[C@@H]3C(C)C)n2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '15.78', 'le': '0.30', 'lle': '1.77', 'sei': '8.58'}",CHEMBL3682077,,CHEMBL3682077,6.57,False,http://www.openphacts.org/units/Nanomolar,2558164,=,37,True,=,,IC50,nM,,268.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,268.0
283713,17666058,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1nc(N[C@@H](C)c2cccc(O[C@H]3CCOC3)c2)ncc1F,,,CHEMBL3638632,,2015.0,"{'bei': '12.95', 'le': '0.25', 'lle': '1.64', 'sei': '6.50'}",CHEMBL3682078,,CHEMBL3682078,5.58,False,http://www.openphacts.org/units/Nanomolar,2558165,=,37,True,=,,IC50,nM,,2660.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2660.0
283714,17666059,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cccc(OC3CCCOC3)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.63', 'le': '0.27', 'lle': '2.05', 'sei': '7.27'}",CHEMBL3682079,,CHEMBL3682079,6.24,False,http://www.openphacts.org/units/Nanomolar,2558166,=,37,True,=,,IC50,nM,,573.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,573.0
283715,17666060,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cccc(Oc3ccccc3)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.84', 'le': '0.31', 'lle': '1.63', 'sei': '9.20'}",CHEMBL3682080,,CHEMBL3682080,7.05,False,http://www.openphacts.org/units/Nanomolar,2558167,=,37,True,=,,IC50,nM,,89.9,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,89.9
283716,17666061,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1nc(N[C@@H](C)c2cccc(Oc3ccccc3)c2)ncc1F,,,CHEMBL3638632,,2015.0,"{'bei': '16.17', 'le': '0.30', 'lle': '1.50', 'sei': '9.22'}",CHEMBL3682081,,CHEMBL3682081,7.06,False,http://www.openphacts.org/units/Nanomolar,2558168,=,37,True,=,,IC50,nM,,87.7,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,87.7
283717,17666062,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)C1CCCO1,,,CHEMBL3638632,,2015.0,,CHEMBL3639809,,CHEMBL3639809,,False,http://www.openphacts.org/units/Nanomolar,2558169,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
283718,17666063,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(OCC(C)C)ccc1[C@H](C)Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.75', 'le': '0.33', 'lle': '2.35', 'sei': '9.56'}",CHEMBL3682082,,CHEMBL3682082,7.32,False,http://www.openphacts.org/units/Nanomolar,2558170,=,37,True,=,,IC50,nM,,47.7,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,47.7
283719,17666064,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CCOC1(c2ccc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)cn2)CC1,,,CHEMBL3638632,,2015.0,"{'bei': '17.07', 'le': '0.32', 'lle': '2.98', 'sei': '7.85'}",CHEMBL3682083,,CHEMBL3682083,7.03,False,http://www.openphacts.org/units/Nanomolar,2558171,=,37,True,=,,IC50,nM,,94.3,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,94.3
283720,17666065,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)ccc1OCC(C)C,,,CHEMBL3638632,,2015.0,"{'bei': '17.87', 'le': '0.34', 'lle': '2.40', 'sei': '9.63'}",CHEMBL3682084,,CHEMBL3682084,7.37,False,http://www.openphacts.org/units/Nanomolar,2558172,=,37,True,=,,IC50,nM,,42.3,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,42.3
283721,17666066,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCn4ccnc4C3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.81', 'le': '0.27', 'lle': '3.00', 'sei': '7.73'}",CHEMBL3682085,,CHEMBL3682085,6.84,False,http://www.openphacts.org/units/Nanomolar,2558173,=,37,True,=,,IC50,nM,,146.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,146.0
283722,17666067,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCC(C)(O)CC3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.46', 'le': '0.27', 'lle': '2.58', 'sei': '7.22'}",CHEMBL3682088,,CHEMBL3682088,6.56,False,http://www.openphacts.org/units/Nanomolar,2558176,=,37,True,=,,IC50,nM,,276.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,276.0
283723,17666068,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCCC(F)(F)C3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.76', 'le': '0.32', 'lle': '2.84', 'sei': '10.91'}",CHEMBL3682089,,CHEMBL3682089,7.70,False,http://www.openphacts.org/units/Nanomolar,2558177,=,37,True,=,,IC50,nM,,19.9,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,19.9
283724,17666069,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCNC4(CC4)C3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.18', 'le': '0.26', 'lle': '2.82', 'sei': '7.73'}",CHEMBL3682090,,CHEMBL3682090,6.39,False,http://www.openphacts.org/units/Nanomolar,2558178,=,37,True,=,,IC50,nM,,410.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,410.0
283725,17666070,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCNCC34CC4)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.79', 'le': '0.28', 'lle': '3.09', 'sei': '8.07'}",CHEMBL3682091,,CHEMBL3682091,6.66,False,http://www.openphacts.org/units/Nanomolar,2558179,=,37,True,=,,IC50,nM,,217.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,217.0
283726,17666071,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1cc(F)nc(N[C@@H](C)c2ccccc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '19.24', 'le': '0.36', 'lle': '2.86', 'sei': '9.84'}",CHEMBL3682094,,CHEMBL3682094,6.62,False,http://www.openphacts.org/units/Nanomolar,2558182,=,37,True,=,,IC50,nM,,237.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,237.0
283727,17666072,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(F)cc(N2C(=O)OCC2(C)C)n1)c1ccc(C(F)(F)F)cc1F,,,CHEMBL3638632,,2015.0,"{'bei': '15.73', 'le': '0.31', 'lle': '1.87', 'sei': '9.72'}",CHEMBL3682095,,CHEMBL3682095,6.55,False,http://www.openphacts.org/units/Nanomolar,2558183,=,37,True,=,,IC50,nM,,283.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,283.0
283728,17666073,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@H]2c2ccccc2)n1)C1CC1,,,CHEMBL3638632,,2015.0,"{'bei': '14.66', 'le': '0.27', 'lle': '1.37', 'sei': '7.06'}",CHEMBL3682096,,CHEMBL3682096,4.75,False,http://www.openphacts.org/units/Nanomolar,2558184,=,37,True,=,,IC50,nM,,17600.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,17600.0
283729,17666074,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2Cc2ccccc2)n1)C1CC1,,,CHEMBL3638632,,2015.0,"{'bei': '13.60', 'le': '0.25', 'lle': '1.35', 'sei': '6.83'}",CHEMBL3682097,,CHEMBL3682097,4.60,False,http://www.openphacts.org/units/Nanomolar,2558185,=,37,True,=,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
283730,17666075,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)c1cccc([C@H](C)Nc2ncc(F)c(N3C(=O)OC[C@@H]3C(C)C)n2)c1,,,CHEMBL3638632,,2015.0,"{'bei': '16.19', 'le': '0.31', 'lle': '1.37', 'sei': '9.29'}",CHEMBL3682098,,CHEMBL3682098,6.26,False,http://www.openphacts.org/units/Nanomolar,2558186,=,37,True,=,,IC50,nM,,552.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,552.0
283731,17666076,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1nc(N[C@@H](C)c2ccc(Cl)cc2)ncc1F,,,CHEMBL3638632,,2015.0,"{'bei': '17.00', 'le': '0.34', 'lle': '2.02', 'sei': '9.56'}",CHEMBL3682099,,CHEMBL3682099,6.44,False,http://www.openphacts.org/units/Nanomolar,2558187,=,37,True,=,,IC50,nM,,364.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,364.0
283732,17666077,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)COc1ccc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '18.56', 'le': '0.35', 'lle': '2.73', 'sei': '9.66'}",CHEMBL3682100,,CHEMBL3682100,7.40,False,http://www.openphacts.org/units/Nanomolar,2558188,=,37,True,=,,IC50,nM,,40.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,40.0
283733,17666078,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)COc1ccc([C@H](C)Nc2ncc(F)c(N3C(=O)OC[C@@H]3C(C)C)n2)cc1,,,CHEMBL3638632,,2015.0,"{'bei': '17.53', 'le': '0.33', 'lle': '2.50', 'sei': '9.53'}",CHEMBL3682101,,CHEMBL3682101,7.30,False,http://www.openphacts.org/units/Nanomolar,2558189,=,37,True,=,,IC50,nM,,50.1,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.1
283734,17666079,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1nc(N[C@@H](C)c2ccc(-c3cnn(C)c3)cc2F)ncc1F,,,CHEMBL3638632,,2015.0,"{'bei': '14.71', 'le': '0.28', 'lle': '2.20', 'sei': '7.64'}",CHEMBL3682102,,CHEMBL3682102,6.51,False,http://www.openphacts.org/units/Nanomolar,2558190,=,37,True,=,,IC50,nM,,309.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,309.0
283735,17666080,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cccc(F)c2F)n1,,,CHEMBL3638632,,2015.0,"{'bei': '19.00', 'le': '0.36', 'lle': '2.98', 'sei': '10.22'}",CHEMBL3682103,,CHEMBL3682103,6.89,False,http://www.openphacts.org/units/Nanomolar,2558191,=,37,True,=,,IC50,nM,,130.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,130.0
283736,17666081,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2CCOC2=O)n1)c1cccc(F)c1F,,,CHEMBL3638632,,2015.0,"{'bei': '15.57', 'le': '0.30', 'lle': '2.25', 'sei': '7.82'}",CHEMBL3682104,,CHEMBL3682104,5.27,False,http://www.openphacts.org/units/Nanomolar,2558192,=,37,True,=,,IC50,nM,,5410.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5410.0
283737,17666082,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N[C@H]3CC[C@H](O)CC3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.30', 'le': '0.27', 'lle': '3.14', 'sei': '5.95'}",CHEMBL3682105,,CHEMBL3682105,6.94,False,http://www.openphacts.org/units/Nanomolar,2558193,=,37,True,=,,IC50,nM,,114.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,114.0
283738,17666083,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(Oc3ccc(F)cc3)nc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.55', 'le': '0.31', 'lle': '2.28', 'sei': '8.09'}",CHEMBL3682106,,CHEMBL3682106,7.24,False,http://www.openphacts.org/units/Nanomolar,2558194,=,37,True,=,,IC50,nM,,57.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,57.5
283739,17666084,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N3CCCCC3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '16.14', 'le': '0.30', 'lle': '2.95', 'sei': '8.39'}",CHEMBL3682107,,CHEMBL3682107,7.35,False,http://www.openphacts.org/units/Nanomolar,2558195,=,37,True,=,,IC50,nM,,44.6,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,44.6
283740,17666085,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1nc(N[C@@H](C)c2ccc(C(=O)N3CCCCC3)c(F)c2)ncc1F,,,CHEMBL3638632,,2015.0,"{'bei': '15.06', 'le': '0.29', 'lle': '2.59', 'sei': '8.13'}",CHEMBL3682108,,CHEMBL3682108,7.13,False,http://www.openphacts.org/units/Nanomolar,2558196,=,37,True,=,,IC50,nM,,74.2,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,74.2
283741,17666086,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1nc(N[C@@H](C)c2ccc(C(=O)NC3CCCCC3)c(F)c2)ncc1F,,,CHEMBL3638632,,2015.0,"{'bei': '14.58', 'le': '0.28', 'lle': '2.14', 'sei': '7.37'}",CHEMBL3682109,,CHEMBL3682109,7.11,False,http://www.openphacts.org/units/Nanomolar,2558197,=,37,True,=,,IC50,nM,,78.1,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,78.1
283742,17666087,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)NC3CCCCC3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.26', 'le': '0.33', 'lle': '3.27', 'sei': '8.40'}",CHEMBL3682110,,CHEMBL3682110,8.11,False,http://www.openphacts.org/units/Nanomolar,2558198,=,37,True,=,,IC50,nM,,7.86,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,7.86
283743,17666088,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(Oc3cncnc3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.43', 'le': '0.29', 'lle': '2.28', 'sei': '6.34'}",CHEMBL3682111,,CHEMBL3682111,6.49,False,http://www.openphacts.org/units/Nanomolar,2558199,=,37,True,=,,IC50,nM,,324.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,324.0
283744,17666089,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC3(CCOCC3)C2c2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '13.28', 'le': '0.24', 'lle': '0.82', 'sei': '7.47'}",CHEMBL3682112,,CHEMBL3682112,5.72,False,http://www.openphacts.org/units/Nanomolar,2558200,=,37,True,=,,IC50,nM,,1910.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1910.0
283745,17666090,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC3(CCOCC3)C2c2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '13.07', 'le': '0.24', 'lle': '0.73', 'sei': '7.35'}",CHEMBL3682112,,CHEMBL3682112,5.62,False,http://www.openphacts.org/units/Nanomolar,2558201,=,37,True,=,,IC50,nM,,2370.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2370.0
283746,17666091,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC3(CCOCC3)C2c2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '13.43', 'le': '0.25', 'lle': '0.88', 'sei': '7.55'}",CHEMBL3682112,,CHEMBL3682112,5.78,False,http://www.openphacts.org/units/Nanomolar,2558201,=,37,True,=,,IC50,nM,,1650.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1650.0
283747,17666092,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC3(COC3)C2c2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '14.84', 'le': '0.27', 'lle': '1.85', 'sei': '7.80'}",CHEMBL3682113,,CHEMBL3682113,5.97,False,http://www.openphacts.org/units/Nanomolar,2558202,=,37,True,=,,IC50,nM,,1070.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1070.0
283748,17666093,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC3(COC3)C2c2ccccc2)n1)c1ccccc1,,,CHEMBL3638632,,2015.0,"{'bei': '15.48', 'le': '0.28', 'lle': '2.11', 'sei': '8.13'}",CHEMBL3682113,,CHEMBL3682113,6.23,False,http://www.openphacts.org/units/Nanomolar,2558202,=,37,True,=,,IC50,nM,,591.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,591.0
283749,17666094,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1nc(N[C@@H](C)c2ccc(C(F)(F)F)cc2F)ncc1F,,,CHEMBL3638632,,2015.0,"{'bei': '15.60', 'le': '0.31', 'lle': '1.78', 'sei': '9.97'}",CHEMBL3682114,,CHEMBL3682114,6.71,False,http://www.openphacts.org/units/Nanomolar,2558203,=,37,True,=,,IC50,nM,,193.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,193.0
283750,17666095,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(NCc2ccc(Oc3ccccc3)cc2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.74', 'le': '0.29', 'lle': '1.50', 'sei': '8.31'}",CHEMBL3682115,,CHEMBL3682115,6.37,False,http://www.openphacts.org/units/Nanomolar,2558204,=,37,True,=,,IC50,nM,,432.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,432.0
283751,17666096,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1)c1nc2c(s1)CCCC2,,,CHEMBL3638632,,2015.0,"{'bei': '17.27', 'le': '0.34', 'lle': '2.72', 'sei': '8.34'}",CHEMBL3682116,,CHEMBL3682116,6.69,False,http://www.openphacts.org/units/Nanomolar,2558205,=,37,True,=,,IC50,nM,,204.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,204.0
283752,17666097,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@H](C)C(F)(F)F)n1,,,CHEMBL3638632,,2015.0,,CHEMBL3682117,,CHEMBL3682117,,False,http://www.openphacts.org/units/Nanomolar,2558206,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
283753,17666098,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@H](C)C(F)(F)F)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.63', 'le': '0.31', 'lle': '2.15', 'sei': '7.39'}",CHEMBL3682117,,CHEMBL3682117,4.97,False,http://www.openphacts.org/units/Nanomolar,2558206,=,37,True,=,,IC50,nM,,10600.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,10600.0
283754,17666099,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2c2ccccc2)n1)C(F)(F)F,,,CHEMBL3638632,,2015.0,"{'bei': '14.69', 'le': '0.28', 'lle': '1.63', 'sei': '7.68'}",CHEMBL3682118,,CHEMBL3682118,5.17,False,http://www.openphacts.org/units/Nanomolar,2558207,=,37,True,=,,IC50,nM,,6700.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6700.0
283755,17666100,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2c2ccccc2)n1)C1CC1,,,CHEMBL3638632,,2015.0,"{'bei': '17.50', 'le': '0.33', 'lle': '2.47', 'sei': '8.90'}",CHEMBL3682119,,CHEMBL3682119,5.99,False,http://www.openphacts.org/units/Nanomolar,2558208,=,37,True,=,,IC50,nM,,1020.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1020.0
283756,17666101,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2c2ccccc2)n1)C1CC1,,,CHEMBL3638632,,2015.0,"{'bei': '17.60', 'le': '0.32', 'lle': '2.33', 'sei': '8.48'}",CHEMBL3682120,,CHEMBL3682120,5.71,False,http://www.openphacts.org/units/Nanomolar,2558209,=,37,True,=,,IC50,nM,,1950.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1950.0
283757,17666102,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2c2ccc(-c3ccccc3)cc2)n1)C1CC1,,,CHEMBL3638632,,2015.0,"{'bei': '15.16', 'le': '0.28', 'lle': '1.02', 'sei': '9.01'}",CHEMBL3682121,,CHEMBL3682121,6.07,False,http://www.openphacts.org/units/Nanomolar,2558210,=,37,True,=,,IC50,nM,,850.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,850.0
283758,17666103,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC(C)(C)C2(C)C)n1)C1CC1,,,CHEMBL3638632,,2015.0,"{'bei': '17.17', 'le': '0.33', 'lle': '2.19', 'sei': '8.22'}",CHEMBL3682122,,CHEMBL3682122,5.54,False,http://www.openphacts.org/units/Nanomolar,2558211,=,37,True,=,,IC50,nM,,2920.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2920.0
283759,17666104,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)NC3CCCC3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '17.84', 'le': '0.34', 'lle': '3.68', 'sei': '8.42'}",CHEMBL3682123,,CHEMBL3682123,8.12,False,http://www.openphacts.org/units/Nanomolar,2558212,=,37,True,=,,IC50,nM,,7.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,7.5
283760,17666105,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)NC3CCC(F)(F)CC3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.32', 'le': '0.29', 'lle': '2.66', 'sei': '8.03'}",CHEMBL3682124,,CHEMBL3682124,7.75,False,http://www.openphacts.org/units/Nanomolar,2558213,=,37,True,=,,IC50,nM,,18.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,18.0
283761,17666106,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)NC3CCOCC3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.09', 'le': '0.29', 'lle': '3.43', 'sei': '6.73'}",CHEMBL3682125,,CHEMBL3682125,7.11,False,http://www.openphacts.org/units/Nanomolar,2558214,=,37,True,=,,IC50,nM,,77.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,77.0
283762,17666107,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N[C@@H]3CCCC[C@@H]3O)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.33', 'le': '0.29', 'lle': '3.64', 'sei': '6.38'}",CHEMBL3682126,,CHEMBL3682126,7.44,False,http://www.openphacts.org/units/Nanomolar,2558215,=,37,True,=,,IC50,nM,,36.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,36.0
283763,17666108,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)NC3CCS(=O)(=O)CC3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '12.99', 'le': '0.26', 'lle': '3.67', 'sei': '5.17'}",CHEMBL3682127,,CHEMBL3682127,6.75,False,http://www.openphacts.org/units/Nanomolar,2558216,=,37,True,=,,IC50,nM,,178.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,178.0
283764,17666109,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N[C@@H]3CCCC[C@H]3O)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.98', 'le': '0.28', 'lle': '3.48', 'sei': '6.24'}",CHEMBL3682128,,CHEMBL3682128,7.28,False,http://www.openphacts.org/units/Nanomolar,2558217,=,37,True,=,,IC50,nM,,53.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,53.0
283765,17666110,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N(C)C3CCOCC3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.03', 'le': '0.27', 'lle': '2.79', 'sei': '7.03'}",CHEMBL3682129,,CHEMBL3682129,6.81,False,http://www.openphacts.org/units/Nanomolar,2558218,=,37,True,=,,IC50,nM,,154.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,154.0
283766,17666111,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N(C)C)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '14.75', 'le': '0.28', 'lle': '2.66', 'sei': '6.99'}",CHEMBL3682130,,CHEMBL3682130,6.13,False,http://www.openphacts.org/units/Nanomolar,2558219,=,37,True,=,,IC50,nM,,741.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,741.0
283767,17666112,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N3CCOCC3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.43', 'le': '0.25', 'lle': '2.91', 'sei': '6.34'}",CHEMBL3682131,,CHEMBL3682131,6.15,False,http://www.openphacts.org/units/Nanomolar,2558220,=,37,True,=,,IC50,nM,,715.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,715.0
283768,17666113,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N3CCOC[C@H]3C)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.95', 'le': '0.26', 'lle': '2.95', 'sei': '6.79'}",CHEMBL3682132,,CHEMBL3682132,6.58,False,http://www.openphacts.org/units/Nanomolar,2558221,=,37,True,=,,IC50,nM,,265.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,265.0
283769,17666114,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N3CCC(O)CC3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.02', 'le': '0.25', 'lle': '2.77', 'sei': '5.69'}",CHEMBL3682133,,CHEMBL3682133,6.14,False,http://www.openphacts.org/units/Nanomolar,2558222,=,37,True,=,,IC50,nM,,729.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,729.0
283770,17666115,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,COC1CCN(C(=O)c2ccc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)cc2F)CC1,,,CHEMBL3638632,,2015.0,"{'bei': '15.19', 'le': '0.29', 'lle': '3.36', 'sei': '7.61'}",CHEMBL3682134,,CHEMBL3682134,7.38,False,http://www.openphacts.org/units/Nanomolar,2558223,=,37,True,=,,IC50,nM,,42.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,42.0
283771,17666116,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N3CCC(F)CC3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.77', 'le': '0.30', 'lle': '3.13', 'sei': '8.52'}",CHEMBL3682135,,CHEMBL3682135,7.47,False,http://www.openphacts.org/units/Nanomolar,2558224,=,37,True,=,,IC50,nM,,34.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,34.0
283772,17666117,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N3CCC[C@@H](O)C3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '13.73', 'le': '0.26', 'lle': '3.10', 'sei': '6.00'}",CHEMBL3682136,,CHEMBL3682136,6.47,False,http://www.openphacts.org/units/Nanomolar,2558225,=,37,True,=,,IC50,nM,,336.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,336.0
283773,17666118,[],CHEMBL3705791,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(C(=O)N3CCCC3)c(F)c2)n1,,,CHEMBL3638632,,2015.0,"{'bei': '15.39', 'le': '0.29', 'lle': '2.78', 'sei': '7.75'}",CHEMBL3682137,,CHEMBL3682137,6.79,False,http://www.openphacts.org/units/Nanomolar,2558226,=,37,True,=,,IC50,nM,,161.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,161.0
431761,17791869,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)OC(C)(C)C)n1)c1cc(-c2ccc(Cl)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '12.04', 'le': '0.24', 'lle': '0.36', 'sei': '5.70'}",CHEMBL4111136,,CHEMBL4111136,5.85,False,http://www.openphacts.org/units/Nanomolar,2894932,=,37,True,=,,IC50,nM,,1410.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1410.0
431762,17791870,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)OC(C)(C)C)n1)c1ncc(-c2ccc(Cl)cc2)o1,,,CHEMBL3886939,,2016.0,"{'bei': '12.68', 'le': '0.25', 'lle': '0.76', 'sei': '6.23'}",CHEMBL4112433,,CHEMBL4112433,6.39,False,http://www.openphacts.org/units/Nanomolar,2894933,=,37,True,=,,IC50,nM,,409.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,409.0
431763,17791871,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)OC(C)(C)C)n3)n2)ccc1Cl,,,CHEMBL3886939,,2016.0,"{'bei': '11.67', 'le': '0.23', 'lle': '0.66', 'sei': '5.06'}",CHEMBL4108047,,CHEMBL4108047,5.85,False,http://www.openphacts.org/units/Nanomolar,2894934,=,37,True,=,,IC50,nM,,1420.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1420.0
431764,17791872,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)OC(C)(C)C)n3)n2)ccc1F,,,CHEMBL3886939,,2016.0,"{'bei': '9.80', 'le': '0.19', 'lle': '0.07', 'sei': '4.11'}",CHEMBL4108555,,CHEMBL4108555,4.75,False,http://www.openphacts.org/units/Nanomolar,2894935,=,37,True,=,,IC50,nM,,17800.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,17800.0
431765,17791873,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,COc1cc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)OC(C)(C)C)n3)n2)ccc1Cl,,,CHEMBL3886939,,2016.0,"{'bei': '11.40', 'le': '0.22', 'lle': '1.01', 'sei': '4.73'}",CHEMBL4109350,,CHEMBL4109350,5.90,False,http://www.openphacts.org/units/Nanomolar,2894936,=,37,True,=,,IC50,nM,,1270.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1270.0
431766,17791874,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)OC(C)(C)C)n1)c1nc(-c2ccc(Cl)c(OC(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '9.69', 'le': '0.19', 'lle': '-0.25', 'sei': '4.43'}",CHEMBL4113250,,CHEMBL4113250,5.53,False,http://www.openphacts.org/units/Nanomolar,2894937,=,37,True,=,,IC50,nM,,2950.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2950.0
431767,17791875,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)OC(C)(C)C)n1)c1nc(-c2ccc3ccn(C)c3c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '11.26', 'le': '0.21', 'lle': '0.97', 'sei': '4.73'}",CHEMBL4112574,,CHEMBL4112574,5.69,False,http://www.openphacts.org/units/Nanomolar,2894938,=,37,True,=,,IC50,nM,,2040.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2040.0
431768,17791876,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)OC(C)(C)C)n1)c1nc(-c2cccc(C(C)(C)C)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '11.12', 'le': '0.21', 'lle': '0.13', 'sei': '4.90'}",CHEMBL4113299,,CHEMBL4113299,5.66,False,http://www.openphacts.org/units/Nanomolar,2894939,=,37,True,=,,IC50,nM,,2200.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2200.0
431769,17791877,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)OC(C)(C)C)n1)c1nc(-c2cccc(OC(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '9.19', 'le': '0.18', 'lle': '-0.20', 'sei': '3.95'}",CHEMBL4112386,,CHEMBL4112386,4.93,False,http://www.openphacts.org/units/Nanomolar,2894940,=,37,True,=,,IC50,nM,,11700.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,11700.0
431770,17791878,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)OC(C)(C)C)n1)c1nc(-c2ccc(F)c(OC(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '9.95', 'le': '0.19', 'lle': '0.25', 'sei': '4.42'}",CHEMBL4113397,,CHEMBL4113397,5.52,False,http://www.openphacts.org/units/Nanomolar,2894941,=,37,True,=,,IC50,nM,,3050.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3050.0
431771,17791879,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)c1ccc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)OC(C)(C)C)n3)n2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '11.09', 'le': '0.21', 'lle': '0.14', 'sei': '4.75'}",CHEMBL4111511,,CHEMBL4111511,5.49,False,http://www.openphacts.org/units/Nanomolar,2894942,=,37,True,=,,IC50,nM,,3270.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3270.0
431772,17791880,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc2c(-c3noc(C(C)Nc4nccc(N5C(=O)OC[C@@H]5[C@@H](C)OC(C)(C)C)n4)n3)cccc2n1C,,,CHEMBL3886939,,2016.0,"{'bei': '10.89', 'le': '0.20', 'lle': '0.63', 'sei': '4.70'}",CHEMBL4107739,,CHEMBL4107739,5.66,False,http://www.openphacts.org/units/Nanomolar,2894943,=,37,True,=,,IC50,nM,,2190.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2190.0
431773,17791881,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1nc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)OC(C)(C)C)n2)oc1-c1ccc(Cl)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '12.79', 'le': '0.25', 'lle': '0.59', 'sei': '6.23'}",CHEMBL4112175,,CHEMBL4112175,6.39,False,http://www.openphacts.org/units/Nanomolar,2894944,=,37,True,=,,IC50,nM,,405.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,405.0
431774,17791882,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1sc(C(C)Nc2ncc(F)c(N3C(=O)OC[C@@H]3[C@@H](C)OC(C)(C)C)n2)nc1-c1ccc(Cl)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '10.25', 'le': '0.21', 'lle': '-0.93', 'sei': '6.12'}",CHEMBL4106664,,CHEMBL4106664,5.47,False,http://www.openphacts.org/units/Nanomolar,2894945,=,37,True,=,,IC50,nM,,3350.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3350.0
431775,17791883,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)OC(C)(C)C)n1)c1nc(-c2ccc(Br)cc2)cs1,,,CHEMBL3886939,,2016.0,"{'bei': '9.84', 'le': '0.22', 'lle': '-0.65', 'sei': '6.21'}",CHEMBL4112250,,CHEMBL4112250,5.55,False,http://www.openphacts.org/units/Nanomolar,2894946,=,37,True,=,,IC50,nM,,2800.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2800.0
431776,17791884,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C1COC(=O)N1c1ccnc(N[C@@H](C)c2nc(-c3ccc(Cl)cc3)no2)n1)C(F)(F)F,,,CHEMBL3886939,,2016.0,"{'bei': '12.35', 'le': '0.25', 'lle': '1.08', 'sei': '5.61'}",CHEMBL3980188,,CHEMBL3980188,5.96,False,http://www.openphacts.org/units/Nanomolar,2894947,=,37,True,=,,IC50,nM,,1090.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1090.0
431777,17791885,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C1COC(=O)N1c1ccnc(N[C@@H](C)c2nc(-c3ccc(Cl)cc3)no2)n1)C(F)(F)F,,,CHEMBL3886939,,2016.0,"{'bei': '12.85', 'le': '0.26', 'lle': '1.32', 'sei': '5.84'}",CHEMBL3980188,,CHEMBL3980188,6.20,False,http://www.openphacts.org/units/Nanomolar,2894947,=,37,True,=,,IC50,nM,,627.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,627.0
431778,17791886,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C1COC(=O)N1c1ccnc(N[C@@H](C)c2nc(-c3ccc(Cl)cc3)no2)n1)C(F)(F)F,,,CHEMBL3886939,,2016.0,"{'bei': '16.15', 'le': '0.32', 'lle': '2.92', 'sei': '7.34'}",CHEMBL3980188,,CHEMBL3980188,7.80,False,http://www.openphacts.org/units/Nanomolar,2894947,=,37,True,=,,IC50,nM,,16.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,16.0
431779,17791887,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C1COC(=O)N1c1ccnc(N[C@@H](C)c2nc(-c3ccc(Cl)cc3)no2)n1)C(F)(F)F,,,CHEMBL3886939,,2016.0,"{'bei': '11.26', 'le': '0.22', 'lle': '0.56', 'sei': '5.12'}",CHEMBL3980188,,CHEMBL3980188,5.44,False,http://www.openphacts.org/units/Nanomolar,2894947,=,37,True,=,,IC50,nM,,3660.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3660.0
431780,17791888,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C1COC(=O)N1c1nc(N[C@@H](C)c2ccc(CO)c(F)c2)ncc1F)C(F)(F)F,,,CHEMBL3886939,,2016.0,"{'bei': '13.55', 'le': '0.27', 'lle': '2.11', 'sei': '6.91'}",CHEMBL3910230,,CHEMBL3910230,6.05,False,http://www.openphacts.org/units/Nanomolar,2894948,=,37,True,=,,IC50,nM,,891.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,891.0
431781,17791889,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2cccc(Cl)c2Cl)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '15.74', 'le': '0.32', 'lle': '3.36', 'sei': '6.60'}",CHEMBL4111396,,CHEMBL4111396,7.48,False,http://www.openphacts.org/units/Nanomolar,2894949,=,37,True,=,,IC50,nM,,33.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,33.0
431782,17791890,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccccc1,,,CHEMBL3886939,,2016.0,"{'bei': '17.82', 'le': '0.33', 'lle': '3.49', 'sei': '6.68'}",CHEMBL3932532,,CHEMBL3932532,5.85,False,http://www.openphacts.org/units/Nanomolar,2894950,=,37,True,=,,IC50,nM,,1410.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1410.0
431783,17791891,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(OC(F)(F)F)c(Cl)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '10.82', 'le': '0.22', 'lle': '1.61', 'sei': '4.10'}",CHEMBL4109008,,CHEMBL4109008,5.57,False,http://www.openphacts.org/units/Nanomolar,2894951,=,37,True,=,,IC50,nM,,2690.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2690.0
431784,17791892,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(OC(F)(F)F)c(Cl)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '14.10', 'le': '0.28', 'lle': '3.30', 'sei': '5.35'}",CHEMBL4109008,,CHEMBL4109008,7.26,False,http://www.openphacts.org/units/Nanomolar,2894951,=,37,True,=,,IC50,nM,,55.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,55.0
431785,17791893,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(F)cc1-c1cnc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)nc1,,,CHEMBL3886939,,2016.0,"{'bei': '15.27', 'le': '0.29', 'lle': '3.43', 'sei': '5.91'}",CHEMBL4114968,,CHEMBL4114968,6.70,False,http://www.openphacts.org/units/Nanomolar,2894952,=,37,True,=,,IC50,nM,,202.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,202.0
431786,17791894,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2ccc(C(F)(F)F)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '14.24', 'le': '0.27', 'lle': '2.93', 'sei': '5.96'}",CHEMBL4108591,,CHEMBL4108591,6.76,False,http://www.openphacts.org/units/Nanomolar,2894953,=,37,True,=,,IC50,nM,,175.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,175.0
431787,17791895,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cnc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)nc2)ccc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.05', 'le': '0.28', 'lle': '3.34', 'sei': '5.82'}",CHEMBL4110531,,CHEMBL4110531,6.60,False,http://www.openphacts.org/units/Nanomolar,2894954,=,37,True,=,,IC50,nM,,253.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,253.0
431788,17791896,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(C(C)(C)C)cn1,,,CHEMBL3886939,,2016.0,,CHEMBL4108175,,CHEMBL4108175,,False,http://www.openphacts.org/units/Nanomolar,2894955,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
431789,17791897,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(Oc2ccccc2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '17.93', 'le': '0.33', 'lle': '3.39', 'sei': '7.79'}",CHEMBL3934588,,CHEMBL3934588,7.54,False,http://www.openphacts.org/units/Nanomolar,2894956,=,37,True,=,,IC50,nM,,29.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,29.0
431790,17791898,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(Oc2ccc(F)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '13.62', 'le': '0.26', 'lle': '2.92', 'sei': '4.89'}",CHEMBL4111672,,CHEMBL4111672,6.00,False,http://www.openphacts.org/units/Nanomolar,2894957,=,37,True,=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1000.0
431791,17791899,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)O)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '12.99', 'le': '0.25', 'lle': '2.54', 'sei': '4.42'}",CHEMBL3903450,,CHEMBL3903450,5.60,False,http://www.openphacts.org/units/Nanomolar,2894958,=,37,True,=,,IC50,nM,,2530.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2530.0
431792,17791900,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnc(-c2cccc(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '15.77', 'le': '0.30', 'lle': '3.65', 'sei': '6.60'}",CHEMBL3974384,,CHEMBL3974384,7.48,False,http://www.openphacts.org/units/Nanomolar,2894959,=,37,True,=,,IC50,nM,,33.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,33.0
431793,17791901,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(O)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN(C)C(C)(C)C3)c(F)c2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '13.02', 'le': '0.25', 'lle': '3.31', 'sei': '6.73'}",CHEMBL3946813,,CHEMBL3946813,6.33,False,http://www.openphacts.org/units/Nanomolar,2894960,=,37,True,=,,IC50,nM,,463.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,463.0
431794,17791902,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2ccc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)nc2)ccc1F,,,CHEMBL3886939,,2016.0,"{'bei': '16.99', 'le': '0.32', 'lle': '3.56', 'sei': '7.40'}",CHEMBL3941489,,CHEMBL3941489,7.43,False,http://www.openphacts.org/units/Nanomolar,2894961,=,37,True,=,,IC50,nM,,37.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,37.0
431795,17791903,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2cccc(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '16.66', 'le': '0.32', 'lle': '3.45', 'sei': '7.85'}",CHEMBL3980106,,CHEMBL3980106,7.89,False,http://www.openphacts.org/units/Nanomolar,2894962,=,37,True,=,,IC50,nM,,13.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,13.0
431796,17791904,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2ccc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)cn2)ccc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.26', 'le': '0.29', 'lle': '2.81', 'sei': '6.65'}",CHEMBL3974345,,CHEMBL3974345,6.68,False,http://www.openphacts.org/units/Nanomolar,2894963,=,37,True,=,,IC50,nM,,210.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,210.0
431797,17791905,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2cccc(C(F)(F)F)c2)nc1,,,CHEMBL3886939,,2016.0,"{'bei': '15.49', 'le': '0.29', 'lle': '2.89', 'sei': '7.30'}",CHEMBL3895367,,CHEMBL3895367,7.33,False,http://www.openphacts.org/units/Nanomolar,2894964,=,37,True,=,,IC50,nM,,46.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,46.5
431798,17791906,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cnc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)cn2)ccc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.82', 'le': '0.30', 'lle': '3.68', 'sei': '6.12'}",CHEMBL3955523,,CHEMBL3955523,6.94,False,http://www.openphacts.org/units/Nanomolar,2894965,=,37,True,=,,IC50,nM,,116.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,116.0
431799,17791907,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2ccnc(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '13.82', 'le': '0.26', 'lle': '2.72', 'sei': '5.78'}",CHEMBL3970058,,CHEMBL3970058,6.55,False,http://www.openphacts.org/units/Nanomolar,2894966,=,37,True,=,,IC50,nM,,279.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,279.0
431800,17791908,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2ccc(C(F)(F)F)nc2)nc1,,,CHEMBL3886939,,2016.0,"{'bei': '11.67', 'le': '0.22', 'lle': '1.70', 'sei': '4.88'}",CHEMBL3963135,,CHEMBL3963135,5.54,False,http://www.openphacts.org/units/Nanomolar,2894967,=,37,True,=,,IC50,nM,,2920.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2920.0
431801,17791909,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2ccc(C(F)(F)F)nc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '12.43', 'le': '0.24', 'lle': '2.07', 'sei': '5.20'}",CHEMBL3986908,,CHEMBL3986908,5.90,False,http://www.openphacts.org/units/Nanomolar,2894968,=,37,True,=,,IC50,nM,,1270.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1270.0
431802,17791910,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2cccc(C(F)(F)F)n2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '15.95', 'le': '0.30', 'lle': '3.74', 'sei': '6.68'}",CHEMBL3981557,,CHEMBL3981557,7.57,False,http://www.openphacts.org/units/Nanomolar,2894969,=,37,True,=,,IC50,nM,,27.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,27.0
431803,17791911,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)ncc1-c1ccnc(C(F)(F)F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '14.51', 'le': '0.28', 'lle': '2.95', 'sei': '6.25'}",CHEMBL3949375,,CHEMBL3949375,7.09,False,http://www.openphacts.org/units/Nanomolar,2894970,=,37,True,=,,IC50,nM,,82.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,82.0
431804,17791912,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2ccnc(C(F)(F)F)c2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '12.10', 'le': '0.23', 'lle': '1.99', 'sei': '5.26'}",CHEMBL3973540,,CHEMBL3973540,5.96,False,http://www.openphacts.org/units/Nanomolar,2894971,=,37,True,=,,IC50,nM,,1100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1100.0
431805,17791913,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2ccnc(C(F)(F)F)c2)cnc1[C@H](C)Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1,,,CHEMBL3886939,,2016.0,"{'bei': '13.32', 'le': '0.25', 'lle': '2.36', 'sei': '5.74'}",CHEMBL3944057,,CHEMBL3944057,6.50,False,http://www.openphacts.org/units/Nanomolar,2894972,=,37,True,=,,IC50,nM,,313.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,313.0
431806,17791914,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1nc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)ccc1-c1ccnc(C(F)(F)F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '12.79', 'le': '0.24', 'lle': '2.11', 'sei': '5.51'}",CHEMBL3897899,,CHEMBL3897899,6.25,False,http://www.openphacts.org/units/Nanomolar,2894973,=,37,True,=,,IC50,nM,,564.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,564.5
431807,17791915,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2ccnc(C(C)(C)C)c2)cn1,,,CHEMBL3886939,,2016.0,,CHEMBL3972554,,CHEMBL3972554,,False,http://www.openphacts.org/units/Nanomolar,2894974,<,37,True,<,,IC50,nM,,15.9,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,15.9
431808,17791916,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2ccnc(C(C)(C)C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,,CHEMBL3986728,,CHEMBL3986728,,False,http://www.openphacts.org/units/Nanomolar,2894975,<,37,True,<,,IC50,nM,,15.9,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,15.9
431809,17791917,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(C#N)cc2)cs1,,,CHEMBL3886939,,2016.0,"{'bei': '13.97', 'le': '0.27', 'lle': '2.75', 'sei': '4.91'}",CHEMBL3958036,,CHEMBL3958036,6.10,False,http://www.openphacts.org/units/Nanomolar,2894976,=,37,True,=,,IC50,nM,,797.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,797.0
431810,17791918,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)cc2)on1,,,CHEMBL3886939,,2016.0,"{'bei': '16.62', 'le': '0.33', 'lle': '3.49', 'sei': '6.29'}",CHEMBL3891227,,CHEMBL3891227,7.15,False,http://www.openphacts.org/units/Nanomolar,2894977,=,37,True,=,,IC50,nM,,71.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,71.5
431811,17791919,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(Cl)cc2Cl)cs1,,,CHEMBL3886939,,2016.0,"{'bei': '12.48', 'le': '0.26', 'lle': '1.21', 'sei': '5.97'}",CHEMBL4111043,,CHEMBL4111043,6.00,False,http://www.openphacts.org/units/Nanomolar,2894978,=,37,True,=,,IC50,nM,,1010.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1010.0
431812,17791920,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(Cl)cc2Cl)cs1,,,CHEMBL3886939,,2016.0,"{'bei': '15.20', 'le': '0.32', 'lle': '2.51', 'sei': '7.27'}",CHEMBL3980854,,CHEMBL3980854,7.30,False,http://www.openphacts.org/units/Nanomolar,2894979,=,37,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
431813,17791921,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(Br)cc2)cs1,,,CHEMBL3886939,,2016.0,"{'bei': '12.63', 'le': '0.28', 'lle': '1.95', 'sei': '6.17'}",CHEMBL4114449,,CHEMBL4114449,6.19,False,http://www.openphacts.org/units/Nanomolar,2894980,=,37,True,=,,IC50,nM,,639.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,639.0
431814,17791922,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(Br)cc2)cs1,,,CHEMBL3886939,,2016.0,"{'bei': '14.55', 'le': '0.32', 'lle': '2.90', 'sei': '7.10'}",CHEMBL3923916,,CHEMBL3923916,7.14,False,http://www.openphacts.org/units/Nanomolar,2894981,=,37,True,=,,IC50,nM,,73.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,73.0
431815,17791923,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(C#N)cc2)cs1,,,CHEMBL3886939,,2016.0,,CHEMBL4113247,,CHEMBL4113247,,False,http://www.openphacts.org/units/Nanomolar,2894982,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
431816,17791924,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cnn(-c2ccc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)cc2F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '15.81', 'le': '0.30', 'lle': '3.75', 'sei': '6.40'}",CHEMBL4114399,,CHEMBL4114399,6.74,False,http://www.openphacts.org/units/Nanomolar,2894983,=,37,True,=,,IC50,nM,,181.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,181.0
431817,17791925,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnc(-c2cccc(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '12.20', 'le': '0.23', 'lle': '1.96', 'sei': '5.11'}",CHEMBL4113642,,CHEMBL4113642,5.79,False,http://www.openphacts.org/units/Nanomolar,2894984,=,37,True,=,,IC50,nM,,1630.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1630.0
431818,17791926,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cnc([C@@H](C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)cn2)ccc1F,,,CHEMBL3886939,,2016.0,"{'bei': '12.03', 'le': '0.23', 'lle': '2.01', 'sei': '4.65'}",CHEMBL4106764,,CHEMBL4106764,5.28,False,http://www.openphacts.org/units/Nanomolar,2894985,=,37,True,=,,IC50,nM,,5310.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5310.0
431819,17791927,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2ccc(F)c(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '15.09', 'le': '0.29', 'lle': '3.46', 'sei': '6.56'}",CHEMBL3905290,,CHEMBL3905290,7.43,False,http://www.openphacts.org/units/Nanomolar,2894986,=,37,True,=,,IC50,nM,,37.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,37.0
431820,17791928,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2ccc(Cl)c(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '15.17', 'le': '0.30', 'lle': '3.24', 'sei': '6.81'}",CHEMBL3976075,,CHEMBL3976075,7.72,False,http://www.openphacts.org/units/Nanomolar,2894987,=,37,True,=,,IC50,nM,,19.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,19.0
431821,17791929,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2ccc(Cl)c(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '12.13', 'le': '0.24', 'lle': '1.69', 'sei': '5.44'}",CHEMBL4113552,,CHEMBL4113552,6.17,False,http://www.openphacts.org/units/Nanomolar,2894988,=,37,True,=,,IC50,nM,,672.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,672.5
431822,17791930,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1ncc(-c2ccc(Cl)c(Cl)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '15.41', 'le': '0.31', 'lle': '3.20', 'sei': '6.46'}",CHEMBL3954956,,CHEMBL3954956,7.32,False,http://www.openphacts.org/units/Nanomolar,2894989,=,37,True,=,,IC50,nM,,47.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,47.5
431823,17791931,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2ccc(Cl)c(Cl)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '12.02', 'le': '0.24', 'lle': '1.59', 'sei': '5.04'}",CHEMBL4110091,,CHEMBL4110091,5.71,False,http://www.openphacts.org/units/Nanomolar,2894990,=,37,True,=,,IC50,nM,,1930.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1930.0
431824,17791932,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2cccc(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '15.58', 'le': '0.30', 'lle': '3.56', 'sei': '6.52'}",CHEMBL3983576,,CHEMBL3983576,7.39,False,http://www.openphacts.org/units/Nanomolar,2894991,=,37,True,=,,IC50,nM,,40.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,40.5
431825,17791933,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2cccc(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '10.91', 'le': '0.21', 'lle': '1.34', 'sei': '4.56'}",CHEMBL4109628,,CHEMBL4109628,5.17,False,http://www.openphacts.org/units/Nanomolar,2894992,=,37,True,=,,IC50,nM,,6690.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6690.0
431826,17791934,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cnc([C@H](C)Nc3nccc(N4C(=O)OCC4[C@@H](C)O)n3)nc2)ccc1Cl,,,CHEMBL3886939,,2016.0,"{'bei': '15.99', 'le': '0.31', 'lle': '3.51', 'sei': '6.42'}",CHEMBL3969422,,CHEMBL3969422,7.28,False,http://www.openphacts.org/units/Nanomolar,2894993,=,37,True,=,,IC50,nM,,53.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,53.0
431827,17791935,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cnc([C@@H](C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)nc2)ccc1Cl,,,CHEMBL3886939,,2016.0,"{'bei': '12.90', 'le': '0.25', 'lle': '2.10', 'sei': '5.18'}",CHEMBL4107785,,CHEMBL4107785,5.87,False,http://www.openphacts.org/units/Nanomolar,2894994,=,37,True,=,,IC50,nM,,1360.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1360.0
431828,17791936,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1ncc(-c2cc(Cl)cc(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '14.68', 'le': '0.29', 'lle': '2.99', 'sei': '6.59'}",CHEMBL3894775,,CHEMBL3894775,7.47,False,http://www.openphacts.org/units/Nanomolar,2894995,=,37,True,=,,IC50,nM,,34.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,34.0
431829,17791937,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1ncc(-c2cc(Cl)cc(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '12.90', 'le': '0.26', 'lle': '2.08', 'sei': '5.79'}",CHEMBL4113024,,CHEMBL4113024,6.56,False,http://www.openphacts.org/units/Nanomolar,2894996,=,37,True,=,,IC50,nM,,274.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,274.0
431830,17791938,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '12.15', 'le': '0.24', 'lle': '2.17', 'sei': '4.14'}",CHEMBL3940942,,CHEMBL3940942,5.24,False,http://www.openphacts.org/units/Nanomolar,2894997,=,37,True,=,,IC50,nM,,5825.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5825.0
431831,17791939,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '15.48', 'le': '0.30', 'lle': '3.61', 'sei': '5.27'}",CHEMBL4108363,,CHEMBL4108363,6.67,False,http://www.openphacts.org/units/Nanomolar,2894998,=,37,True,=,,IC50,nM,,213.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,213.0
431832,17791940,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nnc(-c2ccc(F)cc2)o1,,,CHEMBL3886939,,2016.0,"{'bei': '11.65', 'le': '0.22', 'lle': '2.29', 'sei': '3.82'}",CHEMBL4114500,,CHEMBL4114500,4.83,False,http://www.openphacts.org/units/Nanomolar,2894999,=,37,True,=,,IC50,nM,,14900.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,14900.0
431833,17791941,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nnc(-c2ccc(F)cc2)o1,,,CHEMBL3886939,,2016.0,"{'bei': '14.03', 'le': '0.26', 'lle': '3.28', 'sei': '4.60'}",CHEMBL4109491,,CHEMBL4109491,5.82,False,http://www.openphacts.org/units/Nanomolar,2895000,=,37,True,=,,IC50,nM,,1530.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1530.0
431834,17791942,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(CCOc2ccccc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '13.65', 'le': '0.26', 'lle': '3.65', 'sei': '4.43'}",CHEMBL4108530,,CHEMBL4108530,6.01,False,http://www.openphacts.org/units/Nanomolar,2895001,=,37,True,=,,IC50,nM,,972.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,972.0
431835,17791943,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2nnc(C(C)Nc3nccc(N4C(=O)OCC4[C@@H](C)O)n3)o2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '15.73', 'le': '0.29', 'lle': '3.74', 'sei': '5.10'}",CHEMBL4109504,,CHEMBL4109504,6.46,False,http://www.openphacts.org/units/Nanomolar,2895002,=,37,True,=,,IC50,nM,,351.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,351.0
431836,17791944,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2nnc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)o2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '12.20', 'le': '0.23', 'lle': '2.30', 'sei': '3.96'}",CHEMBL4114305,,CHEMBL4114305,5.01,False,http://www.openphacts.org/units/Nanomolar,2895003,=,37,True,=,,IC50,nM,,9790.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,9790.0
431837,17791945,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(-c2nnc(C(C)Nc3nccc(N4C(=O)OCC4[C@@H](C)O)n3)o2)c1,,,CHEMBL3886939,,2016.0,,CHEMBL4112998,,CHEMBL4112998,,False,http://www.openphacts.org/units/Nanomolar,2895004,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
431838,17791946,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(-c2nnc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)o2)c1,,,CHEMBL3886939,,2016.0,"{'bei': '13.68', 'le': '0.26', 'lle': '2.90', 'sei': '4.44'}",CHEMBL4109178,,CHEMBL4109178,5.61,False,http://www.openphacts.org/units/Nanomolar,2895005,=,37,True,=,,IC50,nM,,2430.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2430.0
431839,17791947,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1-c1nnc(C(C)Nc2nccc(N3C(=O)OCC3[C@@H](C)O)n2)o1,,,CHEMBL3886939,,2016.0,,CHEMBL4109986,,CHEMBL4109986,,False,http://www.openphacts.org/units/Nanomolar,2895006,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
431840,17791948,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1-c1nnc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)o1,,,CHEMBL3886939,,2016.0,"{'bei': '14.41', 'le': '0.27', 'lle': '3.20', 'sei': '4.67'}",CHEMBL4108730,,CHEMBL4108730,5.91,False,http://www.openphacts.org/units/Nanomolar,2895007,=,37,True,=,,IC50,nM,,1220.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1220.0
431841,17791949,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1sc(C(C)Nc2nccc(N3C(=O)OCC3[C@@H](C)O)n2)nc1-c1ccc(Cl)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '10.72', 'le': '0.22', 'lle': '0.49', 'sei': '4.91'}",CHEMBL4106771,,CHEMBL4106771,4.93,False,http://www.openphacts.org/units/Nanomolar,2895008,=,37,True,=,,IC50,nM,,11700.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,11700.0
431842,17791950,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1sc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)nc1-c1ccc(Cl)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '15.04', 'le': '0.30', 'lle': '2.48', 'sei': '6.89'}",CHEMBL4112249,,CHEMBL4112249,6.92,False,http://www.openphacts.org/units/Nanomolar,2895009,=,37,True,=,,IC50,nM,,120.8,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,120.8
431843,17791951,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nnc(-c2cccc(F)c2)o1,,,CHEMBL3886939,,2016.0,,CHEMBL4109729,,CHEMBL4109729,,False,http://www.openphacts.org/units/Nanomolar,2895010,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
431844,17791952,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nnc(-c2cccc(F)c2)o1,,,CHEMBL3886939,,2016.0,"{'bei': '13.41', 'le': '0.25', 'lle': '3.02', 'sei': '4.39'}",CHEMBL4106793,,CHEMBL4106793,5.56,False,http://www.openphacts.org/units/Nanomolar,2895011,=,37,True,=,,IC50,nM,,2780.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2780.0
431845,17791953,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nnc(-c2cccnc2)o1,,,CHEMBL3886939,,2016.0,,CHEMBL4111104,,CHEMBL4111104,,False,http://www.openphacts.org/units/Nanomolar,2895012,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
431846,17791954,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nnc(-c2cccnc2)o1,,,CHEMBL3886939,,2016.0,,CHEMBL4107386,,CHEMBL4107386,,False,http://www.openphacts.org/units/Nanomolar,2895013,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
431847,17791955,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1noc(Cc2ccccc2)n1,,,CHEMBL3886939,,2016.0,,CHEMBL4110975,,CHEMBL4110975,,False,http://www.openphacts.org/units/Nanomolar,2895014,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
431848,17791956,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1noc(Cc2ccccc2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '12.43', 'le': '0.23', 'lle': '2.77', 'sei': '4.03'}",CHEMBL4109470,,CHEMBL4109470,5.10,False,http://www.openphacts.org/units/Nanomolar,2895015,=,37,True,=,,IC50,nM,,7890.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,7890.0
431849,17791957,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OCC2[C@@H](C)O)n1)c1noc(Cc2ccccc2)n1,,,CHEMBL3886939,,2016.0,,CHEMBL4113072,,CHEMBL4113072,,False,http://www.openphacts.org/units/Nanomolar,2895016,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
431850,17791958,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1noc(Cc2ccccc2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '13.66', 'le': '0.26', 'lle': '3.38', 'sei': '4.63'}",CHEMBL4112948,,CHEMBL4112948,5.85,False,http://www.openphacts.org/units/Nanomolar,2895017,=,37,True,=,,IC50,nM,,1410.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1410.0
431851,17791959,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccc(Br)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '11.46', 'le': '0.25', 'lle': '2.28', 'sei': '4.31'}",CHEMBL4110035,,CHEMBL4110035,5.45,False,http://www.openphacts.org/units/Nanomolar,2895018,=,37,True,=,,IC50,nM,,3560.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3560.0
431852,17791960,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(Br)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '15.46', 'le': '0.33', 'lle': '4.18', 'sei': '5.81'}",CHEMBL4114429,,CHEMBL4114429,7.35,False,http://www.openphacts.org/units/Nanomolar,2895019,=,37,True,=,,IC50,nM,,45.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,45.0
431853,17791961,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)n2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.73', 'le': '0.30', 'lle': '3.89', 'sei': '5.33'}",CHEMBL4112995,,CHEMBL4112995,6.74,False,http://www.openphacts.org/units/Nanomolar,2895020,=,37,True,=,,IC50,nM,,182.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,182.0
431854,17791962,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2noc(C(C)Nc3ncc(F)c(N4C(=O)OCC4[C@@H](C)O)n3)n2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '14.41', 'le': '0.27', 'lle': '3.44', 'sei': '5.08'}",CHEMBL4112147,,CHEMBL4112147,6.43,False,http://www.openphacts.org/units/Nanomolar,2895021,=,37,True,=,,IC50,nM,,370.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,370.0
431855,17791963,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2noc(C(C)Nc3ncc(F)c(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)n2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '16.84', 'le': '0.32', 'lle': '4.53', 'sei': '5.94'}",CHEMBL4112957,,CHEMBL4112957,7.52,False,http://www.openphacts.org/units/Nanomolar,2895022,=,37,True,=,,IC50,nM,,30.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,30.5
431856,17791964,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccc(F)c(F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '10.93', 'le': '0.21', 'lle': '2.05', 'sei': '3.74'}",CHEMBL4109718,,CHEMBL4109718,4.73,False,http://www.openphacts.org/units/Nanomolar,2895023,=,37,True,=,,IC50,nM,,18800.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,18800.0
431857,17791965,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(F)c(F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '15.73', 'le': '0.30', 'lle': '4.12', 'sei': '5.38'}",CHEMBL4113399,,CHEMBL4113399,6.80,False,http://www.openphacts.org/units/Nanomolar,2895024,=,37,True,=,,IC50,nM,,158.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,158.0
431858,17791966,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)c(Cl)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '14.13', 'le': '0.29', 'lle': '2.24', 'sei': '5.78'}",CHEMBL4106862,,CHEMBL4106862,6.56,False,http://www.openphacts.org/units/Nanomolar,2895025,=,37,True,=,,IC50,nM,,274.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,274.0
431859,17791967,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)c(Cl)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '16.14', 'le': '0.33', 'lle': '3.17', 'sei': '6.60'}",CHEMBL4113911,,CHEMBL4113911,7.50,False,http://www.openphacts.org/units/Nanomolar,2895026,=,37,True,=,,IC50,nM,,32.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,32.0
431860,17791968,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)cc2Cl)no1,,,CHEMBL3886939,,2016.0,"{'bei': '15.72', 'le': '0.32', 'lle': '2.98', 'sei': '6.43'}",CHEMBL4115076,,CHEMBL4115076,7.30,False,http://www.openphacts.org/units/Nanomolar,2895027,=,37,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
431861,17791969,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)cc2Cl)no1,,,CHEMBL3886939,,2016.0,"{'bei': '12.37', 'le': '0.25', 'lle': '1.42', 'sei': '5.06'}",CHEMBL4115076,,CHEMBL4115076,5.75,False,http://www.openphacts.org/units/Nanomolar,2895027,=,37,True,=,,IC50,nM,,1800.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1800.0
431862,17791970,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccc(F)c(F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '12.92', 'le': '0.25', 'lle': '3.00', 'sei': '4.60'}",CHEMBL4110375,,CHEMBL4110375,5.82,False,http://www.openphacts.org/units/Nanomolar,2895028,=,37,True,=,,IC50,nM,,1510.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1510.0
431863,17791971,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(F)c(F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '16.10', 'le': '0.31', 'lle': '4.43', 'sei': '5.73'}",CHEMBL4106922,,CHEMBL4106922,7.25,False,http://www.openphacts.org/units/Nanomolar,2895029,=,37,True,=,,IC50,nM,,56.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,56.0
431864,17791972,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OCC2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)c(Cl)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '12.48', 'le': '0.26', 'lle': '1.56', 'sei': '5.30'}",CHEMBL4108085,,CHEMBL4108085,6.02,False,http://www.openphacts.org/units/Nanomolar,2895030,=,37,True,=,,IC50,nM,,956.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,956.0
431865,17791973,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)c(Cl)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '16.91', 'le': '0.35', 'lle': '3.69', 'sei': '7.18'}",CHEMBL4107257,,CHEMBL4107257,8.15,False,http://www.openphacts.org/units/Nanomolar,2895031,=,37,True,=,,IC50,nM,,7.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,7.0
431866,17791974,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OCC2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)cc2Cl)no1,,,CHEMBL3886939,,2016.0,"{'bei': '12.10', 'le': '0.25', 'lle': '1.38', 'sei': '5.14'}",CHEMBL4108905,,CHEMBL4108905,5.84,False,http://www.openphacts.org/units/Nanomolar,2895032,=,37,True,=,,IC50,nM,,1460.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1460.0
431867,17791975,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)cc2Cl)no1,,,CHEMBL3886939,,2016.0,"{'bei': '16.50', 'le': '0.34', 'lle': '3.50', 'sei': '7.01'}",CHEMBL4109329,,CHEMBL4109329,7.96,False,http://www.openphacts.org/units/Nanomolar,2895033,=,37,True,=,,IC50,nM,,11.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,11.0
431868,17791976,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccc(F)c(Cl)c2)cs1,,,CHEMBL3886939,,2016.0,"{'bei': '10.66', 'le': '0.22', 'lle': '0.68', 'sei': '4.92'}",CHEMBL4110198,,CHEMBL4110198,4.95,False,http://www.openphacts.org/units/Nanomolar,2895034,=,37,True,=,,IC50,nM,,11300.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,11300.0
431869,17791977,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(F)c(Cl)c2)cs1,,,CHEMBL3886939,,2016.0,"{'bei': '12.77', 'le': '0.26', 'lle': '1.65', 'sei': '5.90'}",CHEMBL4113298,,CHEMBL4113298,5.92,False,http://www.openphacts.org/units/Nanomolar,2895035,=,37,True,=,,IC50,nM,,1190.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1190.0
431870,17791978,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OCC2[C@@H](C)O)n1)c1ncc(-c2cccc(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '16.09', 'le': '0.31', 'lle': '3.95', 'sei': '6.99'}",CHEMBL4107825,,CHEMBL4107825,7.92,False,http://www.openphacts.org/units/Nanomolar,2895036,=,37,True,=,,IC50,nM,,12.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,12.0
431871,17791979,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2cccc(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '13.37', 'le': '0.26', 'lle': '2.62', 'sei': '5.81'}",CHEMBL4111352,,CHEMBL4111352,6.58,False,http://www.openphacts.org/units/Nanomolar,2895037,=,37,True,=,,IC50,nM,,260.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,260.0
431872,17791980,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1cnc(-c2ccccc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '12.09', 'le': '0.23', 'lle': '1.49', 'sei': '4.95'}",CHEMBL4113146,,CHEMBL4113146,4.97,False,http://www.openphacts.org/units/Nanomolar,2895038,=,37,True,=,,IC50,nM,,10600.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,10600.0
431873,17791981,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnc(-c2ccccc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '15.02', 'le': '0.29', 'lle': '2.70', 'sei': '6.15'}",CHEMBL4106644,,CHEMBL4106644,6.18,False,http://www.openphacts.org/units/Nanomolar,2895039,=,37,True,=,,IC50,nM,,660.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,660.0
431874,17791982,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2cccc(Cl)c2)no1,,,CHEMBL3886939,,2016.0,,CHEMBL4114894,,CHEMBL4114894,,False,http://www.openphacts.org/units/Nanomolar,2895040,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
431875,17791983,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2cccc(Cl)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '14.21', 'le': '0.28', 'lle': '3.06', 'sei': '4.84'}",CHEMBL4106699,,CHEMBL4106699,6.12,False,http://www.openphacts.org/units/Nanomolar,2895041,=,37,True,=,,IC50,nM,,756.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,756.0
431876,17791984,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)c1ccc(-c2noc(C(C)Nc3nccc(N4C(=O)OCC4[C@@H](C)O)n3)n2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '13.18', 'le': '0.25', 'lle': '2.25', 'sei': '4.57'}",CHEMBL4113742,,CHEMBL4113742,5.78,False,http://www.openphacts.org/units/Nanomolar,2895042,=,37,True,=,,IC50,nM,,1670.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1670.0
431877,17791985,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)c1ccc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)n2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '17.56', 'le': '0.33', 'lle': '4.17', 'sei': '6.09'}",CHEMBL4110669,,CHEMBL4110669,7.70,False,http://www.openphacts.org/units/Nanomolar,2895043,=,37,True,=,,IC50,nM,,20.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,20.0
431878,17791986,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2noc(C(C)Nc3nccc(N4C(=O)OCC4[C@@H](C)O)n3)n2)ccc1F,,,CHEMBL3886939,,2016.0,"{'bei': '11.71', 'le': '0.22', 'lle': '2.17', 'sei': '3.97'}",CHEMBL4115631,,CHEMBL4115631,5.02,False,http://www.openphacts.org/units/Nanomolar,2895044,=,37,True,=,,IC50,nM,,9590.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,9590.0
431879,17791987,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)n2)ccc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.67', 'le': '0.30', 'lle': '3.86', 'sei': '5.31'}",CHEMBL4107361,,CHEMBL4107361,6.71,False,http://www.openphacts.org/units/Nanomolar,2895045,=,37,True,=,,IC50,nM,,194.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,194.0
431880,17791988,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(-c2noc(C(C)Nc3ncc(F)c(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)n2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '16.64', 'le': '0.31', 'lle': '4.25', 'sei': '5.82'}",CHEMBL4115160,,CHEMBL4115160,7.36,False,http://www.openphacts.org/units/Nanomolar,2895046,=,37,True,=,,IC50,nM,,43.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,43.5
431881,17791989,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2nnc(C(C)Nc3nccc(N4C(=O)OCC4[C@@H](C)O)n3)o2)cc1C,,,CHEMBL3886939,,2016.0,"{'bei': '12.30', 'le': '0.23', 'lle': '2.20', 'sei': '4.13'}",CHEMBL4107474,,CHEMBL4107474,5.22,False,http://www.openphacts.org/units/Nanomolar,2895047,=,37,True,=,,IC50,nM,,5990.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5990.0
431882,17791990,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2nnc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)o2)cc1C,,,CHEMBL3886939,,2016.0,"{'bei': '15.27', 'le': '0.29', 'lle': '3.46', 'sei': '5.12'}",CHEMBL4109054,,CHEMBL4109054,6.48,False,http://www.openphacts.org/units/Nanomolar,2895048,=,37,True,=,,IC50,nM,,329.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,329.0
431883,17791991,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2cccc3ccncc23)no1,,,CHEMBL3886939,,2016.0,"{'bei': '12.84', 'le': '0.24', 'lle': '2.80', 'sei': '4.12'}",CHEMBL4111649,,CHEMBL4111649,5.75,False,http://www.openphacts.org/units/Nanomolar,2895049,=,37,True,=,,IC50,nM,,1790.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1790.0
431884,17791992,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2cccc3ccncc23)no1,,,CHEMBL3886939,,2016.0,"{'bei': '13.68', 'le': '0.25', 'lle': '3.17', 'sei': '4.39'}",CHEMBL4111093,,CHEMBL4111093,6.12,False,http://www.openphacts.org/units/Nanomolar,2895050,=,37,True,=,,IC50,nM,,756.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,756.0
431885,17791993,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccc(Cl)cc2C(F)(F)F)no1,,,CHEMBL3886939,,2016.0,"{'bei': '11.16', 'le': '0.22', 'lle': '1.49', 'sei': '4.40'}",CHEMBL4114521,,CHEMBL4114521,5.57,False,http://www.openphacts.org/units/Nanomolar,2895051,=,37,True,=,,IC50,nM,,2700.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2700.0
431886,17791994,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(Cl)cc2C(F)(F)F)no1,,,CHEMBL3886939,,2016.0,"{'bei': '15.00', 'le': '0.30', 'lle': '3.40', 'sei': '5.91'}",CHEMBL4107415,,CHEMBL4107415,7.48,False,http://www.openphacts.org/units/Nanomolar,2895052,=,37,True,=,,IC50,nM,,33.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,33.0
431887,17791995,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)c1ccc(-c2noc(C(C)Nc3ncc(F)c(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)n2)cc1,,,CHEMBL3886939,,2016.0,,CHEMBL4114088,,CHEMBL4114088,,False,http://www.openphacts.org/units/Nanomolar,2895053,<,37,True,<,,IC50,nM,,15.9,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,15.9
431888,17791996,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2cccc(C(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '12.73', 'le': '0.24', 'lle': '2.49', 'sei': '4.67'}",CHEMBL4112846,,CHEMBL4112846,5.91,False,http://www.openphacts.org/units/Nanomolar,2895054,=,37,True,=,,IC50,nM,,1230.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1230.0
431889,17791997,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2cccc(C(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '14.65', 'le': '0.28', 'lle': '3.38', 'sei': '5.38'}",CHEMBL4110857,,CHEMBL4110857,6.80,False,http://www.openphacts.org/units/Nanomolar,2895055,=,37,True,=,,IC50,nM,,158.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,158.0
431890,17791998,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccc(F)c(OC(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '10.92', 'le': '0.21', 'lle': '2.00', 'sei': '4.01'}",CHEMBL4113541,,CHEMBL4113541,5.44,False,http://www.openphacts.org/units/Nanomolar,2895056,=,37,True,=,,IC50,nM,,3620.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3620.0
431891,17791999,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(F)c(OC(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '14.25', 'le': '0.28', 'lle': '3.66', 'sei': '5.23'}",CHEMBL4114277,,CHEMBL4114277,7.10,False,http://www.openphacts.org/units/Nanomolar,2895057,=,37,True,=,,IC50,nM,,79.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,79.0
431892,17792000,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2cccc(OC(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '11.53', 'le': '0.22', 'lle': '2.32', 'sei': '3.93'}",CHEMBL4115210,,CHEMBL4115210,5.33,False,http://www.openphacts.org/units/Nanomolar,2895058,=,37,True,=,,IC50,nM,,4680.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4680.0
431893,17792001,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2cccc(OC(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '14.74', 'le': '0.28', 'lle': '3.81', 'sei': '5.02'}",CHEMBL4108442,,CHEMBL4108442,6.82,False,http://www.openphacts.org/units/Nanomolar,2895059,=,37,True,=,,IC50,nM,,152.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,152.0
431894,17792002,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,COc1cc(-c2noc(C(C)Nc3nccc(N4C(=O)OCC4[C@@H](C)O)n3)n2)ccc1Cl,,,CHEMBL3886939,,2016.0,"{'bei': '13.15', 'le': '0.26', 'lle': '2.99', 'sei': '4.46'}",CHEMBL4112148,,CHEMBL4112148,6.06,False,http://www.openphacts.org/units/Nanomolar,2895060,=,37,True,=,,IC50,nM,,871.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,871.0
431895,17792003,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,COc1cc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)n2)ccc1Cl,,,CHEMBL3886939,,2016.0,"{'bei': '14.93', 'le': '0.29', 'lle': '3.81', 'sei': '5.07'}",CHEMBL4113375,,CHEMBL4113375,6.88,False,http://www.openphacts.org/units/Nanomolar,2895061,=,37,True,=,,IC50,nM,,131.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,131.0
431896,17792004,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccc3c(c2)OC(F)(F)O3)no1,,,CHEMBL3886939,,2016.0,"{'bei': '11.53', 'le': '0.22', 'lle': '2.76', 'sei': '3.79'}",CHEMBL4112200,,CHEMBL4112200,5.50,False,http://www.openphacts.org/units/Nanomolar,2895062,=,37,True,=,,IC50,nM,,3200.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3200.0
431897,17792005,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc3c(c2)OC(F)(F)O3)no1,,,CHEMBL3886939,,2016.0,"{'bei': '15.58', 'le': '0.30', 'lle': '4.69', 'sei': '5.12'}",CHEMBL4115358,,CHEMBL4115358,7.42,False,http://www.openphacts.org/units/Nanomolar,2895063,=,37,True,=,,IC50,nM,,38.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,38.0
431898,17792006,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccc(Cl)c(C(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '10.89', 'le': '0.22', 'lle': '1.35', 'sei': '4.29'}",CHEMBL4109518,,CHEMBL4109518,5.43,False,http://www.openphacts.org/units/Nanomolar,2895064,=,37,True,=,,IC50,nM,,3690.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3690.0
431899,17792007,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(Cl)c(C(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '14.54', 'le': '0.29', 'lle': '3.17', 'sei': '5.73'}",CHEMBL4106763,,CHEMBL4106763,7.25,False,http://www.openphacts.org/units/Nanomolar,2895065,=,37,True,=,,IC50,nM,,56.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,56.0
431900,17792008,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)n2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '16.94', 'le': '0.32', 'lle': '4.22', 'sei': '5.68'}",CHEMBL4114607,,CHEMBL4114607,7.19,False,http://www.openphacts.org/units/Nanomolar,2895066,=,37,True,=,,IC50,nM,,64.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,64.5
431901,17792009,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccc(C(F)(F)F)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '14.29', 'le': '0.27', 'lle': '3.22', 'sei': '5.25'}",CHEMBL4111513,,CHEMBL4111513,6.64,False,http://www.openphacts.org/units/Nanomolar,2895067,=,37,True,=,,IC50,nM,,230.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,230.0
431902,17792010,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(C(F)(F)F)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '13.74', 'le': '0.26', 'lle': '2.96', 'sei': '5.04'}",CHEMBL4110960,,CHEMBL4110960,6.38,False,http://www.openphacts.org/units/Nanomolar,2895068,=,37,True,=,,IC50,nM,,418.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,418.0
431903,17792011,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(CCc2ccccc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '11.56', 'le': '0.22', 'lle': '2.39', 'sei': '3.88'}",CHEMBL4114215,,CHEMBL4114215,4.91,False,http://www.openphacts.org/units/Nanomolar,2895069,=,37,True,=,,IC50,nM,,12400.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,12400.0
431904,17792012,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(CCc2ccccc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '13.92', 'le': '0.26', 'lle': '3.39', 'sei': '4.67'}",CHEMBL4110130,,CHEMBL4110130,5.91,False,http://www.openphacts.org/units/Nanomolar,2895070,=,37,True,=,,IC50,nM,,1230.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1230.0
431905,17792013,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccc(Cl)c(OC(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '12.08', 'le': '0.24', 'lle': '2.34', 'sei': '4.74'}",CHEMBL4113355,,CHEMBL4113355,6.44,False,http://www.openphacts.org/units/Nanomolar,2895071,=,37,True,=,,IC50,nM,,364.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,364.0
431906,17792014,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(Cl)c(OC(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '15.30', 'le': '0.31', 'lle': '4.05', 'sei': '6.01'}",CHEMBL4106576,,CHEMBL4106576,8.15,False,http://www.openphacts.org/units/Nanomolar,2895072,=,37,True,=,,IC50,nM,,7.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,7.0
431907,17792015,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccc(OC(F)(F)F)cc2)no1,,,CHEMBL3886939,,2016.0,,CHEMBL4112369,,CHEMBL4112369,,False,http://www.openphacts.org/units/Nanomolar,2895073,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
431908,17792016,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(OC(F)(F)F)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '14.28', 'le': '0.28', 'lle': '3.56', 'sei': '5.05'}",CHEMBL4110433,,CHEMBL4110433,6.86,False,http://www.openphacts.org/units/Nanomolar,2895074,=,37,True,=,,IC50,nM,,138.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,138.0
431909,17792017,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2cccc(OCC(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '11.56', 'le': '0.22', 'lle': '2.37', 'sei': '4.21'}",CHEMBL4109825,,CHEMBL4109825,5.72,False,http://www.openphacts.org/units/Nanomolar,2895075,=,37,True,=,,IC50,nM,,1920.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1920.0
431910,17792018,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2cccc(OCC(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '13.94', 'le': '0.27', 'lle': '3.54', 'sei': '5.08'}",CHEMBL4108222,,CHEMBL4108222,6.89,False,http://www.openphacts.org/units/Nanomolar,2895076,=,37,True,=,,IC50,nM,,128.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,128.0
431911,17792019,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1nc(C(C)Nc2nccc(N3C(=O)OCC3[C@@H](C)O)n2)oc1-c1ccc(Cl)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '14.19', 'le': '0.28', 'lle': '2.33', 'sei': '5.54'}",CHEMBL4106800,,CHEMBL4106800,6.30,False,http://www.openphacts.org/units/Nanomolar,2895077,=,37,True,=,,IC50,nM,,502.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,502.0
431912,17792020,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1nc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)oc1-c1ccc(Cl)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '17.21', 'le': '0.34', 'lle': '3.67', 'sei': '6.72'}",CHEMBL4114144,,CHEMBL4114144,7.64,False,http://www.openphacts.org/units/Nanomolar,2895078,=,37,True,=,,IC50,nM,,23.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,23.0
431913,17792021,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1nc(C(C)Nc2ncc(F)c(N3C(=O)OCC3[C@@H](C)O)n2)oc1-c1ccc(Cl)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '12.15', 'le': '0.24', 'lle': '1.50', 'sei': '4.94'}",CHEMBL4115671,,CHEMBL4115671,5.61,False,http://www.openphacts.org/units/Nanomolar,2895079,=,37,True,=,,IC50,nM,,2450.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2450.0
431914,17792022,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1nc(C(C)Nc2ncc(F)c(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)oc1-c1ccc(Cl)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '16.58', 'le': '0.33', 'lle': '3.55', 'sei': '6.74'}",CHEMBL4114829,,CHEMBL4114829,7.66,False,http://www.openphacts.org/units/Nanomolar,2895080,=,37,True,=,,IC50,nM,,22.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,22.0
431915,17792023,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1sc(C(C)Nc2nccc(N3C(=O)OCC3[C@@H](C)O)n2)nc1-c1ccc(Cl)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '11.04', 'le': '0.22', 'lle': '0.64', 'sei': '5.05'}",CHEMBL4106771,,CHEMBL4106771,5.08,False,http://www.openphacts.org/units/Nanomolar,2895081,=,37,True,=,,IC50,nM,,8380.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,8380.0
431916,17792024,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1sc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)nc1-c1ccc(Cl)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '15.64', 'le': '0.32', 'lle': '2.75', 'sei': '7.16'}",CHEMBL4112249,,CHEMBL4112249,7.19,False,http://www.openphacts.org/units/Nanomolar,2895082,=,37,True,=,,IC50,nM,,64.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,64.0
431917,17792025,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccc(Br)cc2)cs1,,,CHEMBL3886939,,2016.0,"{'bei': '14.62', 'le': '0.33', 'lle': '3.05', 'sei': '7.40'}",CHEMBL4108741,,CHEMBL4108741,7.43,False,http://www.openphacts.org/units/Nanomolar,2895083,=,37,True,=,,IC50,nM,,37.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,37.0
431918,17792026,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(Br)cc2)cs1,,,CHEMBL3886939,,2016.0,,CHEMBL4111529,,CHEMBL4111529,,False,http://www.openphacts.org/units/Nanomolar,2895084,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
431919,17792027,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cnc(C(C)Nc3nccc(N4C(=O)OCC4[C@@H](C)O)n3)nc2)ccc1C(F)(F)F,,,CHEMBL3886939,,2016.0,"{'bei': '14.93', 'le': '0.28', 'lle': '3.15', 'sei': '6.43'}",CHEMBL4106559,,CHEMBL4106559,7.29,False,http://www.openphacts.org/units/Nanomolar,2895085,=,37,True,=,,IC50,nM,,51.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,51.0
431920,17792028,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cnc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)nc2)ccc1C(F)(F)F,,,CHEMBL3886939,,2016.0,"{'bei': '11.33', 'le': '0.22', 'lle': '1.39', 'sei': '4.88'}",CHEMBL4108823,,CHEMBL4108823,5.53,False,http://www.openphacts.org/units/Nanomolar,2895086,=,37,True,=,,IC50,nM,,2930.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2930.0
431921,17792029,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1nc(C(C)Nc2nccc(N3C(=O)OCC3[C@H](C)O)n2)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1,,,CHEMBL3886939,,2016.0,,CHEMBL3984716,,CHEMBL3984716,,False,http://www.openphacts.org/units/Nanomolar,2895087,<,37,True,<,,IC50,nM,,15.9,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,15.9
431922,17792030,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1nc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '10.62', 'le': '0.21', 'lle': '0.68', 'sei': '5.03'}",CHEMBL4114954,,CHEMBL4114954,5.70,False,http://www.openphacts.org/units/Nanomolar,2895088,=,37,True,=,,IC50,nM,,2010.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2010.0
431923,17792031,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1nc(C(C)Nc2ncc(F)c(N3C(=O)OCC3[C@H](C)O)n2)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '13.88', 'le': '0.28', 'lle': '2.54', 'sei': '6.79'}",CHEMBL3970574,,CHEMBL3970574,7.70,False,http://www.openphacts.org/units/Nanomolar,2895089,=,37,True,=,,IC50,nM,,20.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,20.0
431924,17792032,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1nc(C(C)Nc2ncc(F)c(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '10.68', 'le': '0.21', 'lle': '0.76', 'sei': '5.22'}",CHEMBL4107381,,CHEMBL4107381,5.92,False,http://www.openphacts.org/units/Nanomolar,2895090,=,37,True,=,,IC50,nM,,1200.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1200.0
431925,17792033,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1ncc(-c2cccc(C(F)(F)F)c2F)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '14.96', 'le': '0.29', 'lle': '3.40', 'sei': '6.50'}",CHEMBL4112644,,CHEMBL4112644,7.37,False,http://www.openphacts.org/units/Nanomolar,2895091,=,37,True,=,,IC50,nM,,43.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,43.0
431926,17792034,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2cccc(C(F)(F)F)c2F)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '13.13', 'le': '0.25', 'lle': '2.49', 'sei': '5.70'}",CHEMBL4113460,,CHEMBL4113460,6.46,False,http://www.openphacts.org/units/Nanomolar,2895092,=,37,True,=,,IC50,nM,,344.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,344.0
431927,17792035,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OCC2[C@@H](C)O)n1)c1ncc(-c2ccc(Cl)cc2)o1,,,CHEMBL3886939,,2016.0,"{'bei': '12.89', 'le': '0.25', 'lle': '1.97', 'sei': '5.08'}",CHEMBL4109380,,CHEMBL4109380,5.78,False,http://www.openphacts.org/units/Nanomolar,2895093,=,37,True,=,,IC50,nM,,1680.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1680.0
431928,17792036,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2ccc(Cl)cc2)o1,,,CHEMBL3886939,,2016.0,"{'bei': '17.41', 'le': '0.34', 'lle': '4.00', 'sei': '6.86'}",CHEMBL4113331,,CHEMBL4113331,7.80,False,http://www.openphacts.org/units/Nanomolar,2895094,=,37,True,=,,IC50,nM,,16.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,16.0
431929,17792037,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '17.15', 'le': '0.34', 'lle': '3.71', 'sei': '6.49'}",CHEMBL4109964,,CHEMBL4109964,7.37,False,http://www.openphacts.org/units/Nanomolar,2895095,=,37,True,=,,IC50,nM,,42.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,42.5
431930,17792038,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '12.95', 'le': '0.25', 'lle': '1.91', 'sei': '4.90'}",CHEMBL4114321,,CHEMBL4114321,5.57,False,http://www.openphacts.org/units/Nanomolar,2895096,=,37,True,=,,IC50,nM,,2700.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2700.0
431931,17792039,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2ccc(Cl)cc2)o1,,,CHEMBL3886939,,2016.0,"{'bei': '17.20', 'le': '0.34', 'lle': '3.73', 'sei': '6.51'}",CHEMBL3986787,,CHEMBL3986787,7.39,False,http://www.openphacts.org/units/Nanomolar,2895097,=,37,True,=,,IC50,nM,,40.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,40.5
431932,17792040,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '17.10', 'le': '0.35', 'lle': '4.25', 'sei': '6.29'}",CHEMBL3961739,,CHEMBL3961739,7.96,False,http://www.openphacts.org/units/Nanomolar,2895098,=,37,True,=,,IC50,nM,,11.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,11.0
431933,17792041,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(C(F)(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.59', 'le': '0.32', 'lle': '2.83', 'sei': '7.99'}",CHEMBL3925345,,CHEMBL3925345,7.00,False,http://www.openphacts.org/units/Nanomolar,2895099,=,37,True,=,,IC50,nM,,101.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,101.0
431934,17792042,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2cnn(C)c2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.32', 'le': '0.30', 'lle': '3.51', 'sei': '6.70'}",CHEMBL3953027,,CHEMBL3953027,7.06,False,http://www.openphacts.org/units/Nanomolar,2895100,=,37,True,=,,IC50,nM,,87.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,87.0
431935,17792043,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(C(F)F)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '14.17', 'le': '0.28', 'lle': '2.82', 'sei': '5.39'}",CHEMBL3951946,,CHEMBL3951946,6.82,False,http://www.openphacts.org/units/Nanomolar,2895101,=,37,True,=,,IC50,nM,,153.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,153.0
431936,17792044,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(N2C(=O)OC[C@@H]2[C@@H](C)O)cc(C(F)(F)F)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '12.64', 'le': '0.25', 'lle': '2.22', 'sei': '4.98'}",CHEMBL3914286,,CHEMBL3914286,6.30,False,http://www.openphacts.org/units/Nanomolar,2895102,=,37,True,=,,IC50,nM,,496.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,496.0
431937,17792045,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](c1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(F)c(-c2cnn(C)c2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '16.07', 'le': '0.32', 'lle': '3.79', 'sei': '7.99'}",CHEMBL3949812,,CHEMBL3949812,7.46,False,http://www.openphacts.org/units/Nanomolar,2895103,=,37,True,=,,IC50,nM,,35.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,35.0
431938,17792046,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OCC2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)cc2)on1,,,CHEMBL3886939,,2016.0,"{'bei': '17.14', 'le': '0.35', 'lle': '3.64', 'sei': '7.01'}",CHEMBL3920353,,CHEMBL3920353,7.96,False,http://www.openphacts.org/units/Nanomolar,2895104,=,37,True,=,,IC50,nM,,11.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,11.0
431939,17792047,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OCC2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)cc2)on1,,,CHEMBL3886939,,2016.0,"{'bei': '16.63', 'le': '0.34', 'lle': '3.40', 'sei': '6.80'}",CHEMBL3920353,,CHEMBL3920353,7.72,False,http://www.openphacts.org/units/Nanomolar,2895104,=,37,True,=,,IC50,nM,,19.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,19.0
431940,17792048,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(-c2ccccc2)on1,,,CHEMBL3886939,,2016.0,"{'bei': '17.07', 'le': '0.33', 'lle': '3.68', 'sei': '6.46'}",CHEMBL3956829,,CHEMBL3956829,7.34,False,http://www.openphacts.org/units/Nanomolar,2895105,=,37,True,=,,IC50,nM,,46.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,46.0
431941,17792049,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(F)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnn(-c2ccc(F)cc2)c1,,,CHEMBL3886939,,2016.0,"{'bei': '16.87', 'le': '0.32', 'lle': '4.44', 'sei': '6.89'}",CHEMBL3925850,,CHEMBL3925850,7.26,False,http://www.openphacts.org/units/Nanomolar,2895106,=,37,True,=,,IC50,nM,,55.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,55.0
431942,17792050,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnc(-c2ccc(Cl)cc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '17.48', 'le': '0.37', 'lle': '3.61', 'sei': '8.36'}",CHEMBL3962229,,CHEMBL3962229,8.40,False,http://www.openphacts.org/units/Nanomolar,2895107,=,37,True,=,,IC50,nM,,4.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4.0
431943,17792051,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnc(-c2ccc(Cl)cc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '16.49', 'le': '0.34', 'lle': '3.38', 'sei': '7.61'}",CHEMBL3934745,,CHEMBL3934745,7.65,False,http://www.openphacts.org/units/Nanomolar,2895108,=,37,True,=,,IC50,nM,,22.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,22.5
431944,17792052,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)cc2)on1,,,CHEMBL3886939,,2016.0,"{'bei': '17.24', 'le': '0.34', 'lle': '3.92', 'sei': '6.80'}",CHEMBL3973220,,CHEMBL3973220,7.72,False,http://www.openphacts.org/units/Nanomolar,2895109,=,37,True,=,,IC50,nM,,19.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,19.0
431945,17792053,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nnc(-c2ccc(Cl)cc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '16.32', 'le': '0.35', 'lle': '3.67', 'sei': '6.93'}",CHEMBL3947095,,CHEMBL3947095,7.85,False,http://www.openphacts.org/units/Nanomolar,2895110,=,37,True,=,,IC50,nM,,14.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,14.0
431946,17792054,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnn(-c2ccc(Cl)cc2)c1,,,CHEMBL3886939,,2016.0,"{'bei': '16.95', 'le': '0.35', 'lle': '4.00', 'sei': '7.45'}",CHEMBL3984447,,CHEMBL3984447,7.85,False,http://www.openphacts.org/units/Nanomolar,2895111,=,37,True,=,,IC50,nM,,14.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,14.0
431947,17792055,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnn(-c2ccc(Cl)cc2)c1,,,CHEMBL3886939,,2016.0,"{'bei': '16.14', 'le': '0.32', 'lle': '3.88', 'sei': '6.85'}",CHEMBL3955826,,CHEMBL3955826,7.21,False,http://www.openphacts.org/units/Nanomolar,2895112,=,37,True,=,,IC50,nM,,61.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,61.0
431948,17792056,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(CF)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)cc2)on1,,,CHEMBL3886939,,2016.0,"{'bei': '15.87', 'le': '0.31', 'lle': '3.20', 'sei': '6.45'}",CHEMBL3942030,,CHEMBL3942030,7.33,False,http://www.openphacts.org/units/Nanomolar,2895113,=,37,True,=,,IC50,nM,,47.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,47.0
431949,17792057,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(CF)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnc(-c2ccc(Cl)cc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '15.61', 'le': '0.32', 'lle': '2.86', 'sei': '7.43'}",CHEMBL3971609,,CHEMBL3971609,7.46,False,http://www.openphacts.org/units/Nanomolar,2895114,=,37,True,=,,IC50,nM,,34.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,34.5
431950,17792058,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1cnc(-c2ccc(Cl)cc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '16.90', 'le': '0.34', 'lle': '3.41', 'sei': '7.50'}",CHEMBL3956474,,CHEMBL3956474,7.54,False,http://www.openphacts.org/units/Nanomolar,2895115,=,37,True,=,,IC50,nM,,29.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,29.0
431951,17792059,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnc(-c2ccc(Cl)cc2)s1,,,CHEMBL3886939,,2016.0,,CHEMBL3889605,,CHEMBL3889605,,False,http://www.openphacts.org/units/Nanomolar,2895116,<,37,True,<,,IC50,nM,,16.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,16.0
431952,17792060,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1cnn(-c2ccc(Cl)cc2)c1,,,CHEMBL3886939,,2016.0,"{'bei': '17.33', 'le': '0.34', 'lle': '4.24', 'sei': '7.05'}",CHEMBL3986808,,CHEMBL3986808,7.43,False,http://www.openphacts.org/units/Nanomolar,2895117,=,37,True,=,,IC50,nM,,37.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,37.0
431953,17792061,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnn(-c2ccc(Cl)cc2)c1,,,CHEMBL3886939,,2016.0,"{'bei': '17.38', 'le': '0.34', 'lle': '4.27', 'sei': '7.07'}",CHEMBL3938198,,CHEMBL3938198,7.46,False,http://www.openphacts.org/units/Nanomolar,2895118,=,37,True,=,,IC50,nM,,35.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,35.0
431954,17792062,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '17.33', 'le': '0.35', 'lle': '3.73', 'sei': '7.08'}",CHEMBL3923174,,CHEMBL3923174,8.05,False,http://www.openphacts.org/units/Nanomolar,2895119,=,37,True,=,,IC50,nM,,9.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,9.0
431955,17792063,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '17.47', 'le': '0.34', 'lle': '4.02', 'sei': '6.89'}",CHEMBL3896034,,CHEMBL3896034,7.82,False,http://www.openphacts.org/units/Nanomolar,2895120,=,37,True,=,,IC50,nM,,15.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,15.0
431956,17792064,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(F)cc(N2C(=O)OCC2[C@@H](C)O)n1)c1cnn(-c2ccc(Cl)cc2)c1,,,CHEMBL3886939,,2016.0,"{'bei': '17.28', 'le': '0.34', 'lle': '4.39', 'sei': '7.33'}",CHEMBL3913635,,CHEMBL3913635,7.72,False,http://www.openphacts.org/units/Nanomolar,2895121,=,37,True,=,,IC50,nM,,19.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,19.0
431957,17792065,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(F)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnn(-c2ccc(Cl)cc2)c1,,,CHEMBL3886939,,2016.0,"{'bei': '17.33', 'le': '0.34', 'lle': '4.41', 'sei': '7.35'}",CHEMBL3955493,,CHEMBL3955493,7.75,False,http://www.openphacts.org/units/Nanomolar,2895122,=,37,True,=,,IC50,nM,,18.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,18.0
431958,17792066,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(-c2ccc(F)cc2)on1,,,CHEMBL3886939,,2016.0,"{'bei': '16.23', 'le': '0.32', 'lle': '3.47', 'sei': '6.40'}",CHEMBL3966360,,CHEMBL3966360,7.27,False,http://www.openphacts.org/units/Nanomolar,2895123,=,37,True,=,,IC50,nM,,54.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,54.0
431959,17792067,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(CN2CCOCC2)on1,,,CHEMBL3886939,,2016.0,,CHEMBL3908537,,CHEMBL3908537,,False,http://www.openphacts.org/units/Nanomolar,2895124,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
431960,17792068,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(CN2CCOCC2)on1,,,CHEMBL3886939,,2016.0,,CHEMBL4108428,,CHEMBL4108428,,False,http://www.openphacts.org/units/Nanomolar,2895125,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
431961,17792069,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(N2C(=O)OC[C@@H]2[C@@H](C)O)nc(N[C@@H](C)c2cnn(-c3ccc(Cl)cc3)c2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '17.20', 'le': '0.34', 'lle': '4.12', 'sei': '7.23'}",CHEMBL3902941,,CHEMBL3902941,7.62,False,http://www.openphacts.org/units/Nanomolar,2895126,=,37,True,=,,IC50,nM,,24.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,24.0
431962,17792070,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnc(-c2ccccn2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '14.37', 'le': '0.29', 'lle': '2.89', 'sei': '5.67'}",CHEMBL3979210,,CHEMBL3979210,6.42,False,http://www.openphacts.org/units/Nanomolar,2895127,=,37,True,=,,IC50,nM,,377.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,377.0
431963,17792071,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnc(-c2cccnc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '14.93', 'le': '0.30', 'lle': '3.14', 'sei': '5.89'}",CHEMBL3903388,,CHEMBL3903388,6.67,False,http://www.openphacts.org/units/Nanomolar,2895128,=,37,True,=,,IC50,nM,,213.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,213.0
431964,17792072,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnc(-c2ccncc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '13.46', 'le': '0.27', 'lle': '2.49', 'sei': '5.31'}",CHEMBL3909040,,CHEMBL3909040,6.02,False,http://www.openphacts.org/units/Nanomolar,2895129,=,37,True,=,,IC50,nM,,964.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,964.0
431965,17792073,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(N2C(=O)OC[C@@H]2[C@@H](C)O)nc(N[C@@H](C)c2cc(-c3ccc(Cl)cc3)on2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '16.85', 'le': '0.33', 'lle': '3.51', 'sei': '6.59'}",CHEMBL3891941,,CHEMBL3891941,7.48,False,http://www.openphacts.org/units/Nanomolar,2895130,=,37,True,=,,IC50,nM,,33.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,33.0
431966,17792074,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(N2C(=O)OC[C@@H]2[C@@H](C)O)nc(N[C@@H](C)c2cnc(-c3ccc(Cl)cc3)s2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '16.63', 'le': '0.34', 'lle': '3.21', 'sei': '7.61'}",CHEMBL3930450,,CHEMBL3930450,7.65,False,http://www.openphacts.org/units/Nanomolar,2895131,=,37,True,=,,IC50,nM,,22.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,22.5
431967,17792075,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(N2C(=O)OC[C@@H]2[C@@H](C)O)nc(N[C@@H](C)c2cn(-c3ccc(Cl)cc3)cn2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '17.36', 'le': '0.34', 'lle': '4.19', 'sei': '7.29'}",CHEMBL3945859,,CHEMBL3945859,7.69,False,http://www.openphacts.org/units/Nanomolar,2895132,=,37,True,=,,IC50,nM,,20.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,20.5
431968,17792076,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(N2C(=O)OC[C@@H]2[C@@H](C)O)nc(N[C@@H](C)c2nc(-c3ccc(Cl)cc3)no2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '16.35', 'le': '0.32', 'lle': '3.90', 'sei': '5.75'}",CHEMBL3917973,,CHEMBL3917973,7.27,False,http://www.openphacts.org/units/Nanomolar,2895133,=,37,True,=,,IC50,nM,,53.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,53.5
431969,17792077,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(N2C(=O)OC[C@@H]2[C@@H](C)O)nc(N[C@@H](C)c2ccn(-c3ccc(Cl)cc3)n2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '15.46', 'le': '0.30', 'lle': '3.35', 'sei': '6.50'}",CHEMBL3913801,,CHEMBL3913801,6.85,False,http://www.openphacts.org/units/Nanomolar,2895134,=,37,True,=,,IC50,nM,,142.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,142.0
431970,17792078,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(N2C(=O)OC[C@@H]2[C@@H](C)O)nc(N[C@@H](C)c2cn(-c3ccc(Cl)cc3)nn2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '15.64', 'le': '0.31', 'lle': '4.04', 'sei': '5.87'}",CHEMBL3901258,,CHEMBL3901258,6.94,False,http://www.openphacts.org/units/Nanomolar,2895135,=,37,True,=,,IC50,nM,,114.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,114.0
431971,17792079,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cn(-c2ccc(Cl)cc2)nn1,,,CHEMBL3886939,,2016.0,"{'bei': '15.89', 'le': '0.32', 'lle': '4.14', 'sei': '6.24'}",CHEMBL3970111,,CHEMBL3970111,7.38,False,http://www.openphacts.org/units/Nanomolar,2895136,=,37,True,=,,IC50,nM,,42.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,42.0
431972,17792080,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cn(-c2ccc(Cl)cc2)nn1,,,CHEMBL3886939,,2016.0,"{'bei': '15.94', 'le': '0.31', 'lle': '4.26', 'sei': '5.79'}",CHEMBL3920306,,CHEMBL3920306,6.85,False,http://www.openphacts.org/units/Nanomolar,2895137,=,37,True,=,,IC50,nM,,141.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,141.0
431973,17792081,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(N2C(=O)OC[C@@H]2[C@@H](C)O)nc(N[C@@H](C)c2ccc(C(C)(F)F)cc2F)n1,,,CHEMBL3886939,,2016.0,"{'bei': '15.37', 'le': '0.30', 'lle': '2.61', 'sei': '7.45'}",CHEMBL3890116,,CHEMBL3890116,6.52,False,http://www.openphacts.org/units/Nanomolar,2895138,=,37,True,=,,IC50,nM,,300.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,300.0
431974,17792082,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(N2C(=O)OC[C@@H]2[C@@H](C)O)nc(N[C@@H](C)c2cc(F)c(OCC(F)(F)F)cc2F)n1,,,CHEMBL3886939,,2016.0,"{'bei': '14.57', 'le': '0.29', 'lle': '3.06', 'sei': '7.17'}",CHEMBL3918178,,CHEMBL3918178,6.94,False,http://www.openphacts.org/units/Nanomolar,2895139,=,37,True,=,,IC50,nM,,115.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,115.0
431975,17792083,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2ncc([C@H](C)Nc3nc(C)cc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)s2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '14.90', 'le': '0.29', 'lle': '3.07', 'sei': '5.79'}",CHEMBL3950349,,CHEMBL3950349,6.56,False,http://www.openphacts.org/units/Nanomolar,2895140,=,37,True,=,,IC50,nM,,273.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,273.0
431976,17792084,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnc(-c2ccc(C(F)(F)F)nc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '14.78', 'le': '0.29', 'lle': '3.21', 'sei': '6.27'}",CHEMBL3912716,,CHEMBL3912716,7.10,False,http://www.openphacts.org/units/Nanomolar,2895141,=,37,True,=,,IC50,nM,,79.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,79.0
431977,17792085,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnc(-c2ccnc(C(F)(F)F)c2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '14.08', 'le': '0.28', 'lle': '2.87', 'sei': '5.97'}",CHEMBL3945074,,CHEMBL3945074,6.76,False,http://www.openphacts.org/units/Nanomolar,2895142,=,37,True,=,,IC50,nM,,172.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,172.0
431978,17792086,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1cc(N2C(=O)OC[C@@H]2[C@@H](C)O)nc(N[C@@H](C)c2cnc(-c3ccc(Cl)cc3)s2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '12.30', 'le': '0.25', 'lle': '2.28', 'sei': '4.89'}",CHEMBL3974495,,CHEMBL3974495,6.20,False,http://www.openphacts.org/units/Nanomolar,2895143,=,37,True,=,,IC50,nM,,635.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,635.0
431979,17792087,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1nc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)cn1-c1ccc(Cl)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '16.81', 'le': '0.33', 'lle': '3.94', 'sei': '7.06'}",CHEMBL3985154,,CHEMBL3985154,7.44,False,http://www.openphacts.org/units/Nanomolar,2895144,=,37,True,=,,IC50,nM,,36.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,36.0
431980,17792088,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnc(-c2ccc(C(F)F)cc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '16.68', 'le': '0.33', 'lle': '3.28', 'sei': '7.66'}",CHEMBL3960143,,CHEMBL3960143,7.70,False,http://www.openphacts.org/units/Nanomolar,2895145,=,37,True,=,,IC50,nM,,20.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,20.0
431981,17792089,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(C(F)(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.71', 'le': '0.31', 'lle': '3.00', 'sei': '7.43'}",CHEMBL3918872,,CHEMBL3918872,6.51,False,http://www.openphacts.org/units/Nanomolar,2895146,=,37,True,=,,IC50,nM,,309.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,309.0
431982,17792090,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CCOC1(c2ccc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)c(F)c2)CC1,,,CHEMBL3886939,,2016.0,"{'bei': '16.17', 'le': '0.31', 'lle': '3.44', 'sei': '7.19'}",CHEMBL3890804,,CHEMBL3890804,6.96,False,http://www.openphacts.org/units/Nanomolar,2895147,=,37,True,=,,IC50,nM,,109.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,109.0
431983,17792091,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(C(=O)NC2CCCC2)c(Cl)c1,,,CHEMBL3886939,,2016.0,"{'bei': '13.99', 'le': '0.27', 'lle': '2.95', 'sei': '5.68'}",CHEMBL3927798,,CHEMBL3927798,6.63,False,http://www.openphacts.org/units/Nanomolar,2895148,=,37,True,=,,IC50,nM,,234.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,234.0
431984,17792092,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(C2(C#N)CC2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.43', 'le': '0.29', 'lle': '3.30', 'sei': '5.70'}",CHEMBL3903325,,CHEMBL3903325,6.35,False,http://www.openphacts.org/units/Nanomolar,2895149,=,37,True,=,,IC50,nM,,450.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,450.0
431985,17792093,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2cnn(C)c2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '14.64', 'le': '0.28', 'lle': '3.34', 'sei': '5.92'}",CHEMBL3975109,,CHEMBL3975109,6.24,False,http://www.openphacts.org/units/Nanomolar,2895150,=,37,True,=,,IC50,nM,,570.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,570.0
431986,17792094,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2cnn(C)c2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '14.50', 'le': '0.27', 'lle': '3.16', 'sei': '5.62'}",CHEMBL3945750,,CHEMBL3945750,5.92,False,http://www.openphacts.org/units/Nanomolar,2895151,=,37,True,=,,IC50,nM,,1200.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1200.0
431987,17792095,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2cn[nH]c2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '14.87', 'le': '0.28', 'lle': '3.25', 'sei': '5.27'}",CHEMBL3913391,,CHEMBL3913391,6.13,False,http://www.openphacts.org/units/Nanomolar,2895152,=,37,True,=,,IC50,nM,,737.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,737.0
431988,17792096,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OCC2[C@@H](C)O)n1)c1ccc(C(F)(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '16.14', 'le': '0.32', 'lle': '3.33', 'sei': '7.97'}",CHEMBL3943232,,CHEMBL3943232,6.98,False,http://www.openphacts.org/units/Nanomolar,2895153,=,37,True,=,,IC50,nM,,105.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,105.0
431989,17792097,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(C(F)(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '16.91', 'le': '0.33', 'lle': '3.66', 'sei': '8.35'}",CHEMBL3951033,,CHEMBL3951033,7.31,False,http://www.openphacts.org/units/Nanomolar,2895154,=,37,True,=,,IC50,nM,,49.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,49.0
431990,17792098,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(C2(C)CC2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '18.47', 'le': '0.35', 'lle': '3.85', 'sei': '8.45'}",CHEMBL3964333,,CHEMBL3964333,7.40,False,http://www.openphacts.org/units/Nanomolar,2895155,=,37,True,=,,IC50,nM,,40.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,40.0
431991,17792099,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)c1ccc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '18.52', 'le': '0.35', 'lle': '3.57', 'sei': '8.21'}",CHEMBL3924385,,CHEMBL3924385,7.19,False,http://www.openphacts.org/units/Nanomolar,2895156,=,37,True,=,,IC50,nM,,64.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,64.0
431992,17792100,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2cnn(C)c2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.88', 'le': '0.30', 'lle': '4.03', 'sei': '6.69'}",CHEMBL3919605,,CHEMBL3919605,7.06,False,http://www.openphacts.org/units/Nanomolar,2895157,=,37,True,=,,IC50,nM,,88.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,88.0
431993,17792101,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(C2(C)CC2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '18.77', 'le': '0.36', 'lle': '4.16', 'sei': '8.97'}",CHEMBL3947403,,CHEMBL3947403,7.85,False,http://www.openphacts.org/units/Nanomolar,2895158,=,37,True,=,,IC50,nM,,14.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,14.0
431994,17792102,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2cn[nH]c2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.84', 'le': '0.30', 'lle': '3.80', 'sei': '5.86'}",CHEMBL3925057,,CHEMBL3925057,6.82,False,http://www.openphacts.org/units/Nanomolar,2895159,=,37,True,=,,IC50,nM,,152.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,152.0
431995,17792103,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(C(C)(C)O)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.02', 'le': '0.29', 'lle': '3.48', 'sei': '5.88'}",CHEMBL3903722,,CHEMBL3903722,6.34,False,http://www.openphacts.org/units/Nanomolar,2895160,=,37,True,=,,IC50,nM,,453.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,453.0
431996,17792104,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(F)c(-c2cnn(C)c2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.83', 'le': '0.30', 'lle': '4.15', 'sei': '6.94'}",CHEMBL3961440,,CHEMBL3961440,7.32,False,http://www.openphacts.org/units/Nanomolar,2895161,=,37,True,=,,IC50,nM,,48.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,48.0
431997,17792105,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)O)n1)c1cnc(-c2ccc(Cl)cc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '14.51', 'le': '0.29', 'lle': '2.34', 'sei': '6.44'}",CHEMBL3918376,,CHEMBL3918376,6.47,False,http://www.openphacts.org/units/Nanomolar,2895162,=,37,True,=,,IC50,nM,,338.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,338.0
431998,17792106,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(C(C)(C)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '14.97', 'le': '0.30', 'lle': '2.25', 'sei': '7.54'}",CHEMBL3917063,,CHEMBL3917063,6.60,False,http://www.openphacts.org/units/Nanomolar,2895163,=,37,True,=,,IC50,nM,,251.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,251.0
431999,17792107,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(Cl)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '14.59', 'le': '0.30', 'lle': '2.91', 'sei': '6.41'}",CHEMBL3927323,,CHEMBL3927323,6.76,False,http://www.openphacts.org/units/Nanomolar,2895164,=,37,True,=,,IC50,nM,,174.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,174.0
432000,17792108,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)c1cc(F)c([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)O)n2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.92', 'le': '0.30', 'lle': '2.71', 'sei': '7.39'}",CHEMBL3954948,,CHEMBL3954948,6.47,False,http://www.openphacts.org/units/Nanomolar,2895165,=,37,True,=,,IC50,nM,,339.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,339.0
432001,17792109,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(O)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cc(F)c(Br)cc2F)n1,,,CHEMBL3886939,,2016.0,"{'bei': '15.64', 'le': '0.35', 'lle': '3.53', 'sei': '7.91'}",CHEMBL3889806,,CHEMBL3889806,6.93,False,http://www.openphacts.org/units/Nanomolar,2895166,=,37,True,=,,IC50,nM,,117.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,117.0
432002,17792110,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(Cl)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '16.95', 'le': '0.34', 'lle': '3.47', 'sei': '7.72'}",CHEMBL3971134,,CHEMBL3971134,6.76,False,http://www.openphacts.org/units/Nanomolar,2895167,=,37,True,=,,IC50,nM,,174.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,174.0
432003,17792111,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(Br)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '11.02', 'le': '0.25', 'lle': '2.11', 'sei': '4.87'}",CHEMBL3965934,,CHEMBL3965934,4.90,False,http://www.openphacts.org/units/Nanomolar,2895168,=,37,True,=,,IC50,nM,,12700.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,12700.0
432004,17792112,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(Br)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '12.24', 'le': '0.28', 'lle': '2.65', 'sei': '5.41'}",CHEMBL4115008,,CHEMBL4115008,5.44,False,http://www.openphacts.org/units/Nanomolar,2895169,=,37,True,=,,IC50,nM,,3640.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3640.0
432005,17792113,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '16.90', 'le': '0.33', 'lle': '4.39', 'sei': '6.00'}",CHEMBL3901219,,CHEMBL3901219,7.58,False,http://www.openphacts.org/units/Nanomolar,2895170,=,37,True,=,,IC50,nM,,26.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,26.0
432006,17792114,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(Br)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '12.60', 'le': '0.28', 'lle': '2.72', 'sei': '5.34'}",CHEMBL3984786,,CHEMBL3984786,5.37,False,http://www.openphacts.org/units/Nanomolar,2895171,=,37,True,=,,IC50,nM,,4270.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4270.0
432007,17792115,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(Br)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '16.17', 'le': '0.36', 'lle': '3.77', 'sei': '8.18'}",CHEMBL3968871,,CHEMBL3968871,7.17,False,http://www.openphacts.org/units/Nanomolar,2895172,=,37,True,=,,IC50,nM,,68.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,68.0
432008,17792116,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnc(C(C)(F)F)c(Cl)c1,,,CHEMBL3886939,,2016.0,"{'bei': '14.75', 'le': '0.30', 'lle': '2.93', 'sei': '6.54'}",CHEMBL3979817,,CHEMBL3979817,6.58,False,http://www.openphacts.org/units/Nanomolar,2895173,=,37,True,=,,IC50,nM,,266.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,266.0
432009,17792117,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnc(OCC(F)(F)F)c(Cl)c1,,,CHEMBL3886939,,2016.0,"{'bei': '15.16', 'le': '0.31', 'lle': '3.80', 'sei': '6.63'}",CHEMBL3912459,,CHEMBL3912459,7.28,False,http://www.openphacts.org/units/Nanomolar,2895174,=,37,True,=,,IC50,nM,,53.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,53.0
432010,17792118,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(Cl)cc1Cl,,,CHEMBL3886939,,2016.0,"{'bei': '17.93', 'le': '0.38', 'lle': '3.64', 'sei': '8.50'}",CHEMBL3908513,,CHEMBL3908513,7.44,False,http://www.openphacts.org/units/Nanomolar,2895175,=,37,True,=,,IC50,nM,,36.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,36.0
432011,17792119,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(Br)nc1,,,CHEMBL3886939,,2016.0,"{'bei': '13.25', 'le': '0.30', 'lle': '3.00', 'sei': '5.62'}",CHEMBL3932931,,CHEMBL3932931,5.65,False,http://www.openphacts.org/units/Nanomolar,2895176,=,37,True,=,,IC50,nM,,2250.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2250.0
432012,17792120,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(Cl)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '18.20', 'le': '0.37', 'lle': '3.97', 'sei': '8.29'}",CHEMBL3895987,,CHEMBL3895987,7.26,False,http://www.openphacts.org/units/Nanomolar,2895177,=,37,True,=,,IC50,nM,,55.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,55.0
432013,17792121,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(Br)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '13.32', 'le': '0.30', 'lle': '3.03', 'sei': '5.65'}",CHEMBL4113431,,CHEMBL4113431,5.68,False,http://www.openphacts.org/units/Nanomolar,2895178,=,37,True,=,,IC50,nM,,2110.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2110.0
432014,17792122,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(Cl)c(Cl)c1,,,CHEMBL3886939,,2016.0,"{'bei': '17.99', 'le': '0.38', 'lle': '3.67', 'sei': '8.53'}",CHEMBL3977830,,CHEMBL3977830,7.47,False,http://www.openphacts.org/units/Nanomolar,2895179,=,37,True,=,,IC50,nM,,34.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,34.0
432015,17792123,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnc(Cl)c(F)c1,,,CHEMBL3886939,,2016.0,,CHEMBL3965354,,CHEMBL3965354,,False,http://www.openphacts.org/units/Nanomolar,2895180,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
432016,17792124,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnc(Cl)c(Cl)c1,,,CHEMBL3886939,,2016.0,"{'bei': '13.77', 'le': '0.29', 'lle': '2.53', 'sei': '5.71'}",CHEMBL3919048,,CHEMBL3919048,5.73,False,http://www.openphacts.org/units/Nanomolar,2895181,=,37,True,=,,IC50,nM,,1850.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1850.0
432017,17792125,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(Cl)cc1Cl,,,CHEMBL3886939,,2016.0,,CHEMBL4107101,,CHEMBL4107101,,False,http://www.openphacts.org/units/Nanomolar,2895182,>,37,True,>,,IC50,nM,,7910.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,7910.0
432018,17792126,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(Cl)cc1Cl,,,CHEMBL3886939,,2016.0,"{'bei': '15.21', 'le': '0.32', 'lle': '3.13', 'sei': '6.30'}",CHEMBL3974305,,CHEMBL3974305,6.33,False,http://www.openphacts.org/units/Nanomolar,2895183,=,37,True,=,,IC50,nM,,466.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,466.0
432019,17792127,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(Cl)cc1Cl,,,CHEMBL3886939,,2016.0,,CHEMBL3896459,,CHEMBL3896459,,False,http://www.openphacts.org/units/Nanomolar,2895184,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
432020,17792128,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(OCC(F)(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '13.76', 'le': '0.28', 'lle': '3.12', 'sei': '6.02'}",CHEMBL3957664,,CHEMBL3957664,6.60,False,http://www.openphacts.org/units/Nanomolar,2895185,=,37,True,=,,IC50,nM,,251.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,251.0
432021,17792129,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccn(-c2ccc(Cl)cc2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '12.37', 'le': '0.24', 'lle': '2.20', 'sei': '5.25'}",CHEMBL4109017,,CHEMBL4109017,5.53,False,http://www.openphacts.org/units/Nanomolar,2895186,=,37,True,=,,IC50,nM,,2960.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2960.0
432022,17792130,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccn(-c2ccc(Cl)cc2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '17.23', 'le': '0.34', 'lle': '4.37', 'sei': '7.30'}",CHEMBL3942379,,CHEMBL3942379,7.70,False,http://www.openphacts.org/units/Nanomolar,2895187,=,37,True,=,,IC50,nM,,20.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,20.0
432023,17792131,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '14.19', 'le': '0.28', 'lle': '3.01', 'sei': '6.02'}",CHEMBL4113600,,CHEMBL4113600,6.34,False,http://www.openphacts.org/units/Nanomolar,2895188,=,37,True,=,,IC50,nM,,457.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,457.0
432024,17792132,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '17.90', 'le': '0.35', 'lle': '4.67', 'sei': '7.59'}",CHEMBL3911306,,CHEMBL3911306,8.00,False,http://www.openphacts.org/units/Nanomolar,2895189,=,37,True,=,,IC50,nM,,10.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,10.0
432025,17792133,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(F)c(OCC(F)(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.98', 'le': '0.32', 'lle': '3.97', 'sei': '7.93'}",CHEMBL3981306,,CHEMBL3981306,7.68,False,http://www.openphacts.org/units/Nanomolar,2895190,=,37,True,=,,IC50,nM,,21.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,21.0
432026,17792134,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OCC(F)(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.89', 'le': '0.31', 'lle': '3.77', 'sei': '7.59'}",CHEMBL3903875,,CHEMBL3903875,7.35,False,http://www.openphacts.org/units/Nanomolar,2895191,=,37,True,=,,IC50,nM,,45.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,45.0
432027,17792135,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OCC(F)(F)F)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '17.40', 'le': '0.34', 'lle': '4.47', 'sei': '8.31'}",CHEMBL3941791,,CHEMBL3941791,8.05,False,http://www.openphacts.org/units/Nanomolar,2895192,=,37,True,=,,IC50,nM,,9.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,9.0
432028,17792136,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccn(-c2ccc(F)cc2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '15.14', 'le': '0.29', 'lle': '3.70', 'sei': '6.18'}",CHEMBL3948296,,CHEMBL3948296,6.52,False,http://www.openphacts.org/units/Nanomolar,2895193,=,37,True,=,,IC50,nM,,304.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,304.0
432029,17792137,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OCC(F)(F)F)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '13.50', 'le': '0.26', 'lle': '3.18', 'sei': '5.48'}",CHEMBL3985326,,CHEMBL3985326,6.01,False,http://www.openphacts.org/units/Nanomolar,2895194,=,37,True,=,,IC50,nM,,968.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,968.0
432030,17792138,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OCC(F)(F)F)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '12.55', 'le': '0.25', 'lle': '2.76', 'sei': '5.10'}",CHEMBL4107582,,CHEMBL4107582,5.59,False,http://www.openphacts.org/units/Nanomolar,2895195,=,37,True,=,,IC50,nM,,2570.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2570.0
432031,17792139,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '17.28', 'le': '0.34', 'lle': '4.22', 'sei': '7.03'}",CHEMBL3893867,,CHEMBL3893867,7.41,False,http://www.openphacts.org/units/Nanomolar,2895196,=,37,True,=,,IC50,nM,,39.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,39.0
432032,17792140,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccn(-c2ccc(Cl)cc2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '16.64', 'le': '0.32', 'lle': '3.95', 'sei': '6.77'}",CHEMBL3909399,,CHEMBL3909399,7.14,False,http://www.openphacts.org/units/Nanomolar,2895197,=,37,True,=,,IC50,nM,,73.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,73.0
432033,17792141,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OCC2[C@@H](C)O)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '18.39', 'le': '0.38', 'lle': '4.67', 'sei': '8.09'}",CHEMBL3980822,,CHEMBL3980822,8.52,False,http://www.openphacts.org/units/Nanomolar,2895198,=,37,True,=,,IC50,nM,,3.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3.0
432034,17792142,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '18.39', 'le': '0.38', 'lle': '4.67', 'sei': '8.09'}",CHEMBL3979625,,CHEMBL3979625,8.52,False,http://www.openphacts.org/units/Nanomolar,2895199,=,37,True,=,,IC50,nM,,3.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3.0
432035,17792143,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccn(-c2ccc(F)cc2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '15.98', 'le': '0.31', 'lle': '3.81', 'sei': '6.78'}",CHEMBL3904714,,CHEMBL3904714,7.14,False,http://www.openphacts.org/units/Nanomolar,2895200,=,37,True,=,,IC50,nM,,72.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,72.0
432036,17792144,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(Cl)cc1Cl,,,CHEMBL3886939,,2016.0,"{'bei': '15.82', 'le': '0.33', 'lle': '2.63', 'sei': '7.18'}",CHEMBL3905837,,CHEMBL3905837,6.29,False,http://www.openphacts.org/units/Nanomolar,2895201,=,37,True,=,,IC50,nM,,518.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,518.0
432037,17792145,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(Cl)c(Cl)c1,,,CHEMBL3886939,,2016.0,"{'bei': '18.07', 'le': '0.38', 'lle': '3.52', 'sei': '8.20'}",CHEMBL3907620,,CHEMBL3907620,7.18,False,http://www.openphacts.org/units/Nanomolar,2895202,=,37,True,=,,IC50,nM,,66.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,66.0
432038,17792146,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccn(-c2ccc(Cl)cc2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '16.62', 'le': '0.34', 'lle': '3.85', 'sei': '7.30'}",CHEMBL3927758,,CHEMBL3927758,7.70,False,http://www.openphacts.org/units/Nanomolar,2895203,=,37,True,=,,IC50,nM,,20.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,20.0
432039,17792147,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(F)c(OCC(F)(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.02', 'le': '0.30', 'lle': '3.37', 'sei': '7.17'}",CHEMBL3922430,,CHEMBL3922430,6.95,False,http://www.openphacts.org/units/Nanomolar,2895204,=,37,True,=,,IC50,nM,,113.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,113.5
432040,17792148,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OCC(F)(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '14.56', 'le': '0.29', 'lle': '3.03', 'sei': '6.68'}",CHEMBL3944541,,CHEMBL3944541,6.47,False,http://www.openphacts.org/units/Nanomolar,2895205,=,37,True,=,,IC50,nM,,337.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,337.5
432041,17792149,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OCC(F)(F)F)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '15.04', 'le': '0.29', 'lle': '3.25', 'sei': '6.91'}",CHEMBL3911852,,CHEMBL3911852,6.68,False,http://www.openphacts.org/units/Nanomolar,2895206,=,37,True,=,,IC50,nM,,206.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,206.5
432042,17792150,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(Br)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '13.06', 'le': '0.29', 'lle': '2.82', 'sei': '5.31'}",CHEMBL3921199,,CHEMBL3921199,5.33,False,http://www.openphacts.org/units/Nanomolar,2895207,=,37,True,=,,IC50,nM,,4665.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4665.0
432043,17792151,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(Br)cn1,,,CHEMBL3886939,,2016.0,,CHEMBL4109915,,CHEMBL4109915,,False,http://www.openphacts.org/units/Nanomolar,2895208,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
432044,17792152,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(Cl)c(Cl)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '17.96', 'le': '0.38', 'lle': '3.66', 'sei': '8.51'}",CHEMBL3963108,,CHEMBL3963108,7.46,False,http://www.openphacts.org/units/Nanomolar,2895209,=,37,True,=,,IC50,nM,,35.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,35.0
432045,17792153,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cn(-c2cc(F)c([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)cc2F)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '14.33', 'le': '0.27', 'lle': '3.24', 'sei': '6.04'}",CHEMBL3973110,,CHEMBL3973110,6.37,False,http://www.openphacts.org/units/Nanomolar,2895210,=,37,True,=,,IC50,nM,,426.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,426.0
432046,17792154,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(Cl)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(Cl)c(Cl)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '17.54', 'le': '0.38', 'lle': '3.43', 'sei': '9.00'}",CHEMBL3978748,,CHEMBL3978748,7.89,False,http://www.openphacts.org/units/Nanomolar,2895211,=,37,True,=,,IC50,nM,,13.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,13.0
432047,17792155,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cc(F)c([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)cc2F)ccn1,,,CHEMBL3886939,,2016.0,"{'bei': '15.69', 'le': '0.30', 'lle': '3.15', 'sei': '7.11'}",CHEMBL3902081,,CHEMBL3902081,7.15,False,http://www.openphacts.org/units/Nanomolar,2895212,=,37,True,=,,IC50,nM,,71.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,71.5
432048,17792156,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2cc(F)c([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)cc2F)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '15.40', 'le': '0.29', 'lle': '3.02', 'sei': '6.98'}",CHEMBL3920505,,CHEMBL3920505,7.01,False,http://www.openphacts.org/units/Nanomolar,2895213,=,37,True,=,,IC50,nM,,96.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,96.5
432049,17792157,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(F)c(-c2ccnc(C(F)(F)F)c2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '14.77', 'le': '0.29', 'lle': '2.81', 'sei': '7.49'}",CHEMBL3892513,,CHEMBL3892513,7.52,False,http://www.openphacts.org/units/Nanomolar,2895214,=,37,True,=,,IC50,nM,,30.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,30.0
432050,17792158,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(F)c(-c2ccc(C(F)(F)F)nc2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '14.50', 'le': '0.28', 'lle': '2.68', 'sei': '7.35'}",CHEMBL3929409,,CHEMBL3929409,7.39,False,http://www.openphacts.org/units/Nanomolar,2895215,=,37,True,=,,IC50,nM,,41.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,41.0
432051,17792159,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)COc1ccc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '17.98', 'le': '0.34', 'lle': '3.81', 'sei': '7.44'}",CHEMBL3940419,,CHEMBL3940419,7.20,False,http://www.openphacts.org/units/Nanomolar,2895216,=,37,True,=,,IC50,nM,,63.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,63.0
432052,17792160,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc([C@H](C)Nc2ncc(F)c(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '16.80', 'le': '0.32', 'lle': '3.99', 'sei': '6.85'}",CHEMBL3934884,,CHEMBL3934884,6.63,False,http://www.openphacts.org/units/Nanomolar,2895217,=,37,True,=,,IC50,nM,,236.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,236.0
432053,17792161,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cccc(F)c1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.77', 'le': '0.30', 'lle': '3.11', 'sei': '6.56'}",CHEMBL3906931,,CHEMBL3906931,5.75,False,http://www.openphacts.org/units/Nanomolar,2895218,=,37,True,=,,IC50,nM,,1800.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1800.0
432054,17792162,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cccc(F)c1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.86', 'le': '0.31', 'lle': '3.29', 'sei': '6.92'}",CHEMBL3943854,,CHEMBL3943854,6.06,False,http://www.openphacts.org/units/Nanomolar,2895219,=,37,True,=,,IC50,nM,,863.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,863.0
432055,17792163,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(F)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '17.19', 'le': '0.33', 'lle': '3.80', 'sei': '7.50'}",CHEMBL3919446,,CHEMBL3919446,6.57,False,http://www.openphacts.org/units/Nanomolar,2895220,=,37,True,=,,IC50,nM,,268.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,268.0
432056,17792164,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '17.58', 'le': '0.34', 'lle': '3.95', 'sei': '7.67'}",CHEMBL3955964,,CHEMBL3955964,6.72,False,http://www.openphacts.org/units/Nanomolar,2895221,=,37,True,=,,IC50,nM,,190.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,190.0
432057,17792165,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(F)cc(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '15.67', 'le': '0.30', 'lle': '3.22', 'sei': '6.84'}",CHEMBL3928350,,CHEMBL3928350,5.99,False,http://www.openphacts.org/units/Nanomolar,2895222,=,37,True,=,,IC50,nM,,1020.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1020.0
432058,17792166,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(Cl)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2ccnc(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '11.82', 'le': '0.24', 'lle': '2.15', 'sei': '4.77'}",CHEMBL3981136,,CHEMBL3981136,6.03,False,http://www.openphacts.org/units/Nanomolar,2895223,=,37,True,=,,IC50,nM,,944.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,944.0
432059,17792167,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OCC(F)(F)F)nc1,,,CHEMBL3886939,,2016.0,"{'bei': '14.52', 'le': '0.28', 'lle': '3.64', 'sei': '5.90'}",CHEMBL3914536,,CHEMBL3914536,6.47,False,http://www.openphacts.org/units/Nanomolar,2895224,=,37,True,=,,IC50,nM,,341.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,341.0
432060,17792168,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(C(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.90', 'le': '0.31', 'lle': '3.02', 'sei': '7.52'}",CHEMBL3976299,,CHEMBL3976299,6.59,False,http://www.openphacts.org/units/Nanomolar,2895225,=,37,True,=,,IC50,nM,,257.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,257.0
432061,17792169,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OCC2[C@@H](C)O)n1)c1ccc(C(C)(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '17.40', 'le': '0.34', 'lle': '3.71', 'sei': '8.51'}",CHEMBL3951969,,CHEMBL3951969,7.46,False,http://www.openphacts.org/units/Nanomolar,2895226,=,37,True,=,,IC50,nM,,35.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,35.0
432062,17792170,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(C(C)(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '17.67', 'le': '0.34', 'lle': '3.82', 'sei': '8.64'}",CHEMBL3905560,,CHEMBL3905560,7.57,False,http://www.openphacts.org/units/Nanomolar,2895227,=,37,True,=,,IC50,nM,,27.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,27.0
432063,17792171,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OCC2[C@@H](C)O)n1)c1ccc(C(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.10', 'le': '0.31', 'lle': '2.41', 'sei': '7.43'}",CHEMBL3904506,,CHEMBL3904506,6.50,False,http://www.openphacts.org/units/Nanomolar,2895228,=,37,True,=,,IC50,nM,,313.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,313.0
432064,17792172,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OCC2[C@@H](C)O)n1)c1ccc(C(C)(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.83', 'le': '0.32', 'lle': '2.78', 'sei': '8.04'}",CHEMBL3978669,,CHEMBL3978669,7.04,False,http://www.openphacts.org/units/Nanomolar,2895229,=,37,True,=,,IC50,nM,,91.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,91.0
432065,17792173,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2ccccc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '17.46', 'le': '0.35', 'lle': '3.03', 'sei': '8.87'}",CHEMBL3904882,,CHEMBL3904882,7.77,False,http://www.openphacts.org/units/Nanomolar,2895230,=,37,True,=,,IC50,nM,,17.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,17.0
432066,17792174,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2ccccn2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '16.18', 'le': '0.33', 'lle': '3.08', 'sei': '7.18'}",CHEMBL3920067,,CHEMBL3920067,7.21,False,http://www.openphacts.org/units/Nanomolar,2895231,=,37,True,=,,IC50,nM,,61.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,61.0
432067,17792175,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cccc(O[C@H]2CCOC2)c1,,,CHEMBL3886939,,2016.0,"{'bei': '12.43', 'le': '0.23', 'lle': '2.63', 'sei': '4.86'}",CHEMBL3918987,,CHEMBL3918987,5.15,False,http://www.openphacts.org/units/Nanomolar,2895232,=,37,True,=,,IC50,nM,,7050.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,7050.0
432068,17792176,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)COc1cccc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)c1,,,CHEMBL3886939,,2016.0,"{'bei': '15.81', 'le': '0.30', 'lle': '2.94', 'sei': '6.54'}",CHEMBL3979363,,CHEMBL3979363,6.33,False,http://www.openphacts.org/units/Nanomolar,2895233,=,37,True,=,,IC50,nM,,465.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,465.0
432069,17792177,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)CS(=O)(=O)c1ccc([C@H](C)Nc2nc(Cl)cc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '14.78', 'le': '0.30', 'lle': '3.70', 'sei': '5.86'}",CHEMBL3934735,,CHEMBL3934735,7.14,False,http://www.openphacts.org/units/Nanomolar,2895234,=,37,True,=,,IC50,nM,,73.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,73.0
432070,17792178,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)(F)F)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '16.30', 'le': '0.32', 'lle': '3.47', 'sei': '6.94'}",CHEMBL3971674,,CHEMBL3971674,6.72,False,http://www.openphacts.org/units/Nanomolar,2895235,=,37,True,=,,IC50,nM,,190.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,190.0
432071,17792179,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)(F)F)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '15.56', 'le': '0.30', 'lle': '3.31', 'sei': '6.92'}",CHEMBL3916173,,CHEMBL3916173,6.70,False,http://www.openphacts.org/units/Nanomolar,2895236,=,37,True,=,,IC50,nM,,201.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,201.0
432072,17792180,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.62', 'le': '0.31', 'lle': '3.33', 'sei': '6.95'}",CHEMBL3985940,,CHEMBL3985940,6.72,False,http://www.openphacts.org/units/Nanomolar,2895237,=,37,True,=,,IC50,nM,,189.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,189.0
432073,17792181,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)F)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '15.53', 'le': '0.30', 'lle': '3.30', 'sei': '6.61'}",CHEMBL3965350,,CHEMBL3965350,6.40,False,http://www.openphacts.org/units/Nanomolar,2895238,=,37,True,=,,IC50,nM,,395.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,395.0
432074,17792182,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)F)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '15.69', 'le': '0.31', 'lle': '3.51', 'sei': '6.97'}",CHEMBL3977787,,CHEMBL3977787,6.75,False,http://www.openphacts.org/units/Nanomolar,2895239,=,37,True,=,,IC50,nM,,177.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,177.0
432075,17792183,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)F)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '15.64', 'le': '0.30', 'lle': '3.21', 'sei': '6.37'}",CHEMBL3925865,,CHEMBL3925865,6.17,False,http://www.openphacts.org/units/Nanomolar,2895240,=,37,True,=,,IC50,nM,,681.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,681.0
432076,17792184,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.48', 'le': '0.30', 'lle': '3.28', 'sei': '6.59'}",CHEMBL3972827,,CHEMBL3972827,6.38,False,http://www.openphacts.org/units/Nanomolar,2895241,=,37,True,=,,IC50,nM,,413.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,413.0
432077,17792185,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cccc(OC(F)(F)F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '16.43', 'le': '0.32', 'lle': '3.52', 'sei': '7.00'}",CHEMBL3932885,,CHEMBL3932885,6.78,False,http://www.openphacts.org/units/Nanomolar,2895242,=,37,True,=,,IC50,nM,,168.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,168.0
432078,17792186,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cccc(OC(F)F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '15.50', 'le': '0.30', 'lle': '3.15', 'sei': '6.31'}",CHEMBL3908468,,CHEMBL3908468,6.11,False,http://www.openphacts.org/units/Nanomolar,2895243,=,37,True,=,,IC50,nM,,770.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,770.0
432079,17792187,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '16.24', 'le': '0.32', 'lle': '3.75', 'sei': '7.22'}",CHEMBL3965898,,CHEMBL3965898,6.99,False,http://www.openphacts.org/units/Nanomolar,2895244,=,37,True,=,,IC50,nM,,103.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,103.0
432080,17792188,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cccc(OC(F)(F)F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '16.94', 'le': '0.33', 'lle': '3.90', 'sei': '7.53'}",CHEMBL3894497,,CHEMBL3894497,7.29,False,http://www.openphacts.org/units/Nanomolar,2895245,=,37,True,=,,IC50,nM,,51.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,51.0
432081,17792189,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cccc(OC(F)F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '16.53', 'le': '0.32', 'lle': '3.72', 'sei': '7.04'}",CHEMBL3980075,,CHEMBL3980075,6.82,False,http://www.openphacts.org/units/Nanomolar,2895246,=,37,True,=,,IC50,nM,,152.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,152.0
432082,17792190,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cccc(Oc2ccccc2)c1,,,CHEMBL3886939,,2016.0,"{'bei': '16.46', 'le': '0.30', 'lle': '2.77', 'sei': '7.15'}",CHEMBL3903445,,CHEMBL3903445,6.92,False,http://www.openphacts.org/units/Nanomolar,2895247,=,37,True,=,,IC50,nM,,120.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,120.0
432083,17792191,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1ccc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '16.68', 'le': '0.31', 'lle': '3.31', 'sei': '6.66'}",CHEMBL3979270,,CHEMBL3979270,6.45,False,http://www.openphacts.org/units/Nanomolar,2895248,=,37,True,=,,IC50,nM,,358.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,358.0
432084,17792192,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)ccc1OCC(C)C,,,CHEMBL3886939,,2016.0,"{'bei': '16.67', 'le': '0.31', 'lle': '3.21', 'sei': '7.14'}",CHEMBL3908969,,CHEMBL3908969,6.91,False,http://www.openphacts.org/units/Nanomolar,2895249,=,37,True,=,,IC50,nM,,123.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,123.0
432085,17792193,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)(F)F)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '15.15', 'le': '0.31', 'lle': '2.86', 'sei': '6.99'}",CHEMBL3962307,,CHEMBL3962307,6.77,False,http://www.openphacts.org/units/Nanomolar,2895250,=,37,True,=,,IC50,nM,,171.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,171.0
432086,17792194,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)(F)F)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '16.85', 'le': '0.33', 'lle': '3.86', 'sei': '7.49'}",CHEMBL3889758,,CHEMBL3889758,7.25,False,http://www.openphacts.org/units/Nanomolar,2895251,=,37,True,=,,IC50,nM,,56.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,56.0
432087,17792195,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.00', 'le': '0.31', 'lle': '2.92', 'sei': '7.20'}",CHEMBL3973284,,CHEMBL3973284,6.97,False,http://www.openphacts.org/units/Nanomolar,2895252,=,37,True,=,,IC50,nM,,107.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,107.0
432088,17792196,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.93', 'le': '0.31', 'lle': '3.61', 'sei': '7.38'}",CHEMBL3902255,,CHEMBL3902255,7.14,False,http://www.openphacts.org/units/Nanomolar,2895253,=,37,True,=,,IC50,nM,,72.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,72.0
432089,17792197,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)COc1ccc([C@H](C)Nc2ncc(F)c(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '18.68', 'le': '0.36', 'lle': '4.48', 'sei': '8.42'}",CHEMBL3960560,,CHEMBL3960560,8.15,False,http://www.openphacts.org/units/Nanomolar,2895254,=,37,True,=,,IC50,nM,,7.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,7.0
432090,17792198,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)F)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '16.75', 'le': '0.33', 'lle': '3.81', 'sei': '7.13'}",CHEMBL3933108,,CHEMBL3933108,6.91,False,http://www.openphacts.org/units/Nanomolar,2895255,=,37,True,=,,IC50,nM,,124.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,124.0
432091,17792199,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)(F)F)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '16.69', 'le': '0.33', 'lle': '3.95', 'sei': '7.73'}",CHEMBL3929833,,CHEMBL3929833,7.48,False,http://www.openphacts.org/units/Nanomolar,2895256,=,37,True,=,,IC50,nM,,33.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,33.0
432092,17792200,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)F)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '15.91', 'le': '0.32', 'lle': '3.21', 'sei': '7.05'}",CHEMBL3904836,,CHEMBL3904836,6.82,False,http://www.openphacts.org/units/Nanomolar,2895257,=,37,True,=,,IC50,nM,,151.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,151.0
432093,17792201,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)(F)F)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '14.84', 'le': '0.30', 'lle': '2.85', 'sei': '7.12'}",CHEMBL3918587,,CHEMBL3918587,6.90,False,http://www.openphacts.org/units/Nanomolar,2895258,=,37,True,=,,IC50,nM,,127.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,127.0
432094,17792202,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)CS(=O)(=O)c1ccc([C@H](C)Nc2ncc(F)c(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '15.09', 'le': '0.30', 'lle': '4.12', 'sei': '5.78'}",CHEMBL3931535,,CHEMBL3931535,7.04,False,http://www.openphacts.org/units/Nanomolar,2895259,=,37,True,=,,IC50,nM,,91.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,91.0
432095,17792203,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)S(=O)(=O)c1ccc([C@H](C)Nc2ncc(F)c(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '14.15', 'le': '0.28', 'lle': '3.72', 'sei': '5.26'}",CHEMBL3955271,,CHEMBL3955271,6.40,False,http://www.openphacts.org/units/Nanomolar,2895260,=,37,True,=,,IC50,nM,,397.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,397.0
432096,17792204,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)S(=O)(=O)c1ccc([C@H](C)Nc2nc(Cl)cc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '13.55', 'le': '0.28', 'lle': '3.17', 'sei': '5.22'}",CHEMBL3896022,,CHEMBL3896022,6.36,False,http://www.openphacts.org/units/Nanomolar,2895261,=,37,True,=,,IC50,nM,,441.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,441.0
432097,17792205,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OCC2CC2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '17.32', 'le': '0.33', 'lle': '3.76', 'sei': '7.13'}",CHEMBL3897081,,CHEMBL3897081,6.90,False,http://www.openphacts.org/units/Nanomolar,2895262,=,37,True,=,,IC50,nM,,125.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,125.0
432098,17792206,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)COc1ccc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '18.01', 'le': '0.34', 'lle': '4.01', 'sei': '7.79'}",CHEMBL3968221,,CHEMBL3968221,7.54,False,http://www.openphacts.org/units/Nanomolar,2895263,=,37,True,=,,IC50,nM,,29.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,29.0
432099,17792207,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CO[C@H](C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cnc(-c3ccc(Cl)cc3)s2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '15.85', 'le': '0.32', 'lle': '2.50', 'sei': '8.15'}",CHEMBL3938372,,CHEMBL3938372,7.29,False,http://www.openphacts.org/units/Nanomolar,2895264,=,37,True,=,,IC50,nM,,51.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,51.0
432100,17792208,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CO[C@H](C)[C@H]1COC(=O)N1c1cc(Cl)nc(N[C@@H](C)c2cc(F)c(-c3cnn(C)c3)cc2F)n1,,,CHEMBL3886939,,2016.0,"{'bei': '15.21', 'le': '0.30', 'lle': '3.15', 'sei': '7.94'}",CHEMBL3939420,,CHEMBL3939420,7.50,False,http://www.openphacts.org/units/Nanomolar,2895265,=,37,True,=,,IC50,nM,,32.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,32.0
432101,17792209,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CO[C@H](C)[C@H]1COC(=O)N1c1cc(Cl)nc(N[C@@H](C)c2ccc(C(F)(F)F)cc2F)n1,,,CHEMBL3886939,,2016.0,"{'bei': '15.19', 'le': '0.31', 'lle': '2.21', 'sei': '9.18'}",CHEMBL3965474,,CHEMBL3965474,7.03,False,http://www.openphacts.org/units/Nanomolar,2895266,=,37,True,=,,IC50,nM,,93.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,93.0
432102,17792210,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CO[C@H](C)[C@H]1COC(=O)N1c1cc(Cl)nc(N[C@@H](C)c2cnc(-c3ccc(Cl)cc3)s2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '15.45', 'le': '0.33', 'lle': '2.20', 'sei': '8.54'}",CHEMBL3953545,,CHEMBL3953545,7.64,False,http://www.openphacts.org/units/Nanomolar,2895267,=,37,True,=,,IC50,nM,,23.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,23.0
432103,17792211,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CO[C@H](C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cc(-c3ccc(Cl)cc3)on2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '16.41', 'le': '0.32', 'lle': '2.96', 'sei': '7.10'}",CHEMBL3986526,,CHEMBL3986526,7.28,False,http://www.openphacts.org/units/Nanomolar,2895268,=,37,True,=,,IC50,nM,,52.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,52.0
432104,17792212,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CO[C@H](C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cn(-c3ccc(Cl)cc3)cn2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '17.11', 'le': '0.33', 'lle': '3.73', 'sei': '8.03'}",CHEMBL3948226,,CHEMBL3948226,7.58,False,http://www.openphacts.org/units/Nanomolar,2895269,=,37,True,=,,IC50,nM,,26.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,26.5
432105,17792213,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CO[C@H](C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cc(F)c(-c3ccc(C)nc3)cc2F)n1,,,CHEMBL3886939,,2016.0,"{'bei': '15.50', 'le': '0.29', 'lle': '2.62', 'sei': '8.13'}",CHEMBL3981347,,CHEMBL3981347,7.28,False,http://www.openphacts.org/units/Nanomolar,2895270,=,37,True,=,,IC50,nM,,53.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,53.0
432106,17792214,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2[C@@H](C)N)n1)c1cnc(-c2ccc(Cl)cc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '16.72', 'le': '0.34', 'lle': '3.34', 'sei': '7.00'}",CHEMBL4114431,,CHEMBL4114431,7.44,False,http://www.openphacts.org/units/Nanomolar,2895271,=,37,True,=,,IC50,nM,,36.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,36.5
432107,17792215,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)N)n1)c1cnc(-c2ccc(Cl)cc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '16.50', 'le': '0.33', 'lle': '3.24', 'sei': '6.91'}",CHEMBL4110366,,CHEMBL4110366,7.34,False,http://www.openphacts.org/units/Nanomolar,2895272,=,37,True,=,,IC50,nM,,45.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,45.5
432108,17792216,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)N)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '16.02', 'le': '0.31', 'lle': '3.70', 'sei': '6.17'}",CHEMBL4111302,,CHEMBL4111302,6.86,False,http://www.openphacts.org/units/Nanomolar,2895273,=,37,True,=,,IC50,nM,,139.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,139.0
432109,17792217,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)N)n1)c1cc(-c2ccc(Cl)cc2)on1,,,CHEMBL3886939,,2016.0,"{'bei': '15.53', 'le': '0.30', 'lle': '3.03', 'sei': '5.58'}",CHEMBL4110501,,CHEMBL4110501,6.66,False,http://www.openphacts.org/units/Nanomolar,2895274,=,37,True,=,,IC50,nM,,219.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,219.0
432110,17792218,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2cc(F)c([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)N)n3)cc2F)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '14.93', 'le': '0.28', 'lle': '2.82', 'sei': '6.39'}",CHEMBL4111785,,CHEMBL4111785,6.79,False,http://www.openphacts.org/units/Nanomolar,2895275,=,37,True,=,,IC50,nM,,164.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,164.0
432111,17792219,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CN[C@H](C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cnc(-c3ccc(Cl)cc3)s2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '10.35', 'le': '0.21', 'lle': '0.39', 'sei': '5.15'}",CHEMBL4115378,,CHEMBL4115378,4.75,False,http://www.openphacts.org/units/Nanomolar,2895276,=,37,True,=,,IC50,nM,,17750.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,17750.0
432112,17792220,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2[C@@H](C)F)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '18.03', 'le': '0.35', 'lle': '3.60', 'sei': '9.12'}",CHEMBL4109951,,CHEMBL4109951,7.77,False,http://www.openphacts.org/units/Nanomolar,2895277,=,37,True,=,,IC50,nM,,17.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,17.0
432113,17792221,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)F)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '17.80', 'le': '0.35', 'lle': '3.50', 'sei': '9.00'}",CHEMBL4107555,,CHEMBL4107555,7.67,False,http://www.openphacts.org/units/Nanomolar,2895278,=,37,True,=,,IC50,nM,,21.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,21.5
432114,17792222,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)F)n1)c1cc(-c2ccc(Cl)cc2)on1,,,CHEMBL3886939,,2016.0,"{'bei': '16.74', 'le': '0.33', 'lle': '2.59', 'sei': '7.74'}",CHEMBL4114420,,CHEMBL4114420,7.23,False,http://www.openphacts.org/units/Nanomolar,2895279,=,37,True,=,,IC50,nM,,59.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,59.0
432115,17792223,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)F)n1)c1cnc(-c2ccc(Cl)cc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '16.67', 'le': '0.34', 'lle': '2.36', 'sei': '9.31'}",CHEMBL4111565,,CHEMBL4111565,7.47,False,http://www.openphacts.org/units/Nanomolar,2895280,=,37,True,=,,IC50,nM,,34.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,34.0
432116,17792224,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL3886939,,2016.0,,CHEMBL3986241,,CHEMBL3986241,,False,http://www.openphacts.org/units/Nanomolar,2895281,<,37,True,<,,IC50,nM,,15.9,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,15.9
432117,17792225,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cnc(-c2ccc(Cl)cc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '17.19', 'le': '0.35', 'lle': '2.59', 'sei': '9.59'}",CHEMBL3964464,,CHEMBL3964464,7.70,False,http://www.openphacts.org/units/Nanomolar,2895282,=,37,True,=,,IC50,nM,,20.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,20.0
432118,17792226,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cc(-c2ccc(Cl)cc2)on1,,,CHEMBL3886939,,2016.0,"{'bei': '17.44', 'le': '0.34', 'lle': '2.89', 'sei': '8.06'}",CHEMBL3906023,,CHEMBL3906023,7.53,False,http://www.openphacts.org/units/Nanomolar,2895283,=,37,True,=,,IC50,nM,,29.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,29.5
432119,17792227,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)F)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '16.82', 'le': '0.33', 'lle': '3.24', 'sei': '6.85'}",CHEMBL4109968,,CHEMBL4109968,7.28,False,http://www.openphacts.org/units/Nanomolar,2895284,=,37,True,=,,IC50,nM,,52.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,52.5
432120,17792228,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)F)n1)c1cnc(-c2ccnc(C(F)(F)F)c2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '14.33', 'le': '0.29', 'lle': '2.05', 'sei': '7.43'}",CHEMBL4108789,,CHEMBL4108789,6.92,False,http://www.openphacts.org/units/Nanomolar,2895285,=,37,True,=,,IC50,nM,,121.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,121.5
432121,17792229,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)F)n1)c1cnc(-c2ccc(C(F)(F)F)nc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '14.84', 'le': '0.30', 'lle': '2.29', 'sei': '7.69'}",CHEMBL4108146,,CHEMBL4108146,7.16,False,http://www.openphacts.org/units/Nanomolar,2895286,=,37,True,=,,IC50,nM,,69.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,69.0
432122,17792230,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)F)n1)c1cnn(-c2ccc(Cl)cc2)c1,,,CHEMBL3886939,,2016.0,"{'bei': '17.13', 'le': '0.34', 'lle': '3.21', 'sei': '8.67'}",CHEMBL4106880,,CHEMBL4106880,7.38,False,http://www.openphacts.org/units/Nanomolar,2895287,=,37,True,=,,IC50,nM,,41.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,41.5
432123,17792231,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)F)n1)c1cnc(-c2ccc(Cl)cc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '15.89', 'le': '0.33', 'lle': '2.15', 'sei': '9.23'}",CHEMBL4108039,,CHEMBL4108039,7.40,False,http://www.openphacts.org/units/Nanomolar,2895288,=,37,True,=,,IC50,nM,,39.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,39.5
432124,17792232,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cnn(-c2ccc(Cl)cc2)c1,,,CHEMBL3886939,,2016.0,"{'bei': '17.38', 'le': '0.34', 'lle': '3.32', 'sei': '8.79'}",CHEMBL3915232,,CHEMBL3915232,7.49,False,http://www.openphacts.org/units/Nanomolar,2895289,=,37,True,=,,IC50,nM,,32.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,32.5
432125,17792233,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)F)n1)c1cnn(-c2ccc(Cl)cc2)c1,,,CHEMBL3886939,,2016.0,"{'bei': '16.00', 'le': '0.32', 'lle': '2.87', 'sei': '8.43'}",CHEMBL4112902,,CHEMBL4112902,7.18,False,http://www.openphacts.org/units/Nanomolar,2895290,=,37,True,=,,IC50,nM,,65.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,65.5
432126,17792234,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2cc([C@H](C)Nc3ncc(F)c(N4C(=O)OC[C@@H]4[C@@H](C)F)n3)no2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '17.25', 'le': '0.33', 'lle': '2.97', 'sei': '7.93'}",CHEMBL4108034,,CHEMBL4108034,7.41,False,http://www.openphacts.org/units/Nanomolar,2895291,=,37,True,=,,IC50,nM,,39.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,39.0
432127,17792235,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)F)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '17.25', 'le': '0.34', 'lle': '3.43', 'sei': '9.09'}",CHEMBL4114410,,CHEMBL4114410,7.75,False,http://www.openphacts.org/units/Nanomolar,2895292,=,37,True,=,,IC50,nM,,18.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,18.0
432128,17792236,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1nc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@H](C)F)n2)cn1-c1ccc(Cl)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '17.07', 'le': '0.33', 'lle': '3.11', 'sei': '8.92'}",CHEMBL3963739,,CHEMBL3963739,7.59,False,http://www.openphacts.org/units/Nanomolar,2895293,=,37,True,=,,IC50,nM,,25.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25.5
432129,17792237,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2[C@H](C)F)n1)c1cn(-c2ccc(F)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '18.28', 'le': '0.34', 'lle': '3.92', 'sei': '8.90'}",CHEMBL3924568,,CHEMBL3924568,7.58,False,http://www.openphacts.org/units/Nanomolar,2895294,=,37,True,=,,IC50,nM,,26.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,26.5
432130,17792238,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cn(-c2ccc(F)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '18.69', 'le': '0.35', 'lle': '4.08', 'sei': '9.09'}",CHEMBL3969682,,CHEMBL3969682,7.75,False,http://www.openphacts.org/units/Nanomolar,2895295,=,37,True,=,,IC50,nM,,18.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,18.0
432131,17792239,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cn(-c2cc(F)c([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4[C@H](C)F)n3)cc2F)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '16.41', 'le': '0.31', 'lle': '3.22', 'sei': '8.60'}",CHEMBL3898499,,CHEMBL3898499,7.33,False,http://www.openphacts.org/units/Nanomolar,2895296,=,37,True,=,,IC50,nM,,47.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,47.0
432132,17792240,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1ccn(-c2ccc(C(F)(F)F)nc2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '14.75', 'le': '0.28', 'lle': '2.93', 'sei': '7.00'}",CHEMBL3926046,,CHEMBL3926046,6.86,False,http://www.openphacts.org/units/Nanomolar,2895297,=,37,True,=,,IC50,nM,,137.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,137.0
432133,17792241,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2CF)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '18.32', 'le': '0.36', 'lle': '3.86', 'sei': '8.97'}",CHEMBL3953686,,CHEMBL3953686,7.64,False,http://www.openphacts.org/units/Nanomolar,2895298,=,37,True,=,,IC50,nM,,23.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,23.0
432134,17792242,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2CF)n1)c1cc(-c2ccc(Cl)cc2)on1,,,CHEMBL3886939,,2016.0,"{'bei': '17.94', 'le': '0.35', 'lle': '3.24', 'sei': '8.03'}",CHEMBL3938511,,CHEMBL3938511,7.50,False,http://www.openphacts.org/units/Nanomolar,2895299,=,37,True,=,,IC50,nM,,32.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,32.0
432135,17792243,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1nc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)F)n2)cn1-c1ccc(Cl)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '16.94', 'le': '0.33', 'lle': '3.06', 'sei': '8.85'}",CHEMBL4108088,,CHEMBL4108088,7.54,False,http://www.openphacts.org/units/Nanomolar,2895300,=,37,True,=,,IC50,nM,,29.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,29.0
432136,17792244,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(O)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)C2CCN(c3ccnc(C(C)(C)C(F)(F)F)c3)CC2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '13.68', 'le': '0.26', 'lle': '3.02', 'sei': '6.89'}",CHEMBL3911629,,CHEMBL3911629,7.15,False,http://www.openphacts.org/units/Nanomolar,2895301,=,37,True,=,,IC50,nM,,71.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,71.0
432137,17792245,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(O)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)C2CCN(c3ccc(Cl)c(OC(F)(F)F)c3)CC2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '13.90', 'le': '0.28', 'lle': '2.92', 'sei': '7.36'}",CHEMBL3907092,,CHEMBL3907092,7.37,False,http://www.openphacts.org/units/Nanomolar,2895302,=,37,True,=,,IC50,nM,,43.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,43.0
432138,17792246,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)C(F)F)n1)c1ccc(C(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '14.90', 'le': '0.29', 'lle': '1.59', 'sei': '9.92'}",CHEMBL4108279,,CHEMBL4108279,6.68,False,http://www.openphacts.org/units/Nanomolar,2895303,=,37,True,=,,IC50,nM,,209.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,209.0
432139,17792247,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)C(F)F)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '16.56', 'le': '0.33', 'lle': '3.12', 'sei': '7.24'}",CHEMBL4109122,,CHEMBL4109122,7.70,False,http://www.openphacts.org/units/Nanomolar,2895304,=,37,True,=,,IC50,nM,,20.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,20.0
432140,17792248,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)C(F)F)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '13.17', 'le': '0.26', 'lle': '1.54', 'sei': '5.76'}",CHEMBL4111017,,CHEMBL4111017,6.12,False,http://www.openphacts.org/units/Nanomolar,2895305,=,37,True,=,,IC50,nM,,756.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,756.0
432141,17792249,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)C(F)F)n1)c1ccc(C(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '16.19', 'le': '0.32', 'lle': '2.02', 'sei': '10.34'}",CHEMBL4111440,,CHEMBL4111440,6.97,False,http://www.openphacts.org/units/Nanomolar,2895306,=,37,True,=,,IC50,nM,,108.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,108.0
432142,17792250,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cnc(C(C)Nc3nccc(N4C(=O)OCC4[C@@H](C)C(F)F)n3)nc2)ccc1F,,,CHEMBL3886939,,2016.0,"{'bei': '16.17', 'le': '0.31', 'lle': '2.86', 'sei': '8.20'}",CHEMBL4108421,,CHEMBL4108421,7.64,False,http://www.openphacts.org/units/Nanomolar,2895307,=,37,True,=,,IC50,nM,,23.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,23.0
432143,17792251,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cnc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)C(F)F)n3)nc2)ccc1F,,,CHEMBL3886939,,2016.0,"{'bei': '11.97', 'le': '0.23', 'lle': '0.88', 'sei': '6.07'}",CHEMBL4107006,,CHEMBL4107006,5.66,False,http://www.openphacts.org/units/Nanomolar,2895308,=,37,True,=,,IC50,nM,,2210.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2210.0
432144,17792252,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc3ccn(C)c3c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '13.73', 'le': '0.26', 'lle': '3.27', 'sei': '4.70'}",CHEMBL4111065,,CHEMBL4111065,6.17,False,http://www.openphacts.org/units/Nanomolar,2895309,=,37,True,=,,IC50,nM,,671.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,671.0
432145,17792253,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2cccc(OC(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '14.60', 'le': '0.28', 'lle': '3.71', 'sei': '5.17'}",CHEMBL4109754,,CHEMBL4109754,7.01,False,http://www.openphacts.org/units/Nanomolar,2895310,=,37,True,=,,IC50,nM,,97.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,97.0
432146,17792254,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc2c(-c3noc(C(C)Nc4nccc(N5C(=O)OC[C@@H]5[C@@H](C)O)n4)n3)cccc2n1C,,,CHEMBL3886939,,2016.0,"{'bei': '14.42', 'le': '0.27', 'lle': '3.47', 'sei': '5.09'}",CHEMBL4108845,,CHEMBL4108845,6.68,False,http://www.openphacts.org/units/Nanomolar,2895311,=,37,True,=,,IC50,nM,,207.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,207.0
432147,17792255,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(Cl)c(OC(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '14.63', 'le': '0.29', 'lle': '3.57', 'sei': '5.55'}",CHEMBL4108766,,CHEMBL4108766,7.53,False,http://www.openphacts.org/units/Nanomolar,2895312,=,37,True,=,,IC50,nM,,29.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,29.5
432148,17792256,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)n2)ccc1Cl,,,CHEMBL3886939,,2016.0,"{'bei': '15.77', 'le': '0.31', 'lle': '3.65', 'sei': '5.55'}",CHEMBL4109147,,CHEMBL4109147,7.02,False,http://www.openphacts.org/units/Nanomolar,2895313,=,37,True,=,,IC50,nM,,96.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,96.0
432149,17792257,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,COc1cc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)n2)ccc1Br,,,CHEMBL3886939,,2016.0,"{'bei': '13.95', 'le': '0.30', 'lle': '3.87', 'sei': '5.19'}",CHEMBL4112002,,CHEMBL4112002,7.05,False,http://www.openphacts.org/units/Nanomolar,2895314,=,37,True,=,,IC50,nM,,89.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,89.0
432150,17792258,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2cccc(C(C)(C)C)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '16.88', 'le': '0.32', 'lle': '3.94', 'sei': '6.04'}",CHEMBL4113581,,CHEMBL4113581,7.64,False,http://www.openphacts.org/units/Nanomolar,2895315,=,37,True,=,,IC50,nM,,23.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,23.0
432151,17792259,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccc3c(c2)CCC3)no1,,,CHEMBL3886939,,2016.0,"{'bei': '13.11', 'le': '0.24', 'lle': '2.83', 'sei': '4.52'}",CHEMBL4111570,,CHEMBL4111570,5.72,False,http://www.openphacts.org/units/Nanomolar,2895316,=,37,True,=,,IC50,nM,,1895.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1895.0
432152,17792260,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc3c(c2)CCC3)no1,,,CHEMBL3886939,,2016.0,"{'bei': '16.97', 'le': '0.32', 'lle': '4.52', 'sei': '5.86'}",CHEMBL4113027,,CHEMBL4113027,7.41,False,http://www.openphacts.org/units/Nanomolar,2895317,=,37,True,=,,IC50,nM,,39.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,39.0
432153,17792261,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1noc(-c2ccc(Cl)cc2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '11.87', 'le': '0.23', 'lle': '2.05', 'sei': '4.04'}",CHEMBL4110061,,CHEMBL4110061,5.11,False,http://www.openphacts.org/units/Nanomolar,2895318,=,37,True,=,,IC50,nM,,7710.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,7710.0
432154,17792262,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1noc(-c2ccc(Cl)cc2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '15.13', 'le': '0.30', 'lle': '3.46', 'sei': '5.15'}",CHEMBL4107323,,CHEMBL4107323,6.52,False,http://www.openphacts.org/units/Nanomolar,2895319,=,37,True,=,,IC50,nM,,303.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,303.0
432155,17792263,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)C(F)F)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL3886939,,2016.0,,CHEMBL4113543,,CHEMBL4113543,,False,http://www.openphacts.org/units/Nanomolar,2895320,<,37,True,<,,IC50,nM,,15.9,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,15.9
432156,17792264,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)C(F)F)n1)c1cn(-c2ccc(F)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '16.41', 'le': '0.31', 'lle': '3.13', 'sei': '8.60'}",CHEMBL4113925,,CHEMBL4113925,7.33,False,http://www.openphacts.org/units/Nanomolar,2895321,=,37,True,=,,IC50,nM,,47.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,47.0
432157,17792265,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cnc(-c2ccnc(C(F)(F)F)c2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '14.86', 'le': '0.30', 'lle': '2.30', 'sei': '7.70'}",CHEMBL3931815,,CHEMBL3931815,7.17,False,http://www.openphacts.org/units/Nanomolar,2895322,=,37,True,=,,IC50,nM,,67.8,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,67.8
432158,17792266,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2CF)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL3886939,,2016.0,,CHEMBL3894881,,CHEMBL3894881,,False,http://www.openphacts.org/units/Nanomolar,2895323,<,37,True,<,,IC50,nM,,16.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,16.0
432159,17792267,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2CF)n1)c1cn(-c2ccc(F)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '17.45', 'le': '0.33', 'lle': '3.89', 'sei': '8.57'}",CHEMBL3922864,,CHEMBL3922864,7.30,False,http://www.openphacts.org/units/Nanomolar,2895324,=,37,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
432160,17792268,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2CF)n1)c1cn(-c2ccc(F)c(F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '16.79', 'le': '0.32', 'lle': '3.78', 'sei': '8.60'}",CHEMBL3921808,,CHEMBL3921808,7.33,False,http://www.openphacts.org/units/Nanomolar,2895325,=,37,True,=,,IC50,nM,,47.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,47.0
432161,17792269,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2CF)n1)c1cn(-c2ccc(Cl)c(F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '17.22', 'le': '0.34', 'lle': '3.74', 'sei': '9.15'}",CHEMBL3946170,,CHEMBL3946170,7.80,False,http://www.openphacts.org/units/Nanomolar,2895326,=,37,True,=,,IC50,nM,,16.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,16.0
432162,17792270,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2CF)n1)c1cn(-c2ccc(F)c(Cl)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '16.55', 'le': '0.33', 'lle': '3.43', 'sei': '8.80'}",CHEMBL3909346,,CHEMBL3909346,7.50,False,http://www.openphacts.org/units/Nanomolar,2895327,=,37,True,=,,IC50,nM,,32.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,32.0
432163,17792271,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2CF)n1)c1cn(-c2ccc(C(F)F)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '17.25', 'le': '0.33', 'lle': '3.56', 'sei': '9.12'}",CHEMBL3986279,,CHEMBL3986279,7.77,False,http://www.openphacts.org/units/Nanomolar,2895328,=,37,True,=,,IC50,nM,,17.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,17.0
432164,17792272,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2CF)n1)c1cn(-c2ccc(C(F)F)c(F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '16.59', 'le': '0.32', 'lle': '3.42', 'sei': '9.12'}",CHEMBL3933810,,CHEMBL3933810,7.77,False,http://www.openphacts.org/units/Nanomolar,2895329,=,37,True,=,,IC50,nM,,17.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,17.0
432165,17792273,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2CF)n1)c1cn(-c2cc(F)cc(F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '16.55', 'le': '0.32', 'lle': '3.67', 'sei': '8.48'}",CHEMBL3967084,,CHEMBL3967084,7.22,False,http://www.openphacts.org/units/Nanomolar,2895330,=,37,True,=,,IC50,nM,,60.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,60.0
432166,17792274,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2CF)n1)c1cc(-c2ccc(Cl)cc2)on1,,,CHEMBL3886939,,2016.0,"{'bei': '17.08', 'le': '0.34', 'lle': '3.05', 'sei': '7.97'}",CHEMBL3954174,,CHEMBL3954174,7.44,False,http://www.openphacts.org/units/Nanomolar,2895331,=,37,True,=,,IC50,nM,,36.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,36.0
432167,17792275,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2CF)n1)c1cnc(-c2ccc(Cl)cc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '16.26', 'le': '0.33', 'lle': '2.49', 'sei': '9.16'}",CHEMBL3926538,,CHEMBL3926538,7.35,False,http://www.openphacts.org/units/Nanomolar,2895332,=,37,True,=,,IC50,nM,,45.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,45.0
432168,17792276,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1nc([C@H](C)Nc2ncc(F)c(N3C(=O)OC[C@@H]3CF)n2)cn1-c1ccc(Cl)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '14.27', 'le': '0.28', 'lle': '2.18', 'sei': '7.52'}",CHEMBL3962908,,CHEMBL3962908,6.41,False,http://www.openphacts.org/units/Nanomolar,2895333,=,37,True,=,,IC50,nM,,392.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,392.0
432169,17792277,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2CF)n1)c1cnc(-c2ccnc(C(F)(F)F)c2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '13.91', 'le': '0.28', 'lle': '2.14', 'sei': '7.26'}",CHEMBL3931951,,CHEMBL3931951,6.76,False,http://www.openphacts.org/units/Nanomolar,2895334,=,37,True,=,,IC50,nM,,172.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,172.0
432170,17792278,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cc(F)c([C@H](C)Nc3ncc(F)c(N4C(=O)OC[C@@H]4CF)n3)cc2F)ccn1,,,CHEMBL3886939,,2016.0,,CHEMBL3970513,,CHEMBL3970513,,False,http://www.openphacts.org/units/Nanomolar,2895335,<,37,True,<,,IC50,nM,,16.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,16.0
432171,17792279,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2cc(F)c([C@H](C)Nc3ncc(F)c(N4C(=O)OC[C@@H]4CF)n3)cc2F)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '16.08', 'le': '0.31', 'lle': '2.69', 'sei': '9.25'}",CHEMBL3940965,,CHEMBL3940965,7.42,False,http://www.openphacts.org/units/Nanomolar,2895336,=,37,True,=,,IC50,nM,,38.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,38.0
432172,17792280,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2CF)n1)c1cc(F)c(-c2ccc(C(F)(F)F)nc2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '14.63', 'le': '0.29', 'lle': '2.10', 'sei': '9.39'}",CHEMBL3978799,,CHEMBL3978799,7.54,False,http://www.openphacts.org/units/Nanomolar,2895337,=,37,True,=,,IC50,nM,,29.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,29.0
432173,17792281,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2CF)n1)c1cc(F)c(-c2ccnc(C(F)(F)F)c2)cc1F,,,CHEMBL3886939,,2016.0,,CHEMBL3953128,,CHEMBL3953128,,False,http://www.openphacts.org/units/Nanomolar,2895338,<,37,True,<,,IC50,nM,,16.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,16.0
432174,17792282,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cn(-c2cc(F)c([C@H](C)Nc3ncc(F)c(N4C(=O)OC[C@@H]4CF)n3)cc2F)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '15.43', 'le': '0.30', 'lle': '3.09', 'sei': '8.16'}",CHEMBL3895605,,CHEMBL3895605,6.95,False,http://www.openphacts.org/units/Nanomolar,2895339,=,37,True,=,,IC50,nM,,112.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,112.0
432175,17792283,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cn(-c2ccc(C(F)F)c(F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '15.70', 'le': '0.30', 'lle': '2.84', 'sei': '8.89'}",CHEMBL3959538,,CHEMBL3959538,7.57,False,http://www.openphacts.org/units/Nanomolar,2895340,=,37,True,=,,IC50,nM,,26.8,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,26.8
432176,17792284,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cn(-c2ccc(C(F)F)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '16.26', 'le': '0.31', 'lle': '2.95', 'sei': '8.87'}",CHEMBL3917430,,CHEMBL3917430,7.55,False,http://www.openphacts.org/units/Nanomolar,2895341,=,37,True,=,,IC50,nM,,28.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,28.0
432177,17792285,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cn(-c2ccc(Cl)c(F)c2)cn1,,,CHEMBL3886939,,2016.0,,CHEMBL3945313,,CHEMBL3945313,,False,http://www.openphacts.org/units/Nanomolar,2895342,<,37,True,<,,IC50,nM,,16.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,16.0
432178,17792286,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cn(-c2cc(F)cc(F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '16.71', 'le': '0.32', 'lle': '3.59', 'sei': '8.84'}",CHEMBL3922872,,CHEMBL3922872,7.53,False,http://www.openphacts.org/units/Nanomolar,2895343,=,37,True,=,,IC50,nM,,29.7,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,29.7
432179,17792287,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL3886939,,2016.0,,CHEMBL3959391,,CHEMBL3959391,,False,http://www.openphacts.org/units/Nanomolar,2895344,<,37,True,<,,IC50,nM,,16.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,16.0
432180,17792288,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cn(-c2ccc(F)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '17.02', 'le': '0.32', 'lle': '3.56', 'sei': '8.64'}",CHEMBL3959448,,CHEMBL3959448,7.36,False,http://www.openphacts.org/units/Nanomolar,2895345,=,37,True,=,,IC50,nM,,43.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,43.5
432181,17792289,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cc(-c2ccc(Cl)cc2)on1,,,CHEMBL3886939,,2016.0,"{'bei': '16.75', 'le': '0.33', 'lle': '2.75', 'sei': '8.07'}",CHEMBL3890377,,CHEMBL3890377,7.53,False,http://www.openphacts.org/units/Nanomolar,2895346,=,37,True,=,,IC50,nM,,29.3,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,29.3
432182,17792290,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cnn(-c2ccc(Cl)cc2)c1,,,CHEMBL3886939,,2016.0,"{'bei': '16.59', 'le': '0.33', 'lle': '3.14', 'sei': '8.74'}",CHEMBL3973867,,CHEMBL3973867,7.45,False,http://www.openphacts.org/units/Nanomolar,2895347,=,37,True,=,,IC50,nM,,35.7,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,35.7
432183,17792291,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cn(-c2cc(F)cc(F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '17.65', 'le': '0.34', 'lle': '3.83', 'sei': '8.96'}",CHEMBL3899328,,CHEMBL3899328,7.63,False,http://www.openphacts.org/units/Nanomolar,2895348,=,37,True,=,,IC50,nM,,23.4,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,23.4
432184,17792292,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cn(-c2ccc(C(F)F)c(F)c2)cn1,,,CHEMBL3886939,,2016.0,,CHEMBL3979786,,CHEMBL3979786,,False,http://www.openphacts.org/units/Nanomolar,2895349,<,37,True,<,,IC50,nM,,16.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,16.0
432185,17792293,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2[C@H](C)F)n1)c1cn(-c2ccc(C(F)F)cc2)cn1,,,CHEMBL3886939,,2016.0,,CHEMBL3986960,,CHEMBL3986960,,False,http://www.openphacts.org/units/Nanomolar,2895350,<,37,True,<,,IC50,nM,,16.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,16.0
432186,17792294,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cn(-c2ccc(C(F)F)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '20.16', 'le': '0.38', 'lle': '4.54', 'sei': '10.57'}",CHEMBL3909586,,CHEMBL3909586,9.00,False,http://www.openphacts.org/units/Nanomolar,2895351,=,37,True,=,,IC50,nM,,1.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1.0
432187,17792295,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cn(-c2ccc(F)c(Cl)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '17.31', 'le': '0.34', 'lle': '3.46', 'sei': '9.12'}",CHEMBL3938657,,CHEMBL3938657,7.77,False,http://www.openphacts.org/units/Nanomolar,2895352,=,37,True,=,,IC50,nM,,17.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,17.0
432188,17792296,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cn(-c2ccc(Cl)c(F)c2)cn1,,,CHEMBL3886939,,2016.0,,CHEMBL3914156,,CHEMBL3914156,,False,http://www.openphacts.org/units/Nanomolar,2895353,<,37,True,<,,IC50,nM,,16.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,16.0
432189,17792297,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cn(-c2ccc(F)c(F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '17.60', 'le': '0.34', 'lle': '3.81', 'sei': '8.93'}",CHEMBL3929638,,CHEMBL3929638,7.61,False,http://www.openphacts.org/units/Nanomolar,2895354,=,37,True,=,,IC50,nM,,24.6,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,24.6
432190,17792298,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cc(F)c(-c2cnn(C)c2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '16.74', 'le': '0.32', 'lle': '3.46', 'sei': '8.78'}",CHEMBL3901690,,CHEMBL3901690,7.47,False,http://www.openphacts.org/units/Nanomolar,2895355,=,37,True,=,,IC50,nM,,33.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,33.5
432191,17792299,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)F)n1)c1cn(-c2ccc(F)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '16.80', 'le': '0.32', 'lle': '3.46', 'sei': '8.53'}",CHEMBL4111339,,CHEMBL4111339,7.26,False,http://www.openphacts.org/units/Nanomolar,2895356,=,37,True,=,,IC50,nM,,54.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,54.5
432192,17792300,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)F)n1)c1ncc(-c2ccnc(C(F)(F)F)c2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '13.92', 'le': '0.27', 'lle': '2.04', 'sei': '7.66'}",CHEMBL4111379,,CHEMBL4111379,7.13,False,http://www.openphacts.org/units/Nanomolar,2895357,=,37,True,=,,IC50,nM,,73.8,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,73.8
432193,17792301,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2[C@H](C)F)n1)c1ncc(-c2ccnc(C(F)(F)F)c2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.01', 'le': '0.29', 'lle': '2.47', 'sei': '7.97'}",CHEMBL3953091,,CHEMBL3953091,7.42,False,http://www.openphacts.org/units/Nanomolar,2895358,=,37,True,=,,IC50,nM,,38.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,38.0
432194,17792302,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1ncc(-c2ccnc(C(F)(F)F)c2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.02', 'le': '0.29', 'lle': '2.48', 'sei': '7.97'}",CHEMBL3984884,,CHEMBL3984884,7.43,False,http://www.openphacts.org/units/Nanomolar,2895359,=,37,True,=,,IC50,nM,,37.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,37.5
432195,17792303,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)F)n1)c1ncc(-c2ccnc(C(F)(F)F)c2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '14.22', 'le': '0.27', 'lle': '2.08', 'sei': '7.55'}",CHEMBL4107387,,CHEMBL4107387,7.03,False,http://www.openphacts.org/units/Nanomolar,2895360,=,37,True,=,,IC50,nM,,93.7,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,93.7
432196,17792304,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1ncc(-c2ccnc(C(F)(F)F)c2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '13.99', 'le': '0.27', 'lle': '2.08', 'sei': '7.70'}",CHEMBL3973629,,CHEMBL3973629,7.17,False,http://www.openphacts.org/units/Nanomolar,2895361,=,37,True,=,,IC50,nM,,68.1,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,68.1
432197,17792305,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@H](C)F)n2)ncc1-c1ccnc(C(F)(F)F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '15.48', 'le': '0.30', 'lle': '2.47', 'sei': '8.15'}",CHEMBL3947537,,CHEMBL3947537,7.59,False,http://www.openphacts.org/units/Nanomolar,2895362,=,37,True,=,,IC50,nM,,25.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25.5
432198,17792306,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2[C@H](C)F)n1)c1ncc(-c2cccc(C(F)(F)F)c2F)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '16.27', 'le': '0.31', 'lle': '3.10', 'sei': '8.64'}",CHEMBL3891698,,CHEMBL3891698,8.05,False,http://www.openphacts.org/units/Nanomolar,2895363,=,37,True,=,,IC50,nM,,9.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,9.0
432199,17792307,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1ccc(-c2ccnc(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '14.47', 'le': '0.28', 'lle': '2.08', 'sei': '7.40'}",CHEMBL3964290,,CHEMBL3964290,6.89,False,http://www.openphacts.org/units/Nanomolar,2895364,=,37,True,=,,IC50,nM,,128.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,128.0
432200,17792308,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cnc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4[C@H](C)F)n3)nc2)ccc1F,,,CHEMBL3886939,,2016.0,"{'bei': '17.48', 'le': '0.33', 'lle': '3.46', 'sei': '8.27'}",CHEMBL3977806,,CHEMBL3977806,7.70,False,http://www.openphacts.org/units/Nanomolar,2895365,=,37,True,=,,IC50,nM,,20.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,20.0
432201,17792309,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2CF)n1)c1cn(-c2ccc(F)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '18.26', 'le': '0.34', 'lle': '4.04', 'sei': '8.58'}",CHEMBL3969410,,CHEMBL3969410,7.31,False,http://www.openphacts.org/units/Nanomolar,2895366,=,37,True,=,,IC50,nM,,49.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,49.0
432202,17792310,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2CF)n1)c1cn(-c2ccc(F)c(Cl)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '16.55', 'le': '0.33', 'lle': '3.43', 'sei': '8.80'}",CHEMBL3909346,,CHEMBL3909346,7.50,False,http://www.openphacts.org/units/Nanomolar,2895327,=,37,True,=,,IC50,nM,,32.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,32.0
432203,17792311,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2CF)n1)c1cn(-c2ccc(Cl)c(F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '17.76', 'le': '0.35', 'lle': '3.80', 'sei': '9.07'}",CHEMBL3961820,,CHEMBL3961820,7.72,False,http://www.openphacts.org/units/Nanomolar,2895367,=,37,True,=,,IC50,nM,,19.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,19.0
432204,17792312,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2CF)n1)c1cn(-c2ccc(F)c(F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '17.00', 'le': '0.32', 'lle': '3.70', 'sei': '8.35'}",CHEMBL3892805,,CHEMBL3892805,7.11,False,http://www.openphacts.org/units/Nanomolar,2895368,=,37,True,=,,IC50,nM,,77.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,77.0
432205,17792313,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2CF)n1)c1cn(-c2ccc(C(F)F)c(F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '17.00', 'le': '0.33', 'lle': '3.45', 'sei': '8.99'}",CHEMBL3937532,,CHEMBL3937532,7.66,False,http://www.openphacts.org/units/Nanomolar,2895369,=,37,True,=,,IC50,nM,,22.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,22.0
432206,17792314,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cn(-c2ccc(Cl)cc2F)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '17.65', 'le': '0.35', 'lle': '3.61', 'sei': '9.30'}",CHEMBL3946068,,CHEMBL3946068,7.92,False,http://www.openphacts.org/units/Nanomolar,2895370,=,37,True,=,,IC50,nM,,12.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,12.0
432207,17792315,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cn(-c2ccc(Cl)cc2F)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '16.64', 'le': '0.33', 'lle': '3.32', 'sei': '9.12'}",CHEMBL3938883,,CHEMBL3938883,7.77,False,http://www.openphacts.org/units/Nanomolar,2895371,=,37,True,=,,IC50,nM,,17.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,17.0
432208,17792316,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cn(-c2ccc(F)cc2F)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '16.86', 'le': '0.32', 'lle': '3.49', 'sei': '8.56'}",CHEMBL3910943,,CHEMBL3910943,7.29,False,http://www.openphacts.org/units/Nanomolar,2895372,=,37,True,=,,IC50,nM,,51.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,51.0
432209,17792317,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cn(-c2ccc(F)cc2F)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '15.68', 'le': '0.30', 'lle': '3.12', 'sei': '8.29'}",CHEMBL3947679,,CHEMBL3947679,7.06,False,http://www.openphacts.org/units/Nanomolar,2895373,=,37,True,=,,IC50,nM,,87.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,87.0
432210,17792318,[],CHEMBL3889082,"Fluorescence Biochemical Assay: The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide phosphate (NADP+) and R (−)-2-hydroxyglutarate (2HG). The reaction can be monitored kinetically by following the oxidation of NADPH to NADP+ which is measured using fluorescence, excitation at 355 nm and emission at 530 nm. Reactions were monitored using the Perkin-Elmer Envision, Model 2101. More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Cat. No. 781076) using a final reaction volume of 20 μL and the following assay buffer conditions: 50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.02% BSA, 0.02% Tween-20, 10 μM NADPH and 100 μM α-KG. The final reaction mixture contained 2.5% DMSO and test compounds with concentrations ranging 0.0000008-25 μM. The IDH1 (R132H) enzyme was used at a final concentration of 10 nM.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2CF)n1)c1ncc(-c2ccc(Cl)cc2)o1,,,CHEMBL3886939,,2016.0,"{'bei': '17.83', 'le': '0.35', 'lle': '3.38', 'sei': '8.32'}",CHEMBL3923366,,CHEMBL3923366,7.77,False,http://www.openphacts.org/units/Nanomolar,2895374,=,37,True,=,,IC50,nM,,17.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,17.0
432211,17792319,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)OC(C)(C)C)n3)n2)ccc1Cl,,,CHEMBL3886939,,2016.0,"{'bei': '11.37', 'le': '0.22', 'lle': '0.51', 'sei': '4.93'}",CHEMBL4108047,,CHEMBL4108047,5.70,False,http://www.openphacts.org/units/Nanomolar,2894934,=,37,True,=,,IC50,nM,,2010.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2010.0
432212,17792320,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)OC(C)(C)C)n3)n2)ccc1F,,,CHEMBL3886939,,2016.0,"{'bei': '11.21', 'le': '0.21', 'lle': '0.75', 'sei': '4.70'}",CHEMBL4108555,,CHEMBL4108555,5.43,False,http://www.openphacts.org/units/Nanomolar,2894935,=,37,True,=,,IC50,nM,,3684.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3684.0
432213,17792321,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,COc1cc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)OC(C)(C)C)n3)n2)ccc1Cl,,,CHEMBL3886939,,2016.0,"{'bei': '11.46', 'le': '0.22', 'lle': '1.04', 'sei': '4.75'}",CHEMBL4109350,,CHEMBL4109350,5.93,False,http://www.openphacts.org/units/Nanomolar,2894936,=,37,True,=,,IC50,nM,,1185.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1185.0
432214,17792322,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)OC(C)(C)C)n1)c1nc(-c2ccc(Cl)c(OC(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '9.66', 'le': '0.19', 'lle': '-0.27', 'sei': '4.42'}",CHEMBL4113250,,CHEMBL4113250,5.51,False,http://www.openphacts.org/units/Nanomolar,2894937,=,37,True,=,,IC50,nM,,3068.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3068.0
432215,17792323,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)OC(C)(C)C)n1)c1nc(-c2ccc3ccn(C)c3c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '11.49', 'le': '0.21', 'lle': '1.09', 'sei': '4.82'}",CHEMBL4112574,,CHEMBL4112574,5.81,False,http://www.openphacts.org/units/Nanomolar,2894938,=,37,True,=,,IC50,nM,,1552.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1552.0
432216,17792324,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)OC(C)(C)C)n1)c1nc(-c2cccc(C(C)(C)C)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '10.85', 'le': '0.20', 'lle': '-0.01', 'sei': '4.78'}",CHEMBL4113299,,CHEMBL4113299,5.52,False,http://www.openphacts.org/units/Nanomolar,2894939,=,37,True,=,,IC50,nM,,3019.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3019.0
432217,17792325,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)OC(C)(C)C)n1)c1nc(-c2cccc(OC(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '10.75', 'le': '0.21', 'lle': '0.64', 'sei': '4.62'}",CHEMBL4112386,,CHEMBL4112386,5.77,False,http://www.openphacts.org/units/Nanomolar,2894940,=,37,True,=,,IC50,nM,,1710.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1710.0
432218,17792326,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)OC(C)(C)C)n1)c1nc(-c2ccc(F)c(OC(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '10.12', 'le': '0.20', 'lle': '0.34', 'sei': '4.50'}",CHEMBL4113397,,CHEMBL4113397,5.61,False,http://www.openphacts.org/units/Nanomolar,2894941,=,37,True,=,,IC50,nM,,2453.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2453.0
432219,17792327,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)c1ccc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)OC(C)(C)C)n3)n2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '12.23', 'le': '0.23', 'lle': '0.70', 'sei': '5.24'}",CHEMBL4111511,,CHEMBL4111511,6.05,False,http://www.openphacts.org/units/Nanomolar,2894942,=,37,True,=,,IC50,nM,,892.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,892.0
432220,17792328,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc2c(-c3noc(C(C)Nc4nccc(N5C(=O)OC[C@@H]5[C@@H](C)OC(C)(C)C)n4)n3)cccc2n1C,,,CHEMBL3886939,,2016.0,,CHEMBL4107739,,CHEMBL4107739,,False,http://www.openphacts.org/units/Nanomolar,2894943,>,37,True,>,,IC50,nM,,5000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5000.0
432221,17792329,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1nc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)OC(C)(C)C)n2)oc1-c1ccc(Cl)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '12.18', 'le': '0.24', 'lle': '0.29', 'sei': '5.94'}",CHEMBL4112175,,CHEMBL4112175,6.09,False,http://www.openphacts.org/units/Nanomolar,2894944,=,37,True,=,,IC50,nM,,813.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,813.0
432222,17792330,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(O)[C@H]1COC(=O)N1c1nc(N[C@@H](C)C2CCN(c3ccc(Cl)c(OC(F)(F)F)c3)CC2)ncc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.15', 'le': '0.31', 'lle': '3.71', 'sei': '8.30'}",CHEMBL3950128,,CHEMBL3950128,8.30,False,http://www.openphacts.org/units/Nanomolar,2895375,=,37,True,=,,IC50,nM,,5.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5.0
432223,17792331,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(O)[C@H]1COC(=O)N1c1nc(N[C@@H](C)C2CCN(c3ccnc(C(C)(C)C(F)(F)F)c3)CC2)ncc1F,,,CHEMBL3886939,,2016.0,"{'bei': '14.00', 'le': '0.27', 'lle': '3.30', 'sei': '7.30'}",CHEMBL3946830,,CHEMBL3946830,7.57,False,http://www.openphacts.org/units/Nanomolar,2895376,=,37,True,=,,IC50,nM,,27.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,27.0
432224,17792332,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(C1COC(=O)N1c1ccnc(N[C@@H](C)c2nc(-c3ccc(Cl)cc3)no2)n1)C(F)(F)F,,,CHEMBL3886939,,2016.0,"{'bei': '13.10', 'le': '0.26', 'lle': '1.45', 'sei': '5.95'}",CHEMBL3980188,,CHEMBL3980188,6.33,False,http://www.openphacts.org/units/Nanomolar,2894947,=,37,True,=,,IC50,nM,,472.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,472.0
432225,17792333,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(C1COC(=O)N1c1ccnc(N[C@@H](C)c2nc(-c3ccc(Cl)cc3)no2)n1)C(F)(F)F,,,CHEMBL3886939,,2016.0,"{'bei': '12.68', 'le': '0.25', 'lle': '1.24', 'sei': '5.76'}",CHEMBL3980188,,CHEMBL3980188,6.12,False,http://www.openphacts.org/units/Nanomolar,2894947,=,37,True,=,,IC50,nM,,757.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,757.0
432226,17792334,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(C1COC(=O)N1c1ccnc(N[C@@H](C)c2nc(-c3ccc(Cl)cc3)no2)n1)C(F)(F)F,,,CHEMBL3886939,,2016.0,"{'bei': '16.57', 'le': '0.33', 'lle': '3.12', 'sei': '7.53'}",CHEMBL3980188,,CHEMBL3980188,8.00,False,http://www.openphacts.org/units/Nanomolar,2894947,=,37,True,=,,IC50,nM,,10.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,10.0
432227,17792335,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(C1COC(=O)N1c1ccnc(N[C@@H](C)c2nc(-c3ccc(Cl)cc3)no2)n1)C(F)(F)F,,,CHEMBL3886939,,2016.0,"{'bei': '11.77', 'le': '0.24', 'lle': '0.80', 'sei': '5.35'}",CHEMBL3980188,,CHEMBL3980188,5.68,False,http://www.openphacts.org/units/Nanomolar,2894947,=,37,True,=,,IC50,nM,,2085.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2085.0
432228,17792336,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(C1COC(=O)N1c1nc(N[C@@H](C)c2ccc(CO)c(F)c2)ncc1F)C(F)(F)F,,,CHEMBL3886939,,2016.0,"{'bei': '13.95', 'le': '0.27', 'lle': '2.29', 'sei': '7.11'}",CHEMBL3910230,,CHEMBL3910230,6.23,False,http://www.openphacts.org/units/Nanomolar,2894948,=,37,True,=,,IC50,nM,,590.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,590.0
432229,17792337,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2cccc(Cl)c2Cl)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '15.27', 'le': '0.31', 'lle': '3.14', 'sei': '6.40'}",CHEMBL4111396,,CHEMBL4111396,7.26,False,http://www.openphacts.org/units/Nanomolar,2894949,=,37,True,=,,IC50,nM,,55.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,55.0
432230,17792338,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccccc1,,,CHEMBL3886939,,2016.0,"{'bei': '16.62', 'le': '0.31', 'lle': '3.10', 'sei': '6.23'}",CHEMBL3932532,,CHEMBL3932532,5.46,False,http://www.openphacts.org/units/Nanomolar,2894950,=,37,True,=,,IC50,nM,,3497.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3497.0
432231,17792339,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(OC(F)(F)F)c(Cl)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '10.54', 'le': '0.21', 'lle': '1.47', 'sei': '4.00'}",CHEMBL4109008,,CHEMBL4109008,5.43,False,http://www.openphacts.org/units/Nanomolar,2894951,=,37,True,=,,IC50,nM,,3745.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3745.0
432232,17792340,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(OC(F)(F)F)c(Cl)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '14.09', 'le': '0.28', 'lle': '3.29', 'sei': '5.34'}",CHEMBL4109008,,CHEMBL4109008,7.25,False,http://www.openphacts.org/units/Nanomolar,2894951,=,37,True,=,,IC50,nM,,56.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,56.0
432233,17792341,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(F)cc1-c1cnc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)nc1,,,CHEMBL3886939,,2016.0,"{'bei': '15.23', 'le': '0.28', 'lle': '3.42', 'sei': '5.89'}",CHEMBL4114968,,CHEMBL4114968,6.68,False,http://www.openphacts.org/units/Nanomolar,2894952,=,37,True,=,,IC50,nM,,211.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,211.0
432234,17792342,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2ccc(C(F)(F)F)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '13.56', 'le': '0.26', 'lle': '2.60', 'sei': '5.67'}",CHEMBL4108591,,CHEMBL4108591,6.43,False,http://www.openphacts.org/units/Nanomolar,2894953,=,37,True,=,,IC50,nM,,370.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,370.0
432235,17792343,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cnc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)nc2)ccc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.39', 'le': '0.29', 'lle': '3.49', 'sei': '5.95'}",CHEMBL4110531,,CHEMBL4110531,6.75,False,http://www.openphacts.org/units/Nanomolar,2894954,=,37,True,=,,IC50,nM,,179.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,179.0
432236,17792344,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(C(C)(C)C)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '15.03', 'le': '0.28', 'lle': '3.37', 'sei': '5.12'}",CHEMBL4108175,,CHEMBL4108175,5.81,False,http://www.openphacts.org/units/Nanomolar,2894955,=,37,True,=,,IC50,nM,,1557.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1557.0
432237,17792345,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2cccc(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '15.49', 'le': '0.30', 'lle': '3.52', 'sei': '6.48'}",CHEMBL4111762,,CHEMBL4111762,7.35,False,http://www.openphacts.org/units/Nanomolar,2895377,=,37,True,=,,IC50,nM,,45.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,45.0
432238,17792346,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(Oc2ccccc2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '17.78', 'le': '0.33', 'lle': '3.32', 'sei': '7.72'}",CHEMBL3934588,,CHEMBL3934588,7.47,False,http://www.openphacts.org/units/Nanomolar,2894956,=,37,True,=,,IC50,nM,,33.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,33.5
432239,17792347,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(Oc2ccc(F)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '13.41', 'le': '0.25', 'lle': '2.83', 'sei': '4.82'}",CHEMBL4111672,,CHEMBL4111672,5.91,False,http://www.openphacts.org/units/Nanomolar,2894957,=,37,True,=,,IC50,nM,,1237.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1237.0
432240,17792348,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)O)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '13.26', 'le': '0.26', 'lle': '2.65', 'sei': '4.52'}",CHEMBL3903450,,CHEMBL3903450,5.71,False,http://www.openphacts.org/units/Nanomolar,2894958,=,37,True,=,,IC50,nM,,1930.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1930.0
432241,17792349,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnc(-c2cccc(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '15.69', 'le': '0.30', 'lle': '3.61', 'sei': '6.57'}",CHEMBL3974384,,CHEMBL3974384,7.44,False,http://www.openphacts.org/units/Nanomolar,2894959,=,37,True,=,,IC50,nM,,36.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,36.0
432242,17792350,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(O)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCN(C)C(C)(C)C3)c(F)c2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '12.56', 'le': '0.24', 'lle': '3.09', 'sei': '6.50'}",CHEMBL3946813,,CHEMBL3946813,6.11,False,http://www.openphacts.org/units/Nanomolar,2894960,=,37,True,=,,IC50,nM,,775.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,775.0
432243,17792351,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(CN2CCC(F)(F)CC2)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '14.65', 'le': '0.28', 'lle': '3.30', 'sei': '7.74'}",CHEMBL3935677,,CHEMBL3935677,7.03,False,http://www.openphacts.org/units/Nanomolar,2895378,=,37,True,=,,IC50,nM,,94.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,94.0
432244,17792352,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2ccc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)nc2)ccc1F,,,CHEMBL3886939,,2016.0,"{'bei': '16.84', 'le': '0.31', 'lle': '3.50', 'sei': '7.33'}",CHEMBL3941489,,CHEMBL3941489,7.37,False,http://www.openphacts.org/units/Nanomolar,2894961,=,37,True,=,,IC50,nM,,43.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,43.0
432245,17792353,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2cccc(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '16.47', 'le': '0.31', 'lle': '3.36', 'sei': '7.76'}",CHEMBL3980106,,CHEMBL3980106,7.80,False,http://www.openphacts.org/units/Nanomolar,2894962,=,37,True,=,,IC50,nM,,16.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,16.0
432246,17792354,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2ccc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)cn2)ccc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.34', 'le': '0.29', 'lle': '2.84', 'sei': '6.68'}",CHEMBL3974345,,CHEMBL3974345,6.71,False,http://www.openphacts.org/units/Nanomolar,2894963,=,37,True,=,,IC50,nM,,194.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,194.0
432247,17792355,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2cccc(C(F)(F)F)c2)nc1,,,CHEMBL3886939,,2016.0,"{'bei': '15.27', 'le': '0.29', 'lle': '2.79', 'sei': '7.20'}",CHEMBL3895367,,CHEMBL3895367,7.23,False,http://www.openphacts.org/units/Nanomolar,2894964,=,37,True,=,,IC50,nM,,59.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,59.0
432248,17792356,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cnc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)cn2)ccc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.79', 'le': '0.30', 'lle': '3.66', 'sei': '6.11'}",CHEMBL3955523,,CHEMBL3955523,6.92,False,http://www.openphacts.org/units/Nanomolar,2894965,=,37,True,=,,IC50,nM,,119.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,119.0
432249,17792357,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2ccnc(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '13.68', 'le': '0.26', 'lle': '2.66', 'sei': '5.73'}",CHEMBL3970058,,CHEMBL3970058,6.49,False,http://www.openphacts.org/units/Nanomolar,2894966,=,37,True,=,,IC50,nM,,323.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,323.0
432250,17792358,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2ccc(C(F)(F)F)nc2)nc1,,,CHEMBL3886939,,2016.0,"{'bei': '12.25', 'le': '0.23', 'lle': '1.98', 'sei': '5.13'}",CHEMBL3963135,,CHEMBL3963135,5.81,False,http://www.openphacts.org/units/Nanomolar,2894967,=,37,True,=,,IC50,nM,,1549.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1549.0
432251,17792359,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2ccc(C(F)(F)F)nc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '12.53', 'le': '0.24', 'lle': '2.12', 'sei': '5.25'}",CHEMBL3986908,,CHEMBL3986908,5.95,False,http://www.openphacts.org/units/Nanomolar,2894968,=,37,True,=,,IC50,nM,,1131.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1131.0
432252,17792360,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2cccc(C(F)(F)F)n2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '15.89', 'le': '0.30', 'lle': '3.71', 'sei': '6.65'}",CHEMBL3981557,,CHEMBL3981557,7.54,False,http://www.openphacts.org/units/Nanomolar,2894969,=,37,True,=,,IC50,nM,,29.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,29.0
432253,17792361,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)ncc1-c1ccnc(C(F)(F)F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '15.32', 'le': '0.29', 'lle': '3.34', 'sei': '6.60'}",CHEMBL3949375,,CHEMBL3949375,7.48,True,http://www.openphacts.org/units/Nanomolar,2894970,=,37,True,=,,IC50,nM,,33.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,33.0
432254,17792362,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2ccnc(C(F)(F)F)c2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '13.60', 'le': '0.26', 'lle': '2.73', 'sei': '5.91'}",CHEMBL3973540,,CHEMBL3973540,6.70,False,http://www.openphacts.org/units/Nanomolar,2894971,=,37,True,=,,IC50,nM,,201.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,201.0
432255,17792363,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2ccnc(C(F)(F)F)c2)cnc1[C@H](C)Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1,,,CHEMBL3886939,,2016.0,"{'bei': '13.94', 'le': '0.27', 'lle': '2.67', 'sei': '6.00'}",CHEMBL3944057,,CHEMBL3944057,6.81,False,http://www.openphacts.org/units/Nanomolar,2894972,=,37,True,=,,IC50,nM,,156.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,156.0
432256,17792364,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1nc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)ccc1-c1ccnc(C(F)(F)F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '14.45', 'le': '0.28', 'lle': '2.92', 'sei': '6.23'}",CHEMBL3897899,,CHEMBL3897899,7.06,False,http://www.openphacts.org/units/Nanomolar,2894973,=,37,True,=,,IC50,nM,,87.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,87.0
432257,17792365,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2ccnc(C(C)(C)C)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '17.95', 'le': '0.33', 'lle': '4.19', 'sei': '7.32'}",CHEMBL3972554,,CHEMBL3972554,8.30,False,http://www.openphacts.org/units/Nanomolar,2894974,=,37,True,=,,IC50,nM,,5.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5.0
432258,17792366,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2ccnc(C(C)(C)C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '15.68', 'le': '0.30', 'lle': '3.45', 'sei': '7.14'}",CHEMBL3986728,,CHEMBL3986728,8.10,False,http://www.openphacts.org/units/Nanomolar,2894975,=,37,True,=,,IC50,nM,,8.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,8.0
432259,17792367,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(C#N)cc2)cs1,,,CHEMBL3886939,,2016.0,"{'bei': '14.28', 'le': '0.27', 'lle': '2.89', 'sei': '5.02'}",CHEMBL3958036,,CHEMBL3958036,6.24,False,http://www.openphacts.org/units/Nanomolar,2894976,=,37,True,=,,IC50,nM,,582.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,582.0
432260,17792368,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)cc2)on1,,,CHEMBL3886939,,2016.0,"{'bei': '16.70', 'le': '0.33', 'lle': '3.52', 'sei': '6.32'}",CHEMBL3891227,,CHEMBL3891227,7.18,False,http://www.openphacts.org/units/Nanomolar,2894977,=,37,True,=,,IC50,nM,,66.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,66.0
432261,17792369,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(Cl)cc2Cl)cs1,,,CHEMBL3886939,,2016.0,"{'bei': '12.16', 'le': '0.26', 'lle': '1.05', 'sei': '5.82'}",CHEMBL4111043,,CHEMBL4111043,5.84,False,http://www.openphacts.org/units/Nanomolar,2894978,=,37,True,=,,IC50,nM,,1437.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1437.0
432262,17792370,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(Cl)cc2Cl)cs1,,,CHEMBL3886939,,2016.0,"{'bei': '14.47', 'le': '0.31', 'lle': '2.16', 'sei': '6.92'}",CHEMBL3980854,,CHEMBL3980854,6.95,False,http://www.openphacts.org/units/Nanomolar,2894979,=,37,True,=,,IC50,nM,,112.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,112.0
432263,17792371,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(Br)cc2)cs1,,,CHEMBL3886939,,2016.0,,CHEMBL4114449,,CHEMBL4114449,,False,http://www.openphacts.org/units/Nanomolar,2894980,>,37,True,>,,IC50,nM,,5000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5000.0
432264,17792372,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(Br)cc2)cs1,,,CHEMBL3886939,,2016.0,"{'bei': '14.47', 'le': '0.32', 'lle': '2.86', 'sei': '7.06'}",CHEMBL3923916,,CHEMBL3923916,7.10,False,http://www.openphacts.org/units/Nanomolar,2894981,=,37,True,=,,IC50,nM,,80.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,80.0
432265,17792373,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(C#N)cc2)cs1,,,CHEMBL3886939,,2016.0,,CHEMBL4113247,,CHEMBL4113247,,False,http://www.openphacts.org/units/Nanomolar,2894982,>,37,True,>,,IC50,nM,,5000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5000.0
432266,17792374,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(CN2CCN(C)CC2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '11.16', 'le': '0.21', 'lle': '2.82', 'sei': '5.23'}",CHEMBL3899743,,CHEMBL3899743,4.92,False,http://www.openphacts.org/units/Nanomolar,2895379,=,37,True,=,,IC50,nM,,12152.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,12152.0
432267,17792375,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cnn(-c2ccc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)cc2F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '14.64', 'le': '0.28', 'lle': '3.25', 'sei': '5.92'}",CHEMBL4114399,,CHEMBL4114399,6.24,False,http://www.openphacts.org/units/Nanomolar,2894983,=,37,True,=,,IC50,nM,,571.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,571.0
432268,17792376,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2ccc(Cl)c(Cl)c2)[nH]1,,,CHEMBL3886939,,2016.0,,CHEMBL4111434,,CHEMBL4111434,,False,http://www.openphacts.org/units/Nanomolar,2895380,>,37,True,>,,IC50,nM,,5000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5000.0
432269,17792377,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(CN2CCC(F)(F)CC2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '13.52', 'le': '0.26', 'lle': '3.27', 'sei': '6.03'}",CHEMBL3936871,,CHEMBL3936871,6.25,False,http://www.openphacts.org/units/Nanomolar,2895381,=,37,True,=,,IC50,nM,,557.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,557.0
432270,17792378,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(CN2CCC(F)(F)CC2)nc1,,,CHEMBL3886939,,2016.0,"{'bei': '13.06', 'le': '0.25', 'lle': '3.06', 'sei': '5.82'}",CHEMBL3899936,,CHEMBL3899936,6.04,False,http://www.openphacts.org/units/Nanomolar,2895382,=,37,True,=,,IC50,nM,,911.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,911.0
432271,17792379,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnc(-c2cccc(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '11.79', 'le': '0.22', 'lle': '1.76', 'sei': '4.93'}",CHEMBL4113642,,CHEMBL4113642,5.59,False,http://www.openphacts.org/units/Nanomolar,2894984,=,37,True,=,,IC50,nM,,2560.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2560.0
432272,17792380,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cnc([C@@H](C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)cn2)ccc1F,,,CHEMBL3886939,,2016.0,,CHEMBL4106764,,CHEMBL4106764,,False,http://www.openphacts.org/units/Nanomolar,2894985,>,37,True,>,,IC50,nM,,5000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5000.0
432273,17792381,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2ccc(F)c(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '15.25', 'le': '0.29', 'lle': '3.54', 'sei': '6.62'}",CHEMBL3905290,,CHEMBL3905290,7.51,False,http://www.openphacts.org/units/Nanomolar,2894986,=,37,True,=,,IC50,nM,,31.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,31.0
432274,17792382,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2ccc(F)c(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '12.11', 'le': '0.23', 'lle': '1.99', 'sei': '5.26'}",CHEMBL4110054,,CHEMBL4110054,5.96,False,http://www.openphacts.org/units/Nanomolar,2895383,=,37,True,=,,IC50,nM,,1089.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1089.0
432275,17792383,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2ccc(Cl)c(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '15.05', 'le': '0.30', 'lle': '3.18', 'sei': '6.76'}",CHEMBL3976075,,CHEMBL3976075,7.66,False,http://www.openphacts.org/units/Nanomolar,2894987,=,37,True,=,,IC50,nM,,22.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,22.0
432276,17792384,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2ccc(Cl)c(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '12.40', 'le': '0.25', 'lle': '1.83', 'sei': '5.57'}",CHEMBL4113552,,CHEMBL4113552,6.31,False,http://www.openphacts.org/units/Nanomolar,2894988,=,37,True,=,,IC50,nM,,489.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,489.0
432277,17792385,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1ncc(-c2ccc(Cl)c(Cl)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '16.59', 'le': '0.34', 'lle': '3.77', 'sei': '6.96'}",CHEMBL3954956,,CHEMBL3954956,7.89,False,http://www.openphacts.org/units/Nanomolar,2894989,=,37,True,=,,IC50,nM,,13.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,13.0
432278,17792386,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2ccc(Cl)c(Cl)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '13.21', 'le': '0.27', 'lle': '2.16', 'sei': '5.54'}",CHEMBL4110091,,CHEMBL4110091,6.28,False,http://www.openphacts.org/units/Nanomolar,2894990,=,37,True,=,,IC50,nM,,524.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,524.0
432279,17792387,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2cccc(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '16.27', 'le': '0.31', 'lle': '3.89', 'sei': '6.81'}",CHEMBL3983576,,CHEMBL3983576,7.72,False,http://www.openphacts.org/units/Nanomolar,2894991,=,37,True,=,,IC50,nM,,19.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,19.0
432280,17792388,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2cccc(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,,CHEMBL4109628,,CHEMBL4109628,,False,http://www.openphacts.org/units/Nanomolar,2894992,>,37,True,>,,IC50,nM,,5000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5000.0
432281,17792389,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cnc([C@H](C)Nc3nccc(N4C(=O)OCC4[C@@H](C)O)n3)nc2)ccc1Cl,,,CHEMBL3886939,,2016.0,"{'bei': '16.42', 'le': '0.32', 'lle': '3.70', 'sei': '6.59'}",CHEMBL3969422,,CHEMBL3969422,7.47,False,http://www.openphacts.org/units/Nanomolar,2894993,=,37,True,=,,IC50,nM,,34.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,34.0
432282,17792390,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cnc([C@@H](C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)nc2)ccc1Cl,,,CHEMBL3886939,,2016.0,"{'bei': '12.64', 'le': '0.25', 'lle': '1.98', 'sei': '5.07'}",CHEMBL4107785,,CHEMBL4107785,5.75,False,http://www.openphacts.org/units/Nanomolar,2894994,=,37,True,=,,IC50,nM,,1776.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1776.0
432283,17792391,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1ncc(-c2cc(Cl)cc(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '15.50', 'le': '0.31', 'lle': '3.41', 'sei': '6.96'}",CHEMBL3894775,,CHEMBL3894775,7.89,False,http://www.openphacts.org/units/Nanomolar,2894995,=,37,True,=,,IC50,nM,,13.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,13.0
432284,17792392,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '12.93', 'le': '0.25', 'lle': '2.51', 'sei': '4.40'}",CHEMBL3940942,,CHEMBL3940942,5.57,False,http://www.openphacts.org/units/Nanomolar,2894997,=,37,True,=,,IC50,nM,,2687.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2687.5
432285,17792393,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '16.45', 'le': '0.32', 'lle': '4.03', 'sei': '5.60'}",CHEMBL4108363,,CHEMBL4108363,7.09,False,http://www.openphacts.org/units/Nanomolar,2894998,=,37,True,=,,IC50,nM,,81.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,81.5
432286,17792394,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nnc(-c2ccc(F)cc2)o1,,,CHEMBL3886939,,2016.0,"{'bei': '11.08', 'le': '0.21', 'lle': '2.05', 'sei': '3.63'}",CHEMBL4114500,,CHEMBL4114500,4.59,False,http://www.openphacts.org/units/Nanomolar,2894999,=,37,True,=,,IC50,nM,,25642.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25642.0
432287,17792395,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nnc(-c2ccc(F)cc2)o1,,,CHEMBL3886939,,2016.0,"{'bei': '14.37', 'le': '0.27', 'lle': '3.41', 'sei': '4.71'}",CHEMBL4109491,,CHEMBL4109491,5.95,False,http://www.openphacts.org/units/Nanomolar,2895000,=,37,True,=,,IC50,nM,,1113.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1113.0
432288,17792396,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(CCOc2ccccc2)no1,,,CHEMBL3886939,,2016.0,,CHEMBL4107669,,CHEMBL4107669,,False,http://www.openphacts.org/units/Nanomolar,2895384,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
432289,17792397,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(CCOc2ccccc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '13.64', 'le': '0.26', 'lle': '3.65', 'sei': '4.43'}",CHEMBL4108530,,CHEMBL4108530,6.01,False,http://www.openphacts.org/units/Nanomolar,2895001,=,37,True,=,,IC50,nM,,984.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,984.0
432290,17792398,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2nnc(C(C)Nc3nccc(N4C(=O)OCC4[C@@H](C)O)n3)o2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '15.38', 'le': '0.29', 'lle': '3.60', 'sei': '4.99'}",CHEMBL4109504,,CHEMBL4109504,6.31,False,http://www.openphacts.org/units/Nanomolar,2895002,=,37,True,=,,IC50,nM,,487.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,487.0
432291,17792399,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2nnc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)o2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '13.44', 'le': '0.25', 'lle': '2.80', 'sei': '4.36'}",CHEMBL4114305,,CHEMBL4114305,5.51,False,http://www.openphacts.org/units/Nanomolar,2895003,=,37,True,=,,IC50,nM,,3057.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3057.0
432292,17792400,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccc(F)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '11.45', 'le': '0.22', 'lle': '2.20', 'sei': '3.75'}",CHEMBL4109507,,CHEMBL4109507,4.74,False,http://www.openphacts.org/units/Nanomolar,2895385,=,37,True,=,,IC50,nM,,18066.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,18066.0
432293,17792401,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(F)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '15.06', 'le': '0.28', 'lle': '3.70', 'sei': '4.93'}",CHEMBL4106695,,CHEMBL4106695,6.24,False,http://www.openphacts.org/units/Nanomolar,2895386,=,37,True,=,,IC50,nM,,572.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,572.0
432294,17792402,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nnc(-c2ccccc2F)o1,,,CHEMBL3886939,,2016.0,,CHEMBL4114157,,CHEMBL4114157,,False,http://www.openphacts.org/units/Nanomolar,2895387,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
432295,17792403,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nnc(-c2ccccc2F)o1,,,CHEMBL3886939,,2016.0,"{'bei': '12.54', 'le': '0.24', 'lle': '2.66', 'sei': '4.11'}",CHEMBL4111117,,CHEMBL4111117,5.20,False,http://www.openphacts.org/units/Nanomolar,2895388,=,37,True,=,,IC50,nM,,6354.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6354.0
432296,17792404,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(-c2nnc(C(C)Nc3nccc(N4C(=O)OCC4[C@@H](C)O)n3)o2)c1,,,CHEMBL3886939,,2016.0,,CHEMBL4112998,,CHEMBL4112998,,False,http://www.openphacts.org/units/Nanomolar,2895004,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
432297,17792405,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(-c2nnc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)o2)c1,,,CHEMBL3886939,,2016.0,"{'bei': '14.04', 'le': '0.26', 'lle': '3.05', 'sei': '4.56'}",CHEMBL4109178,,CHEMBL4109178,5.76,False,http://www.openphacts.org/units/Nanomolar,2895005,=,37,True,=,,IC50,nM,,1720.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1720.0
432298,17792406,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1-c1nnc(C(C)Nc2nccc(N3C(=O)OCC3[C@@H](C)O)n2)o1,,,CHEMBL3886939,,2016.0,"{'bei': '10.92', 'le': '0.20', 'lle': '1.77', 'sei': '3.54'}",CHEMBL4109986,,CHEMBL4109986,4.48,False,http://www.openphacts.org/units/Nanomolar,2895006,=,37,True,=,,IC50,nM,,32926.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,32926.0
432299,17792407,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1-c1nnc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)o1,,,CHEMBL3886939,,2016.0,"{'bei': '14.25', 'le': '0.27', 'lle': '3.14', 'sei': '4.62'}",CHEMBL4108730,,CHEMBL4108730,5.85,False,http://www.openphacts.org/units/Nanomolar,2895007,=,37,True,=,,IC50,nM,,1416.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1416.0
432300,17792408,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1sc(C(C)Nc2nccc(N3C(=O)OCC3[C@@H](C)O)n2)nc1-c1ccc(Cl)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '11.37', 'le': '0.23', 'lle': '0.79', 'sei': '5.20'}",CHEMBL4106771,,CHEMBL4106771,5.23,False,http://www.openphacts.org/units/Nanomolar,2895008,=,37,True,=,,IC50,nM,,5902.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5902.0
432301,17792409,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1sc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)nc1-c1ccc(Cl)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '14.83', 'le': '0.30', 'lle': '2.38', 'sei': '6.79'}",CHEMBL4112249,,CHEMBL4112249,6.82,False,http://www.openphacts.org/units/Nanomolar,2895009,=,37,True,=,,IC50,nM,,151.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,151.5
432302,17792410,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nnc(-c2cccc(F)c2)o1,,,CHEMBL3886939,,2016.0,"{'bei': '11.17', 'le': '0.21', 'lle': '2.09', 'sei': '3.66'}",CHEMBL4109729,,CHEMBL4109729,4.63,False,http://www.openphacts.org/units/Nanomolar,2895010,=,37,True,=,,IC50,nM,,23402.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,23402.0
432303,17792411,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nnc(-c2cccc(F)c2)o1,,,CHEMBL3886939,,2016.0,"{'bei': '13.16', 'le': '0.25', 'lle': '2.91', 'sei': '4.31'}",CHEMBL4106793,,CHEMBL4106793,5.46,False,http://www.openphacts.org/units/Nanomolar,2895011,=,37,True,=,,IC50,nM,,3511.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3511.0
432304,17792412,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nnc(-c2cccnc2)o1,,,CHEMBL3886939,,2016.0,,CHEMBL4111104,,CHEMBL4111104,,False,http://www.openphacts.org/units/Nanomolar,2895012,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
432305,17792413,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nnc(-c2cccnc2)o1,,,CHEMBL3886939,,2016.0,"{'bei': '11.01', 'le': '0.21', 'lle': '2.57', 'sei': '3.14'}",CHEMBL4107386,,CHEMBL4107386,4.37,False,http://www.openphacts.org/units/Nanomolar,2895013,=,37,True,=,,IC50,nM,,42325.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,42325.0
432306,17792414,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1noc(Cc2ccccc2)n1,,,CHEMBL3886939,,2016.0,,CHEMBL4110975,,CHEMBL4110975,,False,http://www.openphacts.org/units/Nanomolar,2895014,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
432307,17792415,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1noc(Cc2ccccc2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '13.22', 'le': '0.25', 'lle': '3.09', 'sei': '4.29'}",CHEMBL4109470,,CHEMBL4109470,5.42,False,http://www.openphacts.org/units/Nanomolar,2895015,=,37,True,=,,IC50,nM,,3760.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3760.0
432308,17792416,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OCC2[C@@H](C)O)n1)c1noc(Cc2ccccc2)n1,,,CHEMBL3886939,,2016.0,,CHEMBL4113072,,CHEMBL4113072,,False,http://www.openphacts.org/units/Nanomolar,2895016,>,37,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50000.0
432309,17792417,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1noc(Cc2ccccc2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '13.30', 'le': '0.25', 'lle': '3.23', 'sei': '4.50'}",CHEMBL4112948,,CHEMBL4112948,5.70,False,http://www.openphacts.org/units/Nanomolar,2895017,=,37,True,=,,IC50,nM,,2010.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2010.0
432310,17792418,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccc(Br)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '12.23', 'le': '0.26', 'lle': '2.64', 'sei': '4.60'}",CHEMBL4110035,,CHEMBL4110035,5.81,False,http://www.openphacts.org/units/Nanomolar,2895018,=,37,True,=,,IC50,nM,,1539.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1539.0
432311,17792419,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(Br)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '15.67', 'le': '0.34', 'lle': '4.28', 'sei': '5.89'}",CHEMBL4114429,,CHEMBL4114429,7.45,False,http://www.openphacts.org/units/Nanomolar,2895019,=,37,True,=,,IC50,nM,,35.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,35.5
432312,17792420,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2noc(C(C)Nc3nccc(N4C(=O)OCC4[C@@H](C)O)n3)n2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '13.01', 'le': '0.25', 'lle': '2.72', 'sei': '4.41'}",CHEMBL4111250,,CHEMBL4111250,5.57,False,http://www.openphacts.org/units/Nanomolar,2895389,=,37,True,=,,IC50,nM,,2668.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2668.0
432313,17792421,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)n2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '16.81', 'le': '0.32', 'lle': '4.35', 'sei': '5.69'}",CHEMBL4112995,,CHEMBL4112995,7.20,False,http://www.openphacts.org/units/Nanomolar,2895020,=,37,True,=,,IC50,nM,,63.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,63.0
432314,17792422,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2noc(C(C)Nc3ncc(F)c(N4C(=O)OCC4[C@@H](C)O)n3)n2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '14.72', 'le': '0.28', 'lle': '3.58', 'sei': '5.20'}",CHEMBL4112147,,CHEMBL4112147,6.57,False,http://www.openphacts.org/units/Nanomolar,2895021,=,37,True,=,,IC50,nM,,268.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,268.0
432315,17792423,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2noc(C(C)Nc3ncc(F)c(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)n2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '16.97', 'le': '0.32', 'lle': '4.59', 'sei': '5.99'}",CHEMBL4112957,,CHEMBL4112957,7.58,False,http://www.openphacts.org/units/Nanomolar,2895022,=,37,True,=,,IC50,nM,,26.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,26.5
432316,17792424,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccc(F)c(F)c2)no1,,,CHEMBL3886939,,2016.0,,CHEMBL4109718,,CHEMBL4109718,,False,http://www.openphacts.org/units/Nanomolar,2895023,>,37,True,>,,IC50,nM,,25000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25000.0
432317,17792425,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(F)c(F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '15.46', 'le': '0.29', 'lle': '4.01', 'sei': '5.29'}",CHEMBL4113399,,CHEMBL4113399,6.69,False,http://www.openphacts.org/units/Nanomolar,2895024,=,37,True,=,,IC50,nM,,206.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,206.0
432318,17792426,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)c(Cl)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '14.36', 'le': '0.29', 'lle': '2.35', 'sei': '5.87'}",CHEMBL4106862,,CHEMBL4106862,6.67,False,http://www.openphacts.org/units/Nanomolar,2895025,=,37,True,=,,IC50,nM,,216.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,216.0
432319,17792427,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)c(Cl)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '16.23', 'le': '0.33', 'lle': '3.22', 'sei': '6.63'}",CHEMBL4113911,,CHEMBL4113911,7.54,False,http://www.openphacts.org/units/Nanomolar,2895026,=,37,True,=,,IC50,nM,,29.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,29.0
432320,17792428,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)cc2Cl)no1,,,CHEMBL3886939,,2016.0,"{'bei': '15.40', 'le': '0.31', 'lle': '2.83', 'sei': '6.29'}",CHEMBL4115076,,CHEMBL4115076,7.15,False,http://www.openphacts.org/units/Nanomolar,2895027,=,37,True,=,,IC50,nM,,71.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,71.0
432321,17792429,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)cc2Cl)no1,,,CHEMBL3886939,,2016.0,"{'bei': '11.95', 'le': '0.24', 'lle': '1.23', 'sei': '4.89'}",CHEMBL4115076,,CHEMBL4115076,5.55,False,http://www.openphacts.org/units/Nanomolar,2895027,=,37,True,=,,IC50,nM,,2814.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2814.0
432322,17792430,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccc(F)c(F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '12.26', 'le': '0.24', 'lle': '2.70', 'sei': '4.37'}",CHEMBL4110375,,CHEMBL4110375,5.52,False,http://www.openphacts.org/units/Nanomolar,2895028,=,37,True,=,,IC50,nM,,2999.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2999.0
432323,17792431,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(F)c(F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '15.08', 'le': '0.29', 'lle': '3.97', 'sei': '5.37'}",CHEMBL4106922,,CHEMBL4106922,6.79,False,http://www.openphacts.org/units/Nanomolar,2895029,=,37,True,=,,IC50,nM,,162.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,162.0
432324,17792432,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OCC2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)c(Cl)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '12.12', 'le': '0.25', 'lle': '1.39', 'sei': '5.15'}",CHEMBL4108085,,CHEMBL4108085,5.85,False,http://www.openphacts.org/units/Nanomolar,2895030,=,37,True,=,,IC50,nM,,1421.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1421.0
432325,17792433,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)c(Cl)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '17.05', 'le': '0.35', 'lle': '3.76', 'sei': '7.24'}",CHEMBL4107257,,CHEMBL4107257,8.22,False,http://www.openphacts.org/units/Nanomolar,2895031,=,37,True,=,,IC50,nM,,6.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6.0
432326,17792434,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OCC2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)cc2Cl)no1,,,CHEMBL3886939,,2016.0,"{'bei': '11.67', 'le': '0.24', 'lle': '1.17', 'sei': '4.95'}",CHEMBL4108905,,CHEMBL4108905,5.63,False,http://www.openphacts.org/units/Nanomolar,2895032,=,37,True,=,,IC50,nM,,2360.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2360.0
432327,17792435,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)cc2Cl)no1,,,CHEMBL3886939,,2016.0,"{'bei': '16.16', 'le': '0.33', 'lle': '3.34', 'sei': '6.86'}",CHEMBL4109329,,CHEMBL4109329,7.80,False,http://www.openphacts.org/units/Nanomolar,2895033,=,37,True,=,,IC50,nM,,16.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,16.0
432328,17792436,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccc(F)c(Cl)c2)cs1,,,CHEMBL3886939,,2016.0,,CHEMBL4110198,,CHEMBL4110198,,False,http://www.openphacts.org/units/Nanomolar,2895034,>,37,True,>,,IC50,nM,,5000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5000.0
432329,17792437,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(F)c(Cl)c2)cs1,,,CHEMBL3886939,,2016.0,"{'bei': '14.08', 'le': '0.29', 'lle': '2.26', 'sei': '6.50'}",CHEMBL4113298,,CHEMBL4113298,6.53,False,http://www.openphacts.org/units/Nanomolar,2895035,=,37,True,=,,IC50,nM,,294.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,294.0
432330,17792438,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OCC2[C@@H](C)O)n1)c1ncc(-c2cccc(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '15.47', 'le': '0.30', 'lle': '3.65', 'sei': '6.72'}",CHEMBL4107825,,CHEMBL4107825,7.62,False,http://www.openphacts.org/units/Nanomolar,2895036,=,37,True,=,,IC50,nM,,24.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,24.0
432331,17792439,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2cccc(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '13.88', 'le': '0.27', 'lle': '2.87', 'sei': '6.03'}",CHEMBL4111352,,CHEMBL4111352,6.84,False,http://www.openphacts.org/units/Nanomolar,2895037,=,37,True,=,,IC50,nM,,146.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,146.0
432332,17792440,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1cnc(-c2ccccc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '13.11', 'le': '0.25', 'lle': '1.91', 'sei': '5.37'}",CHEMBL4113146,,CHEMBL4113146,5.39,False,http://www.openphacts.org/units/Nanomolar,2895038,=,37,True,=,,IC50,nM,,4032.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4032.0
432333,17792441,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnc(-c2ccccc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '16.85', 'le': '0.33', 'lle': '3.46', 'sei': '6.90'}",CHEMBL4106644,,CHEMBL4106644,6.94,False,http://www.openphacts.org/units/Nanomolar,2895039,=,37,True,=,,IC50,nM,,116.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,116.0
432334,17792442,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2cccc(Cl)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '12.53', 'le': '0.25', 'lle': '2.34', 'sei': '4.27'}",CHEMBL4114894,,CHEMBL4114894,5.40,False,http://www.openphacts.org/units/Nanomolar,2895040,=,37,True,=,,IC50,nM,,3977.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3977.0
432335,17792443,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2cccc(Cl)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '14.49', 'le': '0.28', 'lle': '3.18', 'sei': '4.93'}",CHEMBL4106699,,CHEMBL4106699,6.24,False,http://www.openphacts.org/units/Nanomolar,2895041,=,37,True,=,,IC50,nM,,572.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,572.0
432336,17792444,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)c1ccc(-c2noc(C(C)Nc3nccc(N4C(=O)OCC4[C@@H](C)O)n3)n2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '13.17', 'le': '0.25', 'lle': '2.24', 'sei': '4.56'}",CHEMBL4113742,,CHEMBL4113742,5.77,False,http://www.openphacts.org/units/Nanomolar,2895042,=,37,True,=,,IC50,nM,,1685.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1685.0
432337,17792445,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)c1ccc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)n2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '16.98', 'le': '0.32', 'lle': '3.91', 'sei': '5.88'}",CHEMBL4110669,,CHEMBL4110669,7.44,False,http://www.openphacts.org/units/Nanomolar,2895043,=,37,True,=,,IC50,nM,,36.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,36.0
432338,17792446,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccccc2OC(F)(F)F)no1,,,CHEMBL3886939,,2016.0,,CHEMBL4106798,,CHEMBL4106798,,False,http://www.openphacts.org/units/Nanomolar,2895390,>,37,True,>,,IC50,nM,,5000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5000.0
432339,17792447,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccccc2OC(F)(F)F)no1,,,CHEMBL3886939,,2016.0,"{'bei': '13.39', 'le': '0.26', 'lle': '3.13', 'sei': '4.74'}",CHEMBL4107175,,CHEMBL4107175,6.43,False,http://www.openphacts.org/units/Nanomolar,2895391,=,37,True,=,,IC50,nM,,368.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,368.0
432340,17792448,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2noc(C(C)Nc3nccc(N4C(=O)OCC4[C@@H](C)O)n3)n2)ccc1F,,,CHEMBL3886939,,2016.0,,CHEMBL4115631,,CHEMBL4115631,,False,http://www.openphacts.org/units/Nanomolar,2895044,>,37,True,>,,IC50,nM,,5000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5000.0
432341,17792449,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)n2)ccc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.68', 'le': '0.30', 'lle': '3.87', 'sei': '5.31'}",CHEMBL4107361,,CHEMBL4107361,6.72,False,http://www.openphacts.org/units/Nanomolar,2895045,=,37,True,=,,IC50,nM,,192.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,192.0
432342,17792450,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(-c2noc(C(C)Nc3ncc(F)c(N4C(=O)OCC4[C@@H](C)O)n3)n2)cc1,,,CHEMBL3886939,,2016.0,,CHEMBL4113246,,CHEMBL4113246,,False,http://www.openphacts.org/units/Nanomolar,2895392,>,37,True,>,,IC50,nM,,5000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5000.0
432343,17792451,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(-c2noc(C(C)Nc3ncc(F)c(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)n2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '17.90', 'le': '0.34', 'lle': '4.81', 'sei': '6.26'}",CHEMBL4115160,,CHEMBL4115160,7.92,False,http://www.openphacts.org/units/Nanomolar,2895046,=,37,True,=,,IC50,nM,,12.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,12.0
432344,17792452,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2nnc(C(C)Nc3nccc(N4C(=O)OCC4[C@@H](C)O)n3)o2)cc1C,,,CHEMBL3886939,,2016.0,,CHEMBL4107474,,CHEMBL4107474,,False,http://www.openphacts.org/units/Nanomolar,2895047,>,37,True,>,,IC50,nM,,5000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5000.0
432345,17792453,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2nnc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)o2)cc1C,,,CHEMBL3886939,,2016.0,"{'bei': '15.41', 'le': '0.29', 'lle': '3.52', 'sei': '5.17'}",CHEMBL4109054,,CHEMBL4109054,6.54,False,http://www.openphacts.org/units/Nanomolar,2895048,=,37,True,=,,IC50,nM,,288.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,288.0
432346,17792454,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2cccc3ccncc23)no1,,,CHEMBL3886939,,2016.0,"{'bei': '12.10', 'le': '0.22', 'lle': '2.47', 'sei': '3.89'}",CHEMBL4111649,,CHEMBL4111649,5.42,False,http://www.openphacts.org/units/Nanomolar,2895049,=,37,True,=,,IC50,nM,,3839.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3839.0
432347,17792455,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2cccc3ccncc23)no1,,,CHEMBL3886939,,2016.0,"{'bei': '13.56', 'le': '0.25', 'lle': '3.12', 'sei': '4.35'}",CHEMBL4111093,,CHEMBL4111093,6.07,False,http://www.openphacts.org/units/Nanomolar,2895050,=,37,True,=,,IC50,nM,,857.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,857.0
432348,17792456,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccc(Cl)cc2C(F)(F)F)no1,,,CHEMBL3886939,,2016.0,"{'bei': '11.91', 'le': '0.24', 'lle': '1.86', 'sei': '4.70'}",CHEMBL4114521,,CHEMBL4114521,5.94,False,http://www.openphacts.org/units/Nanomolar,2895051,=,37,True,=,,IC50,nM,,1145.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1145.0
432349,17792457,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(Cl)cc2C(F)(F)F)no1,,,CHEMBL3886939,,2016.0,"{'bei': '15.02', 'le': '0.30', 'lle': '3.41', 'sei': '5.92'}",CHEMBL4107415,,CHEMBL4107415,7.50,False,http://www.openphacts.org/units/Nanomolar,2895052,=,37,True,=,,IC50,nM,,32.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,32.0
432350,17792458,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)c1ccc(-c2noc(C(C)Nc3ncc(F)c(N4C(=O)OCC4[C@@H](C)O)n3)n2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '11.74', 'le': '0.22', 'lle': '1.69', 'sei': '4.24'}",CHEMBL4115105,,CHEMBL4115105,5.36,False,http://www.openphacts.org/units/Nanomolar,2895393,=,37,True,=,,IC50,nM,,4374.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4374.0
432351,17792459,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)c1ccc(-c2noc(C(C)Nc3ncc(F)c(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)n2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '18.01', 'le': '0.34', 'lle': '4.55', 'sei': '6.50'}",CHEMBL4114088,,CHEMBL4114088,8.22,False,http://www.openphacts.org/units/Nanomolar,2895053,=,37,True,=,,IC50,nM,,6.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6.0
432352,17792460,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2cccc(C(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '12.82', 'le': '0.25', 'lle': '2.53', 'sei': '4.71'}",CHEMBL4112846,,CHEMBL4112846,5.95,False,http://www.openphacts.org/units/Nanomolar,2895054,=,37,True,=,,IC50,nM,,1115.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1115.0
432353,17792461,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2cccc(C(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '14.03', 'le': '0.27', 'lle': '3.10', 'sei': '5.15'}",CHEMBL4110857,,CHEMBL4110857,6.52,False,http://www.openphacts.org/units/Nanomolar,2895055,=,37,True,=,,IC50,nM,,305.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,305.0
432354,17792462,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccc(F)c(OC(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,,CHEMBL4113541,,CHEMBL4113541,,False,http://www.openphacts.org/units/Nanomolar,2895056,>,37,True,>,,IC50,nM,,5000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5000.0
432355,17792463,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(F)c(OC(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '13.68', 'le': '0.27', 'lle': '3.38', 'sei': '5.02'}",CHEMBL4114277,,CHEMBL4114277,6.82,False,http://www.openphacts.org/units/Nanomolar,2895057,=,37,True,=,,IC50,nM,,152.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,152.0
432356,17792464,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2cccc(OC(F)F)c2)no1,,,CHEMBL3886939,,2016.0,,CHEMBL4115210,,CHEMBL4115210,,False,http://www.openphacts.org/units/Nanomolar,2895058,>,37,True,>,,IC50,nM,,5000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5000.0
432357,17792465,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2cccc(OC(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '14.09', 'le': '0.27', 'lle': '3.51', 'sei': '4.80'}",CHEMBL4108442,,CHEMBL4108442,6.52,False,http://www.openphacts.org/units/Nanomolar,2895059,=,37,True,=,,IC50,nM,,304.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,304.0
432358,17792466,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,COc1cc(-c2noc(C(C)Nc3nccc(N4C(=O)OCC4[C@@H](C)O)n3)n2)ccc1Cl,,,CHEMBL3886939,,2016.0,"{'bei': '14.35', 'le': '0.28', 'lle': '3.54', 'sei': '4.87'}",CHEMBL4112148,,CHEMBL4112148,6.61,False,http://www.openphacts.org/units/Nanomolar,2895060,=,37,True,=,,IC50,nM,,243.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,243.0
432359,17792467,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,COc1cc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)n2)ccc1Cl,,,CHEMBL3886939,,2016.0,"{'bei': '15.50', 'le': '0.30', 'lle': '4.08', 'sei': '5.26'}",CHEMBL4113375,,CHEMBL4113375,7.15,False,http://www.openphacts.org/units/Nanomolar,2895061,=,37,True,=,,IC50,nM,,71.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,71.5
432360,17792468,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccc3c(c2)OC(F)(F)O3)no1,,,CHEMBL3886939,,2016.0,,CHEMBL4112200,,CHEMBL4112200,,False,http://www.openphacts.org/units/Nanomolar,2895062,>,37,True,>,,IC50,nM,,5000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5000.0
432361,17792469,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc3c(c2)OC(F)(F)O3)no1,,,CHEMBL3886939,,2016.0,"{'bei': '15.09', 'le': '0.29', 'lle': '4.46', 'sei': '4.96'}",CHEMBL4115358,,CHEMBL4115358,7.19,False,http://www.openphacts.org/units/Nanomolar,2895063,=,37,True,=,,IC50,nM,,65.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,65.0
432362,17792470,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccc(Cl)c(C(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '11.48', 'le': '0.23', 'lle': '1.64', 'sei': '4.53'}",CHEMBL4109518,,CHEMBL4109518,5.72,False,http://www.openphacts.org/units/Nanomolar,2895064,=,37,True,=,,IC50,nM,,1884.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1884.0
432363,17792471,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(Cl)c(C(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '14.80', 'le': '0.30', 'lle': '3.30', 'sei': '5.84'}",CHEMBL4106763,,CHEMBL4106763,7.38,False,http://www.openphacts.org/units/Nanomolar,2895065,=,37,True,=,,IC50,nM,,41.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,41.5
432364,17792472,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(-c2noc(C(C)Nc3nccc(N4C(=O)OCC4[C@@H](C)O)n3)n2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '12.88', 'le': '0.24', 'lle': '2.50', 'sei': '4.32'}",CHEMBL4107496,,CHEMBL4107496,5.47,False,http://www.openphacts.org/units/Nanomolar,2895394,=,37,True,=,,IC50,nM,,3407.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3407.0
432365,17792473,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)n2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '17.43', 'le': '0.33', 'lle': '4.43', 'sei': '5.85'}",CHEMBL4114607,,CHEMBL4114607,7.40,False,http://www.openphacts.org/units/Nanomolar,2895066,=,37,True,=,,IC50,nM,,40.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,40.0
432366,17792474,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccc(C(F)(F)F)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '14.26', 'le': '0.27', 'lle': '3.20', 'sei': '5.24'}",CHEMBL4111513,,CHEMBL4111513,6.62,False,http://www.openphacts.org/units/Nanomolar,2895067,=,37,True,=,,IC50,nM,,238.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,238.0
432367,17792475,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(C(F)(F)F)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '15.74', 'le': '0.30', 'lle': '3.89', 'sei': '5.78'}",CHEMBL4110960,,CHEMBL4110960,7.31,False,http://www.openphacts.org/units/Nanomolar,2895068,=,37,True,=,,IC50,nM,,49.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,49.0
432368,17792476,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(CCc2ccccc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '12.58', 'le': '0.24', 'lle': '2.82', 'sei': '4.22'}",CHEMBL4114215,,CHEMBL4114215,5.34,False,http://www.openphacts.org/units/Nanomolar,2895069,=,37,True,=,,IC50,nM,,4591.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4591.0
432369,17792477,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(CCc2ccccc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '13.66', 'le': '0.26', 'lle': '3.28', 'sei': '4.58'}",CHEMBL4110130,,CHEMBL4110130,5.80,False,http://www.openphacts.org/units/Nanomolar,2895070,=,37,True,=,,IC50,nM,,1587.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1587.0
432370,17792478,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccc(Cl)c(OC(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '13.35', 'le': '0.27', 'lle': '3.01', 'sei': '5.24'}",CHEMBL4113355,,CHEMBL4113355,7.11,False,http://www.openphacts.org/units/Nanomolar,2895071,=,37,True,=,,IC50,nM,,77.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,77.0
432371,17792479,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(Cl)c(OC(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '15.50', 'le': '0.31', 'lle': '4.16', 'sei': '6.09'}",CHEMBL4106576,,CHEMBL4106576,8.26,False,http://www.openphacts.org/units/Nanomolar,2895072,=,37,True,=,,IC50,nM,,5.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5.5
432372,17792480,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccc(OC(F)(F)F)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '11.58', 'le': '0.22', 'lle': '2.26', 'sei': '4.10'}",CHEMBL4112369,,CHEMBL4112369,5.56,False,http://www.openphacts.org/units/Nanomolar,2895073,=,37,True,=,,IC50,nM,,2728.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2728.0
432373,17792481,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(OC(F)(F)F)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '14.39', 'le': '0.28', 'lle': '3.61', 'sei': '5.09'}",CHEMBL4110433,,CHEMBL4110433,6.91,False,http://www.openphacts.org/units/Nanomolar,2895074,=,37,True,=,,IC50,nM,,122.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,122.0
432374,17792482,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2cccc(OCC(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '11.85', 'le': '0.23', 'lle': '2.51', 'sei': '4.32'}",CHEMBL4109825,,CHEMBL4109825,5.86,False,http://www.openphacts.org/units/Nanomolar,2895075,=,37,True,=,,IC50,nM,,1378.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1378.0
432375,17792483,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2cccc(OCC(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '13.38', 'le': '0.26', 'lle': '3.26', 'sei': '4.87'}",CHEMBL4108222,,CHEMBL4108222,6.61,False,http://www.openphacts.org/units/Nanomolar,2895076,=,37,True,=,,IC50,nM,,243.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,243.0
432376,17792484,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1nc(C(C)Nc2nccc(N3C(=O)OCC3[C@@H](C)O)n2)oc1-c1ccc(Cl)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '13.79', 'le': '0.27', 'lle': '2.15', 'sei': '5.39'}",CHEMBL4106800,,CHEMBL4106800,6.12,False,http://www.openphacts.org/units/Nanomolar,2895077,=,37,True,=,,IC50,nM,,757.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,757.0
432377,17792485,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1nc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)oc1-c1ccc(Cl)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '17.30', 'le': '0.34', 'lle': '3.71', 'sei': '6.76'}",CHEMBL4114144,,CHEMBL4114144,7.68,False,http://www.openphacts.org/units/Nanomolar,2895078,=,37,True,=,,IC50,nM,,21.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,21.0
432378,17792486,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1nc(C(C)Nc2ncc(F)c(N3C(=O)OCC3[C@@H](C)O)n2)oc1-c1ccc(Cl)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '12.10', 'le': '0.24', 'lle': '1.48', 'sei': '4.92'}",CHEMBL4115671,,CHEMBL4115671,5.59,False,http://www.openphacts.org/units/Nanomolar,2895079,=,37,True,=,,IC50,nM,,2583.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2583.0
432379,17792487,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1nc(C(C)Nc2ncc(F)c(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)oc1-c1ccc(Cl)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '17.32', 'le': '0.34', 'lle': '3.89', 'sei': '7.04'}",CHEMBL4114829,,CHEMBL4114829,8.00,False,http://www.openphacts.org/units/Nanomolar,2895080,=,37,True,=,,IC50,nM,,10.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,10.0
432380,17792488,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1sc(C(C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)nc1-c1ccc(Cl)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '14.80', 'le': '0.30', 'lle': '2.37', 'sei': '6.78'}",CHEMBL4112249,,CHEMBL4112249,6.81,False,http://www.openphacts.org/units/Nanomolar,2895082,=,37,True,=,,IC50,nM,,156.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,156.0
432381,17792489,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OCC2[C@@H](C)O)n1)c1nc(-c2ccc(Br)cc2)cs1,,,CHEMBL3886939,,2016.0,"{'bei': '15.45', 'le': '0.35', 'lle': '3.47', 'sei': '7.82'}",CHEMBL4108741,,CHEMBL4108741,7.85,False,http://www.openphacts.org/units/Nanomolar,2895083,=,37,True,=,,IC50,nM,,14.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,14.0
432382,17792490,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OCC2[C@@H](C)O)n1)c1ncc(-c2ccc(Cl)c(Cl)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '16.22', 'le': '0.33', 'lle': '3.74', 'sei': '7.06'}",CHEMBL4111021,,CHEMBL4111021,8.00,False,http://www.openphacts.org/units/Nanomolar,2895395,=,37,True,=,,IC50,nM,,10.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,10.0
432383,17792491,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2ccc(Cl)c(Cl)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '13.07', 'le': '0.27', 'lle': '2.19', 'sei': '5.69'}",CHEMBL4109165,,CHEMBL4109165,6.45,False,http://www.openphacts.org/units/Nanomolar,2895396,=,37,True,=,,IC50,nM,,358.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,358.0
432384,17792492,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1nc(C(C)Nc2nccc(N3C(=O)OCC3[C@H](C)O)n2)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '15.47', 'le': '0.31', 'lle': '3.28', 'sei': '7.32'}",CHEMBL3984716,,CHEMBL3984716,8.30,False,http://www.openphacts.org/units/Nanomolar,2895087,=,37,True,=,,IC50,nM,,5.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5.0
432385,17792493,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1ncc(-c2cccc(C(F)(F)F)c2F)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '16.86', 'le': '0.32', 'lle': '4.33', 'sei': '7.32'}",CHEMBL4112644,,CHEMBL4112644,8.30,False,http://www.openphacts.org/units/Nanomolar,2895091,=,37,True,=,,IC50,nM,,5.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5.0
432386,17792494,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OCC2[C@@H](C)O)n1)c1ncc(-c2ccc(Cl)cc2)o1,,,CHEMBL3886939,,2016.0,"{'bei': '13.31', 'le': '0.26', 'lle': '2.16', 'sei': '5.25'}",CHEMBL4109380,,CHEMBL4109380,5.96,False,http://www.openphacts.org/units/Nanomolar,2895093,=,37,True,=,,IC50,nM,,1093.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1093.0
432387,17792495,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2ccc(Cl)cc2)o1,,,CHEMBL3886939,,2016.0,"{'bei': '18.08', 'le': '0.36', 'lle': '4.30', 'sei': '7.13'}",CHEMBL4113331,,CHEMBL4113331,8.10,False,http://www.openphacts.org/units/Nanomolar,2895094,=,37,True,=,,IC50,nM,,8.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,8.0
432388,17792496,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '17.35', 'le': '0.34', 'lle': '3.80', 'sei': '6.56'}",CHEMBL4109964,,CHEMBL4109964,7.46,False,http://www.openphacts.org/units/Nanomolar,2895095,=,37,True,=,,IC50,nM,,35.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,35.0
432389,17792497,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '13.23', 'le': '0.26', 'lle': '2.03', 'sei': '5.01'}",CHEMBL4114321,,CHEMBL4114321,5.69,False,http://www.openphacts.org/units/Nanomolar,2895096,=,37,True,=,,IC50,nM,,2052.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2052.0
432390,17792498,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2ccc(Cl)cc2)o1,,,CHEMBL3886939,,2016.0,"{'bei': '17.81', 'le': '0.35', 'lle': '4.00', 'sei': '6.74'}",CHEMBL3986787,,CHEMBL3986787,7.66,False,http://www.openphacts.org/units/Nanomolar,2895097,=,37,True,=,,IC50,nM,,22.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,22.0
432391,17792499,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3886939,,2016.0,,CHEMBL3961739,,CHEMBL3961739,,False,http://www.openphacts.org/units/Nanomolar,2895098,<,37,True,<,,IC50,nM,,22.86,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,22.8624
432392,17792500,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2cnn(C)c2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '14.72', 'le': '0.29', 'lle': '3.24', 'sei': '6.44'}",CHEMBL3953027,,CHEMBL3953027,6.79,False,http://www.openphacts.org/units/Nanomolar,2895100,=,37,True,=,,IC50,nM,,164.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,164.0
432393,17792501,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(C(F)F)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '13.37', 'le': '0.27', 'lle': '2.43', 'sei': '5.08'}",CHEMBL3951946,,CHEMBL3951946,6.43,False,http://www.openphacts.org/units/Nanomolar,2895101,=,37,True,=,,IC50,nM,,374.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,374.0
432394,17792502,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(N2C(=O)OC[C@@H]2[C@@H](C)O)cc(C(F)(F)F)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '11.19', 'le': '0.22', 'lle': '1.50', 'sei': '4.41'}",CHEMBL3914286,,CHEMBL3914286,5.58,False,http://www.openphacts.org/units/Nanomolar,2895102,=,37,True,=,,IC50,nM,,2628.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2628.0
432395,17792503,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](c1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(F)c(-c2cnn(C)c2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.62', 'le': '0.31', 'lle': '3.57', 'sei': '7.76'}",CHEMBL3949812,,CHEMBL3949812,7.24,False,http://www.openphacts.org/units/Nanomolar,2895103,=,37,True,=,,IC50,nM,,57.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,57.0
432396,17792504,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OCC2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)cc2)on1,,,CHEMBL3886939,,2016.0,,CHEMBL3920353,,CHEMBL3920353,,False,http://www.openphacts.org/units/Nanomolar,2895104,<,37,True,<,,IC50,nM,,22.86,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,22.8624
432397,17792505,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OCC2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)cc2)on1,,,CHEMBL3886939,,2016.0,"{'bei': '16.68', 'le': '0.34', 'lle': '3.42', 'sei': '6.82'}",CHEMBL3920353,,CHEMBL3920353,7.75,False,http://www.openphacts.org/units/Nanomolar,2895104,=,37,True,=,,IC50,nM,,18.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,18.0
432398,17792506,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(-c2ccccc2)on1,,,CHEMBL3886939,,2016.0,"{'bei': '16.22', 'le': '0.32', 'lle': '3.31', 'sei': '6.14'}",CHEMBL3956829,,CHEMBL3956829,6.97,False,http://www.openphacts.org/units/Nanomolar,2895105,=,37,True,=,,IC50,nM,,107.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,107.0
432399,17792507,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(F)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnn(-c2ccc(F)cc2)c1,,,CHEMBL3886939,,2016.0,"{'bei': '16.06', 'le': '0.30', 'lle': '4.09', 'sei': '6.56'}",CHEMBL3925850,,CHEMBL3925850,6.91,False,http://www.openphacts.org/units/Nanomolar,2895106,=,37,True,=,,IC50,nM,,122.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,122.0
432400,17792508,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnc(-c2ccc(Cl)cc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '16.57', 'le': '0.35', 'lle': '3.17', 'sei': '7.92'}",CHEMBL3962229,,CHEMBL3962229,7.96,False,http://www.openphacts.org/units/Nanomolar,2895107,=,37,True,=,,IC50,nM,,11.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,11.0
432401,17792509,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnc(-c2ccc(Cl)cc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '16.51', 'le': '0.34', 'lle': '3.39', 'sei': '7.62'}",CHEMBL3934745,,CHEMBL3934745,7.66,False,http://www.openphacts.org/units/Nanomolar,2895108,=,37,True,=,,IC50,nM,,22.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,22.0
432402,17792510,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)cc2)on1,,,CHEMBL3886939,,2016.0,"{'bei': '16.77', 'le': '0.33', 'lle': '3.71', 'sei': '6.61'}",CHEMBL3973220,,CHEMBL3973220,7.51,False,http://www.openphacts.org/units/Nanomolar,2895109,=,37,True,=,,IC50,nM,,31.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,31.0
432403,17792511,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nnc(-c2ccc(Cl)cc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '16.25', 'le': '0.34', 'lle': '3.64', 'sei': '6.90'}",CHEMBL3947095,,CHEMBL3947095,7.82,False,http://www.openphacts.org/units/Nanomolar,2895110,=,37,True,=,,IC50,nM,,15.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,15.0
432404,17792512,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnn(-c2ccc(Cl)cc2)c1,,,CHEMBL3886939,,2016.0,"{'bei': '16.77', 'le': '0.34', 'lle': '3.92', 'sei': '7.37'}",CHEMBL3984447,,CHEMBL3984447,7.77,False,http://www.openphacts.org/units/Nanomolar,2895111,=,37,True,=,,IC50,nM,,17.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,17.0
432405,17792513,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnn(-c2ccc(Cl)cc2)c1,,,CHEMBL3886939,,2016.0,"{'bei': '16.42', 'le': '0.32', 'lle': '4.01', 'sei': '6.96'}",CHEMBL3955826,,CHEMBL3955826,7.34,False,http://www.openphacts.org/units/Nanomolar,2895112,=,37,True,=,,IC50,nM,,46.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,46.0
432406,17792514,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(CF)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)cc2)on1,,,CHEMBL3886939,,2016.0,"{'bei': '15.75', 'le': '0.31', 'lle': '3.15', 'sei': '6.40'}",CHEMBL3942030,,CHEMBL3942030,7.28,False,http://www.openphacts.org/units/Nanomolar,2895113,=,37,True,=,,IC50,nM,,53.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,53.0
432407,17792515,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(CF)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnc(-c2ccc(Cl)cc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '16.43', 'le': '0.34', 'lle': '3.25', 'sei': '7.82'}",CHEMBL3971609,,CHEMBL3971609,7.85,False,http://www.openphacts.org/units/Nanomolar,2895114,=,37,True,=,,IC50,nM,,14.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,14.0
432408,17792516,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1cnc(-c2ccc(Cl)cc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '16.97', 'le': '0.34', 'lle': '3.44', 'sei': '7.53'}",CHEMBL3956474,,CHEMBL3956474,7.57,False,http://www.openphacts.org/units/Nanomolar,2895115,=,37,True,=,,IC50,nM,,27.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,27.0
432409,17792517,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnc(-c2ccc(Cl)cc2)s1,,,CHEMBL3886939,,2016.0,,CHEMBL3889605,,CHEMBL3889605,,False,http://www.openphacts.org/units/Nanomolar,2895116,<,37,True,<,,IC50,nM,,22.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,22.0
432410,17792518,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1cnn(-c2ccc(Cl)cc2)c1,,,CHEMBL3886939,,2016.0,"{'bei': '16.79', 'le': '0.33', 'lle': '4.01', 'sei': '6.83'}",CHEMBL3986808,,CHEMBL3986808,7.20,False,http://www.openphacts.org/units/Nanomolar,2895117,=,37,True,=,,IC50,nM,,63.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,63.0
432411,17792519,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnn(-c2ccc(Cl)cc2)c1,,,CHEMBL3886939,,2016.0,"{'bei': '17.24', 'le': '0.34', 'lle': '4.20', 'sei': '7.01'}",CHEMBL3938198,,CHEMBL3938198,7.39,False,http://www.openphacts.org/units/Nanomolar,2895118,=,37,True,=,,IC50,nM,,40.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,40.5
432412,17792520,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(-c2ccc(Cl)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '17.08', 'le': '0.34', 'lle': '3.85', 'sei': '6.73'}",CHEMBL3896034,,CHEMBL3896034,7.65,False,http://www.openphacts.org/units/Nanomolar,2895120,=,37,True,=,,IC50,nM,,22.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,22.5
432413,17792521,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(F)cc(N2C(=O)OCC2[C@@H](C)O)n1)c1cnn(-c2ccc(Cl)cc2)c1,,,CHEMBL3886939,,2016.0,"{'bei': '16.44', 'le': '0.32', 'lle': '4.02', 'sei': '6.97'}",CHEMBL3913635,,CHEMBL3913635,7.35,False,http://www.openphacts.org/units/Nanomolar,2895121,=,37,True,=,,IC50,nM,,45.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,45.0
432414,17792522,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(F)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnn(-c2ccc(Cl)cc2)c1,,,CHEMBL3886939,,2016.0,"{'bei': '17.03', 'le': '0.34', 'lle': '4.28', 'sei': '7.22'}",CHEMBL3955493,,CHEMBL3955493,7.61,False,http://www.openphacts.org/units/Nanomolar,2895122,=,37,True,=,,IC50,nM,,24.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,24.5
432415,17792523,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(-c2ccc(F)cc2)on1,,,CHEMBL3886939,,2016.0,"{'bei': '15.83', 'le': '0.31', 'lle': '3.29', 'sei': '6.24'}",CHEMBL3966360,,CHEMBL3966360,7.09,False,http://www.openphacts.org/units/Nanomolar,2895123,=,37,True,=,,IC50,nM,,81.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,81.0
432416,17792524,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(N2C(=O)OC[C@@H]2[C@@H](C)O)nc(N[C@@H](C)c2cnn(-c3ccc(Cl)cc3)c2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '17.13', 'le': '0.33', 'lle': '4.09', 'sei': '7.20'}",CHEMBL3902941,,CHEMBL3902941,7.58,False,http://www.openphacts.org/units/Nanomolar,2895126,=,37,True,=,,IC50,nM,,26.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,26.0
432417,17792525,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(N2C(=O)OC[C@@H]2[C@@H](C)O)nc(N[C@@H](C)c2cc(-c3ccc(Cl)cc3)on2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '17.21', 'le': '0.34', 'lle': '3.67', 'sei': '6.72'}",CHEMBL3891941,,CHEMBL3891941,7.64,False,http://www.openphacts.org/units/Nanomolar,2895130,=,37,True,=,,IC50,nM,,23.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,23.0
432418,17792526,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(N2C(=O)OC[C@@H]2[C@@H](C)O)nc(N[C@@H](C)c2cnc(-c3ccc(Cl)cc3)s2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '17.15', 'le': '0.35', 'lle': '3.45', 'sei': '7.85'}",CHEMBL3930450,,CHEMBL3930450,7.89,False,http://www.openphacts.org/units/Nanomolar,2895131,=,37,True,=,,IC50,nM,,13.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,13.0
432419,17792527,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(N2C(=O)OC[C@@H]2[C@@H](C)O)nc(N[C@@H](C)c2cn(-c3ccc(Cl)cc3)cn2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '17.88', 'le': '0.35', 'lle': '4.42', 'sei': '7.52'}",CHEMBL3945859,,CHEMBL3945859,7.92,False,http://www.openphacts.org/units/Nanomolar,2895132,=,37,True,=,,IC50,nM,,12.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,12.0
432420,17792528,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(N2C(=O)OC[C@@H]2[C@@H](C)O)nc(N[C@@H](C)c2nc(-c3ccc(Cl)cc3)no2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '17.31', 'le': '0.34', 'lle': '4.33', 'sei': '6.09'}",CHEMBL3917973,,CHEMBL3917973,7.70,False,http://www.openphacts.org/units/Nanomolar,2895133,=,37,True,=,,IC50,nM,,20.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,20.0
432421,17792529,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(N2C(=O)OC[C@@H]2[C@@H](C)O)nc(N[C@@H](C)c2ccn(-c3ccc(Cl)cc3)n2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '16.20', 'le': '0.32', 'lle': '3.67', 'sei': '6.81'}",CHEMBL3913801,,CHEMBL3913801,7.17,False,http://www.openphacts.org/units/Nanomolar,2895134,=,37,True,=,,IC50,nM,,67.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,67.0
432422,17792530,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(N2C(=O)OC[C@@H]2[C@@H](C)O)nc(N[C@@H](C)c2cn(-c3ccc(Cl)cc3)nn2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '15.33', 'le': '0.30', 'lle': '3.90', 'sei': '5.75'}",CHEMBL3901258,,CHEMBL3901258,6.80,False,http://www.openphacts.org/units/Nanomolar,2895135,=,37,True,=,,IC50,nM,,157.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,157.0
432423,17792531,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cn(-c2ccc(Cl)cc2)nn1,,,CHEMBL3886939,,2016.0,"{'bei': '15.67', 'le': '0.32', 'lle': '4.04', 'sei': '6.15'}",CHEMBL3970111,,CHEMBL3970111,7.28,False,http://www.openphacts.org/units/Nanomolar,2895136,=,37,True,=,,IC50,nM,,53.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,53.0
432424,17792532,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cn(-c2ccc(Cl)cc2)nn1,,,CHEMBL3886939,,2016.0,"{'bei': '15.74', 'le': '0.31', 'lle': '4.17', 'sei': '5.72'}",CHEMBL3920306,,CHEMBL3920306,6.76,False,http://www.openphacts.org/units/Nanomolar,2895137,=,37,True,=,,IC50,nM,,172.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,172.0
432425,17792533,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(C(F)(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.40', 'le': '0.30', 'lle': '2.87', 'sei': '7.28'}",CHEMBL3918872,,CHEMBL3918872,6.38,False,http://www.openphacts.org/units/Nanomolar,2895146,=,37,True,=,,IC50,nM,,417.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,417.5
432426,17792534,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CCOC1(c2ccc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)c(F)c2)CC1,,,CHEMBL3886939,,2016.0,"{'bei': '16.07', 'le': '0.30', 'lle': '3.40', 'sei': '7.15'}",CHEMBL3890804,,CHEMBL3890804,6.92,False,http://www.openphacts.org/units/Nanomolar,2895147,=,37,True,=,,IC50,nM,,121.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,121.0
432427,17792535,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2cnn(C)c2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '14.80', 'le': '0.28', 'lle': '3.41', 'sei': '5.99'}",CHEMBL3975109,,CHEMBL3975109,6.31,False,http://www.openphacts.org/units/Nanomolar,2895150,=,37,True,=,,IC50,nM,,489.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,489.0
432428,17792536,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2cn[nH]c2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.42', 'le': '0.29', 'lle': '3.48', 'sei': '5.47'}",CHEMBL3913391,,CHEMBL3913391,6.36,False,http://www.openphacts.org/units/Nanomolar,2895152,=,37,True,=,,IC50,nM,,435.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,435.0
432429,17792537,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OCC2[C@@H](C)O)n1)c1ccc(C(F)(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '16.16', 'le': '0.32', 'lle': '3.34', 'sei': '7.98'}",CHEMBL3943232,,CHEMBL3943232,6.99,False,http://www.openphacts.org/units/Nanomolar,2895153,=,37,True,=,,IC50,nM,,103.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,103.0
432430,17792538,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(C2(C)CC2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '18.50', 'le': '0.35', 'lle': '3.86', 'sei': '8.46'}",CHEMBL3964333,,CHEMBL3964333,7.41,False,http://www.openphacts.org/units/Nanomolar,2895155,=,37,True,=,,IC50,nM,,39.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,39.0
432431,17792539,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)c1ccc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '18.15', 'le': '0.34', 'lle': '3.43', 'sei': '8.05'}",CHEMBL3924385,,CHEMBL3924385,7.05,False,http://www.openphacts.org/units/Nanomolar,2895156,=,37,True,=,,IC50,nM,,89.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,89.0
432432,17792540,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2cnn(C)c2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.25', 'le': '0.29', 'lle': '3.75', 'sei': '6.43'}",CHEMBL3919605,,CHEMBL3919605,6.78,False,http://www.openphacts.org/units/Nanomolar,2895157,=,37,True,=,,IC50,nM,,167.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,167.0
432433,17792541,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2cn[nH]c2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.34', 'le': '0.29', 'lle': '3.58', 'sei': '5.68'}",CHEMBL3925057,,CHEMBL3925057,6.60,False,http://www.openphacts.org/units/Nanomolar,2895159,=,37,True,=,,IC50,nM,,249.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,249.0
432434,17792542,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)c1ccc([C@H](C)Nc2ncc(F)c(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '18.31', 'le': '0.35', 'lle': '3.68', 'sei': '8.50'}",CHEMBL3956110,,CHEMBL3956110,7.44,False,http://www.openphacts.org/units/Nanomolar,2895397,=,37,True,=,,IC50,nM,,36.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,36.0
432435,17792543,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(F)c(-c2cnn(C)c2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.19', 'le': '0.29', 'lle': '3.85', 'sei': '6.66'}",CHEMBL3961440,,CHEMBL3961440,7.02,False,http://www.openphacts.org/units/Nanomolar,2895161,=,37,True,=,,IC50,nM,,95.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,95.0
432436,17792544,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(Cl)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '14.65', 'le': '0.30', 'lle': '2.94', 'sei': '6.44'}",CHEMBL3927323,,CHEMBL3927323,6.79,False,http://www.openphacts.org/units/Nanomolar,2895164,=,37,True,=,,IC50,nM,,163.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,163.0
432437,17792545,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnc(C(C)(F)F)c(Cl)c1,,,CHEMBL3886939,,2016.0,"{'bei': '14.57', 'le': '0.29', 'lle': '2.71', 'sei': '6.20'}",CHEMBL3962357,,CHEMBL3962357,6.23,False,http://www.openphacts.org/units/Nanomolar,2895398,=,37,True,=,,IC50,nM,,585.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,585.0
432438,17792546,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnc(OCC(F)(F)F)c(Cl)c1,,,CHEMBL3886939,,2016.0,"{'bei': '14.24', 'le': '0.29', 'lle': '3.23', 'sei': '6.00'}",CHEMBL3909020,,CHEMBL3909020,6.58,False,http://www.openphacts.org/units/Nanomolar,2895399,=,37,True,=,,IC50,nM,,265.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,265.0
432439,17792547,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(Br)c(F)c1F,,,CHEMBL3886939,,2016.0,"{'bei': '14.68', 'le': '0.33', 'lle': '3.11', 'sei': '7.43'}",CHEMBL3979315,,CHEMBL3979315,6.51,False,http://www.openphacts.org/units/Nanomolar,2895400,=,37,True,=,,IC50,nM,,311.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,311.0
432440,17792548,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(F)c(Br)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.81', 'le': '0.36', 'lle': '3.75', 'sei': '8.33'}",CHEMBL3903487,,CHEMBL3903487,7.29,False,http://www.openphacts.org/units/Nanomolar,2895401,=,37,True,=,,IC50,nM,,51.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,51.0
432441,17792549,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(Cl)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '17.72', 'le': '0.36', 'lle': '3.78', 'sei': '8.07'}",CHEMBL3971134,,CHEMBL3971134,7.07,False,http://www.openphacts.org/units/Nanomolar,2895167,=,37,True,=,,IC50,nM,,86.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,86.0
432442,17792550,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(Cl)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '17.02', 'le': '0.34', 'lle': '3.50', 'sei': '7.75'}",CHEMBL3971134,,CHEMBL3971134,6.79,False,http://www.openphacts.org/units/Nanomolar,2895167,=,37,True,=,,IC50,nM,,163.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,163.0
432443,17792551,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '16.03', 'le': '0.32', 'lle': '3.99', 'sei': '5.69'}",CHEMBL3901219,,CHEMBL3901219,7.19,False,http://www.openphacts.org/units/Nanomolar,2895170,=,37,True,=,,IC50,nM,,64.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,64.0
432444,17792552,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(Br)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '14.90', 'le': '0.33', 'lle': '3.21', 'sei': '7.54'}",CHEMBL3968871,,CHEMBL3968871,6.61,False,http://www.openphacts.org/units/Nanomolar,2895172,=,37,True,=,,IC50,nM,,248.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,248.0
432445,17792553,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cnc(OCC(F)(F)F)c(Cl)c1,,,CHEMBL3886939,,2016.0,"{'bei': '14.25', 'le': '0.29', 'lle': '3.36', 'sei': '6.23'}",CHEMBL3912459,,CHEMBL3912459,6.84,False,http://www.openphacts.org/units/Nanomolar,2895174,=,37,True,=,,IC50,nM,,146.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,146.0
432446,17792554,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(Cl)cc1Cl,,,CHEMBL3886939,,2016.0,"{'bei': '16.47', 'le': '0.35', 'lle': '3.04', 'sei': '7.81'}",CHEMBL3908513,,CHEMBL3908513,6.84,False,http://www.openphacts.org/units/Nanomolar,2895175,=,37,True,=,,IC50,nM,,145.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,145.0
432447,17792555,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(Br)nc1,,,CHEMBL3886939,,2016.0,"{'bei': '10.17', 'le': '0.23', 'lle': '1.68', 'sei': '4.31'}",CHEMBL3932931,,CHEMBL3932931,4.33,False,http://www.openphacts.org/units/Nanomolar,2895176,=,37,True,=,,IC50,nM,,46301.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,46301.0
432448,17792556,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(Cl)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '16.92', 'le': '0.34', 'lle': '3.46', 'sei': '7.71'}",CHEMBL3895987,,CHEMBL3895987,6.75,False,http://www.openphacts.org/units/Nanomolar,2895177,=,37,True,=,,IC50,nM,,178.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,178.0
432449,17792557,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(Cl)c(Cl)c1,,,CHEMBL3886939,,2016.0,"{'bei': '17.52', 'le': '0.37', 'lle': '3.48', 'sei': '8.31'}",CHEMBL3977830,,CHEMBL3977830,7.28,False,http://www.openphacts.org/units/Nanomolar,2895179,=,37,True,=,,IC50,nM,,53.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,53.0
432450,17792558,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(Cl)cc1Cl,,,CHEMBL3886939,,2016.0,"{'bei': '15.01', 'le': '0.32', 'lle': '3.05', 'sei': '6.22'}",CHEMBL3974305,,CHEMBL3974305,6.25,False,http://www.openphacts.org/units/Nanomolar,2895183,=,37,True,=,,IC50,nM,,563.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,563.0
432451,17792559,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(OCC(F)(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '13.67', 'le': '0.28', 'lle': '3.08', 'sei': '5.98'}",CHEMBL3957664,,CHEMBL3957664,6.56,False,http://www.openphacts.org/units/Nanomolar,2895185,=,37,True,=,,IC50,nM,,277.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,277.0
432452,17792560,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccn(-c2ccc(Cl)cc2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '16.60', 'le': '0.33', 'lle': '4.09', 'sei': '7.04'}",CHEMBL3942379,,CHEMBL3942379,7.42,False,http://www.openphacts.org/units/Nanomolar,2895187,=,37,True,=,,IC50,nM,,38.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,38.0
432453,17792561,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '17.39', 'le': '0.34', 'lle': '4.44', 'sei': '7.37'}",CHEMBL3911306,,CHEMBL3911306,7.77,False,http://www.openphacts.org/units/Nanomolar,2895189,=,37,True,=,,IC50,nM,,17.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,17.0
432454,17792562,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(F)c(OCC(F)(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.57', 'le': '0.31', 'lle': '3.77', 'sei': '7.73'}",CHEMBL3981306,,CHEMBL3981306,7.48,False,http://www.openphacts.org/units/Nanomolar,2895190,=,37,True,=,,IC50,nM,,33.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,33.0
432455,17792563,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OCC(F)(F)F)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '15.17', 'le': '0.30', 'lle': '3.43', 'sei': '7.24'}",CHEMBL3941791,,CHEMBL3941791,7.01,False,http://www.openphacts.org/units/Nanomolar,2895192,=,37,True,=,,IC50,nM,,97.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,97.0
432456,17792564,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OCC(F)(F)F)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '13.23', 'le': '0.26', 'lle': '3.06', 'sei': '5.37'}",CHEMBL3985326,,CHEMBL3985326,5.89,False,http://www.openphacts.org/units/Nanomolar,2895194,=,37,True,=,,IC50,nM,,1276.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1276.5
432457,17792565,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '17.30', 'le': '0.34', 'lle': '4.23', 'sei': '7.04'}",CHEMBL3893867,,CHEMBL3893867,7.42,False,http://www.openphacts.org/units/Nanomolar,2895196,=,37,True,=,,IC50,nM,,38.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,38.0
432458,17792566,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccn(-c2ccc(Cl)cc2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '16.64', 'le': '0.32', 'lle': '3.95', 'sei': '6.77'}",CHEMBL3909399,,CHEMBL3909399,7.14,False,http://www.openphacts.org/units/Nanomolar,2895197,=,37,True,=,,IC50,nM,,73.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,73.0
432459,17792567,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OCC2[C@@H](C)O)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '18.13', 'le': '0.37', 'lle': '4.55', 'sei': '7.97'}",CHEMBL3980822,,CHEMBL3980822,8.40,False,http://www.openphacts.org/units/Nanomolar,2895198,=,37,True,=,,IC50,nM,,4.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4.0
432460,17792568,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '18.01', 'le': '0.37', 'lle': '4.50', 'sei': '7.92'}",CHEMBL3979625,,CHEMBL3979625,8.35,False,http://www.openphacts.org/units/Nanomolar,2895199,=,37,True,=,,IC50,nM,,4.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4.5
432461,17792569,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccn(-c2ccc(F)cc2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '15.42', 'le': '0.30', 'lle': '3.56', 'sei': '6.54'}",CHEMBL3904714,,CHEMBL3904714,6.89,False,http://www.openphacts.org/units/Nanomolar,2895200,=,37,True,=,,IC50,nM,,128.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,128.0
432462,17792570,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(Cl)cc1Cl,,,CHEMBL3886939,,2016.0,"{'bei': '15.99', 'le': '0.33', 'lle': '2.69', 'sei': '7.25'}",CHEMBL3905837,,CHEMBL3905837,6.35,False,http://www.openphacts.org/units/Nanomolar,2895201,=,37,True,=,,IC50,nM,,445.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,445.0
432463,17792571,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(Cl)c(Cl)c1,,,CHEMBL3886939,,2016.0,"{'bei': '17.22', 'le': '0.36', 'lle': '3.18', 'sei': '7.81'}",CHEMBL3907620,,CHEMBL3907620,6.84,False,http://www.openphacts.org/units/Nanomolar,2895202,=,37,True,=,,IC50,nM,,144.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,144.0
432464,17792572,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccn(-c2ccc(Cl)cc2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '16.66', 'le': '0.34', 'lle': '3.87', 'sei': '7.33'}",CHEMBL3927758,,CHEMBL3927758,7.72,False,http://www.openphacts.org/units/Nanomolar,2895203,=,37,True,=,,IC50,nM,,19.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,19.0
432465,17792573,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(F)c(OCC(F)(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '14.64', 'le': '0.29', 'lle': '3.19', 'sei': '6.99'}",CHEMBL3922430,,CHEMBL3922430,6.77,False,http://www.openphacts.org/units/Nanomolar,2895204,=,37,True,=,,IC50,nM,,169.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,169.5
432466,17792574,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OCC(F)(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '14.38', 'le': '0.28', 'lle': '2.95', 'sei': '6.60'}",CHEMBL3944541,,CHEMBL3944541,6.39,False,http://www.openphacts.org/units/Nanomolar,2895205,=,37,True,=,,IC50,nM,,406.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,406.5
432467,17792575,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OCC(F)(F)F)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '14.81', 'le': '0.29', 'lle': '3.14', 'sei': '6.80'}",CHEMBL3911852,,CHEMBL3911852,6.58,False,http://www.openphacts.org/units/Nanomolar,2895206,=,37,True,=,,IC50,nM,,261.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,261.0
432468,17792576,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(Cl)c(Cl)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '17.02', 'le': '0.36', 'lle': '3.27', 'sei': '8.07'}",CHEMBL3963108,,CHEMBL3963108,7.07,False,http://www.openphacts.org/units/Nanomolar,2895209,=,37,True,=,,IC50,nM,,86.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,86.0
432469,17792577,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cn(-c2cc(F)c([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)cc2F)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '14.44', 'le': '0.27', 'lle': '3.29', 'sei': '6.09'}",CHEMBL3973110,,CHEMBL3973110,6.42,False,http://www.openphacts.org/units/Nanomolar,2895210,=,37,True,=,,IC50,nM,,381.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,381.0
432470,17792578,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(Cl)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(Cl)c(Cl)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.70', 'le': '0.34', 'lle': '2.60', 'sei': '8.06'}",CHEMBL3978748,,CHEMBL3978748,7.06,False,http://www.openphacts.org/units/Nanomolar,2895211,=,37,True,=,,IC50,nM,,87.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,87.0
432471,17792579,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cc(F)c([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)cc2F)ccn1,,,CHEMBL3886939,,2016.0,"{'bei': '16.20', 'le': '0.31', 'lle': '3.38', 'sei': '7.34'}",CHEMBL3902081,,CHEMBL3902081,7.38,False,http://www.openphacts.org/units/Nanomolar,2895212,=,37,True,=,,IC50,nM,,42.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,42.0
432472,17792580,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2cc(F)c([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)cc2F)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '15.68', 'le': '0.30', 'lle': '3.14', 'sei': '7.11'}",CHEMBL3920505,,CHEMBL3920505,7.14,False,http://www.openphacts.org/units/Nanomolar,2895213,=,37,True,=,,IC50,nM,,72.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,72.0
432473,17792581,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(F)c(-c2ccc(C(F)(F)F)nc2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '13.23', 'le': '0.26', 'lle': '2.03', 'sei': '6.71'}",CHEMBL3929409,,CHEMBL3929409,6.74,False,http://www.openphacts.org/units/Nanomolar,2895215,=,37,True,=,,IC50,nM,,181.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,181.0
432474,17792582,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,COc1ccc([C@H](C)Nc2ncc(F)c(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '15.85', 'le': '0.30', 'lle': '3.61', 'sei': '6.46'}",CHEMBL3934884,,CHEMBL3934884,6.25,False,http://www.openphacts.org/units/Nanomolar,2895217,=,37,True,=,,IC50,nM,,562.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,562.0
432475,17792583,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cccc(F)c1F,,,CHEMBL3886939,,2016.0,"{'bei': '16.64', 'le': '0.32', 'lle': '3.59', 'sei': '7.26'}",CHEMBL3943854,,CHEMBL3943854,6.36,False,http://www.openphacts.org/units/Nanomolar,2895219,=,37,True,=,,IC50,nM,,435.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,435.0
432476,17792584,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(F)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '15.88', 'le': '0.31', 'lle': '3.30', 'sei': '6.93'}",CHEMBL3919446,,CHEMBL3919446,6.07,False,http://www.openphacts.org/units/Nanomolar,2895220,=,37,True,=,,IC50,nM,,850.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,850.0
432477,17792585,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.98', 'le': '0.31', 'lle': '3.34', 'sei': '6.97'}",CHEMBL3955964,,CHEMBL3955964,6.11,False,http://www.openphacts.org/units/Nanomolar,2895221,=,37,True,=,,IC50,nM,,780.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,780.0
432478,17792586,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cc(F)cc(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '16.09', 'le': '0.31', 'lle': '3.38', 'sei': '7.02'}",CHEMBL3928350,,CHEMBL3928350,6.15,False,http://www.openphacts.org/units/Nanomolar,2895222,=,37,True,=,,IC50,nM,,704.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,704.0
432479,17792587,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(Cl)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ncc(-c2ccnc(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '12.15', 'le': '0.24', 'lle': '2.31', 'sei': '4.91'}",CHEMBL3981136,,CHEMBL3981136,6.19,False,http://www.openphacts.org/units/Nanomolar,2895223,=,37,True,=,,IC50,nM,,640.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,640.0
432480,17792588,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OCC(F)(F)F)nc1,,,CHEMBL3886939,,2016.0,"{'bei': '13.53', 'le': '0.27', 'lle': '3.20', 'sei': '5.49'}",CHEMBL3914536,,CHEMBL3914536,6.03,False,http://www.openphacts.org/units/Nanomolar,2895224,=,37,True,=,,IC50,nM,,943.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,943.0
432481,17792589,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(C(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '16.36', 'le': '0.32', 'lle': '3.21', 'sei': '7.74'}",CHEMBL3976299,,CHEMBL3976299,6.78,False,http://www.openphacts.org/units/Nanomolar,2895225,=,37,True,=,,IC50,nM,,166.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,166.5
432482,17792590,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OCC2[C@@H](C)O)n1)c1ccc(C(C)(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '17.06', 'le': '0.33', 'lle': '3.56', 'sei': '8.35'}",CHEMBL3951969,,CHEMBL3951969,7.31,False,http://www.openphacts.org/units/Nanomolar,2895226,=,37,True,=,,IC50,nM,,49.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,49.0
432483,17792591,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(C(C)(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '17.08', 'le': '0.33', 'lle': '3.57', 'sei': '8.36'}",CHEMBL3905560,,CHEMBL3905560,7.32,False,http://www.openphacts.org/units/Nanomolar,2895227,=,37,True,=,,IC50,nM,,48.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,48.0
432484,17792592,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OCC2[C@@H](C)O)n1)c1ccc(C(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '16.07', 'le': '0.33', 'lle': '2.83', 'sei': '7.91'}",CHEMBL3904506,,CHEMBL3904506,6.92,False,http://www.openphacts.org/units/Nanomolar,2895228,=,37,True,=,,IC50,nM,,119.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,119.0
432485,17792593,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OCC2[C@@H](C)O)n1)c1ccc(C(C)(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.81', 'le': '0.32', 'lle': '2.77', 'sei': '8.03'}",CHEMBL3978669,,CHEMBL3978669,7.03,False,http://www.openphacts.org/units/Nanomolar,2895229,=,37,True,=,,IC50,nM,,93.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,93.0
432486,17792594,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2ccccc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '17.07', 'le': '0.35', 'lle': '2.85', 'sei': '8.67'}",CHEMBL3904882,,CHEMBL3904882,7.59,False,http://www.openphacts.org/units/Nanomolar,2895230,=,37,True,=,,IC50,nM,,25.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25.5
432487,17792595,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(-c2ccccn2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '15.52', 'le': '0.32', 'lle': '2.79', 'sei': '6.89'}",CHEMBL3920067,,CHEMBL3920067,6.92,False,http://www.openphacts.org/units/Nanomolar,2895231,=,37,True,=,,IC50,nM,,120.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,120.0
432488,17792596,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)COc1cccc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)c1,,,CHEMBL3886939,,2016.0,"{'bei': '13.48', 'le': '0.25', 'lle': '2.01', 'sei': '5.58'}",CHEMBL3979363,,CHEMBL3979363,5.40,False,http://www.openphacts.org/units/Nanomolar,2895233,=,37,True,=,,IC50,nM,,4001.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4001.0
432489,17792597,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)CS(=O)(=O)c1ccc([C@H](C)Nc2nc(Cl)cc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '13.76', 'le': '0.28', 'lle': '3.21', 'sei': '5.46'}",CHEMBL3934735,,CHEMBL3934735,6.65,False,http://www.openphacts.org/units/Nanomolar,2895234,=,37,True,=,,IC50,nM,,225.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,225.0
432490,17792598,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)(F)F)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '15.82', 'le': '0.31', 'lle': '3.27', 'sei': '6.74'}",CHEMBL3971674,,CHEMBL3971674,6.52,False,http://www.openphacts.org/units/Nanomolar,2895235,=,37,True,=,,IC50,nM,,300.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,300.0
432491,17792599,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)(F)F)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '14.92', 'le': '0.29', 'lle': '3.03', 'sei': '6.63'}",CHEMBL3916173,,CHEMBL3916173,6.42,False,http://www.openphacts.org/units/Nanomolar,2895236,=,37,True,=,,IC50,nM,,378.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,378.0
432492,17792600,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.19', 'le': '0.30', 'lle': '3.15', 'sei': '6.75'}",CHEMBL3985940,,CHEMBL3985940,6.54,False,http://www.openphacts.org/units/Nanomolar,2895237,=,37,True,=,,IC50,nM,,290.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,290.0
432493,17792601,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)F)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '15.15', 'le': '0.29', 'lle': '3.15', 'sei': '6.45'}",CHEMBL3965350,,CHEMBL3965350,6.25,False,http://www.openphacts.org/units/Nanomolar,2895238,=,37,True,=,,IC50,nM,,564.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,564.0
432494,17792602,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)F)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '16.02', 'le': '0.31', 'lle': '3.65', 'sei': '7.12'}",CHEMBL3977787,,CHEMBL3977787,6.89,False,http://www.openphacts.org/units/Nanomolar,2895239,=,37,True,=,,IC50,nM,,128.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,128.0
432495,17792603,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '16.11', 'le': '0.32', 'lle': '3.69', 'sei': '7.16'}",CHEMBL3965898,,CHEMBL3965898,6.93,False,http://www.openphacts.org/units/Nanomolar,2895244,=,37,True,=,,IC50,nM,,117.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,117.0
432496,17792604,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cccc(OC(F)(F)F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '15.21', 'le': '0.30', 'lle': '3.15', 'sei': '6.76'}",CHEMBL3894497,,CHEMBL3894497,6.54,False,http://www.openphacts.org/units/Nanomolar,2895245,=,37,True,=,,IC50,nM,,286.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,286.0
432497,17792605,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cccc(OC(F)F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '15.57', 'le': '0.30', 'lle': '3.32', 'sei': '6.63'}",CHEMBL3980075,,CHEMBL3980075,6.42,False,http://www.openphacts.org/units/Nanomolar,2895246,=,37,True,=,,IC50,nM,,381.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,381.0
432498,17792606,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1cccc(Oc2ccccc2)c1,,,CHEMBL3886939,,2016.0,"{'bei': '16.36', 'le': '0.30', 'lle': '2.73', 'sei': '7.11'}",CHEMBL3903445,,CHEMBL3903445,6.88,False,http://www.openphacts.org/units/Nanomolar,2895247,=,37,True,=,,IC50,nM,,132.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,132.0
432499,17792607,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)Oc1ccc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '16.45', 'le': '0.31', 'lle': '3.22', 'sei': '6.57'}",CHEMBL3979270,,CHEMBL3979270,6.36,False,http://www.openphacts.org/units/Nanomolar,2895248,=,37,True,=,,IC50,nM,,439.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,439.0
432500,17792608,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)(F)F)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '15.03', 'le': '0.31', 'lle': '2.80', 'sei': '6.94'}",CHEMBL3962307,,CHEMBL3962307,6.71,False,http://www.openphacts.org/units/Nanomolar,2895250,=,37,True,=,,IC50,nM,,193.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,193.0
432501,17792609,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)(F)F)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '16.09', 'le': '0.32', 'lle': '3.53', 'sei': '7.15'}",CHEMBL3889758,,CHEMBL3889758,6.92,False,http://www.openphacts.org/units/Nanomolar,2895251,=,37,True,=,,IC50,nM,,119.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,119.0
432502,17792610,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '14.56', 'le': '0.30', 'lle': '2.72', 'sei': '6.99'}",CHEMBL3973284,,CHEMBL3973284,6.77,False,http://www.openphacts.org/units/Nanomolar,2895252,=,37,True,=,,IC50,nM,,170.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,170.0
432503,17792611,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.27', 'le': '0.30', 'lle': '3.32', 'sei': '7.07'}",CHEMBL3902255,,CHEMBL3902255,6.85,False,http://www.openphacts.org/units/Nanomolar,2895253,=,37,True,=,,IC50,nM,,142.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,142.0
432504,17792612,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)COc1ccc([C@H](C)Nc2ncc(F)c(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '18.43', 'le': '0.35', 'lle': '4.38', 'sei': '8.31'}",CHEMBL3960560,,CHEMBL3960560,8.05,False,http://www.openphacts.org/units/Nanomolar,2895254,=,37,True,=,,IC50,nM,,9.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,9.0
432505,17792613,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)F)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '15.57', 'le': '0.30', 'lle': '3.32', 'sei': '6.63'}",CHEMBL3933108,,CHEMBL3933108,6.42,False,http://www.openphacts.org/units/Nanomolar,2895255,=,37,True,=,,IC50,nM,,379.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,379.0
432506,17792614,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)(F)F)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '15.31', 'le': '0.30', 'lle': '3.33', 'sei': '7.09'}",CHEMBL3929833,,CHEMBL3929833,6.86,False,http://www.openphacts.org/units/Nanomolar,2895256,=,37,True,=,,IC50,nM,,137.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,137.0
432507,17792615,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)F)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '15.07', 'le': '0.30', 'lle': '2.85', 'sei': '6.68'}",CHEMBL3904836,,CHEMBL3904836,6.46,False,http://www.openphacts.org/units/Nanomolar,2895257,=,37,True,=,,IC50,nM,,345.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,345.0
432508,17792616,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nc(Cl)cc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OC(F)(F)F)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '14.37', 'le': '0.29', 'lle': '2.63', 'sei': '6.90'}",CHEMBL3918587,,CHEMBL3918587,6.68,False,http://www.openphacts.org/units/Nanomolar,2895258,=,37,True,=,,IC50,nM,,209.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,209.0
432509,17792617,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)CS(=O)(=O)c1ccc([C@H](C)Nc2ncc(F)c(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '14.78', 'le': '0.29', 'lle': '3.98', 'sei': '5.67'}",CHEMBL3931535,,CHEMBL3931535,6.90,False,http://www.openphacts.org/units/Nanomolar,2895259,=,37,True,=,,IC50,nM,,127.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,127.0
432510,17792618,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)S(=O)(=O)c1ccc([C@H](C)Nc2ncc(F)c(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '13.02', 'le': '0.26', 'lle': '3.21', 'sei': '4.84'}",CHEMBL3955271,,CHEMBL3955271,5.89,False,http://www.openphacts.org/units/Nanomolar,2895260,=,37,True,=,,IC50,nM,,1277.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1277.0
432511,17792619,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)S(=O)(=O)c1ccc([C@H](C)Nc2nc(Cl)cc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '12.55', 'le': '0.26', 'lle': '2.70', 'sei': '4.83'}",CHEMBL3896022,,CHEMBL3896022,5.88,False,http://www.openphacts.org/units/Nanomolar,2895261,=,37,True,=,,IC50,nM,,1303.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1303.0
432512,17792620,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1ccc(OCC2CC2)cc1,,,CHEMBL3886939,,2016.0,"{'bei': '17.46', 'le': '0.33', 'lle': '3.82', 'sei': '7.19'}",CHEMBL3897081,,CHEMBL3897081,6.96,False,http://www.openphacts.org/units/Nanomolar,2895262,=,37,True,=,,IC50,nM,,110.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,110.0
432513,17792621,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(C)COc1ccc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)c(F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '18.01', 'le': '0.34', 'lle': '4.01', 'sei': '7.79'}",CHEMBL3968221,,CHEMBL3968221,7.54,False,http://www.openphacts.org/units/Nanomolar,2895263,=,37,True,=,,IC50,nM,,29.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,29.0
432514,17792622,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CO[C@H](C)[C@H]1COC(=O)N1c1cc(Cl)nc(N[C@@H](C)c2cc(F)c(-c3cnn(C)c3)cc2F)n1,,,CHEMBL3886939,,2016.0,"{'bei': '15.58', 'le': '0.31', 'lle': '3.34', 'sei': '8.13'}",CHEMBL3939420,,CHEMBL3939420,7.68,False,http://www.openphacts.org/units/Nanomolar,2895265,=,37,True,=,,IC50,nM,,21.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,21.0
432515,17792623,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CO[C@H](C)[C@H]1COC(=O)N1c1cc(Cl)nc(N[C@@H](C)c2ccc(C(F)(F)F)cc2F)n1,,,CHEMBL3886939,,2016.0,"{'bei': '14.30', 'le': '0.29', 'lle': '1.80', 'sei': '8.64'}",CHEMBL3965474,,CHEMBL3965474,6.62,False,http://www.openphacts.org/units/Nanomolar,2895266,=,37,True,=,,IC50,nM,,241.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,241.0
432516,17792624,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CO[C@H](C)[C@H]1COC(=O)N1c1cc(Cl)nc(N[C@@H](C)c2cnc(-c3ccc(Cl)cc3)s2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '15.31', 'le': '0.32', 'lle': '2.13', 'sei': '8.46'}",CHEMBL3953545,,CHEMBL3953545,7.57,False,http://www.openphacts.org/units/Nanomolar,2895267,=,37,True,=,,IC50,nM,,27.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,27.0
432517,17792625,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2[C@@H](C)N)n1)c1cnc(-c2ccc(Cl)cc2)s1,,,CHEMBL3886939,,2016.0,"{'bei': '16.41', 'le': '0.33', 'lle': '3.20', 'sei': '6.87'}",CHEMBL4114431,,CHEMBL4114431,7.30,False,http://www.openphacts.org/units/Nanomolar,2895271,=,37,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
432518,17792626,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)N)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '16.89', 'le': '0.33', 'lle': '4.07', 'sei': '6.50'}",CHEMBL4111302,,CHEMBL4111302,7.23,False,http://www.openphacts.org/units/Nanomolar,2895273,=,37,True,=,,IC50,nM,,59.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,59.0
432519,17792627,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)N)n1)c1cc(-c2ccc(Cl)cc2)on1,,,CHEMBL3886939,,2016.0,"{'bei': '16.34', 'le': '0.32', 'lle': '3.38', 'sei': '5.87'}",CHEMBL4110501,,CHEMBL4110501,7.01,False,http://www.openphacts.org/units/Nanomolar,2895274,=,37,True,=,,IC50,nM,,98.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,98.0
432520,17792628,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2[C@@H](C)F)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL3886939,,2016.0,,CHEMBL4109951,,CHEMBL4109951,,False,http://www.openphacts.org/units/Nanomolar,2895277,<,37,True,<,,IC50,nM,,23.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,23.0
432521,17792629,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)F)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '18.93', 'le': '0.37', 'lle': '3.98', 'sei': '9.57'}",CHEMBL4107555,,CHEMBL4107555,8.15,False,http://www.openphacts.org/units/Nanomolar,2895278,=,37,True,=,,IC50,nM,,7.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,7.0
432522,17792630,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '19.08', 'le': '0.37', 'lle': '4.05', 'sei': '9.65'}",CHEMBL3986241,,CHEMBL3986241,8.22,False,http://www.openphacts.org/units/Nanomolar,2895281,=,37,True,=,,IC50,nM,,6.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6.0
432523,17792631,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cc(-c2ccc(Cl)cc2)on1,,,CHEMBL3886939,,2016.0,"{'bei': '17.73', 'le': '0.35', 'lle': '3.02', 'sei': '8.20'}",CHEMBL3906023,,CHEMBL3906023,7.66,False,http://www.openphacts.org/units/Nanomolar,2895283,=,37,True,=,,IC50,nM,,22.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,22.0
432524,17792632,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)C(F)F)n1)c1ccc(C(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '14.04', 'le': '0.28', 'lle': '1.20', 'sei': '9.35'}",CHEMBL4108279,,CHEMBL4108279,6.29,False,http://www.openphacts.org/units/Nanomolar,2895303,=,37,True,=,,IC50,nM,,508.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,508.0
432525,17792633,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)C(F)F)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '16.07', 'le': '0.32', 'lle': '2.89', 'sei': '7.03'}",CHEMBL4109122,,CHEMBL4109122,7.47,False,http://www.openphacts.org/units/Nanomolar,2895304,=,37,True,=,,IC50,nM,,34.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,34.0
432526,17792634,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)C(F)F)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '12.47', 'le': '0.25', 'lle': '1.22', 'sei': '5.45'}",CHEMBL4111017,,CHEMBL4111017,5.80,False,http://www.openphacts.org/units/Nanomolar,2895305,=,37,True,=,,IC50,nM,,1601.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1601.0
432527,17792635,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)C(F)F)n1)c1ccc(C(F)F)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '15.21', 'le': '0.30', 'lle': '1.60', 'sei': '9.72'}",CHEMBL4111440,,CHEMBL4111440,6.54,False,http://www.openphacts.org/units/Nanomolar,2895306,=,37,True,=,,IC50,nM,,285.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,285.0
432528,17792636,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc3ccn(C)c3c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '14.89', 'le': '0.28', 'lle': '3.79', 'sei': '5.09'}",CHEMBL4111065,,CHEMBL4111065,6.69,False,http://www.openphacts.org/units/Nanomolar,2895309,=,37,True,=,,IC50,nM,,204.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,204.0
432529,17792637,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2cccc(OC(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '14.49', 'le': '0.28', 'lle': '3.66', 'sei': '5.13'}",CHEMBL4109754,,CHEMBL4109754,6.96,False,http://www.openphacts.org/units/Nanomolar,2895310,=,37,True,=,,IC50,nM,,110.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,110.0
432530,17792638,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc2c(-c3noc(C(C)Nc4nccc(N5C(=O)OC[C@@H]5[C@@H](C)O)n4)n3)cccc2n1C,,,CHEMBL3886939,,2016.0,"{'bei': '14.99', 'le': '0.28', 'lle': '3.74', 'sei': '5.29'}",CHEMBL4108845,,CHEMBL4108845,6.95,False,http://www.openphacts.org/units/Nanomolar,2895311,=,37,True,=,,IC50,nM,,112.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,112.5
432531,17792639,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2ccc(Cl)c(OC(F)(F)F)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '14.26', 'le': '0.29', 'lle': '3.38', 'sei': '5.41'}",CHEMBL4108766,,CHEMBL4108766,7.34,False,http://www.openphacts.org/units/Nanomolar,2895312,=,37,True,=,,IC50,nM,,45.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,45.5
432532,17792640,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)n2)ccc1Cl,,,CHEMBL3886939,,2016.0,"{'bei': '16.42', 'le': '0.32', 'lle': '3.94', 'sei': '5.78'}",CHEMBL4109147,,CHEMBL4109147,7.30,False,http://www.openphacts.org/units/Nanomolar,2895313,=,37,True,=,,IC50,nM,,49.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,49.5
432533,17792641,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,COc1cc(-c2noc(C(C)Nc3nccc(N4C(=O)OC[C@@H]4[C@@H](C)O)n3)n2)ccc1Br,,,CHEMBL3886939,,2016.0,"{'bei': '14.26', 'le': '0.31', 'lle': '4.02', 'sei': '5.31'}",CHEMBL4112002,,CHEMBL4112002,7.20,False,http://www.openphacts.org/units/Nanomolar,2895314,=,37,True,=,,IC50,nM,,62.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,62.5
432534,17792642,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1nc(-c2cccc(C(C)(C)C)c2)no1,,,CHEMBL3886939,,2016.0,"{'bei': '16.97', 'le': '0.32', 'lle': '3.98', 'sei': '6.07'}",CHEMBL4113581,,CHEMBL4113581,7.68,False,http://www.openphacts.org/units/Nanomolar,2895315,=,37,True,=,,IC50,nM,,21.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,21.0
432535,17792643,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OCC2[C@@H](C)O)n1)c1noc(-c2ccc(Cl)cc2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '12.05', 'le': '0.24', 'lle': '2.13', 'sei': '4.10'}",CHEMBL4110061,,CHEMBL4110061,5.19,False,http://www.openphacts.org/units/Nanomolar,2895318,=,37,True,=,,IC50,nM,,6429.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6429.0
432536,17792644,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2C(=O)OC[C@@H]2[C@@H](C)O)n1)c1noc(-c2ccc(Cl)cc2)n1,,,CHEMBL3886939,,2016.0,"{'bei': '15.51', 'le': '0.30', 'lle': '3.62', 'sei': '5.28'}",CHEMBL4107323,,CHEMBL4107323,6.68,False,http://www.openphacts.org/units/Nanomolar,2895319,=,37,True,=,,IC50,nM,,208.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,208.0
432537,17792645,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2[C@H](C)F)n1)c1ncc(-c2ccnc(C(F)(F)F)c2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '16.18', 'le': '0.31', 'lle': '3.05', 'sei': '8.59'}",CHEMBL3953091,,CHEMBL3953091,8.00,False,http://www.openphacts.org/units/Nanomolar,2895358,=,37,True,=,,IC50,nM,,10.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,10.0
432538,17792646,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1ncc(-c2ccnc(C(F)(F)F)c2)cc1F,,,CHEMBL3886939,,2016.0,"{'bei': '14.99', 'le': '0.29', 'lle': '2.46', 'sei': '7.96'}",CHEMBL3984884,,CHEMBL3984884,7.41,False,http://www.openphacts.org/units/Nanomolar,2895359,=,37,True,=,,IC50,nM,,39.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,39.0
432539,17792647,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@H](C)F)n2)ncc1-c1ccnc(C(F)(F)F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '16.23', 'le': '0.31', 'lle': '2.84', 'sei': '8.55'}",CHEMBL3947537,,CHEMBL3947537,7.96,False,http://www.openphacts.org/units/Nanomolar,2895362,=,37,True,=,,IC50,nM,,11.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,11.0
432540,17792648,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OCC2[C@H](C)F)n1)c1ncc(-c2cccc(C(F)(F)F)c2F)cn1,,,CHEMBL3886939,,2016.0,,CHEMBL3891698,,CHEMBL3891698,,False,http://www.openphacts.org/units/Nanomolar,2895363,<,37,True,<,,IC50,nM,,2.29,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2.29
432541,17792649,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1ccc(-c2ccnc(C(F)(F)F)c2)cn1,,,CHEMBL3886939,,2016.0,"{'bei': '16.03', 'le': '0.31', 'lle': '2.83', 'sei': '8.20'}",CHEMBL3964290,,CHEMBL3964290,7.64,False,http://www.openphacts.org/units/Nanomolar,2895364,=,37,True,=,,IC50,nM,,23.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,23.0
432542,17792650,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,Cc1cc([C@H](C)Nc2ncc(F)c(N3C(=O)OC[C@@H]3[C@H](C)F)n2)ncc1-c1ccnc(C(F)(F)F)c1,,,CHEMBL3886939,,2016.0,"{'bei': '15.52', 'le': '0.30', 'lle': '2.63', 'sei': '8.48'}",CHEMBL3907232,,CHEMBL3907232,7.89,False,http://www.openphacts.org/units/Nanomolar,2895402,=,37,True,=,,IC50,nM,,12.8,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,12.8
432543,17792651,[],CHEMBL3889083,"LC-MS Detection of 2-HG Assay: The biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 μL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG. The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 μM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 μL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000×g, minutes). The concentration of 2-HG in the resulting supernatants was measured by LC-MS (see below). LC-MS method. Reaction mixture supernatants were submitted to chromatographic separation on a BiobasicAX column (2.1 mm×20 mm, 5 μm particle, Thermo Scientific Inc.). The chromatographic mobile phases were A) 25 mM ammonium biocarbonate and B) acetonitrile (0.1% ammonium hydroxide). Nicotinamide was eluted at 1 ml/min using a 85-5% B gradient over 0.9 minutes (Agilent 1200SL LC system, Thermofisher LX-4 autosampler) and analyzed by multiple reaction monitoring (MRM) on a API4000 QTrap mass spectrometer (ABSciex, Framingham, Mass.) in the positive electrospray ionization (ESI+) mode. The mass transition for 2-HG and 13C-2-HG were 147→129 and 152→134, respectively.",B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2CF)n1)c1ncc(-c2ccc(Cl)cc2)o1,,,CHEMBL3886939,,2016.0,"{'bei': '19.05', 'le': '0.38', 'lle': '3.91', 'sei': '8.89'}",CHEMBL3923366,,CHEMBL3923366,8.30,False,http://www.openphacts.org/units/Nanomolar,2895374,=,37,True,=,,IC50,nM,,5.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5.0
,18146037,[],CHEMBL4032333,Inhibition of wild type IDH1 (unknown origin) using isocitrate as substrate preincubated for 30 mins followed by substrate addition in presence of NADP+ measured up to 5 mins by resorufin-based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,Cc1nc2ccc(NC(=O)CCNC(=O)CCCc3ccc(CC(C(=O)O)C(=O)O)cc3)cc2s1,,,CHEMBL4028893,J Med Chem,2017.0,,CHEMBL2059811,,CHEMBL2059811,,False,http://www.openphacts.org/units/Nanomolar,3010131,>,1,True,>,,IC50,nM,,57000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,57.0
,18146038,[],CHEMBL4032333,Inhibition of wild type IDH1 (unknown origin) using isocitrate as substrate preincubated for 30 mins followed by substrate addition in presence of NADP+ measured up to 5 mins by resorufin-based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,COc1ncc(-c2ccc3c(Nc4cc(Oc5cc(F)cc(F)c5)cc(C(=O)O)c4)c(S(=O)(=O)NC4CC4)cnc3c2)c(OC)n1,,,CHEMBL4028893,J Med Chem,2017.0,,CHEMBL3335794,,CHEMBL3335794,,False,http://www.openphacts.org/units/Nanomolar,3010160,>,1,True,>,,IC50,nM,,57000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,57.0
,18146039,[],CHEMBL4032333,Inhibition of wild type IDH1 (unknown origin) using isocitrate as substrate preincubated for 30 mins followed by substrate addition in presence of NADP+ measured up to 5 mins by resorufin-based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,O=C1N[C@](c2ccc(N3CCOCC3)cc2)(c2ccsc2)CC(O)=C1Sc1ccccc1Cl,,,CHEMBL4028893,J Med Chem,2017.0,,CHEMBL4065858,,CHEMBL4065858,,False,http://www.openphacts.org/units/Nanomolar,3010161,>,1,True,>,,IC50,nM,,57000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,57.0
,18146040,[],CHEMBL4032333,Inhibition of wild type IDH1 (unknown origin) using isocitrate as substrate preincubated for 30 mins followed by substrate addition in presence of NADP+ measured up to 5 mins by resorufin-based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(Cc2c(-c3ccc(F)c(F)c3)nn(-c3nc(C(=O)O)cs3)c2O)cc1,,,CHEMBL4028893,J Med Chem,2017.0,,CHEMBL4076973,,CHEMBL4076973,,False,http://www.openphacts.org/units/Nanomolar,3010162,>,1,True,>,,IC50,nM,,57000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,57.0
,18146041,[],CHEMBL4032333,Inhibition of wild type IDH1 (unknown origin) using isocitrate as substrate preincubated for 30 mins followed by substrate addition in presence of NADP+ measured up to 5 mins by resorufin-based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(Cc2c(-c3cccc(Br)c3)nn(-c3nc(C(=O)O)cs3)c2O)cc1,,,CHEMBL4028893,J Med Chem,2017.0,,CHEMBL4084774,,CHEMBL4084774,,False,http://www.openphacts.org/units/Nanomolar,3010165,>,1,True,>,,IC50,nM,,57000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,57.0
,18146042,[],CHEMBL4032333,Inhibition of wild type IDH1 (unknown origin) using isocitrate as substrate preincubated for 30 mins followed by substrate addition in presence of NADP+ measured up to 5 mins by resorufin-based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(Cc2c(-c3cccc(-c4ccccc4)c3)nn(-c3nc(C(=O)O)cs3)c2O)cc1,,,CHEMBL4028893,J Med Chem,2017.0,"{'bei': '8.12', 'le': '0.16', 'lle': '0.02', 'sei': '2.91'}",CHEMBL4063125,,CHEMBL4063125,4.32,False,http://www.openphacts.org/units/Nanomolar,3010166,=,1,True,=,,IC50,nM,,47400.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,47.4
,18146043,[],CHEMBL4032333,Inhibition of wild type IDH1 (unknown origin) using isocitrate as substrate preincubated for 30 mins followed by substrate addition in presence of NADP+ measured up to 5 mins by resorufin-based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(Cc2c(-c3cccc(-c4ccccc4F)c3)nn(-c3nc(C(=O)O)cs3)c2O)cc1,,,CHEMBL4028893,J Med Chem,2017.0,,CHEMBL4099443,,CHEMBL4099443,,False,http://www.openphacts.org/units/Nanomolar,3010167,>,1,True,>,,IC50,nM,,57000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,57.0
,18146044,[],CHEMBL4032333,Inhibition of wild type IDH1 (unknown origin) using isocitrate as substrate preincubated for 30 mins followed by substrate addition in presence of NADP+ measured up to 5 mins by resorufin-based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(Cc2cn(-c3nc(C(=O)O)cs3)nc2-c2ccc(F)c(F)c2)cc1,,,CHEMBL4028893,J Med Chem,2017.0,,CHEMBL4069796,,CHEMBL4069796,,False,http://www.openphacts.org/units/Nanomolar,3010171,>,1,True,>,,IC50,nM,,57000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,57.0
,18146045,[],CHEMBL4032333,Inhibition of wild type IDH1 (unknown origin) using isocitrate as substrate preincubated for 30 mins followed by substrate addition in presence of NADP+ measured up to 5 mins by resorufin-based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(Cc2cn(-c3nc(C(=O)O)cs3)nc2-c2ccccc2)cc1,,,CHEMBL4028893,J Med Chem,2017.0,,CHEMBL4090794,,CHEMBL4090794,,False,http://www.openphacts.org/units/Nanomolar,3010172,>,1,True,>,,IC50,nM,,57000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,57.0
,18146046,[],CHEMBL4032333,Inhibition of wild type IDH1 (unknown origin) using isocitrate as substrate preincubated for 30 mins followed by substrate addition in presence of NADP+ measured up to 5 mins by resorufin-based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(Cc2cn(-c3nc(C(=O)O)cs3)nc2-c2cccc(-c3ccccc3)c2)cc1,,,CHEMBL4028893,J Med Chem,2017.0,"{'bei': '8.37', 'le': '0.16', 'lle': '-0.28', 'sei': '3.37'}",CHEMBL4080497,,CHEMBL4080497,4.32,False,http://www.openphacts.org/units/Nanomolar,3010173,=,1,True,=,,IC50,nM,,47400.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,47.4
,18146047,[],CHEMBL4032333,Inhibition of wild type IDH1 (unknown origin) using isocitrate as substrate preincubated for 30 mins followed by substrate addition in presence of NADP+ measured up to 5 mins by resorufin-based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(Nc2cn(-c3nc(C(=O)O)cs3)nc2-c2cccc(-c3ccccc3)c2)cc1,,,CHEMBL4028893,J Med Chem,2017.0,,CHEMBL4076027,,CHEMBL4076027,,False,http://www.openphacts.org/units/Nanomolar,3010175,>,1,True,>,,IC50,nM,,57000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,57.0
,18146048,[],CHEMBL4032333,Inhibition of wild type IDH1 (unknown origin) using isocitrate as substrate preincubated for 30 mins followed by substrate addition in presence of NADP+ measured up to 5 mins by resorufin-based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(Nc2cn(-c3nc(C(=O)O)cs3)nc2-c2ccccc2)cc1,,,CHEMBL4028893,J Med Chem,2017.0,,CHEMBL4076958,,CHEMBL4076958,,False,http://www.openphacts.org/units/Nanomolar,3010176,>,1,True,>,,IC50,nM,,57000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,57.0
,18146049,[],CHEMBL4032333,Inhibition of wild type IDH1 (unknown origin) using isocitrate as substrate preincubated for 30 mins followed by substrate addition in presence of NADP+ measured up to 5 mins by resorufin-based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(Cc2c(-c3ccccc3)nn(-c3nc(C(=O)O)cs3)c2-c2cccnc2)cc1,,,CHEMBL4028893,J Med Chem,2017.0,,CHEMBL4066429,,CHEMBL4066429,,False,http://www.openphacts.org/units/Nanomolar,3010179,>,1,True,>,,IC50,nM,,57000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,57.0
,18146050,[],CHEMBL4032333,Inhibition of wild type IDH1 (unknown origin) using isocitrate as substrate preincubated for 30 mins followed by substrate addition in presence of NADP+ measured up to 5 mins by resorufin-based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(Cc2c(-c3ccccc3)nn(-c3nc(C(=O)O)cs3)c2-c2ccncc2)cc1,,,CHEMBL4028893,J Med Chem,2017.0,,CHEMBL4092360,,CHEMBL4092360,,False,http://www.openphacts.org/units/Nanomolar,3010180,>,1,True,>,,IC50,nM,,57000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,57.0
,18146051,[],CHEMBL4032333,Inhibition of wild type IDH1 (unknown origin) using isocitrate as substrate preincubated for 30 mins followed by substrate addition in presence of NADP+ measured up to 5 mins by resorufin-based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,Nc1c(Cc2ccc(S(N)(=O)=O)cc2)c(-c2cccc(-c3ccccc3)c2)nn1-c1nc(C(=O)O)cs1,,,CHEMBL4028893,J Med Chem,2017.0,,CHEMBL4075666,,CHEMBL4075666,,False,http://www.openphacts.org/units/Nanomolar,3010181,>,1,True,>,,IC50,nM,,57000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,57.0
,18146052,[],CHEMBL4032333,Inhibition of wild type IDH1 (unknown origin) using isocitrate as substrate preincubated for 30 mins followed by substrate addition in presence of NADP+ measured up to 5 mins by resorufin-based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(Cc2c(-c3cccc(-c4ccccc4)c3)nn(-c3nc(C(=O)O)cs3)c2C(F)(F)F)cc1,,,CHEMBL4028893,J Med Chem,2017.0,"{'bei': '7.65', 'le': '0.15', 'lle': '-1.15', 'sei': '3.49'}",CHEMBL4101800,,CHEMBL4101800,4.47,False,http://www.openphacts.org/units/Nanomolar,3010182,=,1,True,=,,IC50,nM,,33500.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,33.5
,18146053,[],CHEMBL4032333,Inhibition of wild type IDH1 (unknown origin) using isocitrate as substrate preincubated for 30 mins followed by substrate addition in presence of NADP+ measured up to 5 mins by resorufin-based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(Cc2c(-c3ccccc3)nn(-c3nc(C(=O)O)cs3)c2C2CC2)cc1,,,CHEMBL4028893,J Med Chem,2017.0,,CHEMBL4090677,,CHEMBL4090677,,False,http://www.openphacts.org/units/Nanomolar,3010183,>,1,True,>,,IC50,nM,,57000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,57.0
,18146054,[],CHEMBL4032333,Inhibition of wild type IDH1 (unknown origin) using isocitrate as substrate preincubated for 30 mins followed by substrate addition in presence of NADP+ measured up to 5 mins by resorufin-based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(Oc2c(-c3cccc(-c4ccccc4)c3)nn(-c3nc(C(=O)O)cs3)c2C2CC2)cc1,,,CHEMBL4028893,J Med Chem,2017.0,"{'bei': '8.19', 'le': '0.16', 'lle': '-1.10', 'sei': '3.33'}",CHEMBL4082867,,CHEMBL4082867,4.58,False,http://www.openphacts.org/units/Nanomolar,3010185,=,1,True,=,,IC50,nM,,26600.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,26.6
,18146055,[],CHEMBL4032333,Inhibition of wild type IDH1 (unknown origin) using isocitrate as substrate preincubated for 30 mins followed by substrate addition in presence of NADP+ measured up to 5 mins by resorufin-based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(Cc2c(-c3cccc(-c4ccccc4)c3)nn(-c3nc(C(=O)O)cs3)c2C2CC2)cc1,,,CHEMBL4028893,J Med Chem,2017.0,"{'bei': '8.04', 'le': '0.16', 'lle': '-1.01', 'sei': '3.49'}",CHEMBL4100845,,CHEMBL4100845,4.47,False,http://www.openphacts.org/units/Nanomolar,3010186,=,1,True,=,,IC50,nM,,33500.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,33.5
,18146056,[],CHEMBL4032333,Inhibition of wild type IDH1 (unknown origin) using isocitrate as substrate preincubated for 30 mins followed by substrate addition in presence of NADP+ measured up to 5 mins by resorufin-based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(Cc2c(-c3ccccc3)nn(-c3nc(C(=O)O)cs3)c2CC2CC2)cc1,,,CHEMBL4028893,J Med Chem,2017.0,"{'bei': '8.74', 'le': '0.17', 'lle': '0.44', 'sei': '3.37'}",CHEMBL4059985,,CHEMBL4059985,4.32,False,http://www.openphacts.org/units/Nanomolar,3010187,=,1,True,=,,IC50,nM,,47400.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,47.4
,18146057,[],CHEMBL4032333,Inhibition of wild type IDH1 (unknown origin) using isocitrate as substrate preincubated for 30 mins followed by substrate addition in presence of NADP+ measured up to 5 mins by resorufin-based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,NS(=O)(=O)c1ccc(Cc2c(-c3cccc(-c4ccccc4)c3)nn(-c3nc(C(=O)O)cs3)c2CC2CC2)cc1,,,CHEMBL4028893,J Med Chem,2017.0,"{'bei': '7.93', 'le': '0.15', 'lle': '-1.02', 'sei': '3.53'}",CHEMBL4081890,,CHEMBL4081890,4.53,False,http://www.openphacts.org/units/Nanomolar,3010188,=,1,True,=,,IC50,nM,,29800.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,29.8
,18328002,[],CHEMBL4135751,Inhibition of IDH1 R132C mutant (unknown origin) assessed as NADPH consumption using alpha-ketoglutarate as substrate by fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@H](C)F)n2)ncc1-c1ccnc(C(F)(F)F)c1,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '15.40', 'le': '0.29', 'lle': '2.43', 'sei': '8.11'}",CHEMBL3947537,,CHEMBL3947537,7.55,False,http://www.openphacts.org/units/Nanomolar,3043147,=,1,True,=,,IC50,nM,,28.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.028
,18328003,[],CHEMBL4135750,Inhibition of wild-type IDH1 (unknown origin) assessed as NADPH production using isocitrate as substrate by fluorescence assay,A,BAO_0000190,BAO_0000357,single protein format,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@H](C)F)n2)ncc1-c1ccnc(C(F)(F)F)c1,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,,CHEMBL3947537,,CHEMBL3947537,5.21,False,http://www.openphacts.org/units/Nanomolar,3043147,=,1,True,=,,IC50,nM,,6140.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,6.14
,18328004,[],CHEMBL4135749,Inhibition of IDH1 R132H mutant (unknown origin) assessed as NADPH consumption using alpha-ketoglutarate as substrate by fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@H](C)F)n2)ncc1-c1ccnc(C(F)(F)F)c1,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '15.43', 'le': '0.30', 'lle': '2.45', 'sei': '8.13'}",CHEMBL3947537,,CHEMBL3947537,7.57,False,http://www.openphacts.org/units/Nanomolar,3043147,=,1,True,=,,IC50,nM,,27.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.027
,18328005,[],CHEMBL4135748,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate by LC-MS/MS analysis,B,BAO_0000190,BAO_0000357,single protein format,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@H](C)F)n2)ncc1-c1ccnc(C(F)(F)F)c1,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '15.79', 'le': '0.30', 'lle': '2.62', 'sei': '8.32'}",CHEMBL3947537,,CHEMBL3947537,7.75,False,http://www.openphacts.org/units/Nanomolar,3043147,=,1,True,=,,IC50,nM,,18.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.018
,18328007,[],CHEMBL4135754,Inhibition of IDH1 R132H mutant in human HCT116 cells assessed as reduction in 2-HG level after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3CF)n2)ncc1-c1ccnc(C(F)(F)F)c1,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '15.03', 'le': '0.29', 'lle': '2.43', 'sei': '7.69'}",CHEMBL4163921,,CHEMBL4163921,7.16,False,http://www.openphacts.org/units/Nanomolar,3043146,=,1,True,=,,IC50,nM,,69.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.069
,18328008,[],CHEMBL4135748,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate by LC-MS/MS analysis,B,BAO_0000190,BAO_0000357,single protein format,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3CF)n2)ncc1-c1ccnc(C(F)(F)F)c1,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '15.85', 'le': '0.30', 'lle': '2.82', 'sei': '8.11'}",CHEMBL4163921,,CHEMBL4163921,7.55,False,http://www.openphacts.org/units/Nanomolar,3043146,=,1,True,=,,IC50,nM,,28.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.028
,18328010,[],CHEMBL4135754,Inhibition of IDH1 R132H mutant in human HCT116 cells assessed as reduction in 2-HG level after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)ncc1-c1ccnc(C(F)(F)F)c1,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '14.31', 'le': '0.27', 'lle': '2.85', 'sei': '6.17'}",CHEMBL3949375,,CHEMBL3949375,6.99,False,http://www.openphacts.org/units/Nanomolar,3043145,=,1,True,=,,IC50,nM,,102.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.102
,18328011,[],CHEMBL4135748,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate by LC-MS/MS analysis,B,BAO_0000190,BAO_0000357,single protein format,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)O)n2)ncc1-c1ccnc(C(F)(F)F)c1,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '15.32', 'le': '0.29', 'lle': '3.34', 'sei': '6.60'}",CHEMBL3949375,,CHEMBL3949375,7.48,False,http://www.openphacts.org/units/Nanomolar,3043145,=,1,True,=,,IC50,nM,,33.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.033
,18328013,[],CHEMBL4135754,Inhibition of IDH1 R132H mutant in human HCT116 cells assessed as reduction in 2-HG level after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cc(C)c(-c3ccnc(C(F)(F)F)c3)cn2)n1,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '15.61', 'le': '0.30', 'lle': '2.21', 'sei': '7.92'}",CHEMBL4160534,,CHEMBL4160534,7.38,False,http://www.openphacts.org/units/Nanomolar,3043144,=,1,True,=,,IC50,nM,,42.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.042
,18328014,[],CHEMBL4135748,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate by LC-MS/MS analysis,B,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cc(C)c(-c3ccnc(C(F)(F)F)c3)cn2)n1,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '15.78', 'le': '0.30', 'lle': '2.29', 'sei': '8.01'}",CHEMBL4160534,,CHEMBL4160534,7.46,False,http://www.openphacts.org/units/Nanomolar,3043144,=,1,True,=,,IC50,nM,,35.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.035
,18328016,[],CHEMBL4135754,Inhibition of IDH1 R132H mutant in human HCT116 cells assessed as reduction in 2-HG level after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C)n2)ncc1-c1ccnc(C(F)(F)F)c1,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '14.37', 'le': '0.27', 'lle': '1.81', 'sei': '7.07'}",CHEMBL4164212,,CHEMBL4164212,6.59,False,http://www.openphacts.org/units/Nanomolar,3043143,=,1,True,=,,IC50,nM,,258.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.258
,18328017,[],CHEMBL4135748,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate by LC-MS/MS analysis,B,BAO_0000190,BAO_0000357,single protein format,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C)n2)ncc1-c1ccnc(C(F)(F)F)c1,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '15.13', 'le': '0.29', 'lle': '2.16', 'sei': '7.45'}",CHEMBL4164212,,CHEMBL4164212,6.94,False,http://www.openphacts.org/units/Nanomolar,3043143,=,1,True,=,,IC50,nM,,116.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.116
,18328019,[],CHEMBL4135754,Inhibition of IDH1 R132H mutant in human HCT116 cells assessed as reduction in 2-HG level after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)ncc1-c1ccnc(C(F)(F)F)c1,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '16.14', 'le': '0.31', 'lle': '2.43', 'sei': '8.43'}",CHEMBL4172087,,CHEMBL4172087,7.85,False,http://www.openphacts.org/units/Nanomolar,3043142,=,1,True,=,,IC50,nM,,14.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.014
,18328020,[],CHEMBL4135748,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate by LC-MS/MS analysis,B,BAO_0000190,BAO_0000357,single protein format,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)ncc1-c1ccnc(C(F)(F)F)c1,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '16.21', 'le': '0.31', 'lle': '2.47', 'sei': '8.47'}",CHEMBL4172087,,CHEMBL4172087,7.89,False,http://www.openphacts.org/units/Nanomolar,3043142,=,1,True,=,,IC50,nM,,13.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.013
,18328035,[],CHEMBL4135755,Inhibition of IDH1 R132H mutant in human MCF10A cells assessed as cell growth inhibition,B,BAO_0000190,BAO_0000219,cell-based format,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@H](C)F)n2)ncc1-c1ccnc(C(F)(F)F)c1,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '15.70', 'le': '0.30', 'lle': '2.58', 'sei': '8.27'}",CHEMBL3947537,,CHEMBL3947537,7.70,False,http://www.openphacts.org/units/Nanomolar,3043147,=,1,True,=,,IC50,nM,,20.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.02
,18328036,[],CHEMBL4135754,Inhibition of IDH1 R132H mutant in human HCT116 cells assessed as reduction in 2-HG level after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@H](C)F)n2)ncc1-c1ccnc(C(F)(F)F)c1,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '15.54', 'le': '0.30', 'lle': '2.50', 'sei': '8.18'}",CHEMBL3947537,,CHEMBL3947537,7.62,False,http://www.openphacts.org/units/Nanomolar,3043147,=,1,True,=,,IC50,nM,,24.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.024
,18328037,[],CHEMBL4135748,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate by LC-MS/MS analysis,B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cnc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)nc2)ccc1F,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '17.64', 'le': '0.33', 'lle': '3.16', 'sei': '8.27'}",CHEMBL4169151,,CHEMBL4169151,7.70,True,http://www.openphacts.org/units/Nanomolar,3043135,=,1,True,=,,IC50,nM,,20.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.02
,18328038,[],CHEMBL4135754,Inhibition of IDH1 R132H mutant in human HCT116 cells assessed as reduction in 2-HG level after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(-c2cnc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)nc2)ccc1F,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '17.99', 'le': '0.34', 'lle': '3.31', 'sei': '8.43'}",CHEMBL4169151,,CHEMBL4169151,7.85,False,http://www.openphacts.org/units/Nanomolar,3043135,=,1,True,=,,IC50,nM,,14.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.014
,18328049,[],CHEMBL4135748,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate by LC-MS/MS analysis,B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cnc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)cn2)ccc1F,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '16.51', 'le': '0.31', 'lle': '2.67', 'sei': '7.74'}",CHEMBL4173642,,CHEMBL4173642,7.21,False,http://www.openphacts.org/units/Nanomolar,3043136,=,1,True,=,,IC50,nM,,62.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.062
,18328050,[],CHEMBL4135754,Inhibition of IDH1 R132H mutant in human HCT116 cells assessed as reduction in 2-HG level after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(-c2cnc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)cn2)ccc1F,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '16.79', 'le': '0.31', 'lle': '2.79', 'sei': '7.87'}",CHEMBL4173642,,CHEMBL4173642,7.33,False,http://www.openphacts.org/units/Nanomolar,3043136,=,1,True,=,,IC50,nM,,47.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.047
,18328053,[],CHEMBL4135748,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate by LC-MS/MS analysis,B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2ccc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)nc2)ccn1,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '15.46', 'le': '0.29', 'lle': '2.07', 'sei': '6.95'}",CHEMBL4165726,,CHEMBL4165726,6.47,False,http://www.openphacts.org/units/Nanomolar,3043137,=,1,True,=,,IC50,nM,,339.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.339
,18328054,[],CHEMBL4135754,Inhibition of IDH1 R132H mutant in human HCT116 cells assessed as reduction in 2-HG level after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(-c2ccc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)nc2)ccn1,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '16.34', 'le': '0.30', 'lle': '2.44', 'sei': '7.34'}",CHEMBL4165726,,CHEMBL4165726,6.84,False,http://www.openphacts.org/units/Nanomolar,3043137,=,1,True,=,,IC50,nM,,145.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.145
,18328057,[],CHEMBL4135748,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate by LC-MS/MS analysis,B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3ccnc(C(C)(C)C)c3)cn2)n1,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '18.23', 'le': '0.34', 'lle': '3.01', 'sei': '9.02'}",CHEMBL4170686,,CHEMBL4170686,8.40,False,http://www.openphacts.org/units/Nanomolar,3043138,=,1,True,=,,IC50,nM,,4.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.004
,18328080,[],CHEMBL4135748,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate by LC-MS/MS analysis,B,BAO_0000190,BAO_0000357,single protein format,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)F)n2)ncc1-c1ccnc(C(F)(F)F)c1,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '14.55', 'le': '0.28', 'lle': '2.02', 'sei': '7.66'}",CHEMBL4167360,,CHEMBL4167360,7.14,False,http://www.openphacts.org/units/Nanomolar,3043148,=,1,True,=,,IC50,nM,,73.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.073
,18328081,[],CHEMBL4135754,Inhibition of IDH1 R132H mutant in human HCT116 cells assessed as reduction in 2-HG level after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,Cc1cc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3[C@@H](C)F)n2)ncc1-c1ccnc(C(F)(F)F)c1,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '13.25', 'le': '0.25', 'lle': '1.38', 'sei': '6.98'}",CHEMBL4167360,,CHEMBL4167360,6.50,False,http://www.openphacts.org/units/Nanomolar,3043148,=,1,True,=,,IC50,nM,,316.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.316
,18328106,[],CHEMBL4135754,Inhibition of IDH1 R132H mutant in human HCT116 cells assessed as reduction in 2-HG level after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(-c2ccnc(C(F)(F)F)c2)cnc1[C@H](C)Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '14.75', 'le': '0.28', 'lle': '1.75', 'sei': '7.70'}",CHEMBL4177420,,CHEMBL4177420,7.17,False,http://www.openphacts.org/units/Nanomolar,3043141,=,1,True,=,,IC50,nM,,67.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.067
,18328107,[],CHEMBL4135748,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate by LC-MS/MS analysis,B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2ccnc(C(F)(F)F)c2)cnc1[C@H](C)Nc1nccc(N2C(=O)OC[C@@H]2C(C)C)n1,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '14.54', 'le': '0.28', 'lle': '1.66', 'sei': '7.60'}",CHEMBL4177420,,CHEMBL4177420,7.08,False,http://www.openphacts.org/units/Nanomolar,3043141,=,1,True,=,,IC50,nM,,84.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.084
,18328109,[],CHEMBL4135754,Inhibition of IDH1 R132H mutant in human HCT116 cells assessed as reduction in 2-HG level after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,Cc1nc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)ccc1-c1ccnc(C(F)(F)F)c1,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '16.21', 'le': '0.31', 'lle': '2.47', 'sei': '8.47'}",CHEMBL4166795,,CHEMBL4166795,7.89,False,http://www.openphacts.org/units/Nanomolar,3043140,=,1,True,=,,IC50,nM,,13.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.013
,18328110,[],CHEMBL4135748,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate by LC-MS/MS analysis,B,BAO_0000190,BAO_0000357,single protein format,Cc1nc([C@H](C)Nc2nccc(N3C(=O)OC[C@@H]3C(C)C)n2)ccc1-c1ccnc(C(F)(F)F)c1,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '16.08', 'le': '0.31', 'lle': '2.40', 'sei': '8.40'}",CHEMBL4166795,,CHEMBL4166795,7.82,False,http://www.openphacts.org/units/Nanomolar,3043140,=,1,True,=,,IC50,nM,,15.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.015
,18328113,[],CHEMBL4135754,Inhibition of IDH1 R132H mutant in human HCT116 cells assessed as reduction in 2-HG level after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3ccnc(C(F)(F)F)c3)cn2)n1,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '15.64', 'le': '0.30', 'lle': '2.28', 'sei': '7.93'}",CHEMBL4162284,,CHEMBL4162284,7.39,False,http://www.openphacts.org/units/Nanomolar,3043139,=,1,True,=,,IC50,nM,,41.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.041
,18328114,[],CHEMBL4135748,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate by LC-MS/MS analysis,B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3ccnc(C(F)(F)F)c3)cn2)n1,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,"{'bei': '15.06', 'le': '0.29', 'lle': '2.00', 'sei': '7.64'}",CHEMBL4162284,,CHEMBL4162284,7.11,False,http://www.openphacts.org/units/Nanomolar,3043139,=,1,True,=,,IC50,nM,,77.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.077
,18328116,[],CHEMBL4135754,Inhibition of IDH1 R132H mutant in human HCT116 cells assessed as reduction in 2-HG level after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3ccnc(C(C)(C)C)c3)cn2)n1,,,CHEMBL4130531,ACS Med Chem Lett,2017.0,,CHEMBL4170686,,CHEMBL4170686,,False,http://www.openphacts.org/units/Nanomolar,3043138,<,1,True,<,,IC50,nM,,2.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.002
,18461383,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cc(F)cc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)n1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '12.92', 'le': '0.24', 'lle': '3.75', 'sei': '6.42'}",CHEMBL4204501,,CHEMBL4204501,7.66,False,http://www.openphacts.org/units/Nanomolar,3063902,=,1,True,=,,IC50,nM,,22.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,22.0
,18461384,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)c1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cc(F)cc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '8.58', 'le': '0.17', 'lle': '1.48', 'sei': '4.73'}",CHEMBL4216167,,CHEMBL4216167,5.53,False,http://www.openphacts.org/units/Nanomolar,3063901,=,1,True,=,,IC50,nM,,2965.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2965.0
,18461385,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,COc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cc(F)cc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,,CHEMBL4208834,,CHEMBL4208834,,False,http://www.openphacts.org/units/Nanomolar,3063900,>,1,True,>,,IC50,nM,,10000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,10000.0
,18461386,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,O=C1CC[C@@H](C(=O)N(c2cc(F)cc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)N1c1cnccn1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '12.15', 'le': '0.23', 'lle': '2.85', 'sei': '7.22'}",CHEMBL4203955,,CHEMBL4203955,6.89,False,http://www.openphacts.org/units/Nanomolar,3063899,=,1,True,=,,IC50,nM,,128.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,128.0
,18461387,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,O=C1CC[C@@H](C(=O)N(c2cc(F)cc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)N1c1ccccn1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,,CHEMBL4212242,,CHEMBL4212242,,False,http://www.openphacts.org/units/Nanomolar,3063898,>,1,True,>,,IC50,nM,,10000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,10000.0
,18461388,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1cccc(N2C(=O)CC[C@H]2C(=O)N(c2cc(F)cc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '9.46', 'le': '0.18', 'lle': '0.46', 'sei': '5.97'}",CHEMBL4207353,,CHEMBL4207353,5.58,False,http://www.openphacts.org/units/Nanomolar,3063897,=,1,True,=,,IC50,nM,,2605.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,2605.0
,18461389,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)OC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '12.57', 'le': '0.24', 'lle': '3.03', 'sei': '6.26'}",CHEMBL4207520,,CHEMBL4207520,7.24,False,http://www.openphacts.org/units/Nanomolar,3063896,=,1,True,=,,IC50,nM,,58.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,58.0
,18461390,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2CCC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '11.07', 'le': '0.21', 'lle': '1.35', 'sei': '6.94'}",CHEMBL4211712,,CHEMBL4211712,6.20,False,http://www.openphacts.org/units/Nanomolar,3063895,=,1,True,=,,IC50,nM,,635.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,635.0
,18461391,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,,CHEMBL4210140,,CHEMBL4210140,,False,http://www.openphacts.org/units/Nanomolar,3063894,>,1,True,>,,IC50,nM,,10000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,10000.0
,18461392,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cc(F)cc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3cccc(Cl)c32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '10.77', 'le': '0.21', 'lle': '1.57', 'sei': '6.34'}",CHEMBL4215069,,CHEMBL4215069,6.75,False,http://www.openphacts.org/units/Nanomolar,3063893,=,1,True,=,,IC50,nM,,180.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,180.0
,18461393,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cc(F)cc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3c(Cl)cccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '11.62', 'le': '0.23', 'lle': '2.11', 'sei': '6.84'}",CHEMBL4207639,,CHEMBL4207639,7.28,False,http://www.openphacts.org/units/Nanomolar,3063892,=,1,True,=,,IC50,nM,,53.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,53.0
,18461394,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3cc(Cl)ccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '12.02', 'le': '0.23', 'lle': '2.28', 'sei': '6.87'}",CHEMBL4212544,,CHEMBL4212544,7.31,False,http://www.openphacts.org/units/Nanomolar,3063891,=,1,True,=,,IC50,nM,,49.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,49.0
,18461395,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3c(Cl)cccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '11.80', 'le': '0.23', 'lle': '2.14', 'sei': '6.74'}",CHEMBL4203298,,CHEMBL4203298,7.17,False,http://www.openphacts.org/units/Nanomolar,3063890,=,1,True,=,,IC50,nM,,67.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,67.0
,18461396,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3cccc(F)c32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '12.33', 'le': '0.23', 'lle': '2.77', 'sei': '6.85'}",CHEMBL4208169,,CHEMBL4208169,7.29,False,http://www.openphacts.org/units/Nanomolar,3063889,=,1,True,=,,IC50,nM,,51.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,51.0
,18461397,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccc(F)cc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '11.60', 'le': '0.22', 'lle': '2.34', 'sei': '6.45'}",CHEMBL4215481,,CHEMBL4215481,6.86,False,http://www.openphacts.org/units/Nanomolar,3063888,=,1,True,=,,IC50,nM,,138.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,138.0
,18461398,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3cc(F)ccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '11.78', 'le': '0.22', 'lle': '2.45', 'sei': '6.55'}",CHEMBL4203806,,CHEMBL4203806,6.97,False,http://www.openphacts.org/units/Nanomolar,3063887,=,1,True,=,,IC50,nM,,108.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,108.0
,18461399,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3c(F)cccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '12.12', 'le': '0.23', 'lle': '2.65', 'sei': '6.74'}",CHEMBL4211065,,CHEMBL4211065,7.17,False,http://www.openphacts.org/units/Nanomolar,3063886,=,1,True,=,,IC50,nM,,68.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,68.0
,18461400,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2ccc(Cl)c(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '11.07', 'le': '0.21', 'lle': '1.70', 'sei': '6.33'}",CHEMBL4216027,,CHEMBL4216027,6.73,False,http://www.openphacts.org/units/Nanomolar,3063885,=,1,True,=,,IC50,nM,,186.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,186.0
,18461401,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cc(F)cc(Cl)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '11.13', 'le': '0.21', 'lle': '1.73', 'sei': '6.36'}",CHEMBL4212804,,CHEMBL4212804,6.76,False,http://www.openphacts.org/units/Nanomolar,3063884,=,1,True,=,,IC50,nM,,172.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,172.0
,18461402,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cc(F)cc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '12.42', 'le': '0.23', 'lle': '2.83', 'sei': '6.90'}",CHEMBL4207897,,CHEMBL4207897,7.35,False,http://www.openphacts.org/units/Nanomolar,3063883,=,1,True,=,,IC50,nM,,45.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,45.0
,18461403,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2ccc(F)c(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '11.87', 'le': '0.22', 'lle': '2.50', 'sei': '6.60'}",CHEMBL4216343,,CHEMBL4216343,7.02,False,http://www.openphacts.org/units/Nanomolar,3063882,=,1,True,=,,IC50,nM,,95.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,95.0
,18461404,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2F)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '11.55', 'le': '0.22', 'lle': '2.31', 'sei': '6.42'}",CHEMBL4202591,,CHEMBL4202591,6.83,False,http://www.openphacts.org/units/Nanomolar,3063881,=,1,True,=,,IC50,nM,,148.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,148.0
,18461405,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cc(F)ccc2F)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '10.94', 'le': '0.21', 'lle': '1.95', 'sei': '6.08'}",CHEMBL4203130,,CHEMBL4203130,6.47,False,http://www.openphacts.org/units/Nanomolar,3063880,=,1,True,=,,IC50,nM,,338.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,338.0
,18461406,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(Cl)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '11.17', 'le': '0.21', 'lle': '1.70', 'sei': '6.20'}",CHEMBL4214783,,CHEMBL4214783,6.59,False,http://www.openphacts.org/units/Nanomolar,3063879,=,1,True,=,,IC50,nM,,255.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,255.0
,18461407,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2ccccc2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '11.85', 'le': '0.22', 'lle': '2.35', 'sei': '6.19'}",CHEMBL4216287,,CHEMBL4216287,6.58,False,http://www.openphacts.org/units/Nanomolar,3063878,=,1,True,=,,IC50,nM,,260.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,260.0
,18461408,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)Nc3ccccc3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,,CHEMBL4211319,,CHEMBL4211319,,False,http://www.openphacts.org/units/Nanomolar,3063877,>,1,True,>,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1000.0
,18461409,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CCOCC3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,,CHEMBL4211838,,CHEMBL4211838,,False,http://www.openphacts.org/units/Nanomolar,3063876,>,1,True,>,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1000.0
,18461410,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CCCCC3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '13.14', 'le': '0.24', 'lle': '2.52', 'sei': '6.98'}",CHEMBL4206945,,CHEMBL4206945,7.43,False,http://www.openphacts.org/units/Nanomolar,3063875,=,1,True,=,,IC50,nM,,37.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,37.0
,18461411,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NCC3CC3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '12.23', 'le': '0.22', 'lle': '2.59', 'sei': '6.18'}",CHEMBL4214891,,CHEMBL4214891,6.58,False,http://www.openphacts.org/units/Nanomolar,3063874,=,1,True,=,,IC50,nM,,266.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,266.0
,18461412,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NCC3CCC(F)(F)CC3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '11.53', 'le': '0.22', 'lle': '1.70', 'sei': '6.67'}",CHEMBL4212118,,CHEMBL4212118,7.10,False,http://www.openphacts.org/units/Nanomolar,3063873,=,1,True,=,,IC50,nM,,80.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,80.0
,18461413,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '12.33', 'le': '0.23', 'lle': '2.69', 'sei': '6.65'}",CHEMBL4210654,,CHEMBL4210654,7.07,False,http://www.openphacts.org/units/Nanomolar,3063872,=,1,True,=,,IC50,nM,,85.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,85.0
,18461414,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '11.15', 'le': '0.21', 'lle': '2.40', 'sei': '5.50'}",CHEMBL4215610,,CHEMBL4215610,6.56,False,http://www.openphacts.org/units/Nanomolar,3063871,=,1,True,=,,IC50,nM,,275.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,275.0
,18461415,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)Cc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '11.72', 'le': '0.22', 'lle': '3.19', 'sei': '5.51'}",CHEMBL4203416,,CHEMBL4203416,6.57,False,http://www.openphacts.org/units/Nanomolar,3063869,=,1,True,=,,IC50,nM,,270.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,270.0
,18461416,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '12.23', 'le': '0.23', 'lle': '3.26', 'sei': '5.89'}",CHEMBL4215084,,CHEMBL4215084,7.03,False,http://www.openphacts.org/units/Nanomolar,3063870,=,1,True,=,,IC50,nM,,94.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,94.0
,18461417,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)OC[C@H]2C(=O)N(c2cc(F)cc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '12.24', 'le': '0.23', 'lle': '2.92', 'sei': '6.29'}",CHEMBL4210785,,CHEMBL4210785,7.27,False,http://www.openphacts.org/units/Nanomolar,3063903,=,1,True,=,,IC50,nM,,54.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,54.0
,18461418,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)OC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3cccc(Cl)c32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '12.09', 'le': '0.23', 'lle': '2.52', 'sei': '6.38'}",CHEMBL4215739,,CHEMBL4215739,7.38,False,http://www.openphacts.org/units/Nanomolar,3063904,=,1,True,=,,IC50,nM,,42.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,42.0
,18461419,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3cccc(Cl)c32)n1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '12.57', 'le': '0.24', 'lle': '3.24', 'sei': '6.42'}",CHEMBL4216785,,CHEMBL4216785,7.66,False,http://www.openphacts.org/units/Nanomolar,3063905,=,1,True,=,,IC50,nM,,22.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,22.0
,18461420,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)OC[C@H]2C(=O)N(c2cc(F)cc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)n1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '12.44', 'le': '0.23', 'lle': '3.66', 'sei': '5.76'}",CHEMBL4202711,,CHEMBL4202711,7.40,False,http://www.openphacts.org/units/Nanomolar,3063906,=,1,True,=,,IC50,nM,,40.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,40.0
,18461421,[],CHEMBL4180676,Inhibition of IDH1 R132H mutant (unknown origin) using alpha-ketoglutarate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)OC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3cccc(Cl)c32)n1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '13.51', 'le': '0.26', 'lle': '4.00', 'sei': '6.42'}",CHEMBL4214223,,CHEMBL4214223,8.25,False,http://www.openphacts.org/units/Nanomolar,3063907,=,1,True,=,,IC50,nM,,5.6,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5.6
Not Determined,18461422,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)Cc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,,CHEMBL4203416,,CHEMBL4203416,,False,,3063869,,1,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
,18461423,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '13.36', 'le': '0.25', 'lle': '3.91', 'sei': '6.44'}",CHEMBL4215084,,CHEMBL4215084,7.68,False,http://www.openphacts.org/units/Nanomolar,3063870,=,1,True,=,,IC50,nM,,21.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,21.0
Not Determined,18461424,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,,CHEMBL4215610,,CHEMBL4215610,,False,,3063871,,1,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
,18461425,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '13.25', 'le': '0.25', 'lle': '3.22', 'sei': '7.14'}",CHEMBL4210654,,CHEMBL4210654,7.60,False,http://www.openphacts.org/units/Nanomolar,3063872,=,1,True,=,,IC50,nM,,25.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,25.0
,18461426,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NCC3CCC(F)(F)CC3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '12.71', 'le': '0.24', 'lle': '2.42', 'sei': '7.35'}",CHEMBL4212118,,CHEMBL4212118,7.82,False,http://www.openphacts.org/units/Nanomolar,3063873,=,1,True,=,,IC50,nM,,15.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,15.0
Not Determined,18461427,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NCC3CC3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,,CHEMBL4214891,,CHEMBL4214891,,False,,3063874,,1,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
,18461428,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CCCCC3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,,CHEMBL4206945,,CHEMBL4206945,,False,http://www.openphacts.org/units/Nanomolar,3063875,<,1,True,<,,IC50,nM,,10.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,10.0
Not Determined,18461429,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CCOCC3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,,CHEMBL4211838,,CHEMBL4211838,,False,,3063876,,1,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
Not Determined,18461430,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)Nc3ccccc3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,,CHEMBL4211319,,CHEMBL4211319,,False,,3063877,,1,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
Not Determined,18461431,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2ccccc2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,,CHEMBL4216287,,CHEMBL4216287,,False,,3063878,,1,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
Not Determined,18461432,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(Cl)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,,CHEMBL4214783,,CHEMBL4214783,,False,,3063879,,1,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
Not Determined,18461433,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cc(F)ccc2F)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,,CHEMBL4203130,,CHEMBL4203130,,False,,3063880,,1,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
Not Determined,18461434,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2F)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,,CHEMBL4202591,,CHEMBL4202591,,False,,3063881,,1,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
Not Determined,18461435,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2ccc(F)c(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,,CHEMBL4216343,,CHEMBL4216343,,False,,3063882,,1,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
,18461436,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cc(F)cc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '14.03', 'le': '0.26', 'lle': '3.78', 'sei': '7.80'}",CHEMBL4207897,,CHEMBL4207897,8.30,False,http://www.openphacts.org/units/Nanomolar,3063883,=,1,True,=,,IC50,nM,,5.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5.0
Not Determined,18461437,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cc(F)cc(Cl)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,,CHEMBL4212804,,CHEMBL4212804,,False,,3063884,,1,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
Not Determined,18461438,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2ccc(Cl)c(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,,CHEMBL4216027,,CHEMBL4216027,,False,,3063885,,1,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
,18461439,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3c(F)cccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '12.79', 'le': '0.24', 'lle': '3.05', 'sei': '7.11'}",CHEMBL4211065,,CHEMBL4211065,7.57,False,http://www.openphacts.org/units/Nanomolar,3063886,=,1,True,=,,IC50,nM,,27.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,27.0
Not Determined,18461440,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3cc(F)ccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,,CHEMBL4203806,,CHEMBL4203806,,False,,3063887,,1,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
Not Determined,18461441,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccc(F)cc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,,CHEMBL4215481,,CHEMBL4215481,,False,,3063888,,1,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
,18461442,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3cccc(F)c32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '12.31', 'le': '0.23', 'lle': '2.76', 'sei': '6.85'}",CHEMBL4208169,,CHEMBL4208169,7.28,False,http://www.openphacts.org/units/Nanomolar,3063889,=,1,True,=,,IC50,nM,,52.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,52.0
,18461443,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3c(Cl)cccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '12.63', 'le': '0.24', 'lle': '2.65', 'sei': '7.22'}",CHEMBL4203298,,CHEMBL4203298,7.68,False,http://www.openphacts.org/units/Nanomolar,3063890,=,1,True,=,,IC50,nM,,21.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,21.0
,18461444,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3cc(Cl)ccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '13.36', 'le': '0.26', 'lle': '3.09', 'sei': '7.64'}",CHEMBL4212544,,CHEMBL4212544,8.12,False,http://www.openphacts.org/units/Nanomolar,3063891,=,1,True,=,,IC50,nM,,7.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,7.5
,18461445,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cc(F)cc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3c(Cl)cccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '12.55', 'le': '0.24', 'lle': '2.68', 'sei': '7.38'}",CHEMBL4207639,,CHEMBL4207639,7.85,False,http://www.openphacts.org/units/Nanomolar,3063892,=,1,True,=,,IC50,nM,,14.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,14.0
Not Determined,18461446,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cc(F)cc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3cccc(Cl)c32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,,CHEMBL4215069,,CHEMBL4215069,,False,,3063893,,1,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
Not Determined,18461447,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,,CHEMBL4210140,,CHEMBL4210140,,False,,3063894,,1,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
Not Determined,18461448,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2CCC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,,CHEMBL4211712,,CHEMBL4211712,,False,,3063895,,1,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
,18461449,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)OC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '13.42', 'le': '0.25', 'lle': '3.51', 'sei': '6.68'}",CHEMBL4207520,,CHEMBL4207520,7.72,False,http://www.openphacts.org/units/Nanomolar,3063896,=,1,True,=,,IC50,nM,,19.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,19.0
Not Determined,18461450,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cccc(N2C(=O)CC[C@H]2C(=O)N(c2cc(F)cc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,,CHEMBL4207353,,CHEMBL4207353,,False,,3063897,,1,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
Not Determined,18461451,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,O=C1CC[C@@H](C(=O)N(c2cc(F)cc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)N1c1ccccn1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,,CHEMBL4212242,,CHEMBL4212242,,False,,3063898,,1,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
Not Determined,18461452,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,O=C1CC[C@@H](C(=O)N(c2cc(F)cc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)N1c1cnccn1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,,CHEMBL4203955,,CHEMBL4203955,,False,,3063899,,1,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
Not Determined,18461453,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,COc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cc(F)cc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,,CHEMBL4208834,,CHEMBL4208834,,False,,3063900,,1,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
Not Determined,18461454,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,CS(=O)(=O)c1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cc(F)cc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,,CHEMBL4216167,,CHEMBL4216167,,False,,3063901,,1,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
,18461455,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cc(F)cc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)n1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '13.21', 'le': '0.25', 'lle': '3.92', 'sei': '6.56'}",CHEMBL4204501,,CHEMBL4204501,7.83,False,http://www.openphacts.org/units/Nanomolar,3063902,=,1,True,=,,IC50,nM,,14.9,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,14.9
,18461456,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)OC[C@H]2C(=O)N(c2cc(F)cc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '13.56', 'le': '0.26', 'lle': '3.70', 'sei': '6.96'}",CHEMBL4210785,,CHEMBL4210785,8.05,False,http://www.openphacts.org/units/Nanomolar,3063903,=,1,True,=,,IC50,nM,,8.9,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,8.9
,18461457,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)OC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3cccc(Cl)c32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '13.19', 'le': '0.26', 'lle': '3.19', 'sei': '6.96'}",CHEMBL4215739,,CHEMBL4215739,8.05,False,http://www.openphacts.org/units/Nanomolar,3063904,=,1,True,=,,IC50,nM,,9.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,9.0
,18461458,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3cccc(Cl)c32)n1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '12.11', 'le': '0.23', 'lle': '2.96', 'sei': '6.18'}",CHEMBL4216785,,CHEMBL4216785,7.38,False,http://www.openphacts.org/units/Nanomolar,3063905,=,1,True,=,,IC50,nM,,42.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,42.0
,18461459,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)OC[C@H]2C(=O)N(c2cc(F)cc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)n1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '10.95', 'le': '0.21', 'lle': '2.77', 'sei': '5.07'}",CHEMBL4202711,,CHEMBL4202711,6.51,False,http://www.openphacts.org/units/Nanomolar,3063906,=,1,True,=,,IC50,nM,,308.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,308.0
,18461460,[],CHEMBL4180677,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)OC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3cccc(Cl)c32)n1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '12.34', 'le': '0.24', 'lle': '3.29', 'sei': '5.86'}",CHEMBL4214223,,CHEMBL4214223,7.54,False,http://www.openphacts.org/units/Nanomolar,3063907,=,1,True,=,,IC50,nM,,29.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,29.0
,18461470,[],CHEMBL4180681,Inhibition of IDH1 (unknown origin) using isocitrate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cc(F)cc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3ccccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '9.21', 'le': '0.17', 'lle': '0.93', 'sei': '5.12'}",CHEMBL4207897,,CHEMBL4207897,5.45,False,http://www.openphacts.org/units/Nanomolar,3063883,=,1,True,=,,IC50,nM,,3560.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3560.0
,18461471,[],CHEMBL4180681,Inhibition of IDH1 (unknown origin) using isocitrate as substrate after 60 mins by resazurin dye based fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cccc(F)c2)[C@@]2(C(=O)NC3CC(F)(F)C3)CCc3cc(Cl)ccc32)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '9.46', 'le': '0.18', 'lle': '0.72', 'sei': '5.40'}",CHEMBL4212544,,CHEMBL4212544,5.75,False,http://www.openphacts.org/units/Nanomolar,3063891,=,1,True,=,,IC50,nM,,1780.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1780.0
,18461488,[],CHEMBL4180690,Inhibition of IDH1 R132H mutant (unknown origin),B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '13.24', 'le': '0.26', 'lle': '3.40', 'sei': '6.47'}",CHEMBL3989958,IVOSIDENIB,CHEMBL3989958,7.72,False,http://www.openphacts.org/units/Nanomolar,3063908,=,1,True,=,,IC50,nM,,19.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,19.0
,18461489,[],CHEMBL4180691,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,,,CHEMBL4177635,Bioorg Med Chem Lett,2017.0,"{'bei': '13.94', 'le': '0.27', 'lle': '3.80', 'sei': '6.81'}",CHEMBL3989958,IVOSIDENIB,CHEMBL3989958,8.12,False,http://www.openphacts.org/units/Nanomolar,3063908,=,1,True,=,,IC50,nM,,7.5,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,7.5
,18462237,[],CHEMBL4180903,Inhibition of IDH1 R132C mutant (unknown origin) using alphaKG as substrate after 2 hrs by fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,C[C@H](O)c1cccc(NC(=O)c2nn(Cc3ccc(F)cc3)c3c2CN(C(=O)c2ccc[nH]2)C[C@H]3C)c1,,,CHEMBL4177644,Bioorg Med Chem,2017.0,"{'bei': '16.79', 'le': '0.31', 'lle': '3.96', 'sei': '8.16'}",CHEMBL4215717,,CHEMBL4215717,8.42,False,http://www.openphacts.org/units/Nanomolar,3064024,=,1,True,=,,IC50,nM,,3.8,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3.8
,18462238,[],CHEMBL4180902,Inhibition of IDH1 R132H mutant (unknown origin) using alphaKG as substrate after 2 hrs by fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,C[C@H](O)c1cccc(NC(=O)c2nn(Cc3ccc(F)cc3)c3c2CN(C(=O)c2ccc[nH]2)C[C@H]3C)c1,,,CHEMBL4177644,Bioorg Med Chem,2017.0,"{'bei': '16.62', 'le': '0.31', 'lle': '3.88', 'sei': '8.07'}",CHEMBL4215717,,CHEMBL4215717,8.34,False,http://www.openphacts.org/units/Nanomolar,3064024,=,1,True,=,,IC50,nM,,4.6,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,4.6
,18462239,[],CHEMBL4180901,Inhibition of IDH1 R132C mutant (unknown origin) using alphaKG as substrate after 90 mins by fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](n2c(Nc3ccc(OC(F)(F)F)cc3)nc3cc(CCC(=O)O)ccc32)CC(C)(C)C1,,,CHEMBL4177644,Bioorg Med Chem,2017.0,"{'bei': '15.98', 'le': '0.31', 'lle': '0.74', 'sei': '10.24'}",CHEMBL4206033,,CHEMBL4206033,7.82,False,http://www.openphacts.org/units/Nanomolar,3064028,=,1,True,=,,IC50,nM,,15.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,15.0
,18462240,[],CHEMBL4180900,Inhibition of IDH1 R132H mutant (unknown origin) using alphaKG as substrate after 90 mins by fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,C[C@H]1C[C@@H](n2c(Nc3ccc(OC(F)(F)F)cc3)nc3cc(CCC(=O)O)ccc32)CC(C)(C)C1,,,CHEMBL4177644,Bioorg Med Chem,2017.0,"{'bei': '15.98', 'le': '0.31', 'lle': '0.74', 'sei': '10.24'}",CHEMBL4206033,,CHEMBL4206033,7.82,False,http://www.openphacts.org/units/Nanomolar,3064028,=,1,True,=,,IC50,nM,,15.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,15.0
,18462241,[],CHEMBL4180899,Inhibition of IDH1 R132H mutant (unknown origin) using alphaKG as substrate after 45 mins by LC-MS analysis,B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(-c3ccccn3)cc2)n1,,,CHEMBL4177644,Bioorg Med Chem,2017.0,"{'bei': '17.42', 'le': '0.32', 'lle': '2.34', 'sei': '8.76'}",CHEMBL3677105,,CHEMBL3677105,7.03,False,http://www.openphacts.org/units/Nanomolar,3064030,=,1,True,=,,IC50,nM,,94.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,94.0
,18462242,[],CHEMBL4180898,Inhibition of IDH1 R132H mutant (unknown origin),B,BAO_0000190,BAO_0000357,single protein format,Cc1cc(-c2cnc([C@H](C)Nc3nccc(N4C(=O)OC[C@@H]4C(C)C)n3)nc2)ccc1F,,,CHEMBL4177644,Bioorg Med Chem,2017.0,"{'bei': '17.64', 'le': '0.33', 'lle': '3.16', 'sei': '8.27'}",CHEMBL4169151,,CHEMBL4169151,7.70,False,http://www.openphacts.org/units/Nanomolar,3064031,=,1,True,=,,IC50,nM,,20.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,20.0
,18462243,[],CHEMBL4180898,Inhibition of IDH1 R132H mutant (unknown origin),B,BAO_0000190,BAO_0000357,single protein format,C[C@@H]1CN([C@@H](C)CO)S(=O)(=O)c2ccc(C#Cc3cccc(F)c3)cc2C[C@H]1CN(C)C(=O)NC1CCCCC1,,,CHEMBL4177644,Bioorg Med Chem,2017.0,"{'bei': '12.81', 'le': '0.25', 'lle': '2.92', 'sei': '8.12'}",CHEMBL4217745,,CHEMBL4217745,7.30,False,http://www.openphacts.org/units/Nanomolar,3064029,=,1,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18462244,[],CHEMBL4180898,Inhibition of IDH1 R132H mutant (unknown origin),B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)C(C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,,,CHEMBL4177644,Bioorg Med Chem,2017.0,"{'bei': '13.89', 'le': '0.27', 'lle': '3.78', 'sei': '6.79'}",CHEMBL4212374,,CHEMBL4212374,8.10,False,http://www.openphacts.org/units/Nanomolar,3064027,=,1,True,=,,IC50,nM,,8.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,8.0
,18462245,[],CHEMBL4180898,Inhibition of IDH1 R132H mutant (unknown origin),B,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1ccnc1C)c1cccc(F)c1,,,CHEMBL4177644,Bioorg Med Chem,2017.0,"{'bei': '15.47', 'le': '0.29', 'lle': '2.29', 'sei': '10.64'}",CHEMBL2180727,,CHEMBL2180727,7.16,False,http://www.openphacts.org/units/Nanomolar,3064026,=,1,True,=,,IC50,nM,,70.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,70.0
,18462246,[],CHEMBL4180897,Inhibition of human N-terminal Strep-tagged IDH1 R132C mutant expressed in Escherichia coli BL21(DE3) using alphaKG as substrate preincubated for 30 mins in presence of NADPH followed by substrate addition by LC-MS/MS analysis,B,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CC(C)(C)c1cc(Cn2ccnc2)c(O)c(Cn2ccnc2)c1,,,CHEMBL4177644,Bioorg Med Chem,2017.0,"{'bei': '17.97', 'le': '0.33', 'lle': '1.99', 'sei': '11.79'}",CHEMBL4208002,,CHEMBL4208002,6.59,False,http://www.openphacts.org/units/Nanomolar,3064025,=,1,True,=,,IC50,nM,,259.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,259.0
,18462247,[],CHEMBL4180897,Inhibition of human N-terminal Strep-tagged IDH1 R132C mutant expressed in Escherichia coli BL21(DE3) using alphaKG as substrate preincubated for 30 mins in presence of NADPH followed by substrate addition by LC-MS/MS analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1cc(Cc2ccccc2)n(O)c(=O)c1,,,CHEMBL4177644,Bioorg Med Chem,2017.0,"{'bei': '32.15', 'le': '0.59', 'lle': '4.94', 'sei': '16.39'}",CHEMBL2386126,,CHEMBL2386126,6.92,False,http://www.openphacts.org/units/Nanomolar,3064023,=,1,True,=,,IC50,nM,,120.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,120.0
,18462248,[],CHEMBL4180896,Inhibition of human N-terminal Strep-tagged IDH1 R132H mutant expressed in Escherichia coli BL21(DE3) using alphaKG as substrate preincubated for 30 mins in presence of NADPH followed by substrate addition by LC-MS/MS analysis,B,BAO_0000190,BAO_0000019,assay format,CC(C)(C)CC(C)(C)c1cc(Cn2ccnc2)c(O)c(Cn2ccnc2)c1,,,CHEMBL4177644,Bioorg Med Chem,2017.0,"{'bei': '21.71', 'le': '0.40', 'lle': '3.36', 'sei': '14.24'}",CHEMBL4208002,,CHEMBL4208002,7.96,False,http://www.openphacts.org/units/Nanomolar,3064025,=,1,True,=,,IC50,nM,,11.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,11.0
,18462249,[],CHEMBL4180896,Inhibition of human N-terminal Strep-tagged IDH1 R132H mutant expressed in Escherichia coli BL21(DE3) using alphaKG as substrate preincubated for 30 mins in presence of NADPH followed by substrate addition by LC-MS/MS analysis,B,BAO_0000190,BAO_0000019,assay format,Cc1cc(Cc2ccccc2)n(O)c(=O)c1,,,CHEMBL4177644,Bioorg Med Chem,2017.0,"{'bei': '31.23', 'le': '0.57', 'lle': '4.74', 'sei': '15.92'}",CHEMBL2386126,,CHEMBL2386126,6.72,False,http://www.openphacts.org/units/Nanomolar,3064023,=,1,True,=,,IC50,nM,,190.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,190.0
,18462250,[],CHEMBL4180895,Inhibition of IDH1 R132C mutant (unknown origin),B,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1ccnc1C)c1cccc(F)c1,,,CHEMBL4177644,Bioorg Med Chem,2017.0,"{'bei': '14.69', 'le': '0.27', 'lle': '1.94', 'sei': '10.11'}",CHEMBL2180727,,CHEMBL2180727,6.80,False,http://www.openphacts.org/units/Nanomolar,3064026,=,1,True,=,,IC50,nM,,160.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,160.0
,18480119,[],CHEMBL4184800,Inhibition of IDH1 R132H mutant (unknown origin) expressed in HEK293T cells assessed as reduction in D2-HG level after 30 mins by resazurin-based fluorescence assay,B,BAO_0000190,BAO_0000219,cell-based format,COC(=O)C1C(=O)C2=C(CC1C)Nc1ccccc1NC2c1c[nH]c2ccccc12,,,CHEMBL4184104,Bioorg Med Chem Lett,2018.0,"{'bei': '10.71', 'le': '0.20', 'lle': '-0.10', 'sei': '5.17'}",CHEMBL4217951,,CHEMBL4217951,4.30,False,http://www.openphacts.org/units/Nanomolar,3067151,=,1,True,=,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,50.0
,18480120,[],CHEMBL4184801,Inhibition of IDH1 R132C mutant (unknown origin) expressed in HEK293T cells assessed as reduction in D2-HG level after 30 mins by resazurin-based fluorescence assay,B,BAO_0000190,BAO_0000219,cell-based format,COC(=O)C1C(=O)C2=C(CC1C)Nc1ccccc1NC2c1c[nH]c2ccccc12,,,CHEMBL4184104,Bioorg Med Chem Lett,2018.0,"{'bei': '10.71', 'le': '0.20', 'lle': '-0.10', 'sei': '5.17'}",CHEMBL4217951,,CHEMBL4217951,4.30,False,http://www.openphacts.org/units/Nanomolar,3067151,=,1,True,=,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,50.0
,18553510,[],CHEMBL4199918,Inhibition of IDH1 R132H mutant (unknown origin) using alphaKG as substrate in presence of NADPH by LC-MS/MS analysis,B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2nc(-c3ccccc3Cl)no2)n1,,,CHEMBL4196126,ACS Med Chem Lett,2018.0,"{'bei': '14.49', 'le': '0.28', 'lle': '1.88', 'sei': '5.85'}",CHEMBL4207387,,CHEMBL4207387,6.21,False,http://www.openphacts.org/units/Nanomolar,3080394,=,1,True,=,,IC50,nM,,610.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.61
,18553511,[],CHEMBL4199918,Inhibition of IDH1 R132H mutant (unknown origin) using alphaKG as substrate in presence of NADPH by LC-MS/MS analysis,B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2nc(-c3ccc(Cl)cc3)no2)n1,,,CHEMBL4196126,ACS Med Chem Lett,2018.0,"{'bei': '17.36', 'le': '0.34', 'lle': '3.11', 'sei': '7.00'}",CHEMBL4214694,,CHEMBL4214694,7.44,False,http://www.openphacts.org/units/Nanomolar,3080395,=,1,True,=,,IC50,nM,,36.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.036
,18553512,[],CHEMBL4199918,Inhibition of IDH1 R132H mutant (unknown origin) using alphaKG as substrate in presence of NADPH by LC-MS/MS analysis,B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1ncc(F)c(N2C(=O)OC(C)(C)C2(C)C)n1)c1nc(-c2ccc(Cl)cc2)no1,,,CHEMBL4196126,ACS Med Chem Lett,2018.0,"{'bei': '13.21', 'le': '0.26', 'lle': '1.08', 'sei': '5.73'}",CHEMBL3682033,,CHEMBL3682033,6.09,False,http://www.openphacts.org/units/Nanomolar,3080396,=,1,True,=,,IC50,nM,,820.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.82
,18553513,[],CHEMBL4199918,Inhibition of IDH1 R132H mutant (unknown origin) using alphaKG as substrate in presence of NADPH by LC-MS/MS analysis,B,BAO_0000190,BAO_0000357,single protein format,CC(Nc1nccc(N2CCOC2=O)n1)c1ncc(Oc2ccc(F)cc2)cn1,,,CHEMBL4196126,ACS Med Chem Lett,2018.0,"{'bei': '12.75', 'le': '0.24', 'lle': '1.73', 'sei': '4.94'}",CHEMBL3677127,,CHEMBL3677127,5.06,False,http://www.openphacts.org/units/Nanomolar,3080397,=,1,True,=,,IC50,nM,,8800.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,8.8
,18553514,[],CHEMBL4199918,Inhibition of IDH1 R132H mutant (unknown origin) using alphaKG as substrate in presence of NADPH by LC-MS/MS analysis,B,BAO_0000190,BAO_0000357,single protein format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ncc(Oc3ccc(F)cc3)cn2)n1,,,CHEMBL4196126,ACS Med Chem Lett,2018.0,"{'bei': '16.90', 'le': '0.32', 'lle': '3.06', 'sei': '7.24'}",CHEMBL4216196,,CHEMBL4216196,7.41,False,http://www.openphacts.org/units/Nanomolar,3080398,=,1,True,=,,IC50,nM,,39.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.039
,18553515,[],CHEMBL4199919,Inhibition of IDH1 R132H mutant (unknown origin) expressed in HCT116 cells assessed as reduction in 2-HG levels after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1ncc(F)c(N2CCOC2=O)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL4196126,ACS Med Chem Lett,2018.0,"{'bei': '15.52', 'le': '0.30', 'lle': '2.67', 'sei': '7.34'}",CHEMBL4212061,,CHEMBL4212061,6.25,False,http://www.openphacts.org/units/Nanomolar,3080399,=,1,True,=,,IC50,nM,,560.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.56
,18553516,[],CHEMBL4199919,Inhibition of IDH1 R132H mutant (unknown origin) expressed in HCT116 cells assessed as reduction in 2-HG levels after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2C)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL4196126,ACS Med Chem Lett,2018.0,"{'bei': '17.58', 'le': '0.35', 'lle': '3.36', 'sei': '8.60'}",CHEMBL4217038,,CHEMBL4217038,7.33,False,http://www.openphacts.org/units/Nanomolar,3080400,=,1,True,=,,IC50,nM,,47.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.047
,18553517,[],CHEMBL4199919,Inhibition of IDH1 R132H mutant (unknown origin) expressed in HCT116 cells assessed as reduction in 2-HG levels after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1COC(=O)N1c1nc(N[C@@H](C)c2cn(-c3ccc(Cl)cc3)cn2)ncc1F,,,CHEMBL4196126,ACS Med Chem Lett,2018.0,"{'bei': '18.30', 'le': '0.36', 'lle': '3.53', 'sei': '9.26'}",CHEMBL4216510,,CHEMBL4216510,7.89,False,http://www.openphacts.org/units/Nanomolar,3080401,=,1,True,=,,IC50,nM,,13.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.013
,18553518,[],CHEMBL4199919,Inhibition of IDH1 R132H mutant (unknown origin) expressed in HCT116 cells assessed as reduction in 2-HG levels after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@@H](C)F)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL4196126,ACS Med Chem Lett,2018.0,"{'bei': '14.75', 'le': '0.29', 'lle': '2.31', 'sei': '7.77'}",CHEMBL4114410,,CHEMBL4114410,6.62,False,http://www.openphacts.org/units/Nanomolar,3080402,=,1,True,=,,IC50,nM,,240.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.24
,18553519,[],CHEMBL4199919,Inhibition of IDH1 R132H mutant (unknown origin) expressed in HCT116 cells assessed as reduction in 2-HG levels after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL4196126,ACS Med Chem Lett,2018.0,"{'bei': '17.06', 'le': '0.34', 'lle': '3.35', 'sei': '8.99'}",CHEMBL3959391,,CHEMBL3959391,7.66,False,http://www.openphacts.org/units/Nanomolar,3080403,=,1,True,=,,IC50,nM,,22.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.022
,18553520,[],CHEMBL4199919,Inhibition of IDH1 R132H mutant (unknown origin) expressed in HCT116 cells assessed as reduction in 2-HG levels after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1ncc(F)c(N2C(=O)OC[C@@H]2CF)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL4196126,ACS Med Chem Lett,2018.0,"{'bei': '17.52', 'le': '0.35', 'lle': '3.70', 'sei': '8.95'}",CHEMBL3894881,,CHEMBL3894881,7.62,False,http://www.openphacts.org/units/Nanomolar,3080404,=,1,True,=,,IC50,nM,,24.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.024
,18553521,[],CHEMBL4199919,Inhibition of IDH1 R132H mutant (unknown origin) expressed in HCT116 cells assessed as reduction in 2-HG levels after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2cn(-c3ccc(Cl)cc3)cn2)n1,,,CHEMBL4196126,ACS Med Chem Lett,2018.0,"{'bei': '18.33', 'le': '0.36', 'lle': '3.35', 'sei': '9.19'}",CHEMBL4208648,,CHEMBL4208648,7.82,False,http://www.openphacts.org/units/Nanomolar,3080405,=,1,True,=,,IC50,nM,,15.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.015
,18553522,[],CHEMBL4199919,Inhibition of IDH1 R132H mutant (unknown origin) expressed in HCT116 cells assessed as reduction in 2-HG levels after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL4196126,ACS Med Chem Lett,2018.0,"{'bei': '19.49', 'le': '0.38', 'lle': '4.23', 'sei': '9.86'}",CHEMBL3986241,,CHEMBL3986241,8.40,False,http://www.openphacts.org/units/Nanomolar,3080406,=,1,True,=,,IC50,nM,,4.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.004
,18553523,[],CHEMBL4199919,Inhibition of IDH1 R132H mutant (unknown origin) expressed in HCT116 cells assessed as reduction in 2-HG levels after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2CF)n1)c1cn(-c2ccc(Cl)cc2)cn1,,,CHEMBL4196126,ACS Med Chem Lett,2018.0,"{'bei': '18.05', 'le': '0.35', 'lle': '3.74', 'sei': '8.83'}",CHEMBL3953686,,CHEMBL3953686,7.52,False,http://www.openphacts.org/units/Nanomolar,3080407,=,1,True,=,,IC50,nM,,30.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.03
,18553524,[],CHEMBL4199919,Inhibition of IDH1 R132H mutant (unknown origin) expressed in HCT116 cells assessed as reduction in 2-HG levels after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2[C@H](C)F)n1)c1cn(-c2ccc(C(F)F)cc2)cn1,,,CHEMBL4196126,ACS Med Chem Lett,2018.0,"{'bei': '17.53', 'le': '0.33', 'lle': '3.36', 'sei': '9.19'}",CHEMBL3909586,,CHEMBL3909586,7.82,False,http://www.openphacts.org/units/Nanomolar,3080408,=,1,True,=,,IC50,nM,,15.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.015
,18553525,[],CHEMBL4199919,Inhibition of IDH1 R132H mutant (unknown origin) expressed in HCT116 cells assessed as reduction in 2-HG levels after 48 hrs by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2CF)n1)c1cn(-c2ccc(C(F)(F)F)cc2)cn1,,,CHEMBL4196126,ACS Med Chem Lett,2018.0,"{'bei': '16.45', 'le': '0.32', 'lle': '3.26', 'sei': '8.70'}",CHEMBL4216983,,CHEMBL4216983,7.41,False,http://www.openphacts.org/units/Nanomolar,3080409,=,1,True,=,,IC50,nM,,39.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.039
,18553550,[],CHEMBL4199932,Inhibition of wild-type IDH1 (unknown origin) assessed as NADPH production using isocitrate as substrate by fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2CF)n1)c1cn(-c2ccc(C(F)(F)F)cc2)cn1,,,CHEMBL4196126,ACS Med Chem Lett,2018.0,"{'bei': '12.43', 'le': '0.24', 'lle': '1.45', 'sei': '6.57'}",CHEMBL4216983,,CHEMBL4216983,5.60,False,http://www.openphacts.org/units/Nanomolar,3080409,=,1,True,=,,IC50,nM,,2520.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,2.52
,18553551,[],CHEMBL4199933,Inhibition of IDH1 R132H mutant (unknown origin) assessed as NADPH consumption using alpha-ketoglutarate as substrate by fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2CF)n1)c1cn(-c2ccc(C(F)(F)F)cc2)cn1,,,CHEMBL4196126,ACS Med Chem Lett,2018.0,"{'bei': '17.05', 'le': '0.33', 'lle': '3.53', 'sei': '9.01'}",CHEMBL4216983,,CHEMBL4216983,7.68,False,http://www.openphacts.org/units/Nanomolar,3080409,=,1,True,=,,IC50,nM,,21.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.021
,18553552,[],CHEMBL4199934,Inhibition of IDH1 R132C mutant (unknown origin) assessed as NADPH consumption using alpha-ketoglutarate as substrate by fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,C[C@H](Nc1nccc(N2C(=O)OC[C@@H]2CF)n1)c1cn(-c2ccc(C(F)(F)F)cc2)cn1,,,CHEMBL4196126,ACS Med Chem Lett,2018.0,"{'bei': '16.31', 'le': '0.31', 'lle': '3.20', 'sei': '8.63'}",CHEMBL4216983,,CHEMBL4216983,7.35,False,http://www.openphacts.org/units/Nanomolar,3080409,=,1,True,=,,IC50,nM,,45.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.045
,18707060,[],CHEMBL4256249,Inhibition of IDH1 R132S mutant in human HCCC-9810 cells assessed as reduction in 2-hydroxyglutarate production by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2CC(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '13.27', 'le': '0.26', 'lle': '3.21', 'sei': '6.64'}",CHEMBL4282663,,CHEMBL4282663,7.92,False,http://www.openphacts.org/units/Nanomolar,3106969,=,1,True,=,,IC50,nM,,12.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,12.0
,18707064,[],CHEMBL4256248,Inhibition of IDH1 R132C mutant in human COR-L105 cells assessed as reduction in 2-hydroxyglutarate production by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2CC(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '13.11', 'le': '0.25', 'lle': '3.11', 'sei': '6.56'}",CHEMBL4282663,,CHEMBL4282663,7.82,False,http://www.openphacts.org/units/Nanomolar,3106969,=,1,True,=,,IC50,nM,,15.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,15.0
,18707065,[],CHEMBL4256247,Inhibition of IDH1 R132H mutant in human Neurospheres assessed as reduction in 2-hydroxyglutarate production by LC-MS/MS analysis,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2CC(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '14.28', 'le': '0.28', 'lle': '3.81', 'sei': '7.14'}",CHEMBL4282663,,CHEMBL4282663,8.52,False,http://www.openphacts.org/units/Nanomolar,3106969,=,1,True,=,,IC50,nM,,3.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3.0
,18707066,[],CHEMBL4256246,Inhibition of IDH1 R132H mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-hydroxyglutarate production by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2CC(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '12.93', 'le': '0.25', 'lle': '3.01', 'sei': '6.47'}",CHEMBL4282663,,CHEMBL4282663,7.72,False,http://www.openphacts.org/units/Nanomolar,3106969,=,1,True,=,,IC50,nM,,19.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,19.0
,18707067,[],CHEMBL4256245,Inhibition of wild type IDH1 (unknown origin) using DL-isocitrate as substrate after 60 mins in presence of NADPH by diaphorase/resazurin coupled fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2CC(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '11.97', 'le': '0.23', 'lle': '2.44', 'sei': '5.99'}",CHEMBL4282663,,CHEMBL4282663,7.15,False,http://www.openphacts.org/units/Nanomolar,3106969,=,1,True,=,,IC50,nM,,71.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,71.0
,18707068,[],CHEMBL4256244,Inhibition of wild type IDH1/IDH1 R132H mutant heterodimer (unknown origin) after 16 hrs in presence of NADPH by diaphorase/resazurin coupled fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2CC(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '13.90', 'le': '0.27', 'lle': '3.59', 'sei': '6.96'}",CHEMBL4282663,,CHEMBL4282663,8.30,False,http://www.openphacts.org/units/Nanomolar,3106969,=,1,True,=,,IC50,nM,,5.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,5.0
,18707069,[],CHEMBL4256243,Inhibition of wild type IDH1/IDH1 R132H mutant heterodimer (unknown origin) after 60 mins in presence of NADPH by diaphorase/resazurin coupled fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2CC(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '13.27', 'le': '0.26', 'lle': '3.21', 'sei': '6.64'}",CHEMBL4282663,,CHEMBL4282663,7.92,False,http://www.openphacts.org/units/Nanomolar,3106969,=,1,True,=,,IC50,nM,,12.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,12.0
,18707070,[],CHEMBL4256242,Inhibition of wild type IDH1 (unknown origin) using DL-isocitrate as substrate after 16 hrs in presence of NADPH by diaphorase/resazurin coupled fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2CC(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '12.76', 'le': '0.25', 'lle': '2.91', 'sei': '6.39'}",CHEMBL4282663,,CHEMBL4282663,7.62,False,http://www.openphacts.org/units/Nanomolar,3106969,=,1,True,=,,IC50,nM,,24.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,24.0
,18707071,[],CHEMBL4256241,Inhibition of IDH1 R132S mutant (unknown origin),B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2CC(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '13.27', 'le': '0.26', 'lle': '3.21', 'sei': '6.64'}",CHEMBL4282663,,CHEMBL4282663,7.92,False,http://www.openphacts.org/units/Nanomolar,3106969,=,1,True,=,,IC50,nM,,12.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,12.0
,18707072,[],CHEMBL4256240,Inhibition of IDH1 R132L mutant (unknown origin),B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2CC(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '13.21', 'le': '0.26', 'lle': '3.18', 'sei': '6.61'}",CHEMBL4282663,,CHEMBL4282663,7.89,False,http://www.openphacts.org/units/Nanomolar,3106969,=,1,True,=,,IC50,nM,,13.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,13.0
,18707073,[],CHEMBL4256239,Inhibition of IDH1 R132G mutant (unknown origin),B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2CC(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '13.56', 'le': '0.26', 'lle': '3.39', 'sei': '6.79'}",CHEMBL4282663,,CHEMBL4282663,8.10,False,http://www.openphacts.org/units/Nanomolar,3106969,=,1,True,=,,IC50,nM,,8.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,8.0
,18707074,[],CHEMBL4256238,Inhibition of IDH1 R132C mutant (unknown origin) assessed as reduction in conversion of alpha-KG to D2-HG after 60 mins in presence of NADPH by diaphorase/resazurin coupled fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2CC(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '13.21', 'le': '0.26', 'lle': '3.18', 'sei': '6.61'}",CHEMBL4282663,,CHEMBL4282663,7.89,False,http://www.openphacts.org/units/Nanomolar,3106969,=,1,True,=,,IC50,nM,,13.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,13.0
,18707122,[],CHEMBL4256231,Inhibition of IDH1 R132H mutant (unknown origin) assessed as reduction in conversion of alpha-KG to D2-HG after 60 mins in presence of NADPH by diaphorase/resazurin coupled fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1[C@@H](C(=O)NC1CCCCC1)N(C(=O)Cn1ccnc1C)c1cccc(F)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '15.47', 'le': '0.29', 'lle': '2.29', 'sei': '10.64'}",CHEMBL4289678,,CHEMBL4289678,7.16,False,http://www.openphacts.org/units/Nanomolar,3106956,=,1,True,=,,IC50,nM,,70.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,70.0
,18707123,[],CHEMBL4256231,Inhibition of IDH1 R132H mutant (unknown origin) assessed as reduction in conversion of alpha-KG to D2-HG after 60 mins in presence of NADPH by diaphorase/resazurin coupled fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,COC(=O)NCC(=O)N(c1cccc(F)c1)[C@H](C(=O)NC1CCCCC1)c1ccccc1C,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '16.11', 'le': '0.30', 'lle': '3.33', 'sei': '8.36'}",CHEMBL4282455,,CHEMBL4282455,7.34,False,http://www.openphacts.org/units/Nanomolar,3106957,=,1,True,=,,IC50,nM,,46.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,46.0
,18707124,[],CHEMBL4256231,Inhibition of IDH1 R132H mutant (unknown origin) assessed as reduction in conversion of alpha-KG to D2-HG after 60 mins in presence of NADPH by diaphorase/resazurin coupled fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,COC(=O)NCC(=O)N(c1cccc(F)c1)[C@H](C(=O)NC1CCCCC1)c1ccccc1Cl,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '13.95', 'le': '0.27', 'lle': '2.28', 'sei': '7.57'}",CHEMBL4293065,,CHEMBL4293065,6.64,False,http://www.openphacts.org/units/Nanomolar,3106958,=,1,True,=,,IC50,nM,,230.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,230.0
,18707125,[],CHEMBL4256231,Inhibition of IDH1 R132H mutant (unknown origin) assessed as reduction in conversion of alpha-KG to D2-HG after 60 mins in presence of NADPH by diaphorase/resazurin coupled fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,COC(=O)N1CCC[C@H]1CC(=O)N(c1cccc(F)c1)[C@H](C(=O)NC1CC(F)(F)C1)c1ccccc1Cl,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '13.67', 'le': '0.27', 'lle': '2.27', 'sei': '9.32'}",CHEMBL4285854,,CHEMBL4285854,7.36,False,http://www.openphacts.org/units/Nanomolar,3106959,=,1,True,=,,IC50,nM,,44.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,44.0
,18707126,[],CHEMBL4256231,Inhibition of IDH1 R132H mutant (unknown origin) assessed as reduction in conversion of alpha-KG to D2-HG after 60 mins in presence of NADPH by diaphorase/resazurin coupled fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,O=C(NC1CC(F)(F)C1)[C@H](c1ccccc1Cl)N(C(=O)C[C@@H]1CCCN1c1ncccn1)c1cccc(F)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '13.38', 'le': '0.26', 'lle': '2.15', 'sei': '9.52'}",CHEMBL4277931,,CHEMBL4277931,7.47,False,http://www.openphacts.org/units/Nanomolar,3106960,=,1,True,=,,IC50,nM,,34.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,34.0
,18707127,[],CHEMBL4256231,Inhibition of IDH1 R132H mutant (unknown origin) assessed as reduction in conversion of alpha-KG to D2-HG after 60 mins in presence of NADPH by diaphorase/resazurin coupled fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,O=C1CC[C@@H](CC(=O)N(c2cccc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)N1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '9.87', 'le': '0.20', 'lle': '0.74', 'sei': '6.21'}",CHEMBL4277739,,CHEMBL4277739,4.88,False,http://www.openphacts.org/units/Nanomolar,3106961,=,1,True,=,,IC50,nM,,13310.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,13310.0
,18707128,[],CHEMBL4256231,Inhibition of IDH1 R132H mutant (unknown origin) assessed as reduction in conversion of alpha-KG to D2-HG after 60 mins in presence of NADPH by diaphorase/resazurin coupled fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,O=C(NC1CC(F)(F)C1)[C@H](c1ccccc1Cl)N(C(=O)C[C@@H]1CCC(=O)N1c1ncccn1)c1cccc(F)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '12.84', 'le': '0.25', 'lle': '2.51', 'sei': '7.69'}",CHEMBL4285677,,CHEMBL4285677,7.35,False,http://www.openphacts.org/units/Nanomolar,3106962,=,1,True,=,,IC50,nM,,45.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,45.0
,18707129,[],CHEMBL4256231,Inhibition of IDH1 R132H mutant (unknown origin) assessed as reduction in conversion of alpha-KG to D2-HG after 60 mins in presence of NADPH by diaphorase/resazurin coupled fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,O=C(NC1CC(F)(F)C1)[C@H](c1ccccc1Cl)N(C(=O)C[C@@H]1CCC(=O)N1c1cc(F)ccn1)c1cccc(F)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '12.56', 'le': '0.25', 'lle': '1.81', 'sei': '8.96'}",CHEMBL4281172,,CHEMBL4281172,7.40,False,http://www.openphacts.org/units/Nanomolar,3106963,=,1,True,=,,IC50,nM,,40.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,40.0
,18707130,[],CHEMBL4256231,Inhibition of IDH1 R132H mutant (unknown origin) assessed as reduction in conversion of alpha-KG to D2-HG after 60 mins in presence of NADPH by diaphorase/resazurin coupled fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2CC(=O)N(c2cccc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '13.50', 'le': '0.26', 'lle': '2.73', 'sei': '7.56'}",CHEMBL4289061,,CHEMBL4289061,8.05,False,http://www.openphacts.org/units/Nanomolar,3106964,=,1,True,=,,IC50,nM,,9.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,9.0
,18707131,[],CHEMBL4256231,Inhibition of IDH1 R132H mutant (unknown origin) assessed as reduction in conversion of alpha-KG to D2-HG after 60 mins in presence of NADPH by diaphorase/resazurin coupled fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2CC(=O)N(c2cc(F)cc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '13.39', 'le': '0.26', 'lle': '2.76', 'sei': '7.73'}",CHEMBL4289465,,CHEMBL4289465,8.22,False,http://www.openphacts.org/units/Nanomolar,3106965,=,1,True,=,,IC50,nM,,6.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,6.0
,18707132,[],CHEMBL4256231,Inhibition of IDH1 R132H mutant (unknown origin) assessed as reduction in conversion of alpha-KG to D2-HG after 60 mins in presence of NADPH by diaphorase/resazurin coupled fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)[C@@H](O)C[C@H]2CC(=O)N(c2cc(F)cc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '12.70', 'le': '0.25', 'lle': '3.57', 'sei': '6.32'}",CHEMBL4278793,,CHEMBL4278793,8.00,False,http://www.openphacts.org/units/Nanomolar,3106966,=,1,True,=,,IC50,nM,,10.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,10.0
,18707133,[],CHEMBL4256231,Inhibition of IDH1 R132H mutant (unknown origin) assessed as reduction in conversion of alpha-KG to D2-HG after 60 mins in presence of NADPH by diaphorase/resazurin coupled fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)[C@@H](O)C[C@H]2CC(=O)N(c2cc(F)cc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)n1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '12.92', 'le': '0.25', 'lle': '4.33', 'sei': '5.84'}",CHEMBL4292864,,CHEMBL4292864,8.15,False,http://www.openphacts.org/units/Nanomolar,3106967,=,1,True,=,,IC50,nM,,7.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,7.0
,18707134,[],CHEMBL4256231,Inhibition of IDH1 R132H mutant (unknown origin) assessed as reduction in conversion of alpha-KG to D2-HG after 60 mins in presence of NADPH by diaphorase/resazurin coupled fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2CC(=O)N(c2cc(F)cc(S(N)(=O)=O)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '11.79', 'le': '0.24', 'lle': '3.99', 'sei': '4.78'}",CHEMBL4282267,,CHEMBL4282267,7.96,False,http://www.openphacts.org/units/Nanomolar,3106968,=,1,True,=,,IC50,nM,,11.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,11.0
,18707135,[],CHEMBL4256231,Inhibition of IDH1 R132H mutant (unknown origin) assessed as reduction in conversion of alpha-KG to D2-HG after 60 mins in presence of NADPH by diaphorase/resazurin coupled fluorescence assay,B,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccnc(N2C(=O)CC[C@H]2CC(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '13.27', 'le': '0.26', 'lle': '3.21', 'sei': '6.64'}",CHEMBL4282663,,CHEMBL4282663,7.92,False,http://www.openphacts.org/units/Nanomolar,3106969,=,1,True,=,,IC50,nM,,12.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,12.0
,18707136,[],CHEMBL4256232,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,Cc1ccccc1[C@@H](C(=O)NC1CCCCC1)N(C(=O)Cn1ccnc1C)c1cccc(F)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '13.63', 'le': '0.25', 'lle': '1.44', 'sei': '9.38'}",CHEMBL4289678,,CHEMBL4289678,6.30,False,http://www.openphacts.org/units/Nanomolar,3106956,=,1,True,=,,IC50,nM,,497.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,497.0
,18707137,[],CHEMBL4256232,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,COC(=O)NCC(=O)N(c1cccc(F)c1)[C@H](C(=O)NC1CCCCC1)c1ccccc1C,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '14.95', 'le': '0.28', 'lle': '2.80', 'sei': '7.76'}",CHEMBL4282455,,CHEMBL4282455,6.81,False,http://www.openphacts.org/units/Nanomolar,3106957,=,1,True,=,,IC50,nM,,155.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,155.0
,18707138,[],CHEMBL4256232,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,COC(=O)NCC(=O)N(c1cccc(F)c1)[C@H](C(=O)NC1CCCCC1)c1ccccc1Cl,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '13.06', 'le': '0.26', 'lle': '1.86', 'sei': '7.09'}",CHEMBL4293065,,CHEMBL4293065,6.22,False,http://www.openphacts.org/units/Nanomolar,3106958,=,1,True,=,,IC50,nM,,605.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,605.0
,18707139,[],CHEMBL4256232,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,COC(=O)N1CCC[C@H]1CC(=O)N(c1cccc(F)c1)[C@H](C(=O)NC1CC(F)(F)C1)c1ccccc1Cl,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '12.18', 'le': '0.24', 'lle': '1.46', 'sei': '8.30'}",CHEMBL4285854,,CHEMBL4285854,6.55,False,http://www.openphacts.org/units/Nanomolar,3106959,=,1,True,=,,IC50,nM,,279.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,279.0
,18707140,[],CHEMBL4256232,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,O=C(NC1CC(F)(F)C1)[C@H](c1ccccc1Cl)N(C(=O)C[C@@H]1CCCN1c1ncccn1)c1cccc(F)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '13.04', 'le': '0.25', 'lle': '1.96', 'sei': '9.28'}",CHEMBL4277931,,CHEMBL4277931,7.28,False,http://www.openphacts.org/units/Nanomolar,3106960,=,1,True,=,,IC50,nM,,53.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,53.0
Not Determined,18707141,[],CHEMBL4256232,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,O=C1CC[C@@H](CC(=O)N(c2cccc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)N1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,,CHEMBL4277739,,CHEMBL4277739,,False,,3106961,,1,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
,18707142,[],CHEMBL4256232,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,O=C(NC1CC(F)(F)C1)[C@H](c1ccccc1Cl)N(C(=O)C[C@@H]1CCC(=O)N1c1ncccn1)c1cccc(F)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '12.48', 'le': '0.24', 'lle': '2.30', 'sei': '7.47'}",CHEMBL4285677,,CHEMBL4285677,7.14,False,http://www.openphacts.org/units/Nanomolar,3106962,=,1,True,=,,IC50,nM,,73.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,73.0
,18707143,[],CHEMBL4256232,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,O=C(NC1CC(F)(F)C1)[C@H](c1ccccc1Cl)N(C(=O)C[C@@H]1CCC(=O)N1c1cc(F)ccn1)c1cccc(F)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '12.19', 'le': '0.24', 'lle': '1.59', 'sei': '8.69'}",CHEMBL4281172,,CHEMBL4281172,7.18,False,http://www.openphacts.org/units/Nanomolar,3106963,=,1,True,=,,IC50,nM,,66.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,66.0
,18707144,[],CHEMBL4256232,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2CC(=O)N(c2cccc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '14.30', 'le': '0.28', 'lle': '3.20', 'sei': '8.01'}",CHEMBL4289061,,CHEMBL4289061,8.52,False,http://www.openphacts.org/units/Nanomolar,3106964,=,1,True,=,,IC50,nM,,3.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,3.0
,18707145,[],CHEMBL4256232,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2CC(=O)N(c2cc(F)cc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '14.66', 'le': '0.29', 'lle': '3.54', 'sei': '8.46'}",CHEMBL4289465,,CHEMBL4289465,9.00,False,http://www.openphacts.org/units/Nanomolar,3106965,=,1,True,=,,IC50,nM,,1.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1.0
,18707146,[],CHEMBL4256232,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)[C@@H](O)C[C@H]2CC(=O)N(c2cc(F)cc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '14.29', 'le': '0.28', 'lle': '4.57', 'sei': '7.11'}",CHEMBL4278793,,CHEMBL4278793,9.00,False,http://www.openphacts.org/units/Nanomolar,3106966,=,1,True,=,,IC50,nM,,1.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,1.0
,18707147,[],CHEMBL4256232,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)[C@@H](O)C[C@H]2CC(=O)N(c2cc(F)cc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)n1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '10.34', 'le': '0.20', 'lle': '2.71', 'sei': '4.68'}",CHEMBL4292864,,CHEMBL4292864,6.53,False,http://www.openphacts.org/units/Nanomolar,3106967,=,1,True,=,,IC50,nM,,297.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,297.0
,18707148,[],CHEMBL4256232,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2CC(=O)N(c2cc(F)cc(S(N)(=O)=O)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '11.68', 'le': '0.23', 'lle': '3.92', 'sei': '4.73'}",CHEMBL4282267,,CHEMBL4282267,7.89,False,http://www.openphacts.org/units/Nanomolar,3106968,=,1,True,=,,IC50,nM,,13.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,13.0
,18707149,[],CHEMBL4256232,Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2-hydroxyglutarate production by LC-MS/MS analysis,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccnc(N2C(=O)CC[C@H]2CC(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1,,,CHEMBL4251730,ACS Med Chem Lett,2018.0,"{'bei': '13.56', 'le': '0.26', 'lle': '3.39', 'sei': '6.79'}",CHEMBL4282663,,CHEMBL4282663,8.10,False,http://www.openphacts.org/units/Nanomolar,3106969,=,1,True,=,,IC50,nM,,8.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,8.0
,18711548,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)c1ccccc1,,,CHEMBL4257005,,,,CHEMBL4287161,,CHEMBL4287161,,False,http://www.openphacts.org/units/Nanomolar,3108022,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711549,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)c1cccc(F)c1,,,CHEMBL4257005,,,,CHEMBL4277726,,CHEMBL4277726,,False,http://www.openphacts.org/units/Nanomolar,3108030,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711550,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cccc(-c2nc(NC3CC4CC4C3)nc(NC3CC4CC4C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4284394,,CHEMBL4284394,,False,http://www.openphacts.org/units/Nanomolar,3108038,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711551,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NC2CCC(C)(C)CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4278831,,CHEMBL4278831,,False,http://www.openphacts.org/units/Nanomolar,3108052,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711552,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCOC3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '16.96', 'le': '0.33', 'lle': '3.55', 'sei': '8.60'}",CHEMBL4282969,,CHEMBL4282969,7.30,False,http://www.openphacts.org/units/Nanomolar,3108054,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711553,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)OC(=O)N1CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '13.22', 'le': '0.26', 'lle': '2.03', 'sei': '6.66'}",CHEMBL4284019,,CHEMBL4284019,7.00,False,http://www.openphacts.org/units/Nanomolar,3108055,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711554,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCNC3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4277787,,CHEMBL4277787,,False,http://www.openphacts.org/units/Nanomolar,3108056,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711555,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N1CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.85', 'le': '0.29', 'lle': '3.42', 'sei': '7.30'}",CHEMBL4287154,,CHEMBL4287154,7.00,False,http://www.openphacts.org/units/Nanomolar,3108057,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711556,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CS(=O)(=O)N1CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.39', 'le': '0.29', 'lle': '4.30', 'sei': '6.46'}",CHEMBL4280113,,CHEMBL4280113,7.30,False,http://www.openphacts.org/units/Nanomolar,3108058,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711557,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccnc2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4294945,,CHEMBL4294945,,False,http://www.openphacts.org/units/Nanomolar,3108059,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711558,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NC2CC3(C2)CC(F)(F)C3)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4294574,,CHEMBL4294574,,False,http://www.openphacts.org/units/Nanomolar,3108060,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711559,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,COC(=O)N1CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4293528,,CHEMBL4293528,,False,http://www.openphacts.org/units/Nanomolar,3108061,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711560,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NC2Cc3ccccc3C2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4285645,,CHEMBL4285645,,False,http://www.openphacts.org/units/Nanomolar,3108062,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711561,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2ccccn2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4284596,,CHEMBL4284596,,False,http://www.openphacts.org/units/Nanomolar,3108063,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711562,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,COCC(COC)Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '17.12', 'le': '0.33', 'lle': '4.06', 'sei': '7.76'}",CHEMBL4280488,,CHEMBL4280488,7.30,False,http://www.openphacts.org/units/Nanomolar,3108064,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711563,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(Cl)c2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '20.40', 'le': '0.40', 'lle': '2.69', 'sei': '11.64'}",CHEMBL4292856,,CHEMBL4292856,7.30,False,http://www.openphacts.org/units/Nanomolar,3108065,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711564,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2ccccc2Cl)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4289148,,CHEMBL4289148,,False,http://www.openphacts.org/units/Nanomolar,3108066,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711565,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2ccncc2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4293882,,CHEMBL4293882,,False,http://www.openphacts.org/units/Nanomolar,3108067,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711566,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)CNc1nc(NC(C)(C)C#N)nc(-c2cc(O)ccc2F)n1,,,CHEMBL4257005,,,"{'bei': '21.20', 'le': '0.40', 'lle': '4.13', 'sei': '6.84'}",CHEMBL4282686,,CHEMBL4282686,7.30,False,http://www.openphacts.org/units/Nanomolar,3108076,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711567,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CN1CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4292335,,CHEMBL4292335,,False,http://www.openphacts.org/units/Nanomolar,3108077,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711568,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NC(C(F)(F)F)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4293346,,CHEMBL4293346,,False,http://www.openphacts.org/units/Nanomolar,3108078,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711569,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4279047,,CHEMBL4279047,,False,http://www.openphacts.org/units/Nanomolar,3108079,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711570,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(N[C@@H]3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4278020,,CHEMBL4278020,,False,http://www.openphacts.org/units/Nanomolar,3108080,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711571,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CCC(Nc1nc(NC(CC)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4293542,,CHEMBL4293542,,False,http://www.openphacts.org/units/Nanomolar,3108081,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711572,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC[C@@H](Nc1nc(N[C@H](CC)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4292520,,CHEMBL4292520,,False,http://www.openphacts.org/units/Nanomolar,3108082,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711573,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cccc(-c2nc(NC3CCC(F)(F)C3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4292152,,CHEMBL4292152,,False,http://www.openphacts.org/units/Nanomolar,3108083,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711574,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4288434,,CHEMBL4288434,,False,http://www.openphacts.org/units/Nanomolar,3108084,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711575,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2cc(F)cc(F)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4288067,,CHEMBL4288067,,False,http://www.openphacts.org/units/Nanomolar,3108085,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711576,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4287015,,CHEMBL4287015,,False,http://www.openphacts.org/units/Nanomolar,3108086,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711577,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cncc(Cl)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4284034,,CHEMBL4284034,,False,http://www.openphacts.org/units/Nanomolar,3108087,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711578,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CCC(Nc1nc(NC(CC)C2CC2)nc(-c2cccc(Cl)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4282989,,CHEMBL4282989,,False,http://www.openphacts.org/units/Nanomolar,3108088,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711579,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@@H](Nc2nc(N[C@@H]3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4294589,,CHEMBL4294589,,False,http://www.openphacts.org/units/Nanomolar,3108089,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711580,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4293545,,CHEMBL4293545,,False,http://www.openphacts.org/units/Nanomolar,3108090,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711581,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(Cl)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280132,,CHEMBL4280132,,False,http://www.openphacts.org/units/Nanomolar,3108091,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711582,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2csc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4279049,,CHEMBL4279049,,False,http://www.openphacts.org/units/Nanomolar,3108092,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711583,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(Cl)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4281282,,CHEMBL4281282,,False,http://www.openphacts.org/units/Nanomolar,3108093,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711584,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280231,,CHEMBL4280231,,False,http://www.openphacts.org/units/Nanomolar,3108094,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711585,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)Nc1nc(Nc2cccc(C#N)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4283138,,CHEMBL4283138,,False,http://www.openphacts.org/units/Nanomolar,3108095,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711586,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(N[C@H]3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4281649,,CHEMBL4281649,,False,http://www.openphacts.org/units/Nanomolar,3108096,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711587,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2cc(F)cc(C#N)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4291656,,CHEMBL4291656,,False,http://www.openphacts.org/units/Nanomolar,3108097,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711588,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3cncc(Cl)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4290600,,CHEMBL4290600,,False,http://www.openphacts.org/units/Nanomolar,3108098,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711589,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-n2ccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4293652,,CHEMBL4293652,,False,http://www.openphacts.org/units/Nanomolar,3108099,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711590,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3nc(C(F)(F)F)cs3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4286666,,CHEMBL4286666,,False,http://www.openphacts.org/units/Nanomolar,3108100,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711591,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4292275,,CHEMBL4292275,,False,http://www.openphacts.org/units/Nanomolar,3108101,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711592,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4293284,,CHEMBL4293284,,False,http://www.openphacts.org/units/Nanomolar,3108102,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711593,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4291118,,CHEMBL4291118,,False,http://www.openphacts.org/units/Nanomolar,3108103,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711594,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4292169,,CHEMBL4292169,,False,http://www.openphacts.org/units/Nanomolar,3108104,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711595,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)C4)nc(-c4cccc(Cl)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4287037,,CHEMBL4287037,,False,http://www.openphacts.org/units/Nanomolar,3108105,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711596,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3nc(C(F)(F)F)cs3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4288084,,CHEMBL4288084,,False,http://www.openphacts.org/units/Nanomolar,3108106,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711597,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cncc(Cl)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280017,,CHEMBL4280017,,False,http://www.openphacts.org/units/Nanomolar,3108107,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711598,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(NC(C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4283785,,CHEMBL4283785,,False,http://www.openphacts.org/units/Nanomolar,3108108,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711599,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Clc1cccc(-c2nc(NC(C3CC3)C3CC3)nc(NC(C3CC3)C3CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4279765,,CHEMBL4279765,,False,http://www.openphacts.org/units/Nanomolar,3108109,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711600,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3nc(C(F)(F)F)cs3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4294619,,CHEMBL4294619,,False,http://www.openphacts.org/units/Nanomolar,3108110,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711601,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@H]4CCC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4294234,,CHEMBL4294234,,False,http://www.openphacts.org/units/Nanomolar,3108111,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711602,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4293189,,CHEMBL4293189,,False,http://www.openphacts.org/units/Nanomolar,3108112,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711603,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NC2CCc3ccccc32)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4293103,,CHEMBL4293103,,False,http://www.openphacts.org/units/Nanomolar,3108113,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711604,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4292077,,CHEMBL4292077,,False,http://www.openphacts.org/units/Nanomolar,3108114,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711605,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@@H]4CCC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4281225,,CHEMBL4281225,,False,http://www.openphacts.org/units/Nanomolar,3108115,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711606,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280154,,CHEMBL4280154,,False,http://www.openphacts.org/units/Nanomolar,3108116,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711607,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3nc(F)ccc3F)n2)c1,,,CHEMBL4257005,,,,CHEMBL4282753,,CHEMBL4282753,,False,http://www.openphacts.org/units/Nanomolar,3108117,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711608,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4278998,,CHEMBL4278998,,False,http://www.openphacts.org/units/Nanomolar,3108118,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711609,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(NC(C)C(F)(F)F)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4277813,,CHEMBL4277813,,False,http://www.openphacts.org/units/Nanomolar,3108119,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711610,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(N[C@@H](C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4278845,,CHEMBL4278845,,False,http://www.openphacts.org/units/Nanomolar,3108120,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711611,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4279216,,CHEMBL4279216,,False,http://www.openphacts.org/units/Nanomolar,3108121,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711612,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3cncc(Cl)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4282985,,CHEMBL4282985,,False,http://www.openphacts.org/units/Nanomolar,3108122,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711613,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1cccc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4283381,,CHEMBL4283381,,False,http://www.openphacts.org/units/Nanomolar,3108123,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711614,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4284375,,CHEMBL4284375,,False,http://www.openphacts.org/units/Nanomolar,3108124,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711615,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cncc(Cl)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4276695,,CHEMBL4276695,,False,http://www.openphacts.org/units/Nanomolar,3108125,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711616,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3nc(C(F)(F)F)cs3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4277748,,CHEMBL4277748,,False,http://www.openphacts.org/units/Nanomolar,3108126,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711617,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280772,,CHEMBL4280772,,False,http://www.openphacts.org/units/Nanomolar,3108127,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711618,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc2c(c1)CC(Nc1nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n1)C2,,,CHEMBL4257005,,,,CHEMBL4281861,,CHEMBL4281861,,False,http://www.openphacts.org/units/Nanomolar,3108128,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711619,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4290840,,CHEMBL4290840,,False,http://www.openphacts.org/units/Nanomolar,3108129,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711620,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3Cc4ccccc4C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4289822,,CHEMBL4289822,,False,http://www.openphacts.org/units/Nanomolar,3108130,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711621,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Nc1ccc(F)c(-c2nc(Nc3cc(F)cc(F)c3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4294923,,CHEMBL4294923,,False,http://www.openphacts.org/units/Nanomolar,3108131,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711622,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4289832,,CHEMBL4289832,,False,http://www.openphacts.org/units/Nanomolar,3108132,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711623,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1nc(-c2nc(NC3CCC(F)(F)C3)nc(NC3CCC(F)(F)C3)n2)cs1,,,CHEMBL4257005,,,,CHEMBL4277782,,CHEMBL4277782,,False,http://www.openphacts.org/units/Nanomolar,3108133,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711624,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(NC(C)C(F)(F)F)nc(-c2cncc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4276732,,CHEMBL4276732,,False,http://www.openphacts.org/units/Nanomolar,3108134,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711625,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCCC1Nc1nc(NC2CCCC2(F)F)nc(-c2cccc(Cl)n2)n1,,,CHEMBL4257005,,,,CHEMBL4281900,,CHEMBL4281900,,False,http://www.openphacts.org/units/Nanomolar,3108135,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711626,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280826,,CHEMBL4280826,,False,http://www.openphacts.org/units/Nanomolar,3108136,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711627,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3nc(C(F)(F)F)cs3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4287902,,CHEMBL4287902,,False,http://www.openphacts.org/units/Nanomolar,3108137,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711628,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cncc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4286852,,CHEMBL4286852,,False,http://www.openphacts.org/units/Nanomolar,3108138,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711629,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4289309,,CHEMBL4289309,,False,http://www.openphacts.org/units/Nanomolar,3108139,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711630,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)Nc1nc(Nc2ccnc(C#N)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4284724,,CHEMBL4284724,,False,http://www.openphacts.org/units/Nanomolar,3108140,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711631,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4277398,,CHEMBL4277398,,False,http://www.openphacts.org/units/Nanomolar,3108141,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711632,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4278417,,CHEMBL4278417,,False,http://www.openphacts.org/units/Nanomolar,3108142,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711633,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Nc1ccc(F)c(-c2nc(Nc3cc(F)cc(F)c3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4291867,,CHEMBL4291867,,False,http://www.openphacts.org/units/Nanomolar,3108143,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711634,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1)CC(Nc1nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n1)C2,,,CHEMBL4257005,,,,CHEMBL4277020,,CHEMBL4277020,,False,http://www.openphacts.org/units/Nanomolar,3108144,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711635,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cccc(Cl)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4290450,,CHEMBL4290450,,False,http://www.openphacts.org/units/Nanomolar,3108145,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711636,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4291491,,CHEMBL4291491,,False,http://www.openphacts.org/units/Nanomolar,3108146,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711637,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CC(F)(F)C4)nc(-n4ccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4284431,,CHEMBL4284431,,False,http://www.openphacts.org/units/Nanomolar,3108147,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711638,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3csc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4292401,,CHEMBL4292401,,False,http://www.openphacts.org/units/Nanomolar,3108148,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711639,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4280719,,CHEMBL4280719,,False,http://www.openphacts.org/units/Nanomolar,3108149,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711640,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4279665,,CHEMBL4279665,,False,http://www.openphacts.org/units/Nanomolar,3108150,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711641,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-n3ccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4295239,,CHEMBL4295239,,False,http://www.openphacts.org/units/Nanomolar,3108151,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711642,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@H]4CCC(F)(F)C4)nc(-n4ccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4294151,,CHEMBL4294151,,False,http://www.openphacts.org/units/Nanomolar,3108152,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711643,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NCC3CC3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4293761,,CHEMBL4293761,,False,http://www.openphacts.org/units/Nanomolar,3108153,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711644,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-n3ccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4290087,,CHEMBL4290087,,False,http://www.openphacts.org/units/Nanomolar,3108154,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711645,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4289717,,CHEMBL4289717,,False,http://www.openphacts.org/units/Nanomolar,3108155,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711646,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4288655,,CHEMBL4288655,,False,http://www.openphacts.org/units/Nanomolar,3108156,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711647,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(Nc2nc(NC3CCC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4285674,,CHEMBL4285674,,False,http://www.openphacts.org/units/Nanomolar,3108157,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711648,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC[C@H](Nc1nc(N[C@@H](CC)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4284624,,CHEMBL4284624,,False,http://www.openphacts.org/units/Nanomolar,3108158,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711649,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4279182,,CHEMBL4279182,,False,http://www.openphacts.org/units/Nanomolar,3108159,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711650,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3Cc4ccc(Cl)cc4C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280254,,CHEMBL4280254,,False,http://www.openphacts.org/units/Nanomolar,3108160,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711651,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3nc(C(F)(F)F)cs3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4283342,,CHEMBL4283342,,False,http://www.openphacts.org/units/Nanomolar,3108161,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711652,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(c4ccccc4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4284334,,CHEMBL4284334,,False,http://www.openphacts.org/units/Nanomolar,3108162,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711653,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)C4)nc(-n4ccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4292283,,CHEMBL4292283,,False,http://www.openphacts.org/units/Nanomolar,3108163,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711654,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1cncc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4293294,,CHEMBL4293294,,False,http://www.openphacts.org/units/Nanomolar,3108164,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711655,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cccc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4293667,,CHEMBL4293667,,False,http://www.openphacts.org/units/Nanomolar,3108165,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711656,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3Cc4cccnc4C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4278816,,CHEMBL4278816,,False,http://www.openphacts.org/units/Nanomolar,3108166,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711657,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)CC4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4294793,,CHEMBL4294793,,False,http://www.openphacts.org/units/Nanomolar,3108167,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711658,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4277305,,CHEMBL4277305,,False,http://www.openphacts.org/units/Nanomolar,3108168,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711659,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CC4(C3)CC(F)(F)C4)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4293221,,CHEMBL4293221,,False,http://www.openphacts.org/units/Nanomolar,3108169,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711660,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4292220,,CHEMBL4292220,,False,http://www.openphacts.org/units/Nanomolar,3108170,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711661,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NC(C2CC2)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4289486,,CHEMBL4289486,,False,http://www.openphacts.org/units/Nanomolar,3108171,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711662,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3ccnc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4288431,,CHEMBL4288431,,False,http://www.openphacts.org/units/Nanomolar,3108172,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711663,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3nc(F)ccc3F)n2)c1,,,CHEMBL4257005,,,,CHEMBL4287770,,CHEMBL4287770,,False,http://www.openphacts.org/units/Nanomolar,3108173,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711664,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC[C@H](Nc1nc(N[C@H](CC)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4286718,,CHEMBL4286718,,False,http://www.openphacts.org/units/Nanomolar,3108174,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711665,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-n3ccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4291846,,CHEMBL4291846,,False,http://www.openphacts.org/units/Nanomolar,3108175,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711666,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4288141,,CHEMBL4288141,,False,http://www.openphacts.org/units/Nanomolar,3108176,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711667,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc([C@H]2C[C@@H](Nc3nc(NC4CCC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)C2)cc1,,,CHEMBL4257005,,,,CHEMBL4280502,,CHEMBL4280502,,False,http://www.openphacts.org/units/Nanomolar,3108177,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711668,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cc(Nc2nc(NCC3CC3)nc(-c3cccc(Cl)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4279427,,CHEMBL4279427,,False,http://www.openphacts.org/units/Nanomolar,3108178,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711669,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4281644,,CHEMBL4281644,,False,http://www.openphacts.org/units/Nanomolar,3108179,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711670,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(-c4ccccc4)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4285379,,CHEMBL4285379,,False,http://www.openphacts.org/units/Nanomolar,3108180,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711671,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4280213,,CHEMBL4280213,,False,http://www.openphacts.org/units/Nanomolar,3108181,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711672,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4281273,,CHEMBL4281273,,False,http://www.openphacts.org/units/Nanomolar,3108182,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711673,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1csc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4281964,,CHEMBL4281964,,False,http://www.openphacts.org/units/Nanomolar,3108183,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711674,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(Cc1ccccc1)Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4282997,,CHEMBL4282997,,False,http://www.openphacts.org/units/Nanomolar,3108184,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711675,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C#N)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4285716,,CHEMBL4285716,,False,http://www.openphacts.org/units/Nanomolar,3108185,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711676,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CC(c4ccccc4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4286730,,CHEMBL4286730,,False,http://www.openphacts.org/units/Nanomolar,3108186,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711677,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1nc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)cs1,,,CHEMBL4257005,,,,CHEMBL4287400,,CHEMBL4287400,,False,http://www.openphacts.org/units/Nanomolar,3108187,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711678,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(Nc2nc(NC3CC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4291112,,CHEMBL4291112,,False,http://www.openphacts.org/units/Nanomolar,3108188,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711679,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cccc(-c2nc(Nc3ccnc(C4(C#N)CC4)c3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4288641,,CHEMBL4288641,,False,http://www.openphacts.org/units/Nanomolar,3108189,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711680,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(Cl)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4289692,,CHEMBL4289692,,False,http://www.openphacts.org/units/Nanomolar,3108190,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711681,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4276701,,CHEMBL4276701,,False,http://www.openphacts.org/units/Nanomolar,3108191,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711682,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(CC#N)Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4277757,,CHEMBL4277757,,False,http://www.openphacts.org/units/Nanomolar,3108192,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711683,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NCC(F)(F)F)nc(-c4cccc(Cl)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4289616,,CHEMBL4289616,,False,http://www.openphacts.org/units/Nanomolar,3108193,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711684,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(CNc2nc(NCC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4294886,,CHEMBL4294886,,False,http://www.openphacts.org/units/Nanomolar,3108194,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711685,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2ccnc(-c3ccccc3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4289777,,CHEMBL4289777,,False,http://www.openphacts.org/units/Nanomolar,3108195,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711686,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cccc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4290807,,CHEMBL4290807,,False,http://www.openphacts.org/units/Nanomolar,3108196,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711687,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCN(c4ccccc4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4283799,,CHEMBL4283799,,False,http://www.openphacts.org/units/Nanomolar,3108197,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711688,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(-c4ccccc4)c3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4284814,,CHEMBL4284814,,False,http://www.openphacts.org/units/Nanomolar,3108198,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711689,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(CNc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4290997,,CHEMBL4290997,,False,http://www.openphacts.org/units/Nanomolar,3108199,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711690,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCN(c4ccccn4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4289977,,CHEMBL4289977,,False,http://www.openphacts.org/units/Nanomolar,3108200,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711691,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3csc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4295099,,CHEMBL4295099,,False,http://www.openphacts.org/units/Nanomolar,3108201,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711692,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1cccc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4291368,,CHEMBL4291368,,False,http://www.openphacts.org/units/Nanomolar,3108202,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711693,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3Cc4ccc(Br)cc4C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4284376,,CHEMBL4284376,,False,http://www.openphacts.org/units/Nanomolar,3108203,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711694,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NCC(F)(F)F)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4276898,,CHEMBL4276898,,False,http://www.openphacts.org/units/Nanomolar,3108204,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711695,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCN(c4ncccn4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4282071,,CHEMBL4282071,,False,http://www.openphacts.org/units/Nanomolar,3108205,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711696,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CC4(C3)CC(F)(F)C4)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4281002,,CHEMBL4281002,,False,http://www.openphacts.org/units/Nanomolar,3108206,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711697,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CC5(C4)CC(F)(F)C5)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4288051,,CHEMBL4288051,,False,http://www.openphacts.org/units/Nanomolar,3108207,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711698,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc([C@H]2C[C@H](Nc3nc(NC4CCC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)C2)cc1,,,CHEMBL4257005,,,,CHEMBL4286997,,CHEMBL4286997,,False,http://www.openphacts.org/units/Nanomolar,3108208,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711699,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(CC#N)Nc1nc(Nc2ccnc(C(C)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4291861,,CHEMBL4291861,,False,http://www.openphacts.org/units/Nanomolar,3108209,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711700,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4292885,,CHEMBL4292885,,False,http://www.openphacts.org/units/Nanomolar,3108210,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711701,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,COCCC(C)Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4277393,,CHEMBL4277393,,False,http://www.openphacts.org/units/Nanomolar,3108211,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711702,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NC2C3CC4CC(C3)CC2C4)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4278414,,CHEMBL4278414,,False,http://www.openphacts.org/units/Nanomolar,3108212,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711703,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,OC(F)(F)CNc1nc(Nc2cc(F)cc(F)c2)nc(-n2ccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4286365,,CHEMBL4286365,,False,http://www.openphacts.org/units/Nanomolar,3108213,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711704,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1ccn(-c2nc(NCC(O)(F)F)nc(Nc3cc(F)cc(Cl)c3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4287398,,CHEMBL4287398,,False,http://www.openphacts.org/units/Nanomolar,3108214,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711705,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3nccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4287795,,CHEMBL4287795,,False,http://www.openphacts.org/units/Nanomolar,3108215,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711706,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CN(c4ccccn4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4291485,,CHEMBL4291485,,False,http://www.openphacts.org/units/Nanomolar,3108216,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711707,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,O=C1C[C@H](Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)CN1c1ccccn1,,,CHEMBL4257005,,,,CHEMBL4288916,,CHEMBL4288916,,False,http://www.openphacts.org/units/Nanomolar,3108217,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711708,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C=Cc1cccc(-c2nc(N[C@H](C)C3CC3)nc(N[C@H](C)C3CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4289959,,CHEMBL4289959,,False,http://www.openphacts.org/units/Nanomolar,3108218,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711709,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(COC(C)C)Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4286667,,CHEMBL4286667,,False,http://www.openphacts.org/units/Nanomolar,3108219,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711710,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccc2c(c1)CC(Nc1nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n1)C2,,,CHEMBL4257005,,,"{'bei': '14.56', 'le': '0.28', 'lle': '2.30', 'sei': '7.34'}",CHEMBL4285688,,CHEMBL4285688,7.30,False,http://www.openphacts.org/units/Nanomolar,3108220,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711711,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CN(c4cccnc4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.83', 'le': '0.28', 'lle': '3.05', 'sei': '7.96'}",CHEMBL4282632,,CHEMBL4282632,7.30,False,http://www.openphacts.org/units/Nanomolar,3108221,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711712,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)CNc1nc(Nc2cc(F)cc(C#N)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '16.32', 'le': '0.31', 'lle': '3.41', 'sei': '6.10'}",CHEMBL4281594,,CHEMBL4281594,7.30,False,http://www.openphacts.org/units/Nanomolar,3108222,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711713,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)Nc1nc(Nc2cc(F)cc(C#N)c2)nc(-c2nccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '16.89', 'le': '0.32', 'lle': '2.99', 'sei': '6.50'}",CHEMBL4281221,,CHEMBL4281221,7.30,False,http://www.openphacts.org/units/Nanomolar,3108223,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711714,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NCCOc2ccccc2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '16.43', 'le': '0.31', 'lle': '2.65', 'sei': '8.60'}",CHEMBL4277498,,CHEMBL4277498,7.30,False,http://www.openphacts.org/units/Nanomolar,3108224,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711715,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C#N)Nc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '15.59', 'le': '0.30', 'lle': '2.48', 'sei': '6.50'}",CHEMBL4279333,,CHEMBL4279333,7.30,False,http://www.openphacts.org/units/Nanomolar,3108225,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711716,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)CNc1nc(Nc2cccc(Cl)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '16.64', 'le': '0.33', 'lle': '2.77', 'sei': '7.62'}",CHEMBL4294615,,CHEMBL4294615,7.30,False,http://www.openphacts.org/units/Nanomolar,3108226,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711717,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Nc1ccc(F)c(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '15.96', 'le': '0.31', 'lle': '2.67', 'sei': '7.18'}",CHEMBL4291587,,CHEMBL4291587,7.30,False,http://www.openphacts.org/units/Nanomolar,3108227,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711718,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(CC#N)Nc1nc(Nc2ccnc(C(C)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '15.72', 'le': '0.30', 'lle': '2.38', 'sei': '6.50'}",CHEMBL4290554,,CHEMBL4290554,7.30,False,http://www.openphacts.org/units/Nanomolar,3108228,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711719,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3ccnc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '16.69', 'le': '0.33', 'lle': '3.53', 'sei': '8.25'}",CHEMBL4294983,,CHEMBL4294983,7.30,False,http://www.openphacts.org/units/Nanomolar,3108229,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711720,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(OC(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '15.20', 'le': '0.30', 'lle': '2.27', 'sei': '8.60'}",CHEMBL4287992,,CHEMBL4287992,7.30,False,http://www.openphacts.org/units/Nanomolar,3108230,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711721,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C#N)Nc1nc(Nc2ccnc(C(C)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '16.21', 'le': '0.31', 'lle': '2.77', 'sei': '6.50'}",CHEMBL4293552,,CHEMBL4293552,7.30,False,http://www.openphacts.org/units/Nanomolar,3108231,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711722,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3Cc4cc(Br)cc(Br)c4C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '11.51', 'le': '0.28', 'lle': '0.64', 'sei': '9.65'}",CHEMBL4280042,,CHEMBL4280042,7.30,False,http://www.openphacts.org/units/Nanomolar,3108232,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711723,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCOCC3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '15.27', 'le': '0.30', 'lle': '2.47', 'sei': '8.25'}",CHEMBL4292464,,CHEMBL4292464,7.00,False,http://www.openphacts.org/units/Nanomolar,3108233,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711724,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3nccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '16.01', 'le': '0.32', 'lle': '3.23', 'sei': '7.91'}",CHEMBL4293462,,CHEMBL4293462,7.00,False,http://www.openphacts.org/units/Nanomolar,3108234,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711725,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC2(CC(Nc3nc(Nc4ccnc(C(F)(F)F)c4)nc(-c4cccc(C(F)(F)F)n4)n3)C2)C1,,,CHEMBL4257005,,,"{'bei': '13.17', 'le': '0.26', 'lle': '0.90', 'sei': '7.91'}",CHEMBL4288364,,CHEMBL4288364,7.00,False,http://www.openphacts.org/units/Nanomolar,3108235,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711726,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C4CC4)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '16.04', 'le': '0.31', 'lle': '1.99', 'sei': '9.26'}",CHEMBL4289397,,CHEMBL4289397,7.00,False,http://www.openphacts.org/units/Nanomolar,3108236,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711727,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)CNc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '14.88', 'le': '0.28', 'lle': '3.17', 'sei': '5.28'}",CHEMBL4281357,,CHEMBL4281357,7.00,False,http://www.openphacts.org/units/Nanomolar,3108237,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711728,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3nc(F)ccc3F)n2)c1,,,CHEMBL4257005,,,"{'bei': '15.41', 'le': '0.30', 'lle': '1.78', 'sei': '9.26'}",CHEMBL4285080,,CHEMBL4285080,7.00,False,http://www.openphacts.org/units/Nanomolar,3108238,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711729,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)C4)nc(-c4nccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '13.90', 'le': '0.27', 'lle': '2.36', 'sei': '5.59'}",CHEMBL4279855,,CHEMBL4279855,7.00,False,http://www.openphacts.org/units/Nanomolar,3108239,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711730,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NCC(C)(C)C#N)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '17.27', 'le': '0.33', 'lle': '2.88', 'sei': '7.04'}",CHEMBL4278807,,CHEMBL4278807,7.00,False,http://www.openphacts.org/units/Nanomolar,3108240,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711731,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,O=C(c1ccccc1)N1CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '13.12', 'le': '0.25', 'lle': '2.12', 'sei': '7.30'}",CHEMBL4283985,,CHEMBL4283985,7.00,False,http://www.openphacts.org/units/Nanomolar,3108241,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711732,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)CNc1nc(NC2CCC(F)(F)C2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '16.19', 'le': '0.32', 'lle': '3.27', 'sei': '7.30'}",CHEMBL4282936,,CHEMBL4282936,7.00,False,http://www.openphacts.org/units/Nanomolar,3108242,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711733,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC2(CC(Nc3nc(NC4CC5(C4)CC(F)(F)C5)nc(-c4cccc(Cl)n4)n3)C2)C1,,,CHEMBL4257005,,,"{'bei': '14.50', 'le': '0.29', 'lle': '1.43', 'sei': '9.26'}",CHEMBL4285110,,CHEMBL4285110,7.00,False,http://www.openphacts.org/units/Nanomolar,3108243,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711734,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CS(=O)(=O)N1CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '13.07', 'le': '0.27', 'lle': '3.22', 'sei': '6.19'}",CHEMBL4284068,,CHEMBL4284068,7.00,False,http://www.openphacts.org/units/Nanomolar,3108244,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711735,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C#N)CNc1nc(Nc2ccnc(C(C)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '14.63', 'le': '0.28', 'lle': '1.84', 'sei': '6.23'}",CHEMBL4278435,,CHEMBL4278435,7.00,False,http://www.openphacts.org/units/Nanomolar,3108245,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711736,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2nccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '17.79', 'le': '0.34', 'lle': '3.23', 'sei': '7.91'}",CHEMBL4285495,,CHEMBL4285495,7.00,False,http://www.openphacts.org/units/Nanomolar,3108246,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711737,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C#N)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '20.03', 'le': '0.37', 'lle': '3.77', 'sei': '7.04'}",CHEMBL4276904,,CHEMBL4276904,7.00,False,http://www.openphacts.org/units/Nanomolar,3108247,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711738,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3ccnc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '14.19', 'le': '0.28', 'lle': '1.67', 'sei': '7.91'}",CHEMBL4294396,,CHEMBL4294396,7.00,False,http://www.openphacts.org/units/Nanomolar,3108248,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711739,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(CC#N)Nc1nc(NC(C)CC#N)nc(-c2cccc(Cl)n2)n1,,,CHEMBL4257005,,,"{'bei': '19.62', 'le': '0.38', 'lle': '3.98', 'sei': '5.68'}",CHEMBL4288016,,CHEMBL4288016,7.00,False,http://www.openphacts.org/units/Nanomolar,3108249,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711740,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc([C@H]2C[C@@H](Nc3nc(N[C@H]4C[C@@H](c5ccc(F)cc5)C4)nc(-c4cccc(C(F)(F)F)n4)n3)C2)cc1,,,CHEMBL4257005,,,"{'bei': '12.67', 'le': '0.24', 'lle': '0.05', 'sei': '9.26'}",CHEMBL4291957,,CHEMBL4291957,7.00,False,http://www.openphacts.org/units/Nanomolar,3108250,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711741,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N1CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '14.01', 'le': '0.27', 'lle': '2.63', 'sei': '7.30'}",CHEMBL4292328,,CHEMBL4292328,7.00,False,http://www.openphacts.org/units/Nanomolar,3108251,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711742,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)OC(=O)N1CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '12.55', 'le': '0.25', 'lle': '1.25', 'sei': '6.66'}",CHEMBL4277506,,CHEMBL4277506,7.00,False,http://www.openphacts.org/units/Nanomolar,3108252,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711743,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)c(C(F)(F)F)n1,,,CHEMBL4257005,,,"{'bei': '14.13', 'le': '0.28', 'lle': '1.73', 'sei': '8.69'}",CHEMBL4277835,,CHEMBL4277835,7.00,False,http://www.openphacts.org/units/Nanomolar,3108253,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711744,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc(F)c(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '15.20', 'le': '0.30', 'lle': '1.81', 'sei': '9.26'}",CHEMBL4278869,,CHEMBL4278869,7.00,False,http://www.openphacts.org/units/Nanomolar,3108254,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711745,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3cccc(OC(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '15.48', 'le': '0.31', 'lle': '2.75', 'sei': '8.25'}",CHEMBL4289797,,CHEMBL4289797,7.00,False,http://www.openphacts.org/units/Nanomolar,3108255,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711746,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cncc(Cl)c2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '19.51', 'le': '0.38', 'lle': '2.99', 'sei': '9.26'}",CHEMBL4290818,,CHEMBL4290818,7.00,False,http://www.openphacts.org/units/Nanomolar,3108256,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711747,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-n2cc(I)cn2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '15.93', 'le': '0.40', 'lle': '3.92', 'sei': '8.69'}",CHEMBL4293859,,CHEMBL4293859,7.00,False,http://www.openphacts.org/units/Nanomolar,3108257,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711748,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCN(Cc4ccccc4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '13.47', 'le': '0.26', 'lle': '1.76', 'sei': '8.88'}",CHEMBL4294899,,CHEMBL4294899,7.00,False,http://www.openphacts.org/units/Nanomolar,3108258,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711749,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](CO)Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '18.31', 'le': '0.35', 'lle': '4.04', 'sei': '7.30'}",CHEMBL4279934,,CHEMBL4279934,7.00,False,http://www.openphacts.org/units/Nanomolar,3108259,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711750,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '15.96', 'le': '0.31', 'lle': '1.78', 'sei': '9.26'}",CHEMBL4294774,,CHEMBL4294774,7.00,False,http://www.openphacts.org/units/Nanomolar,3108260,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711751,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1nc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)cs1,,,CHEMBL4257005,,,"{'bei': '14.16', 'le': '0.29', 'lle': '0.91', 'sei': '9.26'}",CHEMBL4294387,,CHEMBL4294387,7.00,False,http://www.openphacts.org/units/Nanomolar,3108261,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711752,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C#CCNc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '19.32', 'le': '0.37', 'lle': '3.79', 'sei': '9.26'}",CHEMBL4293353,,CHEMBL4293353,7.00,False,http://www.openphacts.org/units/Nanomolar,3108262,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711753,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(N)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '20.62', 'le': '0.38', 'lle': '4.06', 'sei': '6.89'}",CHEMBL4293274,,CHEMBL4293274,7.00,False,http://www.openphacts.org/units/Nanomolar,3108263,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711754,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,COC(=O)CCNc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '17.06', 'le': '0.33', 'lle': '3.86', 'sei': '6.87'}",CHEMBL4292259,,CHEMBL4292259,7.00,False,http://www.openphacts.org/units/Nanomolar,3108264,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711755,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)CNc1nc(NC2CCC(F)(F)CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '15.68', 'le': '0.31', 'lle': '2.87', 'sei': '7.30'}",CHEMBL4281385,,CHEMBL4281385,7.00,False,http://www.openphacts.org/units/Nanomolar,3108265,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711756,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)CNc1nc(Nc2ccnc(C#N)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '16.26', 'le': '0.31', 'lle': '3.85', 'sei': '5.28'}",CHEMBL4280325,,CHEMBL4280325,7.00,False,http://www.openphacts.org/units/Nanomolar,3108266,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711757,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)Nc1nc(Nc2ccnc(C(C)(F)F)c2)nc(-c2nccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '15.40', 'le': '0.30', 'lle': '2.19', 'sei': '6.90'}",CHEMBL4282925,,CHEMBL4282925,7.00,False,http://www.openphacts.org/units/Nanomolar,3108267,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711758,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,OC1CCCC1Nc1nc(NC2CCCC2O)nc(-c2cccc(Cl)n2)n1,,,CHEMBL4257005,,,"{'bei': '17.91', 'le': '0.35', 'lle': '4.76', 'sei': '6.03'}",CHEMBL4279162,,CHEMBL4279162,7.00,False,http://www.openphacts.org/units/Nanomolar,3108268,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711759,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3cc4ccccc4[nH]3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.72', 'le': '0.28', 'lle': '1.22', 'sei': '7.66'}",CHEMBL4292705,,CHEMBL4292705,7.00,False,http://www.openphacts.org/units/Nanomolar,3108269,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711760,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cc(F)ccc2F)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '19.48', 'le': '0.37', 'lle': '2.76', 'sei': '11.16'}",CHEMBL4293737,,CHEMBL4293737,7.00,False,http://www.openphacts.org/units/Nanomolar,3108270,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711761,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3nccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '14.19', 'le': '0.28', 'lle': '1.67', 'sei': '7.91'}",CHEMBL4288632,,CHEMBL4288632,7.00,False,http://www.openphacts.org/units/Nanomolar,3108271,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711762,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,COc1cccc(-c2nc(N[C@H](C)C3CC3)nc(N[C@H](C)C3CC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '19.75', 'le': '0.37', 'lle': '3.64', 'sei': '8.25'}",CHEMBL4289685,,CHEMBL4289685,7.00,False,http://www.openphacts.org/units/Nanomolar,3108272,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711763,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,COCCOCC(C)Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '15.89', 'le': '0.31', 'lle': '3.37', 'sei': '7.44'}",CHEMBL4284594,,CHEMBL4284594,7.00,False,http://www.openphacts.org/units/Nanomolar,3108273,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711764,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(OC(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '13.77', 'le': '0.27', 'lle': '1.19', 'sei': '8.25'}",CHEMBL4288266,,CHEMBL4288266,7.00,False,http://www.openphacts.org/units/Nanomolar,3108274,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711765,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3c[nH]nc3C(F)(F)F)n2)CC1,,,CHEMBL4257005,,,"{'bei': '14.54', 'le': '0.29', 'lle': '1.74', 'sei': '7.66'}",CHEMBL4283186,,CHEMBL4283186,7.00,False,http://www.openphacts.org/units/Nanomolar,3108275,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711766,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)Nc1nc(Nc2ccnc(C(C)(F)F)c2)nc(-c2nccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '15.90', 'le': '0.31', 'lle': '2.58', 'sei': '6.90'}",CHEMBL4284203,,CHEMBL4284203,7.00,False,http://www.openphacts.org/units/Nanomolar,3108276,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711767,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc([C@H]2C[C@H](Nc3nc(N[C@H]4C[C@H](c5ccc(F)cc5)C4)nc(-c4cccc(C(F)(F)F)n4)n3)C2)cc1,,,CHEMBL4257005,,,"{'bei': '12.67', 'le': '0.24', 'lle': '0.05', 'sei': '9.26'}",CHEMBL4279031,,CHEMBL4279031,7.00,False,http://www.openphacts.org/units/Nanomolar,3108277,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711768,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cncc(C(F)(F)F)c2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '17.84', 'le': '0.34', 'lle': '2.63', 'sei': '9.26'}",CHEMBL4280111,,CHEMBL4280111,7.00,False,http://www.openphacts.org/units/Nanomolar,3108278,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711769,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)co1,,,CHEMBL4257005,,,"{'bei': '18.80', 'le': '0.37', 'lle': '3.75', 'sei': '7.89'}",CHEMBL4286024,,CHEMBL4286024,7.00,False,http://www.openphacts.org/units/Nanomolar,3108279,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711770,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-n3cc(Cl)cn3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '15.63', 'le': '0.32', 'lle': '2.31', 'sei': '8.69'}",CHEMBL4285024,,CHEMBL4285024,7.00,False,http://www.openphacts.org/units/Nanomolar,3108280,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711771,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NCC(C)(C)C(N)=O)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4290110,,CHEMBL4290110,,False,http://www.openphacts.org/units/Nanomolar,3108281,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711772,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Cn1ccc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4286384,,CHEMBL4286384,,False,http://www.openphacts.org/units/Nanomolar,3108282,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711773,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C4CC4)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4291516,,CHEMBL4291516,,False,http://www.openphacts.org/units/Nanomolar,3108283,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711774,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(CN1CCOCC1)Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4290474,,CHEMBL4290474,,False,http://www.openphacts.org/units/Nanomolar,3108284,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711775,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(N)=O)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4277032,,CHEMBL4277032,,False,http://www.openphacts.org/units/Nanomolar,3108285,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711776,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1ccnc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4294544,,CHEMBL4294544,,False,http://www.openphacts.org/units/Nanomolar,3108286,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711777,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Oc1ccc(F)c(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4281152,,CHEMBL4281152,,False,http://www.openphacts.org/units/Nanomolar,3108287,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711778,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,COC(=O)c1cccc(-c2nc(N[C@H](C)C3CC3)nc(N[C@H](C)C3CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4280091,,CHEMBL4280091,,False,http://www.openphacts.org/units/Nanomolar,3108288,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711779,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)no1,,,CHEMBL4257005,,,,CHEMBL4280060,,CHEMBL4280060,,False,http://www.openphacts.org/units/Nanomolar,3108289,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711780,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Cc1cnn(-c2nc(N[C@H](C)C3CC3)nc(N[C@H](C)C3CC3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4278994,,CHEMBL4278994,,False,http://www.openphacts.org/units/Nanomolar,3108290,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711781,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc(N2CC(Nc3nc(NC4CCC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)C2)cc1,,,CHEMBL4257005,,,,CHEMBL4294510,,CHEMBL4294510,,False,http://www.openphacts.org/units/Nanomolar,3108291,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711782,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cc(Cl)ccn3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4293474,,CHEMBL4293474,,False,http://www.openphacts.org/units/Nanomolar,3108292,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711783,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,COCCc1ccnc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4293096,,CHEMBL4293096,,False,http://www.openphacts.org/units/Nanomolar,3108293,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711784,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Cn1c(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)cc2ccccc21,,,CHEMBL4257005,,,,CHEMBL4289413,,CHEMBL4289413,,False,http://www.openphacts.org/units/Nanomolar,3108294,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711785,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)c[nH]1,,,CHEMBL4257005,,,,CHEMBL4289057,,CHEMBL4289057,,False,http://www.openphacts.org/units/Nanomolar,3108295,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711786,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cc(C(F)(F)F)ccn3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4288003,,CHEMBL4288003,,False,http://www.openphacts.org/units/Nanomolar,3108296,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711787,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(-c2nc(NC3CCC(F)(F)C3)nc(NC3CCC(F)(F)C3)n2)c[nH]1,,,CHEMBL4257005,,,,CHEMBL4285000,,CHEMBL4285000,,False,http://www.openphacts.org/units/Nanomolar,3108297,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711788,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C#N)c2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4283966,,CHEMBL4283966,,False,http://www.openphacts.org/units/Nanomolar,3108298,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711789,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(F)c(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4282630,,CHEMBL4282630,,False,http://www.openphacts.org/units/Nanomolar,3108299,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711790,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(OC(F)(F)F)c2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4283680,,CHEMBL4283680,,False,http://www.openphacts.org/units/Nanomolar,3108300,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711791,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2ccnc(C(F)(F)F)c2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4286662,,CHEMBL4286662,,False,http://www.openphacts.org/units/Nanomolar,3108301,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711792,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)co1,,,CHEMBL4257005,,,,CHEMBL4287696,,CHEMBL4287696,,False,http://www.openphacts.org/units/Nanomolar,3108302,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711793,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)CNc1nc(Nc2cc(F)cc(F)c2)nc(-c2nccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4277108,,CHEMBL4277108,,False,http://www.openphacts.org/units/Nanomolar,3108303,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711794,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(O)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4287791,,CHEMBL4287791,,False,http://www.openphacts.org/units/Nanomolar,3108304,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711795,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Cc1nsc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4282277,,CHEMBL4282277,,False,http://www.openphacts.org/units/Nanomolar,3108305,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711796,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)no1,,,CHEMBL4257005,,,,CHEMBL4279622,,CHEMBL4279622,,False,http://www.openphacts.org/units/Nanomolar,3108306,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711797,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3ccn[nH]3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4280670,,CHEMBL4280670,,False,http://www.openphacts.org/units/Nanomolar,3108307,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711798,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(CN1CCCCC1)Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4290176,,CHEMBL4290176,,False,http://www.openphacts.org/units/Nanomolar,3108308,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711799,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)c[nH]1,,,CHEMBL4257005,,,,CHEMBL4289141,,CHEMBL4289141,,False,http://www.openphacts.org/units/Nanomolar,3108309,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711800,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3nc(-c4ccccc4)ns3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4294240,,CHEMBL4294240,,False,http://www.openphacts.org/units/Nanomolar,3108310,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711801,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1cc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4282906,,CHEMBL4282906,,False,http://www.openphacts.org/units/Nanomolar,3108389,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711802,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1cc(N[C@@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4286947,,CHEMBL4286947,,False,http://www.openphacts.org/units/Nanomolar,3108391,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711803,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1cc(NC2CCC(F)(F)CC2)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,"{'bei': '16.75', 'le': '0.34', 'lle': '1.76', 'sei': '11.64'}",CHEMBL4291028,,CHEMBL4291028,7.30,False,http://www.openphacts.org/units/Nanomolar,3108393,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711804,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2cc(NC3CCC(F)(F)CC3)nc(-c3cncc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '14.21', 'le': '0.28', 'lle': '1.07', 'sei': '9.26'}",CHEMBL4277604,,CHEMBL4277604,7.00,False,http://www.openphacts.org/units/Nanomolar,3108396,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
Not Active,18711805,[],CHEMBL4257007,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2ccc(Cl)cc2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4277706,,CHEMBL4277706,,False,,3108397,,38,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
,18711806,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCOC3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4282969,,CHEMBL4282969,,False,http://www.openphacts.org/units/Nanomolar,3108054,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711807,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)OC(=O)N1CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '13.79', 'le': '0.27', 'lle': '2.33', 'sei': '6.94'}",CHEMBL4284019,,CHEMBL4284019,7.30,False,http://www.openphacts.org/units/Nanomolar,3108055,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711808,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCNC3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4277787,,CHEMBL4277787,,False,http://www.openphacts.org/units/Nanomolar,3108056,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711809,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N1CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '15.49', 'le': '0.30', 'lle': '3.72', 'sei': '7.61'}",CHEMBL4287154,,CHEMBL4287154,7.30,False,http://www.openphacts.org/units/Nanomolar,3108057,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711810,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CS(=O)(=O)N1CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280113,,CHEMBL4280113,,False,http://www.openphacts.org/units/Nanomolar,3108058,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711811,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccnc2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4294945,,CHEMBL4294945,,False,http://www.openphacts.org/units/Nanomolar,3108059,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711812,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NC2CC3(C2)CC(F)(F)C3)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4294574,,CHEMBL4294574,,False,http://www.openphacts.org/units/Nanomolar,3108060,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711813,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4279047,,CHEMBL4279047,,False,http://www.openphacts.org/units/Nanomolar,3108079,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711814,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cccc(-c2nc(NC3CCC(F)(F)C3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4292152,,CHEMBL4292152,,False,http://www.openphacts.org/units/Nanomolar,3108083,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711815,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CCC(Nc1nc(NC(CC)C2CC2)nc(-c2cccc(Cl)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4282989,,CHEMBL4282989,,False,http://www.openphacts.org/units/Nanomolar,3108088,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711816,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(Cl)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280132,,CHEMBL4280132,,False,http://www.openphacts.org/units/Nanomolar,3108091,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711817,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(Cl)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4281282,,CHEMBL4281282,,False,http://www.openphacts.org/units/Nanomolar,3108093,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711818,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)Nc1nc(Nc2cccc(C#N)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4283138,,CHEMBL4283138,,False,http://www.openphacts.org/units/Nanomolar,3108095,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711819,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-n2ccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4293652,,CHEMBL4293652,,False,http://www.openphacts.org/units/Nanomolar,3108099,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711820,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4292275,,CHEMBL4292275,,False,http://www.openphacts.org/units/Nanomolar,3108101,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711821,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4293284,,CHEMBL4293284,,False,http://www.openphacts.org/units/Nanomolar,3108102,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711822,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4291118,,CHEMBL4291118,,False,http://www.openphacts.org/units/Nanomolar,3108103,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711823,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4292169,,CHEMBL4292169,,False,http://www.openphacts.org/units/Nanomolar,3108104,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711824,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)C4)nc(-c4cccc(Cl)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4287037,,CHEMBL4287037,,False,http://www.openphacts.org/units/Nanomolar,3108105,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711825,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3nc(C(F)(F)F)cs3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4288084,,CHEMBL4288084,,False,http://www.openphacts.org/units/Nanomolar,3108106,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711826,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(NC(C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4283785,,CHEMBL4283785,,False,http://www.openphacts.org/units/Nanomolar,3108108,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711827,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Clc1cccc(-c2nc(NC(C3CC3)C3CC3)nc(NC(C3CC3)C3CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4279765,,CHEMBL4279765,,False,http://www.openphacts.org/units/Nanomolar,3108109,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711828,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4293189,,CHEMBL4293189,,False,http://www.openphacts.org/units/Nanomolar,3108112,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711829,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4292077,,CHEMBL4292077,,False,http://www.openphacts.org/units/Nanomolar,3108114,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711830,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(N[C@@H](C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4278845,,CHEMBL4278845,,False,http://www.openphacts.org/units/Nanomolar,3108120,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711831,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1cccc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4283381,,CHEMBL4283381,,False,http://www.openphacts.org/units/Nanomolar,3108123,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711832,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4284375,,CHEMBL4284375,,False,http://www.openphacts.org/units/Nanomolar,3108124,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711833,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cncc(Cl)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4276695,,CHEMBL4276695,,False,http://www.openphacts.org/units/Nanomolar,3108125,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711834,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280772,,CHEMBL4280772,,False,http://www.openphacts.org/units/Nanomolar,3108127,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711835,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4290840,,CHEMBL4290840,,False,http://www.openphacts.org/units/Nanomolar,3108129,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711836,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3Cc4ccccc4C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4289822,,CHEMBL4289822,,False,http://www.openphacts.org/units/Nanomolar,3108130,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711837,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)Nc1nc(Nc2ccnc(C#N)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4284724,,CHEMBL4284724,,False,http://www.openphacts.org/units/Nanomolar,3108140,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711838,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4278417,,CHEMBL4278417,,False,http://www.openphacts.org/units/Nanomolar,3108142,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711839,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cccc(Cl)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4290450,,CHEMBL4290450,,False,http://www.openphacts.org/units/Nanomolar,3108145,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711840,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3csc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4292401,,CHEMBL4292401,,False,http://www.openphacts.org/units/Nanomolar,3108148,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711841,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-n3ccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4290087,,CHEMBL4290087,,False,http://www.openphacts.org/units/Nanomolar,3108154,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711842,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4288655,,CHEMBL4288655,,False,http://www.openphacts.org/units/Nanomolar,3108156,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711843,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4279182,,CHEMBL4279182,,False,http://www.openphacts.org/units/Nanomolar,3108159,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711844,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3Cc4ccc(Cl)cc4C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280254,,CHEMBL4280254,,False,http://www.openphacts.org/units/Nanomolar,3108160,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711845,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cccc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4293667,,CHEMBL4293667,,False,http://www.openphacts.org/units/Nanomolar,3108165,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711846,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)CC4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4294793,,CHEMBL4294793,,False,http://www.openphacts.org/units/Nanomolar,3108167,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711847,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CC4(C3)CC(F)(F)C4)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4293221,,CHEMBL4293221,,False,http://www.openphacts.org/units/Nanomolar,3108169,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711848,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4292220,,CHEMBL4292220,,False,http://www.openphacts.org/units/Nanomolar,3108170,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711849,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NC(C2CC2)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4289486,,CHEMBL4289486,,False,http://www.openphacts.org/units/Nanomolar,3108171,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711850,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc([C@H]2C[C@@H](Nc3nc(NC4CCC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)C2)cc1,,,CHEMBL4257005,,,,CHEMBL4280502,,CHEMBL4280502,,False,http://www.openphacts.org/units/Nanomolar,3108177,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711851,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4280213,,CHEMBL4280213,,False,http://www.openphacts.org/units/Nanomolar,3108181,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711852,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4276701,,CHEMBL4276701,,False,http://www.openphacts.org/units/Nanomolar,3108191,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711853,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(CC#N)Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4277757,,CHEMBL4277757,,False,http://www.openphacts.org/units/Nanomolar,3108192,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711854,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCN(c4ccccn4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.42', 'le': '0.28', 'lle': '2.66', 'sei': '7.96'}",CHEMBL4289977,,CHEMBL4289977,7.30,False,http://www.openphacts.org/units/Nanomolar,3108200,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711855,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3csc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '14.65', 'le': '0.30', 'lle': '1.31', 'sei': '9.65'}",CHEMBL4295099,,CHEMBL4295099,7.30,False,http://www.openphacts.org/units/Nanomolar,3108201,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711856,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1cccc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4291368,,CHEMBL4291368,,False,http://www.openphacts.org/units/Nanomolar,3108202,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711857,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NCC(F)(F)F)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '15.20', 'le': '0.29', 'lle': '2.68', 'sei': '6.50'}",CHEMBL4276898,,CHEMBL4276898,7.30,False,http://www.openphacts.org/units/Nanomolar,3108204,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711858,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCN(c4ncccn4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.39', 'le': '0.28', 'lle': '3.27', 'sei': '6.98'}",CHEMBL4282071,,CHEMBL4282071,7.30,False,http://www.openphacts.org/units/Nanomolar,3108205,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711859,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CC5(C4)CC(F)(F)C5)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '13.81', 'le': '0.26', 'lle': '1.66', 'sei': '6.50'}",CHEMBL4288051,,CHEMBL4288051,7.30,False,http://www.openphacts.org/units/Nanomolar,3108207,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711860,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(CC#N)Nc1nc(Nc2ccnc(C(C)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '15.26', 'le': '0.29', 'lle': '1.99', 'sei': '6.50'}",CHEMBL4291861,,CHEMBL4291861,7.30,False,http://www.openphacts.org/units/Nanomolar,3108209,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711861,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3nccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4287795,,CHEMBL4287795,,False,http://www.openphacts.org/units/Nanomolar,3108215,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711862,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(COC(C)C)Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '16.49', 'le': '0.32', 'lle': '2.61', 'sei': '8.25'}",CHEMBL4286667,,CHEMBL4286667,7.00,False,http://www.openphacts.org/units/Nanomolar,3108219,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711863,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccc2c(c1)CC(Nc1nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n1)C2,,,CHEMBL4257005,,,"{'bei': '14.56', 'le': '0.28', 'lle': '2.30', 'sei': '7.34'}",CHEMBL4285688,,CHEMBL4285688,7.30,False,http://www.openphacts.org/units/Nanomolar,3108220,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711864,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)CNc1nc(Nc2cc(F)cc(C#N)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '15.65', 'le': '0.30', 'lle': '3.11', 'sei': '5.85'}",CHEMBL4281594,,CHEMBL4281594,7.00,False,http://www.openphacts.org/units/Nanomolar,3108222,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711865,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)Nc1nc(Nc2cc(F)cc(C#N)c2)nc(-c2nccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '16.19', 'le': '0.31', 'lle': '2.69', 'sei': '6.23'}",CHEMBL4281221,,CHEMBL4281221,7.00,False,http://www.openphacts.org/units/Nanomolar,3108223,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711866,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NCCOc2ccccc2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '16.43', 'le': '0.31', 'lle': '2.65', 'sei': '8.60'}",CHEMBL4277498,,CHEMBL4277498,7.30,False,http://www.openphacts.org/units/Nanomolar,3108224,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711867,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C#N)Nc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '15.59', 'le': '0.30', 'lle': '2.48', 'sei': '6.50'}",CHEMBL4279333,,CHEMBL4279333,7.30,False,http://www.openphacts.org/units/Nanomolar,3108225,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711868,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)CNc1nc(Nc2cccc(Cl)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '15.95', 'le': '0.32', 'lle': '2.47', 'sei': '7.30'}",CHEMBL4294615,,CHEMBL4294615,7.00,False,http://www.openphacts.org/units/Nanomolar,3108226,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711869,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(CC#N)Nc1nc(Nc2ccnc(C(C)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '15.07', 'le': '0.29', 'lle': '2.08', 'sei': '6.23'}",CHEMBL4290554,,CHEMBL4290554,7.00,False,http://www.openphacts.org/units/Nanomolar,3108228,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711870,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(OC(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.57', 'le': '0.29', 'lle': '1.97', 'sei': '8.25'}",CHEMBL4287992,,CHEMBL4287992,7.00,False,http://www.openphacts.org/units/Nanomolar,3108230,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711871,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C#N)Nc1nc(Nc2ccnc(C(C)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '15.54', 'le': '0.30', 'lle': '2.47', 'sei': '6.23'}",CHEMBL4293552,,CHEMBL4293552,7.00,False,http://www.openphacts.org/units/Nanomolar,3108231,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711872,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCOCC3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '15.27', 'le': '0.30', 'lle': '2.47', 'sei': '8.25'}",CHEMBL4292464,,CHEMBL4292464,7.00,False,http://www.openphacts.org/units/Nanomolar,3108233,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711873,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3nccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '16.69', 'le': '0.33', 'lle': '3.53', 'sei': '8.25'}",CHEMBL4293462,,CHEMBL4293462,7.30,False,http://www.openphacts.org/units/Nanomolar,3108234,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711874,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC2(CC(Nc3nc(Nc4ccnc(C(F)(F)F)c4)nc(-c4cccc(C(F)(F)F)n4)n3)C2)C1,,,CHEMBL4257005,,,"{'bei': '13.17', 'le': '0.26', 'lle': '0.90', 'sei': '7.91'}",CHEMBL4288364,,CHEMBL4288364,7.00,False,http://www.openphacts.org/units/Nanomolar,3108235,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711875,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3nc(F)ccc3F)n2)c1,,,CHEMBL4257005,,,"{'bei': '16.07', 'le': '0.31', 'lle': '2.08', 'sei': '9.65'}",CHEMBL4285080,,CHEMBL4285080,7.30,False,http://www.openphacts.org/units/Nanomolar,3108238,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711876,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)C4)nc(-c4nccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '14.50', 'le': '0.28', 'lle': '2.66', 'sei': '5.83'}",CHEMBL4279855,,CHEMBL4279855,7.30,False,http://www.openphacts.org/units/Nanomolar,3108239,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711877,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NCC(C)(C)C#N)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '17.27', 'le': '0.33', 'lle': '2.88', 'sei': '7.04'}",CHEMBL4278807,,CHEMBL4278807,7.00,False,http://www.openphacts.org/units/Nanomolar,3108240,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711878,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,O=C(c1ccccc1)N1CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '13.12', 'le': '0.25', 'lle': '2.12', 'sei': '7.30'}",CHEMBL4283985,,CHEMBL4283985,7.00,False,http://www.openphacts.org/units/Nanomolar,3108241,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711879,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC2(CC(Nc3nc(NC4CC5(C4)CC(F)(F)C5)nc(-c4cccc(Cl)n4)n3)C2)C1,,,CHEMBL4257005,,,"{'bei': '14.50', 'le': '0.29', 'lle': '1.43', 'sei': '9.26'}",CHEMBL4285110,,CHEMBL4285110,7.00,False,http://www.openphacts.org/units/Nanomolar,3108243,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711880,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CS(=O)(=O)N1CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '13.07', 'le': '0.27', 'lle': '3.22', 'sei': '6.19'}",CHEMBL4284068,,CHEMBL4284068,7.00,False,http://www.openphacts.org/units/Nanomolar,3108244,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711881,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C#N)CNc1nc(Nc2ccnc(C(C)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '14.63', 'le': '0.28', 'lle': '1.84', 'sei': '6.23'}",CHEMBL4278435,,CHEMBL4278435,7.00,False,http://www.openphacts.org/units/Nanomolar,3108245,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711882,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2nccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4285495,,CHEMBL4285495,,False,http://www.openphacts.org/units/Nanomolar,3108246,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711883,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3ccnc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '14.19', 'le': '0.28', 'lle': '1.67', 'sei': '7.91'}",CHEMBL4294396,,CHEMBL4294396,7.00,False,http://www.openphacts.org/units/Nanomolar,3108248,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711884,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(CC#N)Nc1nc(NC(C)CC#N)nc(-c2cccc(Cl)n2)n1,,,CHEMBL4257005,,,"{'bei': '19.62', 'le': '0.38', 'lle': '3.98', 'sei': '5.68'}",CHEMBL4288016,,CHEMBL4288016,7.00,False,http://www.openphacts.org/units/Nanomolar,3108249,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711885,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc([C@H]2C[C@@H](Nc3nc(N[C@H]4C[C@@H](c5ccc(F)cc5)C4)nc(-c4cccc(C(F)(F)F)n4)n3)C2)cc1,,,CHEMBL4257005,,,"{'bei': '12.67', 'le': '0.24', 'lle': '0.05', 'sei': '9.26'}",CHEMBL4291957,,CHEMBL4291957,7.00,False,http://www.openphacts.org/units/Nanomolar,3108250,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711886,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N1CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '14.01', 'le': '0.27', 'lle': '2.63', 'sei': '7.30'}",CHEMBL4292328,,CHEMBL4292328,7.00,False,http://www.openphacts.org/units/Nanomolar,3108251,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711887,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)OC(=O)N1CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '12.55', 'le': '0.25', 'lle': '1.25', 'sei': '6.66'}",CHEMBL4277506,,CHEMBL4277506,7.00,False,http://www.openphacts.org/units/Nanomolar,3108252,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711888,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc(F)c(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '15.20', 'le': '0.30', 'lle': '1.81', 'sei': '9.26'}",CHEMBL4278869,,CHEMBL4278869,7.00,False,http://www.openphacts.org/units/Nanomolar,3108254,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711889,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-n2cc(I)cn2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '15.93', 'le': '0.40', 'lle': '3.92', 'sei': '8.69'}",CHEMBL4293859,,CHEMBL4293859,7.00,False,http://www.openphacts.org/units/Nanomolar,3108257,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711890,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCN(Cc4ccccc4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4294899,,CHEMBL4294899,,False,http://www.openphacts.org/units/Nanomolar,3108258,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711891,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)Nc1nc(Nc2ccnc(C(C)(F)F)c2)nc(-c2nccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4282925,,CHEMBL4282925,,False,http://www.openphacts.org/units/Nanomolar,3108267,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711892,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3nccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '14.19', 'le': '0.28', 'lle': '1.67', 'sei': '7.91'}",CHEMBL4288632,,CHEMBL4288632,7.00,False,http://www.openphacts.org/units/Nanomolar,3108271,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711893,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(OC(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4288266,,CHEMBL4288266,,False,http://www.openphacts.org/units/Nanomolar,3108274,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711894,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3c[nH]nc3C(F)(F)F)n2)CC1,,,CHEMBL4257005,,,"{'bei': '14.54', 'le': '0.29', 'lle': '1.74', 'sei': '7.66'}",CHEMBL4283186,,CHEMBL4283186,7.00,False,http://www.openphacts.org/units/Nanomolar,3108275,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711895,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)Nc1nc(Nc2ccnc(C(C)(F)F)c2)nc(-c2nccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4284203,,CHEMBL4284203,,False,http://www.openphacts.org/units/Nanomolar,3108276,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711896,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)co1,,,CHEMBL4257005,,,,CHEMBL4286024,,CHEMBL4286024,,False,http://www.openphacts.org/units/Nanomolar,3108279,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711897,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-n3cc(Cl)cn3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '15.63', 'le': '0.32', 'lle': '2.31', 'sei': '8.69'}",CHEMBL4285024,,CHEMBL4285024,7.00,False,http://www.openphacts.org/units/Nanomolar,3108280,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711898,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)no1,,,CHEMBL4257005,,,,CHEMBL4280060,,CHEMBL4280060,,False,http://www.openphacts.org/units/Nanomolar,3108289,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711899,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(F)c(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4282630,,CHEMBL4282630,,False,http://www.openphacts.org/units/Nanomolar,3108299,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711900,[],CHEMBL4257008,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132C mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 30 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)CNc1nc(Nc2cc(F)cc(F)c2)nc(-c2nccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4277108,,CHEMBL4277108,,False,http://www.openphacts.org/units/Nanomolar,3108303,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711901,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cccc(-c2nc(NCC3CC3)nc(NCC3CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4292293,,CHEMBL4292293,,False,http://www.openphacts.org/units/Nanomolar,3108003,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711902,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4278828,,CHEMBL4278828,,False,http://www.openphacts.org/units/Nanomolar,3108004,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711903,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C)Nc1nc(NC(C)C)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '20.57', 'le': '0.40', 'lle': '3.41', 'sei': '9.26'}",CHEMBL4293316,,CHEMBL4293316,7.00,False,http://www.openphacts.org/units/Nanomolar,3108005,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711904,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)Nc1nc(NC(C)(C)C)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '19.82', 'le': '0.38', 'lle': '2.93', 'sei': '9.65'}",CHEMBL4284907,,CHEMBL4284907,7.30,False,http://www.openphacts.org/units/Nanomolar,3108006,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711905,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NCC(N)=O)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4283896,,CHEMBL4283896,,False,http://www.openphacts.org/units/Nanomolar,3108007,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711906,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2ccccc2F)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4286059,,CHEMBL4286059,,False,http://www.openphacts.org/units/Nanomolar,3108008,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711907,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cccc(-c2nc(NCC3CCC3)nc(NCC3CCC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '17.84', 'le': '0.34', 'lle': '2.62', 'sei': '9.26'}",CHEMBL4287094,,CHEMBL4287094,7.00,False,http://www.openphacts.org/units/Nanomolar,3108009,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
Not Active,18711908,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(F)c(-c2nc(N[C@H](C)C3CC3)nc(N[C@H](C)C3CC3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4290152,,CHEMBL4290152,,False,,3108010,,38,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
,18711909,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cccc(-c2nc(NC3CCC3)nc(NC3CCC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '20.04', 'le': '0.38', 'lle': '3.42', 'sei': '9.65'}",CHEMBL4291180,,CHEMBL4291180,7.30,False,http://www.openphacts.org/units/Nanomolar,3108011,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711910,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NCC(C)(C)O)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4280581,,CHEMBL4280581,,False,http://www.openphacts.org/units/Nanomolar,3108012,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711911,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(O)c2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '20.62', 'le': '0.38', 'lle': '3.33', 'sei': '8.44'}",CHEMBL4281641,,CHEMBL4281641,7.00,False,http://www.openphacts.org/units/Nanomolar,3108013,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711912,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(O)CNc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4282029,,CHEMBL4282029,,False,http://www.openphacts.org/units/Nanomolar,3108014,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711913,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C)C(C)Nc1nc(NC(C)C(C)C)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4285713,,CHEMBL4285713,,False,http://www.openphacts.org/units/Nanomolar,3108015,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711914,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(O)CNc1nc(NCC(C)O)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4295153,,CHEMBL4295153,,False,http://www.openphacts.org/units/Nanomolar,3108016,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711915,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(=O)CNc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4290056,,CHEMBL4290056,,False,http://www.openphacts.org/units/Nanomolar,3108017,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711916,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(CO)c2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4292657,,CHEMBL4292657,,False,http://www.openphacts.org/units/Nanomolar,3108018,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711917,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C)[C@H](C)Nc1nc(N[C@@H](C)C(C)C)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '18.42', 'le': '0.36', 'lle': '2.43', 'sei': '9.65'}",CHEMBL4291634,,CHEMBL4291634,7.30,False,http://www.openphacts.org/units/Nanomolar,3108019,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711918,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C)[C@@H](C)Nc1nc(N[C@H](C)C(C)C)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4288565,,CHEMBL4288565,,False,http://www.openphacts.org/units/Nanomolar,3108020,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711919,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CCC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CCC1,,,CHEMBL4257005,,,"{'bei': '17.36', 'le': '0.33', 'lle': '2.15', 'sei': '9.65'}",CHEMBL4287525,,CHEMBL4287525,7.30,False,http://www.openphacts.org/units/Nanomolar,3108021,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711920,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)c1ccccc1,,,CHEMBL4257005,,,"{'bei': '17.04', 'le': '0.32', 'lle': '1.96', 'sei': '9.65'}",CHEMBL4287161,,CHEMBL4287161,7.30,False,http://www.openphacts.org/units/Nanomolar,3108022,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711921,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NCc2ccccc2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4280345,,CHEMBL4280345,,False,http://www.openphacts.org/units/Nanomolar,3108023,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711922,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)c1ccccc1,,,CHEMBL4257005,,,"{'bei': '17.04', 'le': '0.32', 'lle': '1.96', 'sei': '9.65'}",CHEMBL4283130,,CHEMBL4283130,7.30,False,http://www.openphacts.org/units/Nanomolar,3108024,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711923,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@@H]2C[C@H]2c2ccccc2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '16.58', 'le': '0.31', 'lle': '2.17', 'sei': '9.65'}",CHEMBL4282086,,CHEMBL4282086,7.30,False,http://www.openphacts.org/units/Nanomolar,3108025,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711924,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NCc2ccccn2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4277052,,CHEMBL4277052,,False,http://www.openphacts.org/units/Nanomolar,3108026,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711925,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)c1ccccn1,,,CHEMBL4257005,,,,CHEMBL4294559,,CHEMBL4294559,,False,http://www.openphacts.org/units/Nanomolar,3108027,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711926,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(N[C@H](C)c2ccccc2)nc(-c2cccc(C(F)(F)F)n2)n1)c1ccccc1,,,CHEMBL4257005,,,"{'bei': '15.07', 'le': '0.28', 'lle': '0.70', 'sei': '9.26'}",CHEMBL4281837,,CHEMBL4281837,7.00,False,http://www.openphacts.org/units/Nanomolar,3108028,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711927,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)c1cccc(C(F)(F)F)c1,,,CHEMBL4257005,,,"{'bei': '14.71', 'le': '0.28', 'lle': '0.95', 'sei': '9.65'}",CHEMBL4282861,,CHEMBL4282861,7.30,False,http://www.openphacts.org/units/Nanomolar,3108029,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711928,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)c1cccc(F)c1,,,CHEMBL4257005,,,"{'bei': '16.35', 'le': '0.31', 'lle': '1.82', 'sei': '9.65'}",CHEMBL4277726,,CHEMBL4277726,7.30,False,http://www.openphacts.org/units/Nanomolar,3108030,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711929,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NC(=O)c2ccccc2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '16.34', 'le': '0.31', 'lle': '2.58', 'sei': '7.55'}",CHEMBL4289215,,CHEMBL4289215,7.00,False,http://www.openphacts.org/units/Nanomolar,3108031,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711930,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NC2(c3ccccc3)CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '16.58', 'le': '0.31', 'lle': '2.04', 'sei': '9.65'}",CHEMBL4292196,,CHEMBL4292196,7.30,False,http://www.openphacts.org/units/Nanomolar,3108032,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711931,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4277352,,CHEMBL4277352,,False,http://www.openphacts.org/units/Nanomolar,3108033,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711932,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(F)c(-c2nc(NC(C)C)nc(NC(C)(C)C#N)n2)c1,,,CHEMBL4257005,,,,CHEMBL4290773,,CHEMBL4290773,,False,http://www.openphacts.org/units/Nanomolar,3108034,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711933,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(N[C@@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4291820,,CHEMBL4291820,,False,http://www.openphacts.org/units/Nanomolar,3108035,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711934,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4286693,,CHEMBL4286693,,False,http://www.openphacts.org/units/Nanomolar,3108036,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711935,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C)Nc1nc(NC(C)(C)C#N)nc(-c2cc(O)ccc2F)n1,,,CHEMBL4257005,,,,CHEMBL4287732,,CHEMBL4287732,,False,http://www.openphacts.org/units/Nanomolar,3108037,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711936,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cccc(-c2nc(NC3CC4CC4C3)nc(NC3CC4CC4C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4284394,,CHEMBL4284394,,False,http://www.openphacts.org/units/Nanomolar,3108038,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711937,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NC(C)(C)C#N)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '18.65', 'le': '0.36', 'lle': '3.42', 'sei': '7.34'}",CHEMBL4283396,,CHEMBL4283396,7.30,False,http://www.openphacts.org/units/Nanomolar,3108039,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711938,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NC2CCOC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '18.51', 'le': '0.36', 'lle': '3.94', 'sei': '8.60'}",CHEMBL4288448,,CHEMBL4288448,7.30,False,http://www.openphacts.org/units/Nanomolar,3108040,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711939,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CCCC(C)Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4295085,,CHEMBL4295085,,False,http://www.openphacts.org/units/Nanomolar,3108041,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711940,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C#N)Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '19.35', 'le': '0.37', 'lle': '3.81', 'sei': '7.34'}",CHEMBL4289876,,CHEMBL4289876,7.30,False,http://www.openphacts.org/units/Nanomolar,3108042,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711941,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '14.83', 'le': '0.29', 'lle': '1.37', 'sei': '9.65'}",CHEMBL4288840,,CHEMBL4288840,7.30,False,http://www.openphacts.org/units/Nanomolar,3108043,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711942,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H]2CCCC[C@@H]2O)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '17.28', 'le': '0.33', 'lle': '3.42', 'sei': '7.62'}",CHEMBL4293942,,CHEMBL4293942,7.30,False,http://www.openphacts.org/units/Nanomolar,3108044,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711943,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H]2CCC[C@H]2O)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '17.14', 'le': '0.33', 'lle': '3.51', 'sei': '7.30'}",CHEMBL4292892,,CHEMBL4292892,7.00,False,http://www.openphacts.org/units/Nanomolar,3108045,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711944,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,COCC(C)Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '17.66', 'le': '0.34', 'lle': '3.39', 'sei': '8.25'}",CHEMBL4279452,,CHEMBL4279452,7.00,False,http://www.openphacts.org/units/Nanomolar,3108046,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711945,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(Cl)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4278420,,CHEMBL4278420,,False,http://www.openphacts.org/units/Nanomolar,3108047,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711946,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CCN(CC)c1nc(N[C@H](C)C2CC2)nc(-c2cccc(Cl)n2)n1,,,CHEMBL4257005,,,,CHEMBL4294956,,CHEMBL4294956,,False,http://www.openphacts.org/units/Nanomolar,3108048,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711947,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C(=O)O,,,CHEMBL4257005,,,,CHEMBL4292928,,CHEMBL4292928,,False,http://www.openphacts.org/units/Nanomolar,3108049,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711948,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C(=O)N(C)C,,,CHEMBL4257005,,,,CHEMBL4293309,,CHEMBL4293309,,False,http://www.openphacts.org/units/Nanomolar,3108050,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711949,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(CO)Nc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4287607,,CHEMBL4287607,,False,http://www.openphacts.org/units/Nanomolar,3108051,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711950,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NC2CCC(C)(C)CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4278831,,CHEMBL4278831,,False,http://www.openphacts.org/units/Nanomolar,3108052,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711951,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(N3CCC3)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4279901,,CHEMBL4279901,,False,http://www.openphacts.org/units/Nanomolar,3108053,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711952,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C)C(C)Nc1nc(NC(C)C(C)C)nc(-c2cccc(N)n2)n1,,,CHEMBL4257005,,,"{'bei': '21.26', 'le': '0.40', 'lle': '3.87', 'sei': '7.18'}",CHEMBL4281163,,CHEMBL4281163,7.30,False,http://www.openphacts.org/units/Nanomolar,3108075,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711953,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C)CNc1nc(NC(C)(C)C#N)nc(-c2cc(O)ccc2F)n1,,,CHEMBL4257005,,,,CHEMBL4282686,,CHEMBL4282686,,False,http://www.openphacts.org/units/Nanomolar,3108076,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711954,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1cc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '17.88', 'le': '0.34', 'lle': '2.02', 'sei': '11.16'}",CHEMBL4282906,,CHEMBL4282906,7.00,False,http://www.openphacts.org/units/Nanomolar,3108389,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711955,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1cc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '17.88', 'le': '0.34', 'lle': '2.02', 'sei': '11.16'}",CHEMBL4286585,,CHEMBL4286585,7.00,False,http://www.openphacts.org/units/Nanomolar,3108390,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711956,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1cc(N[C@@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '17.88', 'le': '0.34', 'lle': '2.02', 'sei': '11.16'}",CHEMBL4286947,,CHEMBL4286947,7.00,False,http://www.openphacts.org/units/Nanomolar,3108391,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711957,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1cc(NC(C)(C)C)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '18.45', 'le': '0.35', 'lle': '2.02', 'sei': '11.16'}",CHEMBL4287998,,CHEMBL4287998,7.00,False,http://www.openphacts.org/units/Nanomolar,3108392,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711958,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cccc(-c2nc(NCC3CC3)cc(NCC3CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4292065,,CHEMBL4292065,,False,http://www.openphacts.org/units/Nanomolar,3108394,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711959,[],CHEMBL4257009,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1cc(NC(C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '17.88', 'le': '0.34', 'lle': '2.02', 'sei': '11.16'}",CHEMBL4295139,,CHEMBL4295139,7.00,False,http://www.openphacts.org/units/Nanomolar,3108395,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711960,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cccc(-c2nc(NCC3CC3)nc(NCC3CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4292293,,CHEMBL4292293,,False,http://www.openphacts.org/units/Nanomolar,3108003,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711961,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4278828,,CHEMBL4278828,,False,http://www.openphacts.org/units/Nanomolar,3108004,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711962,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C)Nc1nc(NC(C)C)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '21.45', 'le': '0.42', 'lle': '3.71', 'sei': '9.65'}",CHEMBL4293316,,CHEMBL4293316,7.30,False,http://www.openphacts.org/units/Nanomolar,3108005,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711963,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)Nc1nc(NC(C)(C)C)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '19.82', 'le': '0.38', 'lle': '2.93', 'sei': '9.65'}",CHEMBL4284907,,CHEMBL4284907,7.30,False,http://www.openphacts.org/units/Nanomolar,3108006,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
Not Active,18711964,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NCC(N)=O)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4283896,,CHEMBL4283896,,False,,3108007,,38,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
,18711965,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2ccccc2F)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '20.50', 'le': '0.38', 'lle': '2.90', 'sei': '11.16'}",CHEMBL4286059,,CHEMBL4286059,7.00,False,http://www.openphacts.org/units/Nanomolar,3108008,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711966,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cccc(-c2nc(NCC3CCC3)nc(NCC3CCC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4287094,,CHEMBL4287094,,False,http://www.openphacts.org/units/Nanomolar,3108009,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711967,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(F)c(-c2nc(N[C@H](C)C3CC3)nc(N[C@H](C)C3CC3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4290152,,CHEMBL4290152,,False,http://www.openphacts.org/units/Nanomolar,3108010,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711968,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cccc(-c2nc(NC3CCC3)nc(NC3CCC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '19.21', 'le': '0.37', 'lle': '3.12', 'sei': '9.26'}",CHEMBL4291180,,CHEMBL4291180,7.00,False,http://www.openphacts.org/units/Nanomolar,3108011,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711969,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NCC(C)(C)O)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4280581,,CHEMBL4280581,,False,http://www.openphacts.org/units/Nanomolar,3108012,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711970,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(O)c2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '21.51', 'le': '0.40', 'lle': '3.63', 'sei': '8.80'}",CHEMBL4281641,,CHEMBL4281641,7.30,False,http://www.openphacts.org/units/Nanomolar,3108013,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711971,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(O)CNc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4282029,,CHEMBL4282029,,False,http://www.openphacts.org/units/Nanomolar,3108014,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711972,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C)C(C)Nc1nc(NC(C)C(C)C)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '18.42', 'le': '0.36', 'lle': '2.43', 'sei': '9.65'}",CHEMBL4285713,,CHEMBL4285713,7.30,False,http://www.openphacts.org/units/Nanomolar,3108015,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711973,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(O)CNc1nc(NCC(C)O)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4295153,,CHEMBL4295153,,False,http://www.openphacts.org/units/Nanomolar,3108016,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711974,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(=O)CNc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4290056,,CHEMBL4290056,,False,http://www.openphacts.org/units/Nanomolar,3108017,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711975,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(CO)c2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4292657,,CHEMBL4292657,,False,http://www.openphacts.org/units/Nanomolar,3108018,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711976,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C)[C@H](C)Nc1nc(N[C@@H](C)C(C)C)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '18.42', 'le': '0.36', 'lle': '2.43', 'sei': '9.65'}",CHEMBL4291634,,CHEMBL4291634,7.30,False,http://www.openphacts.org/units/Nanomolar,3108019,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711977,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C)[C@@H](C)Nc1nc(N[C@H](C)C(C)C)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '18.42', 'le': '0.36', 'lle': '2.43', 'sei': '9.65'}",CHEMBL4288565,,CHEMBL4288565,7.30,False,http://www.openphacts.org/units/Nanomolar,3108020,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711978,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CCC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CCC1,,,CHEMBL4257005,,,"{'bei': '17.36', 'le': '0.33', 'lle': '2.15', 'sei': '9.65'}",CHEMBL4287525,,CHEMBL4287525,7.30,False,http://www.openphacts.org/units/Nanomolar,3108021,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711979,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)c1ccccc1,,,CHEMBL4257005,,,"{'bei': '17.04', 'le': '0.32', 'lle': '1.96', 'sei': '9.65'}",CHEMBL4287161,,CHEMBL4287161,7.30,False,http://www.openphacts.org/units/Nanomolar,3108022,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711980,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NCc2ccccc2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4280345,,CHEMBL4280345,,False,http://www.openphacts.org/units/Nanomolar,3108023,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711981,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)c1ccccc1,,,CHEMBL4257005,,,"{'bei': '16.34', 'le': '0.31', 'lle': '1.66', 'sei': '9.26'}",CHEMBL4283130,,CHEMBL4283130,7.00,False,http://www.openphacts.org/units/Nanomolar,3108024,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711982,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@@H]2C[C@H]2c2ccccc2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '16.58', 'le': '0.31', 'lle': '2.17', 'sei': '9.65'}",CHEMBL4282086,,CHEMBL4282086,7.30,False,http://www.openphacts.org/units/Nanomolar,3108025,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711983,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NCc2ccccn2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4277052,,CHEMBL4277052,,False,http://www.openphacts.org/units/Nanomolar,3108026,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711984,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)c1ccccn1,,,CHEMBL4257005,,,,CHEMBL4294559,,CHEMBL4294559,,False,http://www.openphacts.org/units/Nanomolar,3108027,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711985,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(N[C@H](C)c2ccccc2)nc(-c2cccc(C(F)(F)F)n2)n1)c1ccccc1,,,CHEMBL4257005,,,,CHEMBL4281837,,CHEMBL4281837,,False,http://www.openphacts.org/units/Nanomolar,3108028,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711986,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)c1cccc(C(F)(F)F)c1,,,CHEMBL4257005,,,"{'bei': '14.10', 'le': '0.27', 'lle': '0.65', 'sei': '9.26'}",CHEMBL4282861,,CHEMBL4282861,7.00,False,http://www.openphacts.org/units/Nanomolar,3108029,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711987,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)c1cccc(F)c1,,,CHEMBL4257005,,,"{'bei': '16.35', 'le': '0.31', 'lle': '1.82', 'sei': '9.65'}",CHEMBL4277726,,CHEMBL4277726,7.30,False,http://www.openphacts.org/units/Nanomolar,3108030,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711988,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NC(=O)c2ccccc2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4289215,,CHEMBL4289215,,False,http://www.openphacts.org/units/Nanomolar,3108031,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711989,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NC2(c3ccccc3)CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '15.89', 'le': '0.30', 'lle': '1.74', 'sei': '9.26'}",CHEMBL4292196,,CHEMBL4292196,7.00,False,http://www.openphacts.org/units/Nanomolar,3108032,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711990,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4277352,,CHEMBL4277352,,False,http://www.openphacts.org/units/Nanomolar,3108033,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18711991,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(F)c(-c2nc(NC(C)C)nc(NC(C)(C)C#N)n2)c1,,,CHEMBL4257005,,,,CHEMBL4290773,,CHEMBL4290773,,False,http://www.openphacts.org/units/Nanomolar,3108034,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711992,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(N[C@@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '18.60', 'le': '0.36', 'lle': '2.93', 'sei': '9.65'}",CHEMBL4291820,,CHEMBL4291820,7.30,False,http://www.openphacts.org/units/Nanomolar,3108035,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711993,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '18.60', 'le': '0.36', 'lle': '2.93', 'sei': '9.65'}",CHEMBL4286693,,CHEMBL4286693,7.30,False,http://www.openphacts.org/units/Nanomolar,3108036,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711994,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C)Nc1nc(NC(C)(C)C#N)nc(-c2cc(O)ccc2F)n1,,,CHEMBL4257005,,,,CHEMBL4287732,,CHEMBL4287732,,False,http://www.openphacts.org/units/Nanomolar,3108037,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711995,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cccc(-c2nc(NC3CC4CC4C3)nc(NC3CC4CC4C3)n2)n1,,,CHEMBL4257005,,,"{'bei': '17.53', 'le': '0.33', 'lle': '2.93', 'sei': '9.65'}",CHEMBL4284394,,CHEMBL4284394,7.30,False,http://www.openphacts.org/units/Nanomolar,3108038,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711996,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NC(C)(C)C#N)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4283396,,CHEMBL4283396,,False,http://www.openphacts.org/units/Nanomolar,3108039,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18711997,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NC2CCOC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '17.75', 'le': '0.34', 'lle': '3.64', 'sei': '8.25'}",CHEMBL4288448,,CHEMBL4288448,7.00,False,http://www.openphacts.org/units/Nanomolar,3108040,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18711998,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CCCC(C)Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '18.51', 'le': '0.36', 'lle': '2.54', 'sei': '9.65'}",CHEMBL4295085,,CHEMBL4295085,7.30,False,http://www.openphacts.org/units/Nanomolar,3108041,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18711999,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C#N)Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '19.35', 'le': '0.37', 'lle': '3.81', 'sei': '7.34'}",CHEMBL4289876,,CHEMBL4289876,7.30,False,http://www.openphacts.org/units/Nanomolar,3108042,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712000,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4288840,,CHEMBL4288840,,False,http://www.openphacts.org/units/Nanomolar,3108043,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712001,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H]2CCCC[C@@H]2O)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '16.57', 'le': '0.32', 'lle': '3.12', 'sei': '7.30'}",CHEMBL4293942,,CHEMBL4293942,7.00,False,http://www.openphacts.org/units/Nanomolar,3108044,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712002,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H]2CCC[C@H]2O)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4292892,,CHEMBL4292892,,False,http://www.openphacts.org/units/Nanomolar,3108045,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712003,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,COCC(C)Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4279452,,CHEMBL4279452,,False,http://www.openphacts.org/units/Nanomolar,3108046,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712004,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(Cl)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '20.34', 'le': '0.40', 'lle': '3.29', 'sei': '9.65'}",CHEMBL4278420,,CHEMBL4278420,7.30,False,http://www.openphacts.org/units/Nanomolar,3108047,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712005,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CCN(CC)c1nc(N[C@H](C)C2CC2)nc(-c2cccc(Cl)n2)n1,,,CHEMBL4257005,,,,CHEMBL4294956,,CHEMBL4294956,,False,http://www.openphacts.org/units/Nanomolar,3108048,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
Not Active,18712006,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C(=O)O,,,CHEMBL4257005,,,,CHEMBL4292928,,CHEMBL4292928,,False,,3108049,,38,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
Not Active,18712007,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C(=O)N(C)C,,,CHEMBL4257005,,,,CHEMBL4293309,,CHEMBL4293309,,False,,3108050,,38,False,,,IC50,,,,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,,,,
,18712008,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(CO)Nc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4287607,,CHEMBL4287607,,False,http://www.openphacts.org/units/Nanomolar,3108051,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712009,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NC2CCC(C)(C)CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '16.80', 'le': '0.32', 'lle': '1.76', 'sei': '9.65'}",CHEMBL4278831,,CHEMBL4278831,7.30,False,http://www.openphacts.org/units/Nanomolar,3108052,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712010,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(N3CCC3)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4279901,,CHEMBL4279901,,False,http://www.openphacts.org/units/Nanomolar,3108053,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712011,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C)C(C)Nc1nc(NC(C)C(C)C)nc(-c2cccc(N)n2)n1,,,CHEMBL4257005,,,"{'bei': '21.26', 'le': '0.40', 'lle': '3.87', 'sei': '7.18'}",CHEMBL4281163,,CHEMBL4281163,7.30,False,http://www.openphacts.org/units/Nanomolar,3108075,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712012,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C)CNc1nc(NC(C)(C)C#N)nc(-c2cc(O)ccc2F)n1,,,CHEMBL4257005,,,,CHEMBL4282686,,CHEMBL4282686,,False,http://www.openphacts.org/units/Nanomolar,3108076,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712013,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1cc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '17.88', 'le': '0.34', 'lle': '2.02', 'sei': '11.16'}",CHEMBL4282906,,CHEMBL4282906,7.00,False,http://www.openphacts.org/units/Nanomolar,3108389,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712014,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1cc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '17.88', 'le': '0.34', 'lle': '2.02', 'sei': '11.16'}",CHEMBL4286585,,CHEMBL4286585,7.00,False,http://www.openphacts.org/units/Nanomolar,3108390,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712015,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1cc(N[C@@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4286947,,CHEMBL4286947,,False,http://www.openphacts.org/units/Nanomolar,3108391,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712016,[],CHEMBL4257010,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 90 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1cc(NC(C)(C)C)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4287998,,CHEMBL4287998,,False,http://www.openphacts.org/units/Nanomolar,3108392,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712017,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4279047,,CHEMBL4279047,,False,http://www.openphacts.org/units/Nanomolar,3108079,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712018,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280231,,CHEMBL4280231,,False,http://www.openphacts.org/units/Nanomolar,3108094,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712019,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4290561,,CHEMBL4290561,,False,http://www.openphacts.org/units/Nanomolar,3108311,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712020,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cncc(C(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4277117,,CHEMBL4277117,,False,http://www.openphacts.org/units/Nanomolar,3108312,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712021,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cncc(C(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4294626,,CHEMBL4294626,,False,http://www.openphacts.org/units/Nanomolar,3108313,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712022,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)CC4)nc(-c4cncc(C(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '14.62', 'le': '0.28', 'lle': '2.35', 'sei': '5.83'}",CHEMBL4281229,,CHEMBL4281229,7.30,False,http://www.openphacts.org/units/Nanomolar,3108314,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712023,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC[C@H](Nc1nc(N[C@@H](CC)C(F)(F)F)nc(-c2cncc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4280159,,CHEMBL4280159,,False,http://www.openphacts.org/units/Nanomolar,3108315,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712024,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3ccnc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '13.82', 'le': '0.27', 'lle': '1.90', 'sei': '6.90'}",CHEMBL4287227,,CHEMBL4287227,7.00,False,http://www.openphacts.org/units/Nanomolar,3108316,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712025,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@H]4CCC(F)(F)C4)nc(-c4ccnc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '13.90', 'le': '0.27', 'lle': '2.36', 'sei': '5.59'}",CHEMBL4286181,,CHEMBL4286181,7.00,False,http://www.openphacts.org/units/Nanomolar,3108317,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712026,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@@H]4CCC(F)(F)C4)nc(-c4ccnc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '13.90', 'le': '0.27', 'lle': '2.36', 'sei': '5.59'}",CHEMBL4294595,,CHEMBL4294595,7.00,False,http://www.openphacts.org/units/Nanomolar,3108318,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712027,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3ccnc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '13.82', 'le': '0.27', 'lle': '1.90', 'sei': '6.90'}",CHEMBL4277087,,CHEMBL4277087,7.00,False,http://www.openphacts.org/units/Nanomolar,3108319,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712028,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2ccnc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,"{'bei': '16.25', 'le': '0.33', 'lle': '3.23', 'sei': '8.25'}",CHEMBL4282694,,CHEMBL4282694,7.30,False,http://www.openphacts.org/units/Nanomolar,3108320,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712029,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC[C@H](Nc1nc(N[C@@H](CC)C(F)(F)F)nc(-c2ccnc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4283760,,CHEMBL4283760,,False,http://www.openphacts.org/units/Nanomolar,3108321,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712030,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC[C@H](Nc1nc(N[C@@H](CC)C(F)(F)F)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4278576,,CHEMBL4278576,,False,http://www.openphacts.org/units/Nanomolar,3108322,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712031,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cccc(C(C)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4282325,,CHEMBL4282325,,False,http://www.openphacts.org/units/Nanomolar,3108323,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712032,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cccc(C(C)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4277173,,CHEMBL4277173,,False,http://www.openphacts.org/units/Nanomolar,3108324,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712033,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4278189,,CHEMBL4278189,,False,http://www.openphacts.org/units/Nanomolar,3108325,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712034,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@@H]4CCC(F)(F)C4)nc(-n4ccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4289705,,CHEMBL4289705,,False,http://www.openphacts.org/units/Nanomolar,3108326,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712035,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4286920,,CHEMBL4286920,,False,http://www.openphacts.org/units/Nanomolar,3108327,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712036,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4281016,,CHEMBL4281016,,False,http://www.openphacts.org/units/Nanomolar,3108328,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712037,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3nc(C(F)(F)F)cs3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280455,,CHEMBL4280455,,False,http://www.openphacts.org/units/Nanomolar,3108329,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712038,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cccc(-c2nc(NCC3CC3(F)F)nc(NCC3CC3(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '16.73', 'le': '0.33', 'lle': '3.21', 'sei': '9.65'}",CHEMBL4276915,,CHEMBL4276915,7.30,False,http://www.openphacts.org/units/Nanomolar,3108330,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712039,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cc(Nc2nc(N[C@@H]3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4294406,,CHEMBL4294406,,False,http://www.openphacts.org/units/Nanomolar,3108331,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712040,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4294324,,CHEMBL4294324,,False,http://www.openphacts.org/units/Nanomolar,3108332,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712041,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1csc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '14.76', 'le': '0.30', 'lle': '1.21', 'sei': '9.65'}",CHEMBL4283829,,CHEMBL4283829,7.30,False,http://www.openphacts.org/units/Nanomolar,3108333,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712042,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4282432,,CHEMBL4282432,,False,http://www.openphacts.org/units/Nanomolar,3108334,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712043,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(-c3ccccc3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4281400,,CHEMBL4281400,,False,http://www.openphacts.org/units/Nanomolar,3108335,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712044,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cc(Nc2nc(N[C@H]3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4284001,,CHEMBL4284001,,False,http://www.openphacts.org/units/Nanomolar,3108336,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712045,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cc(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,"{'bei': '14.16', 'le': '0.28', 'lle': '1.11', 'sei': '8.25'}",CHEMBL4280252,,CHEMBL4280252,7.30,False,http://www.openphacts.org/units/Nanomolar,3108337,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712046,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NCC4CC4(F)F)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '14.95', 'le': '0.28', 'lle': '2.59', 'sei': '6.50'}",CHEMBL4288747,,CHEMBL4288747,7.30,False,http://www.openphacts.org/units/Nanomolar,3108338,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712047,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC[C@H](Nc1nc(N[C@@H](CC)C(F)(F)F)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4289800,,CHEMBL4289800,,False,http://www.openphacts.org/units/Nanomolar,3108339,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712048,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(-c3ccc(Cl)cc3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,"{'bei': '13.52', 'le': '0.27', 'lle': '0.53', 'sei': '8.25'}",CHEMBL4290162,,CHEMBL4290162,7.30,False,http://www.openphacts.org/units/Nanomolar,3108340,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712049,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cc(Nc2nc(NCC3CC3(F)F)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,"{'bei': '14.86', 'le': '0.29', 'lle': '2.12', 'sei': '8.25'}",CHEMBL4283537,,CHEMBL4283537,7.30,False,http://www.openphacts.org/units/Nanomolar,3108341,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712050,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cncc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4294218,,CHEMBL4294218,,False,http://www.openphacts.org/units/Nanomolar,3108342,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712051,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cncc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4276712,,CHEMBL4276712,,False,http://www.openphacts.org/units/Nanomolar,3108343,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712052,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(N[C@H]3CCC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4287603,,CHEMBL4287603,,False,http://www.openphacts.org/units/Nanomolar,3108344,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712053,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(N[C@@H]3CCC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4288650,,CHEMBL4288650,,False,http://www.openphacts.org/units/Nanomolar,3108345,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712054,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cncc(-c2nc(NC3CCC(F)(F)C3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4291708,,CHEMBL4291708,,False,http://www.openphacts.org/units/Nanomolar,3108346,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712055,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(-c3ccc(F)cc3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4292727,,CHEMBL4292727,,False,http://www.openphacts.org/units/Nanomolar,3108347,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712056,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cccc(-c2nc(Nc3ccnc(C4(C#N)CC4)c3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4277708,,CHEMBL4277708,,False,http://www.openphacts.org/units/Nanomolar,3108348,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712057,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@H]4CCC(F)(F)C4)nc(-c4cncc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4295243,,CHEMBL4295243,,False,http://www.openphacts.org/units/Nanomolar,3108349,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712058,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cncc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '14.92', 'le': '0.29', 'lle': '1.88', 'sei': '8.25'}",CHEMBL4281812,,CHEMBL4281812,7.30,False,http://www.openphacts.org/units/Nanomolar,3108350,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712059,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@@H]4CCC(F)(F)C4)nc(-c4nccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '13.90', 'le': '0.27', 'lle': '2.36', 'sei': '5.59'}",CHEMBL4280732,,CHEMBL4280732,7.00,False,http://www.openphacts.org/units/Nanomolar,3108351,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712060,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@H]4CCC(F)(F)C4)nc(-c4nccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4282938,,CHEMBL4282938,,False,http://www.openphacts.org/units/Nanomolar,3108352,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712061,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cncc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4281897,,CHEMBL4281897,,False,http://www.openphacts.org/units/Nanomolar,3108353,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712062,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@@H]4CCC(F)(F)C4)nc(-c4cncc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4294826,,CHEMBL4294826,,False,http://www.openphacts.org/units/Nanomolar,3108354,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712063,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cc(Nc2nc(NCC3CC3)nc(-c3nc(C(F)(F)F)cs3)n2)ccn1,,,CHEMBL4257005,,,"{'bei': '15.82', 'le': '0.32', 'lle': '2.31', 'sei': '8.25'}",CHEMBL4283321,,CHEMBL4283321,7.30,False,http://www.openphacts.org/units/Nanomolar,3108355,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712064,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC2(CC(Nc3nc(Nc4ccnc(C(F)(F)F)c4)nc(-c4cncc(C(F)(F)F)n4)n3)C2)C1,,,CHEMBL4257005,,,"{'bei': '13.15', 'le': '0.26', 'lle': '1.51', 'sei': '6.90'}",CHEMBL4293283,,CHEMBL4293283,7.00,False,http://www.openphacts.org/units/Nanomolar,3108356,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712065,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(Nc2nc(N[C@H]3CCC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4292273,,CHEMBL4292273,,False,http://www.openphacts.org/units/Nanomolar,3108357,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712066,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)CC4)nc(-n4ccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '14.44', 'le': '0.28', 'lle': '2.54', 'sei': '6.23'}",CHEMBL4286039,,CHEMBL4286039,7.30,False,http://www.openphacts.org/units/Nanomolar,3108358,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712067,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(-c3ccc(C#N)cc3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,"{'bei': '13.20', 'le': '0.25', 'lle': '1.01', 'sei': '6.23'}",CHEMBL4291004,,CHEMBL4291004,7.00,False,http://www.openphacts.org/units/Nanomolar,3108359,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712068,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cccc(-c2nc(Nc3ccnc(C4(C#N)CC4)c3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4287374,,CHEMBL4287374,,False,http://www.openphacts.org/units/Nanomolar,3108360,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712069,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CC5(C4)CC(F)(F)C5)nc(-c4cncc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '13.79', 'le': '0.26', 'lle': '2.27', 'sei': '5.83'}",CHEMBL4285701,,CHEMBL4285701,7.30,False,http://www.openphacts.org/units/Nanomolar,3108361,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712070,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2cncc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4283555,,CHEMBL4283555,,False,http://www.openphacts.org/units/Nanomolar,3108362,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712071,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cc(Nc2nc(NCC3CC3)nc(-c3cncc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,"{'bei': '15.34', 'le': '0.30', 'lle': '2.67', 'sei': '6.90'}",CHEMBL4284574,,CHEMBL4284574,7.00,False,http://www.openphacts.org/units/Nanomolar,3108363,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712072,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3nc(C(F)(F)F)cs3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4293197,,CHEMBL4293197,,False,http://www.openphacts.org/units/Nanomolar,3108364,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712073,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cncc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4280467,,CHEMBL4280467,,False,http://www.openphacts.org/units/Nanomolar,3108365,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712074,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.83', 'le': '0.29', 'lle': '2.59', 'sei': '7.20'}",CHEMBL4290944,,CHEMBL4290944,7.30,False,http://www.openphacts.org/units/Nanomolar,3108366,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712075,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4294642,,CHEMBL4294642,,False,http://www.openphacts.org/units/Nanomolar,3108367,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712076,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4279960,,CHEMBL4279960,,False,http://www.openphacts.org/units/Nanomolar,3108368,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712077,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-n3ccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4278901,,CHEMBL4278901,,False,http://www.openphacts.org/units/Nanomolar,3108369,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712078,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)CC4)nc(-c4cncc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4294407,,CHEMBL4294407,,False,http://www.openphacts.org/units/Nanomolar,3108370,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712079,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4293370,,CHEMBL4293370,,False,http://www.openphacts.org/units/Nanomolar,3108371,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712080,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)CNc1nc(Nc2cc(F)cc(C(F)(F)F)c2)nc(-c2cccc(C(C)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '14.39', 'le': '0.28', 'lle': '1.87', 'sei': '7.30'}",CHEMBL4289299,,CHEMBL4289299,7.00,False,http://www.openphacts.org/units/Nanomolar,3108372,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712081,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)CNc1nc(Nc2cc(F)cc(C#N)c2)nc(-c2cccc(C(C)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '15.79', 'le': '0.30', 'lle': '3.02', 'sei': '5.85'}",CHEMBL4288968,,CHEMBL4288968,7.00,False,http://www.openphacts.org/units/Nanomolar,3108373,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712082,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(N[C@@H]3CCC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4287914,,CHEMBL4287914,,False,http://www.openphacts.org/units/Nanomolar,3108374,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712083,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4282949,,CHEMBL4282949,,False,http://www.openphacts.org/units/Nanomolar,3108375,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712084,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CC(F)(F)C4)nc(-c4cncc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4281916,,CHEMBL4281916,,False,http://www.openphacts.org/units/Nanomolar,3108376,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712085,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1csc(-c2nc(NC3CCC(F)(F)C3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,"{'bei': '16.14', 'le': '0.33', 'lle': '2.17', 'sei': '9.65'}",CHEMBL4282389,,CHEMBL4282389,7.30,False,http://www.openphacts.org/units/Nanomolar,3108377,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712086,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1csc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4278630,,CHEMBL4278630,,False,http://www.openphacts.org/units/Nanomolar,3108378,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712087,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(NC(C)C(F)(F)F)nc(-c2nc(C(F)(F)F)cs2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4281715,,CHEMBL4281715,,False,http://www.openphacts.org/units/Nanomolar,3108379,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712088,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3cncc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.45', 'le': '0.28', 'lle': '1.59', 'sei': '8.25'}",CHEMBL4282741,,CHEMBL4282741,7.30,False,http://www.openphacts.org/units/Nanomolar,3108380,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712089,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(N[C@H]3CCC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4286538,,CHEMBL4286538,,False,http://www.openphacts.org/units/Nanomolar,3108381,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712090,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cc(Nc2nc(NCC3CC3)nc(-n3ccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,"{'bei': '15.75', 'le': '0.31', 'lle': '2.94', 'sei': '7.49'}",CHEMBL4291710,,CHEMBL4291710,7.00,False,http://www.openphacts.org/units/Nanomolar,3108382,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712091,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1cncc(-c2nc(NC3CCC(F)(F)C3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4292069,,CHEMBL4292069,,False,http://www.openphacts.org/units/Nanomolar,3108383,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712092,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1cncc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4277241,,CHEMBL4277241,,False,http://www.openphacts.org/units/Nanomolar,3108384,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712093,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@@H](Nc2nc(N[C@@H]3CCC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280571,,CHEMBL4280571,,False,http://www.openphacts.org/units/Nanomolar,3108385,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712094,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1ccnc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,"{'bei': '16.69', 'le': '0.33', 'lle': '3.31', 'sei': '7.91'}",CHEMBL4281625,,CHEMBL4281625,7.00,False,http://www.openphacts.org/units/Nanomolar,3108386,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712095,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1ccnc(-c2nc(NC3CCC(F)(F)C3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,"{'bei': '15.65', 'le': '0.31', 'lle': '2.53', 'sei': '7.91'}",CHEMBL4281482,,CHEMBL4281482,7.00,False,http://www.openphacts.org/units/Nanomolar,3108387,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712096,[],CHEMBL4257011,Inhibition of His-tagged wild type IDH1 (unknown origin)/FLAG-tagged IDH1 R132H mutant heterodimer expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by diaphorase and resazurin addition and measured after 5 mins in presence of NADPH and 300 uM NADP ny fluorescence spectrometry,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3nc(C(F)(F)F)cs3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4282517,,CHEMBL4282517,,False,http://www.openphacts.org/units/Nanomolar,3108388,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712097,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NC(C(F)(F)F)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4293346,,CHEMBL4293346,,False,http://www.openphacts.org/units/Nanomolar,3108078,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712098,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4279047,,CHEMBL4279047,,False,http://www.openphacts.org/units/Nanomolar,3108079,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712099,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(N[C@@H]3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4278020,,CHEMBL4278020,,False,http://www.openphacts.org/units/Nanomolar,3108080,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712100,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CCC(Nc1nc(NC(CC)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4293542,,CHEMBL4293542,,False,http://www.openphacts.org/units/Nanomolar,3108081,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712101,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC[C@@H](Nc1nc(N[C@H](CC)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4292520,,CHEMBL4292520,,False,http://www.openphacts.org/units/Nanomolar,3108082,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712102,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cccc(-c2nc(NC3CCC(F)(F)C3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4292152,,CHEMBL4292152,,False,http://www.openphacts.org/units/Nanomolar,3108083,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712103,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4288434,,CHEMBL4288434,,False,http://www.openphacts.org/units/Nanomolar,3108084,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712104,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2cc(F)cc(F)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4288067,,CHEMBL4288067,,False,http://www.openphacts.org/units/Nanomolar,3108085,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712105,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4287015,,CHEMBL4287015,,False,http://www.openphacts.org/units/Nanomolar,3108086,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712106,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CCC(Nc1nc(NC(CC)C2CC2)nc(-c2cccc(Cl)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '18.87', 'le': '0.37', 'lle': '2.51', 'sei': '9.65'}",CHEMBL4282989,,CHEMBL4282989,7.30,False,http://www.openphacts.org/units/Nanomolar,3108088,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712107,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@@H](Nc2nc(N[C@@H]3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4294589,,CHEMBL4294589,,False,http://www.openphacts.org/units/Nanomolar,3108089,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712108,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4293545,,CHEMBL4293545,,False,http://www.openphacts.org/units/Nanomolar,3108090,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712109,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(Cl)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280132,,CHEMBL4280132,,False,http://www.openphacts.org/units/Nanomolar,3108091,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712110,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(Cl)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4281282,,CHEMBL4281282,,False,http://www.openphacts.org/units/Nanomolar,3108093,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712111,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280231,,CHEMBL4280231,,False,http://www.openphacts.org/units/Nanomolar,3108094,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712112,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(N[C@H]3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4281649,,CHEMBL4281649,,False,http://www.openphacts.org/units/Nanomolar,3108096,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712113,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2cc(F)cc(C#N)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4291656,,CHEMBL4291656,,False,http://www.openphacts.org/units/Nanomolar,3108097,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712114,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3cncc(Cl)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4290600,,CHEMBL4290600,,False,http://www.openphacts.org/units/Nanomolar,3108098,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712115,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-n2ccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '19.14', 'le': '0.37', 'lle': '3.80', 'sei': '9.06'}",CHEMBL4293652,,CHEMBL4293652,7.30,False,http://www.openphacts.org/units/Nanomolar,3108099,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712116,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3nc(C(F)(F)F)cs3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4286666,,CHEMBL4286666,,False,http://www.openphacts.org/units/Nanomolar,3108100,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712117,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4292275,,CHEMBL4292275,,False,http://www.openphacts.org/units/Nanomolar,3108101,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712118,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4293284,,CHEMBL4293284,,False,http://www.openphacts.org/units/Nanomolar,3108102,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712119,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '17.17', 'le': '0.34', 'lle': '3.80', 'sei': '9.06'}",CHEMBL4292169,,CHEMBL4292169,7.30,False,http://www.openphacts.org/units/Nanomolar,3108104,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712120,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)C4)nc(-c4cccc(Cl)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4287037,,CHEMBL4287037,,False,http://www.openphacts.org/units/Nanomolar,3108105,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712121,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3nc(C(F)(F)F)cs3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4288084,,CHEMBL4288084,,False,http://www.openphacts.org/units/Nanomolar,3108106,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712122,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(NC(C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4283785,,CHEMBL4283785,,False,http://www.openphacts.org/units/Nanomolar,3108108,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712123,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,Clc1cccc(-c2nc(NC(C3CC3)C3CC3)nc(NC(C3CC3)C3CC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '17.77', 'le': '0.34', 'lle': '2.51', 'sei': '9.65'}",CHEMBL4279765,,CHEMBL4279765,7.30,False,http://www.openphacts.org/units/Nanomolar,3108109,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712124,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3nc(C(F)(F)F)cs3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4294619,,CHEMBL4294619,,False,http://www.openphacts.org/units/Nanomolar,3108110,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712125,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@H]4CCC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '14.53', 'le': '0.28', 'lle': '2.05', 'sei': '6.50'}",CHEMBL4294234,,CHEMBL4294234,7.30,False,http://www.openphacts.org/units/Nanomolar,3108111,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712126,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4293189,,CHEMBL4293189,,False,http://www.openphacts.org/units/Nanomolar,3108112,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712127,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4292077,,CHEMBL4292077,,False,http://www.openphacts.org/units/Nanomolar,3108114,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712128,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@@H]4CCC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4281225,,CHEMBL4281225,,False,http://www.openphacts.org/units/Nanomolar,3108115,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712129,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280154,,CHEMBL4280154,,False,http://www.openphacts.org/units/Nanomolar,3108116,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712130,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4278998,,CHEMBL4278998,,False,http://www.openphacts.org/units/Nanomolar,3108118,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712131,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(NC(C)C(F)(F)F)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4277813,,CHEMBL4277813,,False,http://www.openphacts.org/units/Nanomolar,3108119,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712132,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(N[C@@H](C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4278845,,CHEMBL4278845,,False,http://www.openphacts.org/units/Nanomolar,3108120,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712133,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4279216,,CHEMBL4279216,,False,http://www.openphacts.org/units/Nanomolar,3108121,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712134,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3cncc(Cl)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4282985,,CHEMBL4282985,,False,http://www.openphacts.org/units/Nanomolar,3108122,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712135,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1cccc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4283381,,CHEMBL4283381,,False,http://www.openphacts.org/units/Nanomolar,3108123,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712136,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4284375,,CHEMBL4284375,,False,http://www.openphacts.org/units/Nanomolar,3108124,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712137,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cncc(Cl)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '15.88', 'le': '0.32', 'lle': '2.34', 'sei': '8.25'}",CHEMBL4276695,,CHEMBL4276695,7.30,False,http://www.openphacts.org/units/Nanomolar,3108125,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712138,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280772,,CHEMBL4280772,,False,http://www.openphacts.org/units/Nanomolar,3108127,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712139,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4290840,,CHEMBL4290840,,False,http://www.openphacts.org/units/Nanomolar,3108129,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712140,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3Cc4ccccc4C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4289822,,CHEMBL4289822,,False,http://www.openphacts.org/units/Nanomolar,3108130,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712141,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,Nc1ccc(F)c(-c2nc(Nc3cc(F)cc(F)c3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4294923,,CHEMBL4294923,,False,http://www.openphacts.org/units/Nanomolar,3108131,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712142,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4289832,,CHEMBL4289832,,False,http://www.openphacts.org/units/Nanomolar,3108132,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712143,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1nc(-c2nc(NC3CCC(F)(F)C3)nc(NC3CCC(F)(F)C3)n2)cs1,,,CHEMBL4257005,,,,CHEMBL4277782,,CHEMBL4277782,,False,http://www.openphacts.org/units/Nanomolar,3108133,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712144,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(NC(C)C(F)(F)F)nc(-c2cncc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4276732,,CHEMBL4276732,,False,http://www.openphacts.org/units/Nanomolar,3108134,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712145,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCCC1Nc1nc(NC2CCCC2(F)F)nc(-c2cccc(Cl)n2)n1,,,CHEMBL4257005,,,,CHEMBL4281900,,CHEMBL4281900,,False,http://www.openphacts.org/units/Nanomolar,3108135,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712146,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.45', 'le': '0.28', 'lle': '1.59', 'sei': '8.25'}",CHEMBL4280826,,CHEMBL4280826,7.30,False,http://www.openphacts.org/units/Nanomolar,3108136,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712147,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3nc(C(F)(F)F)cs3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4287902,,CHEMBL4287902,,False,http://www.openphacts.org/units/Nanomolar,3108137,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712148,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cncc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '14.80', 'le': '0.29', 'lle': '1.97', 'sei': '8.25'}",CHEMBL4286852,,CHEMBL4286852,7.30,False,http://www.openphacts.org/units/Nanomolar,3108138,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712149,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4289309,,CHEMBL4289309,,False,http://www.openphacts.org/units/Nanomolar,3108139,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712150,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)Nc1nc(Nc2ccnc(C#N)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4284724,,CHEMBL4284724,,False,http://www.openphacts.org/units/Nanomolar,3108140,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712151,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,"{'bei': '14.56', 'le': '0.28', 'lle': '1.50', 'sei': '8.25'}",CHEMBL4277398,,CHEMBL4277398,7.30,False,http://www.openphacts.org/units/Nanomolar,3108141,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712152,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,"{'bei': '14.80', 'le': '0.28', 'lle': '1.60', 'sei': '7.34'}",CHEMBL4278417,,CHEMBL4278417,7.30,False,http://www.openphacts.org/units/Nanomolar,3108142,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712153,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,Nc1ccc(F)c(-c2nc(Nc3cc(F)cc(F)c3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '16.17', 'le': '0.31', 'lle': '2.63', 'sei': '7.18'}",CHEMBL4291867,,CHEMBL4291867,7.30,False,http://www.openphacts.org/units/Nanomolar,3108143,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712154,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cccc(Cl)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4290450,,CHEMBL4290450,,False,http://www.openphacts.org/units/Nanomolar,3108145,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712155,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4291491,,CHEMBL4291491,,False,http://www.openphacts.org/units/Nanomolar,3108146,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712156,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CC(F)(F)C4)nc(-n4ccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4284431,,CHEMBL4284431,,False,http://www.openphacts.org/units/Nanomolar,3108147,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712157,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3csc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '15.82', 'le': '0.33', 'lle': '2.57', 'sei': '9.26'}",CHEMBL4292401,,CHEMBL4292401,7.00,False,http://www.openphacts.org/units/Nanomolar,3108148,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712158,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,"{'bei': '14.68', 'le': '0.29', 'lle': '1.83', 'sei': '8.25'}",CHEMBL4280719,,CHEMBL4280719,7.30,False,http://www.openphacts.org/units/Nanomolar,3108149,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712159,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4279665,,CHEMBL4279665,,False,http://www.openphacts.org/units/Nanomolar,3108150,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712160,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-n3ccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4295239,,CHEMBL4295239,,False,http://www.openphacts.org/units/Nanomolar,3108151,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712161,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@H]4CCC(F)(F)C4)nc(-n4ccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4294151,,CHEMBL4294151,,False,http://www.openphacts.org/units/Nanomolar,3108152,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712162,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NCC3CC3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,"{'bei': '17.00', 'le': '0.32', 'lle': '2.77', 'sei': '7.34'}",CHEMBL4293761,,CHEMBL4293761,7.30,False,http://www.openphacts.org/units/Nanomolar,3108153,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712163,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-n3ccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '14.54', 'le': '0.29', 'lle': '1.94', 'sei': '8.69'}",CHEMBL4290087,,CHEMBL4290087,7.00,False,http://www.openphacts.org/units/Nanomolar,3108154,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712164,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,"{'bei': '15.01', 'le': '0.30', 'lle': '2.70', 'sei': '7.81'}",CHEMBL4289717,,CHEMBL4289717,7.30,False,http://www.openphacts.org/units/Nanomolar,3108155,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712165,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.45', 'le': '0.28', 'lle': '1.59', 'sei': '8.25'}",CHEMBL4288655,,CHEMBL4288655,7.30,False,http://www.openphacts.org/units/Nanomolar,3108156,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712166,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(Nc2nc(NC3CCC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4285674,,CHEMBL4285674,,False,http://www.openphacts.org/units/Nanomolar,3108157,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712167,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC[C@H](Nc1nc(N[C@@H](CC)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4284624,,CHEMBL4284624,,False,http://www.openphacts.org/units/Nanomolar,3108158,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712168,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4279182,,CHEMBL4279182,,False,http://www.openphacts.org/units/Nanomolar,3108159,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712169,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3Cc4ccc(Cl)cc4C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '13.70', 'le': '0.27', 'lle': '1.22', 'sei': '9.26'}",CHEMBL4280254,,CHEMBL4280254,7.00,False,http://www.openphacts.org/units/Nanomolar,3108160,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712170,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3nc(C(F)(F)F)cs3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '14.04', 'le': '0.29', 'lle': '1.01', 'sei': '9.26'}",CHEMBL4283342,,CHEMBL4283342,7.00,False,http://www.openphacts.org/units/Nanomolar,3108161,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712171,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)C4)nc(-n4ccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4292283,,CHEMBL4292283,,False,http://www.openphacts.org/units/Nanomolar,3108163,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712172,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1cncc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '14.72', 'le': '0.29', 'lle': '1.75', 'sei': '7.91'}",CHEMBL4293294,,CHEMBL4293294,7.00,False,http://www.openphacts.org/units/Nanomolar,3108164,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712173,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cccc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,"{'bei': '16.19', 'le': '0.32', 'lle': '2.54', 'sei': '9.26'}",CHEMBL4293667,,CHEMBL4293667,7.00,False,http://www.openphacts.org/units/Nanomolar,3108165,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712174,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)CC4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '13.55', 'le': '0.26', 'lle': '1.36', 'sei': '6.23'}",CHEMBL4294793,,CHEMBL4294793,7.00,False,http://www.openphacts.org/units/Nanomolar,3108167,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712175,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.25', 'le': '0.28', 'lle': '1.68', 'sei': '7.91'}",CHEMBL4277305,,CHEMBL4277305,7.00,False,http://www.openphacts.org/units/Nanomolar,3108168,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712176,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CC4(C3)CC(F)(F)C4)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.27', 'le': '0.28', 'lle': '1.46', 'sei': '9.26'}",CHEMBL4293221,,CHEMBL4293221,7.00,False,http://www.openphacts.org/units/Nanomolar,3108169,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712177,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '13.48', 'le': '0.27', 'lle': '0.90', 'sei': '7.91'}",CHEMBL4292220,,CHEMBL4292220,7.00,False,http://www.openphacts.org/units/Nanomolar,3108170,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712178,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NC(C2CC2)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '17.45', 'le': '0.33', 'lle': '2.54', 'sei': '9.65'}",CHEMBL4289486,,CHEMBL4289486,7.30,False,http://www.openphacts.org/units/Nanomolar,3108171,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712179,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3ccnc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '15.04', 'le': '0.30', 'lle': '2.45', 'sei': '7.91'}",CHEMBL4288431,,CHEMBL4288431,7.00,False,http://www.openphacts.org/units/Nanomolar,3108172,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712180,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3nc(F)ccc3F)n2)c1,,,CHEMBL4257005,,,"{'bei': '17.13', 'le': '0.33', 'lle': '2.86', 'sei': '9.65'}",CHEMBL4287770,,CHEMBL4287770,7.30,False,http://www.openphacts.org/units/Nanomolar,3108173,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712181,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC[C@H](Nc1nc(N[C@H](CC)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4286718,,CHEMBL4286718,,False,http://www.openphacts.org/units/Nanomolar,3108174,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712182,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-n3ccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.57', 'le': '0.29', 'lle': '2.56', 'sei': '7.49'}",CHEMBL4291846,,CHEMBL4291846,7.00,False,http://www.openphacts.org/units/Nanomolar,3108175,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712183,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc([C@H]2C[C@@H](Nc3nc(NC4CCC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)C2)cc1,,,CHEMBL4257005,,,"{'bei': '13.77', 'le': '0.27', 'lle': '0.95', 'sei': '9.26'}",CHEMBL4280502,,CHEMBL4280502,7.00,False,http://www.openphacts.org/units/Nanomolar,3108177,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712184,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cc(Nc2nc(NCC3CC3)nc(-c3cccc(Cl)n3)n2)ccn1,,,CHEMBL4257005,,,"{'bei': '17.31', 'le': '0.34', 'lle': '2.73', 'sei': '8.25'}",CHEMBL4279427,,CHEMBL4279427,7.30,False,http://www.openphacts.org/units/Nanomolar,3108178,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712185,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,"{'bei': '15.10', 'le': '0.29', 'lle': '3.17', 'sei': '6.23'}",CHEMBL4281644,,CHEMBL4281644,7.30,False,http://www.openphacts.org/units/Nanomolar,3108179,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712186,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(-c4ccccc4)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '13.63', 'le': '0.26', 'lle': '0.64', 'sei': '7.91'}",CHEMBL4285379,,CHEMBL4285379,7.00,False,http://www.openphacts.org/units/Nanomolar,3108180,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712187,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4280213,,CHEMBL4280213,,False,http://www.openphacts.org/units/Nanomolar,3108181,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712188,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1csc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '14.57', 'le': '0.30', 'lle': '1.09', 'sei': '9.26'}",CHEMBL4281964,,CHEMBL4281964,7.00,False,http://www.openphacts.org/units/Nanomolar,3108183,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712189,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C#N)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,"{'bei': '16.47', 'le': '0.32', 'lle': '3.85', 'sei': '6.23'}",CHEMBL4285716,,CHEMBL4285716,7.30,False,http://www.openphacts.org/units/Nanomolar,3108185,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712190,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1nc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)cs1,,,CHEMBL4257005,,,"{'bei': '15.97', 'le': '0.33', 'lle': '2.47', 'sei': '9.26'}",CHEMBL4287400,,CHEMBL4287400,7.00,False,http://www.openphacts.org/units/Nanomolar,3108187,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712191,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(Nc2nc(NC3CC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,"{'bei': '16.69', 'le': '0.32', 'lle': '4.00', 'sei': '6.23'}",CHEMBL4291112,,CHEMBL4291112,7.30,False,http://www.openphacts.org/units/Nanomolar,3108188,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712192,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cccc(-c2nc(Nc3ccnc(C4(C#N)CC4)c3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '13.66', 'le': '0.26', 'lle': '1.27', 'sei': '6.23'}",CHEMBL4288641,,CHEMBL4288641,7.00,False,http://www.openphacts.org/units/Nanomolar,3108189,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712193,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(Cl)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '15.25', 'le': '0.31', 'lle': '1.43', 'sei': '9.26'}",CHEMBL4289692,,CHEMBL4289692,7.00,False,http://www.openphacts.org/units/Nanomolar,3108190,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712194,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,"{'bei': '16.28', 'le': '0.31', 'lle': '3.13', 'sei': '6.50'}",CHEMBL4276701,,CHEMBL4276701,7.30,False,http://www.openphacts.org/units/Nanomolar,3108191,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712195,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(CC#N)Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '17.88', 'le': '0.34', 'lle': '3.12', 'sei': '7.04'}",CHEMBL4277757,,CHEMBL4277757,7.00,False,http://www.openphacts.org/units/Nanomolar,3108192,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712196,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NCC(F)(F)F)nc(-c4cccc(Cl)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '16.34', 'le': '0.32', 'lle': '3.05', 'sei': '6.50'}",CHEMBL4289616,,CHEMBL4289616,7.30,False,http://www.openphacts.org/units/Nanomolar,3108193,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712197,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(CNc2nc(NCC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '15.07', 'le': '0.30', 'lle': '2.13', 'sei': '9.26'}",CHEMBL4294886,,CHEMBL4294886,7.00,False,http://www.openphacts.org/units/Nanomolar,3108194,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712198,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2ccnc(-c3ccccc3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,"{'bei': '14.45', 'le': '0.28', 'lle': '1.18', 'sei': '8.25'}",CHEMBL4289777,,CHEMBL4289777,7.30,False,http://www.openphacts.org/units/Nanomolar,3108195,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712199,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(-c4ccccc4)c3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '13.84', 'le': '0.26', 'lle': '0.55', 'sei': '8.25'}",CHEMBL4284814,,CHEMBL4284814,7.30,False,http://www.openphacts.org/units/Nanomolar,3108198,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712200,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(CNc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '13.85', 'le': '0.27', 'lle': '1.43', 'sei': '7.91'}",CHEMBL4290997,,CHEMBL4290997,7.00,False,http://www.openphacts.org/units/Nanomolar,3108199,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712201,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCN(c4ccccn4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '13.82', 'le': '0.27', 'lle': '2.36', 'sei': '7.63'}",CHEMBL4289977,,CHEMBL4289977,7.00,False,http://www.openphacts.org/units/Nanomolar,3108200,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712202,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3csc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '14.04', 'le': '0.29', 'lle': '1.01', 'sei': '9.26'}",CHEMBL4295099,,CHEMBL4295099,7.00,False,http://www.openphacts.org/units/Nanomolar,3108201,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712203,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1cccc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '14.75', 'le': '0.29', 'lle': '1.15', 'sei': '9.26'}",CHEMBL4291368,,CHEMBL4291368,7.00,False,http://www.openphacts.org/units/Nanomolar,3108202,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712204,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NCC(F)(F)F)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '14.57', 'le': '0.28', 'lle': '2.38', 'sei': '6.23'}",CHEMBL4276898,,CHEMBL4276898,7.00,False,http://www.openphacts.org/units/Nanomolar,3108204,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712205,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCN(c4ncccn4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '13.79', 'le': '0.27', 'lle': '2.97', 'sei': '6.69'}",CHEMBL4282071,,CHEMBL4282071,7.00,False,http://www.openphacts.org/units/Nanomolar,3108205,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712206,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CC5(C4)CC(F)(F)C5)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '13.25', 'le': '0.25', 'lle': '1.36', 'sei': '6.23'}",CHEMBL4288051,,CHEMBL4288051,7.00,False,http://www.openphacts.org/units/Nanomolar,3108207,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712207,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(CC#N)Nc1nc(Nc2ccnc(C(C)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '14.63', 'le': '0.28', 'lle': '1.69', 'sei': '6.23'}",CHEMBL4291861,,CHEMBL4291861,7.00,False,http://www.openphacts.org/units/Nanomolar,3108209,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712208,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '14.48', 'le': '0.29', 'lle': '1.92', 'sei': '7.91'}",CHEMBL4292885,,CHEMBL4292885,7.00,False,http://www.openphacts.org/units/Nanomolar,3108210,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712209,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NC2C3CC4CC(C3)CC2C4)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '15.27', 'le': '0.29', 'lle': '1.60', 'sei': '9.26'}",CHEMBL4278414,,CHEMBL4278414,7.00,False,http://www.openphacts.org/units/Nanomolar,3108212,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712210,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1ccn(-c2nc(NCC(O)(F)F)nc(Nc3cc(F)cc(Cl)c3)n2)n1,,,CHEMBL4257005,,,"{'bei': '15.56', 'le': '0.32', 'lle': '3.30', 'sei': '6.95'}",CHEMBL4287398,,CHEMBL4287398,7.00,False,http://www.openphacts.org/units/Nanomolar,3108214,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712211,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3nccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '15.04', 'le': '0.30', 'lle': '2.45', 'sei': '7.91'}",CHEMBL4287795,,CHEMBL4287795,7.00,False,http://www.openphacts.org/units/Nanomolar,3108215,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712212,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CN(c4ccccn4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.21', 'le': '0.27', 'lle': '2.75', 'sei': '7.63'}",CHEMBL4291485,,CHEMBL4291485,7.00,False,http://www.openphacts.org/units/Nanomolar,3108216,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712213,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,O=C1C[C@H](Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)CN1c1ccccn1,,,CHEMBL4257005,,,"{'bei': '13.45', 'le': '0.26', 'lle': '2.84', 'sei': '6.43'}",CHEMBL4288916,,CHEMBL4288916,7.00,False,http://www.openphacts.org/units/Nanomolar,3108217,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712214,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(COC(C)C)Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '16.49', 'le': '0.32', 'lle': '2.61', 'sei': '8.25'}",CHEMBL4286667,,CHEMBL4286667,7.00,False,http://www.openphacts.org/units/Nanomolar,3108219,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712215,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccc2c(c1)CC(Nc1nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n1)C2,,,CHEMBL4257005,,,"{'bei': '13.96', 'le': '0.27', 'lle': '2.00', 'sei': '7.04'}",CHEMBL4285688,,CHEMBL4285688,7.00,False,http://www.openphacts.org/units/Nanomolar,3108220,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712216,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CN(c4cccnc4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4282632,,CHEMBL4282632,,False,http://www.openphacts.org/units/Nanomolar,3108221,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712217,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NCCOc2ccccc2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '15.75', 'le': '0.30', 'lle': '2.35', 'sei': '8.25'}",CHEMBL4277498,,CHEMBL4277498,7.00,False,http://www.openphacts.org/units/Nanomolar,3108224,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712218,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C#N)Nc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '14.95', 'le': '0.29', 'lle': '2.18', 'sei': '6.23'}",CHEMBL4279333,,CHEMBL4279333,7.00,False,http://www.openphacts.org/units/Nanomolar,3108225,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712219,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,Nc1ccc(F)c(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4291587,,CHEMBL4291587,,False,http://www.openphacts.org/units/Nanomolar,3108227,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712220,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(CC#N)Nc1nc(Nc2ccnc(C(C)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '15.07', 'le': '0.29', 'lle': '2.08', 'sei': '6.23'}",CHEMBL4290554,,CHEMBL4290554,7.00,False,http://www.openphacts.org/units/Nanomolar,3108228,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712221,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3ccnc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '16.01', 'le': '0.32', 'lle': '3.23', 'sei': '7.91'}",CHEMBL4294983,,CHEMBL4294983,7.00,False,http://www.openphacts.org/units/Nanomolar,3108229,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712222,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(OC(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4287992,,CHEMBL4287992,,False,http://www.openphacts.org/units/Nanomolar,3108230,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712223,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C#N)Nc1nc(Nc2ccnc(C(C)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '15.54', 'le': '0.30', 'lle': '2.47', 'sei': '6.23'}",CHEMBL4293552,,CHEMBL4293552,7.00,False,http://www.openphacts.org/units/Nanomolar,3108231,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712224,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCOCC3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '15.27', 'le': '0.30', 'lle': '2.47', 'sei': '8.25'}",CHEMBL4292464,,CHEMBL4292464,7.00,False,http://www.openphacts.org/units/Nanomolar,3108233,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712225,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3nccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4293462,,CHEMBL4293462,,False,http://www.openphacts.org/units/Nanomolar,3108234,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712226,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC2(CC(Nc3nc(Nc4ccnc(C(F)(F)F)c4)nc(-c4cccc(C(F)(F)F)n4)n3)C2)C1,,,CHEMBL4257005,,,"{'bei': '13.17', 'le': '0.26', 'lle': '0.90', 'sei': '7.91'}",CHEMBL4288364,,CHEMBL4288364,7.00,False,http://www.openphacts.org/units/Nanomolar,3108235,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712227,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)C4)nc(-c4nccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4279855,,CHEMBL4279855,,False,http://www.openphacts.org/units/Nanomolar,3108239,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712228,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NCC(C)(C)C#N)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4278807,,CHEMBL4278807,,False,http://www.openphacts.org/units/Nanomolar,3108240,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712229,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,O=C(c1ccccc1)N1CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '13.12', 'le': '0.25', 'lle': '2.12', 'sei': '7.30'}",CHEMBL4283985,,CHEMBL4283985,7.00,False,http://www.openphacts.org/units/Nanomolar,3108241,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712230,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)CNc1nc(NC2CCC(F)(F)C2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '16.19', 'le': '0.32', 'lle': '3.27', 'sei': '7.30'}",CHEMBL4282936,,CHEMBL4282936,7.00,False,http://www.openphacts.org/units/Nanomolar,3108242,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712231,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC2(CC(Nc3nc(NC4CC5(C4)CC(F)(F)C5)nc(-c4cccc(Cl)n4)n3)C2)C1,,,CHEMBL4257005,,,,CHEMBL4285110,,CHEMBL4285110,,False,http://www.openphacts.org/units/Nanomolar,3108243,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712232,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CS(=O)(=O)N1CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4284068,,CHEMBL4284068,,False,http://www.openphacts.org/units/Nanomolar,3108244,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712233,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C#N)CNc1nc(Nc2ccnc(C(C)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4278435,,CHEMBL4278435,,False,http://www.openphacts.org/units/Nanomolar,3108245,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712234,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2nccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4285495,,CHEMBL4285495,,False,http://www.openphacts.org/units/Nanomolar,3108246,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712235,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3ccnc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4294396,,CHEMBL4294396,,False,http://www.openphacts.org/units/Nanomolar,3108248,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712236,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(CC#N)Nc1nc(NC(C)CC#N)nc(-c2cccc(Cl)n2)n1,,,CHEMBL4257005,,,"{'bei': '19.62', 'le': '0.38', 'lle': '3.98', 'sei': '5.68'}",CHEMBL4288016,,CHEMBL4288016,7.00,False,http://www.openphacts.org/units/Nanomolar,3108249,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712237,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc([C@H]2C[C@@H](Nc3nc(N[C@H]4C[C@@H](c5ccc(F)cc5)C4)nc(-c4cccc(C(F)(F)F)n4)n3)C2)cc1,,,CHEMBL4257005,,,,CHEMBL4291957,,CHEMBL4291957,,False,http://www.openphacts.org/units/Nanomolar,3108250,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712238,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N1CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4292328,,CHEMBL4292328,,False,http://www.openphacts.org/units/Nanomolar,3108251,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712239,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)OC(=O)N1CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4277506,,CHEMBL4277506,,False,http://www.openphacts.org/units/Nanomolar,3108252,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712240,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)c(C(F)(F)F)n1,,,CHEMBL4257005,,,,CHEMBL4277835,,CHEMBL4277835,,False,http://www.openphacts.org/units/Nanomolar,3108253,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712241,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc(F)c(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4278869,,CHEMBL4278869,,False,http://www.openphacts.org/units/Nanomolar,3108254,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712242,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-n2cc(I)cn2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4293859,,CHEMBL4293859,,False,http://www.openphacts.org/units/Nanomolar,3108257,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712243,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCN(Cc4ccccc4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4294899,,CHEMBL4294899,,False,http://www.openphacts.org/units/Nanomolar,3108258,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712244,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1nc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)cs1,,,CHEMBL4257005,,,,CHEMBL4294387,,CHEMBL4294387,,False,http://www.openphacts.org/units/Nanomolar,3108261,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712245,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)CNc1nc(NC2CCC(F)(F)CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4281385,,CHEMBL4281385,,False,http://www.openphacts.org/units/Nanomolar,3108265,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712246,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)Nc1nc(Nc2ccnc(C(C)(F)F)c2)nc(-c2nccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4282925,,CHEMBL4282925,,False,http://www.openphacts.org/units/Nanomolar,3108267,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712247,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3nccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4288632,,CHEMBL4288632,,False,http://www.openphacts.org/units/Nanomolar,3108271,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712248,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(OC(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4288266,,CHEMBL4288266,,False,http://www.openphacts.org/units/Nanomolar,3108274,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712249,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3c[nH]nc3C(F)(F)F)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4283186,,CHEMBL4283186,,False,http://www.openphacts.org/units/Nanomolar,3108275,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712250,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,CC(C)Nc1nc(Nc2ccnc(C(C)(F)F)c2)nc(-c2nccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4284203,,CHEMBL4284203,,False,http://www.openphacts.org/units/Nanomolar,3108276,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712251,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)co1,,,CHEMBL4257005,,,,CHEMBL4286024,,CHEMBL4286024,,False,http://www.openphacts.org/units/Nanomolar,3108279,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712252,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-n3cc(Cl)cn3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4285024,,CHEMBL4285024,,False,http://www.openphacts.org/units/Nanomolar,3108280,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712253,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1ccnc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4294544,,CHEMBL4294544,,False,http://www.openphacts.org/units/Nanomolar,3108286,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712254,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,Oc1ccc(F)c(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4281152,,CHEMBL4281152,,False,http://www.openphacts.org/units/Nanomolar,3108287,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712255,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)no1,,,CHEMBL4257005,,,,CHEMBL4280060,,CHEMBL4280060,,False,http://www.openphacts.org/units/Nanomolar,3108289,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712256,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,COCCc1ccnc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4293096,,CHEMBL4293096,,False,http://www.openphacts.org/units/Nanomolar,3108293,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712257,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)c[nH]1,,,CHEMBL4257005,,,,CHEMBL4289057,,CHEMBL4289057,,False,http://www.openphacts.org/units/Nanomolar,3108295,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712258,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(-c2nc(NC3CCC(F)(F)C3)nc(NC3CCC(F)(F)C3)n2)c[nH]1,,,CHEMBL4257005,,,,CHEMBL4285000,,CHEMBL4285000,,False,http://www.openphacts.org/units/Nanomolar,3108297,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712259,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(F)c(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4282630,,CHEMBL4282630,,False,http://www.openphacts.org/units/Nanomolar,3108299,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712260,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,Cc1nsc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4282277,,CHEMBL4282277,,False,http://www.openphacts.org/units/Nanomolar,3108305,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712261,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,Cc1nc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)c[nH]1,,,CHEMBL4257005,,,,CHEMBL4289141,,CHEMBL4289141,,False,http://www.openphacts.org/units/Nanomolar,3108309,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712262,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3nc(-c4ccccc4)ns3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4294240,,CHEMBL4294240,,False,http://www.openphacts.org/units/Nanomolar,3108310,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712263,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@@H]4CCC(F)(F)C4)nc(-n4ccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4289705,,CHEMBL4289705,,False,http://www.openphacts.org/units/Nanomolar,3108326,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712264,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(N[C@H]3CCC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4287603,,CHEMBL4287603,,False,http://www.openphacts.org/units/Nanomolar,3108344,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712265,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)CC4)nc(-n4ccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '13.85', 'le': '0.27', 'lle': '2.24', 'sei': '5.97'}",CHEMBL4286039,,CHEMBL4286039,7.00,False,http://www.openphacts.org/units/Nanomolar,3108358,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712266,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cncc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '14.03', 'le': '0.28', 'lle': '1.81', 'sei': '7.20'}",CHEMBL4280467,,CHEMBL4280467,7.30,False,http://www.openphacts.org/units/Nanomolar,3108365,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712267,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.42', 'le': '0.28', 'lle': '2.20', 'sei': '7.20'}",CHEMBL4294642,,CHEMBL4294642,7.30,False,http://www.openphacts.org/units/Nanomolar,3108367,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712268,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-n3ccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.77', 'le': '0.29', 'lle': '2.47', 'sei': '7.81'}",CHEMBL4278901,,CHEMBL4278901,7.30,False,http://www.openphacts.org/units/Nanomolar,3108369,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712269,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,"{'bei': '14.39', 'le': '0.29', 'lle': '2.40', 'sei': '7.49'}",CHEMBL4282949,,CHEMBL4282949,7.00,False,http://www.openphacts.org/units/Nanomolar,3108375,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712270,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CC(F)(F)C4)nc(-c4cncc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4281916,,CHEMBL4281916,,False,http://www.openphacts.org/units/Nanomolar,3108376,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712271,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@@H](Nc2nc(N[C@@H]3CCC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280571,,CHEMBL4280571,,False,http://www.openphacts.org/units/Nanomolar,3108385,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712272,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3nc(C(F)(F)F)cs3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4282517,,CHEMBL4282517,,False,http://www.openphacts.org/units/Nanomolar,3108388,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712273,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1cc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '18.65', 'le': '0.36', 'lle': '2.32', 'sei': '11.64'}",CHEMBL4282906,,CHEMBL4282906,7.30,False,http://www.openphacts.org/units/Nanomolar,3108389,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712274,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1cc(NC(C)(C)C)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '18.45', 'le': '0.35', 'lle': '2.02', 'sei': '11.16'}",CHEMBL4287998,,CHEMBL4287998,7.00,False,http://www.openphacts.org/units/Nanomolar,3108392,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712275,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cccc(-c2nc(NCC3CC3)cc(NCC3CC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '19.26', 'le': '0.37', 'lle': '2.80', 'sei': '11.16'}",CHEMBL4292065,,CHEMBL4292065,7.00,False,http://www.openphacts.org/units/Nanomolar,3108394,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712276,[],CHEMBL4257012,"Inhibition of DH1 R132H mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2cc(NC3CCC(F)(F)CC3)nc(-c3cncc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '14.21', 'le': '0.28', 'lle': '1.07', 'sei': '9.26'}",CHEMBL4277604,,CHEMBL4277604,7.00,False,http://www.openphacts.org/units/Nanomolar,3108396,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712277,[],CHEMBL4257013,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4279047,,CHEMBL4279047,,False,http://www.openphacts.org/units/Nanomolar,3108079,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712278,[],CHEMBL4257013,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4288434,,CHEMBL4288434,,False,http://www.openphacts.org/units/Nanomolar,3108084,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712279,[],CHEMBL4257013,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@H]4CCC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '13.93', 'le': '0.27', 'lle': '1.75', 'sei': '6.23'}",CHEMBL4294234,,CHEMBL4294234,7.00,False,http://www.openphacts.org/units/Nanomolar,3108111,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712280,[],CHEMBL4257013,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@@H]4CCC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '13.93', 'le': '0.27', 'lle': '1.75', 'sei': '6.23'}",CHEMBL4281225,,CHEMBL4281225,7.00,False,http://www.openphacts.org/units/Nanomolar,3108115,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712281,[],CHEMBL4257013,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '13.85', 'le': '0.27', 'lle': '1.29', 'sei': '7.91'}",CHEMBL4280826,,CHEMBL4280826,7.00,False,http://www.openphacts.org/units/Nanomolar,3108136,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712282,[],CHEMBL4257013,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cncc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '14.19', 'le': '0.28', 'lle': '1.67', 'sei': '7.91'}",CHEMBL4286852,,CHEMBL4286852,7.00,False,http://www.openphacts.org/units/Nanomolar,3108138,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712283,[],CHEMBL4257013,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '16.69', 'le': '0.33', 'lle': '3.53', 'sei': '8.25'}",CHEMBL4289309,,CHEMBL4289309,7.30,False,http://www.openphacts.org/units/Nanomolar,3108139,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712284,[],CHEMBL4257013,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '14.95', 'le': '0.28', 'lle': '2.44', 'sei': '6.50'}",CHEMBL4291491,,CHEMBL4291491,7.30,False,http://www.openphacts.org/units/Nanomolar,3108146,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712285,[],CHEMBL4257013,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@H]4CCC(F)(F)C4)nc(-n4ccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '14.86', 'le': '0.28', 'lle': '2.93', 'sei': '6.23'}",CHEMBL4294151,,CHEMBL4294151,7.30,False,http://www.openphacts.org/units/Nanomolar,3108152,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712286,[],CHEMBL4257013,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)CC4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '13.55', 'le': '0.26', 'lle': '1.36', 'sei': '6.23'}",CHEMBL4294793,,CHEMBL4294793,7.00,False,http://www.openphacts.org/units/Nanomolar,3108167,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712287,[],CHEMBL4257013,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4277305,,CHEMBL4277305,,False,http://www.openphacts.org/units/Nanomolar,3108168,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712288,[],CHEMBL4257013,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@@H]4CCC(F)(F)C4)nc(-n4ccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '14.86', 'le': '0.28', 'lle': '2.93', 'sei': '6.23'}",CHEMBL4289705,,CHEMBL4289705,7.30,False,http://www.openphacts.org/units/Nanomolar,3108326,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712289,[],CHEMBL4257013,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cncc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '13.45', 'le': '0.27', 'lle': '1.51', 'sei': '6.90'}",CHEMBL4280467,,CHEMBL4280467,7.00,False,http://www.openphacts.org/units/Nanomolar,3108365,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712290,[],CHEMBL4257013,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '13.82', 'le': '0.27', 'lle': '1.90', 'sei': '6.90'}",CHEMBL4294642,,CHEMBL4294642,7.00,False,http://www.openphacts.org/units/Nanomolar,3108367,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712291,[],CHEMBL4257013,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-n3ccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.16', 'le': '0.28', 'lle': '2.17', 'sei': '7.49'}",CHEMBL4278901,,CHEMBL4278901,7.00,False,http://www.openphacts.org/units/Nanomolar,3108369,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712292,[],CHEMBL4257013,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,"{'bei': '14.39', 'le': '0.29', 'lle': '2.40', 'sei': '7.49'}",CHEMBL4282949,,CHEMBL4282949,7.00,False,http://www.openphacts.org/units/Nanomolar,3108375,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712293,[],CHEMBL4257013,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CC(F)(F)C4)nc(-c4cncc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '14.30', 'le': '0.27', 'lle': '2.75', 'sei': '5.59'}",CHEMBL4281916,,CHEMBL4281916,7.00,False,http://www.openphacts.org/units/Nanomolar,3108376,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712294,[],CHEMBL4257013,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@@H](Nc2nc(N[C@@H]3CCC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280571,,CHEMBL4280571,,False,http://www.openphacts.org/units/Nanomolar,3108385,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712295,[],CHEMBL4257013,"Inhibition of DH1 R132C mutant homodimer (unknown origin) expressed in Sf9 cells pre-incubated for 1 hr before addition of alpha-KG followed by 60 mins incubation in presence of NADPH, NADP, diaphorase and resazurin by fluorescence spectrometry",B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1cc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '17.88', 'le': '0.34', 'lle': '2.02', 'sei': '11.16'}",CHEMBL4282906,,CHEMBL4282906,7.00,False,http://www.openphacts.org/units/Nanomolar,3108389,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712584,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4278828,,CHEMBL4278828,,False,http://www.openphacts.org/units/Nanomolar,3108004,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712585,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)Nc1nc(NC(C)(C)C)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '19.82', 'le': '0.38', 'lle': '2.93', 'sei': '9.65'}",CHEMBL4284907,,CHEMBL4284907,7.30,False,http://www.openphacts.org/units/Nanomolar,3108006,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712586,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(O)c2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '21.51', 'le': '0.40', 'lle': '3.63', 'sei': '8.80'}",CHEMBL4281641,,CHEMBL4281641,7.30,False,http://www.openphacts.org/units/Nanomolar,3108013,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712587,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)C(C)Nc1nc(NC(C)C(C)C)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4285713,,CHEMBL4285713,,False,http://www.openphacts.org/units/Nanomolar,3108015,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712588,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)[C@H](C)Nc1nc(N[C@@H](C)C(C)C)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4291634,,CHEMBL4291634,,False,http://www.openphacts.org/units/Nanomolar,3108019,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712589,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)[C@@H](C)Nc1nc(N[C@H](C)C(C)C)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '18.42', 'le': '0.36', 'lle': '2.43', 'sei': '9.65'}",CHEMBL4288565,,CHEMBL4288565,7.30,False,http://www.openphacts.org/units/Nanomolar,3108020,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712590,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CCC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CCC1,,,CHEMBL4257005,,,"{'bei': '17.36', 'le': '0.33', 'lle': '2.15', 'sei': '9.65'}",CHEMBL4287525,,CHEMBL4287525,7.30,False,http://www.openphacts.org/units/Nanomolar,3108021,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712591,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)c1cccc(F)c1,,,CHEMBL4257005,,,"{'bei': '16.35', 'le': '0.31', 'lle': '1.82', 'sei': '9.65'}",CHEMBL4277726,,CHEMBL4277726,7.30,False,http://www.openphacts.org/units/Nanomolar,3108030,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712592,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4277352,,CHEMBL4277352,,False,http://www.openphacts.org/units/Nanomolar,3108033,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712593,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(N[C@@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4291820,,CHEMBL4291820,,False,http://www.openphacts.org/units/Nanomolar,3108035,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712594,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4286693,,CHEMBL4286693,,False,http://www.openphacts.org/units/Nanomolar,3108036,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712595,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CCCC(C)Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '18.51', 'le': '0.36', 'lle': '2.54', 'sei': '9.65'}",CHEMBL4295085,,CHEMBL4295085,7.30,False,http://www.openphacts.org/units/Nanomolar,3108041,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712596,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)C(C)Nc1nc(NC(C)C(C)C)nc(-c2cccc(N)n2)n1,,,CHEMBL4257005,,,"{'bei': '21.26', 'le': '0.40', 'lle': '3.87', 'sei': '7.18'}",CHEMBL4281163,,CHEMBL4281163,7.30,False,http://www.openphacts.org/units/Nanomolar,3108075,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712597,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NC(C(F)(F)F)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4293346,,CHEMBL4293346,,False,http://www.openphacts.org/units/Nanomolar,3108078,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712598,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4279047,,CHEMBL4279047,,False,http://www.openphacts.org/units/Nanomolar,3108079,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712599,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(N[C@@H]3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4278020,,CHEMBL4278020,,False,http://www.openphacts.org/units/Nanomolar,3108080,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712600,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CCC(Nc1nc(NC(CC)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4293542,,CHEMBL4293542,,False,http://www.openphacts.org/units/Nanomolar,3108081,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712601,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC[C@@H](Nc1nc(N[C@H](CC)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4292520,,CHEMBL4292520,,False,http://www.openphacts.org/units/Nanomolar,3108082,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712602,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cccc(-c2nc(NC3CCC(F)(F)C3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4292152,,CHEMBL4292152,,False,http://www.openphacts.org/units/Nanomolar,3108083,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712603,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,"{'bei': '15.65', 'le': '0.31', 'lle': '2.69', 'sei': '8.69'}",CHEMBL4288434,,CHEMBL4288434,7.00,False,http://www.openphacts.org/units/Nanomolar,3108084,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712604,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2cc(F)cc(F)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,"{'bei': '15.44', 'le': '0.31', 'lle': '2.54', 'sei': '8.69'}",CHEMBL4288067,,CHEMBL4288067,7.00,False,http://www.openphacts.org/units/Nanomolar,3108085,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712605,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,"{'bei': '15.83', 'le': '0.31', 'lle': '2.60', 'sei': '9.06'}",CHEMBL4287015,,CHEMBL4287015,7.30,False,http://www.openphacts.org/units/Nanomolar,3108086,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712606,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CCC(Nc1nc(NC(CC)C2CC2)nc(-c2cccc(Cl)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '18.87', 'le': '0.37', 'lle': '2.51', 'sei': '9.65'}",CHEMBL4282989,,CHEMBL4282989,7.30,False,http://www.openphacts.org/units/Nanomolar,3108088,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712607,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@@H](Nc2nc(N[C@@H]3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4294589,,CHEMBL4294589,,False,http://www.openphacts.org/units/Nanomolar,3108089,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712608,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,"{'bei': '14.95', 'le': '0.29', 'lle': '2.57', 'sei': '6.71'}",CHEMBL4293545,,CHEMBL4293545,7.00,False,http://www.openphacts.org/units/Nanomolar,3108090,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712609,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(Cl)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280132,,CHEMBL4280132,,False,http://www.openphacts.org/units/Nanomolar,3108091,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712610,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2csc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4279049,,CHEMBL4279049,,False,http://www.openphacts.org/units/Nanomolar,3108092,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712611,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(Cl)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.84', 'le': '0.30', 'lle': '1.66', 'sei': '7.91'}",CHEMBL4281282,,CHEMBL4281282,7.00,False,http://www.openphacts.org/units/Nanomolar,3108093,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712612,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '13.82', 'le': '0.27', 'lle': '1.90', 'sei': '6.90'}",CHEMBL4280231,,CHEMBL4280231,7.00,False,http://www.openphacts.org/units/Nanomolar,3108094,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712613,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)Nc1nc(Nc2cccc(C#N)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4283138,,CHEMBL4283138,,False,http://www.openphacts.org/units/Nanomolar,3108095,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712614,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(N[C@H]3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4281649,,CHEMBL4281649,,False,http://www.openphacts.org/units/Nanomolar,3108096,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712615,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2cc(F)cc(C#N)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,"{'bei': '15.86', 'le': '0.31', 'lle': '3.11', 'sei': '7.00'}",CHEMBL4291656,,CHEMBL4291656,7.30,False,http://www.openphacts.org/units/Nanomolar,3108097,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712616,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-n2ccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4293652,,CHEMBL4293652,,False,http://www.openphacts.org/units/Nanomolar,3108099,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712617,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3nc(C(F)(F)F)cs3)n2)c1,,,CHEMBL4257005,,,"{'bei': '15.49', 'le': '0.31', 'lle': '2.32', 'sei': '7.34'}",CHEMBL4286666,,CHEMBL4286666,7.30,False,http://www.openphacts.org/units/Nanomolar,3108100,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712618,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,"{'bei': '14.82', 'le': '0.29', 'lle': '1.43', 'sei': '9.26'}",CHEMBL4292275,,CHEMBL4292275,7.00,False,http://www.openphacts.org/units/Nanomolar,3108101,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712619,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)C4)nc(-c4cccc(Cl)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '15.57', 'le': '0.30', 'lle': '2.42', 'sei': '6.50'}",CHEMBL4287037,,CHEMBL4287037,7.30,False,http://www.openphacts.org/units/Nanomolar,3108105,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712620,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3nc(C(F)(F)F)cs3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4288084,,CHEMBL4288084,,False,http://www.openphacts.org/units/Nanomolar,3108106,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712621,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(NC(C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4283785,,CHEMBL4283785,,False,http://www.openphacts.org/units/Nanomolar,3108108,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712622,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3nc(C(F)(F)F)cs3)n2)c1,,,CHEMBL4257005,,,"{'bei': '14.42', 'le': '0.29', 'lle': '1.63', 'sei': '7.04'}",CHEMBL4294619,,CHEMBL4294619,7.00,False,http://www.openphacts.org/units/Nanomolar,3108110,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712623,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@H]4CCC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '13.93', 'le': '0.27', 'lle': '1.75', 'sei': '6.23'}",CHEMBL4294234,,CHEMBL4294234,7.00,False,http://www.openphacts.org/units/Nanomolar,3108111,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712624,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4293189,,CHEMBL4293189,,False,http://www.openphacts.org/units/Nanomolar,3108112,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712625,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4292077,,CHEMBL4292077,,False,http://www.openphacts.org/units/Nanomolar,3108114,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712626,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@@H]4CCC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '14.53', 'le': '0.28', 'lle': '2.05', 'sei': '6.50'}",CHEMBL4281225,,CHEMBL4281225,7.30,False,http://www.openphacts.org/units/Nanomolar,3108115,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712627,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280154,,CHEMBL4280154,,False,http://www.openphacts.org/units/Nanomolar,3108116,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712628,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,"{'bei': '15.41', 'le': '0.30', 'lle': '2.96', 'sei': '6.71'}",CHEMBL4278998,,CHEMBL4278998,7.00,False,http://www.openphacts.org/units/Nanomolar,3108118,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712629,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(NC(C)C(F)(F)F)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4277813,,CHEMBL4277813,,False,http://www.openphacts.org/units/Nanomolar,3108119,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712630,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(N[C@@H](C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4278845,,CHEMBL4278845,,False,http://www.openphacts.org/units/Nanomolar,3108120,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712631,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '15.72', 'le': '0.31', 'lle': '2.15', 'sei': '9.65'}",CHEMBL4279216,,CHEMBL4279216,7.30,False,http://www.openphacts.org/units/Nanomolar,3108121,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712632,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3cncc(Cl)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4282985,,CHEMBL4282985,,False,http://www.openphacts.org/units/Nanomolar,3108122,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712633,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1cccc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,"{'bei': '16.73', 'le': '0.33', 'lle': '2.71', 'sei': '9.26'}",CHEMBL4283381,,CHEMBL4283381,7.00,False,http://www.openphacts.org/units/Nanomolar,3108123,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712634,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cncc(Cl)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '15.22', 'le': '0.31', 'lle': '2.04', 'sei': '7.91'}",CHEMBL4276695,,CHEMBL4276695,7.00,False,http://www.openphacts.org/units/Nanomolar,3108125,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712635,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '16.73', 'le': '0.33', 'lle': '2.93', 'sei': '9.65'}",CHEMBL4280772,,CHEMBL4280772,7.30,False,http://www.openphacts.org/units/Nanomolar,3108127,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712636,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '14.53', 'le': '0.28', 'lle': '2.05', 'sei': '6.50'}",CHEMBL4290840,,CHEMBL4290840,7.30,False,http://www.openphacts.org/units/Nanomolar,3108129,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712637,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Nc1ccc(F)c(-c2nc(Nc3cc(F)cc(F)c3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,"{'bei': '16.69', 'le': '0.32', 'lle': '3.02', 'sei': '7.18'}",CHEMBL4294923,,CHEMBL4294923,7.30,False,http://www.openphacts.org/units/Nanomolar,3108131,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712638,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,"{'bei': '15.04', 'le': '0.29', 'lle': '2.08', 'sei': '7.04'}",CHEMBL4289832,,CHEMBL4289832,7.00,False,http://www.openphacts.org/units/Nanomolar,3108132,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712639,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1nc(-c2nc(NC3CCC(F)(F)C3)nc(NC3CCC(F)(F)C3)n2)cs1,,,CHEMBL4257005,,,"{'bei': '15.65', 'le': '0.32', 'lle': '1.99', 'sei': '9.65'}",CHEMBL4277782,,CHEMBL4277782,7.30,False,http://www.openphacts.org/units/Nanomolar,3108133,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712640,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(NC(C)C(F)(F)F)nc(-c2cncc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4276732,,CHEMBL4276732,,False,http://www.openphacts.org/units/Nanomolar,3108134,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712641,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCCC1Nc1nc(NC2CCCC2(F)F)nc(-c2cccc(Cl)n2)n1,,,CHEMBL4257005,,,,CHEMBL4281900,,CHEMBL4281900,,False,http://www.openphacts.org/units/Nanomolar,3108135,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712642,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '13.85', 'le': '0.27', 'lle': '1.29', 'sei': '7.91'}",CHEMBL4280826,,CHEMBL4280826,7.00,False,http://www.openphacts.org/units/Nanomolar,3108136,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712643,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3nc(C(F)(F)F)cs3)n2)c1,,,CHEMBL4257005,,,"{'bei': '14.63', 'le': '0.30', 'lle': '1.36', 'sei': '9.26'}",CHEMBL4287902,,CHEMBL4287902,7.00,False,http://www.openphacts.org/units/Nanomolar,3108137,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712644,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cncc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4286852,,CHEMBL4286852,,False,http://www.openphacts.org/units/Nanomolar,3108138,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712645,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4289309,,CHEMBL4289309,,False,http://www.openphacts.org/units/Nanomolar,3108139,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712646,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,"{'bei': '13.96', 'le': '0.27', 'lle': '1.20', 'sei': '7.91'}",CHEMBL4277398,,CHEMBL4277398,7.00,False,http://www.openphacts.org/units/Nanomolar,3108141,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712647,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Nc1ccc(F)c(-c2nc(Nc3cc(F)cc(F)c3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '15.51', 'le': '0.30', 'lle': '2.33', 'sei': '6.89'}",CHEMBL4291867,,CHEMBL4291867,7.00,False,http://www.openphacts.org/units/Nanomolar,3108143,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712648,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1)CC(Nc1nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n1)C2,,,CHEMBL4257005,,,"{'bei': '13.82', 'le': '0.27', 'lle': '1.86', 'sei': '8.25'}",CHEMBL4277020,,CHEMBL4277020,7.00,False,http://www.openphacts.org/units/Nanomolar,3108144,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712649,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4291491,,CHEMBL4291491,,False,http://www.openphacts.org/units/Nanomolar,3108146,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712650,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CC(F)(F)C4)nc(-n4ccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4284431,,CHEMBL4284431,,False,http://www.openphacts.org/units/Nanomolar,3108147,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712651,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,"{'bei': '14.08', 'le': '0.28', 'lle': '1.53', 'sei': '7.91'}",CHEMBL4280719,,CHEMBL4280719,7.00,False,http://www.openphacts.org/units/Nanomolar,3108149,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712652,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.45', 'le': '0.28', 'lle': '1.59', 'sei': '8.25'}",CHEMBL4279665,,CHEMBL4279665,7.30,False,http://www.openphacts.org/units/Nanomolar,3108150,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712653,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-n3ccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.77', 'le': '0.29', 'lle': '2.47', 'sei': '7.81'}",CHEMBL4295239,,CHEMBL4295239,7.30,False,http://www.openphacts.org/units/Nanomolar,3108151,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712654,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@H]4CCC(F)(F)C4)nc(-n4ccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '14.86', 'le': '0.28', 'lle': '2.93', 'sei': '6.23'}",CHEMBL4294151,,CHEMBL4294151,7.30,False,http://www.openphacts.org/units/Nanomolar,3108152,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712655,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NCC3CC3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,"{'bei': '16.30', 'le': '0.31', 'lle': '2.47', 'sei': '7.04'}",CHEMBL4293761,,CHEMBL4293761,7.00,False,http://www.openphacts.org/units/Nanomolar,3108153,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712656,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-n3ccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '14.54', 'le': '0.29', 'lle': '1.94', 'sei': '8.69'}",CHEMBL4290087,,CHEMBL4290087,7.00,False,http://www.openphacts.org/units/Nanomolar,3108154,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712657,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,"{'bei': '15.01', 'le': '0.30', 'lle': '2.70', 'sei': '7.81'}",CHEMBL4289717,,CHEMBL4289717,7.30,False,http://www.openphacts.org/units/Nanomolar,3108155,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712658,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '13.85', 'le': '0.27', 'lle': '1.29', 'sei': '7.91'}",CHEMBL4288655,,CHEMBL4288655,7.00,False,http://www.openphacts.org/units/Nanomolar,3108156,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712659,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(Nc2nc(NC3CCC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,"{'bei': '15.51', 'le': '0.30', 'lle': '3.31', 'sei': '5.97'}",CHEMBL4285674,,CHEMBL4285674,7.00,False,http://www.openphacts.org/units/Nanomolar,3108157,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712660,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC[C@H](Nc1nc(N[C@@H](CC)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4284624,,CHEMBL4284624,,False,http://www.openphacts.org/units/Nanomolar,3108158,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712661,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,"{'bei': '15.14', 'le': '0.29', 'lle': '2.44', 'sei': '6.23'}",CHEMBL4279182,,CHEMBL4279182,7.00,False,http://www.openphacts.org/units/Nanomolar,3108159,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712662,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3nc(C(F)(F)F)cs3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '14.65', 'le': '0.30', 'lle': '1.31', 'sei': '9.65'}",CHEMBL4283342,,CHEMBL4283342,7.30,False,http://www.openphacts.org/units/Nanomolar,3108161,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712663,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)C4)nc(-n4ccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '14.86', 'le': '0.28', 'lle': '2.93', 'sei': '6.23'}",CHEMBL4292283,,CHEMBL4292283,7.30,False,http://www.openphacts.org/units/Nanomolar,3108163,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712664,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1cncc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '14.72', 'le': '0.29', 'lle': '1.75', 'sei': '7.91'}",CHEMBL4293294,,CHEMBL4293294,7.00,False,http://www.openphacts.org/units/Nanomolar,3108164,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712665,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3Cc4cccnc4C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4278816,,CHEMBL4278816,,False,http://www.openphacts.org/units/Nanomolar,3108166,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712666,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)CC4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '13.55', 'le': '0.26', 'lle': '1.36', 'sei': '6.23'}",CHEMBL4294793,,CHEMBL4294793,7.00,False,http://www.openphacts.org/units/Nanomolar,3108167,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712667,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.25', 'le': '0.28', 'lle': '1.68', 'sei': '7.91'}",CHEMBL4277305,,CHEMBL4277305,7.00,False,http://www.openphacts.org/units/Nanomolar,3108168,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712668,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CC4(C3)CC(F)(F)C4)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.27', 'le': '0.28', 'lle': '1.46', 'sei': '9.26'}",CHEMBL4293221,,CHEMBL4293221,7.00,False,http://www.openphacts.org/units/Nanomolar,3108169,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712669,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '13.48', 'le': '0.27', 'lle': '0.90', 'sei': '7.91'}",CHEMBL4292220,,CHEMBL4292220,7.00,False,http://www.openphacts.org/units/Nanomolar,3108170,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712670,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3ccnc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '15.69', 'le': '0.31', 'lle': '2.75', 'sei': '8.25'}",CHEMBL4288431,,CHEMBL4288431,7.30,False,http://www.openphacts.org/units/Nanomolar,3108172,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712671,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3nc(F)ccc3F)n2)c1,,,CHEMBL4257005,,,"{'bei': '16.42', 'le': '0.32', 'lle': '2.56', 'sei': '9.26'}",CHEMBL4287770,,CHEMBL4287770,7.00,False,http://www.openphacts.org/units/Nanomolar,3108173,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712672,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC[C@H](Nc1nc(N[C@H](CC)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,"{'bei': '16.49', 'le': '0.34', 'lle': '2.21', 'sei': '9.65'}",CHEMBL4286718,,CHEMBL4286718,7.30,False,http://www.openphacts.org/units/Nanomolar,3108174,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712673,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-n3ccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.57', 'le': '0.29', 'lle': '2.56', 'sei': '7.49'}",CHEMBL4291846,,CHEMBL4291846,7.00,False,http://www.openphacts.org/units/Nanomolar,3108175,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712674,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cc(Nc2nc(NCC3CC3)nc(-c3cccc(Cl)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4279427,,CHEMBL4279427,,False,http://www.openphacts.org/units/Nanomolar,3108178,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712675,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,"{'bei': '15.10', 'le': '0.29', 'lle': '3.17', 'sei': '6.23'}",CHEMBL4281644,,CHEMBL4281644,7.30,False,http://www.openphacts.org/units/Nanomolar,3108179,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712676,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(-c4ccccc4)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '13.63', 'le': '0.26', 'lle': '0.64', 'sei': '7.91'}",CHEMBL4285379,,CHEMBL4285379,7.00,False,http://www.openphacts.org/units/Nanomolar,3108180,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712677,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4280213,,CHEMBL4280213,,False,http://www.openphacts.org/units/Nanomolar,3108181,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712678,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1csc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '15.20', 'le': '0.31', 'lle': '1.39', 'sei': '9.65'}",CHEMBL4281964,,CHEMBL4281964,7.30,False,http://www.openphacts.org/units/Nanomolar,3108183,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712679,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C#N)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,"{'bei': '15.79', 'le': '0.31', 'lle': '3.55', 'sei': '5.97'}",CHEMBL4285716,,CHEMBL4285716,7.00,False,http://www.openphacts.org/units/Nanomolar,3108185,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712680,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1nc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)cs1,,,CHEMBL4257005,,,"{'bei': '15.97', 'le': '0.33', 'lle': '2.47', 'sei': '9.26'}",CHEMBL4287400,,CHEMBL4287400,7.00,False,http://www.openphacts.org/units/Nanomolar,3108187,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712681,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(Nc2nc(NC3CC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,"{'bei': '16.01', 'le': '0.31', 'lle': '3.70', 'sei': '5.97'}",CHEMBL4291112,,CHEMBL4291112,7.00,False,http://www.openphacts.org/units/Nanomolar,3108188,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712682,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cccc(-c2nc(Nc3ccnc(C4(C#N)CC4)c3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '13.66', 'le': '0.26', 'lle': '1.27', 'sei': '6.23'}",CHEMBL4288641,,CHEMBL4288641,7.00,False,http://www.openphacts.org/units/Nanomolar,3108189,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712683,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(Cl)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '15.91', 'le': '0.32', 'lle': '1.73', 'sei': '9.65'}",CHEMBL4289692,,CHEMBL4289692,7.30,False,http://www.openphacts.org/units/Nanomolar,3108190,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712684,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NCC(F)(F)F)nc(-c4cccc(Cl)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '15.67', 'le': '0.31', 'lle': '2.75', 'sei': '6.23'}",CHEMBL4289616,,CHEMBL4289616,7.00,False,http://www.openphacts.org/units/Nanomolar,3108193,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712685,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(CNc2nc(NCC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '15.07', 'le': '0.30', 'lle': '2.13', 'sei': '9.26'}",CHEMBL4294886,,CHEMBL4294886,7.00,False,http://www.openphacts.org/units/Nanomolar,3108194,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712686,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2ccnc(-c3ccccc3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,"{'bei': '13.85', 'le': '0.27', 'lle': '0.88', 'sei': '7.91'}",CHEMBL4289777,,CHEMBL4289777,7.00,False,http://www.openphacts.org/units/Nanomolar,3108195,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712687,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cccc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '14.33', 'le': '0.28', 'lle': '0.98', 'sei': '9.26'}",CHEMBL4290807,,CHEMBL4290807,7.00,False,http://www.openphacts.org/units/Nanomolar,3108196,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712688,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(-c4ccccc4)c3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '13.27', 'le': '0.25', 'lle': '0.25', 'sei': '7.91'}",CHEMBL4284814,,CHEMBL4284814,7.00,False,http://www.openphacts.org/units/Nanomolar,3108198,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712689,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(CNc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4290997,,CHEMBL4290997,,False,http://www.openphacts.org/units/Nanomolar,3108199,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712690,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1cccc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '14.75', 'le': '0.29', 'lle': '1.15', 'sei': '9.26'}",CHEMBL4291368,,CHEMBL4291368,7.00,False,http://www.openphacts.org/units/Nanomolar,3108202,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712691,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CC5(C4)CC(F)(F)C5)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '13.25', 'le': '0.25', 'lle': '1.36', 'sei': '6.23'}",CHEMBL4288051,,CHEMBL4288051,7.00,False,http://www.openphacts.org/units/Nanomolar,3108207,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712692,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(CC#N)Nc1nc(Nc2ccnc(C(C)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4291861,,CHEMBL4291861,,False,http://www.openphacts.org/units/Nanomolar,3108209,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712693,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4292885,,CHEMBL4292885,,False,http://www.openphacts.org/units/Nanomolar,3108210,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712694,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,OC(F)(F)CNc1nc(Nc2cc(F)cc(F)c2)nc(-n2ccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '16.01', 'le': '0.32', 'lle': '3.91', 'sei': '6.95'}",CHEMBL4286365,,CHEMBL4286365,7.00,False,http://www.openphacts.org/units/Nanomolar,3108213,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712695,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1ccn(-c2nc(NCC(O)(F)F)nc(Nc3cc(F)cc(Cl)c3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4287398,,CHEMBL4287398,,False,http://www.openphacts.org/units/Nanomolar,3108214,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712696,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3nccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '15.04', 'le': '0.30', 'lle': '2.45', 'sei': '7.91'}",CHEMBL4287795,,CHEMBL4287795,7.00,False,http://www.openphacts.org/units/Nanomolar,3108215,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712697,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CN(c4ccccn4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.21', 'le': '0.27', 'lle': '2.75', 'sei': '7.63'}",CHEMBL4291485,,CHEMBL4291485,7.00,False,http://www.openphacts.org/units/Nanomolar,3108216,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712698,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,O=C1C[C@H](Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)CN1c1ccccn1,,,CHEMBL4257005,,,"{'bei': '13.45', 'le': '0.26', 'lle': '2.84', 'sei': '6.43'}",CHEMBL4288916,,CHEMBL4288916,7.00,False,http://www.openphacts.org/units/Nanomolar,3108217,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712699,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CN(c4cccnc4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.21', 'le': '0.27', 'lle': '2.75', 'sei': '7.63'}",CHEMBL4282632,,CHEMBL4282632,7.00,False,http://www.openphacts.org/units/Nanomolar,3108221,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712700,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)CNc1nc(Nc2cc(F)cc(C#N)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4281594,,CHEMBL4281594,,False,http://www.openphacts.org/units/Nanomolar,3108222,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712701,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Nc1ccc(F)c(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '15.30', 'le': '0.30', 'lle': '2.37', 'sei': '6.89'}",CHEMBL4291587,,CHEMBL4291587,7.00,False,http://www.openphacts.org/units/Nanomolar,3108227,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712702,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3ccnc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '16.01', 'le': '0.32', 'lle': '3.23', 'sei': '7.91'}",CHEMBL4294983,,CHEMBL4294983,7.00,False,http://www.openphacts.org/units/Nanomolar,3108229,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712703,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCOCC3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '15.27', 'le': '0.30', 'lle': '2.47', 'sei': '8.25'}",CHEMBL4292464,,CHEMBL4292464,7.00,False,http://www.openphacts.org/units/Nanomolar,3108233,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712704,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C4CC4)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4289397,,CHEMBL4289397,,False,http://www.openphacts.org/units/Nanomolar,3108236,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712705,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3nc(F)ccc3F)n2)c1,,,CHEMBL4257005,,,,CHEMBL4285080,,CHEMBL4285080,,False,http://www.openphacts.org/units/Nanomolar,3108238,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712706,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,O=C(c1ccccc1)N1CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '13.12', 'le': '0.25', 'lle': '2.12', 'sei': '7.30'}",CHEMBL4283985,,CHEMBL4283985,7.00,False,http://www.openphacts.org/units/Nanomolar,3108241,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712707,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)CNc1nc(NC2CCC(F)(F)C2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '16.19', 'le': '0.32', 'lle': '3.27', 'sei': '7.30'}",CHEMBL4282936,,CHEMBL4282936,7.00,False,http://www.openphacts.org/units/Nanomolar,3108242,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712708,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CS(=O)(=O)N1CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4284068,,CHEMBL4284068,,False,http://www.openphacts.org/units/Nanomolar,3108244,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712709,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2nccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '17.79', 'le': '0.34', 'lle': '3.23', 'sei': '7.91'}",CHEMBL4285495,,CHEMBL4285495,7.00,False,http://www.openphacts.org/units/Nanomolar,3108246,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712710,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc([C@H]2C[C@@H](Nc3nc(N[C@H]4C[C@@H](c5ccc(F)cc5)C4)nc(-c4cccc(C(F)(F)F)n4)n3)C2)cc1,,,CHEMBL4257005,,,"{'bei': '12.67', 'le': '0.24', 'lle': '0.05', 'sei': '9.26'}",CHEMBL4291957,,CHEMBL4291957,7.00,False,http://www.openphacts.org/units/Nanomolar,3108250,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712711,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(=O)N1CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4292328,,CHEMBL4292328,,False,http://www.openphacts.org/units/Nanomolar,3108251,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712712,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCN(Cc4ccccc4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4294899,,CHEMBL4294899,,False,http://www.openphacts.org/units/Nanomolar,3108258,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712713,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)CNc1nc(NC2CCC(F)(F)CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4281385,,CHEMBL4281385,,False,http://www.openphacts.org/units/Nanomolar,3108265,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712714,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cc(F)ccc2F)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4293737,,CHEMBL4293737,,False,http://www.openphacts.org/units/Nanomolar,3108270,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712715,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@@H]4CCC(F)(F)C4)nc(-n4ccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '14.86', 'le': '0.28', 'lle': '2.93', 'sei': '6.23'}",CHEMBL4289705,,CHEMBL4289705,7.30,False,http://www.openphacts.org/units/Nanomolar,3108326,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712716,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cncc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,"{'bei': '14.13', 'le': '0.27', 'lle': '2.60', 'sei': '5.59'}",CHEMBL4281897,,CHEMBL4281897,7.00,False,http://www.openphacts.org/units/Nanomolar,3108353,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712717,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@@H]4CCC(F)(F)C4)nc(-c4cncc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '14.50', 'le': '0.28', 'lle': '2.66', 'sei': '5.83'}",CHEMBL4294826,,CHEMBL4294826,7.30,False,http://www.openphacts.org/units/Nanomolar,3108354,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712718,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(Nc2nc(N[C@H]3CCC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,"{'bei': '15.51', 'le': '0.30', 'lle': '3.31', 'sei': '5.97'}",CHEMBL4292273,,CHEMBL4292273,7.00,False,http://www.openphacts.org/units/Nanomolar,3108357,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712719,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)CC4)nc(-n4ccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '13.85', 'le': '0.27', 'lle': '2.24', 'sei': '5.97'}",CHEMBL4286039,,CHEMBL4286039,7.00,False,http://www.openphacts.org/units/Nanomolar,3108358,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712720,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cccc(-c2nc(Nc3ccnc(C4(C#N)CC4)c3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,"{'bei': '14.04', 'le': '0.27', 'lle': '1.66', 'sei': '6.23'}",CHEMBL4287374,,CHEMBL4287374,7.00,False,http://www.openphacts.org/units/Nanomolar,3108360,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712721,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CC5(C4)CC(F)(F)C5)nc(-c4cncc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '13.22', 'le': '0.25', 'lle': '1.97', 'sei': '5.59'}",CHEMBL4285701,,CHEMBL4285701,7.00,False,http://www.openphacts.org/units/Nanomolar,3108361,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712722,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2cncc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4283555,,CHEMBL4283555,,False,http://www.openphacts.org/units/Nanomolar,3108362,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712723,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3nc(C(F)(F)F)cs3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.68', 'le': '0.30', 'lle': '1.92', 'sei': '8.25'}",CHEMBL4293197,,CHEMBL4293197,7.30,False,http://www.openphacts.org/units/Nanomolar,3108364,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712724,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cncc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '13.45', 'le': '0.27', 'lle': '1.51', 'sei': '6.90'}",CHEMBL4280467,,CHEMBL4280467,7.00,False,http://www.openphacts.org/units/Nanomolar,3108365,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712725,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.22', 'le': '0.28', 'lle': '2.29', 'sei': '6.90'}",CHEMBL4290944,,CHEMBL4290944,7.00,False,http://www.openphacts.org/units/Nanomolar,3108366,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712726,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '13.82', 'le': '0.27', 'lle': '1.90', 'sei': '6.90'}",CHEMBL4294642,,CHEMBL4294642,7.00,False,http://www.openphacts.org/units/Nanomolar,3108367,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712727,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,"{'bei': '15.10', 'le': '0.29', 'lle': '3.17', 'sei': '6.23'}",CHEMBL4279960,,CHEMBL4279960,7.30,False,http://www.openphacts.org/units/Nanomolar,3108368,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712728,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-n3ccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.16', 'le': '0.28', 'lle': '2.17', 'sei': '7.49'}",CHEMBL4278901,,CHEMBL4278901,7.00,False,http://www.openphacts.org/units/Nanomolar,3108369,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712729,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)CC4)nc(-c4cncc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '13.53', 'le': '0.26', 'lle': '1.97', 'sei': '5.59'}",CHEMBL4294407,,CHEMBL4294407,7.00,False,http://www.openphacts.org/units/Nanomolar,3108370,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712730,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(N[C@@H]3CCC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4287914,,CHEMBL4287914,,False,http://www.openphacts.org/units/Nanomolar,3108374,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712731,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CC(F)(F)C4)nc(-c4cncc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '14.30', 'le': '0.27', 'lle': '2.75', 'sei': '5.59'}",CHEMBL4281916,,CHEMBL4281916,7.00,False,http://www.openphacts.org/units/Nanomolar,3108376,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712732,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1csc(-c2nc(NC3CCC(F)(F)C3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4282389,,CHEMBL4282389,,False,http://www.openphacts.org/units/Nanomolar,3108377,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712733,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1csc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4278630,,CHEMBL4278630,,False,http://www.openphacts.org/units/Nanomolar,3108378,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712734,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(NC(C)C(F)(F)F)nc(-c2nc(C(F)(F)F)cs2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4281715,,CHEMBL4281715,,False,http://www.openphacts.org/units/Nanomolar,3108379,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712735,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3cncc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.45', 'le': '0.28', 'lle': '1.59', 'sei': '8.25'}",CHEMBL4282741,,CHEMBL4282741,7.30,False,http://www.openphacts.org/units/Nanomolar,3108380,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712736,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(N[C@H]3CCC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4286538,,CHEMBL4286538,,False,http://www.openphacts.org/units/Nanomolar,3108381,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712737,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cc(Nc2nc(NCC3CC3)nc(-n3ccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,"{'bei': '15.75', 'le': '0.31', 'lle': '2.94', 'sei': '7.49'}",CHEMBL4291710,,CHEMBL4291710,7.00,False,http://www.openphacts.org/units/Nanomolar,3108382,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712738,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1cncc(-c2nc(NC3CCC(F)(F)C3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4292069,,CHEMBL4292069,,False,http://www.openphacts.org/units/Nanomolar,3108383,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712739,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1cncc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4277241,,CHEMBL4277241,,False,http://www.openphacts.org/units/Nanomolar,3108384,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712740,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@@H](Nc2nc(N[C@@H]3CCC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280571,,CHEMBL4280571,,False,http://www.openphacts.org/units/Nanomolar,3108385,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712741,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1ccnc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,"{'bei': '16.69', 'le': '0.33', 'lle': '3.31', 'sei': '7.91'}",CHEMBL4281625,,CHEMBL4281625,7.00,False,http://www.openphacts.org/units/Nanomolar,3108386,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712742,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1ccnc(-c2nc(NC3CCC(F)(F)C3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,"{'bei': '15.65', 'le': '0.31', 'lle': '2.53', 'sei': '7.91'}",CHEMBL4281482,,CHEMBL4281482,7.00,False,http://www.openphacts.org/units/Nanomolar,3108387,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712743,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3nc(C(F)(F)F)cs3)n2)c1,,,CHEMBL4257005,,,"{'bei': '15.07', 'le': '0.31', 'lle': '1.75', 'sei': '9.26'}",CHEMBL4282517,,CHEMBL4282517,7.00,False,http://www.openphacts.org/units/Nanomolar,3108388,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712744,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1cc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '17.88', 'le': '0.34', 'lle': '2.02', 'sei': '11.16'}",CHEMBL4282906,,CHEMBL4282906,7.00,False,http://www.openphacts.org/units/Nanomolar,3108389,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712745,[],CHEMBL4257016,Inhibition of IDH1 R132H/R132C mutant in human HT1080 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1cc(NC(C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '17.88', 'le': '0.34', 'lle': '2.02', 'sei': '11.16'}",CHEMBL4295139,,CHEMBL4295139,7.00,False,http://www.openphacts.org/units/Nanomolar,3108395,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712746,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cccc(-c2nc(NCC3CC3)nc(NCC3CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4292293,,CHEMBL4292293,,False,http://www.openphacts.org/units/Nanomolar,3108003,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712747,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4278828,,CHEMBL4278828,,False,http://www.openphacts.org/units/Nanomolar,3108004,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712748,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)Nc1nc(NC2CCCOC2)nc(-c2ccccc2)n1,,,CHEMBL4257005,,,"{'bei': '22.33', 'le': '0.42', 'lle': '4.05', 'sei': '9.73'}",CHEMBL4279012,,CHEMBL4279012,7.00,False,http://www.openphacts.org/units/Nanomolar,3108068,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712749,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C=CCCNc1nc(NCCC=C)nc(-c2ccccc2)n1,,,CHEMBL4257005,,,"{'bei': '24.72', 'le': '0.45', 'lle': '3.79', 'sei': '11.64'}",CHEMBL4292494,,CHEMBL4292494,7.30,False,http://www.openphacts.org/units/Nanomolar,3108069,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712750,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,c1ccc(-c2nc(NC3C4COCC43)nc(NC3C4COCC43)n2)cc1,,,CHEMBL4257005,,,"{'bei': '20.78', 'le': '0.38', 'lle': '5.65', 'sei': '8.99'}",CHEMBL4293509,,CHEMBL4293509,7.30,False,http://www.openphacts.org/units/Nanomolar,3108070,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712751,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Clc1cccc(-c2nc(NC3C4COCC43)nc(NC3C4COCC43)n2)n1,,,CHEMBL4257005,,,"{'bei': '18.87', 'le': '0.37', 'lle': '5.60', 'sei': '7.76'}",CHEMBL4294177,,CHEMBL4294177,7.30,False,http://www.openphacts.org/units/Nanomolar,3108071,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712752,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)CNc1nc(NCC(C)(C)C)nc(-c2cccc(N)n2)n1,,,CHEMBL4257005,,,"{'bei': '21.26', 'le': '0.40', 'lle': '3.87', 'sei': '7.18'}",CHEMBL4276680,,CHEMBL4276680,7.30,False,http://www.openphacts.org/units/Nanomolar,3108072,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712753,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)CNc1nc(NCC(C)C)nc(-c2cccc(N)n2)n1,,,CHEMBL4257005,,,"{'bei': '23.15', 'le': '0.43', 'lle': '4.65', 'sei': '7.18'}",CHEMBL4279394,,CHEMBL4279394,7.30,False,http://www.openphacts.org/units/Nanomolar,3108073,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712754,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)CNc1nc(NC2CCOCC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4280463,,CHEMBL4280463,,False,http://www.openphacts.org/units/Nanomolar,3108074,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712755,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CN1CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4292335,,CHEMBL4292335,,False,http://www.openphacts.org/units/Nanomolar,3108077,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712756,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4279047,,CHEMBL4279047,,False,http://www.openphacts.org/units/Nanomolar,3108079,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712757,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(N[C@@H]3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4278020,,CHEMBL4278020,,False,http://www.openphacts.org/units/Nanomolar,3108080,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712758,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CCC(Nc1nc(NC(CC)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4293542,,CHEMBL4293542,,False,http://www.openphacts.org/units/Nanomolar,3108081,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712759,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC[C@@H](Nc1nc(N[C@H](CC)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4292520,,CHEMBL4292520,,False,http://www.openphacts.org/units/Nanomolar,3108082,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712760,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cccc(-c2nc(NC3CCC(F)(F)C3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4292152,,CHEMBL4292152,,False,http://www.openphacts.org/units/Nanomolar,3108083,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712761,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4288434,,CHEMBL4288434,,False,http://www.openphacts.org/units/Nanomolar,3108084,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712762,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2cc(F)cc(F)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4288067,,CHEMBL4288067,,False,http://www.openphacts.org/units/Nanomolar,3108085,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712763,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4287015,,CHEMBL4287015,,False,http://www.openphacts.org/units/Nanomolar,3108086,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712764,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cncc(Cl)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4284034,,CHEMBL4284034,,False,http://www.openphacts.org/units/Nanomolar,3108087,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712765,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CCC(Nc1nc(NC(CC)C2CC2)nc(-c2cccc(Cl)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4282989,,CHEMBL4282989,,False,http://www.openphacts.org/units/Nanomolar,3108088,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712766,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@@H](Nc2nc(N[C@@H]3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4294589,,CHEMBL4294589,,False,http://www.openphacts.org/units/Nanomolar,3108089,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712767,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4293545,,CHEMBL4293545,,False,http://www.openphacts.org/units/Nanomolar,3108090,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712768,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(Cl)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280132,,CHEMBL4280132,,False,http://www.openphacts.org/units/Nanomolar,3108091,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712769,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2csc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4279049,,CHEMBL4279049,,False,http://www.openphacts.org/units/Nanomolar,3108092,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712770,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(Cl)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4281282,,CHEMBL4281282,,False,http://www.openphacts.org/units/Nanomolar,3108093,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712771,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280231,,CHEMBL4280231,,False,http://www.openphacts.org/units/Nanomolar,3108094,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712772,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)Nc1nc(Nc2cccc(C#N)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4283138,,CHEMBL4283138,,False,http://www.openphacts.org/units/Nanomolar,3108095,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712773,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(N[C@H]3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4281649,,CHEMBL4281649,,False,http://www.openphacts.org/units/Nanomolar,3108096,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712774,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2cc(F)cc(C#N)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4291656,,CHEMBL4291656,,False,http://www.openphacts.org/units/Nanomolar,3108097,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712775,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3cncc(Cl)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4290600,,CHEMBL4290600,,False,http://www.openphacts.org/units/Nanomolar,3108098,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712776,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-n2ccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4293652,,CHEMBL4293652,,False,http://www.openphacts.org/units/Nanomolar,3108099,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712777,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3nc(C(F)(F)F)cs3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4286666,,CHEMBL4286666,,False,http://www.openphacts.org/units/Nanomolar,3108100,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712778,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4292275,,CHEMBL4292275,,False,http://www.openphacts.org/units/Nanomolar,3108101,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712779,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4293284,,CHEMBL4293284,,False,http://www.openphacts.org/units/Nanomolar,3108102,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712780,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4291118,,CHEMBL4291118,,False,http://www.openphacts.org/units/Nanomolar,3108103,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712781,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4292169,,CHEMBL4292169,,False,http://www.openphacts.org/units/Nanomolar,3108104,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712782,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)C4)nc(-c4cccc(Cl)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4287037,,CHEMBL4287037,,False,http://www.openphacts.org/units/Nanomolar,3108105,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712783,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3nc(C(F)(F)F)cs3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4288084,,CHEMBL4288084,,False,http://www.openphacts.org/units/Nanomolar,3108106,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712784,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cncc(Cl)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280017,,CHEMBL4280017,,False,http://www.openphacts.org/units/Nanomolar,3108107,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712785,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(NC(C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4283785,,CHEMBL4283785,,False,http://www.openphacts.org/units/Nanomolar,3108108,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712786,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Clc1cccc(-c2nc(NC(C3CC3)C3CC3)nc(NC(C3CC3)C3CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4279765,,CHEMBL4279765,,False,http://www.openphacts.org/units/Nanomolar,3108109,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712787,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3nc(C(F)(F)F)cs3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4294619,,CHEMBL4294619,,False,http://www.openphacts.org/units/Nanomolar,3108110,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712788,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@H]4CCC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4294234,,CHEMBL4294234,,False,http://www.openphacts.org/units/Nanomolar,3108111,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712789,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4293189,,CHEMBL4293189,,False,http://www.openphacts.org/units/Nanomolar,3108112,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712790,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4292077,,CHEMBL4292077,,False,http://www.openphacts.org/units/Nanomolar,3108114,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712791,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@@H]4CCC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4281225,,CHEMBL4281225,,False,http://www.openphacts.org/units/Nanomolar,3108115,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712792,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280154,,CHEMBL4280154,,False,http://www.openphacts.org/units/Nanomolar,3108116,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712793,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3nc(F)ccc3F)n2)c1,,,CHEMBL4257005,,,,CHEMBL4282753,,CHEMBL4282753,,False,http://www.openphacts.org/units/Nanomolar,3108117,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712794,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4278998,,CHEMBL4278998,,False,http://www.openphacts.org/units/Nanomolar,3108118,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712795,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(NC(C)C(F)(F)F)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4277813,,CHEMBL4277813,,False,http://www.openphacts.org/units/Nanomolar,3108119,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712796,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(N[C@@H](C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4278845,,CHEMBL4278845,,False,http://www.openphacts.org/units/Nanomolar,3108120,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712797,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4279216,,CHEMBL4279216,,False,http://www.openphacts.org/units/Nanomolar,3108121,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712798,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3cncc(Cl)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4282985,,CHEMBL4282985,,False,http://www.openphacts.org/units/Nanomolar,3108122,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712799,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1cccc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4283381,,CHEMBL4283381,,False,http://www.openphacts.org/units/Nanomolar,3108123,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712800,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4284375,,CHEMBL4284375,,False,http://www.openphacts.org/units/Nanomolar,3108124,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712801,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cncc(Cl)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4276695,,CHEMBL4276695,,False,http://www.openphacts.org/units/Nanomolar,3108125,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712802,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3nc(C(F)(F)F)cs3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4277748,,CHEMBL4277748,,False,http://www.openphacts.org/units/Nanomolar,3108126,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712803,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280772,,CHEMBL4280772,,False,http://www.openphacts.org/units/Nanomolar,3108127,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712804,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc2c(c1)CC(Nc1nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n1)C2,,,CHEMBL4257005,,,,CHEMBL4281861,,CHEMBL4281861,,False,http://www.openphacts.org/units/Nanomolar,3108128,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712805,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4290840,,CHEMBL4290840,,False,http://www.openphacts.org/units/Nanomolar,3108129,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712806,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3Cc4ccccc4C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4289822,,CHEMBL4289822,,False,http://www.openphacts.org/units/Nanomolar,3108130,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712807,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Nc1ccc(F)c(-c2nc(Nc3cc(F)cc(F)c3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4294923,,CHEMBL4294923,,False,http://www.openphacts.org/units/Nanomolar,3108131,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712808,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4289832,,CHEMBL4289832,,False,http://www.openphacts.org/units/Nanomolar,3108132,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712809,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1nc(-c2nc(NC3CCC(F)(F)C3)nc(NC3CCC(F)(F)C3)n2)cs1,,,CHEMBL4257005,,,,CHEMBL4277782,,CHEMBL4277782,,False,http://www.openphacts.org/units/Nanomolar,3108133,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712810,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(NC(C)C(F)(F)F)nc(-c2cncc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4276732,,CHEMBL4276732,,False,http://www.openphacts.org/units/Nanomolar,3108134,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712811,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCCC1Nc1nc(NC2CCCC2(F)F)nc(-c2cccc(Cl)n2)n1,,,CHEMBL4257005,,,"{'bei': '16.95', 'le': '0.34', 'lle': '2.51', 'sei': '9.65'}",CHEMBL4281900,,CHEMBL4281900,7.30,False,http://www.openphacts.org/units/Nanomolar,3108135,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712812,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280826,,CHEMBL4280826,,False,http://www.openphacts.org/units/Nanomolar,3108136,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712813,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3nc(C(F)(F)F)cs3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4287902,,CHEMBL4287902,,False,http://www.openphacts.org/units/Nanomolar,3108137,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712814,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cncc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4286852,,CHEMBL4286852,,False,http://www.openphacts.org/units/Nanomolar,3108138,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712815,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4289309,,CHEMBL4289309,,False,http://www.openphacts.org/units/Nanomolar,3108139,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712816,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)Nc1nc(Nc2ccnc(C#N)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4284724,,CHEMBL4284724,,False,http://www.openphacts.org/units/Nanomolar,3108140,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712817,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4277398,,CHEMBL4277398,,False,http://www.openphacts.org/units/Nanomolar,3108141,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712818,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4278417,,CHEMBL4278417,,False,http://www.openphacts.org/units/Nanomolar,3108142,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712819,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Nc1ccc(F)c(-c2nc(Nc3cc(F)cc(F)c3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4291867,,CHEMBL4291867,,False,http://www.openphacts.org/units/Nanomolar,3108143,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712820,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cccc(Cl)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4290450,,CHEMBL4290450,,False,http://www.openphacts.org/units/Nanomolar,3108145,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712821,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4291491,,CHEMBL4291491,,False,http://www.openphacts.org/units/Nanomolar,3108146,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712822,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CC(F)(F)C4)nc(-n4ccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4284431,,CHEMBL4284431,,False,http://www.openphacts.org/units/Nanomolar,3108147,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712823,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3csc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4292401,,CHEMBL4292401,,False,http://www.openphacts.org/units/Nanomolar,3108148,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712824,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4280719,,CHEMBL4280719,,False,http://www.openphacts.org/units/Nanomolar,3108149,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712825,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4279665,,CHEMBL4279665,,False,http://www.openphacts.org/units/Nanomolar,3108150,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712826,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-n3ccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4295239,,CHEMBL4295239,,False,http://www.openphacts.org/units/Nanomolar,3108151,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712827,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@H]4CCC(F)(F)C4)nc(-n4ccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4294151,,CHEMBL4294151,,False,http://www.openphacts.org/units/Nanomolar,3108152,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712828,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NCC3CC3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4293761,,CHEMBL4293761,,False,http://www.openphacts.org/units/Nanomolar,3108153,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712829,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-n3ccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4290087,,CHEMBL4290087,,False,http://www.openphacts.org/units/Nanomolar,3108154,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712830,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4289717,,CHEMBL4289717,,False,http://www.openphacts.org/units/Nanomolar,3108155,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712831,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4288655,,CHEMBL4288655,,False,http://www.openphacts.org/units/Nanomolar,3108156,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712832,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(Nc2nc(NC3CCC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4285674,,CHEMBL4285674,,False,http://www.openphacts.org/units/Nanomolar,3108157,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712833,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC[C@H](Nc1nc(N[C@@H](CC)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,"{'bei': '15.81', 'le': '0.33', 'lle': '1.91', 'sei': '9.26'}",CHEMBL4284624,,CHEMBL4284624,7.00,False,http://www.openphacts.org/units/Nanomolar,3108158,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712834,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4279182,,CHEMBL4279182,,False,http://www.openphacts.org/units/Nanomolar,3108159,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712835,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3Cc4ccc(Cl)cc4C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280254,,CHEMBL4280254,,False,http://www.openphacts.org/units/Nanomolar,3108160,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712836,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3nc(C(F)(F)F)cs3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4283342,,CHEMBL4283342,,False,http://www.openphacts.org/units/Nanomolar,3108161,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712837,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(c4ccccc4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4284334,,CHEMBL4284334,,False,http://www.openphacts.org/units/Nanomolar,3108162,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712838,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)C4)nc(-n4ccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4292283,,CHEMBL4292283,,False,http://www.openphacts.org/units/Nanomolar,3108163,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712839,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1cncc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4293294,,CHEMBL4293294,,False,http://www.openphacts.org/units/Nanomolar,3108164,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712840,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cccc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4293667,,CHEMBL4293667,,False,http://www.openphacts.org/units/Nanomolar,3108165,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712841,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)CC4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4294793,,CHEMBL4294793,,False,http://www.openphacts.org/units/Nanomolar,3108167,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712842,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4277305,,CHEMBL4277305,,False,http://www.openphacts.org/units/Nanomolar,3108168,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712843,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CC4(C3)CC(F)(F)C4)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4293221,,CHEMBL4293221,,False,http://www.openphacts.org/units/Nanomolar,3108169,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712844,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4292220,,CHEMBL4292220,,False,http://www.openphacts.org/units/Nanomolar,3108170,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712845,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NC(C2CC2)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4289486,,CHEMBL4289486,,False,http://www.openphacts.org/units/Nanomolar,3108171,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712846,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3ccnc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '15.69', 'le': '0.31', 'lle': '2.75', 'sei': '8.25'}",CHEMBL4288431,,CHEMBL4288431,7.30,False,http://www.openphacts.org/units/Nanomolar,3108172,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712847,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3nc(F)ccc3F)n2)c1,,,CHEMBL4257005,,,,CHEMBL4287770,,CHEMBL4287770,,False,http://www.openphacts.org/units/Nanomolar,3108173,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712848,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC[C@H](Nc1nc(N[C@H](CC)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,"{'bei': '15.81', 'le': '0.33', 'lle': '1.91', 'sei': '9.26'}",CHEMBL4286718,,CHEMBL4286718,7.00,False,http://www.openphacts.org/units/Nanomolar,3108174,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712849,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-n3ccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4291846,,CHEMBL4291846,,False,http://www.openphacts.org/units/Nanomolar,3108175,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712850,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4288141,,CHEMBL4288141,,False,http://www.openphacts.org/units/Nanomolar,3108176,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712851,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc([C@H]2C[C@@H](Nc3nc(NC4CCC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)C2)cc1,,,CHEMBL4257005,,,,CHEMBL4280502,,CHEMBL4280502,,False,http://www.openphacts.org/units/Nanomolar,3108177,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712852,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cc(Nc2nc(NCC3CC3)nc(-c3cccc(Cl)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4279427,,CHEMBL4279427,,False,http://www.openphacts.org/units/Nanomolar,3108178,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712853,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4281644,,CHEMBL4281644,,False,http://www.openphacts.org/units/Nanomolar,3108179,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712854,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(-c4ccccc4)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4285379,,CHEMBL4285379,,False,http://www.openphacts.org/units/Nanomolar,3108180,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712855,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4280213,,CHEMBL4280213,,False,http://www.openphacts.org/units/Nanomolar,3108181,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712856,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4281273,,CHEMBL4281273,,False,http://www.openphacts.org/units/Nanomolar,3108182,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712857,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1csc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4281964,,CHEMBL4281964,,False,http://www.openphacts.org/units/Nanomolar,3108183,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712858,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C#N)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4285716,,CHEMBL4285716,,False,http://www.openphacts.org/units/Nanomolar,3108185,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712859,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1nc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)cs1,,,CHEMBL4257005,,,,CHEMBL4287400,,CHEMBL4287400,,False,http://www.openphacts.org/units/Nanomolar,3108187,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712860,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(Nc2nc(NC3CC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4291112,,CHEMBL4291112,,False,http://www.openphacts.org/units/Nanomolar,3108188,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712861,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cccc(-c2nc(Nc3ccnc(C4(C#N)CC4)c3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4288641,,CHEMBL4288641,,False,http://www.openphacts.org/units/Nanomolar,3108189,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712862,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(Cl)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4289692,,CHEMBL4289692,,False,http://www.openphacts.org/units/Nanomolar,3108190,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712863,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4276701,,CHEMBL4276701,,False,http://www.openphacts.org/units/Nanomolar,3108191,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712864,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(CC#N)Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4277757,,CHEMBL4277757,,False,http://www.openphacts.org/units/Nanomolar,3108192,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712865,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NCC(F)(F)F)nc(-c4cccc(Cl)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4289616,,CHEMBL4289616,,False,http://www.openphacts.org/units/Nanomolar,3108193,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712866,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(CNc2nc(NCC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4294886,,CHEMBL4294886,,False,http://www.openphacts.org/units/Nanomolar,3108194,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712867,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2ccnc(-c3ccccc3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4289777,,CHEMBL4289777,,False,http://www.openphacts.org/units/Nanomolar,3108195,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712868,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cccc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4290807,,CHEMBL4290807,,False,http://www.openphacts.org/units/Nanomolar,3108196,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712869,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(-c4ccccc4)c3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '13.84', 'le': '0.26', 'lle': '0.55', 'sei': '8.25'}",CHEMBL4284814,,CHEMBL4284814,7.30,False,http://www.openphacts.org/units/Nanomolar,3108198,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712870,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(CNc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4290997,,CHEMBL4290997,,False,http://www.openphacts.org/units/Nanomolar,3108199,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712871,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCN(c4ccccn4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '13.82', 'le': '0.27', 'lle': '2.36', 'sei': '7.63'}",CHEMBL4289977,,CHEMBL4289977,7.00,False,http://www.openphacts.org/units/Nanomolar,3108200,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712872,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3csc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4295099,,CHEMBL4295099,,False,http://www.openphacts.org/units/Nanomolar,3108201,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712873,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1cccc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4291368,,CHEMBL4291368,,False,http://www.openphacts.org/units/Nanomolar,3108202,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712874,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NCC(F)(F)F)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4276898,,CHEMBL4276898,,False,http://www.openphacts.org/units/Nanomolar,3108204,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712875,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCN(c4ncccn4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '13.79', 'le': '0.27', 'lle': '2.97', 'sei': '6.69'}",CHEMBL4282071,,CHEMBL4282071,7.00,False,http://www.openphacts.org/units/Nanomolar,3108205,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712876,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CC4(C3)CC(F)(F)C4)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4281002,,CHEMBL4281002,,False,http://www.openphacts.org/units/Nanomolar,3108206,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712877,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CC5(C4)CC(F)(F)C5)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4288051,,CHEMBL4288051,,False,http://www.openphacts.org/units/Nanomolar,3108207,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712878,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc([C@H]2C[C@H](Nc3nc(NC4CCC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)C2)cc1,,,CHEMBL4257005,,,,CHEMBL4286997,,CHEMBL4286997,,False,http://www.openphacts.org/units/Nanomolar,3108208,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712879,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(CC#N)Nc1nc(Nc2ccnc(C(C)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4291861,,CHEMBL4291861,,False,http://www.openphacts.org/units/Nanomolar,3108209,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712880,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4292885,,CHEMBL4292885,,False,http://www.openphacts.org/units/Nanomolar,3108210,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712881,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,OC(F)(F)CNc1nc(Nc2cc(F)cc(F)c2)nc(-n2ccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4286365,,CHEMBL4286365,,False,http://www.openphacts.org/units/Nanomolar,3108213,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712882,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1ccn(-c2nc(NCC(O)(F)F)nc(Nc3cc(F)cc(Cl)c3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4287398,,CHEMBL4287398,,False,http://www.openphacts.org/units/Nanomolar,3108214,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712883,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3nccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4287795,,CHEMBL4287795,,False,http://www.openphacts.org/units/Nanomolar,3108215,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712884,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)CNc1nc(Nc2cc(F)cc(C#N)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4281594,,CHEMBL4281594,,False,http://www.openphacts.org/units/Nanomolar,3108222,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712885,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)Nc1nc(Nc2cc(F)cc(C#N)c2)nc(-c2nccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4281221,,CHEMBL4281221,,False,http://www.openphacts.org/units/Nanomolar,3108223,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712886,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NCCOc2ccccc2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '16.43', 'le': '0.31', 'lle': '2.65', 'sei': '8.60'}",CHEMBL4277498,,CHEMBL4277498,7.30,False,http://www.openphacts.org/units/Nanomolar,3108224,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712887,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C#N)Nc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4279333,,CHEMBL4279333,,False,http://www.openphacts.org/units/Nanomolar,3108225,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712888,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)CNc1nc(Nc2cccc(Cl)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4294615,,CHEMBL4294615,,False,http://www.openphacts.org/units/Nanomolar,3108226,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712889,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Nc1ccc(F)c(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '15.30', 'le': '0.30', 'lle': '2.37', 'sei': '6.89'}",CHEMBL4291587,,CHEMBL4291587,7.00,False,http://www.openphacts.org/units/Nanomolar,3108227,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712890,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(CC#N)Nc1nc(Nc2ccnc(C(C)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4290554,,CHEMBL4290554,,False,http://www.openphacts.org/units/Nanomolar,3108228,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712891,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3ccnc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '16.01', 'le': '0.32', 'lle': '3.23', 'sei': '7.91'}",CHEMBL4294983,,CHEMBL4294983,7.00,False,http://www.openphacts.org/units/Nanomolar,3108229,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712892,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(OC(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4287992,,CHEMBL4287992,,False,http://www.openphacts.org/units/Nanomolar,3108230,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712893,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C#N)Nc1nc(Nc2ccnc(C(C)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4293552,,CHEMBL4293552,,False,http://www.openphacts.org/units/Nanomolar,3108231,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712894,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3nccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4293462,,CHEMBL4293462,,False,http://www.openphacts.org/units/Nanomolar,3108234,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712895,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC2(CC(Nc3nc(Nc4ccnc(C(F)(F)F)c4)nc(-c4cccc(C(F)(F)F)n4)n3)C2)C1,,,CHEMBL4257005,,,,CHEMBL4288364,,CHEMBL4288364,,False,http://www.openphacts.org/units/Nanomolar,3108235,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712896,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C4CC4)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4289397,,CHEMBL4289397,,False,http://www.openphacts.org/units/Nanomolar,3108236,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712897,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)CNc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4281357,,CHEMBL4281357,,False,http://www.openphacts.org/units/Nanomolar,3108237,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712898,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3nc(F)ccc3F)n2)c1,,,CHEMBL4257005,,,,CHEMBL4285080,,CHEMBL4285080,,False,http://www.openphacts.org/units/Nanomolar,3108238,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712899,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)C4)nc(-c4nccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4279855,,CHEMBL4279855,,False,http://www.openphacts.org/units/Nanomolar,3108239,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712900,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C#N)CNc1nc(Nc2ccnc(C(C)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4278435,,CHEMBL4278435,,False,http://www.openphacts.org/units/Nanomolar,3108245,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712901,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2nccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '18.56', 'le': '0.36', 'lle': '3.53', 'sei': '8.25'}",CHEMBL4285495,,CHEMBL4285495,7.30,False,http://www.openphacts.org/units/Nanomolar,3108246,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712902,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3ccnc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '14.19', 'le': '0.28', 'lle': '1.67', 'sei': '7.91'}",CHEMBL4294396,,CHEMBL4294396,7.00,False,http://www.openphacts.org/units/Nanomolar,3108248,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712903,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc([C@H]2C[C@@H](Nc3nc(N[C@H]4C[C@@H](c5ccc(F)cc5)C4)nc(-c4cccc(C(F)(F)F)n4)n3)C2)cc1,,,CHEMBL4257005,,,"{'bei': '12.67', 'le': '0.24', 'lle': '0.05', 'sei': '9.26'}",CHEMBL4291957,,CHEMBL4291957,7.00,False,http://www.openphacts.org/units/Nanomolar,3108250,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712904,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3cccc(OC(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '16.14', 'le': '0.32', 'lle': '3.05', 'sei': '8.60'}",CHEMBL4289797,,CHEMBL4289797,7.30,False,http://www.openphacts.org/units/Nanomolar,3108255,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712905,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cncc(Cl)c2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4290818,,CHEMBL4290818,,False,http://www.openphacts.org/units/Nanomolar,3108256,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712906,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-n2cc(I)cn2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '15.93', 'le': '0.40', 'lle': '3.92', 'sei': '8.69'}",CHEMBL4293859,,CHEMBL4293859,7.00,False,http://www.openphacts.org/units/Nanomolar,3108257,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712907,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1nc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)cs1,,,CHEMBL4257005,,,"{'bei': '14.16', 'le': '0.29', 'lle': '0.91', 'sei': '9.26'}",CHEMBL4294387,,CHEMBL4294387,7.00,False,http://www.openphacts.org/units/Nanomolar,3108261,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712908,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(N)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4293274,,CHEMBL4293274,,False,http://www.openphacts.org/units/Nanomolar,3108263,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18712909,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)CNc1nc(NC2CCC(F)(F)CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '15.68', 'le': '0.31', 'lle': '2.87', 'sei': '7.30'}",CHEMBL4281385,,CHEMBL4281385,7.00,False,http://www.openphacts.org/units/Nanomolar,3108265,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712910,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)CNc1nc(Nc2ccnc(C#N)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '16.26', 'le': '0.31', 'lle': '3.85', 'sei': '5.28'}",CHEMBL4280325,,CHEMBL4280325,7.00,False,http://www.openphacts.org/units/Nanomolar,3108266,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712911,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)Nc1nc(Nc2ccnc(C(C)(F)F)c2)nc(-c2nccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4282925,,CHEMBL4282925,,False,http://www.openphacts.org/units/Nanomolar,3108267,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712912,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3nccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '14.80', 'le': '0.29', 'lle': '1.97', 'sei': '8.25'}",CHEMBL4288632,,CHEMBL4288632,7.30,False,http://www.openphacts.org/units/Nanomolar,3108271,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712913,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)Nc1nc(Nc2ccnc(C(C)(F)F)c2)nc(-c2nccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4284203,,CHEMBL4284203,,False,http://www.openphacts.org/units/Nanomolar,3108276,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712914,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-n3cc(Cl)cn3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '15.63', 'le': '0.32', 'lle': '2.31', 'sei': '8.69'}",CHEMBL4285024,,CHEMBL4285024,7.00,False,http://www.openphacts.org/units/Nanomolar,3108280,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712915,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1ccnc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '14.72', 'le': '0.29', 'lle': '1.75', 'sei': '7.91'}",CHEMBL4294544,,CHEMBL4294544,7.00,False,http://www.openphacts.org/units/Nanomolar,3108286,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712916,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)CNc1nc(Nc2cc(F)cc(F)c2)nc(-c2nccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4277108,,CHEMBL4277108,,False,http://www.openphacts.org/units/Nanomolar,3108303,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712917,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC[C@H](Nc1nc(N[C@@H](CC)C(F)(F)F)nc(-c2cncc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4280159,,CHEMBL4280159,,False,http://www.openphacts.org/units/Nanomolar,3108315,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712918,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3ccnc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4287227,,CHEMBL4287227,,False,http://www.openphacts.org/units/Nanomolar,3108316,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712919,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@H]4CCC(F)(F)C4)nc(-c4ccnc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4286181,,CHEMBL4286181,,False,http://www.openphacts.org/units/Nanomolar,3108317,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712920,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@@H]4CCC(F)(F)C4)nc(-c4ccnc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4294595,,CHEMBL4294595,,False,http://www.openphacts.org/units/Nanomolar,3108318,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712921,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3ccnc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4277087,,CHEMBL4277087,,False,http://www.openphacts.org/units/Nanomolar,3108319,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712922,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2ccnc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,"{'bei': '16.25', 'le': '0.33', 'lle': '3.23', 'sei': '8.25'}",CHEMBL4282694,,CHEMBL4282694,7.30,False,http://www.openphacts.org/units/Nanomolar,3108320,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712923,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC[C@H](Nc1nc(N[C@@H](CC)C(F)(F)F)nc(-c2ccnc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,"{'bei': '14.66', 'le': '0.30', 'lle': '2.15', 'sei': '7.91'}",CHEMBL4283760,,CHEMBL4283760,7.00,False,http://www.openphacts.org/units/Nanomolar,3108321,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712924,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC[C@H](Nc1nc(N[C@@H](CC)C(F)(F)F)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4278576,,CHEMBL4278576,,False,http://www.openphacts.org/units/Nanomolar,3108322,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712925,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cccc(C(C)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4282325,,CHEMBL4282325,,False,http://www.openphacts.org/units/Nanomolar,3108323,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712926,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cccc(C(C)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4277173,,CHEMBL4277173,,False,http://www.openphacts.org/units/Nanomolar,3108324,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712927,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4278189,,CHEMBL4278189,,False,http://www.openphacts.org/units/Nanomolar,3108325,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712928,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@@H]4CCC(F)(F)C4)nc(-n4ccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4289705,,CHEMBL4289705,,False,http://www.openphacts.org/units/Nanomolar,3108326,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712929,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4286920,,CHEMBL4286920,,False,http://www.openphacts.org/units/Nanomolar,3108327,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712930,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4281016,,CHEMBL4281016,,False,http://www.openphacts.org/units/Nanomolar,3108328,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712931,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3nc(C(F)(F)F)cs3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280455,,CHEMBL4280455,,False,http://www.openphacts.org/units/Nanomolar,3108329,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712932,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cccc(-c2nc(NCC3CC3(F)F)nc(NCC3CC3(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4276915,,CHEMBL4276915,,False,http://www.openphacts.org/units/Nanomolar,3108330,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712933,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cc(Nc2nc(N[C@@H]3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4294406,,CHEMBL4294406,,False,http://www.openphacts.org/units/Nanomolar,3108331,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712934,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4294324,,CHEMBL4294324,,False,http://www.openphacts.org/units/Nanomolar,3108332,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712935,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1csc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4283829,,CHEMBL4283829,,False,http://www.openphacts.org/units/Nanomolar,3108333,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712936,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4282432,,CHEMBL4282432,,False,http://www.openphacts.org/units/Nanomolar,3108334,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712937,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(-c3ccccc3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4281400,,CHEMBL4281400,,False,http://www.openphacts.org/units/Nanomolar,3108335,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712938,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cc(Nc2nc(N[C@H]3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4284001,,CHEMBL4284001,,False,http://www.openphacts.org/units/Nanomolar,3108336,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712939,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cc(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4280252,,CHEMBL4280252,,False,http://www.openphacts.org/units/Nanomolar,3108337,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712940,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC[C@H](Nc1nc(N[C@@H](CC)C(F)(F)F)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,"{'bei': '15.69', 'le': '0.32', 'lle': '2.72', 'sei': '9.06'}",CHEMBL4289800,,CHEMBL4289800,7.30,False,http://www.openphacts.org/units/Nanomolar,3108339,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712941,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(-c3ccc(Cl)cc3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4290162,,CHEMBL4290162,,False,http://www.openphacts.org/units/Nanomolar,3108340,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712942,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cc(Nc2nc(NCC3CC3(F)F)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4283537,,CHEMBL4283537,,False,http://www.openphacts.org/units/Nanomolar,3108341,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712943,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cncc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4294218,,CHEMBL4294218,,False,http://www.openphacts.org/units/Nanomolar,3108342,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712944,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cncc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4276712,,CHEMBL4276712,,False,http://www.openphacts.org/units/Nanomolar,3108343,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712945,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(N[C@H]3CCC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4287603,,CHEMBL4287603,,False,http://www.openphacts.org/units/Nanomolar,3108344,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712946,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(N[C@@H]3CCC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4288650,,CHEMBL4288650,,False,http://www.openphacts.org/units/Nanomolar,3108345,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712947,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cncc(-c2nc(NC3CCC(F)(F)C3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4291708,,CHEMBL4291708,,False,http://www.openphacts.org/units/Nanomolar,3108346,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712948,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(-c3ccc(F)cc3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4292727,,CHEMBL4292727,,False,http://www.openphacts.org/units/Nanomolar,3108347,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712949,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cccc(-c2nc(Nc3ccnc(C4(C#N)CC4)c3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4277708,,CHEMBL4277708,,False,http://www.openphacts.org/units/Nanomolar,3108348,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712950,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@H]4CCC(F)(F)C4)nc(-c4cncc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4295243,,CHEMBL4295243,,False,http://www.openphacts.org/units/Nanomolar,3108349,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712951,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cncc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4281812,,CHEMBL4281812,,False,http://www.openphacts.org/units/Nanomolar,3108350,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712952,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@@H]4CCC(F)(F)C4)nc(-c4nccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4280732,,CHEMBL4280732,,False,http://www.openphacts.org/units/Nanomolar,3108351,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712953,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@H]4CCC(F)(F)C4)nc(-c4nccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4282938,,CHEMBL4282938,,False,http://www.openphacts.org/units/Nanomolar,3108352,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712954,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cncc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4281897,,CHEMBL4281897,,False,http://www.openphacts.org/units/Nanomolar,3108353,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712955,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@@H]4CCC(F)(F)C4)nc(-c4cncc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4294826,,CHEMBL4294826,,False,http://www.openphacts.org/units/Nanomolar,3108354,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712956,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cc(Nc2nc(NCC3CC3)nc(-c3nc(C(F)(F)F)cs3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4283321,,CHEMBL4283321,,False,http://www.openphacts.org/units/Nanomolar,3108355,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712957,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC2(CC(Nc3nc(Nc4ccnc(C(F)(F)F)c4)nc(-c4cncc(C(F)(F)F)n4)n3)C2)C1,,,CHEMBL4257005,,,,CHEMBL4293283,,CHEMBL4293283,,False,http://www.openphacts.org/units/Nanomolar,3108356,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712958,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(Nc2nc(N[C@H]3CCC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4292273,,CHEMBL4292273,,False,http://www.openphacts.org/units/Nanomolar,3108357,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712959,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)CC4)nc(-n4ccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4286039,,CHEMBL4286039,,False,http://www.openphacts.org/units/Nanomolar,3108358,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712960,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(-c3ccc(C#N)cc3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4291004,,CHEMBL4291004,,False,http://www.openphacts.org/units/Nanomolar,3108359,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712961,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cccc(-c2nc(Nc3ccnc(C4(C#N)CC4)c3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4287374,,CHEMBL4287374,,False,http://www.openphacts.org/units/Nanomolar,3108360,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712962,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CC5(C4)CC(F)(F)C5)nc(-c4cncc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4285701,,CHEMBL4285701,,False,http://www.openphacts.org/units/Nanomolar,3108361,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712963,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2cncc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4283555,,CHEMBL4283555,,False,http://www.openphacts.org/units/Nanomolar,3108362,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712964,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cc(Nc2nc(NCC3CC3)nc(-c3cncc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4284574,,CHEMBL4284574,,False,http://www.openphacts.org/units/Nanomolar,3108363,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712965,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3nc(C(F)(F)F)cs3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4293197,,CHEMBL4293197,,False,http://www.openphacts.org/units/Nanomolar,3108364,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712966,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cncc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4280467,,CHEMBL4280467,,False,http://www.openphacts.org/units/Nanomolar,3108365,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712967,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4290944,,CHEMBL4290944,,False,http://www.openphacts.org/units/Nanomolar,3108366,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712968,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4294642,,CHEMBL4294642,,False,http://www.openphacts.org/units/Nanomolar,3108367,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712969,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4279960,,CHEMBL4279960,,False,http://www.openphacts.org/units/Nanomolar,3108368,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712970,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-n3ccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4278901,,CHEMBL4278901,,False,http://www.openphacts.org/units/Nanomolar,3108369,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712971,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)CC4)nc(-c4cncc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4294407,,CHEMBL4294407,,False,http://www.openphacts.org/units/Nanomolar,3108370,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712972,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4293370,,CHEMBL4293370,,False,http://www.openphacts.org/units/Nanomolar,3108371,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712973,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)CNc1nc(Nc2cc(F)cc(C(F)(F)F)c2)nc(-c2cccc(C(C)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4289299,,CHEMBL4289299,,False,http://www.openphacts.org/units/Nanomolar,3108372,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712974,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)CNc1nc(Nc2cc(F)cc(C#N)c2)nc(-c2cccc(C(C)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4288968,,CHEMBL4288968,,False,http://www.openphacts.org/units/Nanomolar,3108373,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712975,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(N[C@@H]3CCC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4287914,,CHEMBL4287914,,False,http://www.openphacts.org/units/Nanomolar,3108374,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712976,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4282949,,CHEMBL4282949,,False,http://www.openphacts.org/units/Nanomolar,3108375,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712977,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CC(F)(F)C4)nc(-c4cncc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4281916,,CHEMBL4281916,,False,http://www.openphacts.org/units/Nanomolar,3108376,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712978,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1csc(-c2nc(NC3CCC(F)(F)C3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4282389,,CHEMBL4282389,,False,http://www.openphacts.org/units/Nanomolar,3108377,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712979,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1csc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4278630,,CHEMBL4278630,,False,http://www.openphacts.org/units/Nanomolar,3108378,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712980,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(NC(C)C(F)(F)F)nc(-c2nc(C(F)(F)F)cs2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4281715,,CHEMBL4281715,,False,http://www.openphacts.org/units/Nanomolar,3108379,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712981,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3cncc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4282741,,CHEMBL4282741,,False,http://www.openphacts.org/units/Nanomolar,3108380,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712982,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(N[C@H]3CCC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4286538,,CHEMBL4286538,,False,http://www.openphacts.org/units/Nanomolar,3108381,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712983,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cc(Nc2nc(NCC3CC3)nc(-n3ccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4291710,,CHEMBL4291710,,False,http://www.openphacts.org/units/Nanomolar,3108382,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712984,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1cncc(-c2nc(NC3CCC(F)(F)C3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4292069,,CHEMBL4292069,,False,http://www.openphacts.org/units/Nanomolar,3108383,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712985,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1cncc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4277241,,CHEMBL4277241,,False,http://www.openphacts.org/units/Nanomolar,3108384,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712986,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@@H](Nc2nc(N[C@@H]3CCC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280571,,CHEMBL4280571,,False,http://www.openphacts.org/units/Nanomolar,3108385,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712987,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1ccnc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,"{'bei': '17.41', 'le': '0.34', 'lle': '3.61', 'sei': '8.25'}",CHEMBL4281625,,CHEMBL4281625,7.30,False,http://www.openphacts.org/units/Nanomolar,3108386,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712988,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1ccnc(-c2nc(NC3CCC(F)(F)C3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,"{'bei': '16.32', 'le': '0.32', 'lle': '2.83', 'sei': '8.25'}",CHEMBL4281482,,CHEMBL4281482,7.30,False,http://www.openphacts.org/units/Nanomolar,3108387,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712989,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3nc(C(F)(F)F)cs3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4282517,,CHEMBL4282517,,False,http://www.openphacts.org/units/Nanomolar,3108388,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712990,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cccc(-c2nc(NCC3CC3)cc(NCC3CC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '19.26', 'le': '0.37', 'lle': '2.80', 'sei': '11.16'}",CHEMBL4292065,,CHEMBL4292065,7.00,False,http://www.openphacts.org/units/Nanomolar,3108394,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18712991,[],CHEMBL4257017,Inhibition of IDH1 R132C mutant (unknown origin) expressed in human U87MG cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1cc(NC(C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,"{'bei': '18.65', 'le': '0.36', 'lle': '2.32', 'sei': '11.64'}",CHEMBL4295139,,CHEMBL4295139,7.30,False,http://www.openphacts.org/units/Nanomolar,3108395,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18712992,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NC(C(F)(F)F)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4293346,,CHEMBL4293346,,False,http://www.openphacts.org/units/Nanomolar,3108078,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712993,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4279047,,CHEMBL4279047,,False,http://www.openphacts.org/units/Nanomolar,3108079,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712994,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(N[C@@H]3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4278020,,CHEMBL4278020,,False,http://www.openphacts.org/units/Nanomolar,3108080,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712995,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CCC(Nc1nc(NC(CC)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4293542,,CHEMBL4293542,,False,http://www.openphacts.org/units/Nanomolar,3108081,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712996,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cccc(-c2nc(NC3CCC(F)(F)C3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4292152,,CHEMBL4292152,,False,http://www.openphacts.org/units/Nanomolar,3108083,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712997,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4288434,,CHEMBL4288434,,False,http://www.openphacts.org/units/Nanomolar,3108084,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712998,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2cc(F)cc(F)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4288067,,CHEMBL4288067,,False,http://www.openphacts.org/units/Nanomolar,3108085,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18712999,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4287015,,CHEMBL4287015,,False,http://www.openphacts.org/units/Nanomolar,3108086,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713000,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cncc(Cl)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4284034,,CHEMBL4284034,,False,http://www.openphacts.org/units/Nanomolar,3108087,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713001,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CCC(Nc1nc(NC(CC)C2CC2)nc(-c2cccc(Cl)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4282989,,CHEMBL4282989,,False,http://www.openphacts.org/units/Nanomolar,3108088,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713002,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@@H](Nc2nc(N[C@@H]3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4294589,,CHEMBL4294589,,False,http://www.openphacts.org/units/Nanomolar,3108089,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713003,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4293545,,CHEMBL4293545,,False,http://www.openphacts.org/units/Nanomolar,3108090,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713004,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(Cl)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280132,,CHEMBL4280132,,False,http://www.openphacts.org/units/Nanomolar,3108091,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713005,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2csc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4279049,,CHEMBL4279049,,False,http://www.openphacts.org/units/Nanomolar,3108092,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713006,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(Cl)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4281282,,CHEMBL4281282,,False,http://www.openphacts.org/units/Nanomolar,3108093,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713007,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280231,,CHEMBL4280231,,False,http://www.openphacts.org/units/Nanomolar,3108094,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713008,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(N[C@H]3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4281649,,CHEMBL4281649,,False,http://www.openphacts.org/units/Nanomolar,3108096,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713009,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2cc(F)cc(C#N)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4291656,,CHEMBL4291656,,False,http://www.openphacts.org/units/Nanomolar,3108097,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713010,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3cncc(Cl)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4290600,,CHEMBL4290600,,False,http://www.openphacts.org/units/Nanomolar,3108098,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713011,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-n2ccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4293652,,CHEMBL4293652,,False,http://www.openphacts.org/units/Nanomolar,3108099,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713012,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3nc(C(F)(F)F)cs3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4286666,,CHEMBL4286666,,False,http://www.openphacts.org/units/Nanomolar,3108100,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713013,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4292275,,CHEMBL4292275,,False,http://www.openphacts.org/units/Nanomolar,3108101,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713014,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4293284,,CHEMBL4293284,,False,http://www.openphacts.org/units/Nanomolar,3108102,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713015,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4291118,,CHEMBL4291118,,False,http://www.openphacts.org/units/Nanomolar,3108103,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713016,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4292169,,CHEMBL4292169,,False,http://www.openphacts.org/units/Nanomolar,3108104,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713017,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)C4)nc(-c4cccc(Cl)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4287037,,CHEMBL4287037,,False,http://www.openphacts.org/units/Nanomolar,3108105,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713018,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3nc(C(F)(F)F)cs3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4288084,,CHEMBL4288084,,False,http://www.openphacts.org/units/Nanomolar,3108106,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713019,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cncc(Cl)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280017,,CHEMBL4280017,,False,http://www.openphacts.org/units/Nanomolar,3108107,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713020,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Clc1cccc(-c2nc(NC(C3CC3)C3CC3)nc(NC(C3CC3)C3CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4279765,,CHEMBL4279765,,False,http://www.openphacts.org/units/Nanomolar,3108109,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713021,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3nc(C(F)(F)F)cs3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4294619,,CHEMBL4294619,,False,http://www.openphacts.org/units/Nanomolar,3108110,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713022,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@H]4CCC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4294234,,CHEMBL4294234,,False,http://www.openphacts.org/units/Nanomolar,3108111,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713023,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4293189,,CHEMBL4293189,,False,http://www.openphacts.org/units/Nanomolar,3108112,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713024,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NC2CCc3ccccc32)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4293103,,CHEMBL4293103,,False,http://www.openphacts.org/units/Nanomolar,3108113,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713025,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4292077,,CHEMBL4292077,,False,http://www.openphacts.org/units/Nanomolar,3108114,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713026,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@@H]4CCC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4281225,,CHEMBL4281225,,False,http://www.openphacts.org/units/Nanomolar,3108115,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713027,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280154,,CHEMBL4280154,,False,http://www.openphacts.org/units/Nanomolar,3108116,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713028,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3nc(F)ccc3F)n2)c1,,,CHEMBL4257005,,,,CHEMBL4282753,,CHEMBL4282753,,False,http://www.openphacts.org/units/Nanomolar,3108117,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713029,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4278998,,CHEMBL4278998,,False,http://www.openphacts.org/units/Nanomolar,3108118,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713030,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(NC(C)C(F)(F)F)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4277813,,CHEMBL4277813,,False,http://www.openphacts.org/units/Nanomolar,3108119,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713031,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(N[C@@H](C)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4278845,,CHEMBL4278845,,False,http://www.openphacts.org/units/Nanomolar,3108120,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713032,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4279216,,CHEMBL4279216,,False,http://www.openphacts.org/units/Nanomolar,3108121,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713033,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3cncc(Cl)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4282985,,CHEMBL4282985,,False,http://www.openphacts.org/units/Nanomolar,3108122,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713034,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1cccc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4283381,,CHEMBL4283381,,False,http://www.openphacts.org/units/Nanomolar,3108123,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713035,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4284375,,CHEMBL4284375,,False,http://www.openphacts.org/units/Nanomolar,3108124,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713036,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cncc(Cl)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4276695,,CHEMBL4276695,,False,http://www.openphacts.org/units/Nanomolar,3108125,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713037,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3nc(C(F)(F)F)cs3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4277748,,CHEMBL4277748,,False,http://www.openphacts.org/units/Nanomolar,3108126,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713038,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280772,,CHEMBL4280772,,False,http://www.openphacts.org/units/Nanomolar,3108127,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713039,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc2c(c1)CC(Nc1nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n1)C2,,,CHEMBL4257005,,,,CHEMBL4281861,,CHEMBL4281861,,False,http://www.openphacts.org/units/Nanomolar,3108128,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713040,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4290840,,CHEMBL4290840,,False,http://www.openphacts.org/units/Nanomolar,3108129,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713041,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3Cc4ccccc4C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4289822,,CHEMBL4289822,,False,http://www.openphacts.org/units/Nanomolar,3108130,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713042,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4289832,,CHEMBL4289832,,False,http://www.openphacts.org/units/Nanomolar,3108132,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713043,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1nc(-c2nc(NC3CCC(F)(F)C3)nc(NC3CCC(F)(F)C3)n2)cs1,,,CHEMBL4257005,,,,CHEMBL4277782,,CHEMBL4277782,,False,http://www.openphacts.org/units/Nanomolar,3108133,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713044,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(NC(C)C(F)(F)F)nc(-c2cncc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4276732,,CHEMBL4276732,,False,http://www.openphacts.org/units/Nanomolar,3108134,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713045,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCCC1Nc1nc(NC2CCCC2(F)F)nc(-c2cccc(Cl)n2)n1,,,CHEMBL4257005,,,,CHEMBL4281900,,CHEMBL4281900,,False,http://www.openphacts.org/units/Nanomolar,3108135,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713046,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280826,,CHEMBL4280826,,False,http://www.openphacts.org/units/Nanomolar,3108136,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713047,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3nc(C(F)(F)F)cs3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4287902,,CHEMBL4287902,,False,http://www.openphacts.org/units/Nanomolar,3108137,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713048,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cncc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4286852,,CHEMBL4286852,,False,http://www.openphacts.org/units/Nanomolar,3108138,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713049,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4289309,,CHEMBL4289309,,False,http://www.openphacts.org/units/Nanomolar,3108139,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713050,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)Nc1nc(Nc2ccnc(C#N)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4284724,,CHEMBL4284724,,False,http://www.openphacts.org/units/Nanomolar,3108140,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713051,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4277398,,CHEMBL4277398,,False,http://www.openphacts.org/units/Nanomolar,3108141,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713052,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4278417,,CHEMBL4278417,,False,http://www.openphacts.org/units/Nanomolar,3108142,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713053,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Nc1ccc(F)c(-c2nc(Nc3cc(F)cc(F)c3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4291867,,CHEMBL4291867,,False,http://www.openphacts.org/units/Nanomolar,3108143,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713054,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1)CC(Nc1nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n1)C2,,,CHEMBL4257005,,,,CHEMBL4277020,,CHEMBL4277020,,False,http://www.openphacts.org/units/Nanomolar,3108144,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713055,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cccc(Cl)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4290450,,CHEMBL4290450,,False,http://www.openphacts.org/units/Nanomolar,3108145,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713056,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4291491,,CHEMBL4291491,,False,http://www.openphacts.org/units/Nanomolar,3108146,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713057,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CC(F)(F)C4)nc(-n4ccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4284431,,CHEMBL4284431,,False,http://www.openphacts.org/units/Nanomolar,3108147,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713058,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3csc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4292401,,CHEMBL4292401,,False,http://www.openphacts.org/units/Nanomolar,3108148,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713059,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4280719,,CHEMBL4280719,,False,http://www.openphacts.org/units/Nanomolar,3108149,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713060,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4279665,,CHEMBL4279665,,False,http://www.openphacts.org/units/Nanomolar,3108150,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713061,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-n3ccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4295239,,CHEMBL4295239,,False,http://www.openphacts.org/units/Nanomolar,3108151,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713062,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@H]4CCC(F)(F)C4)nc(-n4ccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4294151,,CHEMBL4294151,,False,http://www.openphacts.org/units/Nanomolar,3108152,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713063,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(F)cc(Nc2nc(NCC3CC3)nc(-c3cccc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4293761,,CHEMBL4293761,,False,http://www.openphacts.org/units/Nanomolar,3108153,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713064,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-n3ccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4290087,,CHEMBL4290087,,False,http://www.openphacts.org/units/Nanomolar,3108154,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713065,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4289717,,CHEMBL4289717,,False,http://www.openphacts.org/units/Nanomolar,3108155,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713066,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4288655,,CHEMBL4288655,,False,http://www.openphacts.org/units/Nanomolar,3108156,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713067,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(Nc2nc(NC3CCC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4285674,,CHEMBL4285674,,False,http://www.openphacts.org/units/Nanomolar,3108157,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713068,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC[C@H](Nc1nc(N[C@@H](CC)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4284624,,CHEMBL4284624,,False,http://www.openphacts.org/units/Nanomolar,3108158,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713069,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4279182,,CHEMBL4279182,,False,http://www.openphacts.org/units/Nanomolar,3108159,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713070,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3Cc4ccc(Cl)cc4C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280254,,CHEMBL4280254,,False,http://www.openphacts.org/units/Nanomolar,3108160,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713071,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3nc(C(F)(F)F)cs3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4283342,,CHEMBL4283342,,False,http://www.openphacts.org/units/Nanomolar,3108161,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713072,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(c4ccccc4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4284334,,CHEMBL4284334,,False,http://www.openphacts.org/units/Nanomolar,3108162,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713073,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)C4)nc(-n4ccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4292283,,CHEMBL4292283,,False,http://www.openphacts.org/units/Nanomolar,3108163,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713074,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1cncc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4293294,,CHEMBL4293294,,False,http://www.openphacts.org/units/Nanomolar,3108164,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713075,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cccc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4293667,,CHEMBL4293667,,False,http://www.openphacts.org/units/Nanomolar,3108165,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713076,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3Cc4cccnc4C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4278816,,CHEMBL4278816,,False,http://www.openphacts.org/units/Nanomolar,3108166,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713077,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)CC4)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4294793,,CHEMBL4294793,,False,http://www.openphacts.org/units/Nanomolar,3108167,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713078,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4277305,,CHEMBL4277305,,False,http://www.openphacts.org/units/Nanomolar,3108168,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713079,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CC4(C3)CC(F)(F)C4)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4293221,,CHEMBL4293221,,False,http://www.openphacts.org/units/Nanomolar,3108169,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713080,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4292220,,CHEMBL4292220,,False,http://www.openphacts.org/units/Nanomolar,3108170,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713081,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(NC(C2CC2)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4289486,,CHEMBL4289486,,False,http://www.openphacts.org/units/Nanomolar,3108171,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713082,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3ccnc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4288431,,CHEMBL4288431,,False,http://www.openphacts.org/units/Nanomolar,3108172,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713083,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3nc(F)ccc3F)n2)c1,,,CHEMBL4257005,,,,CHEMBL4287770,,CHEMBL4287770,,False,http://www.openphacts.org/units/Nanomolar,3108173,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713084,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC[C@H](Nc1nc(N[C@H](CC)C(F)(F)F)nc(-c2cccc(Cl)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4286718,,CHEMBL4286718,,False,http://www.openphacts.org/units/Nanomolar,3108174,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713085,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-n3ccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4291846,,CHEMBL4291846,,False,http://www.openphacts.org/units/Nanomolar,3108175,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713086,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4288141,,CHEMBL4288141,,False,http://www.openphacts.org/units/Nanomolar,3108176,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713087,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc([C@H]2C[C@@H](Nc3nc(NC4CCC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)C2)cc1,,,CHEMBL4257005,,,,CHEMBL4280502,,CHEMBL4280502,,False,http://www.openphacts.org/units/Nanomolar,3108177,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713088,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cc(Nc2nc(NCC3CC3)nc(-c3cccc(Cl)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4279427,,CHEMBL4279427,,False,http://www.openphacts.org/units/Nanomolar,3108178,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713089,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4281644,,CHEMBL4281644,,False,http://www.openphacts.org/units/Nanomolar,3108179,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713090,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(-c4ccccc4)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4285379,,CHEMBL4285379,,False,http://www.openphacts.org/units/Nanomolar,3108180,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713091,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4280213,,CHEMBL4280213,,False,http://www.openphacts.org/units/Nanomolar,3108181,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713092,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4281273,,CHEMBL4281273,,False,http://www.openphacts.org/units/Nanomolar,3108182,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713093,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1csc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4281964,,CHEMBL4281964,,False,http://www.openphacts.org/units/Nanomolar,3108183,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713094,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Cc1ccccc1)Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4282997,,CHEMBL4282997,,False,http://www.openphacts.org/units/Nanomolar,3108184,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713095,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C#N)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4285716,,CHEMBL4285716,,False,http://www.openphacts.org/units/Nanomolar,3108185,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713096,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CC(c4ccccc4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4286730,,CHEMBL4286730,,False,http://www.openphacts.org/units/Nanomolar,3108186,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713097,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1nc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)cs1,,,CHEMBL4257005,,,,CHEMBL4287400,,CHEMBL4287400,,False,http://www.openphacts.org/units/Nanomolar,3108187,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713098,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(Nc2nc(NC3CC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4291112,,CHEMBL4291112,,False,http://www.openphacts.org/units/Nanomolar,3108188,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713099,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cccc(-c2nc(Nc3ccnc(C4(C#N)CC4)c3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4288641,,CHEMBL4288641,,False,http://www.openphacts.org/units/Nanomolar,3108189,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713100,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(Cl)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4289692,,CHEMBL4289692,,False,http://www.openphacts.org/units/Nanomolar,3108190,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713101,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4276701,,CHEMBL4276701,,False,http://www.openphacts.org/units/Nanomolar,3108191,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713102,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(CC#N)Nc1nc(N[C@H](C)C2CC2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4277757,,CHEMBL4277757,,False,http://www.openphacts.org/units/Nanomolar,3108192,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713103,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NCC(F)(F)F)nc(-c4cccc(Cl)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4289616,,CHEMBL4289616,,False,http://www.openphacts.org/units/Nanomolar,3108193,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713104,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(CNc2nc(NCC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4294886,,CHEMBL4294886,,False,http://www.openphacts.org/units/Nanomolar,3108194,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713105,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(Nc2ccnc(-c3ccccc3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4289777,,CHEMBL4289777,,False,http://www.openphacts.org/units/Nanomolar,3108195,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713106,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cccc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4290807,,CHEMBL4290807,,False,http://www.openphacts.org/units/Nanomolar,3108196,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713107,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCN(c4ccccc4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4283799,,CHEMBL4283799,,False,http://www.openphacts.org/units/Nanomolar,3108197,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713108,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(-c4ccccc4)c3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4284814,,CHEMBL4284814,,False,http://www.openphacts.org/units/Nanomolar,3108198,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713109,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(CNc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4290997,,CHEMBL4290997,,False,http://www.openphacts.org/units/Nanomolar,3108199,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713110,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCN(c4ccccn4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4289977,,CHEMBL4289977,,False,http://www.openphacts.org/units/Nanomolar,3108200,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713111,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3csc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4295099,,CHEMBL4295099,,False,http://www.openphacts.org/units/Nanomolar,3108201,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713112,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1cccc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4291368,,CHEMBL4291368,,False,http://www.openphacts.org/units/Nanomolar,3108202,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713113,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3Cc4ccc(Br)cc4C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4284376,,CHEMBL4284376,,False,http://www.openphacts.org/units/Nanomolar,3108203,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713114,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NCC(F)(F)F)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4276898,,CHEMBL4276898,,False,http://www.openphacts.org/units/Nanomolar,3108204,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713115,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCN(c4ncccn4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4282071,,CHEMBL4282071,,False,http://www.openphacts.org/units/Nanomolar,3108205,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713116,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CC4(C3)CC(F)(F)C4)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4281002,,CHEMBL4281002,,False,http://www.openphacts.org/units/Nanomolar,3108206,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713117,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CC5(C4)CC(F)(F)C5)nc(-c4cccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4288051,,CHEMBL4288051,,False,http://www.openphacts.org/units/Nanomolar,3108207,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713118,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc([C@H]2C[C@H](Nc3nc(NC4CCC(F)(F)C4)nc(-c4cccc(C(F)(F)F)n4)n3)C2)cc1,,,CHEMBL4257005,,,,CHEMBL4286997,,CHEMBL4286997,,False,http://www.openphacts.org/units/Nanomolar,3108208,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713119,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(CC#N)Nc1nc(Nc2ccnc(C(C)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4291861,,CHEMBL4291861,,False,http://www.openphacts.org/units/Nanomolar,3108209,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713120,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4292885,,CHEMBL4292885,,False,http://www.openphacts.org/units/Nanomolar,3108210,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713121,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,OC(F)(F)CNc1nc(Nc2cc(F)cc(F)c2)nc(-n2ccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4286365,,CHEMBL4286365,,False,http://www.openphacts.org/units/Nanomolar,3108213,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713122,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3nccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4287795,,CHEMBL4287795,,False,http://www.openphacts.org/units/Nanomolar,3108215,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713123,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CN(c4ccccn4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4291485,,CHEMBL4291485,,False,http://www.openphacts.org/units/Nanomolar,3108216,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713124,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,O=C1C[C@H](Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)CN1c1ccccn1,,,CHEMBL4257005,,,,CHEMBL4288916,,CHEMBL4288916,,False,http://www.openphacts.org/units/Nanomolar,3108217,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713125,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CN(c4cccnc4)C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4282632,,CHEMBL4282632,,False,http://www.openphacts.org/units/Nanomolar,3108221,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713126,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)CNc1nc(Nc2cc(F)cc(C#N)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4281594,,CHEMBL4281594,,False,http://www.openphacts.org/units/Nanomolar,3108222,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713127,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)Nc1nc(Nc2cc(F)cc(C#N)c2)nc(-c2nccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4281221,,CHEMBL4281221,,False,http://www.openphacts.org/units/Nanomolar,3108223,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713128,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C#N)Nc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4279333,,CHEMBL4279333,,False,http://www.openphacts.org/units/Nanomolar,3108225,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713129,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Nc1ccc(F)c(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '15.96', 'le': '0.31', 'lle': '2.67', 'sei': '7.18'}",CHEMBL4291587,,CHEMBL4291587,7.30,False,http://www.openphacts.org/units/Nanomolar,3108227,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18713130,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(CC#N)Nc1nc(Nc2ccnc(C(C)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4290554,,CHEMBL4290554,,False,http://www.openphacts.org/units/Nanomolar,3108228,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713131,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3ccnc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4294983,,CHEMBL4294983,,False,http://www.openphacts.org/units/Nanomolar,3108229,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713132,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(OC(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '15.20', 'le': '0.30', 'lle': '2.27', 'sei': '8.60'}",CHEMBL4287992,,CHEMBL4287992,7.30,False,http://www.openphacts.org/units/Nanomolar,3108230,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18713133,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C#N)Nc1nc(Nc2ccnc(C(C)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4293552,,CHEMBL4293552,,False,http://www.openphacts.org/units/Nanomolar,3108231,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713134,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3Cc4cc(Br)cc(Br)c4C3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '11.51', 'le': '0.28', 'lle': '0.64', 'sei': '9.65'}",CHEMBL4280042,,CHEMBL4280042,7.30,False,http://www.openphacts.org/units/Nanomolar,3108232,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18713135,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(NC3CC(F)(F)C3)nc(-c3nccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4293462,,CHEMBL4293462,,False,http://www.openphacts.org/units/Nanomolar,3108234,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713136,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)C4)nc(-c4nccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,"{'bei': '14.50', 'le': '0.28', 'lle': '2.66', 'sei': '5.83'}",CHEMBL4279855,,CHEMBL4279855,7.30,False,http://www.openphacts.org/units/Nanomolar,3108239,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18713137,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(C)(O)CNc1nc(NC2CCC(F)(F)C2)nc(-c2cccc(C(F)(F)F)n2)n1,,,CHEMBL4257005,,,"{'bei': '16.88', 'le': '0.33', 'lle': '3.57', 'sei': '7.62'}",CHEMBL4282936,,CHEMBL4282936,7.30,False,http://www.openphacts.org/units/Nanomolar,3108242,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18713138,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CS(=O)(=O)N1CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4284068,,CHEMBL4284068,,False,http://www.openphacts.org/units/Nanomolar,3108244,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713139,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(-c2nccc(C(F)(F)F)n2)n1)C1CC1,,,CHEMBL4257005,,,,CHEMBL4285495,,CHEMBL4285495,,False,http://www.openphacts.org/units/Nanomolar,3108246,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713140,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3nccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4288632,,CHEMBL4288632,,False,http://www.openphacts.org/units/Nanomolar,3108271,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18713141,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C4CC4)n3)n2)CC1,,,CHEMBL4257005,,,"{'bei': '15.07', 'le': '0.29', 'lle': '1.21', 'sei': '9.26'}",CHEMBL4291516,,CHEMBL4291516,7.00,False,http://www.openphacts.org/units/Nanomolar,3108283,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18713142,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1ccnc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,"{'bei': '14.72', 'le': '0.29', 'lle': '1.75', 'sei': '7.91'}",CHEMBL4294544,,CHEMBL4294544,7.00,False,http://www.openphacts.org/units/Nanomolar,3108286,=,38,True,=,,IC50,nM,,100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,1.0,0.1
,18713143,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cc(C(F)(F)F)ccn3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4288003,,CHEMBL4288003,,False,http://www.openphacts.org/units/Nanomolar,3108296,>=,38,True,>=,,IC50,nM,,1000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,1.0
,18713144,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4290561,,CHEMBL4290561,,False,http://www.openphacts.org/units/Nanomolar,3108311,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713145,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cncc(C(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4277117,,CHEMBL4277117,,False,http://www.openphacts.org/units/Nanomolar,3108312,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713146,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cncc(C(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4294626,,CHEMBL4294626,,False,http://www.openphacts.org/units/Nanomolar,3108313,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713147,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)CC4)nc(-c4cncc(C(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4281229,,CHEMBL4281229,,False,http://www.openphacts.org/units/Nanomolar,3108314,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713148,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC[C@H](Nc1nc(N[C@@H](CC)C(F)(F)F)nc(-c2cncc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4280159,,CHEMBL4280159,,False,http://www.openphacts.org/units/Nanomolar,3108315,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713149,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3ccnc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,"{'bei': '14.42', 'le': '0.28', 'lle': '2.20', 'sei': '7.20'}",CHEMBL4287227,,CHEMBL4287227,7.30,False,http://www.openphacts.org/units/Nanomolar,3108316,=,38,True,=,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,100.0,50.0
,18713150,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@H]4CCC(F)(F)C4)nc(-c4ccnc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4286181,,CHEMBL4286181,,False,http://www.openphacts.org/units/Nanomolar,3108317,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713151,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@@H]4CCC(F)(F)C4)nc(-c4ccnc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4294595,,CHEMBL4294595,,False,http://www.openphacts.org/units/Nanomolar,3108318,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713152,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2ccnc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4282694,,CHEMBL4282694,,False,http://www.openphacts.org/units/Nanomolar,3108320,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713153,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC[C@H](Nc1nc(N[C@@H](CC)C(F)(F)F)nc(-c2ccnc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4283760,,CHEMBL4283760,,False,http://www.openphacts.org/units/Nanomolar,3108321,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713154,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC[C@H](Nc1nc(N[C@@H](CC)C(F)(F)F)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4278576,,CHEMBL4278576,,False,http://www.openphacts.org/units/Nanomolar,3108322,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713155,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cccc(C(C)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4282325,,CHEMBL4282325,,False,http://www.openphacts.org/units/Nanomolar,3108323,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713156,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cccc(C(C)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4277173,,CHEMBL4277173,,False,http://www.openphacts.org/units/Nanomolar,3108324,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713157,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4278189,,CHEMBL4278189,,False,http://www.openphacts.org/units/Nanomolar,3108325,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713158,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@@H]4CCC(F)(F)C4)nc(-n4ccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4289705,,CHEMBL4289705,,False,http://www.openphacts.org/units/Nanomolar,3108326,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713159,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4286920,,CHEMBL4286920,,False,http://www.openphacts.org/units/Nanomolar,3108327,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713160,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4281016,,CHEMBL4281016,,False,http://www.openphacts.org/units/Nanomolar,3108328,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713161,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3nc(C(F)(F)F)cs3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280455,,CHEMBL4280455,,False,http://www.openphacts.org/units/Nanomolar,3108329,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713162,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cccc(-c2nc(NCC3CC3(F)F)nc(NCC3CC3(F)F)n2)n1,,,CHEMBL4257005,,,,CHEMBL4276915,,CHEMBL4276915,,False,http://www.openphacts.org/units/Nanomolar,3108330,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713163,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cc(Nc2nc(N[C@@H]3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4294406,,CHEMBL4294406,,False,http://www.openphacts.org/units/Nanomolar,3108331,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713164,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@H](Nc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4294324,,CHEMBL4294324,,False,http://www.openphacts.org/units/Nanomolar,3108332,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713165,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1csc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4283829,,CHEMBL4283829,,False,http://www.openphacts.org/units/Nanomolar,3108333,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713166,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cc(Nc2nc(NC3CC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4282432,,CHEMBL4282432,,False,http://www.openphacts.org/units/Nanomolar,3108334,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713167,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(-c3ccccc3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4281400,,CHEMBL4281400,,False,http://www.openphacts.org/units/Nanomolar,3108335,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713168,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cc(Nc2nc(N[C@H]3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4284001,,CHEMBL4284001,,False,http://www.openphacts.org/units/Nanomolar,3108336,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713169,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cc(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4280252,,CHEMBL4280252,,False,http://www.openphacts.org/units/Nanomolar,3108337,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713170,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC[C@H](Nc1nc(N[C@@H](CC)C(F)(F)F)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4289800,,CHEMBL4289800,,False,http://www.openphacts.org/units/Nanomolar,3108339,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713171,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(-c3ccc(Cl)cc3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4290162,,CHEMBL4290162,,False,http://www.openphacts.org/units/Nanomolar,3108340,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713172,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cc(Nc2nc(NCC3CC3(F)F)nc(-c3cccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4283537,,CHEMBL4283537,,False,http://www.openphacts.org/units/Nanomolar,3108341,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713173,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cncc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4294218,,CHEMBL4294218,,False,http://www.openphacts.org/units/Nanomolar,3108342,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713174,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(NC3CCC(F)(F)CC3)nc(-c3cncc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4276712,,CHEMBL4276712,,False,http://www.openphacts.org/units/Nanomolar,3108343,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713175,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(N[C@H]3CCC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4287603,,CHEMBL4287603,,False,http://www.openphacts.org/units/Nanomolar,3108344,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713176,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,Fc1cc(F)cc(Nc2nc(N[C@@H]3CCC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)c1,,,CHEMBL4257005,,,,CHEMBL4288650,,CHEMBL4288650,,False,http://www.openphacts.org/units/Nanomolar,3108345,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713177,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cncc(-c2nc(NC3CCC(F)(F)C3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4291708,,CHEMBL4291708,,False,http://www.openphacts.org/units/Nanomolar,3108346,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713178,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(-c3ccc(F)cc3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4292727,,CHEMBL4292727,,False,http://www.openphacts.org/units/Nanomolar,3108347,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713179,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cccc(-c2nc(Nc3ccnc(C4(C#N)CC4)c3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4277708,,CHEMBL4277708,,False,http://www.openphacts.org/units/Nanomolar,3108348,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713180,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@H]4CCC(F)(F)C4)nc(-c4cncc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4295243,,CHEMBL4295243,,False,http://www.openphacts.org/units/Nanomolar,3108349,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713181,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cncc(-c2nc(NC3CCC(F)(F)CC3)nc(NC3CCC(F)(F)CC3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4281812,,CHEMBL4281812,,False,http://www.openphacts.org/units/Nanomolar,3108350,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713182,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@@H]4CCC(F)(F)C4)nc(-c4nccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4280732,,CHEMBL4280732,,False,http://www.openphacts.org/units/Nanomolar,3108351,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713183,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-c2cncc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4281897,,CHEMBL4281897,,False,http://www.openphacts.org/units/Nanomolar,3108353,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713184,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(N[C@@H]4CCC(F)(F)C4)nc(-c4cncc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4294826,,CHEMBL4294826,,False,http://www.openphacts.org/units/Nanomolar,3108354,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713185,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cc(Nc2nc(NCC3CC3)nc(-c3nc(C(F)(F)F)cs3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4283321,,CHEMBL4283321,,False,http://www.openphacts.org/units/Nanomolar,3108355,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713186,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC2(CC(Nc3nc(Nc4ccnc(C(F)(F)F)c4)nc(-c4cncc(C(F)(F)F)n4)n3)C2)C1,,,CHEMBL4257005,,,,CHEMBL4293283,,CHEMBL4293283,,False,http://www.openphacts.org/units/Nanomolar,3108356,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713187,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cc(Nc2nc(N[C@H]3CCC(F)(F)C3)nc(-n3ccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4292273,,CHEMBL4292273,,False,http://www.openphacts.org/units/Nanomolar,3108357,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713188,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)CC4)nc(-n4ccc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4286039,,CHEMBL4286039,,False,http://www.openphacts.org/units/Nanomolar,3108358,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713189,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(-c3ccc(C#N)cc3)c2)nc(-c2cccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4291004,,CHEMBL4291004,,False,http://www.openphacts.org/units/Nanomolar,3108359,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713190,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(F)(F)c1cccc(-c2nc(Nc3ccnc(C4(C#N)CC4)c3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4287374,,CHEMBL4287374,,False,http://www.openphacts.org/units/Nanomolar,3108360,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713191,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CC5(C4)CC(F)(F)C5)nc(-c4cncc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4285701,,CHEMBL4285701,,False,http://www.openphacts.org/units/Nanomolar,3108361,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713192,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(N[C@H](C)C(F)(F)F)nc(-c2cncc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4283555,,CHEMBL4283555,,False,http://www.openphacts.org/units/Nanomolar,3108362,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713193,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cc(Nc2nc(NCC3CC3)nc(-c3cncc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4284574,,CHEMBL4284574,,False,http://www.openphacts.org/units/Nanomolar,3108363,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713194,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3nc(C(F)(F)F)cs3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4293197,,CHEMBL4293197,,False,http://www.openphacts.org/units/Nanomolar,3108364,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713195,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cncc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4280467,,CHEMBL4280467,,False,http://www.openphacts.org/units/Nanomolar,3108365,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713196,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC(Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4290944,,CHEMBL4290944,,False,http://www.openphacts.org/units/Nanomolar,3108366,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713197,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4294642,,CHEMBL4294642,,False,http://www.openphacts.org/units/Nanomolar,3108367,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713198,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C3(C#N)CC3)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4279960,,CHEMBL4279960,,False,http://www.openphacts.org/units/Nanomolar,3108368,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713199,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(Nc3ccnc(C(F)(F)F)c3)nc(-n3ccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4278901,,CHEMBL4278901,,False,http://www.openphacts.org/units/Nanomolar,3108369,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713200,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CCC(F)(F)CC4)nc(-c4cncc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4294407,,CHEMBL4294407,,False,http://www.openphacts.org/units/Nanomolar,3108370,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713201,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(NC3CCC(F)(F)C3)nc(-c3cccc(C(F)(F)F)n3)n2)CC1,,,CHEMBL4257005,,,,CHEMBL4293370,,CHEMBL4293370,,False,http://www.openphacts.org/units/Nanomolar,3108371,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713202,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(N[C@@H]3CCC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4287914,,CHEMBL4287914,,False,http://www.openphacts.org/units/Nanomolar,3108374,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713203,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,C[C@@H](Nc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-n2ccc(C(F)(F)F)n2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4282949,,CHEMBL4282949,,False,http://www.openphacts.org/units/Nanomolar,3108375,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713204,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,N#CC1(c2cc(Nc3nc(NC4CC(F)(F)C4)nc(-c4cncc(C(F)(F)F)n4)n3)ccn2)CC1,,,CHEMBL4257005,,,,CHEMBL4281916,,CHEMBL4281916,,False,http://www.openphacts.org/units/Nanomolar,3108376,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713205,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1csc(-c2nc(NC3CCC(F)(F)C3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4282389,,CHEMBL4282389,,False,http://www.openphacts.org/units/Nanomolar,3108377,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713206,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1csc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4278630,,CHEMBL4278630,,False,http://www.openphacts.org/units/Nanomolar,3108378,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713207,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,CC(Nc1nc(NC(C)C(F)(F)F)nc(-c2nc(C(F)(F)F)cs2)n1)C(F)(F)F,,,CHEMBL4257005,,,,CHEMBL4281715,,CHEMBL4281715,,False,http://www.openphacts.org/units/Nanomolar,3108379,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713208,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CCC(Nc2nc(Nc3cncc(C(F)(F)F)c3)nc(-c3cccc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4282741,,CHEMBL4282741,,False,http://www.openphacts.org/units/Nanomolar,3108380,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713209,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@H](Nc2nc(N[C@H]3CCC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4286538,,CHEMBL4286538,,False,http://www.openphacts.org/units/Nanomolar,3108381,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713210,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)(F)c1cc(Nc2nc(NCC3CC3)nc(-n3ccc(C(F)(F)F)n3)n2)ccn1,,,CHEMBL4257005,,,,CHEMBL4291710,,CHEMBL4291710,,False,http://www.openphacts.org/units/Nanomolar,3108382,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713211,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1cncc(-c2nc(NC3CCC(F)(F)C3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4292069,,CHEMBL4292069,,False,http://www.openphacts.org/units/Nanomolar,3108383,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713212,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1cncc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4277241,,CHEMBL4277241,,False,http://www.openphacts.org/units/Nanomolar,3108384,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713213,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC1(F)CC[C@@H](Nc2nc(N[C@@H]3CCC(F)(F)C3)nc(-c3cncc(C(F)(F)F)n3)n2)C1,,,CHEMBL4257005,,,,CHEMBL4280571,,CHEMBL4280571,,False,http://www.openphacts.org/units/Nanomolar,3108385,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713214,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1ccnc(-c2nc(NC3CC(F)(F)C3)nc(NC3CC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4281625,,CHEMBL4281625,,False,http://www.openphacts.org/units/Nanomolar,3108386,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18713215,[],CHEMBL4257018,Inhibition of DH1 R132H mutant in human TS603 cells assessed as reduction in 2-HG formation incubated for 48 hrs by LC-MS method,B,BAO_0000190,BAO_0000219,cell-based format,FC(F)c1ccnc(-c2nc(NC3CCC(F)(F)C3)nc(NC3CCC(F)(F)C3)n2)n1,,,CHEMBL4257005,,,,CHEMBL4281482,,CHEMBL4281482,,False,http://www.openphacts.org/units/Nanomolar,3108387,<,38,True,<,,IC50,nM,,50.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,nM,UO_0000065,,50.0
,18722392,[],CHEMBL4258458,Inhibition of His-tagged recombinant human IDH1 R132H mutant expressed in Escherichia coli Rosetta (DE3) preincubated for 30 mins followed by NADPH/alpha-KG addition and measured after 1 hr,B,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1ccnc1C)c1cccc(F)c1,,,CHEMBL4257476,MedChemComm,2018.0,"{'bei': '15.34', 'le': '0.29', 'lle': '2.24', 'sei': '10.56'}",CHEMBL2180727,,CHEMBL2180727,7.10,False,http://www.openphacts.org/units/Nanomolar,3110506,=,1,True,=,,IC50,nM,,80.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,0.08
,18722393,[],CHEMBL4258458,Inhibition of His-tagged recombinant human IDH1 R132H mutant expressed in Escherichia coli Rosetta (DE3) preincubated for 30 mins followed by NADPH/alpha-KG addition and measured after 1 hr,B,BAO_0000190,BAO_0000019,assay format,Cc1cc(=O)c(O)c(Cc2ccccc2)o1,,,CHEMBL4257476,MedChemComm,2018.0,,CHEMBL4280797,,CHEMBL4280797,,False,http://www.openphacts.org/units/Nanomolar,3110507,>,1,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,50.0
,18722394,[],CHEMBL4258458,Inhibition of His-tagged recombinant human IDH1 R132H mutant expressed in Escherichia coli Rosetta (DE3) preincubated for 30 mins followed by NADPH/alpha-KG addition and measured after 1 hr,B,BAO_0000190,BAO_0000019,assay format,Cc1cc(=O)c(O)c(Cc2ccc(F)cc2)o1,,,CHEMBL4257476,MedChemComm,2018.0,,CHEMBL4280398,,CHEMBL4280398,,False,http://www.openphacts.org/units/Nanomolar,3110508,>,1,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,50.0
,18722395,[],CHEMBL4258458,Inhibition of His-tagged recombinant human IDH1 R132H mutant expressed in Escherichia coli Rosetta (DE3) preincubated for 30 mins followed by NADPH/alpha-KG addition and measured after 1 hr,B,BAO_0000190,BAO_0000019,assay format,Cc1cc(=O)c(O)c(Cc2ccc(Cl)cc2)o1,,,CHEMBL4257476,MedChemComm,2018.0,,CHEMBL4291032,,CHEMBL4291032,,False,http://www.openphacts.org/units/Nanomolar,3110509,>,1,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,50.0
,18722396,[],CHEMBL4258458,Inhibition of His-tagged recombinant human IDH1 R132H mutant expressed in Escherichia coli Rosetta (DE3) preincubated for 30 mins followed by NADPH/alpha-KG addition and measured after 1 hr,B,BAO_0000190,BAO_0000019,assay format,Cc1cc(=O)c(O)c(Cc2ccc(C(F)(F)F)cc2)o1,,,CHEMBL4257476,MedChemComm,2018.0,,CHEMBL4282653,,CHEMBL4282653,,False,http://www.openphacts.org/units/Nanomolar,3110510,>,1,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,50.0
,18722397,[],CHEMBL4258458,Inhibition of His-tagged recombinant human IDH1 R132H mutant expressed in Escherichia coli Rosetta (DE3) preincubated for 30 mins followed by NADPH/alpha-KG addition and measured after 1 hr,B,BAO_0000190,BAO_0000019,assay format,Cc1cc(=O)c(O)c(Cc2ccc(OCc3ccccc3)cc2)o1,,,CHEMBL4257476,MedChemComm,2018.0,,CHEMBL4293250,,CHEMBL4293250,,False,http://www.openphacts.org/units/Nanomolar,3110511,>,1,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,50.0
,18722398,[],CHEMBL4258458,Inhibition of His-tagged recombinant human IDH1 R132H mutant expressed in Escherichia coli Rosetta (DE3) preincubated for 30 mins followed by NADPH/alpha-KG addition and measured after 1 hr,B,BAO_0000190,BAO_0000019,assay format,Cc1cc(=O)c(O)c(C(c2ccc(OCc3ccccc3)cc2)c2oc(C)cc(=O)c2O)o1,,,CHEMBL4257476,MedChemComm,2018.0,"{'bei': '10.38', 'le': '0.19', 'lle': '0.26', 'sei': '4.21'}",CHEMBL4286032,,CHEMBL4286032,4.64,False,http://www.openphacts.org/units/Nanomolar,3110512,=,1,True,=,,IC50,nM,,23100.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,23.1
,18722399,[],CHEMBL4258458,Inhibition of His-tagged recombinant human IDH1 R132H mutant expressed in Escherichia coli Rosetta (DE3) preincubated for 30 mins followed by NADPH/alpha-KG addition and measured after 1 hr,B,BAO_0000190,BAO_0000019,assay format,COc1ccc(COc2ccc(C(c3oc(C)cc(=O)c3O)c3oc(C)cc(=O)c3O)cc2)cc1,,,CHEMBL4257476,MedChemComm,2018.0,"{'bei': '9.43', 'le': '0.18', 'lle': '0.10', 'sei': '3.77'}",CHEMBL4278116,,CHEMBL4278116,4.50,False,http://www.openphacts.org/units/Nanomolar,3110513,=,1,True,=,,IC50,nM,,32000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,32.0
,18722400,[],CHEMBL4258458,Inhibition of His-tagged recombinant human IDH1 R132H mutant expressed in Escherichia coli Rosetta (DE3) preincubated for 30 mins followed by NADPH/alpha-KG addition and measured after 1 hr,B,BAO_0000190,BAO_0000019,assay format,Cc1cc(=O)c(O)c(C(c2ccc(OCc3ccc([N+](=O)[O-])cc3)cc2)c2oc(C)cc(=O)c2O)o1,,,CHEMBL4257476,MedChemComm,2018.0,,CHEMBL4294325,,CHEMBL4294325,,False,http://www.openphacts.org/units/Nanomolar,3110514,>,1,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,50.0
,18722401,[],CHEMBL4258458,Inhibition of His-tagged recombinant human IDH1 R132H mutant expressed in Escherichia coli Rosetta (DE3) preincubated for 30 mins followed by NADPH/alpha-KG addition and measured after 1 hr,B,BAO_0000190,BAO_0000019,assay format,Cc1cc(=O)c(O)c(C(c2ccc(CCc3ccccc3)cc2)c2oc(C)cc(=O)c2O)o1,,,CHEMBL4257476,MedChemComm,2018.0,,CHEMBL4286444,,CHEMBL4286444,,False,http://www.openphacts.org/units/Nanomolar,3110515,>,1,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,50.0
,18722402,[],CHEMBL4258458,Inhibition of His-tagged recombinant human IDH1 R132H mutant expressed in Escherichia coli Rosetta (DE3) preincubated for 30 mins followed by NADPH/alpha-KG addition and measured after 1 hr,B,BAO_0000190,BAO_0000019,assay format,CCCOc1ccc(C(c2oc(C)cc(=O)c2O)c2oc(C)cc(=O)c2O)cc1,,,CHEMBL4257476,MedChemComm,2018.0,,CHEMBL4279183,,CHEMBL4279183,,False,http://www.openphacts.org/units/Nanomolar,3110516,>,1,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,50.0
,18722403,[],CHEMBL4258458,Inhibition of His-tagged recombinant human IDH1 R132H mutant expressed in Escherichia coli Rosetta (DE3) preincubated for 30 mins followed by NADPH/alpha-KG addition and measured after 1 hr,B,BAO_0000190,BAO_0000019,assay format,C=CCOc1ccc(C(c2oc(C)cc(=O)c2O)c2oc(C)cc(=O)c2O)cc1,,,CHEMBL4257476,MedChemComm,2018.0,,CHEMBL4289867,,CHEMBL4289867,,False,http://www.openphacts.org/units/Nanomolar,3110517,>,1,True,>,,IC50,nM,,50000.0,CHEMBL2007625,Homo sapiens,Isocitrate dehydrogenase [NADP] cytoplasmic,9606,,,IC50,uM,UO_0000065,,50.0
